Citrus Sinensis ID: 014911
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 416 | 2.2.26 [Sep-21-2011] | |||||||
| O65554 | 441 | CBL-interacting serine/th | yes | no | 0.963 | 0.909 | 0.771 | 0.0 | |
| Q9LWM4 | 461 | CBL-interacting protein k | yes | no | 0.978 | 0.882 | 0.613 | 1e-158 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.949 | 0.899 | 0.617 | 1e-150 | |
| Q6Z9F4 | 451 | CBL-interacting protein k | no | no | 0.951 | 0.878 | 0.632 | 1e-147 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.951 | 0.866 | 0.600 | 1e-146 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.949 | 0.891 | 0.584 | 1e-144 | |
| Q9SN43 | 489 | CBL-interacting serine/th | no | no | 0.951 | 0.809 | 0.562 | 1e-143 | |
| Q9FJ55 | 483 | CBL-interacting serine/th | no | no | 0.942 | 0.811 | 0.553 | 1e-138 | |
| Q6ERS0 | 404 | Putative CBL-interacting | no | no | 0.894 | 0.920 | 0.569 | 1e-137 | |
| Q9C562 | 479 | CBL-interacting serine/th | no | no | 0.944 | 0.820 | 0.541 | 1e-136 |
| >sp|O65554|CIPK6_ARATH CBL-interacting serine/threonine-protein kinase 6 OS=Arabidopsis thaliana GN=CIPK6 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/411 (77%), Positives = 367/411 (89%), Gaps = 10/411 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARN+QTGKS+AMKVVGK+KV+KVGM++QIKREISVM+MVKH +IVELH
Sbjct: 29 LLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKHPNIVELH 88
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF K+AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK
Sbjct: 89 EVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 148
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+GNLKVTDFGLSAF+EHLKQDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+W
Sbjct: 149 PENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGYDGAKADLW 208
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VLLAG+LPFQDDN+V+MYRKIYRGDFKCP W SS+ARRL+TKLLDPNPN+RI
Sbjct: 209 SCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLDPNPNTRIT 268
Query: 241 ISKIMESSWFKKSAPK---------VVITKQEMEFEADKSSKQPETLNAFHIISLSEGFD 291
I K+M+S WFKK A + + T+++++F KS ++ ETLNAFHII+LSEGFD
Sbjct: 269 IEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEETETLNAFHIIALSEGFD 328
Query: 292 LSPLFEEKKRAEREELRFATTRPASSVISRFEEVAK-AVKFNVKTSESRVRLQGQESGRK 350
LSPLFEEKK+ E+ E+RFAT+RPASSVIS EE A+ KF+V+ SESRVR++G+++GRK
Sbjct: 329 LSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGNKFDVRKSESRVRIEGKQNGRK 388
Query: 351 GKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMST 401
GKLA+ A+IFAV PS +VVEVKKD+GDTLEYN FCS LRPALKDI W ST
Sbjct: 389 GKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPALKDIFWTST 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 557 bits (1435), Expect = e-158, Method: Compositional matrix adjust.
Identities = 263/429 (61%), Positives = 335/429 (78%), Gaps = 22/429 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
MLG GTFAKVY ARNL + +S+A+KV+ K+KV++VGM++QIKREIS+M++V+H +IV+LH
Sbjct: 17 MLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKREISIMRLVRHPNIVQLH 76
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+ V+GGELF+++A+GRL+ED AR YFQQLI AVDFCHSRGVYHRDLK
Sbjct: 77 EVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIGAVDFCHSRGVYHRDLK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLL+DE+GNLKV+DFGLSAF E KQDGLLHTTCGTPAYVAPE+I+K+GYDGAKADIW
Sbjct: 137 PENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAPEIINKRGYDGAKADIW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VLLAG+LPF D N++ MYRKI +GD K P WF+++ RRL+++LLDPNPN RI
Sbjct: 197 SCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVRRLLSRLLDPNPNIRIT 256
Query: 241 ISKIMESSWFKKSAPKVVITKQEME----------FEADK-----------SSKQPETLN 279
+ K++E WFKK V+ Q E F AD SS +P +LN
Sbjct: 257 VEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNEGKAKEPASSLKPVSLN 316
Query: 280 AFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESR 339
AF IISLS+GFDLS LFE K ++ + RF T +PAS+++S+ E++A+ F VK +
Sbjct: 317 AFDIISLSKGFDLSGLFENDKE-QKADSRFMTQKPASAIVSKLEQIAETESFKVKKQDGL 375
Query: 340 VRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWM 399
V+LQG + GRKG+LAI+A+IF VTPS VVEVKK GDTLEY +FC+ LRP+L+DI W
Sbjct: 376 VKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEYEKFCNKGLRPSLRDICWD 435
Query: 400 STADNPTLG 408
+++P+L
Sbjct: 436 GQSEHPSLA 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 252/408 (61%), Positives = 322/408 (78%), Gaps = 13/408 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY ARN++TG+S+A+KV+ K KV KVG+++QIKREISVM++V+H H+V LH
Sbjct: 17 LLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHPHVVFLH 76
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASK+KIYFAM+ VKGGELF+K++KG+L+E++AR YFQQLI A+D+CHSRGVYHRDLK
Sbjct: 77 EVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYCHSRGVYHRDLK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+G+LK++DFGLSA E +QDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+W
Sbjct: 137 PENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADVW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGV+LYVLLAGFLPF + N+V MYRKI +G+FKCP WF E ++L++++LDPNPNSRI
Sbjct: 197 SCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDPNPNSRIK 256
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADK--------SSKQPETLNAFHII-SLSEGFD 291
I KIME+SWF+K K+ K + D S +P + NAF +I SLS+GFD
Sbjct: 257 IEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMSYNAFDLISSLSQGFD 316
Query: 292 LSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAV-KFNVKTSESRVRLQGQESGRK 350
LS LFE + ER E +F T + A ++S+FEE+A + +FN+ S+ V+++ + GRK
Sbjct: 317 LSGLFE---KEERSESKFTTKKDAKEIVSKFEEIATSSERFNLTKSDVGVKMEDKREGRK 373
Query: 351 GKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVW 398
G LAI+ +IF VT S +VE KK GDT+EY QFC ELRP+LKDIVW
Sbjct: 374 GHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKDIVW 421
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6Z9F4|CIPK6_ORYSJ CBL-interacting protein kinase 6 OS=Oryza sativa subsp. japonica GN=CIPK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1346), Expect = e-147, Method: Compositional matrix adjust.
Identities = 262/414 (63%), Positives = 326/414 (78%), Gaps = 18/414 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHG F +V++AR+L+TG+S+A+KVV K+KV++ GMMEQIKREI+VMK V H +IVELH
Sbjct: 28 VLGHGNFGRVHVARDLRTGRSVAVKVVAKEKVVRAGMMEQIKREIAVMKRVSHPNIVELH 87
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
EVMA++SKIY A++LV+GGELF +I + GR+RED AR YF+QL+SAVDFCHSRGVYHRDL
Sbjct: 88 EVMATRSKIYLALELVRGGELFGRIVRLGRVREDAARHYFRQLVSAVDFCHSRGVYHRDL 147
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KPENLLLDE GNLKV DFGLSA ++H + DGLLHT CGTP Y APEV+ KGYDGAKAD+
Sbjct: 148 KPENLLLDEAGNLKVVDFGLSALADHARADGLLHTLCGTPGYAAPEVLRDKGYDGAKADL 207
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
WSCGVILYVLLAG LPF DDNIV++YRK RGD++CP W S++ARRLI +LLDPNP +RI
Sbjct: 208 WSCGVILYVLLAGSLPFPDDNIVTLYRKAQRGDYRCPAWLSTDARRLIPRLLDPNPTTRI 267
Query: 240 AISKIMESSWFKKSAPKVVITKQ---------EMEFEADKSSKQPETLNAFHIISLSEGF 290
++++++E+ WFKK++ ++ + + EA+K +PETLNAFH+ISLSEGF
Sbjct: 268 SVAQLVETPWFKKTSISRPVSIELPPAFADPAPAKEEAEKD--EPETLNAFHLISLSEGF 325
Query: 291 DLSPLFEEKKRAEREE--LRFATTRPASSVISRFEEVAK--AVKFNVKTSESR-VRLQGQ 345
DLSPLFE R + + FAT PAS VISR E VA + V S +R VRL+G
Sbjct: 326 DLSPLFEGDSAKGRRDGGMLFATREPASGVISRLEGVAARGGGRMRVTKSGARGVRLEGA 385
Query: 346 E-SGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVW 398
E G KG+LA+ ADIF+V PS+LVV+VKKD GDTLEY FCS ELRPAL+DIVW
Sbjct: 386 ERGGAKGRLAVAADIFSVAPSVLVVDVKKDGGDTLEYRSFCSEELRPALQDIVW 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 519 bits (1337), Expect = e-146, Method: Compositional matrix adjust.
Identities = 254/423 (60%), Positives = 322/423 (76%), Gaps = 27/423 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY RN+ T +S+A+KV+ KDK+ KVG+M+QIKREISVMK+V+H +IV+L+
Sbjct: 20 LLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKREISVMKLVRHPNIVQLY 79
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+KSKIYF ++ VKGGELFNK+AKGRL+ED AR YFQQL+SAVDFCHSRGVYHRDLK
Sbjct: 80 EVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVSAVDFCHSRGVYHRDLK 139
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLL+DE+GNLK+TDFGLSA +E +QDGLLHTTCGTPAYVAPEVIS+KGYDG K D W
Sbjct: 140 PENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAPEVISRKGYDGVKVDTW 199
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AG+LPFQD N++ MYRKI + +FKCP WFSS+ R+L++++LDPNP SR+
Sbjct: 200 SCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVRKLVSRILDPNPRSRMP 259
Query: 241 ISKIMESSWFKKSAPKVVITKQ------------------------EMEFEADKSSKQPE 276
I+KIME+ WFKK +I K + E + + +
Sbjct: 260 ITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGSSSSKKTEEKQDAGKLT 319
Query: 277 TLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTS 336
LNAF IISLSEGFDLS LFEE + ++E RF +++ AS++IS+ E+VA K VK
Sbjct: 320 NLNAFDIISLSEGFDLSGLFEETDK--KKEARFTSSQSASAIISKLEDVASCSKLTVKKK 377
Query: 337 ESRV-RLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKD 395
E V +++G GRKG LAI+A+IF VTPS +VE+KK+NGDTLEY +++PALKD
Sbjct: 378 EGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLEYQHLWKEDMKPALKD 437
Query: 396 IVW 398
IVW
Sbjct: 438 IVW 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 512 bits (1319), Expect = e-144, Method: Compositional matrix adjust.
Identities = 242/414 (58%), Positives = 326/414 (78%), Gaps = 19/414 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY ARN +T +S+A+K++ K+KV+K G+M+QIKREISVMK+V+H +IV+L+
Sbjct: 18 LLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKREISVMKLVRHPNIVQLY 77
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K+KIYF ++ VKGGELFNK+ +GRL+ED AR YFQQLI AVDFCHSRGVYHRDLK
Sbjct: 78 EVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICAVDFCHSRGVYHRDLK 137
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPEVI+++GYDGAKADIW
Sbjct: 138 PENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRRGYDGAKADIW 197
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VLLAG+LPF D N++ MY+KI + +FKCP WF+++ RRL+ ++LDPNP++RI+
Sbjct: 198 SCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRRLLLRILDPNPSTRIS 257
Query: 241 ISKIMESSWFKKS----------APKVVI-TKQEMEFEADKSS----KQPETLNAFHIIS 285
+ KIME+ WF+K PK I +F++ S+ K+P LNAF IIS
Sbjct: 258 MDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSAPTLEKKPSNLNAFDIIS 317
Query: 286 LSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNV-KTSESRVRLQG 344
LS G DLS +FEE ++++E +F +T AS++IS+ E++AK ++ + K ++++G
Sbjct: 318 LSTGLDLSGMFEE---SDKKESKFTSTSTASTIISKIEDIAKGLRLKLTKKDGGLLKMEG 374
Query: 345 QESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVW 398
+ GRKG + I+A+IF VTP+ +VE+KK NGDTLEY + + E+RPALKDIVW
Sbjct: 375 SKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKVLNQEMRPALKDIVW 428
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SN43|CIPKC_ARATH CBL-interacting serine/threonine-protein kinase 12 OS=Arabidopsis thaliana GN=CIPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1305), Expect = e-143, Method: Compositional matrix adjust.
Identities = 246/437 (56%), Positives = 321/437 (73%), Gaps = 41/437 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVYLARN++T +S+A+KV+ K+KV+K G++ IKREIS+++ V+H +IV+L
Sbjct: 31 LLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRRVRHPNIVQLF 90
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K+KIYF M+ V+GGELFNK+AKGRL+E+VAR YFQQLISAV FCH+RGVYHRDLK
Sbjct: 91 EVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCHARGVYHRDLK 150
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+GNLKV+DFGLSA S+ ++QDGL HT CGTPAYVAPEV+++KGYD AK DIW
Sbjct: 151 PENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKGYDAAKVDIW 210
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AG+LPF D N+++MY+KIYRG+F+CP WFS+E RL++KLL+ NP R
Sbjct: 211 SCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKLLETNPEKRFT 270
Query: 241 ISKIMESSWFKKSAPKV-----------VITKQEME---FEADKSSK------------- 273
+IME+SWFKK + V+ E+E E+D+ S
Sbjct: 271 FPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAASESEIEYLEPRR 330
Query: 274 ------QPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAK 327
+P +LNAF IIS S+GFDLS LF++ + E RF + P S +IS+ EE+AK
Sbjct: 331 RVGGLPRPASLNAFDIISFSQGFDLSGLFDD----DGEGSRFVSGAPVSKIISKLEEIAK 386
Query: 328 AVKFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSN 387
V F V+ + RV L+G G KG L I A+IF +TPSL+VVEVKK GD EY FC+N
Sbjct: 387 VVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGGDKTEYEDFCNN 446
Query: 388 ELRPALKDIVWMSTADN 404
EL+P L+++ TAD+
Sbjct: 447 ELKPKLQNL----TADD 459
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ55|CIPKJ_ARATH CBL-interacting serine/threonine-protein kinase 19 OS=Arabidopsis thaliana GN=CIPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 239/432 (55%), Positives = 312/432 (72%), Gaps = 40/432 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVYLARN Q+G+S+A+KV+ K+KV+K G++ IKREIS+++ V+H +IV+L
Sbjct: 33 LLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRRVRHPNIVQLF 92
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+KSKIYF M+ VKGGELFNK+AKGRL+E++AR YFQQLISAV FCH RGVYHRDLK
Sbjct: 93 EVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAVSFCHFRGVYHRDLK 152
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+GNLKV+DFGLSA S+ ++QDGL HT CGTPAYVAPEV+++KGYDGAK DIW
Sbjct: 153 PENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKGYDGAKVDIW 212
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AGFLPF D N+++MY+KIYRGDF+CP WF E RL+ ++L+ P R
Sbjct: 213 SCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRMLETKPERRFT 272
Query: 241 ISKIMESSWFKKSAPKV------------VITKQEME-----------------FEA--- 268
+ IME+SWFKK + V E+E FE+
Sbjct: 273 MPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRSSTVSEPEDFESFDG 332
Query: 269 ---DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEV 325
S +P +LNAF +IS S GFDLS LFE+ + E RF + P +IS+ EE+
Sbjct: 333 RRRGGSMPRPASLNAFDLISFSPGFDLSGLFED----DGEGSRFVSGAPVGQIISKLEEI 388
Query: 326 AKAVKFNVKTSESRVRLQGQESGR-KGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQF 384
A+ V F V+ + +V L+G G KG L+I A+IF +TP+L+VVEVKK GD +EY++F
Sbjct: 389 ARIVSFTVRKKDCKVSLEGSREGSMKGPLSIAAEIFELTPALVVVEVKKKGGDKMEYDEF 448
Query: 385 CSNELRPALKDI 396
C+ EL+P L+++
Sbjct: 449 CNKELKPKLQNL 460
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ERS0|CIPKR_ORYSJ Putative CBL-interacting protein kinase 27 OS=Oryza sativa subsp. japonica GN=CIPK27 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 238/418 (56%), Positives = 295/418 (70%), Gaps = 46/418 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHG F +V+ AR+++TG+++AMKVV KDKV + GM EQIKREI+VMKMV H +VELH
Sbjct: 16 VLGHGNFGRVHAARDVRTGRAVAMKVVSKDKVERAGMAEQIKREIAVMKMVSHPSVVELH 75
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
EVMA+++K+Y A++LV+GGELF++IA+ GR+ E VAR YF+QL+SAVDFCH RGVYHRDL
Sbjct: 76 EVMATRTKVYLALELVRGGELFDRIARHGRVGEGVARRYFRQLVSAVDFCHGRGVYHRDL 135
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KPENLLLDE GNLKV DFGLSA + H + DGLLHT CGTPAYVAPEV++ GYDGAKAD+
Sbjct: 136 KPENLLLDEAGNLKVADFGLSALACHARPDGLLHTACGTPAYVAPEVLAGNGYDGAKADL 195
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
WSCGVILYVLLAG LPFQDDN+V MYRK+ RGDF CPPW +++AR+LI LLDPNP +RI
Sbjct: 196 WSCGVILYVLLAGALPFQDDNLVCMYRKMRRGDFCCPPWVTTDARKLIKSLLDPNPGTRI 255
Query: 240 AISKIMESSWFKKSAP---KVVITKQEMEFE-----ADKSSKQPETLNAFHIISLSEGFD 291
++ ++E+ WF+K+AP ++ + D + PE LNAFH+ISLSEGFD
Sbjct: 256 TVAGLLETPWFRKTAPVPRPIIADPAAAPVDTRGNAGDDKDEPPEVLNAFHLISLSEGFD 315
Query: 292 LSPLFEE-------KKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQG 344
LSPLFE + A RFAT AS V++R E +A + G
Sbjct: 316 LSPLFEHDPAASPGRATARAGGTRFATREAASGVVARLEALA---------------MGG 360
Query: 345 QESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTA 402
V PSLL+V+VKKD GD +EY F S ELRPALKDIVW A
Sbjct: 361 AR---------------VAPSLLMVDVKKDGGDAMEYRPFFSEELRPALKDIVWSPAA 403
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 236/436 (54%), Positives = 321/436 (73%), Gaps = 43/436 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY R++ T +S+A+K++ K+KV+KVG++EQIKREISVM++ +H ++VEL+
Sbjct: 17 LLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREISVMRIARHPNVVELY 76
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K++IYF M+ KGGELFNK+AKG+LR+DVA YF QLI+AVDFCHSR VYHRD+K
Sbjct: 77 EVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAVDFCHSREVYHRDIK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD++ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPEVI++KGYDG KADIW
Sbjct: 137 PENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYDGTKADIW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGV+L+VLLAG+LPF D N++ MYRKI + DFK P WF+ E RRL+ K+LDPNP +RI
Sbjct: 197 SCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRLLCKMLDPNPETRIT 256
Query: 241 ISKIMESSWFKKSAPKVVITKQEME--------FEA------------------------ 268
I++I ESSWF+K + + +++ME EA
Sbjct: 257 IARIRESSWFRKG---LHMKQKKMEKRVKEINSVEAGTAGTNENGAGPSENGAGPSENGD 313
Query: 269 ----DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEE 324
+ + +P LNAF +I+LS GFDL+ LF + + E RF + +PAS +IS+ EE
Sbjct: 314 RVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNKRES---RFTSQKPASVIISKLEE 370
Query: 325 VAKAVKFNVKTSESRV-RLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQ 383
VA+ +K +++ E+ + +L+ + GRKG L+++A+IF VTP+ +VEVKK NGDTLEY +
Sbjct: 371 VAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVKKSNGDTLEYQK 430
Query: 384 FCSNELRPALKDIVWM 399
+ +LRPAL DIVW+
Sbjct: 431 LVAEDLRPALSDIVWV 446
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 416 | ||||||
| 224091733 | 437 | predicted protein [Populus trichocarpa] | 0.978 | 0.931 | 0.856 | 0.0 | |
| 255586705 | 432 | CBL-interacting serine/threonine-protein | 0.978 | 0.942 | 0.873 | 0.0 | |
| 449457907 | 430 | PREDICTED: CBL-interacting serine/threon | 0.971 | 0.939 | 0.869 | 0.0 | |
| 449503175 | 430 | PREDICTED: CBL-interacting serine/threon | 0.971 | 0.939 | 0.866 | 0.0 | |
| 224104503 | 439 | predicted protein [Populus trichocarpa] | 0.978 | 0.927 | 0.846 | 0.0 | |
| 118488669 | 393 | unknown [Populus trichocarpa] | 0.923 | 0.977 | 0.857 | 0.0 | |
| 225445621 | 426 | PREDICTED: CBL-interacting serine/threon | 0.963 | 0.941 | 0.846 | 0.0 | |
| 166788445 | 438 | protein kinase [Phaseolus vulgaris] | 0.973 | 0.924 | 0.822 | 0.0 | |
| 449442979 | 433 | PREDICTED: CBL-interacting serine/threon | 0.975 | 0.937 | 0.828 | 0.0 | |
| 356500647 | 430 | PREDICTED: CBL-interacting serine/threon | 0.961 | 0.930 | 0.789 | 0.0 |
| >gi|224091733|ref|XP_002309336.1| predicted protein [Populus trichocarpa] gi|116265936|gb|ABJ91216.1| CBL-interacting protein kinase 9 [Populus trichocarpa] gi|222855312|gb|EEE92859.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/417 (85%), Positives = 383/417 (91%), Gaps = 10/417 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNLQ+GKS+AMKVVGK+KVIKVGMMEQ+KREISVMKMV+H HIVEL+
Sbjct: 22 LLGHGTFAKVYHARNLQSGKSVAMKVVGKEKVIKVGMMEQVKREISVMKMVRHPHIVELN 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF+KIAKGRLREDVARVYFQQLISA+DFCHSRGVYHRDLK
Sbjct: 82 EVMASKSKIYFAMELVRGGELFSKIAKGRLREDVARVYFQQLISAIDFCHSRGVYHRDLK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDEDG LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+W
Sbjct: 142 PENLLLDEDGKLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADLW 201
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKCP WFSSEARRLITKLLDPNP++RI
Sbjct: 202 SCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKCPQWFSSEARRLITKLLDPNPSTRIT 261
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEA---------DKSSKQPETLNAFHIISLSEGFD 291
SK+M+S+WFKKS PK V +K+EMEFEA DK +KQPETLNAFHIISLS+GFD
Sbjct: 262 TSKVMDSTWFKKSLPKTVRSKEEMEFEAFNGEEDANGDK-AKQPETLNAFHIISLSQGFD 320
Query: 292 LSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKG 351
LSPLFEEK R +EELRFATTRPASSVISR EEVAKA FNVK S+S+VRLQGQE GRKG
Sbjct: 321 LSPLFEEKTREGKEELRFATTRPASSVISRLEEVAKAGNFNVKKSDSKVRLQGQERGRKG 380
Query: 352 KLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNPTLG 408
KLAI ADIFAVTPS LVVEVKKDNGDTLEYNQFCSNELRPALKDIVW S A+N TL
Sbjct: 381 KLAIAADIFAVTPSFLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWTSPAENSTLA 437
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586705|ref|XP_002533977.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223526040|gb|EEF28408.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/411 (87%), Positives = 385/411 (93%), Gaps = 4/411 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY RNLQTGKS+AMKVVGK+KVIKVGMMEQ+KREI+VMKMVKH +IVELH
Sbjct: 23 LLGHGTFAKVYHGRNLQTGKSVAMKVVGKEKVIKVGMMEQVKREIAVMKMVKHPNIVELH 82
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF+KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK
Sbjct: 83 EVMASKSKIYFAMELVRGGELFSKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 142
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDEDGNLKVTDFGLSAF+EHLKQDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+W
Sbjct: 143 PENLLLDEDGNLKVTDFGLSAFAEHLKQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADLW 202
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKCPPWFSSEARRLITKLLDPNP +RI
Sbjct: 203 SCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPATRIT 262
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEA---DKSSKQPETLNAFHIISLSEGFDLSPLFE 297
ISKIM+SSW KKS PK V +K+EMEF+A DK SKQPETLNAFHIISLSEGFDLSPLFE
Sbjct: 263 ISKIMDSSWIKKSVPKTVTSKEEMEFDAFNGDK-SKQPETLNAFHIISLSEGFDLSPLFE 321
Query: 298 EKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINA 357
EKKR E+EELRFATTRPASSVIS EEVAKA KF+VK SE++VR+QGQESGRKGKLAI A
Sbjct: 322 EKKREEKEELRFATTRPASSVISTLEEVAKAGKFSVKKSETKVRMQGQESGRKGKLAIAA 381
Query: 358 DIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNPTLG 408
+IFAVTP+ LVVEVKKDNGDTLEYNQFCS ELRPALKDI+W S ADN T+
Sbjct: 382 EIFAVTPAFLVVEVKKDNGDTLEYNQFCSKELRPALKDILWTSPADNSTIA 432
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457907|ref|XP_004146689.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/405 (86%), Positives = 380/405 (93%), Gaps = 1/405 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNLQ+G SMAMKVVGK+KVIKVGMMEQIKREISVMKMVKH +IVELH
Sbjct: 22 LLGHGTFAKVYHARNLQSGTSMAMKVVGKEKVIKVGMMEQIKREISVMKMVKHPNIVELH 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF+KI+KGRLREDVARVYFQQLISA+DFCHSRGVYHRDLK
Sbjct: 82 EVMASKSKIYFAMELVRGGELFSKISKGRLREDVARVYFQQLISAIDFCHSRGVYHRDLK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD+DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI KKGY+GAKAD+W
Sbjct: 142 PENLLLDDDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIGKKGYNGAKADLW 201
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS EARRL+TKLLDPNPN+RI
Sbjct: 202 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSPEARRLVTKLLDPNPNTRIP 261
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEF-EADKSSKQPETLNAFHIISLSEGFDLSPLFEEK 299
SKIMESSWF+KS PK V+TK+E EF E+++ KQ ETLNAFHIISLSEGFDLSPLFEEK
Sbjct: 262 TSKIMESSWFRKSIPKTVVTKEEQEFIESNEKLKQSETLNAFHIISLSEGFDLSPLFEEK 321
Query: 300 KRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINADI 359
KR E+EELRFATTRPASSVIS+ EEVAKA KF+VK SESRVRLQGQE GRKGKL++ A+I
Sbjct: 322 KREEKEELRFATTRPASSVISKLEEVAKAGKFSVKKSESRVRLQGQECGRKGKLSVAAEI 381
Query: 360 FAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADN 404
FAVTPS LVVEVKKD+GDTLEYNQFCS ELRPALKDIVW S +N
Sbjct: 382 FAVTPSFLVVEVKKDHGDTLEYNQFCSKELRPALKDIVWTSPTEN 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503175|ref|XP_004161871.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/405 (86%), Positives = 380/405 (93%), Gaps = 1/405 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNLQ+G SMAMKVVGK+KVIKVGMMEQ+KREISVMKMVKH +IVELH
Sbjct: 22 LLGHGTFAKVYHARNLQSGTSMAMKVVGKEKVIKVGMMEQVKREISVMKMVKHPNIVELH 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF+KI+KGRLREDVARVYFQQLISA+DFCHSRGVYHRDLK
Sbjct: 82 EVMASKSKIYFAMELVRGGELFSKISKGRLREDVARVYFQQLISAIDFCHSRGVYHRDLK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD+DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI KKGY+GAKAD+W
Sbjct: 142 PENLLLDDDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIGKKGYNGAKADLW 201
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS EARRL+TKLLDPNPN+RI
Sbjct: 202 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSPEARRLVTKLLDPNPNTRIP 261
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEF-EADKSSKQPETLNAFHIISLSEGFDLSPLFEEK 299
SKIMESSWF+KS PK V+TK+E EF E+++ KQ ETLNAFHIISLSEGFDLSPLFEEK
Sbjct: 262 TSKIMESSWFRKSIPKTVVTKEEQEFIESNEKLKQSETLNAFHIISLSEGFDLSPLFEEK 321
Query: 300 KRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINADI 359
KR E+EELRFATTRPASSVIS+ EEVAKA KF+VK SESRVRLQGQE GRKGKL++ A+I
Sbjct: 322 KREEKEELRFATTRPASSVISKLEEVAKAGKFSVKKSESRVRLQGQECGRKGKLSVAAEI 381
Query: 360 FAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADN 404
FAVTPS LVVEVKKD+GDTLEYNQFCS ELRPALKDIVW S +N
Sbjct: 382 FAVTPSFLVVEVKKDHGDTLEYNQFCSKELRPALKDIVWTSPTEN 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104503|ref|XP_002333931.1| predicted protein [Populus trichocarpa] gi|224142403|ref|XP_002324548.1| predicted protein [Populus trichocarpa] gi|116265932|gb|ABJ91214.1| CBL-interacting protein kinase 7 [Populus trichocarpa] gi|116265934|gb|ABJ91215.1| CBL-interacting protein kinase 8 [Populus trichocarpa] gi|222839165|gb|EEE77516.1| predicted protein [Populus trichocarpa] gi|222865982|gb|EEF03113.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/417 (84%), Positives = 383/417 (91%), Gaps = 10/417 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNLQ+GKS+AMKVVGK+KVIKVGMMEQIKREISVMKMVKH +IVELH
Sbjct: 22 LLGHGTFAKVYHARNLQSGKSVAMKVVGKEKVIKVGMMEQIKREISVMKMVKHPNIVELH 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF+KI KGRLREDVARVYFQQLISA+DFCHSRGVYHRDLK
Sbjct: 82 EVMASKSKIYFAMELVRGGELFSKIEKGRLREDVARVYFQQLISAIDFCHSRGVYHRDLK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+G LKVTDFGLSAF+EHLKQDGLLHTTCGTPAYVAPEVI K+GYDGAKAD+W
Sbjct: 142 PENLLLDENGKLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVIGKQGYDGAKADLW 201
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKCPPWFSSEARRLITKLLDPNP++RI
Sbjct: 202 SCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPSTRIT 261
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEA---------DKSSKQPETLNAFHIISLSEGFD 291
ISK+M+S+WFKKS PK V +K+EMEFEA DK SKQ ETLNAFHIISLS+GFD
Sbjct: 262 ISKVMDSTWFKKSVPKTVKSKEEMEFEAFNGDEDANGDK-SKQLETLNAFHIISLSQGFD 320
Query: 292 LSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKG 351
LSPLFEE+KR E+EELRFATTRPASSVISR EEV KA F+VK S+S+VRLQGQE GRKG
Sbjct: 321 LSPLFEERKREEKEELRFATTRPASSVISRLEEVGKAGNFSVKKSDSKVRLQGQERGRKG 380
Query: 352 KLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNPTLG 408
KLAI ADIFAVTPS LVVEVKKDNGDTLE+NQFCS LRPALKDIVW+S A+N TL
Sbjct: 381 KLAIAADIFAVTPSFLVVEVKKDNGDTLEFNQFCSKALRPALKDIVWISPAENSTLA 437
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118488669|gb|ABK96146.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/394 (85%), Positives = 361/394 (91%), Gaps = 10/394 (2%)
Query: 24 MKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFN 83
MKVVGK+KVIKVGMMEQ+KREISVMKMV+H HIVEL+EVMASKSKIYFAM+LV+GGELF+
Sbjct: 1 MKVVGKEKVIKVGMMEQVKREISVMKMVRHPHIVELNEVMASKSKIYFAMELVRGGELFS 60
Query: 84 KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 143
KIAKGRLREDVARVYFQQLISA+DFCHSRGVYHRDLKPENLLLDEDG LKVTDFGLSAFS
Sbjct: 61 KIAKGRLREDVARVYFQQLISAIDFCHSRGVYHRDLKPENLLLDEDGKLKVTDFGLSAFS 120
Query: 144 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS 203
EHLKQDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+WSCGVILYVLLAGFLPFQDDNIV+
Sbjct: 121 EHLKQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADLWSCGVILYVLLAGFLPFQDDNIVA 180
Query: 204 MYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 263
MYRKIYRGDFKCP WFSSEARRLITKLLDPNP++RI SK+M+S+WFKKS PK V +K+E
Sbjct: 181 MYRKIYRGDFKCPQWFSSEARRLITKLLDPNPSTRITTSKVMDSTWFKKSLPKTVRSKEE 240
Query: 264 MEFEA---------DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRP 314
MEFEA DK +KQPETLNAFHIISLS+GFDLSPLFEEK R +EELRFATTRP
Sbjct: 241 MEFEAFNGEEDANGDK-AKQPETLNAFHIISLSQGFDLSPLFEEKTREGKEELRFATTRP 299
Query: 315 ASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKD 374
ASSVISR EEVAKA FNVK S+S+VRLQGQE GRKGKLAI ADIFAVTPS LVVEVKKD
Sbjct: 300 ASSVISRLEEVAKAGNFNVKKSDSKVRLQGQERGRKGKLAIAADIFAVTPSFLVVEVKKD 359
Query: 375 NGDTLEYNQFCSNELRPALKDIVWMSTADNPTLG 408
NGDTLEYNQFCSNELRPALKDIVW S A+N TL
Sbjct: 360 NGDTLEYNQFCSNELRPALKDIVWTSPAENSTLA 393
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225445621|ref|XP_002262667.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6 [Vitis vinifera] gi|147782993|emb|CAN68670.1| hypothetical protein VITISV_026919 [Vitis vinifera] gi|229609807|gb|ACQ83519.1| CBL-interacting protein kinase 03 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/403 (84%), Positives = 373/403 (92%), Gaps = 2/403 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNLQTGKS+AMKVVGKDKVIKVGM EQ+KREISVMKMV+H +IVELH
Sbjct: 22 LLGHGTFAKVYHARNLQTGKSVAMKVVGKDKVIKVGMTEQVKREISVMKMVQHPNIVELH 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF+KI+KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK
Sbjct: 82 EVMASKSKIYFAMELVRGGELFSKISKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE GNLKVTDFGLSA SEHLKQDGLLHTTCGTPAYVAPEVI K GYDGAKAD+W
Sbjct: 142 PENLLLDESGNLKVTDFGLSALSEHLKQDGLLHTTCGTPAYVAPEVIGKNGYDGAKADLW 201
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKCPPWFS E+RRL+TKLLDP PN+RI
Sbjct: 202 SCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKCPPWFSPESRRLVTKLLDPTPNTRIT 261
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKS--SKQPETLNAFHIISLSEGFDLSPLFEE 298
I+KI+ESSWFKKS PK ++TK+E EFE+ +KQPETLNAFHIISLSEGFDLSPLFEE
Sbjct: 262 IAKIVESSWFKKSVPKTILTKEEQEFESFNCGKAKQPETLNAFHIISLSEGFDLSPLFEE 321
Query: 299 KKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINAD 358
KKR ++EELRFATT+PASSVIS+ EEVAKA KF+VK SE+ VRLQGQE GRKGKLAI A+
Sbjct: 322 KKREQKEELRFATTQPASSVISKLEEVAKAGKFSVKKSETIVRLQGQERGRKGKLAIGAE 381
Query: 359 IFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMST 401
IFAV PS LVVEVKK +GD+LEY+QFC+ ELRPALKDIVW ST
Sbjct: 382 IFAVAPSFLVVEVKKHHGDSLEYDQFCNKELRPALKDIVWTST 424
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|166788445|dbj|BAG06678.1| protein kinase [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/412 (82%), Positives = 374/412 (90%), Gaps = 7/412 (1%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNL++GKS+AMKVVGK+KV+KVGMMEQIKREIS M MVKH IV+LH
Sbjct: 26 LLGHGTFAKVYHARNLKSGKSVAMKVVGKEKVMKVGMMEQIKREISAMNMVKHPSIVQLH 85
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIY AM+LV+GGELFNKIA+GRLRE+ AR+YFQQL+SAVDFCHSRGVYHRDLK
Sbjct: 86 EVMASKSKIYIAMELVRGGELFNKIARGRLREETARLYFQQLVSAVDFCHSRGVYHRDLK 145
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDEDGNLKVTDFGLS FSEHL+QDGLLHTTCGTPAYVAPEVI KKGYDGAKADIW
Sbjct: 146 PENLLLDEDGNLKVTDFGLSTFSEHLRQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADIW 205
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDN+V++Y+KIYRGDFKCPPWFSSEARRLITKLLDPNPN+RI
Sbjct: 206 SCGVILYVLLAGFLPFQDDNLVALYKKIYRGDFKCPPWFSSEARRLITKLLDPNPNNRIT 265
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPE-----TLNAFHIISLSEGFDLSPL 295
ISKIMESSWFKK+ PK V+ + E + ++ KQ E T+NAFHIISLSEGFDLSPL
Sbjct: 266 ISKIMESSWFKKAVPKNVMGVKREELDLEEKIKQQEECKSSTMNAFHIISLSEGFDLSPL 325
Query: 296 FEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAI 355
FEEKK E +E+RFATTRPASSVISR EEVAKAVKF+VK SE++VRLQGQE GRKGKLAI
Sbjct: 326 FEEKK-REEKEIRFATTRPASSVISRLEEVAKAVKFDVKKSENQVRLQGQERGRKGKLAI 384
Query: 356 NADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVW-MSTADNPT 406
AD++AVTPS LVVEVKKDNGDTLEYNQFCSN+LRPALKDIVW S +NPT
Sbjct: 385 AADLYAVTPSFLVVEVKKDNGDTLEYNQFCSNQLRPALKDIVWRTSPPENPT 436
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442979|ref|XP_004139258.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like [Cucumis sativus] gi|449525178|ref|XP_004169595.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1761), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/409 (82%), Positives = 365/409 (89%), Gaps = 3/409 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNL+TGKS+AMKVVGK+K+IKVGMMEQIKREISVMKMVKH +IVELH
Sbjct: 23 LLGHGTFAKVYHARNLRTGKSVAMKVVGKEKIIKVGMMEQIKREISVMKMVKHPNIVELH 82
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+ V+GGELF+KIAKGRLREDVARVYFQQLISA+DFCHSRGVYHRDLK
Sbjct: 83 EVMASKSKIYFAMEFVRGGELFSKIAKGRLREDVARVYFQQLISAIDFCHSRGVYHRDLK 142
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDEDGNLKVTDFGL+AFSEHLKQDGLLHTTCGTPAYVAPEVI K GYDGAKAD+W
Sbjct: 143 PENLLLDEDGNLKVTDFGLTAFSEHLKQDGLLHTTCGTPAYVAPEVIGKHGYDGAKADLW 202
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDN+V+MYRKIYRGDFKCP WFS EARRLITKLLDPNP +R
Sbjct: 203 SCGVILYVLLAGFLPFQDDNMVAMYRKIYRGDFKCPSWFSPEARRLITKLLDPNPVTRAG 262
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEAD---KSSKQPETLNAFHIISLSEGFDLSPLFE 297
I+KI SSWFKKS PK +ITK E E + KS ETLNAFHIISLSEGFDLSPLFE
Sbjct: 263 ITKITSSSWFKKSVPKSLITKDEQEQTEENFTKSKPPAETLNAFHIISLSEGFDLSPLFE 322
Query: 298 EKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINA 357
EKKR E+EE+RFAT+ ASSVIS+ EEV KAVKF+VK SE+ VRLQGQE GRKGKL I A
Sbjct: 323 EKKREEKEEMRFATSSTASSVISKLEEVGKAVKFDVKKSETWVRLQGQEMGRKGKLTIAA 382
Query: 358 DIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNPT 406
DIFA+TPS +VVEVKKDNGDTLEYNQFC ELRPALKDIVW S N T
Sbjct: 383 DIFAMTPSFVVVEVKKDNGDTLEYNQFCRKELRPALKDIVWTSPTGNST 431
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500647|ref|XP_003519143.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/404 (78%), Positives = 370/404 (91%), Gaps = 4/404 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARNL TG+ +AMKVVGK+KVIKVGMMEQ+KREISVMKMVKH++IVELH
Sbjct: 26 VLGHGTFAKVYHARNLNTGQHVAMKVVGKEKVIKVGMMEQVKREISVMKMVKHQNIVELH 85
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIY AM+LV+GGELFNK++KGRL+EDVAR+YFQQLISAVDFCHSRGVYHRDLK
Sbjct: 86 EVMASKSKIYIAMELVRGGELFNKVSKGRLKEDVARLYFQQLISAVDFCHSRGVYHRDLK 145
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE GNLKV+DFGL+AFSEHLK+DGLLHTTCGTPAYV+PEVI+KKGYDGAKADIW
Sbjct: 146 PENLLLDEHGNLKVSDFGLTAFSEHLKEDGLLHTTCGTPAYVSPEVIAKKGYDGAKADIW 205
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILYVLLAGFLPFQDDN+V+MY+KIYRGDFKCPPWFS +AR+L+TKLLDPNPN+RI+
Sbjct: 206 SCGVILYVLLAGFLPFQDDNLVAMYKKIYRGDFKCPPWFSLDARKLVTKLLDPNPNTRIS 265
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLSPLFEEKK 300
ISK+MESSWFKK P+ + ++++ E +K Q ET+NAFHIISLSEGF+LSPLFE+K+
Sbjct: 266 ISKVMESSWFKKPVPR-KLAAEKVDLEEEKIESQLETINAFHIISLSEGFNLSPLFEDKR 324
Query: 301 RAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINADIF 360
REE+RFAT S+VISR EEVAKA KF+V++SE++VRLQGQE GRKGKLAI ADI+
Sbjct: 325 ---REEMRFATAGTPSTVISRLEEVAKAGKFDVRSSETKVRLQGQERGRKGKLAIAADIY 381
Query: 361 AVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADN 404
AVTPS +VVEVKKDNGDTLEYNQFCS +LRPALKDI W S+ ++
Sbjct: 382 AVTPSFMVVEVKKDNGDTLEYNQFCSKQLRPALKDIFWNSSQNS 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 416 | ||||||
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.963 | 0.909 | 0.715 | 1.3e-155 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.963 | 0.913 | 0.574 | 1.3e-125 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.605 | 0.515 | 0.662 | 4.6e-120 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.605 | 0.526 | 0.650 | 2.3e-116 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.692 | 0.553 | 0.576 | 2.3e-116 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.603 | 0.486 | 0.642 | 8.7e-115 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.661 | 0.603 | 0.610 | 4.8e-114 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.612 | 0.529 | 0.616 | 2.3e-112 | |
| TAIR|locus:2040824 | 502 | CIPK13 "CBL-interacting protei | 0.682 | 0.565 | 0.574 | 1e-109 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.963 | 0.821 | 0.516 | 3.9e-108 |
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1517 (539.1 bits), Expect = 1.3e-155, P = 1.3e-155
Identities = 294/411 (71%), Positives = 338/411 (82%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVY ARN+QTGKS+A +QIKREISVM+MVKH +IVELH
Sbjct: 29 LLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKHPNIVELH 88
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASKSKIYFAM+LV+GGELF K+AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK
Sbjct: 89 EVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 148
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+GNLKVTDFGLSAF+EHLKQDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+W
Sbjct: 149 PENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGYDGAKADLW 208
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VLLAG+LPFQDDN+V+MYRKIYRGDFKCP W SS+ARRL+TKLLDPNPN+RI
Sbjct: 209 SCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLDPNPNTRIT 268
Query: 241 ISKIMESSWFKKSAPK---------VVITKQEMEFEADKSSKQPETLNAFHIISLSEGFD 291
I K+M+S WFKK A + + T+++++F KS ++ ETLNAFHII+LSEGFD
Sbjct: 269 IEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEETETLNAFHIIALSEGFD 328
Query: 292 LSPXXXXXXXXXXXXXXXXTTRPASSVISRFEEVAKAV-KFNVKTSESRVRLQGQESGRK 350
LSP T+RPASSVIS EE A+ KF+V+ SESRVR++G+++GRK
Sbjct: 329 LSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGNKFDVRKSESRVRIEGKQNGRK 388
Query: 351 GKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMST 401
GKLA+ A+IFAV PS +VVEVKKD+GDTLEYN FCS LRPALKDI W ST
Sbjct: 389 GKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPALKDIFWTST 439
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1234 (439.4 bits), Expect = 1.3e-125, P = 1.3e-125
Identities = 238/414 (57%), Positives = 303/414 (73%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY ARN++TG+S+A +QIKREISVM++V+H H+V LH
Sbjct: 17 LLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHPHVVFLH 76
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMASK+KIYFAM+ VKGGELF+K++KG+L+E++AR YFQQLI A+D+CHSRGVYHRDLK
Sbjct: 77 EVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYCHSRGVYHRDLK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+G+LK++DFGLSA E +QDGLLHTTCGTPAYVAPEVI KKGYDGAKAD+W
Sbjct: 137 PENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADVW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGV+LYVLLAGFLPF + N+V MYRKI +G+FKCP WF E ++L++++LDPNPNSRI
Sbjct: 197 SCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDPNPNSRIK 256
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKS--------SKQPETLNAFHIIS-LSEGFD 291
I KIME+SWF+K K+ K + D S +P + NAF +IS LS+GFD
Sbjct: 257 IEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMSYNAFDLISSLSQGFD 316
Query: 292 LSPXXXXXXXXXXXXXXXXTTRPASSVISRFEEVA-KAVKFNVKTSESRVRLQGQESGRK 350
LS T + A ++S+FEE+A + +FN+ S+ V+++ + GRK
Sbjct: 317 LS---GLFEKEERSESKFTTKKDAKEIVSKFEEIATSSERFNLTKSDVGVKMEDKREGRK 373
Query: 351 GKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADN 404
G LAI+ +IF VT S +VE KK GDT+EY QFC ELRP+LKDIVW +N
Sbjct: 374 GHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKDIVWKWQGNN 427
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 4.6e-120, Sum P(2) = 4.6e-120
Identities = 167/252 (66%), Positives = 209/252 (82%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVYLARN++T +S+A IKREIS+++ V+H +IV+L
Sbjct: 31 LLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRRVRHPNIVQLF 90
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K+KIYF M+ V+GGELFNK+AKGRL+E+VAR YFQQLISAV FCH+RGVYHRDLK
Sbjct: 91 EVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCHARGVYHRDLK 150
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+GNLKV+DFGLSA S+ ++QDGL HT CGTPAYVAPEV+++KGYD AK DIW
Sbjct: 151 PENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKGYDAAKVDIW 210
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AG+LPF D N+++MY+KIYRG+F+CP WFS+E RL++KLL+ NP R
Sbjct: 211 SCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKLLETNPEKRFT 270
Query: 241 ISKIMESSWFKK 252
+IME+SWFKK
Sbjct: 271 FPEIMENSWFKK 282
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 898 (321.2 bits), Expect = 2.3e-116, Sum P(2) = 2.3e-116
Identities = 164/252 (65%), Positives = 205/252 (81%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY R++ T +S+A EQIKREISVM++ +H ++VEL+
Sbjct: 17 LLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREISVMRIARHPNVVELY 76
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K++IYF M+ KGGELFNK+AKG+LR+DVA YF QLI+AVDFCHSR VYHRD+K
Sbjct: 77 EVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAVDFCHSREVYHRDIK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD++ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPEVI++KGYDG KADIW
Sbjct: 137 PENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYDGTKADIW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGV+L+VLLAG+LPF D N++ MYRKI + DFK P WF+ E RRL+ K+LDPNP +RI
Sbjct: 197 SCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRLLCKMLDPNPETRIT 256
Query: 241 ISKIMESSWFKK 252
I++I ESSWF+K
Sbjct: 257 IARIRESSWFRK 268
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 2.3e-116, Sum P(2) = 2.3e-116
Identities = 166/288 (57%), Positives = 216/288 (75%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKVYLA+N+++G +A IKREIS+++ V+H +IV L
Sbjct: 79 LLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILRRVRHPYIVHLF 138
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+KSKIYF M+ V GGELFN +AKGRL E+ AR YFQQLIS+V FCH RGVYHRDLK
Sbjct: 139 EVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFCHGRGVYHRDLK 198
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD GNLKV+DFGLSA +E L+QDGL HT CGTPAY+APEV+++KGYD AKAD+W
Sbjct: 199 PENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTRKGYDAAKADVW 258
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AG +PF D NI+ MY+KIY+G+F+CP WFSS+ RL+T+LLD NP++RI
Sbjct: 259 SCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTRLLDTNPDTRIT 318
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSE 288
I +IM++ WFKK V ++ + + ++ E ++ ++SE
Sbjct: 319 IPEIMKNRWFKKGFKHVKFYIEDDKLCREDEDEEEEASSSGRSSTVSE 366
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 8.7e-115, Sum P(2) = 8.7e-115
Identities = 162/252 (64%), Positives = 209/252 (82%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LGHGTFAKV+LA+N++TG+++A IKREIS+++ V+H +IV+L
Sbjct: 31 LLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKREISILRRVRHPNIVQLF 90
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K+KIYF M+ V+GGELFNK+AKGRL+E+VAR YFQQLI AV+FCH+RGV+HRD+K
Sbjct: 91 EVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAVEFCHARGVFHRDIK 150
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE+GNLKV+DFGLSA S+ +KQDGL HT CGTPAYVAPEV+S+KGYDG K DIW
Sbjct: 151 PENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEVLSRKGYDGGKVDIW 210
Query: 181 SCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
SCGV+L+VL+AG+LPF D +N++ MY+KIY+GDF+CP WFS E L+T+LLD P +RI
Sbjct: 211 SCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVNLLTRLLDTKPQTRI 270
Query: 240 AISKIMESSWFK 251
+I +IME+ WFK
Sbjct: 271 SIPEIMENRWFK 282
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 4.8e-114, Sum P(2) = 4.8e-114
Identities = 168/275 (61%), Positives = 213/275 (77%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LG GTFAKVY R+ T +S+A +QIKREISVM++ KH ++VEL+
Sbjct: 17 LLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREISVMRIAKHPNVVELY 76
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+KS+IYF ++ KGGELFNK+AKG+L+EDVA YF QLISAVDFCHSRGVYHRD+K
Sbjct: 77 EVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLISAVDFCHSRGVYHRDIK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD++ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPEVI++KGY+G KADIW
Sbjct: 137 PENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYEGTKADIW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGV+L+VLLAG+LPF D N++ MYRKI + DFKCP WF+ E +RL+ K+LDPN +RI
Sbjct: 197 SCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRLLCKMLDPNHETRIT 256
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQP 275
I+KI ESSWF+K ++ME + + + P
Sbjct: 257 IAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNP 291
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 2.3e-112, Sum P(2) = 2.3e-112
Identities = 159/258 (61%), Positives = 206/258 (79%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELHE 61
LG GTFAKV ARN++ G ++A QIKREIS MK++KH +++ + E
Sbjct: 37 LGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIKHPNVIRMFE 96
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
VMASK+KIYF ++ V GGELF+KI+ GRL+ED AR YFQQLI+AVD+CHSRGVYHRDLK
Sbjct: 97 VMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSRGVYHRDLK 156
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD +G LKV+DFGLSA + +++DGLLHTTCGTP YVAPEVI+ KGYDGAKAD+W
Sbjct: 157 PENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 216
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AG+LPF+D N+ S+Y+KI++ +F CPPWFS+ A++LI ++LDPNP +RI
Sbjct: 217 SCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATRIT 276
Query: 241 ISKIMESSWFKKS--APK 256
++++E+ WFKK APK
Sbjct: 277 FAEVIENEWFKKGYKAPK 294
|
|
| TAIR|locus:2040824 CIPK13 "CBL-interacting protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 1.0e-109, Sum P(2) = 1.0e-109
Identities = 166/289 (57%), Positives = 212/289 (73%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LGHG+FAKVYLARN+ +G+ +A IKREIS+++ V+H +IV L
Sbjct: 62 LLGHGSFAKVYLARNIHSGEDVAIKVIDKEKIVKSGLAGHIKREISILRRVRHPYIVHLL 121
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K+KIY M+ V+GGEL+N +A+GRLRE AR YFQQLIS+V FCHSRGVYHRDLK
Sbjct: 122 EVMATKTKIYIVMEYVRGGELYNTVARGRLREGTARRYFQQLISSVAFCHSRGVYHRDLK 181
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
ENLLLD+ GN+KV+DFGLS SE LKQ+G+ T CGTPAY+APEV+++KGY+GAKADIW
Sbjct: 182 LENLLLDDKGNVKVSDFGLSVVSEQLKQEGICQTFCGTPAYLAPEVLTRKGYEGAKADIW 241
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVIL+VL+AG+LPF D NI+ MY KIY+G FKCP WFS E RL+T++LD NP++RI
Sbjct: 242 SCGVILFVLMAGYLPFDDKNILVMYTKIYKGQFKCPKWFSPELARLVTRMLDTNPDTRIT 301
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEG 289
I +IM+ WFKK V + E DK ++ + + SLS G
Sbjct: 302 IPEIMKHRWFKKGFKHV-----KFYIENDKLCREDDDNDDDDSSSLSSG 345
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 3.9e-108, P = 3.9e-108
Identities = 218/422 (51%), Positives = 284/422 (67%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKMVKHKHIVELH 60
+LG GTF KVY + + TG+S+A EQIKREIS+M++V+H +IVEL
Sbjct: 48 LLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMRLVRHPNIVELK 107
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
EVMA+K+KI+F M+ VKGGELF+KI KG+L+ED AR YFQQLISAVDFCHSRGV HRDLK
Sbjct: 108 EVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLISAVDFCHSRGVSHRDLK 167
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLL+DE+G+LKV+DFGLSA E + QDGLLHT CGTPAYVAPEV+ KKGYDGAK DIW
Sbjct: 168 PENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLRKKGYDGAKGDIW 227
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCG+ILYVLLAGFLPFQD+N++ MYRKI++ +F+ PPWFS E++RLI+KLL +PN RI+
Sbjct: 228 SCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLISKLLVVDPNKRIS 287
Query: 241 ISKIMESSWFKKSAPKVVITK-QEMEFE--ADKSSK-------------QPETLNAFHII 284
I IM + WF+K+ + K E+E + D++ P+ NAF I
Sbjct: 288 IPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPTTTATTATTTTTPVSPKFFNAFEFI 347
Query: 285 SLSEGFDLSPXXXXXXXXXXXXXXXXTTR-PASSVISRFEEVAKAVKFNVK-TSESRVRL 342
S T+R AS ++ + E + K + VK T + +V+L
Sbjct: 348 S---SMSSGFDLSSLFESKRKLRSMFTSRWSASEIMGKLEGIGKEMNMKVKRTKDFKVKL 404
Query: 343 QGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTA 402
G+ GRKG++A+ A++F V P + VVE+ K GDTLEYN+ +RPAL++IVW
Sbjct: 405 FGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRLYEEHVRPALEEIVWSWHG 464
Query: 403 DN 404
DN
Sbjct: 465 DN 466
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O65554 | CIPK6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7712 | 0.9639 | 0.9092 | yes | no |
| Q9LWM4 | CIPK5_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6130 | 0.9783 | 0.8828 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK9 | SubName- Full=CBL-interacting protein kinase 9; (437 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | CBL1 | SubName- Full=Calcineurin B-like protein 1; (213 aa) | • | 0.649 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 416 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-103 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-86 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-82 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-79 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-69 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-68 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-66 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-63 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-59 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-57 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-53 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-52 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-51 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-51 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-50 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-50 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-49 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-49 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-49 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-48 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-48 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 8e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-47 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-47 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-46 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-46 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-46 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-45 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-44 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-44 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-44 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-43 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-42 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-42 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-41 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-41 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-40 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-40 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-39 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-39 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-39 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-39 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-38 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-38 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-37 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-37 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-37 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-36 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-36 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-35 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-35 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-35 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-35 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-34 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-34 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-33 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-33 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-32 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-32 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-32 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-28 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-28 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-28 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-24 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 2e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-19 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 0.002 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 306 bits (787), Expect = e-103
Identities = 116/254 (45%), Positives = 166/254 (65%), Gaps = 11/254 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F KVYLAR+ +TGK +A+KV+ K K+ K E+I REI ++K +KH +IV L++
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLYD 64
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V + K+Y M+ +GG+LF+ + +GRL ED AR Y +Q++SA+++ HS+G+ HRDLK
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLK 124
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLDEDG++K+ DFGL+ L L T GTP Y+APEV+ KGY DIW
Sbjct: 125 PENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGYGK-AVDIW 180
Query: 181 SCGVILYVLLAGFLPFQ-DDNIVSMYRKIYRGDFKCPPW---FSSEARRLITKLLDPNPN 236
S GVILY LL G PF DD ++ +++KI + PP S EA+ LI KLL +P
Sbjct: 181 SLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPE 240
Query: 237 SRIAISKIMESSWF 250
R+ + ++ +F
Sbjct: 241 KRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 264 bits (676), Expect = 1e-86
Identities = 101/257 (39%), Positives = 150/257 (58%), Gaps = 11/257 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F VY A++ TGK +A+K++ K K + +REI +++ + H +IV L +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K +Y M+ +GG+LF+ +++ G L ED A+ Q++ +++ HS G+ HRDLK
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLK 125
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLDE+G +K+ DFGL+ LK L T GTP Y+APEV+ G K D+W
Sbjct: 126 PENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----DFKCPPW--FSSEARRLITKLLDP 233
S GVILY LL G PF +NI+ + I R +F P W S EA+ LI K L+
Sbjct: 184 SLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNK 243
Query: 234 NPNSRIAISKIMESSWF 250
+P+ R +I++ WF
Sbjct: 244 DPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 7e-82
Identities = 103/240 (42%), Positives = 149/240 (62%), Gaps = 6/240 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F KV L R TGK AMKV+ K K+IK +E E +++ + H IV+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++ K+Y ++ GGELF+ ++K GR E+ AR Y +++ A+++ HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADI 179
PEN+LLD DG++K+TDFGL+ L +G +T CGTP Y+APEV+ KGY A D
Sbjct: 121 PENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDW 176
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
WS GV+LY +L G PF ++ +Y KI + + P + S EAR LI+ LL +P R+
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL 236
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 2e-79
Identities = 104/256 (40%), Positives = 156/256 (60%), Gaps = 12/256 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V L R+ +GK A+K++ K K++K+ +E + E +++ ++H +V L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
S +Y M+ V GGELF+ + K GR E VAR Y Q++ A+++ HS + +RDLK
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD DG +K+TDFG F++ +K G +T CGTP Y+APE+I KGY A D W
Sbjct: 129 PENLLLDSDGYIKITDFG---FAKRVK--GRTYTLCGTPEYLAPEIILSKGYGKA-VDWW 182
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
+ G+++Y +LAG+ PF DDN + +Y KI G + P +FS +A+ LI LL + R+
Sbjct: 183 ALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLG 242
Query: 241 ISK-----IMESSWFK 251
K I WF
Sbjct: 243 NLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 2e-69
Identities = 93/249 (37%), Positives = 137/249 (55%), Gaps = 38/249 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F VYLAR+ +TGK +A+K++ K+ ++E++ REI ++K + H +IV+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
V ++ +Y M+ +GG L + + + G+L ED Q++ +++ HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 120 KPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
KPEN+LLD D G +K+ DFGLS K LL T GTPAY+APEV+ KGY K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
IWS GVILY L E + LI K+L +P R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 239 IAISKIMES 247
+ +I+E
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 5e-68
Identities = 87/258 (33%), Positives = 137/258 (53%), Gaps = 20/258 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM-----EQIKREISVMKMVKHKH 55
+G G+F KVYL R GK +K I + M E E+ ++K + H +
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKE------IDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-----LREDVARVYFQQLISAVDFCH 110
I++ +E K K+ M+ GG+L KI K + E+ +F QL A+ + H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
SR + HRD+KP+N+ L +G +K+ DFG+S L T GTP Y++PE+ K
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNK 178
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITK 229
Y+ K+DIWS G +LY L PF+ +N++ + KI +G + P +SSE R L++
Sbjct: 179 PYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237
Query: 230 LLDPNPNSRIAISKIMES 247
LL +P R +I++I++S
Sbjct: 238 LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 1e-66
Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 13/259 (5%)
Query: 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 64
G + +V+LA+ TG A+KV+ K +I+ ++Q+ E ++ + ++V+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 65 SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 123
K +Y M+ + GG+L + + G L EDVAR+Y +++ A+++ HS G+ HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 124 LLLDEDGNLKVTDFGLSAF---SEHLKQDGLL---HTTCGTPAYVAPEVISKKGYDGAKA 177
+L+D +G+LK+TDFGLS + + GTP Y+APEVI +G+
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--PWFSSEARRLITKLLDPNP 235
D WS G ILY L G PF + +++ I G + P S EA LI+KLL P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 236 NSRI---AISKIMESSWFK 251
R+ +I +I +FK
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 4e-66
Identities = 99/259 (38%), Positives = 141/259 (54%), Gaps = 14/259 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V L + ++ A+K V K +++ G E I E +++ H IV+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K IY M+ GGEL+ + +G E AR Y ++ A ++ H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD +G +K+ DFG F++ LK T CGTP YVAPE+I KGYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 181 SCGVILYVLLAGFLPFQDDNIVSM--YRKIYRGDFKC--PPWFSSEARRLITKLLDPNPN 236
S G++LY LL G PF +D+ M Y I +G+ K P + A+ LI +LL NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 237 SRI-----AISKIMESSWF 250
R+ I I + WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 86/266 (32%), Positives = 148/266 (55%), Gaps = 21/266 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELH 60
+G G+F+ V LA+ +T K A+K++ K ++IK ++ +K E V+ ++ H I++L+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ +YF ++ GEL I K G L E R Y +++ A+++ HS+G+ HRDL
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDL 128
Query: 120 KPENLLLDEDGNLKVTDFGLSAF------SEHLKQDGLLHTT------------CGTPAY 161
KPEN+LLD+D ++K+TDFG + E K D + GT Y
Sbjct: 129 KPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS 221
V+PE++++K G +D+W+ G I+Y +L G PF+ N ++KI + ++ PP F
Sbjct: 189 VSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPP 247
Query: 222 EARRLITKLLDPNPNSRIAISKIMES 247
+A+ LI KLL +P R+ +++ +
Sbjct: 248 DAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-60
Identities = 95/239 (39%), Positives = 145/239 (60%), Gaps = 7/239 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V +A++ TG+ A+K + K +++K+ ++ + +E S++ + H IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++++YF ++ V GGELF + K GR DVA+ Y +L+ A ++ HS+ + +RDLK
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD G++KVTDFG F++ + T CGTP Y+APEVI KG+ A D W
Sbjct: 146 PENLLLDNKGHVKVTDFG---FAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKA-VDWW 199
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
+ GV+LY +AG+ PF DD +Y KI G K P WF AR L+ LL + R+
Sbjct: 200 TMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 7e-59
Identities = 79/246 (32%), Positives = 130/246 (52%), Gaps = 12/246 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL- 59
+LG G+F VYLA + TG+ MA+K V + + E ++REI ++ ++H +IV
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHPNIVRYY 65
Query: 60 -HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHR 117
E K+ + ++ V GG L + + K G+L E V R Y +Q++ + + HS G+ HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
D+K N+L+D DG +K+ DFG + ++ + GTP ++APEVI + Y G A
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY-GRAA 184
Query: 178 DIWSCGVILYVLLAGFLPF--QDDNIVSMYRKIYRGDFKCPP---WFSSEARRLITKLLD 232
DIWS G + + G P+ + + ++Y+ G+ P S EA+ + K L
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE--PPEIPEHLSEEAKDFLRKCLR 242
Query: 233 PNPNSR 238
+P R
Sbjct: 243 RDPKKR 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 4e-57
Identities = 92/257 (35%), Positives = 144/257 (56%), Gaps = 12/257 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GTF +V+L R+ + A+KV+ +VI++ + + E V+K V H I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ +Y M+ V GGELF+ + GR Y +++ A+++ HS+ + +RDLK
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLD++G++K+TDFG F++ L+ T CGTP Y+APEVI KG++ A D W
Sbjct: 129 PENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKA-VDWW 182
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
+ G+++Y +L G+ PF DDN +Y KI G + P A+ LI KLL + R+
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLG 242
Query: 241 ISK-----IMESSWFKK 252
K + WFK
Sbjct: 243 NMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 5e-53
Identities = 92/244 (37%), Positives = 141/244 (57%), Gaps = 8/244 (3%)
Query: 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGM-MEQIKREISVMKMVKHKHI 56
+LG G + KV+ R + TGK AMKV+ K +++ K E ++++ VKH I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVY 115
V+L + K+Y ++ + GGELF + + G ED A Y ++ A++ H +G+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII 122
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
+RDLKPEN+LLD G++K+TDFGL E + + + HT CGT Y+APE++ + G+ G
Sbjct: 123 YRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-GK 179
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235
D WS G ++Y +L G PF +N KI +G PP+ + EAR L+ KLL NP
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239
Query: 236 NSRI 239
+SR+
Sbjct: 240 SSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 92/256 (35%), Positives = 141/256 (55%), Gaps = 9/256 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L R TGK AMK++ K+ +I + E V++ +H + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ F M+ GGELF +++ R+ ED AR Y +++SA+ + HS V +RDL
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y G D
Sbjct: 122 KLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 178
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +P R+
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
Query: 240 A-----ISKIMESSWF 250
+IME +F
Sbjct: 239 GGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 93/240 (38%), Positives = 132/240 (55%), Gaps = 5/240 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELH 60
+G G+F KV LA++ GK A+KV+ K ++K + I E +V+ K VKH +V LH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ K+YF +D V GGELF + + R E AR Y ++ SA+ + HS + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KPEN+LLD G++ +TDFGL E ++ T CGTP Y+APEV+ K+ YD D
Sbjct: 123 KPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-VDW 179
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W G +LY +L G PF + MY I + P S AR L+ LL + R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-52
Identities = 78/256 (30%), Positives = 133/256 (51%), Gaps = 14/256 (5%)
Query: 3 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 62
G G F KV + + T K AMK + K K ++ G + + E +++ + H +V L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 63 MASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+ +Y +DL+ GG+L ++ K + E+ + + +++ A+++ HS+G+ HRD+KP
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
+N+LLDE G++ +TDF ++ + D L +T GTP Y+APEV+ ++GY D WS
Sbjct: 129 DNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWS 184
Query: 182 CGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-----PPWFSSEARRLITKLLDPNPN 236
GV Y L G P+ R R + P +S+EA I KLL+ +P
Sbjct: 185 LGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQ 242
Query: 237 SRI--AISKIMESSWF 250
R+ + + +F
Sbjct: 243 KRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 177 bits (448), Expect = 2e-51
Identities = 104/378 (27%), Positives = 164/378 (43%), Gaps = 32/378 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELH 60
LG G+F +VYLAR+ K +A+KV+ K K +E+ REI ++ + H +IV+L+
Sbjct: 8 LGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 61 EVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + +Y M+ V GG L KG L E A Q++SA+++ HS+G+ H
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 117 RDLKPENLLLDEDGN-LKVTDFGLSAF----SEHLKQDGLLHTTCGTPAYVAPEVIS--K 169
RD+KPEN+LLD DG +K+ DFGL+ L T+ GTP Y+APEV+
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKC---------P 216
Y + +DIWS G+ LY LL G PF+ + S + I P
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNP 244
Query: 217 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK----KSAPKVVITKQEMEFEADKSS 272
S A L+ KLL +P +R++ S + K + + K + S
Sbjct: 245 ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSL 304
Query: 273 KQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFN 332
+ SL+ L + E +++ SS + +K
Sbjct: 305 PPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLP 364
Query: 333 VKTSESRVRLQGQESGRK 350
++ S S ++
Sbjct: 365 KISARSSPSSLSSSSRQQ 382
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 4e-51
Identities = 87/241 (36%), Positives = 139/241 (57%), Gaps = 5/241 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LA T + A+KV+ KD +++ +E E V+ + KH + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H +K +++F M+ V GG+L I + GR E AR Y +++ + F H RG+ +RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G++K+ DFG+ E + T CGTP Y+APE++S + Y G D
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +LAG PF+ D+ +++ I + + P W S EA+ ++ L NP R
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238
Query: 239 I 239
+
Sbjct: 239 L 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-50
Identities = 95/256 (37%), Positives = 146/256 (57%), Gaps = 9/256 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L R +GK AMK++ K+ +I + E V+K +H + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRDL 119
+K ++ F M+ V GGELF +++ R+ ED R Y +++SA+D+ HS + +RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y G D
Sbjct: 122 KLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 178
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W GV++Y ++ G LPF + + ++ I D K P S++A+ L++ LL +PN R+
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
Query: 240 A-----ISKIMESSWF 250
+IM S+F
Sbjct: 239 GGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 7e-50
Identities = 93/284 (32%), Positives = 141/284 (49%), Gaps = 35/284 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F +V+L R+ TG+ AMKV+ K +IK + ++ E ++ IV+L+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 62 VMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ +Y M+ + GG+L N I K E+ AR Y +L+ A+D H G HRD+K
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIK 128
Query: 121 PENLLLDEDGNLKVTDFGLSA---------------------------FSEHLKQDGLLH 153
P+N+L+D DG++K+ DFGL +H ++ +
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRG 211
+T GTP Y+APEV+ Y + D WS GVILY +L GF PF D + Y KI ++
Sbjct: 189 STVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE 247
Query: 212 DFKCPP--WFSSEARRLITKLLDPNPNSRI-AISKIMESSWFKK 252
+ PP S EA LI +LL P R+ + +I +FK
Sbjct: 248 SLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 91/243 (37%), Positives = 146/243 (60%), Gaps = 8/243 (3%)
Query: 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
+LG G+F KV+L R + G+ AMKV+ K +KV + K E ++ V H IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYH 116
+LH ++ K+Y +D ++GG+LF +++K + E+ + Y +L A+D HS G+ +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RDLKPEN+LLDE+G++K+TDFGLS E + + ++ CGT Y+APEV++++G+ +
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS- 178
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPN 236
AD WS GV+++ +L G LPFQ + I + P + S EA+ L+ L NP
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238
Query: 237 SRI 239
+R+
Sbjct: 239 NRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 82/263 (31%), Positives = 130/263 (49%), Gaps = 27/263 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM-----EQIKREISVMKMVKHKHI 56
+G G+F V R GK + K I G M +Q+ E+++++ +KH +I
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKE------IDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 57 VEL--HEVMASKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFC 109
V + S +Y M+ +GG+L I K + E+ QL+ A+ C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 110 HSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 164
H+R V HRDLKP N+ LD + N+K+ DFGL+ H T GTP Y++P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMSP 179
Query: 165 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEA 223
E ++ YD K+DIWS G ++Y L A PF N + + KI G F+ P +SSE
Sbjct: 180 EQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238
Query: 224 RRLITKLLDPNPNSRIAISKIME 246
+I +L+ +P+ R + ++++
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 86/240 (35%), Positives = 137/240 (57%), Gaps = 4/240 (1%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L R TG+ AMK++ K+ +I + E V++ +H + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ F M+ GGELF +++ R+ E+ AR Y +++SA+++ HSR V +RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y G D
Sbjct: 122 KLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 178
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +P R+
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-49
Identities = 87/242 (35%), Positives = 131/242 (54%), Gaps = 4/242 (1%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F KV R T + A+K + K ++ + E +V+ V IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
S K+Y + + GGELF+ + + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLD G++ + DFGL + +K D +T CGTP Y+APE++ GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
+ GV+LY +L G PF D+N+ MYRKI + + P F +A+ L+ LL +P R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 241 IS 242
+
Sbjct: 238 YN 239
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 86/256 (33%), Positives = 132/256 (51%), Gaps = 16/256 (6%)
Query: 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVM 63
G F VYLA+ TG A+KV+ K +I + +K E ++M + ++ +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 64 ASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 122
SK +Y M+ + GG+ + I G L ED A+ Y +++ V+ H RG+ HRD+KPE
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 123 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSC 182
NLL+D+ G+LK+TDFGLS K+ GTP Y+APE I G D +D WS
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKM-SDWWSL 179
Query: 183 GVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDPNPNSR 238
G +++ L G+ PF + +++ I P + S EA LI +LL +P R
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
Query: 239 IA---ISKIMESSWFK 251
+ +I +FK
Sbjct: 240 LGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 6e-48
Identities = 93/242 (38%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
++G G+F KV LAR+ K A+KV+ K ++K + I E +V+ K VKH +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + K+YF +D + GGELF + + R E AR Y ++ SA+ + HS + +RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LKPEN+LLD G++ +TDFGL E+++ +G T CGTP Y+APEV+ K+ YD D
Sbjct: 122 LKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W G +LY +L G PF N MY I + P ++ AR L+ LL + R
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238
Query: 239 IA 240
+
Sbjct: 239 LG 240
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 8e-48
Identities = 62/117 (52%), Positives = 84/117 (71%), Gaps = 2/117 (1%)
Query: 279 NAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSES 338
NAF +ISLS G DLS LFEE+ +RE RF + +PA +I + EE AK + F V+ +
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRET-RFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
Query: 339 -RVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALK 394
V+L+GQ+ GRKG+LA++ ++F VTPSL+VVEVKK GDTLEY++F + LRP LK
Sbjct: 60 GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 84/243 (34%), Positives = 126/243 (51%), Gaps = 12/243 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G F +VY AR+ +TGK +A+KV+ K+ E+I EI ++K KH +IV+ +
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 61 EVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
K +++ M+ GG L + K L E ++L+ +++ HS G+ HRD
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRD 123
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
+K N+LL DG +K+ DFGLSA K +T GTP ++APEVI+ K YD KAD
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGKPYDY-KAD 179
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNP 235
IWS G+ L G P+ + + KI + P +S E + + K L NP
Sbjct: 180 IWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP 239
Query: 236 NSR 238
R
Sbjct: 240 EKR 242
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 89/265 (33%), Positives = 139/265 (52%), Gaps = 26/265 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
+G GTF KVY A NL TG+ MA+K + K IK +I E+ V++++KH ++V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-----EIADEMKVLELLKHPNLV 62
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYH 116
+ + V + K+Y M+ GG L + GR L E V RVY QL+ + + HS G+ H
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAF--SEHLKQDGLLHTTCGTPAYVAPEVISK---KG 171
RD+KP N+ LD +G +K+ DFG + + + + GTPAY+APEVI+ KG
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 172 YDGAKADIWSCGVILYVLLAGFLPF--QDDNIVSMYRKIYRGDFKCPPW-----FSSEAR 224
+ A ADIWS G ++ + G P+ D+ M+ G PP S E +
Sbjct: 183 HGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV---GAGHKPPIPDSLQLSPEGK 238
Query: 225 RLITKLLDPNPNSRIAISKIMESSW 249
+ + L+ +P R S++++ +
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 87/286 (30%), Positives = 140/286 (48%), Gaps = 37/286 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G +V+L R TGK A+KV+ K ++IK ++++ E ++ + H + L+
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 62 VMASKSKIYFAMDLVKGGELF---NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+++ + MD GGELF + L E+VAR Y +++ A+++ H G+ +RD
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRD 128
Query: 119 LKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTT-------------------- 155
LKPEN+LL E G++ ++DF LS L +
Sbjct: 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188
Query: 156 ----CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG 211
GT Y+APEVIS G+ A D W+ G++LY +L G PF+ N + I +
Sbjct: 189 SNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK 247
Query: 212 DFKCP--PWFSSEARRLITKLLDPNPNSRIA----ISKIMESSWFK 251
+ P P SS AR LI KLL +P+ R+ ++I + +F+
Sbjct: 248 EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 88/265 (33%), Positives = 134/265 (50%), Gaps = 25/265 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G + +V+LA+ TG+ +A+K + K + K+ + + E ++ K + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 62 VMASKSKIYFAMDLVKGGE---LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+Y AM+ V GG+ L N G L ED AR Y ++ AVD H G HRD
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL---HTTCGTPAYVAPEVISKKGYDGA 175
LKPEN L+D G++K+TDFGLS G++ ++ G+P Y+APEV+ KGYD
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-F 177
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--RGDFKCPPW------FSSEARRLI 227
D WS G +LY L GF PF + + + + P + S EA LI
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237
Query: 228 TKLLDPNPNSRIAISKIMESSWFKK 252
TKL++ ++ I +FK+
Sbjct: 238 TKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 91/290 (31%), Positives = 139/290 (47%), Gaps = 55/290 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
LG GT+ VY AR+ +TG+ +A+K + D E I REIS++K +KH +IV
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-----EGIPSTALREISLLKELKHPNIV 61
Query: 58 ELHEVMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 112
+L +V+ ++ K+ Y MDL K + G L ++ + QL+ + +CHS
Sbjct: 62 KLLDVIHTERKLYLVFEYCDMDLKK----YLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTT-CGTPAYVAPEVI-SK 169
+ HRDLKP+N+L++ DG LK+ DFGL+ AF L+ +T T Y APE++
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYRAPEILLGS 173
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--------------------Y 209
K Y A DIWS G I ++ G F D+ + KI Y
Sbjct: 174 KHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 210 RGDF---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
+ F K P E L++K+L NP RI+ + ++ +F
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-46
Identities = 94/267 (35%), Positives = 141/267 (52%), Gaps = 19/267 (7%)
Query: 2 LGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHK-HI 56
LG G + KV+L R + GK AMKV+ K ++ K E + E V++ V+ +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVY 115
V LH + +K++ +D V GGELF + + E RVY +++ A+D H G+
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII 127
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHTTCGTPAYVAPEVISKK--GY 172
+RD+K EN+LLD +G++ +TDFGLS E L ++ ++ CGT Y+APEVI G+
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLS--KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC----PPWFSSEARRLIT 228
D A D WS GV+ + LL G PF D + +I R K P S+EAR I
Sbjct: 186 DKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244
Query: 229 KLLDPNPNSRIA---ISKIMESSWFKK 252
KLL+ +P R+ +I +F+
Sbjct: 245 KLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 2e-46
Identities = 90/257 (35%), Positives = 145/257 (56%), Gaps = 10/257 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L + TG+ AMK++ K+ ++ + E V++ +H + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHS-RGVYHRD 118
+ ++ F M+ GGELF +++ R+ ED AR Y +++SA+D+ HS + V +RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK ENL+LD+DG++K+TDFGL E +K + T CGTP Y+APEV+ Y G D
Sbjct: 122 LKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W GV++Y ++ G LPF + + ++ I + + P S EA+ L++ LL +P R
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238
Query: 239 IA-----ISKIMESSWF 250
+ +IM+ +F
Sbjct: 239 LGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-46
Identities = 91/249 (36%), Positives = 135/249 (54%), Gaps = 6/249 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
++G G+F KV LA+ G A+KV+ K ++K I E +V+ K +KH +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + K+YF +D V GGELF + + R E AR Y ++ SA+ + HS + +RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LKPEN+LLD G++ +TDFGL E ++ + T CGTP Y+APEV+ K+ YD D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-VD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W G +LY +L G PF ++ MY I + P + A L+ LL + R
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRR 238
Query: 239 I-AISKIME 246
+ A + +E
Sbjct: 239 LGAKADFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 93/242 (38%), Positives = 132/242 (54%), Gaps = 5/242 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
++G G+F KV LA+ GK A+KV+ K V+ + I E +V+ K VKH +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + K+YF +D V GGELF + + R E AR Y ++ SA+ + HS + +RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LKPEN+LLD G++ +TDFGL E + Q T CGTP Y+APEVI K+ YD D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-VD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W G +LY +L G PF ++ MY I P S A ++ +LL+ + R
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238
Query: 239 IA 240
+
Sbjct: 239 LG 240
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 86/244 (35%), Positives = 132/244 (54%), Gaps = 9/244 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK---MVKHKHIVE 58
+G GTF +VY R T + AMKV+ K +++ + E +++ + + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHR 117
L + S +Y D + GGELF + K GR ED A+ Y +L+ A++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV-ISKKGYDGAK 176
DLKPEN+LLD G++ + DFGLS +L + +T CGT Y+APEV + +KGY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-WFSSEARRLITKLLDPNP 235
D WS GV+++ + G+ PF ++ MYR I G + P S E R+ + LL+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 236 NSRI 239
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 83/241 (34%), Positives = 133/241 (55%), Gaps = 5/241 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LA T + A+KV+ KD +++ ++ E ++ + KH + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
H +K +++F M+ V GG+L +I + R E +R Y ++ A+ F H GV +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G+ K+ DFG+ E + T CGTP Y+APE++ + Y G D
Sbjct: 122 LKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV++Y ++AG PF+ DN ++ I D P W S EA ++ + NPN R
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKR 238
Query: 239 I 239
+
Sbjct: 239 L 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-44
Identities = 81/241 (33%), Positives = 135/241 (56%), Gaps = 5/241 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVEL 59
+LG G+F KV LAR ++G+ A+KV+ KD +++ +E E ++ + + H + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ + +++F M+ V GG+L I K R E AR Y ++ SA+ F H +G+ +RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G+ K+ DFG+ E + T CGTP Y+APE++ + Y G D
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +L G PF+ +N ++ I + P W S +A ++ + NP R
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238
Query: 239 I 239
+
Sbjct: 239 L 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 5e-43
Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 22/258 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKMVKHKHI 56
LG G++ VY + L + A+K V +G M Q +R EI ++ V H +I
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEV------DLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-----LREDVARVYFQQLISAVDFCHS 111
+ E +K+ M+ G+L I+K + + E F QL+ + H
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
+ + HRDLK N+LL + +K+ D G+S + + + T GTP Y+APEV +
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKL 230
Y K+DIWS G +LY + PF+ ++ + K+ RG + PP +S + + I +
Sbjct: 178 YS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236
Query: 231 LDPNPNSRIAISKIMESS 248
L P R KI+ S
Sbjct: 237 LQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 85/295 (28%), Positives = 139/295 (47%), Gaps = 46/295 (15%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L + TG AMK + K ++++ + ++ E ++ + +V+L+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ +Y M+ + GG++ + K E+ R Y + I A+D H G HRD+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127
Query: 120 KPENLLLDEDGNLKVTDFGL---------SAFSEHLKQD--------------------- 149
KP+NLLLD G++K++DFGL + F L
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187
Query: 150 ------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS 203
L ++T GTP Y+APEV + GY + D WS GVI+Y +L G+ PF DN
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246
Query: 204 MYRKI--YRGDFKCPP--WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFK 251
YRKI ++ + P S EA+ LI +L R+ +++I +FK
Sbjct: 247 TYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-42
Identities = 91/299 (30%), Positives = 134/299 (44%), Gaps = 51/299 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F +V L R + T AMK + K V+ +K E ++ ++ +V+L+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 62 VMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K +YF MD + GG++ + I G ED+AR Y +L A++ H G HRD+K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128
Query: 121 PENLLLDEDGNLKVTDFGL-SAF-----------SEHLKQDG------------------ 150
P+N+L+D DG++K+TDFGL + F +H +QD
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188
Query: 151 -----------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD 199
L H+ GTP Y+APEV+ + GY D WS GVILY +L G PF D
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLAD 247
Query: 200 NIVSMYRKI--YRGDFKCPPW--FSSEARRLITKLLDPNPNSRIA---ISKIMESSWFK 251
K+ + P S EA LI +L R+ +I +FK
Sbjct: 248 TPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 5/296 (1%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LA T + A+K + KD V++ +E E V+ + +H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+K ++F M+ + GG+L I + GR E AR Y ++I + F H +G+ +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD+DG++K+ DFG+ E++ +G T CGTP Y+APE++ + Y+ D
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
WS GV+LY +L G PF ++ ++ I P W S EA+ ++KL + +P R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
Query: 239 IAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLSP 294
+ + + F + + K+E+ K P + F +E LSP
Sbjct: 239 LGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSP 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 77/253 (30%), Positives = 130/253 (51%), Gaps = 10/253 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F VY NL+TG +A+K + +K IK ++ I +EI ++K +KH +IV+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ + +Y ++ + G L I K G E + VY Q++ + + H +GV HRD+K
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
N+L +DG +K+ DFG++ ++ + GTP ++APEVI G +DIW
Sbjct: 127 AANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS-TASDIW 183
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---FSSEARRLITKLLDPNPNS 237
S G + LL G P+ D N ++ +I + D PP S E + + + +PN
Sbjct: 184 SLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPPLPEGISPELKDFLMQCFQKDPNL 241
Query: 238 RIAISKIMESSWF 250
R ++++ W
Sbjct: 242 RPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 80/266 (30%), Positives = 142/266 (53%), Gaps = 22/266 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKV--VGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
+G G +VY A + TGK +A+K + K E I EI +MK KH +IV+
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQN------KELIINEILIMKDCKHPNIVD 79
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLRED-VARVYFQQLISAVDFCHSRGVY 115
++ +++ M+ + GG L + I R+ E +A V ++++ +++ HS+ V
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQNVI 138
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
HRD+K +N+LL +DG++K+ DFG +A E K+ ++ GTP ++APEVI +K Y
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYG 194
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRG--DFKCPPWFSSEARRLITKL 230
K DIWS G++ + G P+ + + +++ +G K P +S E + + K
Sbjct: 195 -PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253
Query: 231 LDPNPNSRIAISKIMESSWFKKSAPK 256
L +P R + ++++ + KK+ PK
Sbjct: 254 LVKDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 80/241 (33%), Positives = 133/241 (55%), Gaps = 5/241 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVEL 59
+LG G+F KV LA T + A+K++ KD +I+ +E E V+ + + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + ++YF M+ V GG+L I + G+ +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y G D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +LAG PF ++ +++ I + P S EA + LL +P R
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 239 I 239
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 92/267 (34%), Positives = 148/267 (55%), Gaps = 18/267 (6%)
Query: 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHK-H 55
+LG G + KV+L R + TGK AMKV+ K ++ K +E + E +V++ V+
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 114
+V LH +++K++ +D V GGE+F + + ED R Y ++I A++ H G+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
+RD+K EN+LLD +G++ +TDFGLS F K+ ++ CGT Y+APE+I KG
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER--TYSFCGTIEYMAPEIIRGKGGH 184
Query: 174 GAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 229
G D WS G++++ LL G PF + + + R+I + D P + EA+ L+ K
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244
Query: 230 LLDPNPNSRI-----AISKIMESSWFK 251
LL +P R+ S+I E +FK
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-40
Identities = 84/271 (30%), Positives = 147/271 (54%), Gaps = 21/271 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++ +G + VYL R+ +T + AMK + K +I ++Q+ E ++ ++ +V +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+K + M+ V+GG+ + G L D+AR+YF + + A+++ H+ G+ HRDL
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127
Query: 120 KPENLLLDEDGNLKVTDFGLSA----------FSEHLKQDG---LLHTTCGTPAYVAPEV 166
KP+NLL+ G++K+TDFGLS + H+++D L CGTP Y+APEV
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187
Query: 167 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---FSSEA 223
I ++GY G D W+ G+ILY L G +PF D ++ ++ D + P ++A
Sbjct: 188 ILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADA 246
Query: 224 RRLITKLLDPNPNSRIAIS---KIMESSWFK 251
+ LI++LL NP R+ ++ + +F
Sbjct: 247 QDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 77/251 (30%), Positives = 134/251 (53%), Gaps = 8/251 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV--GKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
+LG G+F VY NL G A+K V D ++Q+++EI+++ ++H +IV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+ +Y ++LV GG L + K G E V R+Y +Q++ +++ H R HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
D+K N+L+D +G +K+ DFG+ ++ + + + G+P ++APEVI+++G G A
Sbjct: 127 DIKGANILVDTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-GDF-KCPPWFSSEARRLITKLLDPNP 235
DIWS G + + G P+ V+ KI R + P S EA+ I K L +P
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243
Query: 236 NSRIAISKIME 246
+ R ++++E
Sbjct: 244 SLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 86/262 (32%), Positives = 135/262 (51%), Gaps = 14/262 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L R+ + + AMK++ K ++IK E +M + IV+LH
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+Y M+ + GG+L N ++ + E AR Y +++ A+D HS G HRD+K
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH--TTCGTPAYVAPEVISKKGYD---GA 175
P+N+LLD+ G+LK+ DFG + +G++ T GTP Y++PEV+ +G D G
Sbjct: 170 PDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRLITKLL 231
+ D WS GV LY +L G PF D++V Y KI ++ P S +A+ LI L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286
Query: 232 DPNPN--SRIAISKIMESSWFK 251
R + +I +FK
Sbjct: 287 TDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 9e-40
Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG----MMEQIKREISVMKMVKHKHIV 57
LG G+ VY R+ TGK A+K I V +Q+ RE+ ++ + ++V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVY 115
+ + + +I ++ + GG L + + K G++ E V +Q++ +D+ H+ R +
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRD+KP NLL++ G +K+ DFG+S E +T GT Y++PE I +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYMSPERIQGE-SYSY 179
Query: 176 KADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPW----FSSEARRLIT 228
ADIWS G+ L G PF + + I G P FS E R I+
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPEFRDFIS 237
Query: 229 KLLDPNPNSRIAISKIMESSWFKKSA 254
L +P R + +++++ + KK+
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 80/265 (30%), Positives = 129/265 (48%), Gaps = 17/265 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V + R TG AMKV+ K ++ + + E ++ + I +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
K +Y M+ GG+L + + + + ED+A+ Y +L+ A+ H G HRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVI-----SKKG 171
+KPEN+L+D G++K+ DFG +A L + ++++ GTP Y+APEV+ KG
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRLI 227
G + D WS GVI Y ++ G PF + Y I ++ K P P SS+ LI
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI 244
Query: 228 TKLLDPNPNSRIAISKIMESSWFKK 252
LL R+ + +F K
Sbjct: 245 QSLL-CGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 85/300 (28%), Positives = 130/300 (43%), Gaps = 62/300 (20%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMK--VVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG GT+A VY AR+ +TG+ +A+K +G+ K K G+ REI +++ +KH +I+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSRGVYHR 117
+V KS I + + +L I + A + Y + +++ HS + HR
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-----------YVAPEV 166
DLKP NLL+ DG LK+ DFGL+ + G+P Y APE+
Sbjct: 127 DLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 167 ISKKGYDGAKADIWSCGVILYVLLAG--FLPFQDDNIVSMYRKIYRG----------DFK 214
+ + G D+WS G I LL FLP D + KI+
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGVT 231
Query: 215 CPPWF------------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
P + S +A L+ +LL NPN RI + +E +F + P
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 78/258 (30%), Positives = 126/258 (48%), Gaps = 11/258 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQI---KREISVMKMVKHKHIVE 58
LG G F KV LA +TG+ A+K + K +I +E + KR +H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
L ++ + F M+ GG+L I E A Y ++ + + H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +NLLLD +G +K+ DFGL E + T CGTP ++APEV+++ Y A D
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-VD 183
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W GV++Y +L G PF D+ ++ I + + P + S EA ++ +LL NP R
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERR 243
Query: 239 IAISK-----IMESSWFK 251
+ + + + +F+
Sbjct: 244 LGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 81/244 (33%), Positives = 132/244 (54%), Gaps = 7/244 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
MLG G+F KV+LA T + A+K + KD V+ +E E V+ + +H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF--QQLISAVDFCHSRGVYHR 117
+ +K ++F M+ + GG+L I + D+ R F ++I + F HS+G+ +R
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DLK +N+LLD DG++K+ DFG+ E++ D T CGTP Y+APE++ + Y
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 237
D WS GV+LY +L G PF + +++ I + P W + EA+ ++ KL P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 238 RIAI 241
R+ +
Sbjct: 238 RLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 7e-39
Identities = 91/295 (30%), Positives = 151/295 (51%), Gaps = 5/295 (1%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LA G+ A+K + KD V+ +E E V+ + ++ + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ +K ++F M+ + GG+L I KGR A Y +++ + F HS+G+ +RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N++LD DG++K+ DFG+ E++ D T CGTP Y+APE++ Y + D
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-VD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
WS GV+LY +L G PF D+ ++ I P W + E++ ++ KL + +P R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
Query: 239 IAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLS 293
+ + + F K+ + K+E++ K P + F LSE LS
Sbjct: 239 LGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLS 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 8e-39
Identities = 78/252 (30%), Positives = 135/252 (53%), Gaps = 10/252 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F K L ++ + GK +K + K + E+ ++E++V+ +KH +IV+ E
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHSRGVYHRD 118
+Y MD +GG+L+ KI R ED +F Q+ A+ H R + HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKKGYDGAKA 177
+K +N+ L +DG +K+ DFG++ L L TC GTP Y++PE+ + Y+ K+
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLSPEICENRPYNN-KS 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPN 236
DIW+ G +LY + F+ N+ ++ KI RG + +S + R L+++L NP
Sbjct: 183 DIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPR 242
Query: 237 SRIAISKIMESS 248
R +++ I+E +
Sbjct: 243 DRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 82/293 (27%), Positives = 126/293 (43%), Gaps = 56/293 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME----QIKREISVMKMVKHKHIV 57
+G GT+ +VY ARN +TG+ +A+K K+ E REI +++ ++H +IV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 58 ELHEVMASKSKI-------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
L E++ SK K Y DL G L + K E + Y +QL+ + + H
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDL--TGLLDSPEVK--FTESQIKCYMKQLLEGLQYLH 117
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--S 168
S G+ HRD+K N+L++ DG LK+ DFGL+ + T Y PE++ +
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G--------DFKCPPW 218
+ Y D+WS G IL L G FQ + KI+ G PW
Sbjct: 177 TR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 219 F---------------------SSEARRLITKLLDPNPNSRIAISKIMESSWF 250
F A L+ KLL +P RI+ + ++ +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 83/256 (32%), Positives = 130/256 (50%), Gaps = 13/256 (5%)
Query: 2 LGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G+F +V LA +A+K K K+IK ++ + E ++ + H V L+
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+S +Y ++ V GGE F + + R DV Y Q++ ++ S + +RDL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDL 157
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KPENLLLD+DG +K+TDFG + D +T CGTP Y+APE++ G+ G AD
Sbjct: 158 KPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKAADW 211
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W+ G+ +Y +L G PF + + +Y+KI G P + + + L+ KLL + R
Sbjct: 212 WTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRY 271
Query: 240 AISK-----IMESSWF 250
K + E WF
Sbjct: 272 GNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 84/282 (29%), Positives = 130/282 (46%), Gaps = 38/282 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY AR+ TG+ +A+K + K + G+ + REI ++K + H +I++L +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHSRGVYHRD 118
V K +Y + + K+ K R L E + + Y QL+ + FCHS G+ HRD
Sbjct: 66 VFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LKPENLL++ +G LK+ DFGL A S H T Y APE++ D
Sbjct: 124 LKPENLLINTEGVLKLADFGL-ARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPVD 181
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GD-----------------FKCPPW- 218
IWS G I LL+ F + + KI+R G F P
Sbjct: 182 IWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241
Query: 219 ----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
S +A L++++L +P+ RI + + +F
Sbjct: 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 85/259 (32%), Positives = 141/259 (54%), Gaps = 10/259 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LA T + A+K++ KD VI+ +E E V+ + K + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + ++YF M+ V GG+L I + G+ +E A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N++LD +G++K+ DFG+ EH+ T CGTP Y+APE+I+ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +LAG PF ++ +++ I + P S EA + L+ +P+ R
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 239 IAISK-----IMESSWFKK 252
+ I E ++F++
Sbjct: 244 LGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 82/242 (33%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LA T + A+K++ KD VI+ +E E V+ + K + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + ++YF M+ V GG+L +I + GR +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +LAG PF+ ++ +++ I + P S EA + L+ +P R
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243
Query: 239 IA 240
+
Sbjct: 244 LG 245
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 82/263 (31%), Positives = 136/263 (51%), Gaps = 24/263 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR---EISVMKMVKHKHIVE 58
LG G F KVY A++ +TG A K+ I++ E+++ EI ++ KH +IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 59 LHEVMASKSKIYFAMDLVKGGELFN---KIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
L+E ++K++ ++ GG L + ++ +G L E R +Q++ A++F HS V
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-----SKK 170
HRDLK N+LL DG++K+ DFG+SA ++ Q T GTP ++APEV+
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDN 183
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLI 227
YD KADIWS G+ L L P + N + + KI + + P +SS +
Sbjct: 184 PYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 228 TKLLDPNPNSRIAISKIMESSWF 250
L +P+ R +++++ +
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 24/260 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKMVKHKHI 56
+G G F+ VY A L G+ +A+K KV MM+ R EI ++K + H ++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKI----AKGRLREDVAR-VYFQQLISAVDFCHS 111
++ +++ ++L G+L I + RL + YF QL SA++ HS
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
+ + HRD+KP N+ + G +K+ D GL FS + H+ GTP Y++PE I +
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPYYMSPERIHEN 181
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPP--WFSSEARRL 226
GY+ K+DIWS G +LY + A PF D N+ S+ +KI + D+ P +S E R L
Sbjct: 182 GYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240
Query: 227 ITKLLDPNPNSRIAISKIME 246
+++ ++P+P R IS +++
Sbjct: 241 VSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 81/271 (29%), Positives = 145/271 (53%), Gaps = 26/271 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
++G G++AKV L +T + AMKV+ K+ V ++ ++ E V + H +V L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 60 HEVMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H ++S+++F ++ V GG+L F+ + +L E+ AR Y ++ A++F H RG+ +RD
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G++K+TD+G+ E ++ T CGTP Y+APE++ + Y G D
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVD 178
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSM------------YRKIYRGDFKCPPWFSSEARRL 226
W+ GV+++ ++AG PF +IV M ++ I + P S +A +
Sbjct: 179 WWALGVLMFEMMAGRSPF---DIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235
Query: 227 ITKLLDPNPNSRI------AISKIMESSWFK 251
+ L+ +P R+ I +F+
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-37
Identities = 77/255 (30%), Positives = 135/255 (52%), Gaps = 19/255 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV-------GKDKVIKVGMMEQIKREISVMKMVKH 53
++G GT+ +VYLA N+ TG+ MA+K V G+ + M++ ++ EI +K + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR 112
+IV+ ++ + ++ V GG + + + GR E + R + +Q++ + + HS+
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--SKK 170
G+ HRDLK +NLL+D DG K++DFG+S S+ + + + G+ ++APEVI +
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW-------FSSEA 223
GY AK DIWS G ++ + AG P+ D+ ++ K+ PP S A
Sbjct: 188 GYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNLSPVA 245
Query: 224 RRLITKLLDPNPNSR 238
+ NP++R
Sbjct: 246 LDFLNACFTINPDNR 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 90/279 (32%), Positives = 132/279 (47%), Gaps = 51/279 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V LAR + T AMK + K V+ + +K E ++ ++ +V L+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K +YF MD + GG++ + + + G ED+AR Y +L AV+ H G HRD+K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128
Query: 121 PENLLLDEDGNLKVTDFGL-SAF-----------SEHLKQDG------------------ 150
P+N+L+D DG++K+TDFGL + F +H++QD
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188
Query: 151 ---------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP 195
L H+ GTP Y+APEV+ + GY D WS GVILY +L G P
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPP 247
Query: 196 FQDDNIVSMYRKI--YRGDFKCPPW--FSSEARRLITKL 230
F + K+ ++ PP S EA LI KL
Sbjct: 248 FLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 74/267 (27%), Positives = 134/267 (50%), Gaps = 17/267 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G+F +VY A + +T + +A+KV+ ++ +E I++EI + + +I + +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITKYY 65
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
SK++ M+ GG + + G+L E ++++ +++ H G HRD+K
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISKKGYDGAKADI 179
N+LL E+G++K+ DFG+S L +T GTP ++APEVI + GYD KADI
Sbjct: 126 AANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE-KADI 181
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP------WFSSEARRLITKLLDP 233
WS G+ L G P D + M ++ K P FS + ++ L+
Sbjct: 182 WSLGITAIELAKGEPPLSD--LHPM--RVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237
Query: 234 NPNSRIAISKIMESSWFKKSAPKVVIT 260
+P R + ++++ + KK+ +T
Sbjct: 238 DPKERPSAKELLKHKFIKKAKKTSYLT 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 77/247 (31%), Positives = 123/247 (49%), Gaps = 23/247 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G++ VY A + +TG+ +A+KVV + +++I +EIS++K +IV+ +
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 62 VMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ M+ G + + KI L E+ Q + +++ HS HRD+
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 120 KPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
K N+LL+E+G K+ DFG+S K++ T GTP ++APEVI + GY+ KA
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAKRN----TVIGTPFWMAPEVIQEIGYN-NKA 180
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------SSEARRLITKLL 231
DIWS G+ + G P+ D I M R I+ K PP S E + K L
Sbjct: 181 DIWSLGITAIEMAEGKPPYSD--IHPM-RAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237
Query: 232 DPNPNSR 238
+P R
Sbjct: 238 VKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 6e-36
Identities = 83/240 (34%), Positives = 127/240 (52%), Gaps = 12/240 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L R+ T K AMK++ K ++IK E +M +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+Y M+ + GG+L N ++ + E AR Y +++ A+D HS G HRD+K
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH--TTCGTPAYVAPEVISKK---GYDGA 175
P+N+LLD+ G+LK+ DFG + ++G++ T GTP Y++PEV+ + GY G
Sbjct: 170 PDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRLITKLL 231
+ D WS GV LY +L G PF D++V Y KI ++ P S EA+ LI L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 80/252 (31%), Positives = 142/252 (56%), Gaps = 14/252 (5%)
Query: 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHK-H 55
+LG G + KV+L R + +GK AMKV+ K ++ K E + E V++ ++
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGV 114
+V LH + +K++ +D + GGELF ++ + R +E ++Y +++ A++ H G+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS--KKGY 172
+RD+K EN+LLD +G++ +TDFGLS H + ++ CGT Y+AP+++ G+
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 173 DGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 228
D A D WS GV++Y LL G PF + ++ + R+I + + P S+ A+ +I
Sbjct: 186 DKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQ 244
Query: 229 KLLDPNPNSRIA 240
+LL +P R+
Sbjct: 245 RLLMKDPKKRLG 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY AR+ TG+ +A+K + + G+ REIS++K + H +IV L +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 62 VMASKSKIYFA-----MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V+ S++K+Y +DL K + L + + Y QL+ + +CHS V H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKK---YMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122
Query: 117 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
RDLKP+NLL+D +G LK+ DFGL+ AF ++ H T Y APE++
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGSRQYST 179
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC--PP 217
DIWS G I ++ F D+ + +I+R D+K P
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239
Query: 218 W-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
W + L++K+L +P RI+ ++ +F
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 85/265 (32%), Positives = 140/265 (52%), Gaps = 18/265 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V + + TG+ AMK++ K +++K + E V+ + I LH
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
++ +Y MD GG+L ++K RL ED+AR Y +++ A+D H G HRD
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRD 127
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK----KGY 172
+KP+N+LLD++G++++ DFG S L DG + + GTP Y++PE++ KG
Sbjct: 128 IKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW---FSSEARRLI 227
G + D WS GV +Y +L G PF +++V Y KI ++ F+ PP S EA+ LI
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244
Query: 228 TKLLDPNPN--SRIAISKIMESSWF 250
+L+ R + + +F
Sbjct: 245 RRLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 74/267 (27%), Positives = 120/267 (44%), Gaps = 27/267 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V + TGK MA+K + + I + +QI RE+ ++ +IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 62 VMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRD 118
+ I M+ + GG L K +GR+ E + ++ + + H + HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGAK 176
+KP N+L++ G +K+ DFG+S Q + L T GT +Y+APE I Y K
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVS------GQLVNSLAKTFVGTSSYMAPERIQGNDY-SVK 179
Query: 177 ADIWSCGVILYVLLAGFLPF-----QDDNIVSMYRKIYRGDFKCPP-----WFSSEARRL 226
+DIWS G+ L L G P+ D I + + I PP FS + +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQDF 236
Query: 227 ITKLLDPNPNSRIAISKIMESSWFKKS 253
+ L +P R + +++E + KK
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 80/251 (31%), Positives = 140/251 (55%), Gaps = 14/251 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
++G G++AKV L R +T + AMKVV K+ V ++ ++ E V + H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
H ++S+++F ++ V GG+L + + R L E+ AR Y ++ A+++ H RG+ +RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G++K+TD+G+ E L+ T CGTP Y+APE++ + Y G D
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVD 178
Query: 179 IWSCGVILYVLLAGFLPFQ--------DDNIVS-MYRKIYRGDFKCPPWFSSEARRLITK 229
W+ GV+++ ++AG PF D N +++ I + P S +A ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 238
Query: 230 LLDPNPNSRIA 240
L+ +P R+
Sbjct: 239 FLNKDPKERLG 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 77/245 (31%), Positives = 129/245 (52%), Gaps = 9/245 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKHKHIVE 58
+LG G F +VYL ++ TG+ +A+K V D E ++ EI ++K ++H+ IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+ + + M+ + GG + +++ A G L E V R Y +Q++ V++ HS + HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSE--HLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
D+K N+L D GN+K+ DFG S + G+ T GTP +++PEVIS +GY G
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGEGY-GR 186
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPWFSSEARRLITKLLDP 233
KAD+WS G + +L P+ + ++ KI + + P S +AR + +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246
Query: 234 NPNSR 238
N R
Sbjct: 247 NAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 68/242 (28%), Positives = 114/242 (47%), Gaps = 10/242 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F V+ + AMK + K+ + E+ E V+ + +I+ +E
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSYIIRYYE 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLR----EDVARVYFQQLISAVDFCHSRGVYHR 117
K K+ M+ + G+L + R R + V R + Q L+ + HS+ + HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-GLAHLHSKKILHR 125
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
D+K NL LD N+K+ D G++ +T GTP Y++PE+ K Y+ K+
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKPYN-EKS 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNPN 236
D+W+ GV+LY G PF +N ++ KI RG F +S + +LI + L +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYR 242
Query: 237 SR 238
R
Sbjct: 243 QR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 76/245 (31%), Positives = 119/245 (48%), Gaps = 11/245 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V + TGK A K + K ++ K + E +++ V + IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 62 VMASKSKIYFAMDLVKGGEL---FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+K + M L+ GG+L + + E A Y Q+I ++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LKPEN+LLD+ GN++++D GL+ LK + GTP Y+APEV+ + YD D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 179 IWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 234
++ G LY ++AG PF+ + R+ + P FS EA+ L LL +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 235 PNSRI 239
P R+
Sbjct: 237 PEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 41/284 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G V+ A++ +TG+++A+K V ++ G+ Q REI ++ +H ++V+L +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGR--LREDVARVYFQQLISAVDFCHSRGVYHRDL 119
V S M+ + +L + L E + Y + L+ V + H+ G+ HRDL
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDL 125
Query: 120 KPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHT-TCGTPAYVAPEVI-SKKGYDGAK 176
KP NLL+ DG LK+ DFGL+ FSE ++ L++ T Y APE++ + YD
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSE---EEPRLYSHQVATRWYRAPELLYGARKYDPG- 181
Query: 177 ADIWSCGVILYVLLAG--FLPFQDD----NIV-----SM-------------YRKIYRGD 212
D+W+ G I LL G P ++D IV + Y KI +
Sbjct: 182 VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE 241
Query: 213 FKCPPW------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
K P S EA L+ LL +P+ R++ ++ + +F
Sbjct: 242 SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 87/279 (31%), Positives = 129/279 (46%), Gaps = 51/279 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V LA + T AMK + K V+ + +K E ++ ++ +V+L+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K +YF MD + GG++ + + + E +AR Y +L A++ H G HRD+K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128
Query: 121 PENLLLDEDGNLKVTDFGL-SAF-----------SEHLKQDG------------------ 150
P+N+L+D DG++K+TDFGL + F H++QD
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 151 ---------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP 195
L H+ GTP Y+APEV+ +KGY D WS GVIL+ +L G P
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPP 247
Query: 196 FQDDNIVSMYRKI--YRGDFKCPPW--FSSEARRLITKL 230
F K+ + PP S EA LITKL
Sbjct: 248 FLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 7e-35
Identities = 73/213 (34%), Positives = 117/213 (54%), Gaps = 8/213 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L R+ + K AMK++ K ++IK E +M +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+Y M+ + GG+L N ++ + E A+ Y +++ A+D HS G+ HRD+K
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH--TTCGTPAYVAPEVISKK---GYDGA 175
P+N+LLD+ G+LK+ DFG + + G++ T GTP Y++PEV+ + GY G
Sbjct: 170 PDNMLLDKHGHLKLADFGTCM---KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 208
+ D WS GV L+ +L G PF D++V Y KI
Sbjct: 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 69/262 (26%), Positives = 127/262 (48%), Gaps = 16/262 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G A VY A L + +A+K + +K ++++++E+ M H ++V+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 62 VMASKSKIYFAMDLVKGGELFN----KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+++ M + GG L + +G L E + ++++ +++ HS G HR
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVIS-KKGYDG 174
D+K N+LL EDG++K+ DFG+SA + + T GTP ++APEV+ GYD
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD- 185
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW------FSSEARRLIT 228
KADIWS G+ L G P+ + + + D +S R++I+
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245
Query: 229 KLLDPNPNSRIAISKIMESSWF 250
L +P+ R ++++ +F
Sbjct: 246 LCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 79/249 (31%), Positives = 137/249 (55%), Gaps = 12/249 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVEL 59
++G G++AKV L R + + AMKVV K+ V ++ ++ E V + + +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + S+++ ++ V GG+L + + R L E+ AR Y ++ A++F H RG+ +RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD DG++K+TD+G+ E L T CGTP Y+APE++ + Y G D
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVD 178
Query: 179 IWSCGVILYVLLAGFLPFQ------DDNIVS-MYRKIYRGDFKCPPWFSSEARRLITKLL 231
W+ GV+++ ++AG PF D N +++ I + P + S +A ++ L
Sbjct: 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238
Query: 232 DPNPNSRIA 240
+ +P R+
Sbjct: 239 NKDPKERLG 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 77/250 (30%), Positives = 131/250 (52%), Gaps = 10/250 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F V+L R K + +K + +++ K + E V+K++ H +I+E +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYY 65
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHSRGVYHR 117
E + M+ GG L I K L ED +F Q++ A+ H++ + HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 118 DLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
DLK +N+LLD+ +K+ DFG+ S+ L +T GTP Y++PE+ K Y+ K
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGI---SKILSSKSKAYTVVGTPCYISPELCEGKPYN-QK 181
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNP 235
+DIW+ G +LY L + F+ N+ ++ KI G F +S + R+LI +L+ +P
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDP 241
Query: 236 NSRIAISKIM 245
+ R +S+IM
Sbjct: 242 SKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 83/284 (29%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY ARN TG+ +A+K + D + G+ REIS++K + H +IV+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 62 VMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V+ +++K+Y DL K + + + + Y QL+ + FCHS V H
Sbjct: 67 VIHTENKLYLVFEFLHQDLKK---FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 117 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
RDLKP+NLL++ +G +K+ DFGL+ AF ++ H T Y APE++ Y
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 180
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------DFKC--PP 217
DIWS G I ++ F D+ + +I+R D+K P
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 218 W-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
W + R L++++L +PN RI+ + +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 77/244 (31%), Positives = 132/244 (54%), Gaps = 16/244 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V + + K AMK++ K +++K + E V+ ++ I LH
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
++ +Y MD GG+L ++K RL ED+AR Y +++ A+D H HRD
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK----KGY 172
+KP+N+L+D +G++++ DFG L +DG + ++ GTP Y++PE++ KG
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW---FSSEARRLI 227
G + D WS GV +Y +L G PF +++V Y KI ++ F+ P S +A+ LI
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244
Query: 228 TKLL 231
+L+
Sbjct: 245 RRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-33
Identities = 78/251 (31%), Positives = 131/251 (52%), Gaps = 11/251 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F K+YLA+ + +K + K + V E K+E+ ++ +KH +IV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHSRGVYHRD 118
+++ M+ GG+L +I + R ED +F Q+ + H R + HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 119 LKPENLLLDEDGNL-KVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKKGYDGAK 176
+K +N+ L ++G + K+ DFG++ L L TC GTP Y++PE+ + Y+ K
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQNRPYNN-K 182
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNP 235
DIWS G +LY L PF+ +N+ + KI +G F P FS + R LI++L +P
Sbjct: 183 TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSP 242
Query: 236 NSRIAISKIME 246
R +I+ I++
Sbjct: 243 RDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 78/252 (30%), Positives = 128/252 (50%), Gaps = 9/252 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G+F + L +++ + + AMK + K +E ++E ++ +KH +IV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIA--KGRL-REDVARVYFQQLISAVDFCHSRGVYHR 117
E + +Y M+ GG+L KI +G+L ED +F Q+ V H + V HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
D+K +N+ L ++G +K+ DFG + T GTP YV PE+ Y+ K+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMPYNN-KS 181
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNPN 236
DIWS G ILY L PFQ ++ ++ K+ +G +K P +S E R LI ++ NP
Sbjct: 182 DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR 241
Query: 237 SRIAISKIMESS 248
SR + + I+
Sbjct: 242 SRPSATTILSRG 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 87/303 (28%), Positives = 136/303 (44%), Gaps = 53/303 (17%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L + TGK AMK + K ++ K + +K E V+ +V L+
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRDL 119
+Y M+ + GG+L + K EDV R Y + + A++ H G HRD+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 120 KPENLLLDEDGNLKVTDFGLS---------AFSEHLKQDG-------------------- 150
KP+N+L+D G++K++DFGLS A+ + L Q
Sbjct: 128 KPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLT 187
Query: 151 ----------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194
+ ++T GTP Y+APE+ ++GY G + D WS G I++ L G+
Sbjct: 188 MSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWP 246
Query: 195 PFQDDNIVSMYRKI--YRGDFKCPP--WFSSEARRLITKLLDPNPN--SRIAISKIMESS 248
PF +N YRKI +R P S EA LI +L+ N R +I
Sbjct: 247 PFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHP 306
Query: 249 WFK 251
+F+
Sbjct: 307 FFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 87/291 (29%), Positives = 135/291 (46%), Gaps = 56/291 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG GT+A VY RN TG+ +A+K + D + G REIS+MK +KH++IV LH+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 62 VMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V+ +++K+ Y DL K + +G L + + + QL+ + FCH V H
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 117 RDLKPENLLLDEDGNLKVTDFGL--------SAFSEHLKQDGLLHTTCGTPAYVAPEVIS 168
RDLKP+NLL+++ G LK+ DFGL + FS + T Y AP+V+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----------TLWYRAPDVLL 173
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKI---------------- 208
DIWS G I+ ++ G F +D ++ ++R +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 209 YRGDF-KCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
Y+ F + P P L+ +LL NP RI+ ++ WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 72/268 (26%), Positives = 141/268 (52%), Gaps = 23/268 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKRE-----ISVMKMVKHKHI 56
+G G+ V +A + TG+ +A+K K+ + +Q +RE + +M+ +H +I
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK--------KMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
VE++ +++ M+ ++GG L + + R+ E+ ++ A+ F H++GV H
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
RD+K +++LL DG +K++DFG A S+ + + L GTP ++APEVIS+ Y G
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPEVISRLPY-GT 194
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----FKCPPWFSSEARRLITKLL 231
+ DIWS G+++ ++ G P+ ++ + ++I R + K S R + ++L
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLKNLHKVSPRLRSFLDRML 253
Query: 232 DPNPNSRIAISKIMESSWFKKSAPKVVI 259
+P R ++++ + K+ P I
Sbjct: 254 VRDPAQRATAAELLNHPFLAKAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 80/254 (31%), Positives = 132/254 (51%), Gaps = 16/254 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F++VY A L G +A+K V ++ +EI ++K + H ++++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+++ ++L G+L I K + E YF QL SA++ HSR V H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RD+KP N+ + G +K+ D GL F + H+ GTP Y++PE I + GY+ K
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYN-FK 186
Query: 177 ADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPW----FSSEARRLITKL 230
+DIWS G +LY + A PF D N+ S+ +KI + D+ PP +S E R+L+
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMC 244
Query: 231 LDPNPNSRIAISKI 244
++P+P R I+ +
Sbjct: 245 INPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 77/266 (28%), Positives = 140/266 (52%), Gaps = 23/266 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV--------GKDKVIKVGMMEQIKREISVMKMVK 52
++G G+F VYL N +G+ MA+K V KD+ K M++ + REI+++K ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDR--KRSMLDALAREIALLKELQ 64
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS 111
H++IV+ + ++ V GG + + G E + R + +Q++ +++ H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLS----AFSEHLKQDGLLHTTCGTPAYVAPEVI 167
RG+ HRD+K N+L+D G +K++DFG+S A S K +G + G+ ++APEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF----SSEA 223
+ Y KADIWS G ++ +L G PF D + + I++ P SSEA
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGENASPEIPSNISSEA 240
Query: 224 RRLITKLLDPNPNSRIAISKIMESSW 249
+ K + + N R +++++ +
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 21/260 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKS-MAMKVV-------GKDKVIKVGMMEQIKREISVMK-MVK 52
LG G F VY R G++ +A+K + GKDK + + I E++++K ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKG---GELFN--KIAKGRLREDVARVYFQQLISAVD 107
H +IV ++ ++Y MDL++G GE FN K K R E+ F Q++ A+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 108 FCH-SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 166
+ H + + HRDL P N++L ED + +TDFGL ++ + + L + GT Y PE+
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTILYSCPEI 184
Query: 167 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--WFSSEAR 224
+ + Y G KAD+W+ G ILY + PF N++S+ KI ++ P +S +
Sbjct: 185 VKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243
Query: 225 RLITKLLDPNPNSRIAISKI 244
+IT L P+ +R I ++
Sbjct: 244 DVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 80/258 (31%), Positives = 136/258 (52%), Gaps = 16/258 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F++VY A L K +A+K V +++ + +EI ++K + H ++++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 62 VMASKSKIYFAMDLVKGGEL-----FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+++ ++L G+L + K K + E YF QL SAV+ HSR V H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RD+KP N+ + G +K+ D GL F + H+ GTP Y++PE I + GY+ K
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYN-FK 186
Query: 177 ADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPW----FSSEARRLITKL 230
+DIWS G +LY + A PF D N+ S+ +KI + D+ PP +S + R L++
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTEHYSEKLRELVSMC 244
Query: 231 LDPNPNSRIAISKIMESS 248
+ P+P+ R I + + +
Sbjct: 245 IYPDPDQRPDIGYVHQIA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 75/268 (27%), Positives = 138/268 (51%), Gaps = 27/268 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVG----KDKVIKVGMMEQIKREISVMKMVKH--- 53
++G G + VY +++ TG+ +A+K++ D V I+RE++++ ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV------SDIQREVALLSQLRQSQP 61
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+I + + +++ M+ +GG + + G + E V ++++ A+ + H G
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVISK-KG 171
V HRD+K N+L+ GN+K+ DFG++A L Q+ +T GTP ++APEVI++ K
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAA---LLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-----WFSSEARRL 226
YD KADIWS G+ +Y + G P+ D V +R + PP +S R
Sbjct: 179 YD-TKADIWSLGITIYEMATGNPPYSD---VDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234
Query: 227 ITKLLDPNPNSRIAISKIMESSWFKKSA 254
+ LD P R++ ++++S W K +
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIKAHS 262
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 86/290 (29%), Positives = 135/290 (46%), Gaps = 55/290 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVK-HKHIVE 58
+G GTF++V A++ +TGK A+K + K + EQ+ REI ++ + H +I+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSL---EQVNNLREIQALRRLSPHPNILR 62
Query: 59 LHEVM-----ASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCH 110
L EV+ + ++ MD+ L+ I KGR L E + Y QL+ ++D H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDM----NLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVISK 169
G++HRD+KPEN+L+ +D LK+ DFG S + K +T T Y APE +
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFG-SCRGIYSKPP---YTEYISTRWYRAPECLLT 172
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------------------- 210
GY G K DIW+ G + + +L+ F F N + KI+
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 211 ----------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
G K P S+E L+ KLL +P+ RI + + +F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 77/244 (31%), Positives = 130/244 (53%), Gaps = 16/244 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V + + T + AMK++ K +++K + E +V+ + I LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
++ +Y MD GG+L ++K RL ED+AR Y +++ A+ H HRD
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRD 127
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK----KGY 172
+KP+N+LLD +G++++ DFG + QDG + ++ GTP Y++PE++ G
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCL---KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPWF---SSEARRLI 227
G + D WS GV +Y +L G PF +++V Y KI + F+ P S EA+ LI
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244
Query: 228 TKLL 231
+L+
Sbjct: 245 QRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-32
Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMA---MKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
++G G + V RN TG+ +A K D+ +K + RE+ V++ ++H++IV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQLRHENIV 63
Query: 58 ELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
L E K ++Y + V+ EL G L D R Y QL+ A+ +CHS +
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKGYD 173
HRD+KPEN+L+ E G LK+ DFG F+ L+ T T Y APE++
Sbjct: 123 HRDIKPENILVSESGVLKLCDFG---FARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 174 GAKADIWSCGVILYVLLAG 192
G D+W+ G I+ LL G
Sbjct: 180 GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 46/286 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ V+ A+N +T + +A+K V D + G+ REI ++K +KHK+IV L++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYD 66
Query: 62 VMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V+ S K+ Y DL K + G + ++ + + QL+ + FCHS V H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKK----YFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122
Query: 117 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGYDG 174
RDLKP+NLL++++G LK+ DFGL+ AF ++ T Y P+V+ K Y
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFGAKLYS- 178
Query: 175 AKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYR----------------GDFKCPP 217
D+WS G I L P F +++ ++I+R D+K P
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238
Query: 218 WF-------------SSEARRLITKLLDPNPNSRIAISKIMESSWF 250
+ +S R L+ LL NP RI+ + ++ +F
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 26/253 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-MMEQIK---REISVMKMVKHKHI 56
LG G F +VY + G ++V K +K +QI+ RE +M+ + H ++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVK--TLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC------ 109
V+L V + +Y M+ ++GG+L LR++ ++ L+S A+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDL-----LSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-P-AYVAPEVI 167
S+ HRDL N L+ E+ +K++DFGL S L D G P ++APE +
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 168 SKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARR 225
+ + +K+D+WS GV+L+ + G P+ + + + G PP E
Sbjct: 176 KEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234
Query: 226 LITKLLDPNPNSR 238
L+ + +P R
Sbjct: 235 LMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 72/250 (28%), Positives = 129/250 (51%), Gaps = 10/250 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F + L R + + K V ++ + + + EI ++ +++H +I+ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNIIAYYN 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIA--KGRL-REDVARVYFQQLISAVDFCHSRGVYHRD 118
+ + M+ GG L++KI KG+L E++ Y Q++SAV + H G+ HRD
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKKGYDGAKA 177
+K N+ L + G +K+ DFG+ S+ L + + T GTP Y++PE+ Y+ K+
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGI---SKILGSEYSMAETVVGTPYYMSPELCQGVKYN-FKS 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNPN 236
DIW+ G +LY LL F N +++ KI +G++ +SSE L+ LL +P
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPE 242
Query: 237 SRIAISKIME 246
R ++++
Sbjct: 243 KRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 68/190 (35%), Positives = 109/190 (57%), Gaps = 15/190 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY AR++ TG+ +A+KV+ K+ E I++EIS++K +H +IV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 62 VMASKSKIYFAMDLVKGGELFN--KIAKGRLRED-VARVYFQQLISAVDFCHSRGVYHRD 118
+ K++ M+ GG L + ++ +G L E +A V + L + + H G HRD
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-KGLAYLHETGKIHRD 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYDG 174
+K N+LL EDG++K+ DFG+SA + + + + GTP ++APEV K GYDG
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVAAVERKGGYDG 183
Query: 175 AKADIWSCGV 184
K DIW+ G+
Sbjct: 184 -KCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 84/284 (29%), Positives = 137/284 (48%), Gaps = 40/284 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L + TG AMK++ K +++ + I+ E ++ +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
K +Y M+ + GG++ + K L E+ + Y + + A+D H G HRD+
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127
Query: 120 KPENLLLDEDGNLKVTDFGL---------------------SAFS----------EHLKQ 148
KP+NLLLD G++K++DFGL S FS E K+
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 149 D--GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 206
+ L ++T GTP Y+APEV + GY+ D WS GVI+Y +L G+ PF + YR
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYR 246
Query: 207 KI--YRGDFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIME 246
K+ ++ PP S +A+ LI + + N RI + + E
Sbjct: 247 KVMNWKETLVFPPEVPISEKAKDLILRFCTDSEN-RIGSNGVEE 289
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 7e-30
Identities = 79/262 (30%), Positives = 132/262 (50%), Gaps = 18/262 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F KVY A+N +TG A KV+ + +E EI ++ H +IV+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYMVEIEILATCNHPYIVKLLG 76
Query: 62 VMASKSKIYFAMDLVKGGE---LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
K++ ++ GG + ++ +G L E +V +Q++ A+ + HS + HRD
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-----SKKGYD 173
LK N+LL DG++K+ DFG+SA +++K + GTP ++APEV+ YD
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKL 230
KADIWS G+ L + P + N + + KI + + P +S E R +
Sbjct: 194 -YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTA 252
Query: 231 LDPNPNSRIAISKIMESSWFKK 252
LD +P +R + ++++E +
Sbjct: 253 LDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 21/199 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK-----DKVIKVGMMEQIKREI-SVMKMVKHKH 55
LG GTF VYLARN +TG+ +A+K + K ++ + + RE+ S+ K+ +H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-------REVKSLRKLNEHPN 59
Query: 56 IVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
IV+L EV ++YF + ++G +L E V R Q++ + H G
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
+HRDLKPENLL+ +K+ DFGL + ++ T Y APE++ +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRAPEILLRSTSY 176
Query: 174 GAKADIWSCGVI---LYVL 189
+ DIW+ G I LY L
Sbjct: 177 SSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 70/304 (23%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-------IKREISVMKMVKHK 54
+G G + V A + +TG+ +A+K K+ + I REI +++ ++H+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIK--------KISNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 55 HIVELHEVMASKSK-----IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDF 108
+I+ L +++ S +Y +L +L I + L +D + + Q++ + +
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEHLKQDGLLHTTCGTPAYV---- 162
HS V HRDLKP N+L++ + +LK+ DFGL+ + ++ L YV
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTRW 171
Query: 163 --APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G-----D 212
APE++ S Y A DIWS G I LL F + + I G D
Sbjct: 172 YRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 213 FKCP------------------PW------FSSEARRLITKLLDPNPNSRIAISKIMESS 248
K P S EA L+ K+L +P RI + +
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290
Query: 249 WFKK 252
+ +
Sbjct: 291 YLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 88/286 (30%), Positives = 141/286 (49%), Gaps = 45/286 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY RN +TG+ +AMK + + + + G+ REIS++K ++H +IV L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 62 VMASKSKIYF-----AMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVY 115
V+ +S++Y +MDL K + + KG+ + ++ + Y Q++ + FCHSR V
Sbjct: 67 VLMQESRLYLIFEFLSMDLKK---YLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
HRDLKP+NLL+D G +K+ DFGL+ AF ++ H T Y APEV+
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVV-TLWYRAPEVLLGSPRYS 180
Query: 175 AKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYR----------------GDFKC-- 215
DIWS G I + +A P F D+ + +I+R D+K
Sbjct: 181 TPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 216 PPW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
P W + L+ K+L +P RI+ K + +F
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 27/254 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-MMEQIK---REISVMKMVKHKHI 56
LG G F +VY G ++V K +K +QI+ RE +M+ + H +I
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVK--TLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC----- 109
V+L V + + M+ + GG+L LR+ + L+S A+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDL-----LDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 110 -HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-P-AYVAPEV 166
S+ HRDL N L+ E+ +K++DFGL S L D G P ++APE
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 167 ISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEAR 224
+ + + +K+D+WS GV+L+ + G P+ + + + +G PP E
Sbjct: 176 LKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELY 234
Query: 225 RLITKLLDPNPNSR 238
+L+ + +P R
Sbjct: 235 KLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 84/265 (31%), Positives = 134/265 (50%), Gaps = 20/265 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKVGMMEQIKREI--SVMKMVKHKHIV 57
++G G F +VY R TGK AMK + K ++ +K G + I S++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDG 174
RDLKP N+LLDE G+++++D GL+ FS+ H + GT Y+APEV+ K YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQKGVAYD- 174
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMY---RKIYRGDFKCPPWFSSEARRLITKLL 231
+ AD +S G +L+ LL G PF+ + R + P FS E R L+ LL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234
Query: 232 DPNPNSRIAI-----SKIMESSWFK 251
+ N R+ ++ E +F+
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 13/263 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVG---KDKVIKVGMMEQIKREISVMKMVKHKHIV 57
LG G F+ Y AR+++TG MA+K V + ++E +++EI +M + H HI+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ S ++ + GG + + ++K G +E V Y +QL+ + + H + H
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 117 RDLKPENLLLDEDGN-LKVTDFGLSA-FSEHLKQDGLLH-TTCGTPAYVAPEVISKKGYD 173
RD+K NLL+D G L++ DFG +A + G GT A++APEV+ + Y
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY- 185
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----GDFKCPPWFSSEARRLIT 228
G D+WS G ++ + P+ + + I++ P S R +
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL 245
Query: 229 KLLDPNPNSRIAISKIMESSWFK 251
+ L+ P R ++++ F+
Sbjct: 246 RCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-29
Identities = 76/259 (29%), Positives = 137/259 (52%), Gaps = 13/259 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G VY A ++ TG+ +A+K + + K E I EI VM+ KH +IV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPNIVNYLD 83
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ + GG L + + + + E ++ + A++F HS V HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
+N+LL DG++K+TDFG A E K+ T GTP ++APEV+++K Y G K DI
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY-GPKVDI 198
Query: 180 WSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPN 236
WS G++ ++ G P+ ++N + ++Y G + + P S+ R + + L+ +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 258
Query: 237 SRIAISKIMESSWFKKSAP 255
R + ++++ + K + P
Sbjct: 259 KRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 85/300 (28%), Positives = 128/300 (42%), Gaps = 62/300 (20%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY AR+ +G+ +A+K V D + G+ REI+++ ++H +IVEL E
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 62 VMASKS--KIYFAM-----DLVKGGELFNKIAKGRLREDVARVY--------FQQLISAV 106
V+ K I+ M DL L +++ + QL+ +
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDL------------ASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 107 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 166
+ H + HRDLK NLLL + G LK+ DFGL+ + + T Y APE+
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPEL 179
Query: 167 I-SKKGYDGAKADIWSCGVILYVLLAG--FLP-----FQDDNIVSMY----RKIYRGDFK 214
+ Y A D+W+ G IL LLA LP Q D I+ + I+ G
Sbjct: 180 LLGCTTYTTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238
Query: 215 CP-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255
P PW S RL+ LL +P R + +ESS+FK+
Sbjct: 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 80/258 (31%), Positives = 125/258 (48%), Gaps = 25/258 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV---GKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
+G G VY + TG+ A+KV+ +D V + QI REI +++ V H ++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNHPNVVK 136
Query: 59 LHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
H++ +I ++ + GG L IA + DVAR Q++S + + H R + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTCGTPAYVAPEVI----SKKGY 172
D+KP NLL++ N+K+ DFG+S L Q +++ GT AY++PE I + Y
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 173 DGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 228
DG DIWS GV + G PF Q D M + P S E R I+
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFIS 309
Query: 229 KLLDPNPNSRIAISKIME 246
L P R + ++++
Sbjct: 310 CCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 89/264 (33%), Positives = 128/264 (48%), Gaps = 26/264 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHI 56
+LG G V A+ + G+ A+KVV + GM E K E+ + I
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDME-----GMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 57 VELHEVMASK--------SKIYFAMDLVKGGELFNKIAKGR------LREDVARVYFQQL 102
V+ HE A K I +D G+L +I K R RE A + F Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFIQV 152
Query: 103 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 162
+ AV HS+ + HRD+K N+LL +G +K+ DFG S D + T CGTP YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 163 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSS 221
APE+ +K Y KAD++S GV+LY LL PF +N+ + K G + PP S
Sbjct: 213 APEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP 271
Query: 222 EARRLITKLLDPNPNSRIAISKIM 245
E + ++T LL +P R + SK++
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 75/262 (28%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G VY A ++ TG+ +A+K + + K E I EI VM+ K+ +IV +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLD 83
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ + GG L + + + + E ++ + A+DF HS V HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
+N+LL DG++K+TDFG A + + T GTP ++APEV+++K Y G K DIWS
Sbjct: 144 DNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWS 200
Query: 182 CGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPNSR 238
G++ ++ G P+ ++N + ++Y G + + P S+ R + + L+ + + R
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 239 IAISKIMESSWFKKSAPKVVIT 260
+ ++++ + K + P +T
Sbjct: 261 GSAKELLQHPFLKLAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 39/268 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L + TG AMK++ K +++ + I+ E ++ +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
K +Y M+ + GG++ + K L E+ + Y + + A+D H G HRD+
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127
Query: 120 KPENLLLDEDGNLKVTDFGL---------SAFSEHLKQD--------------------- 149
KP+NLLLD G++K++DFGL + F +L
Sbjct: 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKR 187
Query: 150 ---GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 206
L +T GTP Y+APEV + GY+ D WS GVI+Y +L G+ PF + Y+
Sbjct: 188 NRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYK 246
Query: 207 KI--YRGDFKCPPW--FSSEARRLITKL 230
K+ ++ PP S +A+ LI +
Sbjct: 247 KVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 81/264 (30%), Positives = 133/264 (50%), Gaps = 18/264 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKVGMMEQIKREI--SVMKMVKHKHIV 57
++G G F +VY R TGK AMK + K ++ +K G + I S++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
RDLKP N+LLDE G+++++D GL+ FS+ H + GT Y+APEV+ K +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQKGTAYDS 175
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMY---RKIYRGDFKCPPWFSSEARRLITKLLD 232
AD +S G +L+ LL G PF+ + R + + P FS E + L+ LL
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 233 PNPNSRIAI-----SKIMESSWFK 251
+ + R+ ++ E +FK
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 19/257 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
LG G F +VY G+ KV V K +K G E+ + E S+MK + H +I
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAV---KTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA-RVYF-QQLISAVDFCHSRGV 114
V L V +Y + + GG+L + + K + + + Q+ +++ S+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVISKKG 171
HRDL N L+ E+ +K++DFGLS + +D G ++APE +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRD---IYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 172 YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITK 229
+ +K+D+WS GV+L+ + G P+ + + + G P E L+ +
Sbjct: 181 FT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ 239
Query: 230 LLDPNPNSRIAISKIME 246
+P R S+++E
Sbjct: 240 CWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-28
Identities = 77/241 (31%), Positives = 127/241 (52%), Gaps = 13/241 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKHKHIVE 58
+LG G F +VYL + TG+ +A+K V D E ++ EI ++K + H+ IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 59 ----LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 113
L + M I+ M+ + GG + +++ + G L E+V R Y +Q++ V + HS
Sbjct: 69 YYGCLRDPMERTLSIF--MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISKKGY 172
+ HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEVIS +GY
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GDFKCPPWFSSEARRLITKL 230
G KADIWS G + +L P+ + ++ KI + PP S R + ++
Sbjct: 187 -GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245
Query: 231 L 231
Sbjct: 246 F 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 29/269 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELH 60
+G GT+ KVY AR+ +TG+ +A+K++ + + E+IK E +++ K H +I +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSNHPNIATFY 69
Query: 61 EVMASKS------KIYFAMDLVKGG---ELFNKIAK--GRLREDVARVYFQQLISAVDFC 109
K+ +++ M+L GG +L + K RL+E+ ++ + + +
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTCGTPAYVAPEVIS 168
H V HRD+K +N+LL ++ +K+ DFG+SA L G +T GTP ++APEVI+
Sbjct: 130 HENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTPYWMAPEVIA 186
Query: 169 KK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFS 220
YD A++D+WS G+ L G P D + + KI R K P +S
Sbjct: 187 CDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWS 245
Query: 221 SEARRLITKLLDPNPNSRIAISKIMESSW 249
+ I++ L N R + +++E +
Sbjct: 246 KKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 67/193 (34%), Positives = 112/193 (58%), Gaps = 9/193 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKHKHIVE 58
+LG G F +VYL + TG+ +A+K V D + E ++ EI ++K ++H IV+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 59 LHEVM--ASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+ + + K+ ++ + GG + +++ A G L E+V R Y +Q++ V + HS +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISKKGYDG 174
HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEVIS +GY G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-G 187
Query: 175 AKADIWS--CGVI 185
KAD+WS C V+
Sbjct: 188 RKADVWSVACTVV 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 83/290 (28%), Positives = 123/290 (42%), Gaps = 45/290 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELH 60
+G GT+ KVY AR+ TGK +A+K + ++ + G+ REIS+++M+ +IV L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 61 EVMASKSKI----------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
+V + K Y DL K + + L + + QL+ V CH
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 111 SRGVYHRDLKPENLLLDEDGN-LKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVIS 168
GV HRDLKP+NLL+D+ LK+ D GL AFS +K H T Y APEV+
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV-TLWYRAPEVLL 184
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----------GDFKCPP 217
+ DIWS G I + F D+ + I++ G K
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD 244
Query: 218 W-----------------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
W S E L+ K+L +P RI+ + +F
Sbjct: 245 WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-27
Identities = 73/236 (30%), Positives = 122/236 (51%), Gaps = 29/236 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKHKHIVE 58
+LG G F +VYL ++ TG+ +A K V D E ++ EI ++K ++H+ IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 59 LHEVMASKSK--IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+ + +++ + M+ + GG + +++ A G L E V R Y +Q++ + + HS +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISKKGYDG 174
HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEVIS +GY G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-G 187
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 230
KAD+WS G + +L + PPW EA I K+
Sbjct: 188 RKADVWSLGCTVVEMLT----------------------EKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 84/267 (31%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 4 HGTFAKVYLARNLQTGKSMAMK-VVGKDKVIKVGMMEQIKR-------EISVMKMVKHKH 55
H + RN T +A + K+KV+ +M +R E+ + H
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFG 126
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDV------ARVYFQQLISAVDFC 109
IV+ + S K+ M+ GG+L NK K RL+E + + F Q++ A+D
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVIS 168
HSR + HRDLK N+ L G +K+ DFG S +S+ + D + + CGTP Y+APE+
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWE 244
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLI 227
+K Y KAD+WS GVILY LL PF+ + + +++ G + P SS + L+
Sbjct: 245 RKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303
Query: 228 TKLLDPNPNSRIAISKIMESSWFKKSA 254
LL NP R +++ + + K A
Sbjct: 304 DPLLSKNPALRPTTQQLLHTEFLKYVA 330
|
Length = 478 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 75/264 (28%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G VY A ++ TG+ +A++ + + K E I EI VM+ K+ +IV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLD 84
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ + GG L + + + + E ++ + A++F HS V HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
+N+LL DG++K+TDFG A E K+ ++ GTP ++APEV+++K Y G K DI
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAY-GPKVDI 199
Query: 180 WSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPN 236
WS G++ ++ G P+ ++N + ++Y G + + P S+ R + + LD +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 237 SRIAISKIMESSWFKKSAPKVVIT 260
R + ++++ + K + P +T
Sbjct: 260 KRGSAKELLQHQFLKIAKPLSSLT 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 52/291 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMVK---HK 54
+G G + VY AR+L TG+ +A+K V ++ G+ REI+++K ++ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-----GIPLSTLREIALLKQLESFEHP 61
Query: 55 HIVELHEV-----MASKSKIYFAMDLVKG--GELFNKIAKGRLREDVARVYFQQLISAVD 107
+IV L +V + K+ + V +K K L + + +QL+ VD
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 108 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEV 166
F HS + HRDLKP+N+L+ DG +K+ DFGL+ +S + L + T Y APEV
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LTSVVVTLWYRAPEV 177
Query: 167 ISKKGYDGAKADIWSCGVI---LYVLLAGF-----------------LPFQDD---NIV- 202
+ + Y D+WS G I L+ F LP +++ N+
Sbjct: 178 LLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236
Query: 203 --SMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
S + FK P E L+ K+L NP+ RI+ + ++ +F
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 74/256 (28%), Positives = 126/256 (49%), Gaps = 18/256 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-----QIKREISVMKMVKHKHI 56
LG G+F VYL ++ + +KV+ K I VG + Q +E ++ + H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL---KEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHS 111
V+ H + + +G +L K+ L E+ +F QL+ V + H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
R + HRDLK +N+ L ++ LK+ DFG+S + L T GTP Y++PE + +G
Sbjct: 125 RRILHRDLKAKNIFL-KNNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPEALKHQG 181
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKL 230
YD +K+DIWS G ILY + F+ N +S+ +I G P +S + ++ +
Sbjct: 182 YD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSM 240
Query: 231 LDPNPNSRIAISKIME 246
L+ +P+ R + ++I+
Sbjct: 241 LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 81/276 (29%), Positives = 123/276 (44%), Gaps = 26/276 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V R TG A+K + D + +QI RE+ + K K +IV+ +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL--QKQILRELEINKSCKSPYIVKYYG 66
Query: 62 --VMASKSKIYFAMDLVKGGEL---FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGV 114
+ S S I AM+ +GG L + K+ K GR+ E V + ++ + + HSR +
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
HRD+KP N+LL G +K+ DFG+S G T GT Y+APE I K Y
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSG-ELVNSLAG---TFTGTSFYMAPERIQGKPYS- 181
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDN------------IVSMYRKIYRGDFKCPPWFSSE 222
+D+WS G+ L + PF + IV+M + + +S E
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEE 241
Query: 223 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 258
+ I + L+ +P R ++E W K K V
Sbjct: 242 FKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 70/266 (26%), Positives = 144/266 (54%), Gaps = 18/266 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+ V +AR +G+ +A+K++ K + E + E+ +M+ +H+++VE+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYK 85
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ ++GG L + +++ RL E+ + ++ A+ + HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 122 ENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
+++LL DG +K++DFG A S+ + + L GTP ++APEVIS+ Y G + DIW
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------SSEARRLITKLLDPN 234
S G+++ ++ G P+ D+ V +++ PP S R + ++L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKISPVLRDFLERMLTRE 258
Query: 235 PNSRIAISKIMESSW-FKKSAPKVVI 259
P R ++++ + + P+ ++
Sbjct: 259 PQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 74/262 (28%), Positives = 138/262 (52%), Gaps = 9/262 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G V+ A ++ TG+ +A+K + K K E I EI VMK +K+ +IV +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLD 83
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ + GG L + + + + E ++ + A++F H+ V HRD+K
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKS 143
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
+N+LL DG++K+TDFG A + + T GTP ++APEV+++K Y G K DIWS
Sbjct: 144 DNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWS 200
Query: 182 CGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPNSR 238
G++ ++ G P+ ++N + ++Y G + + P S R + + L+ + R
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260
Query: 239 IAISKIMESSWFKKSAPKVVIT 260
+ ++++ + K + P +T
Sbjct: 261 GSAKELLQHPFLKLAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-26
Identities = 73/266 (27%), Positives = 137/266 (51%), Gaps = 19/266 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+ V +A TGK +A+K K + K E + E+ +M+ H+++V+++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ ++GG L + + R+ E+ ++ A+ + H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
+++LL DG +K++DFG A E K+ L+ GTP ++APEVIS+ Y G + DI
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPY-GTEVDI 201
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------SSEARRLITKLLDP 233
WS G+++ ++ G P+ ++ + R+I PP SS R + +L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 234 NPNSRIAISKIMESSWFKKSAPKVVI 259
P+ R ++++ + K + P I
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPPSCI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 43/286 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY AR+ T +++A+K + ++ + G+ REIS++K ++H +IV L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 62 VMASKSKIYFA-----MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V+ S+ ++Y +DL K + AK + + Y Q++ + +CHS V H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN---PRLIKTYLYQILRGIAYCHSHRVLH 125
Query: 117 RDLKPENLLLDEDGN-LKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
RDLKP+NLL+D N LK+ DFGL+ AF ++ H T Y APE++ +
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYRAPEILLGSRHYS 182
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC--P 216
DIWS G I ++ F D+ + KI+R D+K P
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP 242
Query: 217 PW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
W L++K+L +P+ RI +E +FK
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 11/214 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVG---KDKVIKVGMMEQIKREISVMKMVKHKHIV 57
+LG G + VY G+ +A+K V + + E+++ E+ ++K +KH +IV
Sbjct: 7 VLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + I M+ V GG + + + + G L E V Y +Q++ V + H+ V H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 117 RDLKPENLLLDEDGNLKVTDFG----LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 172
RD+K N++L +G +K+ DFG L+ H +L + GTP ++APEVI++ GY
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMY 205
G K+DIWS G ++ + G P D + +M+
Sbjct: 186 -GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + VY + TG +MAMK + + + QI E+ ++ +IV+ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSR-GVY 115
+ +Y M+ + G L +K+ A + EDV R ++ + F +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRD+KP N+L++ +G +K+ DFG+S L T G +Y+APE I G +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 176 -----KADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGD-FKCPPWFSSEARRL 226
++D+WS G+ + + G P+ NI + I GD P +S +A+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241
Query: 227 ITKLLDPNPNSRIAISKIMESSWFKK 252
+ K L+ PN R ++++E W K
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 57/296 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ +VY AR+ TG+ +A+K V D K G REI +++ + H++IV L E
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-------GRLR-------EDVARVYFQQLISAVD 107
++ K A+D K F + + G L ED + + +QL+ ++
Sbjct: 74 IVTDKQD---ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 108 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEV 166
+CH + HRD+K N+LL+ G +K+ DFGL+ ++ +T T Y PE+
Sbjct: 131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVITLWYRPPEL 188
Query: 167 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----------------------- 203
+ + G D+WSCG IL L FQ + ++
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL 248
Query: 204 ----------MYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249
YR+ R +F P + A L+ +L +P+ R + + S W
Sbjct: 249 PYFNTMKPKKQYRRRLREEFSFIP---TPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 40/269 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
LG G F +VY + L+ A+K + +D + + +E VMK + H ++V
Sbjct: 3 LGEGAFGEVYKGK-LKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVV 59
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE--------DVARVYFQQLIS-AVDF 108
L V + +Y ++ ++GG+L LR+ + + + + L+S A+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDL-----LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 109 C------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 162
S+ HRDL N L+ ED +K++DFGL S + D G +
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPI 171
Query: 163 ---APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF---QDDNIVSMYRKIYRGDFKC 215
APE + + +K+D+WS GV+L+ + G P+ ++ ++ RK YR
Sbjct: 172 RWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR--LPK 228
Query: 216 PPWFSSEARRLITKLLDPNPNSRIAISKI 244
P + E L+ +P R S++
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 78/250 (31%), Positives = 122/250 (48%), Gaps = 18/250 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V + TGK A K + K ++ K E E ++ V + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+K+ + M ++ GG+L I E A Y Q+IS ++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKGYDG 174
RDLKPEN+LLD DGN++++D GL+ LK DG T GTP ++APE++ + YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV---ELK-DGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 175 AKADIWSCGVILYVLLAGFLPFQD-----DNIVSMYRKIYRGDFKCPPWFSSEARRLITK 229
+ D ++ GV LY ++A PF+ +N + ++I P FS ++
Sbjct: 177 S-VDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 230 LLDPNPNSRI 239
LL +P R+
Sbjct: 235 LLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 50/137 (36%), Positives = 81/137 (59%), Gaps = 1/137 (0%)
Query: 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 64
G F KVYL R K A+KVV K +I M+ Q++ E + + K IV L+ +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 65 SKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 123
S + +Y M+ + GG++ + + G E++A Y ++ A+D+ H G+ HRDLKP+N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 124 LLLDEDGNLKVTDFGLS 140
+L+ +G++K+TDFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 31/275 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKMVKHKHI 56
+G GT +VY R +TG MA+K ++ + G E+ KR ++ V+K +I
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDV-VLKSHDCPYI 76
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR- 112
V+ + + S ++ M+L+ +K+ K G + ED+ ++ A+ + +
Sbjct: 77 VKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT-TCGTPAYVAPEVI---- 167
GV HRD+KP N+LLD GN+K+ DFG+S D T + G AY+APE I
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGR----LVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFKCPPW---FSSEA 223
YD +AD+WS G+ L L G P+++ + KI + + P FS +
Sbjct: 191 PNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 258
+ L + R ++++ + ++ V
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-24
Identities = 32/57 (56%), Positives = 45/57 (78%)
Query: 278 LNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 334
LNAF +ISLS G DLS LFEE+K+++++E RF + +PAS +IS+ EE+AK + F VK
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVK 57
|
Length = 58 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 63/200 (31%), Positives = 108/200 (54%), Gaps = 10/200 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V AR+ TG+++A+K + K V + ++ RE+ ++K ++H++I+ L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHENIISLSD 76
Query: 62 VMASKSK-IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ S + IYF +L+ G +L + L + + + Q++ + + HS GV HRDLK
Sbjct: 77 IFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
P N+L++E+ +LK+ DFGL+ QD + T Y APE++ + DIW
Sbjct: 136 PSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIW 190
Query: 181 SCGVILYVLLAG--FLPFQD 198
S G I +L G P +D
Sbjct: 191 SAGCIFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 74/257 (28%), Positives = 131/257 (50%), Gaps = 20/257 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F KVY A+N +TG A KV+ + +E EI ++ H +IV+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLD 69
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGR--LREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ ++ ++ GG + + + L E RV +Q + A+++ H + HRDL
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHL--KQDGLLHTTCGTPAYVAPEVI-----SKKGY 172
K N+L DG++K+ DFG+SA + ++D + GTP ++APEV+ + Y
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 185
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 229
D KAD+WS G+ L + P + N + + KI + + P +SSE + + K
Sbjct: 186 D-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244
Query: 230 LLDPNPNSRIAISKIME 246
L+ N ++R +++++
Sbjct: 245 CLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 74/257 (28%), Positives = 131/257 (50%), Gaps = 18/257 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVG-KDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+LG GT+ VY AR+L T +A+K + +D + E EI++ +KH++IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSYLKHRNIVQY 70
Query: 60 HEVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+ M+ V GG L +K + E Y +Q++ + + H +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 116 HRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK--KGY 172
HRD+K +N+L++ G +K++DFG S + + T GT Y+APEVI K +GY
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYR-KIYRGDFKCPPWFSSEARRLITK 229
GA ADIWS G + + G PF + + +M++ +++ + P S+EA+ I +
Sbjct: 189 -GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247
Query: 230 LLDPNPNSRIAISKIME 246
+P+P+ R + +++
Sbjct: 248 CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 68/261 (26%), Positives = 135/261 (51%), Gaps = 9/261 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+ V +A +GK +A+K K + K E + E+ +M+ +H+++VE++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ ++GG L + + R+ E+ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
+++LL DG +K++DFG A + K+ + GTP ++APE+IS+ Y G + DIWS
Sbjct: 145 DSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 182 CGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
G+++ ++ G P+ ++ + M R K S + + +LL +P R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 239 IAISKIMESSWFKKSAPKVVI 259
+++++ + K+ P I
Sbjct: 262 ATAAELLKHPFLAKAGPPSCI 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-24
Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F +VY + +T + +A+K++ ++ +E I++EI+V+ +I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+K++ M+ + GG + + G L E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
N+LL E G++K+ DFG++ +K++ T GTP ++APEVI + YD KADI
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 180 WSCGVILYVLLAGFLPFQD 198
WS G+ L G P D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 8e-24
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 46/285 (16%)
Query: 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE-VM 63
GT+ VY AR+ +TG+ +A+K + +K K G REI+++ ++H +IV + E V+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVV 74
Query: 64 ASKS-KIYFAMDLV----KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
S KIY M+ V K L + K + + QL+S V H + HRD
Sbjct: 75 GSNLDKIYMVMEYVEHDLKS--LMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131
Query: 119 LKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
LK NLLL+ G LK+ DFGL+ + LK L T Y APE++
Sbjct: 132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW---YRAPELLLGAKEYSTAI 188
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------------------GDFKCP 216
D+WS G I LL F + + KI++ F
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248
Query: 217 PWFSSEAR-----------RLITKLLDPNPNSRIAISKIMESSWF 250
P+ + L+ +LL +P RI+ ++ +F
Sbjct: 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 32/206 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
+G GTF +V+ AR+ +T + +A+K V +ME K REI +++++KH
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV---------LMENEKEGFPITALREIKILQLLKH 70
Query: 54 KHIVELHEVMASKSK--------IYFAMDLVK---GGELFNKIAKGRLREDVARVYFQQL 102
+++V L E+ +K+ Y + + G L NK K L E + +V + L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE-IKKV-MKML 128
Query: 103 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTT-CGTPA 160
++ + + H + HRD+K N+L+ +DG LK+ DFGL+ AFS +T T
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 161 YVAPEVISKKGYDGAKADIWSCGVIL 186
Y PE++ + G D+W G I+
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 66/261 (25%), Positives = 132/261 (50%), Gaps = 16/261 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F +V+ + +T K +A+K++ ++ +E I++EI+V+ ++ + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+K++ M+ + GG + + G L E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
N+LL E G +K+ DFG++ +K++ + GTP ++APEVI + YD +KADI
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYD-SKADI 184
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW----FSSEARRLITKLLDPNP 235
WS G+ L G P + + + + I + + PP +S + + L+ P
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEP 241
Query: 236 NSRIAISKIMESSWFKKSAPK 256
+ R ++++ + + A K
Sbjct: 242 SFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 55/303 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV-----------GKDKVIKVGMMEQIKREISVMKM 50
LG GT+ KV A + TGK +A+K V + V G+ RE+ +M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 51 VKHKHIVELHEVMASKSKIYFAMDLVKG--GELFNKIAKGRLREDVARVYFQQLISAVDF 108
+KH++I+ L +V I MD++ ++ + K RL E + Q+++ ++
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKCILLQILNGLNV 134
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS------------AFSEHLKQDGLLHTTC 156
H HRDL P N+ ++ G K+ DFGL+ + E +++ + +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--RG--- 211
T Y APE++ D+WS G I LL G F +N + +I+ G
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPN 254
Query: 212 -----DFKCPPWF------------------SSEARRLITKLLDPNPNSRIAISKIMESS 248
K P + S +A L+ LL NP RI+ + ++
Sbjct: 255 EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314
Query: 249 WFK 251
+FK
Sbjct: 315 YFK 317
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 70/252 (27%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 61 EVMASKSKIYFAMDLVKGGEL---FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+K + + L+ GG+L + + E A Y ++ ++ H + +R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DLKPEN+LLD+ G+++++D GL+ H+ + + GT Y+APEV+ + Y +
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-P 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------GDFKCPPWFSSEARRLIT 228
D W+ G +LY ++AG PFQ +KI R + FS +AR L
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237
Query: 229 KLLDPNPNSRIA 240
LL +P R+
Sbjct: 238 MLLCKDPKERLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMK-VVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G+ V+ A + K +A+K +V D ++ REI +++ + H +IV+++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ----SVKHALREIKIIRRLDHDNIVKVY 68
Query: 61 EVMASKSK--------------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 106
EV+ +Y + ++ +L N + +G L E+ AR++ QL+ +
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 107 DFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSE-HLKQDGLLHTTCGTPAYVAP 164
+ HS V HRDLKP N+ ++ ED LK+ DFGL+ + H G L T Y +P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 165 E-VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN 200
++S Y A D+W+ G I +L G F +
Sbjct: 188 RLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 9e-23
Identities = 69/261 (26%), Positives = 134/261 (51%), Gaps = 16/261 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F +V+ + +T + +A+K++ ++ +E I++EI+V+ ++ + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+K++ M+ + GG + + G E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
N+LL E G++K+ DFG++ +K++ T GTP ++APEVI + YD +KADI
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW----FSSEARRLITKLLDPNP 235
WS G+ L G P D + + + I + + PP FS + I L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDP 241
Query: 236 NSRIAISKIMESSWFKKSAPK 256
+ R ++++ + K+A K
Sbjct: 242 SFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V + TGK A K + K ++ K + E +++ V IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 62 VMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARV--YFQQLISAVDFCHSRGVYHRD 118
SK+ + M L+ GG+L ++ G ++ RV Y Q+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
+KPEN+LLD+ GN +++D GL+ LK + GT Y+APE++ ++ Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVD 176
Query: 179 IWSCGVILYVLLAGFLPFQD 198
++ G +Y ++AG PF+D
Sbjct: 177 WFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 73/257 (28%), Positives = 128/257 (49%), Gaps = 17/257 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ--IKREISVMKMVKHKHIVEL 59
+G G++ +V L R+ GK +K K + E+ ++E ++ +KH +IV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIK---KLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 60 HEVMASKS-KIYFAMDLVKGGELFNKIA--KGRL-REDVARVYFQQLISAVDFCHSRGVY 115
E + +Y M +GG+L++K+ KG+L E+ +F Q+ A+ + H + +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRDLK +N+ L +KV D G++ E+ Q + T GTP Y++PE+ S K Y+
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPYN-Y 181
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---FSSEARRLITKLLD 232
K+D+W+ G +Y + F ++ S+ +I G K PP +S E LI +L
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLPPMPKDYSPELGELIATMLS 239
Query: 233 PNPNSRIAISKIMESSW 249
P R ++ I+ +
Sbjct: 240 KRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 45/286 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV---GKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
+G G++ V+ RN +TG+ +A+K D VIK + REI ++K +KH ++V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 59 LHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
L EV K K++ + L K +G + ++ +Q L AV+FCH H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTL-QAVNFCHKHNCIH 123
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKKGYDGA 175
RD+KPEN+L+ + G +K+ DFG F+ L G +T T Y APE++ G
Sbjct: 124 RDVKPENILITKQGQIKLCDFG---FARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 176 KADIWSCGVILYVLLAG--FLPFQDD------------NIVSMYRKIYRGD-----FKCP 216
D+W+ G + LL G P + D +++ +++I+ + P
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240
Query: 217 ------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
P SS A + L +P R++ +++E +F
Sbjct: 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 16/217 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMVKHKHI 56
++G G++ V ++ +TG+ +A+K V K+ M REI ++K ++H+++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENL 62
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGV 114
V L EV K ++Y + V + + + K L E R Y Q++ ++FCHS +
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVISKKGYD 173
HRD+KPEN+L+ + G +K+ DFG F+ L G ++T T Y APE++
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFG---FARTLAAPGEVYTDYVATRWYRAPELLVGDTKY 178
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 210
G DIW+ G ++ +L G F D+ + I +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-22
Identities = 72/258 (27%), Positives = 125/258 (48%), Gaps = 23/258 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
+G GT+ VY ARN+ TG+ A+KV+ G+D +++EI +MK KH +IV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-------FAVVQQEIIMMKDCKHSNIV 69
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ K++ M+ GG L + G L E ++ + + + HS+G H
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEV--ISKKGYD 173
RD+K N+LL ++G++K+ DFG+SA + + + + GTP ++APEV + +KG
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAAVERKGGY 186
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW-----FSSEARRLIT 228
DIW+ G+ L P D + + + + +F+ P +S+ +
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246
Query: 229 KLLDPNPNSRIAISKIME 246
L NP R K+++
Sbjct: 247 MALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 63/190 (33%), Positives = 100/190 (52%), Gaps = 10/190 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G + V R+ +T + +A+K KD + E RE+ +++ +K ++IVEL
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 61 EVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
E + K+Y + V+ EL ++ G E V R Y QLI A+ +CH + HRD
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCHKNDIVHRD 125
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKGYDGAK 176
+KPENLL+ + LK+ DFG F+ +L + + T T Y +PE++ Y G
Sbjct: 126 IKPENLLISHNDVLKLCDFG---FARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKA 181
Query: 177 ADIWSCGVIL 186
D+WS G IL
Sbjct: 182 VDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 27/271 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV---GKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
+GHG+F VY AR+++T + +A+K + GK K + I +E+ ++ ++H + +E
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQQLRHPNTIE 79
Query: 59 LHEVMASKSKIYFAMDLVKG--GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + M+ G ++ K L+E + + + HS H
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYD 173
RD+K N+LL E G +K+ DFG ++ ++ GTP ++APEVI + YD
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS-----EARRLIT 228
G K D+WS G+ L P + N +S I + D P SS R +
Sbjct: 193 G-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVD 248
Query: 229 KLLDPNPNSRIAISKIMESSWFKKSAPKVVI 259
L P R + ++++ + + P VI
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 11/247 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 61 EVMASKSKIYFAMDLVKGGEL-FNKIAKGR--LREDVARVYFQQLISAVDFCHSRGVYHR 117
+K + + ++ GG+L F+ G E+ A Y +++ ++ H +R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DLKPEN+LLD+ G+++++D GL+ + + + GT Y+APEV++ + Y
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSP 182
Query: 178 DIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233
D W G ++Y ++ G PF+ + R++ + FS EA+ + LL
Sbjct: 183 DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTK 242
Query: 234 NPNSRIA 240
+P R+
Sbjct: 243 DPKQRLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 63/246 (25%), Positives = 114/246 (46%), Gaps = 11/246 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 61 EVMASKSKIYFAMDLVKGGEL---FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+K + + L+ GG+L + E+ A Y ++ ++ H + +R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DLKPEN+LLD+ G+++++D GL+ + + + GT Y+APEV+ + Y
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFSP 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233
D W G ++Y ++ G PF+ + R++ + FS AR + +LL
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTK 242
Query: 234 NPNSRI 239
+P R+
Sbjct: 243 DPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 18/226 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V+ + +A+K++ D ++K + +E+ +K ++HKH++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQ---KEVQALKRLRHKHLISLFA 69
Query: 62 VMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQ-QLISAVDFCHSRGVYHRD 118
V + +Y +L++ G L F + +G++ + + Q+ + + + HRD
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP-AYVAPEVISKKGYDGAKA 177
L N+L+ ED KV DFGL+ +K+D L + P + APE S + K+
Sbjct: 130 LAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGTFS-TKS 185
Query: 178 DIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG-----DFKCPP 217
D+WS G++LY + G +P+ N +Y +I G KCP
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (238), Expect = 4e-21
Identities = 82/290 (28%), Positives = 139/290 (47%), Gaps = 39/290 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G+G F +V+L ++ +T + K + + +K Q+ E++VM+ +KHK+IV +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 62 VMASKS--KIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHS--- 111
+K+ K+Y M+ G+L I K G++ E +QL+ A+ +CH+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 112 ----RGVYHRDLKPENLLLD-----------EDGNL------KVTDFGLSAFSEHLKQDG 150
V HRDLKP+N+ L + NL K+ DFGLS +++ +
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS---KNIGIES 196
Query: 151 LLHTTCGTPAYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRK 207
+ H+ GTP Y +PE++ K YD K+D+W+ G I+Y L +G PF +N + +
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255
Query: 208 IYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 257
+ RG S E LI LL+ + R + + + K P V
Sbjct: 256 LKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPPV 305
|
Length = 1021 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 62/213 (29%), Positives = 113/213 (53%), Gaps = 22/213 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVEL 59
++G+GT+ +VY R+++TG+ A+KV+ + E+IK EI+++K H ++I
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 60 HEVMASKS------KIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCH 110
+ KS +++ M+ G + + + + L+ED ++++ + H
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS-- 168
+ V HRD+K +N+LL E+ +K+ DFG+SA + + G +T GTP ++APEVI+
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMAPEVIACD 196
Query: 169 ---KKGYDGAKADIWSCGVILYVLLAGFLPFQD 198
YD ++DIWS G+ + G P D
Sbjct: 197 ENPDATYD-YRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 73/309 (23%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI----KVGMMEQIKREISVMKMVKHKHIV 57
LG GTF +VY AR ++TG+ +A+K K++ K G REI ++K +KH ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 58 ELHEVMASKSKI-------------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 104
L ++ + Y DL G L N +L E + Y QL+
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENP--SVKLTESQIKCYMLQLLE 126
Query: 105 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV-- 162
+++ H + HRD+K N+L+D G LK+ DFGL+ + + GT Y
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 163 -------APE-VISKKGYDGAKADIWSCGVILYVLLAG---------------------- 192
PE ++ ++ Y A DIW G + +
Sbjct: 187 VVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
Query: 193 ----------FLP-FQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAI 241
LP + + + Y + F E L++KLL +P R+
Sbjct: 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK---LGPEGLDLLSKLLSLDPYKRLTA 302
Query: 242 SKIMESSWF 250
S +E +F
Sbjct: 303 SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 60/188 (31%), Positives = 101/188 (53%), Gaps = 12/188 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY ARNL TG+ A+K++ + +++Q EI ++K KH +IV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
S+ K++ M+ GG L + G L E ++ + + + HS+G HRD+K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133
Query: 121 PENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEV--ISKKGYDGAK 176
N+LL ++G++K+ DFG++A + K+ + GTP ++APEV + K G
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSFI----GTPYWMAPEVAAVEKNGGYNQL 189
Query: 177 ADIWSCGV 184
DIW+ G+
Sbjct: 190 CDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 84/283 (29%), Positives = 131/283 (46%), Gaps = 56/283 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVMKMVKHKH 55
+G G + V A + TG +A+K K+ E + REI +++ KH++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIK--------KISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 56 IVELHEVMASKS-----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
I+ + +++ S +Y +L++ +L+ I L D + + Q++ + + H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYVAPEV-I 167
S V HRDLKP NLLL+ + +LK+ DFGL A EH G L T Y APE+ +
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEIML 182
Query: 168 SKKGYDGAKADIWSCGVILYVLLA------------------GFL--PFQDD--NIVSMY 205
+ KGY A DIWS G IL +L+ G L P Q+D I+S+
Sbjct: 183 NSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241
Query: 206 RKIY-RGDFKCP--PW------FSSEARRLITKLLDPNPNSRI 239
+ Y + P PW +A L+ K+L NP+ RI
Sbjct: 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
+G G + V A + ++GK +A+K K+ + + RE+ +++ KH +I+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 58 ELHEVMASKSK----IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 112
+ +++ +Y MDL+ +L + I + L E+ R + QL+ + + HS
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYVAPEVI-SK 169
V HRDLKP NLL++ED L++ DFG+ S + + T Y APE++ S
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186
Query: 170 KGYDGAKADIWSCGVIL 186
Y A D+WS G I
Sbjct: 187 PEYTTA-IDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 28/263 (10%)
Query: 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
LG G F KV L R TG+ +A+K + + +REI +++ + H++I
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHENI 68
Query: 57 VELHEVM--ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSR 112
V+ V + M+ + G L + + + R + ++ R+ + Q+ +D+ S+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISKKG 171
HRDL N+L++ + +K++DFGL+ K + +P + APE +
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 172 YDGAKADIWSCGVILYVLL----------AGFL----PFQDDNIVS-MYRKIYRGD-FKC 215
+ + +D+WS GV LY L A FL Q IV+ + + G+
Sbjct: 189 FS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247
Query: 216 PPWFSSEARRLITKLLDPNPNSR 238
PP E L+ + P R
Sbjct: 248 PPSCPDEVYDLMKLCWEAEPQDR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 51/151 (33%), Positives = 80/151 (52%), Gaps = 25/151 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK-------REISVMKMVKHK 54
LG G++A VY R+ TG+ +A+K + +E + RE S++K +KH
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI---------RLEHEEGAPFTAIREASLLKDLKHA 63
Query: 55 HIVELHEVMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 109
+IV LH+++ +K + Y DL + + L R++ QL+ + +C
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVRLFLFQLLRGLAYC 119
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140
H R V HRDLKP+NLL+ E G LK+ DFGL+
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG GT+A V+ R+ T +A+K + + + G RE+S++K +KH +IV LH+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 62 VMASKSKIYFAMD-LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++ + + + L K + + + +++ Q++ + +CH R V HRDLK
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 121 PENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
P+NLL++E G LK+ DFGL+ A S K T Y P+V+ + D+
Sbjct: 132 PQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC-------- 215
W G I + + +G F + I+R +FK
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP 248
Query: 216 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 257
P +E L+TK L RI+ + M+ ++F+ ++
Sbjct: 249 QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI 296
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 92/322 (28%), Positives = 143/322 (44%), Gaps = 53/322 (16%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G++ V A + TG+ +A+K + D V +I REI ++++++H IVE+
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 61 EVMASKSK-----IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 114
+M S+ IY +L+ +L I A L + + + QL+ A+ + H+ V
Sbjct: 66 HIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANV 124
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEV----ISK 169
+HRDLKP+N+L + D LK+ DFGL+ + + + T T Y APE+ SK
Sbjct: 125 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 184
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--------------------- 208
Y A DIWS G I +L G F N+V I
Sbjct: 185 --YTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR 241
Query: 209 -YRGDF--KCPPWFSSE-------ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV- 257
Y K P FS + A RL+ +LL +P R + + +FK A
Sbjct: 242 RYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER 301
Query: 258 -----VITKQEMEFEADKSSKQ 274
ITK E EFE + +K+
Sbjct: 302 EPSAQPITKLEFEFERRRLTKE 323
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 7e-20
Identities = 71/264 (26%), Positives = 131/264 (49%), Gaps = 26/264 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVEL 59
++G+GT+ +VY R+++TG+ A+KV+ + E+IK+EI+++K H ++I
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATY 68
Query: 60 HEVMASKS------KIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCH 110
+ K+ +++ M+ G + + I + L+E+ ++++ + H
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS-- 168
V HRD+K +N+LL E+ +K+ DFG+SA + + G +T GTP ++APEVI+
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMAPEVIACD 186
Query: 169 ---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSE 222
YD K+D+WS G+ + G P D + + I R K W S +
Sbjct: 187 ENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW-SKK 244
Query: 223 ARRLITKLLDPNPNSRIAISKIME 246
+ I L N + R ++M+
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVE 58
+G G + VY AR+ +G +A+K V + + + G+ RE++++K ++ H +IV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 59 LHEVMAS-----KSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHS 111
L +V A+ ++K+ + V +K+ L + + +Q + +DF H+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
+ HRDLKPEN+L+ G +K+ DFGL+ +S + ++ T Y APEV+ +
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YRAPEVLLQS 182
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY------------------RGD 212
Y D+WS G I + F ++ KI+ RG
Sbjct: 183 TY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241
Query: 213 F---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
F P +L+ ++L NP+ RI+ + ++ +F
Sbjct: 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G++A VY ++ GK +A+KV+ + + G RE S++K +KH +IV LH+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ +K + + V +L + K G L + +++ QL+ + + H R + HRDL
Sbjct: 71 IIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL 129
Query: 120 KPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
KP+NLL+ + G LK+ DFGL+ + H + ++ T Y P+V+
Sbjct: 130 KPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLGSTEYSTC 184
Query: 177 ADIWSCGVILYVLLAGFLPF 196
D+W G I ++ G F
Sbjct: 185 LDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 45/249 (18%)
Query: 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEV 62
G KV L + +T ++ +K + K + + I + H ++V LH+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILK-----GLRKSSEYSRERLTI-----IPHCVPNMVCLHKY 53
Query: 63 MASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+ S+ ++ + +GG+L++ I+K + E+ + + +++ A+D H G+ RDL P
Sbjct: 54 IVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA----YVAPEV--ISKKGYDGA 175
N+LLD+ G++++T F +SE + +C A Y APEV IS+ +
Sbjct: 114 NNILLDDRGHIQLTYFS--RWSE-------VEDSCDGEAVENMYCAPEVGGISE---ETE 161
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----DFKCPPWFSSEARRLITKL 230
D WS G IL+ LL G ++ G P W S EAR L+ +L
Sbjct: 162 ACDWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQL 212
Query: 231 LDPNPNSRI 239
L NP R+
Sbjct: 213 LQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V +++ TG MA KVV K + +QI RE+ +M + +IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDV----ARVYFQQLISAVDFCHSRGVY 115
+++ I M+ + G L ++I K G + ++ A + L + +
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IM 126
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRD+KP N+L++ G +K+ DFG+S E + + + T GT Y++PE I Y
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSG--ELI--NSIADTFVGTSTYMSPERIQGGKYT-V 181
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVS 203
K+D+WS G+ + L G PF NI
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LGHG VY A +L T + +A+KV+ D I V + +QI E+ ++ +I+ +
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 61 EVMASKSKIYFAMDLVKGGEL--FNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHR 117
+++I + + GG L + KI + L R VA ++ + + S + HR
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA------VVKGLTYLWSLKILHR 119
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGA 175
D+KP N+L++ G +K+ DFG+S Q + + T GT AY+APE IS + Y G
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVS------TQLVNSIAKTYVGTNAYMAPERISGEQY-GI 172
Query: 176 KADIWSCGVILYVLLAGFLPF 196
+D+WS G+ L G P+
Sbjct: 173 HSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 22/242 (9%)
Query: 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELHEVM 63
G F KV + ++ T K + V K+IK I E V + M + + ++L+ +
Sbjct: 27 GKFGKVSVLKHKPTQK---LFVQ---KIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSV 78
Query: 64 ASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 122
+ MD +K G+LF+ + +G+L E + +QL+ A++ H + H D+K E
Sbjct: 79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138
Query: 123 NLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
N+L D + + D+GL + + GT Y +PE I YD D W+
Sbjct: 139 NVLYDRAKDRIYLCDYGL---CKIIGTPSCYD---GTLDYFSPEKIKGHNYD-VSFDWWA 191
Query: 182 CGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 237
GV+ Y LL G PF++D + K + S A + +L N N
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 238 RI 239
R+
Sbjct: 252 RL 253
|
Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 72/271 (26%), Positives = 134/271 (49%), Gaps = 30/271 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELH 60
+G GT+ KVY N + G A+K++ D + V E+I+ E ++++ + H ++V+ +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVD--EEIEAEYNILQSLPNHPNVVKFY 85
Query: 61 EVM-----ASKSKIYFAMDLVKGGELFNKIAKG------RLREDVARVYFQQLISAVDFC 109
+ +++ ++L GG + ++ KG RL E + + +
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVI 167
H+ + HRD+K N+LL +G +K+ DFG+SA S L+++ T+ GTP ++APEVI
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFWMAPEVI 200
Query: 168 S-KKGYD---GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFS 220
+ ++ YD A+ D+WS G+ L G P D + V KI R P +
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWC 260
Query: 221 SEARRLITKLLDPNPNSRIAISKIMESSWFK 251
I++ L + +R +++ ++E + K
Sbjct: 261 RSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V L G+ +A+K + D + E SVM ++H ++V+L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDD----STAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC------HSRGVY 115
V+ + +Y + + G L + + R R QQL A+D C +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV 124
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISKKGYDG 174
HRDL N+L+ ED KV+DFGL+ K+ + P + APE + +K +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKFS- 177
Query: 175 AKADIWSCGVILYVLLA-GFLPFQD---DNIVSMYRKIYRGDF--KCPPWFSSEARRLIT 228
K+D+WS G++L+ + + G +P+ ++V K YR + CPP E +++
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP----EVYKVMK 233
Query: 229 KLLDPNPNSRIAISKIMES 247
+ +P R ++ E
Sbjct: 234 DCWELDPAKRPTFKQLREQ 252
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 72/267 (26%), Positives = 129/267 (48%), Gaps = 32/267 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELH 60
+G GT+ KV+ N + G A+K++ D + + E+I+ E +++K + H ++V+ +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDID--EEIEAEYNILKALSDHPNVVKFY 81
Query: 61 EVMASKS-----KIYFAMDLVKGGELFNKIAKG------RLREDVARVYFQQLISAVDFC 109
+ K +++ ++L GG + + KG R+ E + + + +
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVI 167
H HRD+K N+LL +G +K+ DFG+SA S L+++ T+ GTP ++APEVI
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFWMAPEVI 196
Query: 168 S-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWF 219
+ YD A+ D+WS G+ L G P D + + KI R P +
Sbjct: 197 ACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW 255
Query: 220 SSEARRLITKLLDPNPNSRIAISKIME 246
S+E I K L + R +S +++
Sbjct: 256 SNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME---------QIKREISVMKMVK 52
+G G + +V A + +TG+ +A+K + + RE+ ++K +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIK----------KLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 53 HKHIVELHEVMASKS------KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 106
H++++ L +V S +Y L+ G +L N + +L +D + Q++ +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 107 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 166
+ HS G+ HRDLKP N+ ++ED LK+ DFGL+ ++ + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEI 186
Query: 167 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 208
+ + DIWS G I+ LL G F + + ++I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG GT+A VY R+ T +A+K + + + G RE+S++K +KH +IV LH+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 62 VMASKSKIYFAMD-LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++ ++ + + L K + + + +++ QL+ +++CH R V HRDLK
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 121 PENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
P+NLL++E G LK+ DFGL+ A S K T Y P+++ + D+
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC-------- 215
W G I Y + G F + I+R +FK
Sbjct: 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRA 248
Query: 216 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
P S+ L++KLL RI+ + M+ +F
Sbjct: 249 DCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 73/250 (29%), Positives = 112/250 (44%), Gaps = 44/250 (17%)
Query: 43 REISVMK-MVKHKHIVELHEVM-ASKSK-IYFAMDLVKGGELFNKIAKGRLREDVARVYF 99
REI ++ + H +IV+L V+ A K IY + ++ +L I L + R
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIM 113
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHL--KQDGLLHTTC 156
QL+ A+ + HS V HRDLKP N+LL+ D +K+ DFGL+ + SE ++ +L
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 157 GTPAYVAPEVI--SKKGYDGAKA-DIWSCGVILYVLLAGFLPF-------QDDNIV---- 202
T Y APE++ S + Y K D+WS G IL +L G F Q + I+
Sbjct: 174 ATRWYRAPEILLGSTR-Y--TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230
Query: 203 ----------------SMYRKIYRGDFKCP----PWFSSEARRLITKLLDPNPNSRIAIS 242
+M + K P S +A L+ KLL NPN R+
Sbjct: 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE 290
Query: 243 KIMESSWFKK 252
+ +E + +
Sbjct: 291 EALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 89/318 (27%), Positives = 135/318 (42%), Gaps = 80/318 (25%)
Query: 3 GHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
G GT+ +VY A+ N + GK A+K DK G+ + REI++++ +KH+++V L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 61 EVMASKS--KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ---------QLISAVDFC 109
EV + +Y D + +L+ I R RV Q+++ V +
Sbjct: 69 EVFLEHADKSVYLLFDYAE-HDLWQIIKFHR---QAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 110 HSRGVYHRDLKPENLLL----DEDGNLKVTDFGLS-AFSEHLKQ----DGLLHTTCGTPA 160
HS V HRDLKP N+L+ E G +K+ D GL+ F+ LK D ++ T
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW---- 180
Query: 161 YVAPEVI-SKKGYDGAKADIWSCGVILYVLLAG---F----------LPFQDD------- 199
Y APE++ + Y A DIW+ G I LL F PFQ D
Sbjct: 181 YRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 200 -----------NIVSM--YRKIYRGDFKC--------PPWF------SSEARRLITKLLD 232
+I M Y + + DFK W S+ L+ KLL+
Sbjct: 240 VLGTPTEKDWPDIKKMPEYDTLMK-DFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298
Query: 233 PNPNSRIAISKIMESSWF 250
+P RI + +E +F
Sbjct: 299 YDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 13/247 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 61 EVMASKSKIYFAMDLVKGGEL----FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+K + + ++ GG+L +N G E A Y +L ++ + +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RDLKPEN+LLD+ G+++++D GL+ + + + GT Y+APEVI+ + Y +
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCPPWFSSEARRLITKLLD 232
D W G ++Y ++ G PF+ + R++ + FS +A+ + LL
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 233 PNPNSRI 239
NP R+
Sbjct: 242 KNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG GT+A V+ R+ T +A+K + + + G RE+S++K +KH +IV LH+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 62 VMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
++ ++ + Y DL + + +V +++ QL+ + +CH R + H
Sbjct: 71 IIHTERCLTLVFEYLDSDL---KQYLDNCGNLMSMHNV-KIFMFQLLRGLSYCHKRKILH 126
Query: 117 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
RDLKP+NLL++E G LK+ DFGL+ A S K T Y P+V+
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGSTEYST 183
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 210
D+W G ILY + G F + I+R
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 53/318 (16%)
Query: 2 LGHGTFAKVYLARNLQT--GKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVK-HKHI 56
LG G + V ARN +T +++A+K + K I + ++ RE+ +++ + HK+I
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI---LAKRALRELKLLRHFRGHKNI 64
Query: 57 VELHE---VMASK-SKIYFAMDLVKGGELFNKIAKGRLREDVARVYF-QQLISAVDFCHS 111
L++ V +++Y +L++ +L I G+ D F Q++ + + HS
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSE-HLKQDGLLHTTCGTPAYVAPEV-IS 168
V HRDLKP NLL++ D LK+ DFGL+ FSE + G + T Y APE+ +S
Sbjct: 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQ------------------DDNIVSMYRKIYR 210
+ Y A D+WS G IL LL F+ D+ +S
Sbjct: 184 FQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKA 242
Query: 211 GDF--------KCP-----PWFSSEARRLITKLLDPNPNSRIAISKIME----SSWFKKS 253
++ K P P + A L+ KLL +P RI++ + +E + W
Sbjct: 243 QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD 302
Query: 254 APKVVITKQEMEFEADKS 271
V + FE++ S
Sbjct: 303 DEPVCQKPFDFSFESEDS 320
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 22/242 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G + V A + +TG +A+K + + +I ++ RE+ ++K +KH++++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGL 81
Query: 60 HEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+V +Y L+ G +L N + +L +D + Q++ + + HS
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
+ HRDLKP NL ++ED LK+ DFGL+ + D + T Y APE++ +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHY 195
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF-----SSEARRLIT 228
DIWS G I+ LL G F + + + I R S AR I
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255
Query: 229 KL 230
L
Sbjct: 256 SL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G + V A + + + +A+K + + +I + RE+ ++K +KH++++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKHENVIGL 79
Query: 60 HEVMASK------SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+V +++Y +L+ G +L N + +L ++ + QL+ + + HS G
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
+ HRDLKP N+ ++ED L++ DFGL+ + D + T Y APE++ +
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 208
DIWS G I+ LL G F ++ + ++I
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G++A VY + G+ +A+KV+ + G+ RE S++K +KH +IV LH+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ +K + F + + +L + + G L R++ QL+ + + H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KP+NLL+ G LK+ DFGL+ Q + T Y P+V+ + DI
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 180 WSCGVILYVLLAG 192
W G I +L G
Sbjct: 188 WGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 31/267 (11%)
Query: 17 QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM-DL 75
TG +A+K++ D + + +RE ++ + H +IV L + + + FA+ +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 76 VKGGELFNKIA-KGRLR-EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--- 130
V G L +A G L + R+ Q L A+ H++G+ HRDLKP+N+++ + G
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVL-DALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 131 NLKVTDFGLSA----FSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVI 185
+ KV DFG+ + GTP Y APE + + +D+++ G+I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLI 178
Query: 186 LYVLLAGFLPFQDDNIVS-MYRKIYRGDFKCPPWFSSEARRL---ITKLLDPNPNSRIAI 241
L G Q ++ +Y+++ D PPW L + K L+ +P R A
Sbjct: 179 FLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKDPRQRAA- 235
Query: 242 SKIMESSWFKKSAPKVVITKQEMEFEA 268
SAP + + +E A
Sbjct: 236 -----------SAPALAERFRALELCA 251
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 44/268 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHIV 57
+G G F VY L+ +A+K + + +KR E ++K H +IV
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFCH 110
+L V K IY M+LV GG L LR+ R+ ++L+ + +++
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTTCGTPAYVAPEVI 167
S+ HRDL N L+ E+ LK++DFG+S + DGL + APE +
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPEAL 167
Query: 168 SKKGYDGAKADIWSCGVILY-VLLAGFLPFQD-------DNIVSMYRKIYRGDFKCPPWF 219
+ Y +++D+WS G++L+ G P+ + I S YR P
Sbjct: 168 NYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR------MPAPQLC 220
Query: 220 SSEARRLITKLLDPNPNSRIAISKIMES 247
E RL+ + +P +R + S+I
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G + V A+N +T + +A+K + D I ++ REI +++ + H++++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVIAI 69
Query: 60 HEVMASKSK-----IYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRG 113
++M + +Y +L+ +L I + L +D + + QL+ + + HS
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGY 172
V HRDLKP NLLL+ + +LK+ DFGL+ + ++ + T Y APE++ + Y
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWYRAPELLLNCSEY 186
Query: 173 DGAKADIWSCGVILYVLL 190
D+WS G I LL
Sbjct: 187 -TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 15/265 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+GHG+F VY A N T + +A+K + + I +E+ ++ +KH + +E
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 62 VMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ + M+ G ++ K L+E + + + HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYDGAKA 177
N+LL E G +K+ DFG ++ S ++ GTP ++APEVI + YDG K
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDG-KV 201
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPN 234
D+WS G+ L P + N +S I + D + W + R + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQKI 260
Query: 235 PNSRIAISKIMESSWFKKSAPKVVI 259
P R A ++++ + ++ P V+
Sbjct: 261 PQERPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 65/265 (24%), Positives = 120/265 (45%), Gaps = 15/265 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+GHG+F VY AR+++T + +A+K + + I +E+ ++ +KH + +E
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 62 VMASKSKIYFAMDLVKG-GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ + M+ G ++ K L+E + + + HS + HRD+K
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYDGAKA 177
N+LL E G +K+ DFG ++ + ++ GTP ++APEVI + YDG K
Sbjct: 153 AGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDG-KV 205
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPN 234
D+WS G+ L P + N +S I + + + W S R + L
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW-SDYFRNFVDSCLQKI 264
Query: 235 PNSRIAISKIMESSWFKKSAPKVVI 259
P R ++++ + + P+ V+
Sbjct: 265 PQDRPTSEELLKHMFVLRERPETVL 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G + V A + +TG+ +A+K + + ++ ++ RE++++K ++H++++ L +
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGLLD 81
Query: 62 VMASKS------KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
V S Y M ++ KI L ED + Q++ + + HS G+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGII 139
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEVI +
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVILNWMHYNQ 194
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 210
DIWS G I+ +L G F+ + + +I +
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 55/289 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-GMMEQIKREISVMKMV---KHKHIV 57
+G+G F V+ + + GK +A+K K+ V + KR +KM+ KH +++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK-----KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 58 ELHEVMASK-----SKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHS 111
+++ +IY +L++ +L I + L D +V+ Q++ + + HS
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK 169
G+ HRD+KP NLL++ + LK+ DFGL+ E D H T T Y APE++
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE---PDESKHMTQEVVTQYYRAPEILMG 178
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQ----------------DDNIVSMY-------R 206
+ + DIWS G I LL + FQ ++ +M
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238
Query: 207 KIYRGDFKCPPWFSS----------EARRLITKLLDPNPNSRIAISKIM 245
I RG K PP EA L+ ++L +P+ RI+ + +
Sbjct: 239 HILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 63/259 (24%), Positives = 125/259 (48%), Gaps = 31/259 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKD--KVIKVGMMEQIKREISVMKMVKHKHIVE 58
+LG G F +V+ L+ +A+K +D + +K+ + + + ++K H +IV+
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLSEAR----ILKQYDHPNIVK 56
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVD------FCHS 111
L V + IY M+LV GG+ + LR+ + +QL+ A+D + S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLS-----FLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP----AYVAPEVI 167
+ HRDL N L+ E+ LK++DFG+S ++D ++++ G + APE +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 168 SKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 225
+ Y +++D+WS G++L+ + G P+ ++ +G CP + +
Sbjct: 167 NYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225
Query: 226 LITKLLDPNPNSRIAISKI 244
++ + D P +R S++
Sbjct: 226 VMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 74/275 (26%), Positives = 134/275 (48%), Gaps = 33/275 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKMVKHKHI 56
LG G + V R++ TG MA+K + V EQ KR +IS M+ V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRA----TVNSQEQ-KRLLMDLDIS-MRSVDCPYT 62
Query: 57 VELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLR--EDVARVYFQQLISAVDFCHSR 112
V + + + ++ M+++ + + K+ L ED+ ++ A+++ HS+
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 113 -GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVI--- 167
V HRD+KP N+L++ +G +K+ DFG+S +L D + T G Y+APE I
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISG---YL-VDSVAKTIDAGCKPYMAPERINPE 178
Query: 168 -SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW-----FSS 221
++KGYD K+D+WS G+ + L G P+ D+ + ++++ + + P FS
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPAEKFSP 235
Query: 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
E + + K L N R ++++ +F+ K
Sbjct: 236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 68/281 (24%), Positives = 129/281 (45%), Gaps = 56/281 (19%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G +VYLA + + +A+K + +D + ++ RE + + H IV ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY------------FQQLISAVDF 108
+ + +Y+ M ++G L + + +E +++ F ++ + +++
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---------GLLHTT---- 155
HS+GV HRDLKP+N+LL G + + D+G + F + ++D + +++
Sbjct: 129 VHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIP 188
Query: 156 ---CGTPAYVAPEVISKKGYDGA-KADIWSCGVILYVLLAGFLPFQ---------DDNI- 201
GTP Y+APE G + DI++ GVILY +L P++ D I
Sbjct: 189 GKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL 246
Query: 202 ----VSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
V+ YR+I PP+ S ++ K L +P R
Sbjct: 247 SPIEVAPYREI-------PPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 18/240 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G + V A + +TG +A+K + + ++ ++ RE+ ++K +KH++++ L +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHENVIGLLD 81
Query: 62 VMASKSKI------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
V + Y M + G +L + +L ED + Q++ + + H+ G+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEVI +
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQ 195
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF-----SSEARRLITKL 230
DIWS G I+ +L G F+ + + +I + F S +A+ + KL
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 25/258 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F +V+ R +A+K + + + + +E ++K H +IV L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFCHSRGV 114
V K IY M+LV+GG+ LR + R+ ++LI + +++ S+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLT-----FLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP----AYVAPEVISKK 170
HRDL N L+ E LK++DFG+S E DG+ +T G + APE ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEE----DGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 171 GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLIT 228
Y +++D+WS G++L+ + G +P+ + + I +G CP RL+
Sbjct: 172 RYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME 230
Query: 229 KLLDPNPNSRIAISKIME 246
+ + +P R + S + +
Sbjct: 231 RCWEYDPGQRPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 2 LGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIV 57
+G G + KV+ AR+L+ G + +A+K V + + + GM RE++V++ ++ H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 58 ELHEVMA-----SKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
L +V ++K+ + V +K+ + + + + QL+ +DF H
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
S V HRDLKP+N+L+ G +K+ DFGL+ L + T Y APEV+ +
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQS 184
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 209
Y D+WS G I + F+ + V KI
Sbjct: 185 SY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 17/266 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+GHG+F VY AR+++ + +A+K + + I +E+ ++ ++H + ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 62 VMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ + M+ G +L ++ K L+E + + + HS + HRD+
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYDGAK 176
K N+LL E G +K+ DFG ++ + GTP ++APEVI + YDG K
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG-K 194
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDP 233
D+WS G+ L P + N +S I + + + W S R + L
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQK 253
Query: 234 NPNSRIAISKIMESSWFKKSAPKVVI 259
P R +++ + + P VI
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+L + + +A+K + + + + +E+ K VM + H +V+L+
Sbjct: 12 LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQLYG 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
V + +Y + ++ G L N + +G+L +D+ Q + +++ HRDL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVISKKGYDGAK 176
N L+ G +KV+DFG++ + D ++ G + PEV + Y +K
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWSPPEVFNFSKYS-SK 181
Query: 177 ADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD 212
+D+WS GV+++ V G +PF+ + + I RG
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 61/278 (21%)
Query: 43 REISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVAR 96
RE+ ++K V HK+I+ L V + +Y M+L+ ++ L +
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMS 126
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + + ++
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYV 183
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI-------- 208
T Y APEVI GY DIWS G I+ L+ G + FQ + + + K+
Sbjct: 184 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 209 --------------------YRG-DFK--CPPWF-----------SSEARRLITKLLDPN 234
Y G F+ P W +S+AR L++K+L +
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302
Query: 235 PNSRIAISKIME----SSWF---KKSAPKVVITKQEME 265
P+ RI++ + + + W+ + AP I ++E
Sbjct: 303 PDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLE 340
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 66/280 (23%), Positives = 123/280 (43%), Gaps = 48/280 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMK-----VVGKDKVIKVGMMEQIKREI-SVMKMVKHKH 55
+G G F V + +G MA+K V K+ +++ ++ VM+ +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-------QKRLLMDLDVVMRSSDCPY 64
Query: 56 IVELHEVMASKSKIYFAMDLVKGG-ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG- 113
IV+ + + + + M+L+ + F K L+ + ++++ + +
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP----EEILGKIAVATVKAL 120
Query: 114 --------VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAP 164
+ HRD+KP N+LLD +GN+K+ DFG+S L D + T G Y+AP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QL-VDSIAKTRDAGCRPYMAP 176
Query: 165 EVI---SKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPP--- 217
E I ++ GYD ++D+WS G+ LY + G P+ +++ ++ +GD PP
Sbjct: 177 ERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---PPILS 232
Query: 218 -----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
FS I L + + R +++E + K
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 14/174 (8%)
Query: 43 REISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVAR 96
RE+ +MK+V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMS 121
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT- 155
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + T
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPY 177
Query: 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 209
T Y APEVI GY DIWS G I+ ++ G + F + + + KI
Sbjct: 178 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V + +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDV-ARVYFQQLISAVDFCHSRGVYHRD 118
S +I M+ + GG L +++ K GR+ E++ ++ L + HRD
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGAK 176
+KP N+L++ G +K+ DFG+S Q D + ++ GT +Y++PE + Y +
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSG------QLIDSMANSFVGTRSYMSPERLQGTHY-TVQ 178
Query: 177 ADIWSCGVILYVLLAGFLP 195
+DIWS G+ L + G P
Sbjct: 179 SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 66/257 (25%), Positives = 123/257 (47%), Gaps = 23/257 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + +VY + ++A+K + +D + +E+ +E +VMK +KH ++V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ---QLISAVDFCHSRGVYHRD 118
V + Y + + G L + + + +E A V Q+ SA+++ + HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HTTCGTP-AYVAPEVISKKGYDGAK 176
L N L+ E+ +KV DFGLS + D H P + APE ++ + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IK 185
Query: 177 ADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKI---YRGDFK--CPPWFSSEARRLITKL 230
+D+W+ GV+L+ + G P+ ++ +Y + YR + CPP + L+
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP----KVYELMRAC 241
Query: 231 LDPNPNSRIAISKIMES 247
NP+ R + ++I ++
Sbjct: 242 WQWNPSDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 2 LGHGTFAKVY--LARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIV 57
LG G+F VY LA+ + G +V K M E+I+ E SVMK H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKG-EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY--------FQ---QLISAV 106
L V+++ M+L+ G+L + + R + Q ++ +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 107 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDG--LLHTTCGTPA- 160
+ ++ HRDL N ++ ED +K+ DFG++ +++ ++ G LL P
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL------PVR 186
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQ 197
++APE + K G K+D+WS GV+L+ + P+Q
Sbjct: 187 WMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 12/172 (6%)
Query: 43 REISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVAR 96
RE+ +MK V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + ++
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 186
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 208
T Y APEVI GY DIWS G I+ ++ G + F + + + K+
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V+ + +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDL 119
S +I M+ + GG L + K GR+ E + +I + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 180 WSCGVILYVLLAGFLP 195
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V ++ +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRL--REDVARVYFQQLISAVDFCHSRGVYHRDL 119
S +I M+ + GG L + + + E + +V L + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 180 WSCGVILYVLLAGFLP 195
WS G+ L L G P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 31 KVIKVGMM--EQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFN--KIA 86
K+I+ G M + E VM + H ++V+L+ V + I+ + + G L N +
Sbjct: 34 KMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER 93
Query: 87 KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146
KG+L + + A+++ S G HRDL N L+ ED +KV+DFGL+ +
Sbjct: 94 KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV--- 150
Query: 147 KQDGLLHTTCGTP---AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD---- 198
D ++ GT + PEV + +K+D+WS GV+++ V G +P++
Sbjct: 151 -LDDQYTSSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNS 208
Query: 199 ---DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247
+++ + YR +YR P +E ++ P R A K++
Sbjct: 209 EVVESVSAGYR-LYR-----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 12/172 (6%)
Query: 43 REISVMKMVKHKHIVELHEVMASK------SKIYFAMDLVKGGELFNKIAKGRLREDVAR 96
RE+ +MK V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 122
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + ++
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 179
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 208
T Y APEVI GY DIWS G I+ ++ + F + + + K+
Sbjct: 180 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 2 LGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
LG G F KV L N TG+ +A+K + ++ K+EI+++K + H++IV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIV 69
Query: 58 ELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+ + + + M+ V G L + + K +L ++ QQ+ + + HS+
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYI 129
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLS-AFSE-----HLKQDGLLHTTCGTPAY-VAPEVIS 168
HRDL N+LLD D +K+ DFGL+ A E +++DG +P + A E +
Sbjct: 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVECLK 183
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQ 197
+ + A +D+WS GV LY LL Q
Sbjct: 184 ENKFSYA-SDVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 31 KVIKVGMM--EQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG 88
K+IK G M ++ E VM + H+ +V+L+ V + IY + + G L N
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN----- 88
Query: 89 RLREDVARVYFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141
LRE R QL+ + + S+ HRDL N L+D+ G +KV+DFGLS
Sbjct: 89 YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 142 FSEHLKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQ 197
+ D ++ G+ V PEV+ + +K+D+W+ GV+++ V G +P++
Sbjct: 149 YV----LDDEYTSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYE 203
Query: 198 DDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253
N K+ +G P +SE + IM S W +K+
Sbjct: 204 RFNNSETVEKVSQGLRLYRPHLASE-----------------KVYAIMYSCWHEKA 242
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 27/254 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V TG+ +A+K + D V +E E +VM + HK++V L
Sbjct: 14 IGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLE----ETAVMTKLHHKNLVRLLG 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARV--YFQQLISAVDFCHSRGVYHRD 118
V+ +Y M+L+ G L N + +GR V ++ + + +++ S+ + HRD
Sbjct: 67 VILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
L N+L+ EDG KV+DFGL+ + L + APE + K + +K+D
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFS-SKSD 179
Query: 179 IWSCGVILY-VLLAGFLPFQD---DNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLLD 232
+WS GV+L+ V G P+ + K YR + CP + L+T +
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA----DVYVLMTSCWE 235
Query: 233 PNPNSRIAISKIME 246
P R + K+ E
Sbjct: 236 TEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 30/271 (11%)
Query: 2 LGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
LG G F KV L R TG+ +A+K + + + +K+EI +++ + H++IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 58 ELHEVMASK--SKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSRG 113
+ + + I M+ + G L + + + + ++ + Y Q+ +D+ SR
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-VAPE-VISKKG 171
HRDL N+L++ + +K+ DFGL+ E K+ + +P + APE +I K
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189
Query: 172 YDGAKADIWSCGVILYVLL----------AGFL----PFQDDNIVSMYRKIYRGD--FKC 215
Y +D+WS GV LY LL FL P V+ ++
Sbjct: 190 Y--IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247
Query: 216 PPWFSSEARRLITKLLDPNPNSRIAISKIME 246
PP E +L+ K + P+ R ++E
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 71/253 (28%), Positives = 124/253 (49%), Gaps = 28/253 (11%)
Query: 1 MLGHGTFAKVYLA--RNLQTGK-SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
+G G F VY + + K ++A+K V E+ +E +M+ H HIV
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHPHIV 70
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSRGVY 115
+L V+ +++ ++ M+L GEL + + + D+A + Y QL +A+ + S+
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV 129
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-P-AYVAPEVISKKGYD 173
HRD+ N+L+ +K+ DFGLS + L+ + + G P ++APE I+ + +
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 174 GAKADIWSCGVILY-VLLAGFLPFQ--DDNIVSMYRKIYRGDF-----KCPPWFSSEARR 225
A +D+W GV ++ +L+ G PFQ +N V +I G+ CPP S
Sbjct: 187 SA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIG--RIENGERLPMPPNCPPTLYS---- 239
Query: 226 LITKLLDPNPNSR 238
L+TK +P+ R
Sbjct: 240 LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
+G G F V+L L+ K K I+ G M E E VM + H +V+L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAI-------KTIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 60 HEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+ V +S I + ++ G L + + +G+ ++ + + + S V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVISKKGYDG 174
DL N L+ E+ +KV+DFG++ F D ++ GT + +PEV S Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSSPEVFSFSKYS- 179
Query: 175 AKADIWSCGVILY-VLLAGFLPFQD 198
+K+D+WS GV+++ V G P+++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 29/234 (12%)
Query: 2 LGHGTFAKV----YLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
LGHG F V YL ++ + +A+K + ++ + ++ RE SVM + H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE-VEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIV 59
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA--RVYFQQLISAVDFCHSRGVY 115
L V + + M+L G L K K R V+ + Q+ + + S+
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLS----AFSEHLKQDGLLHTTCGT-P-AYVAPEVISK 169
HRDL N+LL K++DFG+S A S++ + TT G P + APE I+
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-----TTAGRWPLKWYAPECINY 172
Query: 170 KGYDGAKADIWSCGVILYVLLA-GFLPFQD---DNIVSMYRKIYRGDF--KCPP 217
+ +K+D+WS GV L+ + G P+ + +++M R +CP
Sbjct: 173 GKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ 225
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 12/167 (7%)
Query: 40 QIKREISVMKMVKHKHIVELHEVMASKSKIY-----FAMDLVK--GGELFNKIAKGRLRE 92
Q++ EI + + H++I+++ E++ S++ Y + DL E F+ + L++
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 93 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152
R +QL+ AV++ H + + HRD+K EN+ L+ DG + + DFG + E +++
Sbjct: 269 --TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK-EREAFD 325
Query: 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQD 198
+ GT A +PE+++ GY DIWSCG+IL +L+ F P D
Sbjct: 326 YGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V L G +A+K + D + + E SVM ++H ++V+L
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEA-----SVMTQLRHSNLVQLLG 66
Query: 62 VMAS-KSKIYFAMDLVKGGELFNKI-AKGR--LREDVARVYFQQLISAVDFCHSRGVYHR 117
V+ K +Y + + G L + + ++GR L D + + A+++ + HR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISKKGYDGAK 176
DL N+L+ ED KV+DFGL+ K+ T P + APE + +K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFS-TK 179
Query: 177 ADIWSCGVILYVLLA-GFLPFQD---DNIVSMYRKIYRGDFK--CPP 217
+D+WS G++L+ + + G +P+ ++V K Y+ D CPP
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 30/199 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
LG G F +V++ T K +A+K +K G M E +E +MK ++H +V+L
Sbjct: 14 LGAGQFGEVWMGTWNGTTK-VAVKT------LKPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR-VYFQQLI-------SAVDFCHS 111
+ V + + IY + + G L + L+ + + QL+ + + S
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVIS 168
R HRDL N+L+ E+ K+ DFGL+ L +D G + APE +
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 169 KKGYDGAKADIWSCGVILY 187
G K+D+WS G++L
Sbjct: 178 -YGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 32 VIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI-----YFAMDLVKGGELFNKIA 86
V+K+G E +++ V H ++ + + + S + +++ DL +
Sbjct: 95 VLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYT----YLTKR 150
Query: 87 KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146
L D A + +Q++ + + H++ + HRD+K EN+ +++ + + D G + F
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 147 KQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA 191
GL GT APEV+++ Y+ +KADIWS G++L+ +LA
Sbjct: 211 PAFLGL----AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 1 MLGHGTFAKVYLAR--NLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
LG G F V L R LQ TG+ +A+K + + +REI ++K ++H +I
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNI 67
Query: 57 VELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSR 112
V+ V S + + M+ + G L + + K R R D ++ Y Q+ +++ S+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-VAPEVISKKG 171
HRDL N+L++ + +K+ DFGL+ K+ + +P + APE +++
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 172 YDGAKADIWSCGVILYVL 189
+ A +D+WS GV+LY L
Sbjct: 188 FSVA-SDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 2 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G GT+ VY A+ + + K A+K ++ G+ REI++++ +KH +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK-----QIEGTGISMSACREIALLRELKHPNVIAL 63
Query: 60 HEVMASKS--KIYFAMDLVKGGEL----FNKIAKG-----RLREDVARVYFQQLISAVDF 108
+V S S K++ D + F++ +K +L + + Q++ + +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 109 CHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVA 163
H+ V HRDLKP N+L+ E G +K+ D G + F+ LK L T Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 164 PEVISKKGYDGAKADIWSCGVILYVLL 190
PE++ + DIW+ G I LL
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 3/155 (1%)
Query: 43 REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQ 101
REI ++K + H+ I+ L KS + M K +LF + G L + A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 102 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161
L+ A+ + H RG+ HRD+K EN+ LDE N + DFG + + + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF 196
+PE+++ Y AK DIWS G++L+ + +
Sbjct: 254 NSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 65/254 (25%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVE 58
LG G F +V+ N T +A+K +K G M + E +MK ++H +++
Sbjct: 14 LGAGQFGEVWEGLWNNTT--PVAVKT------LKPGTMDPKDFLAEAQIMKKLRHPKLIQ 65
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-------DVARVYFQQLISAVDFCHS 111
L+ V + IY +L+K G L + G R D+A Q+ S + + +
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGMAYLEA 121
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVIS 168
+ HRDL N+L+ E+ KV DFGL+ +K+D + G + APE
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAPEAAL 177
Query: 169 KKGYDGAKADIWSCGVILYVLLA-GFLPF---QDDNIVSMYRKIYRGDFKCPPWFSSEAR 224
+ K+D+WS G++L ++ G +P+ + ++ + YR CPP E
Sbjct: 178 YNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--MPCPPGCPKELY 234
Query: 225 RLITKLLDPNPNSR 238
++ +P+ R
Sbjct: 235 DIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 1 MLGHGTFAKV---YLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
MLG G F V L + + +A+K++ K + +E+ RE + MK H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 58 ELHEV-MASKSKIYFAMDLV-----KGGELFNKIAKGRLREDVARVYFQQLI-------S 104
+L V + S++K + +V K G+L + R+ E+ + Q L+ S
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 105 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTP--- 159
+++ S+ HRDL N +L+E+ + V DFGLS +S + G C +
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG-----CASKLPV 179
Query: 160 AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPP 217
++A E ++ Y +D+W+ GV ++ ++ G P+ +Y + +G+ K PP
Sbjct: 180 KWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238
Query: 218 WFSSEARRLITKLLDPNPNSR 238
+ L+ + P P R
Sbjct: 239 DCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 2 LGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
LG G+F V +G +A+K + DK+ + M+ +E ++M + H++++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARV--YFQQLISAVDFCHSRGVY 115
L+ V+ + + +L G L +++ K L ++ + Y Q+ + + + S+
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLS----------AFSEHLKQDGLLHTTCGTP-AYVAP 164
HRDL N+LL D +K+ DFGL EHLK P A+ AP
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK----------VPFAWCAP 169
Query: 165 EVISKKGYDGAKADIWSCGVILYVLLA-GFLPF 196
E + + + A +D+W GV L+ + G P+
Sbjct: 170 ESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHI 56
++G G F +V R GK + K +K G E+ +R E S+M H +I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAI---KTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFC 109
+ L V+ + + ++ G L LR++ + QL+ + + +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGAL-----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---YVAPEV 166
HRDL N+L++ + KV+DFGLS F E D ++ G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 167 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 217
I+ + + A +D+WS G++++ V+ G P+ D + + I + D++ PP
Sbjct: 183 IAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
+G G F +V R GK + K +K G ++ + E S+M H +I+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAI---KTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFCH 110
L V+ + + ++ G L LRE+ + QL+ S + +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSL-----DKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG--TPA-YVAPEVI 167
HRDL N+L++ + KV+DFGLS E + +TT G P + APE I
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT---YTTKGGKIPIRWTAPEAI 180
Query: 168 SKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
+ + + A +D+WS G++++ V+ G P+ D
Sbjct: 181 AYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 21/228 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
V+LA++ T +A+K + D K ++ +++EI + ++H +I+
Sbjct: 10 FEDLMI--VHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 62 VMASKSKIYFAMDLVKGG---ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
S++Y L+ G +L L E + +++A+D+ HS+G HR
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRS 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-------VAPEVISK-- 169
+K ++LL DG KV GL +K P ++PEV+ +
Sbjct: 127 VKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 217
+GY+ K+DI+S G+ L G +PF+D M + RG P
Sbjct: 185 QGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG---TVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 2 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G GT+ VY A+ + + + A+K ++ G+ REI++++ +KH +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELKHPNVISL 63
Query: 60 HEVMASKS--KIYFAMDLVKGGEL----FNKIAKG-----RLREDVARVYFQQLISAVDF 108
+V S + K++ D + F++ +K +L + + Q++ + +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 109 CHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVA 163
H+ V HRDLKP N+L+ E G +K+ D G + F+ LK L T Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 164 PEVISKKGYDGAKADIWSCGVILYVLL 190
PE++ + DIW+ G I LL
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G+G+F VY A + T + +A+K V +D K RE+ +MK + H +I+ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK-------NRELLIMKNLNHINIIFLK 125
Query: 61 E------VMASKSKIYFAMDLVKGGELFNKIAKGRLRED------VARVYFQQLISAVDF 108
+ ++ I+ + + + +K K R + + ++Y QL A+ +
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 109 CHSRGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 167
HS+ + HRDLKP+NLL+D + + LK+ DFG SA + Q + + + Y APE++
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYIC--SRFYRAPELM 242
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 208
D+WS G I+ ++ G+ F + V +I
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159
+QL+SA+D+ H G+ HRD+K EN+L++ ++ + DFG + F+ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 160 AYVAPEVISKKGYDGAKADIWSCGVILY 187
APEV++ Y DIWS G++++
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 53/221 (23%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
LG G F +V++ + K K +K G M + E ++MK ++H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAV-------KTLKPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKI---AKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ V+ + IY + + G L + + G++ + Q+ + + + H
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
RDL+ N+L+ E K+ DFGL+ +E+ ++G + APE I+ +
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAINFGSFT 182
Query: 174 GAKADIWSCGVILY-VLLAGFLPF---QDDNIVSMYRKIYR 210
K+D+WS G++LY ++ G +P+ + +++S ++ YR
Sbjct: 183 -IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR 222
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 58/277 (20%), Positives = 104/277 (37%), Gaps = 47/277 (16%)
Query: 2 LGHGTFAKVYLARNLQ-TGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIV- 57
LG G F KVY + A V K + + + ++ ++E +M ++H +IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 58 ---------------------ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR 96
+LHE + S V + D
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPH----SDVGAESGDETVKSSLDCSDFLH 128
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLH 153
+ Q + + +++ S HRDL N L+ E +K++DFGLS +++ +
Sbjct: 129 IAIQ-IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV---QS 184
Query: 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP---FQDDNIVSMYRK-- 207
+ ++ PE I G ++DIWS GV+L+ + + G P F + ++ M R
Sbjct: 185 KSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 208 IYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKI 244
+ CP + L+ + + P R I
Sbjct: 244 LLPCPEDCPARVYA----LMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KH 53
LG G F +V +A + K +A+K++ D K + + E+ +MKM+ KH
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 83
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY-------------FQ 100
K+I+ L +Y ++ G L + R R Y F+
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 101 QLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153
L+S +++ S+ HRDL N+L+ ED +K+ DFGL+ H+ D
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYKK 198
Query: 154 TTCGT-PA-YVAPEVISKKGYDGAKADIWSCGVILY 187
TT G P ++APE + + Y ++D+WS GV+L+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 56/285 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KH 53
LG G F +V A KS +A+K++ KD + + I E+ +MK++ KH
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKLIGKH 77
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE--------------DVARVY- 98
K+I+ L V + +Y ++ AKG LRE D+ +V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYA---------AKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 99 ----FQQLISAV-------DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147
F+ L+S ++ SR HRDL N+L+ ED +K+ DFGL+ +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI- 187
Query: 148 QDGLLHTTCG-TPA-YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD---DNI 201
D T+ G P ++APE + + Y ++D+WS G++++ + G P+ + +
Sbjct: 188 -DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
Query: 202 VSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
+ R+ +R D P + E L+ + P R +++E
Sbjct: 246 FKLLREGHRMD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
LG G F +V++A + K K +K G M E E +VMK ++H +V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAV-------KTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 60 HEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQ-QLISAVDFCHSRGVYH 116
H V+ +K IY + + G L F K +G + + F Q+ + F R H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
RDL+ N+L+ K+ DFGL+ +E+ ++G + APE I+ +
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAINFGSFT 181
Query: 174 GAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG 211
K+D+WS G++L ++ G +P+ + + R + RG
Sbjct: 182 -IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 4/162 (2%)
Query: 32 VIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR 91
VIK G E +++ + H I++L + K +L+ +A R
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI 179
Query: 92 EDVARVYFQQ-LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 150
+ ++ ++ A+ + H + HRD+K EN+ ++ G++ + DFG + F + +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG 192
+ GT A APE++++ Y G DIWS G++L+ +
Sbjct: 240 -YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 1 MLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKH 55
++G G F +V R L + + + + K +K G E+ +R E S+M H +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAI----KTLKAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDF 108
I+ L V+ + + ++ G L LR+ + QL+ S + +
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSL-----DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---YVAPE 165
G HRDL N+L++ + KV+DFGLS E + +TT G + APE
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPE 179
Query: 166 VISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
I+ + + A +D+WS G++++ V+ G P+ +
Sbjct: 180 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 2 LGHGTFAKVYLARNLQTGK-------SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KH 53
LG G F +V +A L K ++A+K++ D K + + E+ +MKM+ KH
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 80
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-----DVARV-----YFQQLI 103
K+I+ L +Y ++ G L + R D+ARV F+ L+
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 104 S-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
S +++ S+ HRDL N+L+ E+ +K+ DFGL+ ++ D TT
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--DYYKKTTN 198
Query: 157 GT-PA-YVAPEVISKKGYDGAKADIWSCGVILY 187
G P ++APE + + Y ++D+WS GV+++
Sbjct: 199 GRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 31/251 (12%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVE 58
LG G F +V++ N T ++ K +K G M E +E VMK ++H+ +V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAI--------KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR----LREDVARVYFQQLISAVDFCHSRGV 114
L+ V+ S+ IY + + G L + + KG LR Q+ S + +
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
HRDL+ N+L+ E+ KV DFGL+ +E+ + G + APE + G
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI----KWTAPEA-ALYG 178
Query: 172 YDGAKADIWSCGVILYVLLA-GFLPFQ---DDNIVSMYRKIYRGDFKCPPWFSSEARRLI 227
K+D+WS G++L L G +P+ + ++ + YR CPP L+
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLM 236
Query: 228 TKLLDPNPNSR 238
+ P R
Sbjct: 237 CQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 31/251 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
LG+G F +V++ K K +K G M E E +MK ++H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAV-------KTLKPGTMSPESFLEEAQIMKKLRHDKLVQL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-------DVARVYFQQLISAVDFCHSR 112
+ V+ S+ IY + + G L + + G R D+A Q+ + + +
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYIERM 121
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVISK 169
HRDL+ N+L+ + K+ DFGL+ L +D G + APE +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLA----RLIEDNEYTARQGAKFPIKWTAPEA-AL 176
Query: 170 KGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLI 227
G K+D+WS G++L L+ G +P+ N + ++ RG CP L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236
Query: 228 TKLLDPNPNSR 238
+ +P R
Sbjct: 237 LQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMV-KHKH 55
LG G F +V A + K++K E+ + E+ +MKM+ KHK+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR----------LREDVARVYFQQLIS- 104
I+ L V + +Y ++ G L + + R R + + L+S
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 105 ------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG- 157
++F S+ HRDL N+L+ ED +K+ DFGL+ H D TT G
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYRKTTNGR 195
Query: 158 TPA-YVAPEVISKKGYDGAKADIWSCGVILY 187
P ++APE + + Y ++D+WS GV+L+
Sbjct: 196 LPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 50/222 (22%)
Query: 2 LGHGTFAKVYLARNLQTGK-------SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KH 53
LG G F +V +A + K ++A+K++ D K + + E+ +MKM+ KH
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK--DLSDLVSEMEMMKMIGKH 77
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE--------------DVARV-- 97
K+I+ L +Y L +KG LRE D ++
Sbjct: 78 KNIINLLGACTQDGPLYV---------LVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 98 ---YFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147
F+ L+S +++ S+ HRDL N+L+ ED +K+ DFGL+ ++
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI- 187
Query: 148 QDGLLHTTCGT-PA-YVAPEVISKKGYDGAKADIWSCGVILY 187
D TT G P ++APE + + Y ++D+WS GV+L+
Sbjct: 188 -DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 23/247 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
LG G F +V++ K +A+K +K G M E E ++MK ++H +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTK-VAIKS------LKQGSMSPEAFLAEANLMKQLQHPRLVRL 66
Query: 60 HEVMASKSKIYFAMDLVKGGEL--FNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVYH 116
+ V+ ++ IY + ++ G L F K +G +L + Q+ + F + H
Sbjct: 67 YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
RDL+ N+L+ E K+ DFGL+ +E+ ++G + APE I+ G
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAIN-YGTF 180
Query: 174 GAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLL 231
K+D+WS G++L ++ G +P+ + + + RG P E L+
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCW 240
Query: 232 DPNPNSR 238
P R
Sbjct: 241 KEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 2 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG G F KV+LA NL K + V K + + +RE ++ ++H+HIV+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 60 HEVMASKSKIYFAMDLVKGGELFNK-----------IAKGRLREDVARVYFQQLI----- 103
+ V + + +K G+L NK + G+ R+ + Q++
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 104 --SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHTTCGT 158
S + + S+ HRDL N L+ + +K+ DFG+S +++ + G HT
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI 189
Query: 159 PAYVAPEVISKKGYDGAKADIWSCGVILY 187
++ PE I + + ++D+WS GVIL+
Sbjct: 190 -RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 2 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG G F KV+LA NL + + V K + RE ++ ++H+HIV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 60 HEVMASKSKIYFAMDLVKGGELFNK-----------IAKGRLREDVARVYF----QQLIS 104
+ V + + +K G+L NK +A+G ++ + QQ+ +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 105 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHTTCGTPAY 161
+ + S+ HRDL N L+ E+ +K+ DFG+S +++ + G HT +
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI-RW 188
Query: 162 VAPEVISKKGYDGAKADIWSCGVILY 187
+ PE I + + ++D+WS GV+L+
Sbjct: 189 MPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 28/268 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM-----MEQIKREISVMKMVKHKH 55
+LG G F V + Q S V K +K+ + +E+ E + MK H +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAV---KTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 56 IVELHEV---MASKSKIYFAM---DLVKGGELFNKIAKGRLREDVARVYFQQLI------ 103
+++L V +S KI M +K G+L + + RL ++ Q L+
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 104 -SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEHLKQDGLLHTTCGTPA 160
+++ +R HRDL N +L ED + V DFGLS +S + G
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG--RIAKMPVK 180
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPW 218
++A E ++ + Y +K+D+W+ GV ++ + G P+ +Y + G+ K P
Sbjct: 181 WIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239
Query: 219 FSSEARRLITKLLDPNPNSRIAISKIME 246
E L+ +P R +K+ E
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
++G G F +V AR + G M + + E+ V+ K+ H +I+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----------VARVYFQQLIS----- 104
+ +Y A++ G L + + K R+ E + + QQL+
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 105 --AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-PA- 160
+D+ + HRDL N+L+ E+ K+ DFGLS Q+ + T G P
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVR 188
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPW 218
++A E ++ Y +D+WS GV+L+ +++ G P+ +Y K+ +G + P
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247
Query: 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247
E L+ + P R + ++I+ S
Sbjct: 248 CDDEVYDLMRQCWREKPYERPSFAQILVS 276
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 61/251 (24%), Positives = 108/251 (43%), Gaps = 31/251 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
LG G F +V++ T K K +K G M E +E +MK ++H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAI-------KTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL 66
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-------DVARVYFQQLISAVDFCHSR 112
+ V+ S+ IY + + G L + + +G + D+A Q+ + +
Sbjct: 67 YAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA----AQIADGMAYIERM 121
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISK 169
HRDL+ N+L+ ++ K+ DFGL+ +E+ + G + APE +
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA-AL 176
Query: 170 KGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLI 227
G K+D+WS G++L L+ G +P+ + ++ RG CP L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236
Query: 228 TKLLDPNPNSR 238
+P+ R
Sbjct: 237 KLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 33/271 (12%)
Query: 2 LGHGTFAKVYLA--RNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
LG G F KV+L +L+ + V K +K + RE ++ +H++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAV---KTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 56 IVELHEVMASKSKIYFAMDLVKGGEL---------------FNKIAKGRLREDVARVYFQ 100
IV+ + V + ++ G+L G L
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHTTCG 157
Q+ S + + S+ HRDL N L+ D +K+ DFG+S +++ + G T
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG---HTML 186
Query: 158 TPAYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFK-C 215
++ PE I + + ++D+WS GV+L+ + G P+ + + I +G
Sbjct: 187 PIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245
Query: 216 PPWFSSEARRLITKLLDPNPNSRIAISKIME 246
P SE ++ +P RI I I E
Sbjct: 246 PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 98 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157
Y Q+ ++F SR HRDL N+LL E+ +K+ DFGL A + D + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 158 TP-AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--F 213
P ++APE I K Y ++D+WS GV+L+ + + G P+ I + + +
Sbjct: 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
+ P + E R++ +P R S ++E
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 13/220 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
+LG G F VY + G+ +A+KV+ ++ K ++I E VM V H H+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMASVDHPHV 71
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGV 114
V L + S S++ L+ G L + + K + + Q+ + + + +
Sbjct: 72 VRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL 130
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP-AYVAPEVISKKGYD 173
HRDL N+L+ ++K+TDFGL+ + + + P ++A E I + Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLD-VDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 174 GAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD 212
K+D+WS GV ++ L+ G P++ V + + +G+
Sbjct: 190 -HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHI 56
++G G F +V+ G+ + K +K G E+ ++ E S+M H +I
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAI---KTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFC 109
+ L V+ + ++ G L LR+ QL+ + + +
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGAL-----DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---YVAPEV 166
HRDL N+L++ + KV+DFGLS E + +TT G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEA 181
Query: 167 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
I+ + + A +D+WS G++++ V+ G P+ D
Sbjct: 182 IAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL--LHTTCGT 158
Q+ + + H RGV H+D+ N ++DE+ +K+TD +A S L L
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNENR 181
Query: 159 P-AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMY---RKIYR--G 211
P ++A E + K Y A +D+WS GV+L+ L+ G P+ + + M + YR
Sbjct: 182 PVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240
Query: 212 DFKCP 216
CP
Sbjct: 241 PINCP 245
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 2 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG G F KV+LA NL + + V K + +RE ++ +++H+HIV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 60 HEVMASKSKIYFAMDLVKGGELFN---------KIAKGRLREDVARVYFQQLISAVDFCH 110
+ V + + ++ G+L KI G ++ Q+++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 111 SRGVY-------HRDLKPENLLLDEDGNLKVTDFGLS--AFSEHLKQDGLLHTTCGTPAY 161
S VY HRDL N L+ + +K+ DFG+S +S + G T +
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG--GRTMLPIRW 190
Query: 162 VAPEVISKKGYDGAKADIWSCGVILY 187
+ PE I + + ++DIWS GV+L+
Sbjct: 191 MPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 28/164 (17%)
Query: 98 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157
Y Q+ ++F SR HRDL N+LL E+ +K+ DFGL + + +D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 226
Query: 158 TPAYV------------APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSM 204
P YV APE I K Y ++D+WS GV+L+ + + G P+ I
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
Query: 205 Y-RKIYRGDFKCPPWFSS-EARRLITKLLDPNPNSRIAISKIME 246
+ R++ G P +++ E ++ NP R S+++E
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 59/247 (23%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 2 LGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
LG F KVY T +++A+K + KDK + + E+ K E + ++H +I
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV-----------------YF 99
V L V+ + + +L + DV
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLLHTTCG 157
Q+ + ++F S V H+DL N+L+ + N+K++D GL F E D L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL--FREVYAADYYKLMGNSLL 188
Query: 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP---FQDDNIVSMY--RKIYRG 211
+++PE I G +DIWS GV+L+ + + G P + + +++ M R++
Sbjct: 189 PIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247
Query: 212 DFKCPPW 218
CP W
Sbjct: 248 PDDCPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 32/266 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK---------REISVMKMVK 52
LG G F +V+LA K+ ++ G + ++ V +++ K RE+ + + +
Sbjct: 13 LGRGEFGEVFLA------KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCH 110
HK++V L + Y ++ G+L F + K + + + A+
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 111 SRGV--------YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-Y 161
+ G+ HRDL N L+ +KV+ LS + + P +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRW 184
Query: 162 VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS 220
+APE + + + K+D+WS GV+++ V G LPF + + ++ G + P
Sbjct: 185 LAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 221 --SEARRLITKLLDPNPNSRIAISKI 244
S +L+T+ NP R + S++
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 36/270 (13%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVM-KMVKHKH 55
++G G F +V A + G M + K++K E R E+ V+ K+ H +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----------VARVYFQQLIS- 104
I+ L ++ +Y A++ G L + + K R+ E + + QQL+
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 105 AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE-HLKQDGLLHTTCG 157
A D + + HRDL N+L+ E+ K+ DFGLS E ++K+ T
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK-----TMGR 179
Query: 158 TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFK 214
P ++A E ++ Y K+D+WS GV+L+ +++ G P+ +Y K+ +G +
Sbjct: 180 LPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 215 CPPWFSSEARRLITKLLDPNPNSRIAISKI 244
P E L+ + P R ++I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 98 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157
Y Q+ ++F SR HRDL N+LL E+ +K+ DFGL A + D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 158 TP-AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMY-RKIYRGD-F 213
P ++APE I + Y ++D+WS GV+L+ + + G P+ I + R++ G
Sbjct: 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
+ P + + E + + P+ R S+++E
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 35/236 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVM-KMVKHKH 55
++G G F +V AR + G M + K +K + R E+ V+ K+ H +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAI----KRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----------VARVYFQQLI-- 103
I+ L + +Y A++ G L + + K R+ E + + QQL+
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 104 -----SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE-HLKQDGLLHTTCG 157
+D+ + HRDL N+L+ E+ K+ DFGLS E ++K+ T
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-----TMGR 172
Query: 158 TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG 211
P ++A E ++ Y +D+WS GV+L+ +++ G P+ +Y K+ +G
Sbjct: 173 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 62/261 (23%), Positives = 113/261 (43%), Gaps = 35/261 (13%)
Query: 1 MLGHGTFAKVYLARNL-QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
++G G F VY + G+ + V +++ + +EQ +E +MK H +++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 60 HEVM-ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSRGVYH 116
+ S+ + +K G+L N I V + + Q+ +++ S+ H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSA-------FSEHLKQDGLLHTTCGTPAYVAPEVISK 169
RDL N +LDE +KV DFGL+ +S H L ++A E +
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-----WMALESLQT 176
Query: 170 KGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 228
+ + K+D+WS GV+L+ L+ G P+ D + + + +G RRL+
Sbjct: 177 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG------------RRLLQ 223
Query: 229 KLLDPNPNSRIAISKIMESSW 249
P+P + ++M S W
Sbjct: 224 PEYCPDP-----LYEVMLSCW 239
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 10 VYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 69
V LAR TG+ + ++ + + M+ ++ E+ V K+ H +IV + +++
Sbjct: 16 VNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 70 YFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL 126
+ + G + I + E Q ++ A+D+ H G HR +K ++L+
Sbjct: 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134
Query: 127 DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-------VAPEVISK--KGYDGAKA 177
DG KV GL + + L P Y ++PEV+ + +GYD AK+
Sbjct: 135 SVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKS 191
Query: 178 DIWSCGVILYVLLAGFLPFQD 198
DI+S G+ L G +PF+D
Sbjct: 192 DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 2 LGHGTFAKVY--LARNLQTGKS---MAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 54
LG G+F VY AR++ G++ +A+K V + ++ E+I+ E SVMK
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEASVMKGFTCH 69
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-------------LREDVARVYFQQ 101
H+V L V++ M+L+ G+L + + R L+E + +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA--AE 127
Query: 102 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQ--DGLLHTTC 156
+ + + +++ HRDL N ++ D +K+ DFG++ +++ ++ GLL
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILY 187
++APE + K G +D+WS GV+L+
Sbjct: 187 ----WMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 15/246 (6%)
Query: 2 LGHGTFAKVY--LARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG G F V + + ++ K++A+K++ K+ + +++ RE +VM+ + + +IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ ++S + M+L + G L + K + + E Q+ + + HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP----AYVAPEVISKKGYDG 174
L N+LL K++DFGL S+ L D + + APE ++ +
Sbjct: 121 LAARNVLLVTQHYAKISDFGL---SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 175 AKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232
+K+D+WS GV+++ + G P++ + + I G+ +CP E L+
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 233 PNPNSR 238
+ R
Sbjct: 237 YGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 64/266 (24%), Positives = 107/266 (40%), Gaps = 32/266 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV--GMMEQIKREISV--------MKMV 51
LG GT ++Y A L +K IKV +++ R+IS+ M+ V
Sbjct: 3 LGRGTRTQIY-AGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV 61
Query: 52 KHKHIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFC 109
HKHIV L+ V + + V+ G +LF L +QL SA+ +
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121
Query: 110 HSRGVYHRDLKPENLLLDEDG-------NLKVTDFG--LSAFSEHLKQDGLLHTTCGTPA 160
+ + H ++ +N+LL +G +K++D G ++ S + +
Sbjct: 122 EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--------P 173
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF 219
++APE + AD WS G L+ + G +P +D + R Y G
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPS 232
Query: 220 SSEARRLITKLLDPNPNSRIAISKIM 245
E L+T ++ +PN R IM
Sbjct: 233 CKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP 216
GTP Y+APE++ K + A D W+ GV L+ L G PF D+ +++ I D
Sbjct: 542 GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 217 PW------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
PW S A+ I LL +P R + ++ + F
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 63/293 (21%), Positives = 121/293 (41%), Gaps = 57/293 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKV--IKVGMMEQ---------IKREISVMKM 50
LG G F KV K+ A ++ G+ + V M+++ + E +++K
Sbjct: 8 LGEGEFGKVV--------KATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 51 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFN------KIAKGRLREDVAR-------- 96
V H H+++L+ + + ++ K G L + K+ L D R
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 97 -----------VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145
+ Q+ + + + HRDL N+L+ E +K++DFGLS +
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RDV 177
Query: 146 LKQDGLLHTTCG-TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF---QDD 199
++D + + G P ++A E + Y ++D+WS GV+L+ ++ G P+ +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 200 NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
+ ++ + YR + P S E L+ P+ R + I S +K
Sbjct: 237 RLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADI--SKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 52/212 (24%)
Query: 59 LHEVMASKSKIYFA--MDLVKGGELFNKIAKGRLRED-VARVYFQQLISAVDFCHSRGVY 115
L ++M SK Y L K +L KG RE+ + + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPYLLGKVQDL----PKGLERENKIIQTIMRQILFALDGLHSTGIV 277
Query: 116 HRDLKPENLLLDE-DGNLKVTDFGLSA----FSEHLKQDGLLHTTCGTPAYVAPE--VIS 168
HRD+KP+N++ E G+ K+ D G +A ++ ++ LL P Y APE ++S
Sbjct: 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL-----DPRYAAPEQYIMS 332
Query: 169 KKGYDGAKA-------------------DIWSCGVILYVLLAGFLPF--QDDNIVSMYRK 207
+ A DI+S G+I L P D N++ R+
Sbjct: 333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI---FLQMAFPNLRSDSNLIQFNRQ 389
Query: 208 IYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
+ R D+ W KL++P + +
Sbjct: 390 LKRNDYDLVAW---------RKLVEPRASPDL 412
|
Length = 566 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 27/237 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVE 58
LG G F V +KV K I + ME E MK H +++
Sbjct: 7 LGEGEFGSV--MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 59 LHEV--MASKSKIYFA----MDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SA 105
L V +S+ Y + + +K G+L + + RL + + Q L+ S
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 106 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHTTCGTPAYV 162
+++ S+ HRDL N +L+E+ N+ V DFGLS ++ +Q + ++
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV---KWI 181
Query: 163 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPP 217
A E ++ + Y K+D+WS GV ++ + G P+ +Y + +G+ K PP
Sbjct: 182 AIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 2 LGHGTFA----KVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
LG G F VY R Q ++ + +K ++ MM RE +M + + +IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM----REAEIMHQLDNPYIV 58
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARV--YFQQLISAVDFCHSRGV 114
+ V +++ + M++ GG L NK G+ E V+ V Q+ + + +
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT--TCGT-P-AYVAPEVISKK 170
HRDL N+LL K++DFGL S+ L D + + G P + APE I+ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGL---SKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 171 GYDGAKADIWSCGVILY 187
+ +++D+WS G+ ++
Sbjct: 174 KFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
+LG G F VY + G+ + A+K + + K ++I E VM V + H+
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHV 71
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-------AVDFC 109
L + + S + L+ G L + + RE + Q L++ +++
Sbjct: 72 CRLLGICLT-STVQLITQLMPFGCLLDYV-----REHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG-TP-AYVAPEVI 167
R + HRDL N+L+ ++K+TDFGL+ +++ H G P ++A E I
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKWMALESI 183
Query: 168 SKKGYDGAKADIWSCGVILYVLLA-GFLPF 196
+ Y ++D+WS GV ++ L+ G P+
Sbjct: 184 LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
+G+G F KV L G S A +VV K+ EQ+ +E+ + + H ++++
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE------DVARVYFQQLISAVDFCHSRG 113
++ G+L N + R DV + ++ S + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTP-AYVAPEVISKKG 171
H DL N L D ++K+ D+GL A ++ +D + C P ++APE++ +G
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALEQY-PEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 172 YD------GAKADIWSCGVILYVLL-AGFLPFQD 198
D K++IWS GV ++ L A P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 1 MLGHGTFAKVYLARNLQ-----TGKS-MAMKVVGKDKVIKVGMMEQIK--REISVMKMVK 52
LG G F +VY +G +A+K + K + E+ + +E +M
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ----EKKEFLKEAHLMSNFN 57
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLIS-AVDFCH 110
H +IV+L V Y M+L++GG+L + + R+ R + ++L+ +D
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 111 SRGVY-------HRDLKPENLLLDEDGN-----LKVTDFGLSAFSEHLKQD-------GL 151
VY HRDL N L+ E G +K+ DFGL+ + K D GL
Sbjct: 118 G-CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--RDIYKSDYYRKEGEGL 174
Query: 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 190
L ++APE + G ++D+WS GV+++ +L
Sbjct: 175 LPVR-----WMAPESLL-DGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
+LG G F VY + G+++ A+K++ + K + + E +M + H H+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGV 114
V L V S + I L+ G L + + K + + + Q+ + + R +
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
HRDL N+L+ ++K+TDFGL+ E +++ ++A E I + +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT- 189
Query: 175 AKADIWSCGVILYVLL 190
++D+WS GV ++ L+
Sbjct: 190 HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 2 LGHGTFAKVY--LARNL---QTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 54
LG G+F VY +A+ + + +A+K V + M E+I+ E SVMK
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCH 69
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----VARVYFQQLIS------ 104
H+V L V++ M+L+ G+L + + R + A +++I
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 105 -AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQ--DGLLHTTCGT 158
+ + ++ HRDL N ++ ED +K+ DFG++ +++ ++ GLL
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 159 PAYVAPEVISKKGYDGAKADIWSCGVILY 187
+++PE + K G +D+WS GV+L+
Sbjct: 187 --WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 19/46 (41%), Positives = 31/46 (67%)
Query: 93 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 138
+V + +Q+++ + H G+ HRD+KPENLL+ DG +K+ DFG
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 44/263 (16%)
Query: 2 LGHGTFAKVYLARNLQTG---KSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHI 56
LG GTF K++ + G + +V+ K DK + E S+M + HKH+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHL 61
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGR------LREDVARVYFQQLISAVDFCH 110
V + V + + VK G L + K + + +VA+ QL A+ F
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAK----QLAWALHFLE 117
Query: 111 SRGVYHRDLKPENLLLDEDGN--------LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 162
+G+ H ++ +N+LL + + +K++D G+S L ++ LL +V
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--LPKEILLERI----PWV 171
Query: 163 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY---RKIY----RGDFKC 215
PE I AD WS G L+ + +G D +S +K+ R
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSALDSQKKLQFYEDRHQLPA 226
Query: 216 PPWFSSEARRLITKLLDPNPNSR 238
P W +E LI + +D P+ R
Sbjct: 227 PKW--TELANLINQCMDYEPDFR 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 36/115 (31%), Positives = 46/115 (40%), Gaps = 26/115 (22%)
Query: 92 EDVARVYFQQL----ISAV--DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145
D+ V + L I AV + HR K N+LL DG
Sbjct: 4 ADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDG--------------L 49
Query: 146 LKQDGLLHTTC-----GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP 195
LK DG + P ++APEVI + Y KADI+S G+ LY L LP
Sbjct: 50 LKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 24/237 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMA-MKVVGK------DKVIKVGMMEQIKREISVMKMV-KH 53
LG G F KV A KS A MKV K + +M ++K +M + H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK----IMSHLGNH 98
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCH 110
++IV L I + G+L N + + R L + + Q+ + F
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGTPA-YVAPEVI 167
S+ HRDL N+LL +K+ DFGL + + D ++ P ++APE I
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGL---ARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 168 SKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRGDFKCPPWFSSE 222
Y ++D+WS G++L+ + + G P+ + S Y+ I G P +
Sbjct: 216 FNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 37/266 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG F K+Y G A V K + + ++E S+M + H +IV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ------------------Q 101
V+ + + + + G+L + DV + Q
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 102 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL-----SAFSEHLKQDGLLHTTC 156
+ + +++ S H+DL N+L+ E ++K++D GL SA ++ LL
Sbjct: 133 IAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR- 191
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP---FQDDNIVSMYRKIYRGD 212
++ PE I + + +DIWS GV+L+ + + G P F + ++ M RK R
Sbjct: 192 ----WMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244
Query: 213 FKCPPWFSSEARRLITKLLDPNPNSR 238
C L+T+ P+ R
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 3 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 62
G VYLAR+ TG + +++ + + ++ ++ E+ + +H +I+ V
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 63 MASKSKIYFAMDLVKGGE----LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ S ++ + G L +G + E + + +++ H G HR+
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIHRN 126
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--------DGLLHTTCGTPAYVAPEVISKK 170
+K ++L+ DG V+ GLS ++ D +T P +++PE++ +
Sbjct: 127 IKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQD 183
Query: 171 --GYDGAKADIWSCGVILYVLLAGFLPFQD 198
GY+ K+DI+S G+ L G +PFQD
Sbjct: 184 LYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV------GKDKVIKVGMMEQIKR-----EISVMK 49
+LG GTF KV A + + + A+K+V +D I++ ME++++ +MK
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 50 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 109
+ ++ H + +D + F+ +A++ FQ + A+D+
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS-------HRHLAQIIFQTGV-ALDYF 247
Query: 110 HSR-GVYHRDLKPENLLLD----------------EDGNLKVTDFGLSAFSEHLKQDGLL 152
H+ + H DLKPEN+L++ + +++ D G H +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT---- 303
Query: 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194
T Y +PEV+ G+ D+WS G I+Y L G L
Sbjct: 304 -AIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 40/182 (21%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 44 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQ 101
E + H +IV L V+ + + + + G L F + +G+L
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 102 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL--LHTTCG-- 157
L S + + G H+ L +L++ D K++ F L++D ++TT
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGK 169
Query: 158 TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKC 215
+P + APE I + A +D+WS G++++ +++ G P+ D + + + + G F+
Sbjct: 170 SPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRL 227
Query: 216 PP 217
P
Sbjct: 228 PA 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160
Q+ ++F S+ HRDL N+LL + +K+ DFGL+ H +T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRG-DFKCPP 217
++APE I Y +D+WS G++L+ + + G P+ + S Y KI G P
Sbjct: 305 WMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363
Query: 218 WFSSEARRLITKLLDPNPNSR---IAISKIMES 247
+ E ++ K + P R + +S I+ES
Sbjct: 364 HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 59/264 (22%), Positives = 98/264 (37%), Gaps = 45/264 (17%)
Query: 2 LGHGTFAKVYLARNLQTGK----------SMAMKVVGKDKVIKVGMMEQIKREISVMKMV 51
LG GTF +Y S+ +KV+G D S+M +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS----LAFFETASLMSQL 58
Query: 52 KHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFC 109
HKH+V+L+ V I + VK G L F K + +QL SA+ +
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 110 HSRGVYHRDLKPENLLLDEDGN-------LKVTDFG--LSAFSEHLKQDGLLHTTCGTPA 160
+ + H ++ +N+L+ G +K++D G ++ S + + +
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------P 169
Query: 161 YVAPEVISKKGYDGAK-----ADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFK 214
++APE I +G AD WS G L + G P + R Y+ +
Sbjct: 170 WIAPECIR----NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHR 224
Query: 215 CPPWFSSEARRLITKLLDPNPNSR 238
P +E LI + +P R
Sbjct: 225 LPMPDCAELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGT 158
Q+ + F S+ HRDL N+LL K+ DFGL + ++ D ++
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIRNDSNYVVKGNARL 278
Query: 159 PA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFK-- 214
P ++APE I Y ++D+WS G++L+ + + G P+ + S + K+ + ++
Sbjct: 279 PVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
P SE ++ D +P R +I++
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 46 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA--RVYFQQLI 103
S+M V H H+ +H V S+ + V+ G L + K + R VA QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 104 SAVDFCHSRGVYHRDLKPENLLLD----EDGN---LKVTDFGLS--AFSEHLKQDGLLHT 154
SA+ + + + H ++ +N+LL +G +K++D G+S A S + + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 155 TCGTPAYVAPEVISKKGYDGAKADIWSCG-VILYVLLAGFLPFQDDNIVSMYRKIYRGDF 213
++APE + AD WS G +L + G +P ++ S + Y
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEKERFYEKKH 238
Query: 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIM 245
+ P E LI++ L P R + I+
Sbjct: 239 RLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 2 LGHGTFAKVY--LARNLQTGKS-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
LGHG F +VY L R + + V + E +M H++IV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR-EDVARVYFQQLIS-AVDF---CH--- 110
L V + + ++L+ GG+L + + + R R E + + + L+ A D C
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 111 SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSA---FSEHLKQDGLLHTTCGTPAYVAP 164
HRD+ N LL G K+ DFG++ + + ++ G ++ P
Sbjct: 134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLPIKWMPP 190
Query: 165 EVISKKGYDG---AKADIWSCGVILY-VLLAGFLPF 196
E DG +K D+WS GV+L+ + G++P+
Sbjct: 191 EAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 25/164 (15%)
Query: 2 LGHGTFAKVYL--ARNLQTGKSM-AMKVVGKDKVIKVGMME---------QIKREISVMK 49
LG G F +V+L A L A + G+ ++ V M+ +EI +M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 50 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR------VYFQ--- 100
+K+ +I+ L V S + + ++ G+L +++ + V
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 101 ----QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140
Q+ S + + S HRDL N L+ +K+ DFG+S
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
+LG G F VY + G+++ A+KV+ ++ K ++I E VM V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYV 71
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGV 114
L + + S + L+ G L + + K R+ + Q+ + + +
Sbjct: 72 CRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG-TP-AYVAPEVISKKGY 172
HRDL N+L+ ++K+TDFGL+ + + + H G P ++A E I + +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRRF 188
Query: 173 DGAKADIWSCGVILYVLLA-GFLPFQ 197
++D+WS GV ++ L+ G P+
Sbjct: 189 T-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 20/147 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV--EL 59
L G +VYL + +K+ + +RE+++++++ K + ++
Sbjct: 6 LKGGLTNRVYLLGT--KDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKV 58
Query: 60 HEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVY--FQQLISAVDFCHSRGVY 115
S Y M+ ++G L ++ K + E +A + QL V CH
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV-LCH----- 112
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAF 142
DL P N+L+D+ L + D+ + +
Sbjct: 113 -GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS----VMKMVKHKHI 56
+LG G F V+ + G S+ + V K I+ Q +EI+ M + H +I
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVA--IKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSRGV 114
V L + S + L G L + + + R D R+ + Q+ + + +
Sbjct: 72 VRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGTP-AYVAPEVISKKG 171
HR+L N+LL D +++ DFG+ ++ L D ++ TP ++A E I
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGV---ADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 172 YDGAKADIWSCGVILYVLLA 191
Y ++D+WS GV ++ +++
Sbjct: 188 YT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 42/229 (18%)
Query: 2 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVG----MMEQIKREISVMKMVKHKH 55
+G G F +V+ AR L + M V K++K M +RE ++M H +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFN-----------KIAKGRLREDVARVYFQQLIS 104
IV+L V A + + + G+L ++ + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 105 AVDFCHSRGV------------YHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQD 149
C ++ V HRDL N L+ E+ +K+ DFGLS +++ K
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 150 GLLHTTCGTPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF 196
P ++ PE I Y ++D+W+ GV+L+ + + G P+
Sbjct: 190 E----NDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 2/99 (2%)
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160
Q+ + ++F S+ HRDL N+L+ E +K+ DFGL+ +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
++APE I Y +D+WS G++L+ + G P+ +
Sbjct: 307 WMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
+G+G F KV L + +G + A +VV K+ + + EQ+K E + ++H ++++
Sbjct: 3 IGNGWFGKVILGE-VNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA--RVYFQQL----ISAVDFCHSRG 113
+ M+ G+L + R E + Q++ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG---TP-AYVAPEVISK 169
H DL N LL D +K+ D+GLS H K + T P ++APE++ +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 170 KG-----YDGAK-ADIWSCGVILYVLL 190
D K +++WS GV ++ L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 0.002
Identities = 17/66 (25%), Positives = 33/66 (50%), Gaps = 5/66 (7%)
Query: 72 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 131
M+ + G EL + R+ ED V +++ + + G+ H DL N+L+D+D
Sbjct: 109 VMEYIDGVEL----YRVRVLEDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163
Query: 132 LKVTDF 137
+ + D+
Sbjct: 164 IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 2 LGHGTFAKVYL--ARNLQ--TGKSMAMKVVGKDKV-IKVGMMEQ---------IKREISV 47
LG G F +V+L A ++ K ++ V G V + V M+ + +EI +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 48 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-----DVARVYFQQL 102
M +K +I+ L V + + + ++ G+L +++ +E DV + + L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 103 I-------SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140
I S + + S HRDL N L+ ++ +K+ DFG+S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 36.8 bits (85), Expect = 0.002
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 306 ELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQ-ESGRKGK---LAINADIFA 361
EL + S + +V + N+ + + G+ + +++
Sbjct: 5 ELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVYE 64
Query: 362 VTPSLLVVEVKKDNGDTLEYNQFCS 386
V P L +V+ KK G T + + +
Sbjct: 65 VGPGLFMVDFKKKTGSTKTFTKLAT 89
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 34/168 (20%), Positives = 64/168 (38%), Gaps = 32/168 (19%)
Query: 2 LGHGTFAKVYLARNL----------QTGKS------MAMKVVGKDKVIKVGMMEQIKREI 45
LG G F +V+L + +A+KV+ D + +K E+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLK-EV 70
Query: 46 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ----- 100
++ + +I L V + M+ ++ G+L N+ + + E
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSF 129
Query: 101 --------QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140
Q+ S + + S HRDL N L+ ++ +K+ DFG+S
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 14/152 (9%)
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLLHTT 155
Q+ +DF S+ HRD+ N+LL + K+ DFGL+ + +K + L
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRG-D 212
++APE I Y ++D+WS G++L+ + + G P+ + S Y+ + RG
Sbjct: 280 -----WMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333
Query: 213 FKCPPWFSSEARRLITKLLDPNPNSRIAISKI 244
P + E ++ + P R S+I
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 416 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.32 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.29 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.07 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.95 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.82 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.82 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.72 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.38 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.12 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.06 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.58 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.1 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.48 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.45 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.4 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.4 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.15 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=477.58 Aligned_cols=250 Identities=56% Similarity=0.995 Sum_probs=235.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch--hhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV--GMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+|++|.+..+|+.||+|++++...... ...+.+.+|+.+++.++ ||||+++++++...+.+|+|||||.
T Consensus 24 ~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~ 103 (370)
T KOG0583|consen 24 TLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCS 103 (370)
T ss_pred eecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecC
Confidence 48999999999999999999999998877633311 35678889999999999 9999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
||+|++++.. ++++|.+++.+|+|+++||+|||++||+||||||||||++.+ +++||+|||++.... .....+.+.
T Consensus 104 gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~ 181 (370)
T KOG0583|consen 104 GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTF 181 (370)
T ss_pred CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCC
Confidence 9999999987 899999999999999999999999999999999999999999 999999999998654 456788999
Q ss_pred ccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF-SSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~li~~~L~~ 233 (416)
||||.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.++ |+++++||++||.+
T Consensus 182 cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~ 261 (370)
T KOG0583|consen 182 CGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVP 261 (370)
T ss_pred CCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCC
Confidence 9999999999999988 999999999999999999999999999999999999999999999999 99999999999999
Q ss_pred CCCCcCCHHHHhcCccccc
Q 014911 234 NPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 234 dP~~R~s~~eil~hp~f~~ 252 (416)
||.+|+|+.+|+.||||+.
T Consensus 262 ~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 262 DPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcccCCCHHHHhhChhhcc
Confidence 9999999999999999997
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-63 Score=467.14 Aligned_cols=251 Identities=39% Similarity=0.742 Sum_probs=224.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
+||+|+||.|.+|.++.||+.||||++++...... .....+.+|++||++|+|||||+++++|...+..||||||+
T Consensus 179 ~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v 258 (475)
T KOG0615|consen 179 TLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYV 258 (475)
T ss_pred eecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEe
Confidence 48999999999999999999999999998776542 23345789999999999999999999999999999999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC---CCeEEeeccccccccccccCCcc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
.||+|++++.. +.+.|+.-+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|.+.. ....+
T Consensus 259 ~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm 335 (475)
T KOG0615|consen 259 EGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFM 335 (475)
T ss_pred cCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc---cceeh
Confidence 99999999975 789999999999999999999999999999999999999876 469999999998654 45678
Q ss_pred cccccCCCCCchHHhhhcCC--CCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCC--CC--CCHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP--PW--FSSEARR 225 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~--~s~~~~~ 225 (416)
.|.||||.|+|||++...++ ++.++|+||+|||||.+|+|.+||.+.... .+.+.|.+|.+.+- .| +|.++++
T Consensus 336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~d 415 (475)
T KOG0615|consen 336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALD 415 (475)
T ss_pred hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHH
Confidence 99999999999999986653 345789999999999999999999886554 48899999987553 33 7999999
Q ss_pred HHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 226 LITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
||.+||..||++|||+.++|+||||+...
T Consensus 416 lI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 416 LINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=479.00 Aligned_cols=254 Identities=37% Similarity=0.663 Sum_probs=240.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+|+.||.+++..+|+.||+|++.+..+.+..+.+.+.+||+|++.|+|||||+++++|++.+++|||+|+|..++
T Consensus 25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s 104 (592)
T KOG0575|consen 25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS 104 (592)
T ss_pred eeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCcc
Confidence 58999999999999999999999999999888888889999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++++ +.++|.+++.|++||+.||.|||+++|+|||||..|++++++.+|||+|||||+..... .....|.||||
T Consensus 105 L~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--~Erk~TlCGTP 182 (592)
T KOG0575|consen 105 LMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--GERKKTLCGTP 182 (592)
T ss_pred HHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc--ccccceecCCC
Confidence 9999986 78999999999999999999999999999999999999999999999999999976542 24467899999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.++ +..+||||+|||||.||.|++||...+..+.|.+|...++..|..+|.++++||.+||++||.+||
T Consensus 183 NYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rp 261 (592)
T KOG0575|consen 183 NYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERP 261 (592)
T ss_pred cccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCC
Confidence 9999999998887 599999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCccccccCccc
Q 014911 240 AISKIMESSWFKKSAPKV 257 (416)
Q Consensus 240 s~~eil~hp~f~~~~~~~ 257 (416)
|++++|.|+||+.+..+.
T Consensus 262 sl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 262 SLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred CHHHHhcCHhhhCCCcCC
Confidence 999999999997665443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-62 Score=482.95 Aligned_cols=250 Identities=41% Similarity=0.783 Sum_probs=239.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||.|+-|.|.+|++..||+.+|||++.+...........+.+||-||+.+.||||+++|++++++.++|+|+||++||+
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGE 98 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGE 98 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCch
Confidence 58999999999999999999999999988865555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
||+++.+ |+++|.++.++|+||+.|+.|||..+||||||||+|+|||..+++||+|||+|.+ ...+.++.|.||+|
T Consensus 99 LFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL---e~~gklLeTSCGSP 175 (786)
T KOG0588|consen 99 LFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL---EVPGKLLETSCGSP 175 (786)
T ss_pred hHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec---ccCCccccccCCCc
Confidence 9999975 9999999999999999999999999999999999999999999999999999985 33467899999999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|.|||++.+.+|+|.++||||||||||.||+|.+||++.+...++.++.+|.+..|..+|+++++||++||..||.+|+
T Consensus 176 HYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 176 HYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred ccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCcccccc
Q 014911 240 AISKIMESSWFKKS 253 (416)
Q Consensus 240 s~~eil~hp~f~~~ 253 (416)
|.+||++|||+...
T Consensus 256 T~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 256 TTEEILKHPFLSGY 269 (786)
T ss_pred cHHHHhhCchhhcC
Confidence 99999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-59 Score=437.59 Aligned_cols=253 Identities=40% Similarity=0.746 Sum_probs=235.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||.++.+.|++.+|+|++++..+...+..+..+.|..||..++||.||.++..|.++.++|+|+||+.||+
T Consensus 32 viGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe 111 (357)
T KOG0598|consen 32 VIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE 111 (357)
T ss_pred eeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence 58999999999999999999999999999998887788999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|+..+++ +.++|+.++.|+..|+.||.|||++||+||||||+|||+|.+|+++|+|||+++..- .......+.|||+
T Consensus 112 Lf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~~~t~tfcGT~ 189 (357)
T KOG0598|consen 112 LFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDGDATRTFCGTP 189 (357)
T ss_pred HHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cCCCccccccCCc
Confidence 9999985 899999999999999999999999999999999999999999999999999998432 2334567789999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHccCCCCCCc
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-PWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R 238 (416)
.|||||++.+.+|+ ..+|.|||||++|+|++|.+||.+.+...++++|.++....+ ..+|.++++||+++|+.||.+|
T Consensus 190 eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 190 EYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred cccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHh
Confidence 99999999999986 899999999999999999999999999999999999985554 4599999999999999999999
Q ss_pred C----CHHHHhcCccccccCcc
Q 014911 239 I----AISKIMESSWFKKSAPK 256 (416)
Q Consensus 239 ~----s~~eil~hp~f~~~~~~ 256 (416)
. ++.+|.+||||......
T Consensus 269 Lg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred cCCCCChHHhhcCcccccCCHH
Confidence 6 68999999999876543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-59 Score=423.78 Aligned_cols=252 Identities=42% Similarity=0.773 Sum_probs=238.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||.|+||.|-+++++.+|..+|+|++++..+.+..+.++..+|..+|+.+.||.++++++.+.+.+.+|+||||++||+
T Consensus 51 tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGE 130 (355)
T KOG0616|consen 51 TLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGE 130 (355)
T ss_pred eeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCcc
Confidence 58999999999999999999999999999999888899999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|+.++++ +++++..++.|+.|++.||+|||+++|++|||||||||+|.+|.+||+|||+|... .+...|.||||
T Consensus 131 lFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~~rT~TlCGTP 205 (355)
T KOG0616|consen 131 LFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----SGRTWTLCGTP 205 (355)
T ss_pred HHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----cCcEEEecCCc
Confidence 9999987 89999999999999999999999999999999999999999999999999999743 23478899999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++..++|. .++|.|||||++|||++|.+||.+.+...+|.+|..+...+|+.+++++++||+++|+.|-.+|.
T Consensus 206 eYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 206 EYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred cccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 99999999999985 89999999999999999999999999999999999999999999999999999999999999995
Q ss_pred -----CHHHHhcCccccccCcccc
Q 014911 240 -----AISKIMESSWFKKSAPKVV 258 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~~~~~ 258 (416)
...+|.+||||+.......
T Consensus 285 gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 285 GNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred cCcCCCccccccCcccccccHHHH
Confidence 4689999999997655443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=444.34 Aligned_cols=254 Identities=35% Similarity=0.639 Sum_probs=236.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||.|+|++|++|+++.+++.||||++++..+.++....-+.+|-.+|.+| +||.|++||..|.+...+|+|+||+++|
T Consensus 80 ~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG 159 (604)
T KOG0592|consen 80 ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG 159 (604)
T ss_pred eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence 489999999999999999999999999999988888888999999999999 8999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-------C-
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-------G- 150 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-------~- 150 (416)
+|.++|.+ |.|++..++.|+.||+.||+|||++|||||||||||||+|.||++||+|||.|......... .
T Consensus 160 dll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~ 239 (604)
T KOG0592|consen 160 DLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQ 239 (604)
T ss_pred cHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCccc
Confidence 99999988 99999999999999999999999999999999999999999999999999999876543222 1
Q ss_pred -c--ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014911 151 -L--LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 227 (416)
Q Consensus 151 -~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 227 (416)
. ..+++||..|++||++..... ++.+|+|+||||||.|++|.+||.+.+..-.+++|..-.+++|+.+++.+++||
T Consensus 240 a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv 318 (604)
T KOG0592|consen 240 ASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLI 318 (604)
T ss_pred ccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHH
Confidence 1 145789999999999987654 699999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 228 TKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+++|..||++|+|+.+|.+||||.....
T Consensus 319 ~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 319 KKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHHccCccccccHHHHhhCcccccCCh
Confidence 9999999999999999999999987543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-56 Score=417.66 Aligned_cols=248 Identities=31% Similarity=0.538 Sum_probs=225.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-KIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~~~gg 79 (416)
.||+|+.|+||+|+++.|++.+|+|++... .+.....++.+|+++++.++|||||.+|+.|..+. .++|+|||+.||
T Consensus 86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 86 VLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 489999999999999999999999999433 24466789999999999999999999999999999 599999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+|.+.+.. |+++|..+.+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.|+..-. ....+..|
T Consensus 164 SLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn----S~a~tfvG 239 (364)
T KOG0581|consen 164 SLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN----SIANTFVG 239 (364)
T ss_pred CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh----hhcccccc
Confidence 99999987 899999999999999999999995 9999999999999999999999999999985443 26688999
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-----cHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHc
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRGD-FKCPPW-FSSEARRLITKL 230 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~~ 230 (416)
|..|||||.+.+..| +.++||||||+.+.|+++|+.||... +..+++..|..+. ...|.. +|+++++||..|
T Consensus 240 T~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 240 TSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCC 318 (364)
T ss_pred cccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 999999999998877 58999999999999999999999875 6678888998865 456775 999999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccccCc
Q 014911 231 LDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
|++||.+|+|+.|+++|||+++...
T Consensus 319 L~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 319 LRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred hcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999986543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=416.45 Aligned_cols=248 Identities=38% Similarity=0.681 Sum_probs=227.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|+++.++..||||.+.+.... ....+.+..||.+|+.++|||||+++++...++.+|+|||||.||+|
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 89999999999999999999999999887753 35678889999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC------CCeEEeeccccccccccccCCcccc
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED------GNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~------~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
.+++.+ ++++|..++.++.||+.||++||+++|+||||||+||||+.. -.+||+|||+|+... ......+
T Consensus 97 s~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~t 173 (429)
T KOG0595|consen 97 SDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAET 173 (429)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC---chhHHHH
Confidence 999987 799999999999999999999999999999999999999875 348999999999755 4567889
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHcc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLL 231 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L 231 (416)
.||||.|||||++....|+ .|+|+||+|+|+|++++|++||+..+..+++..+.++.. ..|.++++...+|+...|
T Consensus 174 lcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll 252 (429)
T KOG0595|consen 174 LCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLL 252 (429)
T ss_pred hhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHH
Confidence 9999999999999988886 999999999999999999999999999999998887754 345578899999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccC
Q 014911 232 DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.+|..|.+..+-+.|++.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 253 QRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hcCccccCchHHhhhhhhcccCc
Confidence 99999999999999999987654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=418.53 Aligned_cols=254 Identities=40% Similarity=0.716 Sum_probs=239.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+|.+|.+...|+.||||.|+++.+.++..+-.+++||+||..|+||||+.+|++|++.+.+.|||||..||+
T Consensus 60 tLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge 139 (668)
T KOG0611|consen 60 TLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE 139 (668)
T ss_pred HhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCcc
Confidence 58999999999999999999999999999999988888999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|+|++.+ +.++|.+++.+|+||.+|+.|||.++++|||||.+|||+|.++++||+|||++.++. ....++++||+|
T Consensus 140 LYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kfLqTFCGSP 216 (668)
T KOG0611|consen 140 LYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKFLQTFCGSP 216 (668)
T ss_pred HHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccHHHHhcCCc
Confidence 9999976 899999999999999999999999999999999999999999999999999998654 356789999999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|.+||++++.+|.|+.+|-|||||+||.|..|..||++.+...+.+.|.+|.+.-|+. +.++.-||+.||..||.+|.
T Consensus 217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLmVNP~RRA 295 (668)
T KOG0611|consen 217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLMVNPERRA 295 (668)
T ss_pred ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHhcCcccch
Confidence 99999999999999999999999999999999999999999999999999998877664 66788999999999999999
Q ss_pred CHHHHhcCccccccCcccc
Q 014911 240 AISKIMESSWFKKSAPKVV 258 (416)
Q Consensus 240 s~~eil~hp~f~~~~~~~~ 258 (416)
|+++|-.|=|.+-++...+
T Consensus 296 TieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 296 TIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred hHHHHhhhheeeccccccc
Confidence 9999999999876554433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-55 Score=424.98 Aligned_cols=255 Identities=36% Similarity=0.648 Sum_probs=230.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+||||.||+|+.+.||..+|+|++++......+..+.++.|-.+|...++|+||+||..|.+...+|+||||++||+
T Consensus 148 ~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD 227 (550)
T KOG0605|consen 148 VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD 227 (550)
T ss_pred eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence 48999999999999999999999999999998888999999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc------------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK------------ 147 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~------------ 147 (416)
+..++.+ +.|+|+.++.|+.+++.|++.+|+.|++||||||+|+|||..|++||+||||++......
T Consensus 228 ~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~ 307 (550)
T KOG0605|consen 228 MMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQ 307 (550)
T ss_pred HHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhh
Confidence 9999976 889999999999999999999999999999999999999999999999999996322100
Q ss_pred --------cC-------------------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCC
Q 014911 148 --------QD-------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194 (416)
Q Consensus 148 --------~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~ 194 (416)
.. ......+|||.|+|||++.+.+| +..+|.||||||+||||.|.+
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~ImyEmLvGyP 386 (550)
T KOG0605|consen 308 INLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGCIMYEMLVGYP 386 (550)
T ss_pred hhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHHHHHHHHhCCC
Confidence 00 01234579999999999999997 499999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCCCCCCcCC---HHHHhcCccccccCccc
Q 014911 195 PFQDDNIVSMYRKIYRGD--FKCPP--WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKSAPKV 257 (416)
Q Consensus 195 Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~f~~~~~~~ 257 (416)
||.+.++.+.+++|..-. +.+|. .++++++|||.+||. ||.+|.. ++||..||||+......
T Consensus 387 PF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 387 PFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred CCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 999999999999998754 55665 478999999999999 9999985 89999999999765543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=392.31 Aligned_cols=248 Identities=37% Similarity=0.699 Sum_probs=224.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+|+.||++.+..||+.+|+|+++...+... ..+.+.+|++|-+.|+||||+++++.+.+....|+|+|++.|++
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d 96 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 96 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence 48999999999999999999999999988777654 56889999999999999999999999999999999999999999
Q ss_pred hhhHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC---CCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~-~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|+.-|. +--++|..+-.+++||++||+|||.+||+|||+||+|+++-.. .-+||+|||+|.-.. .........
T Consensus 97 l~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~ 173 (355)
T KOG0033|consen 97 LFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFA 173 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---Ccccccccc
Confidence 976664 4568999999999999999999999999999999999999543 349999999997443 344566788
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~ 232 (416)
|||.|+|||++.+.+| +.++|||+||||||.||.|++||.+.+...+|+.|..+.+.+|+ .+++++++|+++||.
T Consensus 174 GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~ 252 (355)
T KOG0033|consen 174 GTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLT 252 (355)
T ss_pred CCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhc
Confidence 9999999999998888 58999999999999999999999999999999999999887765 379999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
.||.+|+|+.|+|+|||+++.
T Consensus 253 ~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 253 VNPKKRITADEALKHPWICNR 273 (355)
T ss_pred cChhhhccHHHHhCCchhcch
Confidence 999999999999999999753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=394.05 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=214.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.+|+|+||+||+|+++.||+.||||.+.... .+....+-..|||++|++|+|||+|.++++|.....+++|+|||.. +
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 4799999999999999999999999995443 2334456678999999999999999999999999999999999987 6
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+.+-+++ ..++++.++.|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.... +....+.++.|
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVAT 164 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVAT 164 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhhhhhhh
Confidence 6666654 5599999999999999999999999999999999999999999999999999987553 44567788999
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---------------------CCCC-
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------FKCP- 216 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------~~~p- 216 (416)
.||+|||.+.+...+|.++||||+||++.||++|.+.|++.+..+....|.+.. ++.|
T Consensus 165 RWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~ 244 (396)
T KOG0593|consen 165 RWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPE 244 (396)
T ss_pred hhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCC
Confidence 999999999987667899999999999999999999999987776665554311 1111
Q ss_pred ---------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 217 ---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 217 ---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
+.++.-+.+|+++||..||.+|+|.+|+|.||||..
T Consensus 245 ~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 245 HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 235778999999999999999999999999999943
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=426.12 Aligned_cols=253 Identities=32% Similarity=0.618 Sum_probs=237.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+|++|..+.+++.+|||+++++.+...+..+.++.|.+|+...+ ||.+++++..|.+++++|+||||+.||
T Consensus 375 vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Gg 454 (694)
T KOG0694|consen 375 VLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGG 454 (694)
T ss_pred EeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCC
Confidence 5999999999999999999999999999999998899999999999999885 999999999999999999999999999
Q ss_pred chhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 80 ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 80 ~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
++..++..+.|++..++.|+..++.||.|||++||+|||||.+|||||.+|++||+|||++.- .........|.||||
T Consensus 455 dm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~~g~~TsTfCGTp 532 (694)
T KOG0694|consen 455 DLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMGQGDRTSTFCGTP 532 (694)
T ss_pred cEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCCCCCccccccCCh
Confidence 977777778999999999999999999999999999999999999999999999999999973 233455678999999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..|. ..+|.|||||+||+||.|..||.+++.++++..|...+..+|-|+|.++.++++++|+.||++|.
T Consensus 533 ey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 533 EFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRL 611 (694)
T ss_pred hhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCccccc
Confidence 99999999998884 99999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CH-----HHHhcCccccccCcc
Q 014911 240 AI-----SKIMESSWFKKSAPK 256 (416)
Q Consensus 240 s~-----~eil~hp~f~~~~~~ 256 (416)
.+ .+|..||||+.-...
T Consensus 612 G~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 612 GSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CCCCCCchhhhhCCccccCCHH
Confidence 64 789999999976543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=409.67 Aligned_cols=250 Identities=33% Similarity=0.562 Sum_probs=223.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
.||+|+||.||+|++..+|+.||+|.+..+... .+......|||.||++|+||||++|.++..+. ..+|+|+||++.
T Consensus 124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 389999999999999999999999999877643 46777889999999999999999999998876 789999999987
Q ss_pred CchhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|..++... +|++.+++.|++||+.||+|||++||+|||||..|||||.+|++||+|||||+++..... ..++..+
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~~~T~rV 280 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-APYTSRV 280 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC-cccccce
Confidence 898888773 799999999999999999999999999999999999999999999999999998775443 3467778
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CC--------CCC----------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF--------KCP---------- 216 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~--------~~p---------- 216 (416)
-|.||+|||++.+...++..+|+||+||||.||++|++.|.+.+..+...+|.+- .+ .+|
T Consensus 281 vTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~ 360 (560)
T KOG0600|consen 281 VTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQP 360 (560)
T ss_pred EEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCc
Confidence 8999999999999888899999999999999999999999999999888888652 11 112
Q ss_pred ---------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 217 ---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 217 ---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..++..+.+|+..||..||.+|.|+.++|+|+||...
T Consensus 361 y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 361 YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 1257889999999999999999999999999999543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=393.40 Aligned_cols=236 Identities=34% Similarity=0.605 Sum_probs=213.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEE-EEEeCC-EEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE-VMASKS-KIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~-~~~lV~E~~~gg 79 (416)
||+|+||+||++++..+|..||.|.+..... +....+.+..|+.+|++|+|||||++++ .|...+ .++||||||.+|
T Consensus 27 IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G 105 (375)
T KOG0591|consen 27 IGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG 105 (375)
T ss_pred HcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence 8999999999999999999999999975544 3355678889999999999999999998 444444 499999999999
Q ss_pred chhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeccCCCCcEEeccCCCeEEeeccccccccccccCC
Q 014911 80 ELFNKIAK-----GRLREDVARVYFQQLISAVDFCHS--RG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 80 ~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~--~g--i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
+|...|+. ..++|..+++|+.|++.||..||+ .. |+||||||.||+++.+|.+||+|||++++++.. ..
T Consensus 106 DLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~--~t 183 (375)
T KOG0591|consen 106 DLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK--TT 183 (375)
T ss_pred CHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch--hH
Confidence 99999963 569999999999999999999999 45 999999999999999999999999999987653 34
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CC-CCCCHHHHHHHH
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CP-PWFSSEARRLIT 228 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~li~ 228 (416)
..++.+|||+||+||++...+|+ .+|||||+||++|||++-.+||.+.+...+.++|.+++++ +| ..+|.++..||.
T Consensus 184 fA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~ 262 (375)
T KOG0591|consen 184 FAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELIN 262 (375)
T ss_pred HHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHH
Confidence 56788999999999999999996 9999999999999999999999999999999999999876 67 579999999999
Q ss_pred HccCCCCCCcCCH
Q 014911 229 KLLDPNPNSRIAI 241 (416)
Q Consensus 229 ~~L~~dP~~R~s~ 241 (416)
.|+.+||..||+.
T Consensus 263 ~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 263 MCIAVDPEQRPDT 275 (375)
T ss_pred HHccCCcccCCCc
Confidence 9999999999996
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=406.74 Aligned_cols=254 Identities=35% Similarity=0.634 Sum_probs=225.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccch-----------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----------GMMEQIKREISVMKMVKHKHIVELHEVMASK--SK 68 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 68 (416)
||+|.||+|.+|++..+++.||||++.+...... ..++.+++||.||++|.|||||+|+++..+. +.
T Consensus 105 iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~ 184 (576)
T KOG0585|consen 105 IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDK 184 (576)
T ss_pred hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCc
Confidence 8999999999999999999999999987554321 2347899999999999999999999999764 68
Q ss_pred EEEEEeccCCCchhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc-
Q 014911 69 IYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL- 146 (416)
Q Consensus 69 ~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~- 146 (416)
+|||+|||..|++...-..+. +++.++++|+++++.||+|||.+||+||||||.|+||+++|.+||+|||.+..+...
T Consensus 185 ~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~ 264 (576)
T KOG0585|consen 185 LYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGS 264 (576)
T ss_pred eEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCC
Confidence 999999999998866555555 999999999999999999999999999999999999999999999999998765222
Q ss_pred --ccCCcccccccCCCCCchHHhhh---cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC--C
Q 014911 147 --KQDGLLHTTCGTPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW--F 219 (416)
Q Consensus 147 --~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~ 219 (416)
..+..+....|||.|+|||.+.. ..+.+.+.||||+||+||+|+.|..||-+....+++.+|.+..+.+|.. +
T Consensus 265 ~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~ 344 (576)
T KOG0585|consen 265 DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEI 344 (576)
T ss_pred ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccc
Confidence 12223455789999999999987 5677899999999999999999999999999999999999998888865 7
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
.+.+++||.+||.+||.+|+++.+|..|||......
T Consensus 345 ~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 345 NEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred cHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 999999999999999999999999999999987643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-54 Score=380.08 Aligned_cols=247 Identities=36% Similarity=0.673 Sum_probs=234.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|-||.||+|+..+++-.||+|++.++.+.+.+...++++|++|...|+||||+++|++|.+...+|+++||+++|+
T Consensus 29 ~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~ge 108 (281)
T KOG0580|consen 29 PLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGE 108 (281)
T ss_pred cccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCch
Confidence 38999999999999999999999999999988887888999999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++..+.. .++++..+..|+.|++.||.|||.++|+||||||+|+|++.+|.+||+|||.+.... .+...+.||
T Consensus 109 l~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcg 184 (281)
T KOG0580|consen 109 LYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCG 184 (281)
T ss_pred HHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeec
Confidence 9999983 569999999999999999999999999999999999999999999999999987432 455678999
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|..|.|||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+..+.+|+.+|.+++|||.+||..+|.+
T Consensus 185 t~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~ 263 (281)
T KOG0580|consen 185 TLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIE 263 (281)
T ss_pred ccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccc
Confidence 9999999999999886 889999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCHHHHhcCccccc
Q 014911 238 RIAISKIMESSWFKK 252 (416)
Q Consensus 238 R~s~~eil~hp~f~~ 252 (416)
|.+..|++.|||...
T Consensus 264 r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 264 RLALTEVMDHPWIVA 278 (281)
T ss_pred cccHHHHhhhHHHHh
Confidence 999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-53 Score=401.66 Aligned_cols=252 Identities=32% Similarity=0.540 Sum_probs=215.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--KIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~lV~E~~~g 78 (416)
.||+|+||+||++.+..+|+..|||.+...... ..+.+.+|+.+|+.++|||||++++...... .++++|||++|
T Consensus 24 ~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 24 LLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred cccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 489999999999999999999999999776322 2678999999999999999999999754444 79999999999
Q ss_pred CchhhHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeecccccccccc-ccCCcccc
Q 014911 79 GELFNKIAK-G-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHL-KQDGLLHT 154 (416)
Q Consensus 79 g~L~~~i~~-~-~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~-~~~~~~~~ 154 (416)
|+|.+++.+ + +++|+.++.|.+|++.||.|||++||+||||||+|||++. ++.+||+|||++...... ........
T Consensus 101 GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~ 180 (313)
T KOG0198|consen 101 GSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELS 180 (313)
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccccccc
Confidence 999999987 4 7999999999999999999999999999999999999999 799999999998755431 11122345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHcc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L 231 (416)
..|||.|||||++......+.++||||+||++.||+||.+||.. .........+... .+.+|.++|+++++||.+||
T Consensus 181 ~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~ 260 (313)
T KOG0198|consen 181 VQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCF 260 (313)
T ss_pred ccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHh
Confidence 78999999999998633333589999999999999999999997 4444444444433 35788999999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccCc
Q 014911 232 DPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
..||++|||++++|+|||.+....
T Consensus 261 ~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 261 KRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred hcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999976544
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=407.86 Aligned_cols=251 Identities=40% Similarity=0.693 Sum_probs=234.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|-|+.|.+|++..||+.||||++++.+... -...++.+|++.|+.++|||||+||++..+...+|+|+|+-.||+
T Consensus 25 TlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 5899999999999999999999999999988654 345688899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-cCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|+|+|.+ ..++|+.+++||.||+.|+.|||+..++||||||||+.+- .-|-+||+|||++..+. +...+.+.||
T Consensus 104 l~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---PG~kL~TsCG 180 (864)
T KOG4717|consen 104 LFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---PGKKLTTSCG 180 (864)
T ss_pred HHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC---Ccchhhcccc
Confidence 9999965 5699999999999999999999999999999999998775 56889999999986443 4567899999
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
+..|.|||++.+..|+.+++||||||||||.|.+|.+||...+..+.+-.|+...+..|..+|.++++||..||..||.+
T Consensus 181 SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkk 260 (864)
T KOG4717|consen 181 SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKK 260 (864)
T ss_pred hhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCHHHHhcCccccccCc
Q 014911 238 RIAISKIMESSWFKKSAP 255 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~ 255 (416)
|.|.++|..|+|++....
T Consensus 261 RAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 261 RASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hccHHHHhccccccCCCC
Confidence 999999999999987643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=411.00 Aligned_cols=248 Identities=31% Similarity=0.596 Sum_probs=230.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|+.+.+.+.||+|.+++..-. ...+..+.+|++|++.|+||||+.+++.|++..++|+|.|||.| +
T Consensus 9 ~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 9 MIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 489999999999999999999999999876543 34567899999999999999999999999999999999999988 9
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|+.+++. +.++|+.++.++.|++.||.|||+++|.|||+||.|||++..|.+|+||||+|+.... ........-|||
T Consensus 87 L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtP 164 (808)
T KOG0597|consen 87 LFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTP 164 (808)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcc
Confidence 9999986 8899999999999999999999999999999999999999999999999999986543 334556678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|||||++.+.+|+ ..+|+||+|||+||+++|++||-......+.+.|.......|+..|..+.+|+..+|.+||.+|+
T Consensus 165 lYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~Rl 243 (808)
T KOG0597|consen 165 LYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRL 243 (808)
T ss_pred cccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcc
Confidence 99999999988886 89999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCcccccc
Q 014911 240 AISKIMESSWFKKS 253 (416)
Q Consensus 240 s~~eil~hp~f~~~ 253 (416)
|..+++.|||.+..
T Consensus 244 tW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 244 TWTDLLGHPFWKGK 257 (808)
T ss_pred cHHHHhcChHHhhh
Confidence 99999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=371.17 Aligned_cols=250 Identities=33% Similarity=0.519 Sum_probs=219.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..||+.||||.+...... .+......|||+.|+.++||||+.+.++|...+.+.+|+||++. +
T Consensus 9 ~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-d 86 (318)
T KOG0659|consen 9 KLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-D 86 (318)
T ss_pred hhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-c
Confidence 489999999999999999999999999877543 35556788999999999999999999999999999999999976 9
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|...|+. ..++...++.|+.+++.||+|||++.|+||||||+|+|++++|.+||+|||+|+++...... .+..+-|
T Consensus 87 Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~~~V~T 164 (318)
T KOG0659|consen 87 LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--QTHQVVT 164 (318)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--cccceee
Confidence 9999976 46999999999999999999999999999999999999999999999999999987654332 3333789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--C---CCC-----------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--F---KCP----------------- 216 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~---~~p----------------- 216 (416)
.||+|||++.+...++..+||||.|||+.||+-|.+-|.+.+..+....|.+.- . ..|
T Consensus 165 RWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~ 244 (318)
T KOG0659|consen 165 RWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKP 244 (318)
T ss_pred eeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCC
Confidence 999999999988777899999999999999999999999998887777775521 0 011
Q ss_pred ------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 217 ------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 217 ------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+..++++.||+.+||.+||.+|+|+.|+++||||+...
T Consensus 245 ~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 245 PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred ccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 12467899999999999999999999999999998743
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=402.14 Aligned_cols=248 Identities=30% Similarity=0.503 Sum_probs=217.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-EEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKS-KIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-~~~lV~E~~~gg 79 (416)
||.|+||.||+|+...+|+.||||.+.+....-+ . ..-.||+..|++|+ |||||++.+++.+.+ .+|+||||+..
T Consensus 18 lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~- 94 (538)
T KOG0661|consen 18 LGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-E-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC- 94 (538)
T ss_pred hcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-H-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-
Confidence 8999999999999999999999999976554322 2 22348999999999 999999999998887 99999999965
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
.|+.+++. ..|++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+-. ......+.++.
T Consensus 95 NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev---~SkpPYTeYVS 171 (538)
T KOG0661|consen 95 NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV---RSKPPYTEYVS 171 (538)
T ss_pred hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc---ccCCCcchhhh
Confidence 99999975 56999999999999999999999999999999999999998899999999999844 34556778899
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-------------------CCCCC--
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------DFKCP-- 216 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~p-- 216 (416)
|.||+|||++.+.++++.+.|||++|||++|+.+-++.|.+.+..+.+.+|..- .+.+|
T Consensus 172 TRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~ 251 (538)
T KOG0661|consen 172 TRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQV 251 (538)
T ss_pred cccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcC
Confidence 999999999999999999999999999999999999999999888777777431 12222
Q ss_pred ---------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 217 ---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 217 ---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+..+.++.+||.+||.+||++|||+.++|+||||+....
T Consensus 252 ~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 252 KPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 236889999999999999999999999999999986543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=401.87 Aligned_cols=250 Identities=36% Similarity=0.655 Sum_probs=225.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999987654444556678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ........+||+
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~ 159 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 159 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecCc
Confidence 9999876 6799999999999999999999999999999999999999999999999999864221 122344568999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..+...+|..+++++.+||++||+.||++||
T Consensus 160 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 160 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999987776 589999999999999999999999988888888888888889999999999999999999999999
Q ss_pred -----CHHHHhcCcccccc
Q 014911 240 -----AISKIMESSWFKKS 253 (416)
Q Consensus 240 -----s~~eil~hp~f~~~ 253 (416)
++.++++||||...
T Consensus 239 ~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 239 GGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCHHHHHcCCCcCCC
Confidence 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=377.66 Aligned_cols=249 Identities=36% Similarity=0.666 Sum_probs=223.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-----hhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----VGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
+||.|..++|-++.++.+|..+|+|++....... ....+...+|+.||+++ .||||+++.++++++..+++|+|
T Consensus 24 ilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFd 103 (411)
T KOG0599|consen 24 ILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFD 103 (411)
T ss_pred HhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhh
Confidence 4899999999999999999999999997543321 23456778899999998 69999999999999999999999
Q ss_pred ccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 75 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 75 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
.|+.|+|+|++.. -.++|.+.+++++|++.|+.|||.++|+||||||+|||+|++.++||+|||+|+... +...+.
T Consensus 104 l~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~---~GekLr 180 (411)
T KOG0599|consen 104 LMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE---PGEKLR 180 (411)
T ss_pred hcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC---CchhHH
Confidence 9999999999987 579999999999999999999999999999999999999999999999999998543 455678
Q ss_pred ccccCCCCCchHHhhhc-----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC--CCC--CCHHHH
Q 014911 154 TTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPW--FSSEAR 224 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~--~s~~~~ 224 (416)
..||||+|+|||.+... +-++..+|+|+||||||-||.|.+||......-+++.|..|.+.+ |.| +|...+
T Consensus 181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~K 260 (411)
T KOG0599|consen 181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVK 260 (411)
T ss_pred HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHH
Confidence 89999999999998532 223578999999999999999999999999899999999998755 666 789999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
+||++||+.||.+|+|++++|.||||..
T Consensus 261 dLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 261 DLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 9999999999999999999999999953
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=400.21 Aligned_cols=247 Identities=38% Similarity=0.756 Sum_probs=225.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++.+|+||||+.||+
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 104 (329)
T PTZ00263 25 TLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGE 104 (329)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCCh
Confidence 38999999999999999999999999987654444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...+.+||+
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~ 179 (329)
T PTZ00263 105 LFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTP 179 (329)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----CcceecCCh
Confidence 9999976 6799999999999999999999999999999999999999999999999999874322 223568999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|.+++..+++||.+||+.||.+|+
T Consensus 180 ~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 180 EYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred hhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcC
Confidence 9999999987776 589999999999999999999999988888889999888999999999999999999999999999
Q ss_pred C-----HHHHhcCcccccc
Q 014911 240 A-----ISKIMESSWFKKS 253 (416)
Q Consensus 240 s-----~~eil~hp~f~~~ 253 (416)
+ ++++++||||+..
T Consensus 259 ~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 259 GTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CCCCCCHHHHhcCCccCCC
Confidence 7 7999999999864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-51 Score=400.48 Aligned_cols=249 Identities=42% Similarity=0.774 Sum_probs=228.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|.||.||.|+++.||+.+|+|++.+.........+.+.+|+.||+++. |||||.++++|++.+.+|+|||+|.||
T Consensus 42 ~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GG 121 (382)
T KOG0032|consen 42 ELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGG 121 (382)
T ss_pred hhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCc
Confidence 4899999999999999999999999999887765555678999999999998 999999999999999999999999999
Q ss_pred chhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC----CCeEEeeccccccccccccCCccccc
Q 014911 80 ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED----GNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 80 ~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~----~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+|++.+.+..++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||+|..... .....+.
T Consensus 122 eLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~ 198 (382)
T KOG0032|consen 122 ELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTI 198 (382)
T ss_pred hHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeee
Confidence 99999976459999999999999999999999999999999999999644 4799999999986554 5568899
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC--CC--CCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--PW--FSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~~~~li~~~L 231 (416)
||||.|+|||++...+| +..+||||+||++|.|++|.+||.+.+.......+..+.+.++ +| +|..++++|++||
T Consensus 199 ~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll 277 (382)
T KOG0032|consen 199 VGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLL 277 (382)
T ss_pred cCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhc
Confidence 99999999999988777 4899999999999999999999999998888899999877553 34 7899999999999
Q ss_pred CCCCCCcCCHHHHhcCcccccc
Q 014911 232 DPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..||.+|+|+.++|+|||++..
T Consensus 278 ~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 278 EFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=395.06 Aligned_cols=249 Identities=35% Similarity=0.653 Sum_probs=224.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765444445567788999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
.+++.+ +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999975 6899999999999999999999999999999999999999999999999999874322 1223345689999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC-
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI- 239 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~- 239 (416)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|..+++.+++||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988776 488999999999999999999999988888889998888899999999999999999999999997
Q ss_pred --CHHHHhcCcccccc
Q 014911 240 --AISKIMESSWFKKS 253 (416)
Q Consensus 240 --s~~eil~hp~f~~~ 253 (416)
++.++++||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=391.49 Aligned_cols=247 Identities=36% Similarity=0.661 Sum_probs=224.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 87 (291)
T cd05612 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE 87 (291)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCC
Confidence 48999999999999999999999999976544333455678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ...+.+||+
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~ 162 (291)
T cd05612 88 LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTP 162 (291)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----CcccccCCh
Confidence 9999976 6799999999999999999999999999999999999999999999999999875432 223467999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|..+++.+++||++||+.||.+|+
T Consensus 163 ~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 241 (291)
T cd05612 163 EYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRL 241 (291)
T ss_pred hhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHcc
Confidence 9999999987776 489999999999999999999999998888899999888899999999999999999999999999
Q ss_pred C-----HHHHhcCcccccc
Q 014911 240 A-----ISKIMESSWFKKS 253 (416)
Q Consensus 240 s-----~~eil~hp~f~~~ 253 (416)
+ ++++++||||...
T Consensus 242 ~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 242 GNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCccCCHHHHhcCccccCC
Confidence 5 9999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=394.51 Aligned_cols=250 Identities=37% Similarity=0.668 Sum_probs=225.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 58999999999999999999999999987655444556788899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~ 159 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGTP 159 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCCc
Confidence 9999876 6799999999999999999999999999999999999999999999999999864221 122334568999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||+.||.+|+
T Consensus 160 ~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 160 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred CccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999987766 589999999999999999999999888888888888888889999999999999999999999997
Q ss_pred -----CHHHHhcCcccccc
Q 014911 240 -----AISKIMESSWFKKS 253 (416)
Q Consensus 240 -----s~~eil~hp~f~~~ 253 (416)
++.++++||||...
T Consensus 239 ~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 89999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=401.54 Aligned_cols=248 Identities=31% Similarity=0.563 Sum_probs=223.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+.|.||.|+...+++.||||.++.....+ .+-+.+|+.+|+..+|+|||++++.|...+.+|+||||++||+|
T Consensus 281 igqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 281 IGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 899999999999999999999999998776543 46788999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCC
Q 014911 82 FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161 (416)
Q Consensus 82 ~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 161 (416)
.|.+..-.++|.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||++....... ....+.+|||+|
T Consensus 358 TDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmVGTPYW 435 (550)
T KOG0578|consen 358 TDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMVGTPYW 435 (550)
T ss_pred hhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--CccccccCCCCc
Confidence 999999889999999999999999999999999999999999999999999999999998665433 245678999999
Q ss_pred CchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh-C--CCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-G--DFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 162 ~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
||||++.+..| |+++||||||++++||+-|++||-..++......|.. + .+..|..+|+.+++||.+||+.||.+|
T Consensus 436 MAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~R 514 (550)
T KOG0578|consen 436 MAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQR 514 (550)
T ss_pred cchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcC
Confidence 99999999888 6999999999999999999999987666555555544 3 346678899999999999999999999
Q ss_pred CCHHHHhcCccccccCc
Q 014911 239 IAISKIMESSWFKKSAP 255 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~~ 255 (416)
+|+.++|+||||+...+
T Consensus 515 asA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 515 ASAKELLEHPFLKMAKP 531 (550)
T ss_pred CCHHHHhcChhhhhcCC
Confidence 99999999999965443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=392.03 Aligned_cols=250 Identities=33% Similarity=0.650 Sum_probs=224.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 589999999999999999999999999876544445566778899998876 6999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 159 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGT 159 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcccccccC
Confidence 99999875 6799999999999999999999999999999999999999999999999999864221 12234456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+..+....|.++++++.+||++||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 160 PDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred ccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999987766 48899999999999999999999999988899999988888999999999999999999999999
Q ss_pred CCH------HHHhcCcccccc
Q 014911 239 IAI------SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~------~eil~hp~f~~~ 253 (416)
|++ +++++||||...
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCC
Confidence 998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=392.66 Aligned_cols=251 Identities=35% Similarity=0.658 Sum_probs=225.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999987654444456678889999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~ 159 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 159 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCCc
Confidence 9998876 6799999999999999999999999999999999999999999999999999864211 122334567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+|+
T Consensus 160 ~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 160 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 9999999987766 589999999999999999999999988888888888888888999999999999999999999998
Q ss_pred -----CHHHHhcCccccccC
Q 014911 240 -----AISKIMESSWFKKSA 254 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~ 254 (416)
++.++++||||....
T Consensus 239 ~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=390.55 Aligned_cols=250 Identities=34% Similarity=0.631 Sum_probs=224.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 589999999999999999999999999876544445556778899999866 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 159 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCGT 159 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCccccccccC
Confidence 99999865 6799999999999999999999999999999999999999999999999999864321 22234456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+.......|.+++.++.++|.+||+.||++|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 160 PDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred ccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 99999999987776 48999999999999999999999999998999999988888999999999999999999999999
Q ss_pred C-------CHHHHhcCcccccc
Q 014911 239 I-------AISKIMESSWFKKS 253 (416)
Q Consensus 239 ~-------s~~eil~hp~f~~~ 253 (416)
+ +++++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCCC
Confidence 9 89999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=393.31 Aligned_cols=247 Identities=33% Similarity=0.625 Sum_probs=223.4
Q ss_pred CcccCCceEEEEEEEcCCC-cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+||||+.||
T Consensus 37 ~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g 116 (340)
T PTZ00426 37 TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116 (340)
T ss_pred EEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCC
Confidence 3899999999999876655 689999997765544455678889999999999999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..... ...+.+||
T Consensus 117 ~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt 191 (340)
T PTZ00426 117 EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGT 191 (340)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-----CcceecCC
Confidence 99999976 6799999999999999999999999999999999999999999999999999875432 23456899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+...+|+.+++.++++|++||+.||.+|
T Consensus 192 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 192 PEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred hhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHc
Confidence 99999999987666 58999999999999999999999999888889999998888999999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 014911 239 I-----AISKIMESSWFKKS 253 (416)
Q Consensus 239 ~-----s~~eil~hp~f~~~ 253 (416)
+ |++++++||||...
T Consensus 271 ~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 271 YGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 6 89999999999864
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=403.24 Aligned_cols=250 Identities=41% Similarity=0.794 Sum_probs=236.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|.|++|.+|++..++..||||++++...... ....+.+|+++|+.|+|||||+++.++..+..+|+||||+.||+
T Consensus 63 tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge 141 (596)
T KOG0586|consen 63 TIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE 141 (596)
T ss_pred eeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence 58999999999999999999999999998876543 33458999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||++.++.. ...+.+.||+|
T Consensus 142 ~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~~~lqt~cgsp 218 (596)
T KOG0586|consen 142 LFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY---GLMLQTFCGSP 218 (596)
T ss_pred hHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc---cccccccCCCC
Confidence 9999987 8999999999999999999999999999999999999999999999999999998763 56788999999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|.|||++.+..|+++++|+||+|+++|.|++|.+||++.+...+......+.+.+|-.++.++.+||+++|.++|.+|+
T Consensus 219 pyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~ 298 (596)
T KOG0586|consen 219 PYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRG 298 (596)
T ss_pred CccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhccCccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCccccccC
Q 014911 240 AISKIMESSWFKKSA 254 (416)
Q Consensus 240 s~~eil~hp~f~~~~ 254 (416)
++++++.|+|.....
T Consensus 299 ~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 299 PCDQIMKDRWRNDLL 313 (596)
T ss_pred CHHHhhhhcccchhh
Confidence 999999999997543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=370.78 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=217.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg 79 (416)
|++|+||.||+|+++.|++.||+|.++.+. .+.+..-...|||.+|.+++|||||.+.++... -+.+|+|||||+.
T Consensus 84 I~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh- 161 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH- 161 (419)
T ss_pred cccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-
Confidence 899999999999999999999999998776 344565677899999999999999999998865 4679999999987
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+|...+.. .+|+..+++.+..|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+... ...++..+-
T Consensus 162 DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVV 239 (419)
T KOG0663|consen 162 DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVV 239 (419)
T ss_pred hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEE
Confidence 89999876 58999999999999999999999999999999999999999999999999999966543 234566678
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------CCCCC--------C-
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----------DFKCP--------P- 217 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-----------~~~~p--------~- 217 (416)
|.||+|||++.+...++.++|+||+|||+.||+++++.|.+....+...+|.+- ....| .
T Consensus 240 TLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~ 319 (419)
T KOG0663|consen 240 TLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEH 319 (419)
T ss_pred EeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCC
Confidence 999999999999887789999999999999999999999999888888777541 00111 0
Q ss_pred ----------C--CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 218 ----------W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 218 ----------~--~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+ +|+...+|+..+|.+||.+|.|++|.|+|+||.+..
T Consensus 320 pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 320 PYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred CchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 1 358889999999999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=380.53 Aligned_cols=253 Identities=32% Similarity=0.553 Sum_probs=223.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||.|.-++||+|+...+++.||||+++.+++.. ..+.+.+|+..|+.++||||+.++..|..+..+|+||.|+.+|+
T Consensus 33 ~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 33 VIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 4899999999999999999999999999988764 37899999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCc-cccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGL-LHTT 155 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~-~~~~ 155 (416)
+++.+.. ..++|..+..+++++++||.|||.+|-+|||||+.||||+.+|.|||+|||.+........ ... +.+.
T Consensus 111 ~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tf 190 (516)
T KOG0582|consen 111 LLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTF 190 (516)
T ss_pred HHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccc
Confidence 9999975 4499999999999999999999999999999999999999999999999998764433221 111 2677
Q ss_pred ccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----------CCCHHH
Q 014911 156 CGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----------WFSSEA 223 (416)
Q Consensus 156 ~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----------~~s~~~ 223 (416)
.|||+|||||++.. .+|+ .|+||||+||+..||.+|..||....++.++-.-.++.++.|. .++..+
T Consensus 191 vgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf 269 (516)
T KOG0582|consen 191 VGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSF 269 (516)
T ss_pred cCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHH
Confidence 89999999999543 4665 9999999999999999999999999888777666666655332 267889
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccccccCcc
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 256 (416)
+.+|..||+.||.+|||++++|+|+||+.....
T Consensus 270 ~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 270 REMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 999999999999999999999999999876543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=376.35 Aligned_cols=251 Identities=27% Similarity=0.473 Sum_probs=217.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-----KSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~lV~E~~ 76 (416)
||+|+||.|+.|.+..+|+.||||.+.... .+.-.+.+..||+++|+.++|+||+.+++++.. -+.+|+|+|++
T Consensus 30 iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM 108 (359)
T KOG0660|consen 30 IGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM 108 (359)
T ss_pred ccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH
Confidence 899999999999999999999999986332 334556788999999999999999999999865 45799999999
Q ss_pred CCCchhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 77 KGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 77 ~gg~L~~~i~~~~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+.+|...++.+. ++++.++.++.|++.||.|+|+.||+||||||.|++++.+..+||+|||+|+........+.++..
T Consensus 109 -etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeY 187 (359)
T KOG0660|consen 109 -ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEY 187 (359)
T ss_pred -hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcc
Confidence 459999998876 999999999999999999999999999999999999999999999999999976654455667888
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------------C
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----------------------D 212 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-----------------------~ 212 (416)
..|.||+|||++.....++...||||+||||.||++|++.|.+.+....+..|..- .
T Consensus 188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl 267 (359)
T KOG0660|consen 188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL 267 (359)
T ss_pred eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC
Confidence 99999999999987666679999999999999999999999987765555544321 1
Q ss_pred CCCC--------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 FKCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~~~p--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...| +..++.+.+|+.+||..||.+|+|++|+|.|||+..-.
T Consensus 268 p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 268 PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 1111 34689999999999999999999999999999997543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=390.77 Aligned_cols=250 Identities=35% Similarity=0.659 Sum_probs=224.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 58999999999999999999999999987654444455677889999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+||
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 159 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGT 159 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccCC
Confidence 9999876 679999999999999999999997 8999999999999999999999999999864221 12233456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 160 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred cccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 99999999987766 58999999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 014911 239 I-----AISKIMESSWFKKS 253 (416)
Q Consensus 239 ~-----s~~eil~hp~f~~~ 253 (416)
+ ++.++++||||...
T Consensus 239 ~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 7 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=386.25 Aligned_cols=250 Identities=32% Similarity=0.613 Sum_probs=221.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||.||+|++..+|+.||+|++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||+.||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 589999999999999999999999999765433333455677788888754 8999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........+||
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt 159 (316)
T cd05620 82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCGT 159 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCCC
Confidence 99999876 6799999999999999999999999999999999999999999999999999863211 12234567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.......|.+++.++++||.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 160 PDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred cCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999987776 48999999999999999999999998888888888888888899999999999999999999999
Q ss_pred CCH-HHHhcCcccccc
Q 014911 239 IAI-SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~-~eil~hp~f~~~ 253 (416)
+++ +++++||||...
T Consensus 239 ~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 239 LGVVGNIRGHPFFKTI 254 (316)
T ss_pred CCChHHHHcCCCcCCC
Confidence 998 588999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=388.08 Aligned_cols=250 Identities=30% Similarity=0.605 Sum_probs=219.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999999999999999999876554445567788999999988 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.+ +++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.... .......+.+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~gt 159 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCGT 159 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccCC
Confidence 99998865 789999999999999999999999999999999999999999999999999986321 122334567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---------cHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------NIVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
+.|+|||++.+..+ +.++|+||+||++|+|++|..||+.. ........+.......|..++..+.++|++
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 160 PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG 238 (329)
T ss_pred ccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999987766 48999999999999999999999631 223355666777788899999999999999
Q ss_pred ccCCCCCCcCC------HHHHhcCcccccc
Q 014911 230 LLDPNPNSRIA------ISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~R~s------~~eil~hp~f~~~ 253 (416)
||+.||.+|+| ++++++||||...
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999997 7899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=377.26 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=229.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|.-|+||+|+...++..+|+|++++..........++..|-.||.+++||.++.||..|++....|+|||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 38999999999999999999999999999988777778889999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc------------
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------------ 145 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~------------ 145 (416)
|..+.++ +.++++.++.|+..++.||+|||-.|||+||||||||||-++|++.|+||.|+.-...
T Consensus 164 L~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~ 243 (459)
T KOG0610|consen 164 LHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRS 243 (459)
T ss_pred HHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCC
Confidence 9999875 5699999999999999999999999999999999999999999999999998742110
Q ss_pred ---------------------c-cc--------------------CCcccccccCCCCCchHHhhhcCCCCchhhHHHHH
Q 014911 146 ---------------------L-KQ--------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCG 183 (416)
Q Consensus 146 ---------------------~-~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG 183 (416)
. .. .......+||-.|+|||++.+.++ +.++|.|+||
T Consensus 244 ~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gsAVDWWtfG 322 (459)
T KOG0610|consen 244 SGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GSAVDWWTFG 322 (459)
T ss_pred CCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-CchhhHHHHH
Confidence 0 00 001233468999999999999988 5899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHccCCCCCCcCC----HHHHhcCccccccCcc
Q 014911 184 VILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--WFSSEARRLITKLLDPNPNSRIA----ISKIMESSWFKKSAPK 256 (416)
Q Consensus 184 vil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~f~~~~~~ 256 (416)
|++||||.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|+. +.||.+||||+...+.
T Consensus 323 IflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 323 IFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 9999999999999999999999999988877775 57899999999999999999998 9999999999977654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=386.62 Aligned_cols=250 Identities=30% Similarity=0.563 Sum_probs=222.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK---MVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.++. .++||||+++++++.+.+..|+||||++
T Consensus 6 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 85 (324)
T cd05589 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA 85 (324)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC
Confidence 4899999999999999999999999998665444445567778877664 5679999999999999999999999999
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
||+|...+..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ......+.+|
T Consensus 86 ~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 163 (324)
T cd05589 86 GGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRTSTFCG 163 (324)
T ss_pred CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCccccccc
Confidence 99999999888899999999999999999999999999999999999999999999999999863221 1223345689
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|..+++.+.++|.+||+.||.+
T Consensus 164 ~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 242 (324)
T cd05589 164 TPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242 (324)
T ss_pred CccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 999999999987766 5889999999999999999999999988888888888888889999999999999999999999
Q ss_pred cC-----CHHHHhcCcccccc
Q 014911 238 RI-----AISKIMESSWFKKS 253 (416)
Q Consensus 238 R~-----s~~eil~hp~f~~~ 253 (416)
|| ++.++++||||+..
T Consensus 243 R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 243 RLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCCCCCCCHHHHhhCCCcCCC
Confidence 99 69999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=385.14 Aligned_cols=250 Identities=34% Similarity=0.651 Sum_probs=220.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++...........+.+..|..++.. .+||||+++++++...+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 58999999999999999999999999987654333445566677777765 48999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~gt 159 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGT 159 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccCC
Confidence 99999875 6799999999999999999999999999999999999999999999999999874322 12334456899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 160 PDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred ccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999987766 48899999999999999999999999888888888887788899999999999999999999999
Q ss_pred CCHH-HHhcCcccccc
Q 014911 239 IAIS-KIMESSWFKKS 253 (416)
Q Consensus 239 ~s~~-eil~hp~f~~~ 253 (416)
|++. ++++||||...
T Consensus 239 ~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 239 LGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCChHHHHcCcccCCC
Confidence 9874 88899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=391.21 Aligned_cols=252 Identities=30% Similarity=0.577 Sum_probs=217.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||++||+
T Consensus 8 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (363)
T cd05628 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGD 87 (363)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCc
Confidence 48999999999999999999999999987654444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ----------- 148 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~----------- 148 (416)
|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 167 (363)
T cd05628 88 MMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167 (363)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccc
Confidence 9999975 7899999999999999999999999999999999999999999999999999874322100
Q ss_pred ----------------------CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHH
Q 014911 149 ----------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 206 (416)
Q Consensus 149 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~ 206 (416)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~ 246 (363)
T cd05628 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246 (363)
T ss_pred cccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0012345899999999999887774 89999999999999999999999988888888
Q ss_pred HHHhC--CCCCCCC--CCHHHHHHHHHccCCCCC---CcCCHHHHhcCccccccC
Q 014911 207 KIYRG--DFKCPPW--FSSEARRLITKLLDPNPN---SRIAISKIMESSWFKKSA 254 (416)
Q Consensus 207 ~i~~~--~~~~p~~--~s~~~~~li~~~L~~dP~---~R~s~~eil~hp~f~~~~ 254 (416)
++... ...+|+. +++++++||.+|+. +|. .||+++++++||||+...
T Consensus 247 ~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 247 KVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred HHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 88753 3445543 68999999999775 444 568999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=384.45 Aligned_cols=250 Identities=35% Similarity=0.673 Sum_probs=224.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999999999999999999999999876544445566778899999888 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.+ +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~ 159 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCGT 159 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceecC
Confidence 99999876 5899999999999999999999999999999999999999999999999999863211 12233456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+. .++|+||+||++|+|++|..||.+.+.......+.......|..++..+.+||++||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 160 PDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred ccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 999999999877764 8999999999999999999999998888888888888888889999999999999999999999
Q ss_pred CCH-----HHHhcCcccccc
Q 014911 239 IAI-----SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~-----~eil~hp~f~~~ 253 (416)
||+ .++++||||+..
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=382.01 Aligned_cols=251 Identities=32% Similarity=0.606 Sum_probs=221.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++................|..++.. ++||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 48999999999999999999999999976543333344566778888876 48999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt 159 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCGT 159 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecCC
Confidence 99999976 6799999999999999999999999999999999999999999999999999863221 12233456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|.+++.+++++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 160 PDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred ccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhc
Confidence 99999999987766 58999999999999999999999998888888888877777888999999999999999999999
Q ss_pred CCHH-HHhcCccccccC
Q 014911 239 IAIS-KIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~~-eil~hp~f~~~~ 254 (416)
|++. ++++||||....
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 239 LGVKGDIRQHPFFREID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 9996 899999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=372.88 Aligned_cols=252 Identities=36% Similarity=0.655 Sum_probs=235.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+|-+++.+.+|+.+|||+++++.+...+....-..|-++|+.++||.+..+...|...+++|+||||+.||+
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe 254 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE 254 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence 58999999999999999999999999999988877778888899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|+-.+.+ .-++|+.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||++.- .........+.||||
T Consensus 255 Lf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~g~t~kTFCGTP 332 (516)
T KOG0690|consen 255 LFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKYGDTTKTFCGTP 332 (516)
T ss_pred EeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccccceeccccCCh
Confidence 9998876 6699999999999999999999999999999999999999999999999999862 334455678999999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++....| +..+|.|.+||++|||+||++||...+...++.-|...++.+|..+|++++.|+..+|..||.+|.
T Consensus 333 EYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 333 EYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 9999999988877 599999999999999999999999999999999999999999999999999999999999999998
Q ss_pred C-----HHHHhcCccccccCc
Q 014911 240 A-----ISKIMESSWFKKSAP 255 (416)
Q Consensus 240 s-----~~eil~hp~f~~~~~ 255 (416)
. +.+|++|+||.....
T Consensus 412 GgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 412 GGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred CCCchhHHHHHhhhhhccCCH
Confidence 4 889999999987544
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=384.05 Aligned_cols=250 Identities=38% Similarity=0.703 Sum_probs=221.8
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..++.+|+||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 4899999999999864 57899999999765432 2233456789999999999999999999999999999999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..... ........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~ 160 (323)
T cd05584 83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTHTF 160 (323)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccccc
Confidence 99999999976 6789999999999999999999999999999999999999999999999999864221 22233456
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|+.+++.+.+||.+||+.||
T Consensus 161 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 79999999999987766 48999999999999999999999999888888888888889999999999999999999999
Q ss_pred CCcC-----CHHHHhcCcccccc
Q 014911 236 NSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 236 ~~R~-----s~~eil~hp~f~~~ 253 (416)
.+|| +++++++||||...
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=384.73 Aligned_cols=250 Identities=36% Similarity=0.630 Sum_probs=220.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999999999999999997654433333445555555 567899999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~gt 159 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGT 159 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc--cCCCccccccCC
Confidence 99999876 679999999999999999999999999999999999999999999999999986422 122234456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......++.+++.+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 160 PEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred hhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 99999999987776 48999999999999999999999999888888898888888888899999999999999999999
Q ss_pred CCH----HHHhcCcccccc
Q 014911 239 IAI----SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~----~eil~hp~f~~~ 253 (416)
|++ .++++||||...
T Consensus 239 ~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 239 LGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCHHHHHcCCCcCCC
Confidence 997 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=376.83 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=215.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+..|+||||++||+
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~ 86 (285)
T cd05631 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGD 86 (285)
T ss_pred EEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCc
Confidence 48999999999999999999999999976654433344567899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... ........|
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g 163 (285)
T cd05631 87 LKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVG 163 (285)
T ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCeecCCCC
Confidence 9888753 3589999999999999999999999999999999999999999999999999875322 122345579
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+. ......+.......+..+++++.+||++||+.
T Consensus 164 ~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 242 (285)
T cd05631 164 TVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTK 242 (285)
T ss_pred CCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhc
Confidence 999999999987776 4889999999999999999999987543 23333444455667778999999999999999
Q ss_pred CCCCcCC-----HHHHhcCccccccC
Q 014911 234 NPNSRIA-----ISKIMESSWFKKSA 254 (416)
Q Consensus 234 dP~~R~s-----~~eil~hp~f~~~~ 254 (416)
||.+||| ++++++||||....
T Consensus 243 ~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 243 NPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred CHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999997 89999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=382.67 Aligned_cols=250 Identities=33% Similarity=0.614 Sum_probs=222.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|++..+++.||||++.+.........+.+..|+.++..++|+ +|+++++++...+.+|+||||++||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (324)
T cd05587 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (324)
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCC
Confidence 489999999999999999999999999876544445567788899999999765 6888999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+||
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 164 (324)
T cd05587 87 DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTTRTFCGT 164 (324)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCceeeecCC
Confidence 99999875 6799999999999999999999999999999999999999999999999999863211 12234456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|..+++++.++|++||++||.+|
T Consensus 165 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 243 (324)
T cd05587 165 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243 (324)
T ss_pred ccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 99999999987776 48999999999999999999999999888889999888888899999999999999999999999
Q ss_pred CCH-----HHHhcCcccccc
Q 014911 239 IAI-----SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~-----~eil~hp~f~~~ 253 (416)
++. +++++||||...
T Consensus 244 ~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 244 LGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=391.69 Aligned_cols=253 Identities=34% Similarity=0.573 Sum_probs=216.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 8 ~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~ 87 (381)
T cd05626 8 TLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (381)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 48999999999999999999999999987665555667789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ----------- 148 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~----------- 148 (416)
|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~ 167 (381)
T cd05626 88 MMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167 (381)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccc
Confidence 9999976 6799999999999999999999999999999999999999999999999999753311000
Q ss_pred ----------------------------------CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCC
Q 014911 149 ----------------------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194 (416)
Q Consensus 149 ----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~ 194 (416)
.....+.+||+.|+|||++.+..+. .++||||+||++|+|++|..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~ 246 (381)
T cd05626 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQP 246 (381)
T ss_pred ccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHHHHhCCC
Confidence 0011345799999999999887764 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHcc--CCCCCCcCCHHHHhcCccccccC
Q 014911 195 PFQDDNIVSMYRKIYR--GDFKCPP--WFSSEARRLITKLL--DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 195 Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
||...+.......+.. .....|+ .+++++.+||.+|| ..+|..|+|+.++++||||....
T Consensus 247 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred CCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 9998877666666553 2344454 47999999999965 45566699999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=383.83 Aligned_cols=250 Identities=31% Similarity=0.613 Sum_probs=218.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999999876554445566788999998876 8999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 159 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGT 159 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccCC
Confidence 99988865 6799999999999999999999999999999999999999999999999999864221 12233456899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---------DNIVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.. .........+......+|..++..+.+||++
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 160 PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 238 (329)
T ss_pred ccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 99999999987766 4899999999999999999999952 1223455666777788899999999999999
Q ss_pred ccCCCCCCcCC------HHHHhcCcccccc
Q 014911 230 LLDPNPNSRIA------ISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~R~s------~~eil~hp~f~~~ 253 (416)
||+.||.+||| +.++++||||+..
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 239 FLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=367.53 Aligned_cols=250 Identities=31% Similarity=0.517 Sum_probs=216.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC------EEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~------~~~lV~E 74 (416)
||+|+||+||+|+++.+|+.||+|.++.+... ++......+|+.+|+.|+|+| |+++++++.+.+ .+|+|+|
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 89999999999999999999999999876542 455677889999999999999 999999998877 8999999
Q ss_pred ccCCCchhhHHhc-C----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC
Q 014911 75 LVKGGELFNKIAK-G----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i~~-~----~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 149 (416)
|+.- +|..++.. + .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|+.... +.
T Consensus 98 ~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i--p~ 174 (323)
T KOG0594|consen 98 FLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI--PM 174 (323)
T ss_pred eecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC--Cc
Confidence 9965 89998875 2 478889999999999999999999999999999999999999999999999985442 23
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC------------------
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------ 211 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------ 211 (416)
.......+|.+|+|||++.+...++...||||+|||++||+++++.|.+....+....|.+-
T Consensus 175 ~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~ 254 (323)
T KOG0594|consen 175 RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY 254 (323)
T ss_pred ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc
Confidence 34667789999999999999877789999999999999999999999998887777777441
Q ss_pred CCCCCCC------------CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 212 DFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 212 ~~~~p~~------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
...+|.| .+++..+++.+||+.+|.+|.|+..+|.||||.....
T Consensus 255 k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 255 KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0112222 2358899999999999999999999999999987643
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=383.58 Aligned_cols=247 Identities=34% Similarity=0.593 Sum_probs=218.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||+
T Consensus 8 ~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 87 (333)
T cd05600 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGD 87 (333)
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCC
Confidence 48999999999999999999999999987654444456778899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....+||+
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~ 162 (333)
T cd05600 88 FRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSP 162 (333)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCc
Confidence 9999976 6799999999999999999999999999999999999999999999999999874432 334567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCC------CCCHHHHHHHHHcc
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP------WFSSEARRLITKLL 231 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~li~~~L 231 (416)
.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+.... ...|. .+++++.+||.+||
T Consensus 163 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 241 (333)
T cd05600 163 DYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241 (333)
T ss_pred cccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHh
Confidence 9999999987766 489999999999999999999999988877776665422 22232 35899999999999
Q ss_pred CCCCCCcCCHHHHhcCcccccc
Q 014911 232 DPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..+|.+|||+.++++||||...
T Consensus 242 ~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 242 NDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred hChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-51 Score=387.69 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=223.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|+++.+... ..++.+.+|+.+|..+++|||.++|+.+..+..++++||||.||+
T Consensus 20 ~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 20 LIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 489999999999999999999999999887643 457899999999999999999999999999999999999999999
Q ss_pred hhhHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~~~l-~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+.+.++.+.+ .|..+..++++++.||.|||+++.+|||||+.|||+..+|++||+|||.+........ ...+..|||
T Consensus 98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTP 175 (467)
T KOG0201|consen 98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTP 175 (467)
T ss_pred hhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--ccccccccc
Confidence 9999998665 9999999999999999999999999999999999999999999999999986554322 237889999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
.|||||++...+|+ .++||||||++.|||++|.+||...+++.....|.+..+ .+...+|+.+++|+..||++||+.|
T Consensus 176 fwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~R 254 (467)
T KOG0201|consen 176 FWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFR 254 (467)
T ss_pred cccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 99999999987886 999999999999999999999999888665555554433 2234689999999999999999999
Q ss_pred CCHHHHhcCccccccC
Q 014911 239 IAISKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~ 254 (416)
||+.++|+|+|++...
T Consensus 255 psA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 255 PSAKELLKHKFIKRAK 270 (467)
T ss_pred cCHHHHhhhHHHHhcC
Confidence 9999999999999844
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=388.54 Aligned_cols=251 Identities=33% Similarity=0.612 Sum_probs=217.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.............+.+|+.+|+.++||||+++++++.+++.+|+||||++||+
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (364)
T cd05599 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGD 87 (364)
T ss_pred EEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcH
Confidence 48999999999999999999999999987654444556778899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---------- 149 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~---------- 149 (416)
|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 167 (364)
T cd05599 88 MMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167 (364)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccc
Confidence 9999875 67999999999999999999999999999999999999999999999999998643211100
Q ss_pred --------------------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH
Q 014911 150 --------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS 203 (416)
Q Consensus 150 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~ 203 (416)
....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf~~~~~~~ 246 (364)
T cd05599 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246 (364)
T ss_pred cccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCCCCCCHHH
Confidence 01123579999999999987776 489999999999999999999999988877
Q ss_pred HHHHHHhCC--CCCCC--CCCHHHHHHHHHccCCCCCCcCC---HHHHhcCcccccc
Q 014911 204 MYRKIYRGD--FKCPP--WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKS 253 (416)
Q Consensus 204 ~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~f~~~ 253 (416)
.+..+.... ...|. .+++++++||.+||. +|.+|++ +.++++||||+..
T Consensus 247 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 247 TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 777776533 33444 468999999999997 9999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=388.63 Aligned_cols=252 Identities=34% Similarity=0.568 Sum_probs=220.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||||++||+
T Consensus 50 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05596 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCc
Confidence 48999999999999999999999999976544443445668899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+.+||+.
T Consensus 130 L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~~~~~~gt~~ 208 (370)
T cd05596 130 LVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAVGTPD 208 (370)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cccCCCCCCCcC
Confidence 9999988889999999999999999999999999999999999999999999999999987543211 112245679999
Q ss_pred CCchHHhhhcC---CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCC
Q 014911 161 YVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP--WFSSEARRLITKLLDP 233 (416)
Q Consensus 161 y~aPE~~~~~~---~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~ 233 (416)
|+|||++.... +.+.++|||||||++|+|++|.+||.+.+....+..+.... ..+|. .+|.++.+||++||+.
T Consensus 209 y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 288 (370)
T cd05596 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTD 288 (370)
T ss_pred eECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccC
Confidence 99999987543 34689999999999999999999999988888888887643 44554 4799999999999999
Q ss_pred CCCC--cCCHHHHhcCcccccc
Q 014911 234 NPNS--RIAISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~--R~s~~eil~hp~f~~~ 253 (416)
+|.+ |+|++++++||||+..
T Consensus 289 ~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 289 REVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred hhhccCCCCHHHHhcCcccCCC
Confidence 9988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=371.76 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=214.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|.+..+|+.||+|.+...........+.+..|+.+++.++||||+++++++...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544434456778899999999999999999999999999999999999999
Q ss_pred hhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 82 FNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 82 ~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887732 46999999999999999999999999999999999999999999999999998654321 12233457
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..++ .++|+||+||++|+|++|+.||...+. ......+.......|+.+++.+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 89999999999887764 899999999999999999999976532 2334444455566778899999999999999
Q ss_pred CCCCCcC-----CHHHHhcCcccccc
Q 014911 233 PNPNSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~-----s~~eil~hp~f~~~ 253 (416)
.||.+|| |++++++||||+..
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 9999999 88999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=384.33 Aligned_cols=250 Identities=34% Similarity=0.608 Sum_probs=218.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
||+|+||+||+|++..+|+.||||++.+..............|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333444556677777665 699999999999999999999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999999875 7799999999999999999999999999999999999999999999999999864221 2233456789
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHccCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-WFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~~L~~dP~ 236 (416)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+..+...+|. .+++++.+||++||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976554468999999999999999999999999888888888888777775 4799999999999999999
Q ss_pred CcC----CHHHHhcCcccccc
Q 014911 237 SRI----AISKIMESSWFKKS 253 (416)
Q Consensus 237 ~R~----s~~eil~hp~f~~~ 253 (416)
+|| ++.++++||||...
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HCCCCCCCHHHHhcCccccCC
Confidence 998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=379.49 Aligned_cols=250 Identities=34% Similarity=0.617 Sum_probs=222.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++.+..............|..++..+ +||+|+++++++.+.+.+|+||||++||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (323)
T cd05616 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (323)
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCC
Confidence 489999999999999999999999999876544444456677888888877 5899999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 164 (323)
T cd05616 87 DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTTKTFCGT 164 (323)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCccccCCCC
Confidence 99999875 7799999999999999999999999999999999999999999999999999864321 12233456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+++.+||+.||.+|
T Consensus 165 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R 243 (323)
T cd05616 165 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243 (323)
T ss_pred hhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhc
Confidence 99999999988776 48999999999999999999999999988899999988888999999999999999999999999
Q ss_pred CCH-----HHHhcCcccccc
Q 014911 239 IAI-----SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~-----~eil~hp~f~~~ 253 (416)
++. .++++||||+..
T Consensus 244 ~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 244 LGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 984 899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=371.40 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=206.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+||||+.| +
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (288)
T cd07871 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D 88 (288)
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence 489999999999999999999999999754322 2335677999999999999999999999999999999999986 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .........++
T Consensus 89 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~~~~~~~~~ 166 (288)
T cd07871 89 LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTKTYSNEVVT 166 (288)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCccccCceec
Confidence 9888864 3589999999999999999999999999999999999999999999999999864322 12223455789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------CCC----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FKC---- 215 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~---- 215 (416)
+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+.... ...
T Consensus 167 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07871 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR 246 (288)
T ss_pred ccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC
Confidence 999999998765545689999999999999999999998877655544432210 001
Q ss_pred -------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 216 -------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 216 -------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.+.+++++++||++||++||.+|||++|+++||||
T Consensus 247 ~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 247 AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 12467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=381.48 Aligned_cols=250 Identities=37% Similarity=0.625 Sum_probs=219.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5899999999999999999999999997654433334455556655 467899999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 159 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGT 159 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccCC
Confidence 99998876 6799999999999999999999999999999999999999999999999999863221 12233456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+.......++..+..+.++|++||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 160 PEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred hhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhc
Confidence 999999999887764 8999999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCH----HHHhcCcccccc
Q 014911 239 IAI----SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~----~eil~hp~f~~~ 253 (416)
|++ .++++||||...
T Consensus 239 ~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 239 LGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 986 589999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=389.33 Aligned_cols=251 Identities=36% Similarity=0.626 Sum_probs=215.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||||++||+
T Consensus 8 ~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (382)
T cd05625 8 TLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 87 (382)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCc
Confidence 48999999999999999999999999977654444566789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc------------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK------------ 147 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~------------ 147 (416)
|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~ 167 (382)
T cd05625 88 MMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167 (382)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccc
Confidence 9999876 679999999999999999999999999999999999999999999999999975321100
Q ss_pred ---------------------------------cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCC
Q 014911 148 ---------------------------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194 (416)
Q Consensus 148 ---------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~ 194 (416)
......+.+||+.|+|||++.+.++. .++||||+||++|+|++|.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~ 246 (382)
T cd05625 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQP 246 (382)
T ss_pred cccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHHHHhCCC
Confidence 00011245799999999999888775 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccCCCCCCcCC---HHHHhcCcccccc
Q 014911 195 PFQDDNIVSMYRKIYRG--DFKCP--PWFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKS 253 (416)
Q Consensus 195 Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~f~~~ 253 (416)
||.+.+.......+... ....| ..+++++.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 247 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 247 PFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99988877666666542 23344 357999999999987 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=379.12 Aligned_cols=251 Identities=31% Similarity=0.605 Sum_probs=219.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999999876555445567788999999888 6999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt 159 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCGT 159 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccCC
Confidence 99998875 6799999999999999999999999999999999999999999999999999863221 12234567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-------DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 231 (416)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......+..+.......|..++..+.++|++||
T Consensus 160 ~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 238 (327)
T cd05617 160 PNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238 (327)
T ss_pred cccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 99999999987766 5899999999999999999999953 223345566666677888889999999999999
Q ss_pred CCCCCCcCC------HHHHhcCccccccC
Q 014911 232 DPNPNSRIA------ISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s------~~eil~hp~f~~~~ 254 (416)
+.||.+|++ ++++++||||+...
T Consensus 239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 239 NKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 999999998 57999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=388.96 Aligned_cols=251 Identities=33% Similarity=0.599 Sum_probs=214.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (377)
T cd05629 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGD 87 (377)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCc
Confidence 48999999999999999999999999976554444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---------- 149 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~---------- 149 (416)
|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~ 167 (377)
T cd05629 88 LMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167 (377)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccc
Confidence 9999976 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred -----------------------------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCC
Q 014911 150 -----------------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194 (416)
Q Consensus 150 -----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~ 194 (416)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~ 246 (377)
T cd05629 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWP 246 (377)
T ss_pred ccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhhhhhcCCC
Confidence 00013579999999999987776 589999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHccCCCCCCc---CCHHHHhcCcccccc
Q 014911 195 PFQDDNIVSMYRKIYRG--DFKCPP--WFSSEARRLITKLLDPNPNSR---IAISKIMESSWFKKS 253 (416)
Q Consensus 195 Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R---~s~~eil~hp~f~~~ 253 (416)
||.+.+....+..+... ...+|. .++.++++||++||. +|.+| +|+.+++.||||+..
T Consensus 247 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 247 PFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred CCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99988877777777642 344454 478999999999998 67665 599999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=386.52 Aligned_cols=252 Identities=33% Similarity=0.563 Sum_probs=218.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||||++||+
T Consensus 50 ~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05621 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCc
Confidence 48999999999999999999999999976544443445678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+.+||+.
T Consensus 130 L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~ 208 (370)
T cd05621 130 LVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPD 208 (370)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcc
Confidence 9999988789999999999999999999999999999999999999999999999999987543211 112346689999
Q ss_pred CCchHHhhhcC---CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCC
Q 014911 161 YVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP--WFSSEARRLITKLLDP 233 (416)
Q Consensus 161 y~aPE~~~~~~---~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~ 233 (416)
|+|||++.+.+ +.+.++|+||+||++|+|++|..||...+....+..+.... +..|. .++..++++|.+||+.
T Consensus 209 Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~ 288 (370)
T cd05621 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTD 288 (370)
T ss_pred cCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccC
Confidence 99999997643 34689999999999999999999999988888888887643 44554 4699999999999986
Q ss_pred CCCC--cCCHHHHhcCcccccc
Q 014911 234 NPNS--RIAISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~--R~s~~eil~hp~f~~~ 253 (416)
+|.+ |+|+.++++||||+..
T Consensus 289 ~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 289 REVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred chhccCCCCHHHHhcCcccCCC
Confidence 6654 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=378.89 Aligned_cols=250 Identities=35% Similarity=0.609 Sum_probs=219.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999999999999999997654433333445555554 678899999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.... .........+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~gt 159 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGT 159 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCC--CCCCccccccCC
Confidence 99988875 679999999999999999999999999999999999999999999999999986421 122334456899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......|+..+..+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 160 PEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred cccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 999999999877664 8899999999999999999999999888888888888888888999999999999999999999
Q ss_pred CCH----HHHhcCcccccc
Q 014911 239 IAI----SKIMESSWFKKS 253 (416)
Q Consensus 239 ~s~----~eil~hp~f~~~ 253 (416)
+++ .++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 239 LGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred CCCCCCHHHHhCCCCcCCC
Confidence 975 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=378.78 Aligned_cols=250 Identities=37% Similarity=0.640 Sum_probs=218.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++||
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999999999999999997654333233334444444 568899999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 159 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGT 159 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccCC
Confidence 99999976 6799999999999999999999999999999999999999999999999999864221 22334566899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+....+..+.......++.+++.+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 160 PEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred ccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 999999999877664 8999999999999999999999998888888888888788888899999999999999999999
Q ss_pred CCHH----HHhcCcccccc
Q 014911 239 IAIS----KIMESSWFKKS 253 (416)
Q Consensus 239 ~s~~----eil~hp~f~~~ 253 (416)
+++. ++++|+||...
T Consensus 239 ~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 239 LGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCCHHHHhcCcccCCC
Confidence 9876 89999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=376.97 Aligned_cols=250 Identities=33% Similarity=0.609 Sum_probs=222.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+...........+..|+.+++.+. ||+|+++++++.+.+.+|+||||++||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g 86 (323)
T cd05615 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG 86 (323)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCC
Confidence 4899999999999999999999999998765444445567788999998885 578889999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 87 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~~~~~gt 164 (323)
T cd05615 87 DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTTRTFCGT 164 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccccCccCC
Confidence 99999976 7899999999999999999999999999999999999999999999999999864221 12223456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++|+||+||++|+|++|..||.+.+.......+.......|..++.++.+++.+||+.||.+|
T Consensus 165 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R 243 (323)
T cd05615 165 PDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243 (323)
T ss_pred ccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhC
Confidence 99999999987766 48999999999999999999999999888888999888888999999999999999999999999
Q ss_pred CC-----HHHHhcCcccccc
Q 014911 239 IA-----ISKIMESSWFKKS 253 (416)
Q Consensus 239 ~s-----~~eil~hp~f~~~ 253 (416)
++ .+++++||||+..
T Consensus 244 ~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 244 LGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CCCCCCCHHHHhcCcccCCC
Confidence 97 4789999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=372.37 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=204.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.+....|+||||+. ++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 489999999999999999999999999754322 223467789999999999999999999999999999999996 57
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~ 166 (303)
T cd07869 89 LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVT 166 (303)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCccCCCCccc
Confidence 8877764 5699999999999999999999999999999999999999999999999999864322 12233456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhC--CC---------C------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRG--DF---------K------------ 214 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~--~~---------~------------ 214 (416)
+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+... .. .
T Consensus 167 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (303)
T cd07869 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246 (303)
T ss_pred CCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccccc
Confidence 9999999987655556899999999999999999999987532 2222222110 00 0
Q ss_pred CCC---------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 215 CPP---------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 215 ~p~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
.|. .+++++.+||++||+.||.+|||+.++++||||+...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred CCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 010 13578999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=369.64 Aligned_cols=247 Identities=27% Similarity=0.439 Sum_probs=206.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||||++++.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 489999999999999999999999999765432 2345678899999999999999999999999999999999999977
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+..+... +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ........||+
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~ 165 (287)
T cd07848 87 LELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATR 165 (287)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-ccccccccccc
Confidence 7655543 569999999999999999999999999999999999999999999999999987543211 12233457899
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------CCCC----
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FKCP---- 216 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~p---- 216 (416)
.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+.......+.... ...|
T Consensus 166 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd07848 166 WYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH 244 (287)
T ss_pred ccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccC
Confidence 9999999987776 589999999999999999999998765543332222110 0011
Q ss_pred ---------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 217 ---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 217 ---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..+|+++.+||++||++||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=384.08 Aligned_cols=251 Identities=37% Similarity=0.673 Sum_probs=220.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|+||||++|++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (350)
T cd05573 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGD 87 (350)
T ss_pred EEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCC
Confidence 48999999999999999999999999987655444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc------------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK------------ 147 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~------------ 147 (416)
|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 88 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 167 (350)
T cd05573 88 LMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167 (350)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccc
Confidence 9999976 689999999999999999999999999999999999999999999999999987544322
Q ss_pred ---------------cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh--
Q 014911 148 ---------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-- 210 (416)
Q Consensus 148 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-- 210 (416)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 246 (350)
T cd05573 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK 246 (350)
T ss_pred cccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccC
Confidence 0112345579999999999988766 5899999999999999999999999888777777766
Q ss_pred CCCCCCCC--CCHHHHHHHHHccCCCCCCcCC-HHHHhcCcccccc
Q 014911 211 GDFKCPPW--FSSEARRLITKLLDPNPNSRIA-ISKIMESSWFKKS 253 (416)
Q Consensus 211 ~~~~~p~~--~s~~~~~li~~~L~~dP~~R~s-~~eil~hp~f~~~ 253 (416)
.....|.. +++++.+||.+||. ||.+|++ +.++++||||+..
T Consensus 247 ~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 247 ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 44445544 59999999999998 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=379.71 Aligned_cols=249 Identities=37% Similarity=0.671 Sum_probs=221.0
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||++++. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.+.+.+|+||||++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4899999999999863 578999999997654322 234567789999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ........+
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceeccc
Confidence 9999999975 6799999999999999999999999999999999999999999999999999874322 112334567
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.+||++||+.||.
T Consensus 160 g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 160 GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred CChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 9999999999987766 489999999999999999999999988888888888888889999999999999999999999
Q ss_pred CcCC-----HHHHhcCcccccc
Q 014911 237 SRIA-----ISKIMESSWFKKS 253 (416)
Q Consensus 237 ~R~s-----~~eil~hp~f~~~ 253 (416)
+||| +.+++.||||...
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCC
Confidence 9999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=386.43 Aligned_cols=251 Identities=34% Similarity=0.603 Sum_probs=214.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||||++||+
T Consensus 8 ~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (376)
T cd05598 8 TIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (376)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCc
Confidence 48999999999999999999999999976544444456778899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ----------- 148 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~----------- 148 (416)
|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~ 167 (376)
T cd05598 88 MMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167 (376)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccc
Confidence 9999976 6789999999999999999999999999999999999999999999999999753211000
Q ss_pred ------------------------------CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC
Q 014911 149 ------------------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD 198 (416)
Q Consensus 149 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~ 198 (416)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-CcceeeeeccceeeehhhCCCCCCC
Confidence 001123579999999999988776 4899999999999999999999998
Q ss_pred CcHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccCCCCCCcC---CHHHHhcCcccccc
Q 014911 199 DNIVSMYRKIYRG--DFKCP--PWFSSEARRLITKLLDPNPNSRI---AISKIMESSWFKKS 253 (416)
Q Consensus 199 ~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~f~~~ 253 (416)
.+.......+... ....| ..+++.+.++|.+|+ .+|.+|+ |+.++++||||+..
T Consensus 247 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 247 DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 8877666665543 22333 357999999999977 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=383.96 Aligned_cols=252 Identities=31% Similarity=0.612 Sum_probs=217.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++.............+.+|+.++..++||||+++++.+.+.+.+|+||||++||+
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (360)
T cd05627 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGD 87 (360)
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCcc
Confidence 48999999999999999999999999976554444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ----------- 148 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~----------- 148 (416)
|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~ 167 (360)
T cd05627 88 MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167 (360)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCC
Confidence 9999975 6799999999999999999999999999999999999999999999999999864321100
Q ss_pred ----------------------CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHH
Q 014911 149 ----------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 206 (416)
Q Consensus 149 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~ 206 (416)
.....+.+||+.|+|||++.+.++. .++|||||||++|+|++|.+||.+.+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~ 246 (360)
T cd05627 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246 (360)
T ss_pred cccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCCCHHHHHH
Confidence 0112245799999999999887775 89999999999999999999999988888877
Q ss_pred HHHhC--CCCCCCC--CCHHHHHHHHHccCCCCCCcC---CHHHHhcCccccccC
Q 014911 207 KIYRG--DFKCPPW--FSSEARRLITKLLDPNPNSRI---AISKIMESSWFKKSA 254 (416)
Q Consensus 207 ~i~~~--~~~~p~~--~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~f~~~~ 254 (416)
.+... ...+|+. +++++++||.+|+. ||.+|+ +++++++||||....
T Consensus 247 ~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 247 KVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred HHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence 77653 3444543 78999999999875 999998 489999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.75 Aligned_cols=239 Identities=28% Similarity=0.481 Sum_probs=208.4
Q ss_pred cccCCceEEEEEEEcCCCcE-EEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQTGKS-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-KIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~~~gg 79 (416)
||.|+||+||+|.+ .|+. ||+|++......... .+.+.+|+.+|.+++|||||++++++..+. ..++||||+++|
T Consensus 49 iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred cccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 79999999999998 4555 999999876654433 779999999999999999999999998887 799999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEeccCC-CeEEeeccccccccccccCCcccc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRG-VYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~g-i~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+|.+++.. +.++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++...... .....
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~ 203 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTS 203 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccC
Confidence 99999955 67999999999999999999999999 99999999999999998 99999999998544321 23334
Q ss_pred cccCCCCCchHHhh--hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHH-hC-CCCCCCCCCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-RG-DFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~~~~~li~~~ 230 (416)
..||+.|||||++. ...| +.++||||+|++||||+||..||.+.........+. .+ ...+|..+++.+..|+..|
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~C 282 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERC 282 (362)
T ss_pred CCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHh
Confidence 68999999999998 4566 499999999999999999999999988765555554 33 3556777999999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|..||..||++.+++.
T Consensus 283 W~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 283 WLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCCCcCCCHHHHHH
Confidence 9999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=378.53 Aligned_cols=251 Identities=31% Similarity=0.547 Sum_probs=216.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (330)
T cd05601 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD 87 (330)
T ss_pred EEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCC
Confidence 48999999999999999999999999987654444456778899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........ .......||
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt 166 (330)
T cd05601 88 LLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166 (330)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-eeeecccCC
Confidence 9999975 5799999999999999999999999999999999999999999999999999875432211 122345799
Q ss_pred CCCCchHHhhh-----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCC--CCCCCHHHHHHHHH
Q 014911 159 PAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKC--PPWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~--p~~~s~~~~~li~~ 229 (416)
+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+..+.... ..+ ++.+++++.+||.+
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 246 (330)
T cd05601 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQS 246 (330)
T ss_pred ccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHH
Confidence 99999999863 2233588999999999999999999999888777777775532 223 34589999999999
Q ss_pred ccCCCCCCcCCHHHHhcCcccccc
Q 014911 230 LLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
||+ +|.+|||++++++||||...
T Consensus 247 ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 247 LLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred Hcc-ChhhCCCHHHHhCCCCcCCC
Confidence 998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=374.62 Aligned_cols=252 Identities=36% Similarity=0.619 Sum_probs=215.5
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+|+||||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (332)
T cd05614 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDY 86 (332)
T ss_pred EEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeC
Confidence 4899999999999864 47899999999764432 223456788999999999 599999999999999999999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 87 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-~~~~~~ 165 (332)
T cd05614 87 VSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYS 165 (332)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-CCcccc
Confidence 999999999865 679999999999999999999999999999999999999999999999999987543221 122335
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 230 (416)
.+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+.......|..+++.+.++|.+|
T Consensus 166 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (332)
T cd05614 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKL 245 (332)
T ss_pred ccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 679999999999986654568999999999999999999999643 3344555666667778888999999999999
Q ss_pred cCCCCCCcC-----CHHHHhcCcccccc
Q 014911 231 LDPNPNSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 231 L~~dP~~R~-----s~~eil~hp~f~~~ 253 (416)
|+.||++|| +++++++||||+..
T Consensus 246 l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 246 LRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred cCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=379.86 Aligned_cols=252 Identities=34% Similarity=0.561 Sum_probs=217.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 50 ~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (371)
T cd05622 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 129 (371)
T ss_pred EEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCc
Confidence 48999999999999999999999999976544443445668899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....+.+||+.
T Consensus 130 L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~ 208 (371)
T cd05622 130 LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPD 208 (371)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccccCcccCcc
Confidence 9999988889999999999999999999999999999999999999999999999999987543211 112345679999
Q ss_pred CCchHHhhhcC---CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHHHHHHHHHccCC
Q 014911 161 YVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP--PWFSSEARRLITKLLDP 233 (416)
Q Consensus 161 y~aPE~~~~~~---~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~ 233 (416)
|+|||++...+ +.+.++|||||||++|+|++|..||...+....+..+.... ..+| ..++..+++||.+||..
T Consensus 209 y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 288 (371)
T cd05622 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 288 (371)
T ss_pred ccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCC
Confidence 99999997543 34689999999999999999999999998888888887643 3344 35899999999999985
Q ss_pred CCCC--cCCHHHHhcCcccccc
Q 014911 234 NPNS--RIAISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~--R~s~~eil~hp~f~~~ 253 (416)
+|.+ |++++++++||||+..
T Consensus 289 ~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 289 REVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred hhhhcCCCCHHHHhcCcccCCC
Confidence 4443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=364.09 Aligned_cols=243 Identities=31% Similarity=0.491 Sum_probs=207.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C---EEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--S---KIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~---~~~lV~E~ 75 (416)
++|.|+||.||.|....+++.||||.+-.+.-.+ .+|+.+|+.++|||||++..+|... + ...+||||
T Consensus 31 liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 31 LIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 5899999999999999999999999886554332 3899999999999999999988543 2 35689999
Q ss_pred cCCCchhhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccccC
Q 014911 76 VKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 76 ~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~ 149 (416)
++. +|.+.++ +.+++.-.++-|..||+.||+|||+.|||||||||.|+|+|.+ |.+||||||.|......
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~--- 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG--- 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC---
Confidence 976 9999987 3679999999999999999999999999999999999999987 89999999999865542
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------C
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----------------D 212 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (416)
....++..|..|+|||.+.+...++.+.||||+|||+.||+-|.+-|.+.+..+....|.+- +
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 33356778999999999998887789999999999999999999999998877666665331 1
Q ss_pred CCCC------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 FKCP------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~~~p------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..+| ...++++.+|+.++|+++|.+|.|+.|++.||||..-.
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 1111 23589999999999999999999999999999997543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=356.93 Aligned_cols=241 Identities=38% Similarity=0.686 Sum_probs=213.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS----KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~~~~lV~E~ 75 (416)
+||-|-.|+|-.+.++.||+.+|+|++... ...++|++.+-+. .|||||++++++++ ...+.+|||.
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 589999999999999999999999998433 4678999987776 59999999999854 4568899999
Q ss_pred cCCCchhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC---CCeEEeeccccccccccccC
Q 014911 76 VKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 76 ~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 149 (416)
++||+||.+++. | .++|.++..|++||..|+.|||+.+|+||||||||+|.... ..+||+|||+|.... ..
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~---~~ 217 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ---EP 217 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC---CC
Confidence 999999999986 3 49999999999999999999999999999999999999754 459999999997433 35
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCCCCCCC--C--CCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPP--W--FSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~--~s~ 221 (416)
+.+.+.|-||+|+|||++....|+ ..+|+||+||++|.||+|++||-... ...+..+|..+.+.+|. | +|+
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 678899999999999999888876 88999999999999999999997643 34678889999887764 4 799
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.++++|+++|..+|.+|.|++++++|||+...
T Consensus 297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 99999999999999999999999999999764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=370.14 Aligned_cols=251 Identities=28% Similarity=0.459 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 48999999999999999999999999864322 223345788999999999999999999988543 358999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLH 153 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 153 (416)
+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 86 ~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 164 (338)
T cd07859 86 ME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164 (338)
T ss_pred CC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcccccc
Confidence 95 589988875 67999999999999999999999999999999999999999999999999998754322111 1224
Q ss_pred ccccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh----------------------
Q 014911 154 TTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------------------- 210 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~---------------------- 210 (416)
...||+.|+|||++.+. ...+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 165 ~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 244 (338)
T cd07859 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244 (338)
T ss_pred CCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHH
Confidence 46799999999998652 2335899999999999999999999987654332211110
Q ss_pred ----CCCCC-----CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 211 ----GDFKC-----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 211 ----~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
...+. .+.+++.+.++|.+||+.||.+|||++++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00001 12367889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=361.91 Aligned_cols=249 Identities=26% Similarity=0.462 Sum_probs=213.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++.+|+||||+.||+
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05605 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCc
Confidence 48999999999999999999999999976554333334567789999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..... .......+|
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~ 163 (285)
T cd05605 87 LKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVG 163 (285)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCccccccC
Confidence 9988753 4699999999999999999999999999999999999999999999999999875432 122234578
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHH----HHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM----YRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.... ...+.......|+.++..+.+||.+||+.
T Consensus 164 ~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05605 164 TVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTK 242 (285)
T ss_pred CCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccC
Confidence 999999999987665 5889999999999999999999987654332 23334444566777999999999999999
Q ss_pred CCCCcC-----CHHHHhcCcccccc
Q 014911 234 NPNSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~R~-----s~~eil~hp~f~~~ 253 (416)
||.+|| ++.++++||||...
T Consensus 243 ~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 243 DPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred CHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999 89999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.45 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=209.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333345566799999999999999999999999999999999999999
Q ss_pred hhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 82 FNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 82 ~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 988854 3488999999999999999999999999999999999999999999999999875432 1223345789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH----HHHHHHHHhCCCCCC-CCCCHHHHHHHHHccCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCP-PWFSSEARRLITKLLDP 233 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~ 233 (416)
+.|+|||++.+..+ +.++|+||+||++|+|++|..||..... ..............+ ..+++++++||++||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 5899999999999999999999976432 233344443333332 45899999999999999
Q ss_pred CCCCcCCH----HHHhcCcccccc
Q 014911 234 NPNSRIAI----SKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~R~s~----~eil~hp~f~~~ 253 (416)
||.+||++ ++++.||||+..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 99999999 678899999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=364.70 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=209.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+|..+|+|++.... .......+.+|+.+|+.++||||+++++++...+.+|+||||++||+
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred eecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 4899999999999999999999999997543 22345689999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..... .......||
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~g~ 165 (331)
T cd06649 90 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 165 (331)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----cccccCCCC
Confidence 9999976 6799999999999999999999986 699999999999999999999999999874322 223455799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh----------------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------------------------- 210 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~---------------------------- 210 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+...+...+..
T Consensus 166 ~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (331)
T cd06649 166 RSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG 244 (331)
T ss_pred cCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccc
Confidence 99999999987766 5899999999999999999999987655433222111
Q ss_pred ------------------CC-CCC-CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 211 ------------------GD-FKC-PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 211 ------------------~~-~~~-p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. ... ...+++++++||.+||+.||++|||+.++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 245 MDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00 011 113688999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=366.24 Aligned_cols=252 Identities=32% Similarity=0.575 Sum_probs=213.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (331)
T cd05597 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGD 87 (331)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCc
Confidence 48999999999999999999999999976544444455678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .......+||
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt 166 (331)
T cd05597 88 LLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGT 166 (331)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Cccccceecc
Confidence 9999975 579999999999999999999999999999999999999999999999999986433211 1112335799
Q ss_pred CCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCC---CCCCHHHHHHHHH
Q 014911 159 PAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP---PWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~~~li~~ 229 (416)
+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+....+..+.... ...| +.+++.+++||++
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (331)
T cd05597 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR 246 (331)
T ss_pred ccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHH
Confidence 99999999973 2344688999999999999999999999888777777775432 3333 3479999999999
Q ss_pred ccCCCCCC--cCCHHHHhcCcccccc
Q 014911 230 LLDPNPNS--RIAISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~--R~s~~eil~hp~f~~~ 253 (416)
||..++++ |+++.++++||||...
T Consensus 247 ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 247 LICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HccCcccccCCCCHHHHhcCCCCCCC
Confidence 99764443 8899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=352.60 Aligned_cols=253 Identities=32% Similarity=0.618 Sum_probs=220.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+|+.|--++...+|..+|||++++... ....++.||+.++.+++ |+||++|+++|+++++.|+|||.+.||
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 58999999999999999999999999987732 34578889999999995 999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeecccccccccc-----ccCC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHL-----KQDG 150 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~~~~~-----~~~~ 150 (416)
+|...|.+ ..|+|.++.++.+.|+.||.|||++||.||||||+|||...-.. +||+||.+..-.... ....
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 99999976 67999999999999999999999999999999999999976554 899999987533221 1223
Q ss_pred cccccccCCCCCchHHhh----hcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---------------cHHHHHHHHHhC
Q 014911 151 LLHTTCGTPAYVAPEVIS----KKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------------NIVSMYRKIYRG 211 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---------------~~~~~~~~i~~~ 211 (416)
.+.+.+|+..|||||+.. ...+++.++|.||||||||.||+|++||.+. -...++..|..|
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 456789999999999974 2334458999999999999999999999653 135788999999
Q ss_pred CCCCCCC----CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCcc
Q 014911 212 DFKCPPW----FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 212 ~~~~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 256 (416)
.+++|.. +|.++++||+.+|..||.+|.++.++++|||++...+.
T Consensus 322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 9999963 89999999999999999999999999999999876543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=381.42 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=198.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--------CEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--------SKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--------~~~~lV 72 (416)
.||+|+||+||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++... ..+++|
T Consensus 73 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 4899999999999999999999999885432 2345799999999999999999887432 257799
Q ss_pred EeccCCCchhhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeecccccccccc
Q 014911 73 MDLVKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHL 146 (416)
Q Consensus 73 ~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~ 146 (416)
|||+++ +|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~- 223 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA- 223 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC-
Confidence 999986 6766664 25699999999999999999999999999999999999999765 699999999975432
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---------------
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--------------- 211 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--------------- 211 (416)
.......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 224 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 301 (440)
T PTZ00036 224 --GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301 (440)
T ss_pred --CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence 222345678999999999876554568999999999999999999999887655444443221
Q ss_pred --CC------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 212 --DF------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 212 --~~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.. .+|...++++++||++||++||.+|||+.|+++||||...
T Consensus 302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1234567899999999999999999999999999999754
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=380.27 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=222.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||-|+||+||+|.++.++-..|-|+|... ....++.+.-||.||..|+||+||+|++.|...+.++|+.|||.||-+
T Consensus 40 LGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 40 LGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred hcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 79999999999999999999999998543 446678899999999999999999999999999999999999999999
Q ss_pred hhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
...+.. ..+++++++.+++|++.||+|||+++|+|||||..|||++-+|.++|+|||.+.... .......++.|||
T Consensus 117 DaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTP 194 (1187)
T KOG0579|consen 117 DAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTP 194 (1187)
T ss_pred hHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCc
Confidence 888865 569999999999999999999999999999999999999999999999999986422 2233456789999
Q ss_pred CCCchHHhh-----hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHcc
Q 014911 160 AYVAPEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---CPPWFSSEARRLITKLL 231 (416)
Q Consensus 160 ~y~aPE~~~-----~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L 231 (416)
+|||||++. ..+|+ +++||||||++|.+|..+.+|-..-+++..+-+|.+..++ .|..|+..+.||+++||
T Consensus 195 YWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL 273 (1187)
T KOG0579|consen 195 YWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCL 273 (1187)
T ss_pred ccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHH
Confidence 999999975 45665 9999999999999999999999999999999999887654 47789999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccCc
Q 014911 232 DPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
..||..||++.++++||||++...
T Consensus 274 ~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 274 VKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred hcCCccCCCHHHHhhCcccccCCc
Confidence 999999999999999999986543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=381.79 Aligned_cols=248 Identities=29% Similarity=0.464 Sum_probs=217.0
Q ss_pred CcccCCceEEEEEEEcCC-CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQT-GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+|+.++||||+++++++...+.+|+||||++||
T Consensus 74 ~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 489999999999998877 7889999774432 234467788999999999999999999999999999999999999
Q ss_pred chhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 80 ELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 80 ~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~ 230 (478)
T PTZ00267 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230 (478)
T ss_pred CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccc
Confidence 99987742 4689999999999999999999999999999999999999999999999999986543322233456
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 233 (416)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..+.. +.|..++++++++|.+||+.
T Consensus 231 ~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 309 (478)
T PTZ00267 231 FCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSK 309 (478)
T ss_pred cCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhcc
Confidence 689999999999987766 5899999999999999999999999888887777776654 45667899999999999999
Q ss_pred CCCCcCCHHHHhcCccccc
Q 014911 234 NPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 234 dP~~R~s~~eil~hp~f~~ 252 (416)
||++|||+.+++.|||++.
T Consensus 310 dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 310 NPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=370.69 Aligned_cols=248 Identities=29% Similarity=0.507 Sum_probs=228.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK-IYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~lV~E~~~gg 79 (416)
++|+|+||.+++++++..+..+++|.+........ ......+|+.++++++|||||.+.+.|..++. .+|||+||+||
T Consensus 11 ~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 11 QVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 48999999999999999999999999988776543 33478899999999999999999999988887 99999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
++.+.|.+ .-++|+.+..||.|++.||.|||++.|+|||||+.||+++.++.+||+|||+|...... .....+..
T Consensus 90 ~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~--~~~a~tvv 167 (426)
T KOG0589|consen 90 DLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE--DSLASTVV 167 (426)
T ss_pred CHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--hhhhheec
Confidence 99999975 34999999999999999999999999999999999999999999999999999875542 24677889
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|||.|+.||++.+.+|. .|+|||||||++|||++-+++|...+...+..+|.++. .+.|..+|.+++.||+.||..+|
T Consensus 168 GTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P 246 (426)
T KOG0589|consen 168 GTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNP 246 (426)
T ss_pred CCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCC
Confidence 99999999999999985 99999999999999999999999999999999999887 67888999999999999999999
Q ss_pred CCcCCHHHHhcCccccc
Q 014911 236 NSRIAISKIMESSWFKK 252 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~ 252 (416)
..||++.++|.+|....
T Consensus 247 ~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 247 EHRPSALELLRRPHLLR 263 (426)
T ss_pred ccCCCHHHHhhChhhhh
Confidence 99999999999988764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=356.70 Aligned_cols=244 Identities=29% Similarity=0.460 Sum_probs=201.3
Q ss_pred CcccCCceEEEEEEEcC-CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEE-----eCCEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMA-----SKSKIYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-----~~~~~~l 71 (416)
.||+|+||+||+|++.. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++. ....+++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred EeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 48999999999999864 56889999987554322 2334566788887766 6999999999875 3467999
Q ss_pred EEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 72 AMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 162 (290)
T cd07862 87 VFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 162 (290)
T ss_pred EEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC---
Confidence 999997 489888864 4589999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------- 213 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 213 (416)
........||+.|+|||++....+ +.++||||+||++|+|++|.+||.+.+....+..+.....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (290)
T cd07862 163 QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241 (290)
T ss_pred CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc
Confidence 223445678999999999987766 4889999999999999999999998877666655543210
Q ss_pred ------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 ------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
...+.+++.+++||.+||+.||++|||+.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=370.54 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=209.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E~ 75 (416)
.||+|+||+||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++...+ ..|+||||
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 48999999999999999999999999864322 2234567889999999999999999999998776 89999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 86 ~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~~~~~~~ 163 (372)
T cd07853 86 MQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-ESKHMTQ 163 (372)
T ss_pred cc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-ccccCCC
Confidence 96 478887765 67999999999999999999999999999999999999999999999999998754322 1122334
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh-----------------------C
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----------------------G 211 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-----------------------~ 211 (416)
..+|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+.. .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 243 (372)
T cd07853 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243 (372)
T ss_pred CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhC
Confidence 56899999999998766556899999999999999999999988776554444322 1
Q ss_pred CC---------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 212 DF---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 212 ~~---------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. ......++++.+||.+||+.||.+|||+.++++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11 12234578999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=383.49 Aligned_cols=251 Identities=33% Similarity=0.527 Sum_probs=219.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--------EEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--------KIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--------~~~lV 72 (416)
+||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++.+...+ .+++|
T Consensus 39 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV 117 (496)
T PTZ00283 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117 (496)
T ss_pred EEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence 489999999999999999999999999776543 244567889999999999999999998775432 47899
Q ss_pred EeccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc
Q 014911 73 MDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 147 (416)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~ 197 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV 197 (496)
T ss_pred EeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccc
Confidence 999999999998853 458999999999999999999999999999999999999999999999999997654433
Q ss_pred cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHH
Q 014911 148 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRL 226 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 226 (416)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+.. +.|+.+++++.++
T Consensus 198 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 276 (496)
T PTZ00283 198 SDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEI 276 (496)
T ss_pred cccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 3334456789999999999987776 4899999999999999999999999888877777776544 5678899999999
Q ss_pred HHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 227 ITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 227 i~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+.+||+.||.+|||+.++++|||++..
T Consensus 277 i~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 277 VTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 999999999999999999999998753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=367.41 Aligned_cols=247 Identities=28% Similarity=0.476 Sum_probs=206.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++...+.+|+||||+.+|+
T Consensus 81 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 4899999999999999999999999986543 22345678999999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........||+.
T Consensus 159 L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~ 233 (353)
T PLN00034 159 LEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIA 233 (353)
T ss_pred cccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cccccccccCcc
Confidence 8654 34678888999999999999999999999999999999999999999999998754321 112345579999
Q ss_pred CCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH---HHHHHHHH-hCCCCCCCCCCHHHHHHHHHccC
Q 014911 161 YVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---VSMYRKIY-RGDFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 161 y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~ 232 (416)
|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..++.++++||.+||+
T Consensus 234 y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 313 (353)
T PLN00034 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQ 313 (353)
T ss_pred ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHcc
Confidence 999998743 24456789999999999999999999974322 22222222 22345566789999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.||.+|||+.|+++||||....
T Consensus 314 ~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 314 REPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999998753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=358.60 Aligned_cols=249 Identities=27% Similarity=0.497 Sum_probs=207.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+||||+.+ +
T Consensus 13 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 389999999999999999999999999755422 2334677899999999999999999999999999999999976 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ........+|
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~ 167 (309)
T cd07872 90 LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TKTYSNEVVT 167 (309)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--cccccccccc
Confidence 8887754 45899999999999999999999999999999999999999999999999998643221 1223345689
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-------------------CCCC----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------DFKC---- 215 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~---- 215 (416)
+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+... ....
T Consensus 168 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (309)
T cd07872 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYK 247 (309)
T ss_pred ccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccC
Confidence 99999999876555568999999999999999999999887655443333211 0111
Q ss_pred -------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 216 -------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 216 -------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+.+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 248 PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 124688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=355.31 Aligned_cols=248 Identities=40% Similarity=0.774 Sum_probs=224.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+|+||||++|++
T Consensus 8 ~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (290)
T cd05580 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE 87 (290)
T ss_pred EeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCC
Confidence 48999999999999999999999999976655444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||+|.||+++.++.+||+|||++...... ....+|++
T Consensus 88 L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~ 162 (290)
T cd05580 88 LFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTP 162 (290)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCc
Confidence 9999976 67999999999999999999999999999999999999999999999999998754322 34457899
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||.+....+ +.++|+||+|+++|+|++|..||...+.......+..+....|..++..++++|.+||+.||.+|+
T Consensus 163 ~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 163 EYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred cccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHcc
Confidence 9999999876655 488999999999999999999999888777788888888888999999999999999999999999
Q ss_pred -----CHHHHhcCccccccC
Q 014911 240 -----AISKIMESSWFKKSA 254 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~ 254 (416)
+++++++||||+...
T Consensus 242 ~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 242 GNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CcccCCHHHHHcCcccccCC
Confidence 899999999997644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=363.59 Aligned_cols=252 Identities=30% Similarity=0.547 Sum_probs=214.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||||++||+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~ 87 (332)
T cd05623 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGD 87 (332)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCc
Confidence 48999999999999999999999999976544444445668899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........+||
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~~~~~~gt 166 (332)
T cd05623 88 LLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 166 (332)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-CcceecccccC
Confidence 9999975 57999999999999999999999999999999999999999999999999998643221 11122345799
Q ss_pred CCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCC---CCCHHHHHHHHH
Q 014911 159 PAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP---WFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~~~li~~ 229 (416)
+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+..+.... ...|. .+++++++||++
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ 246 (332)
T cd05623 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR 246 (332)
T ss_pred ccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHH
Confidence 99999999863 2334689999999999999999999999988888888776543 23333 479999999999
Q ss_pred ccCCCCCC--cCCHHHHhcCcccccc
Q 014911 230 LLDPNPNS--RIAISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~--R~s~~eil~hp~f~~~ 253 (416)
||..+|.+ |++++++++||||...
T Consensus 247 ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 247 LICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99765554 7899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=346.62 Aligned_cols=249 Identities=29% Similarity=0.525 Sum_probs=213.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+||+|+||.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.....+|+|+||++|
T Consensus 9 ~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 88 (263)
T cd06625 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88 (263)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCC
Confidence 5899999999999999999999999987554321 12346788999999999999999999999999999999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Ccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 156 (416)
++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......... .......
T Consensus 89 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 168 (263)
T cd06625 89 GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168 (263)
T ss_pred CcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCC
Confidence 999999875 67999999999999999999999999999999999999999999999999998754322111 1113456
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~d 234 (416)
|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+... ....|..++..+.++|++||..+
T Consensus 169 ~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (263)
T cd06625 169 GTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247 (263)
T ss_pred cCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcC
Confidence 8899999999987665 58999999999999999999999887665554444333 34567788999999999999999
Q ss_pred CCCcCCHHHHhcCccc
Q 014911 235 PNSRIAISKIMESSWF 250 (416)
Q Consensus 235 P~~R~s~~eil~hp~f 250 (416)
|.+|||+.++++||||
T Consensus 248 p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 248 AKKRPSAEELLRHFFV 263 (263)
T ss_pred cccCCCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=354.26 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=210.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+.+.+.+|+||||++|++
T Consensus 7 ~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 86 (285)
T cd05630 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCc
Confidence 48999999999999999999999999976654443445667889999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ........|
T Consensus 87 L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~g 163 (285)
T cd05630 87 LKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVG 163 (285)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---CccccCCCC
Confidence 9998853 3589999999999999999999999999999999999999999999999999864322 122234578
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH---HHHHHH-HhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---SMYRKI-YRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
++.|+|||++.+..+ +.++|+||+||++|+|++|..||...... ...... .......+..+++++++||.+||+.
T Consensus 164 ~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05630 164 TVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCK 242 (285)
T ss_pred CccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhc
Confidence 999999999987766 58899999999999999999999864321 111111 2223345667899999999999999
Q ss_pred CCCCcCC-----HHHHhcCcccccc
Q 014911 234 NPNSRIA-----ISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~R~s-----~~eil~hp~f~~~ 253 (416)
||.+||| ++++++||||+..
T Consensus 243 ~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 243 DPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred CHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999 8999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=369.22 Aligned_cols=241 Identities=19% Similarity=0.330 Sum_probs=197.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++||||+++++++......|+|||++. ++
T Consensus 99 ~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 99 TFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 38999999999999999999999996532 346789999999999999999999999999999999995 58
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|....... .......+||+
T Consensus 169 L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~ 247 (391)
T PHA03212 169 LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTI 247 (391)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCcc
Confidence 8888865 679999999999999999999999999999999999999999999999999986433211 12234568999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-------HHHHHHHH------------------------
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-------IVSMYRKI------------------------ 208 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-------~~~~~~~i------------------------ 208 (416)
.|+|||++.+..+ +.++||||+||++|+|++|..||.... .......+
T Consensus 248 ~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~ 326 (391)
T PHA03212 248 ATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYI 326 (391)
T ss_pred CCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHH
Confidence 9999999987776 589999999999999999998864321 01111111
Q ss_pred --HhCCC----CCCC-----CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 209 --YRGDF----KCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 209 --~~~~~----~~p~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..... ..|. .++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 327 GLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 11101 1111 145689999999999999999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=364.15 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=204.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||.|+||+||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++... ...|++++
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 22 PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred ecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 489999999999999999999999998654322 22345677899999999999999999987543 45799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 101 ~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~ 174 (343)
T cd07878 101 LM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTG 174 (343)
T ss_pred cC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-----CcCC
Confidence 98 77999988888899999999999999999999999999999999999999999999999999874332 2345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 212 (416)
..||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 175 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07878 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS 254 (343)
T ss_pred ccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc
Confidence 6789999999999775555689999999999999999999998776554444332210
Q ss_pred -CCCC--------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 -FKCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 -~~~p--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
...| ...++.+.+||.+||.+||.+|||+.++++||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 1346778999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=349.39 Aligned_cols=247 Identities=35% Similarity=0.634 Sum_probs=208.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++....... .......+|+.+++.++||||+++++++......|+||||+.+++
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 6 KLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 3899999999999999999999999998775433 223344569999999999999999999999999999999999999
Q ss_pred hhhHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~-~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++. .+.+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+... ...........+++
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~ 162 (260)
T PF00069_consen 85 LQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTP 162 (260)
T ss_dssp HHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 999998 588999999999999999999999999999999999999999999999999998643 12233445667899
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
.|+|||++......+.++|+||||+++|+|++|..||...+ ...............+ ...++.+.++|.+||+
T Consensus 163 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 242 (260)
T PF00069_consen 163 EYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLS 242 (260)
T ss_dssp GGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHcc
Confidence 99999998734445699999999999999999999999873 3333333333222111 1124899999999999
Q ss_pred CCCCCcCCHHHHhcCccc
Q 014911 233 PNPNSRIAISKIMESSWF 250 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f 250 (416)
.||++|||+.++++||||
T Consensus 243 ~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 243 KDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSGGGSTTHHHHHTSGGG
T ss_pred CChhHCcCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=362.04 Aligned_cols=252 Identities=30% Similarity=0.536 Sum_probs=214.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+..|+||||++||+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~ 87 (331)
T cd05624 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGD 87 (331)
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence 48999999999999999999999999976544333445668899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .......+||
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt 166 (331)
T cd05624 88 LLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGT 166 (331)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-ceeeccccCC
Confidence 9999975 579999999999999999999999999999999999999999999999999987543211 1112345799
Q ss_pred CCCCchHHhhhc----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCC---CCCHHHHHHHHH
Q 014911 159 PAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP---WFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~~----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~~~li~~ 229 (416)
+.|+|||++... +..+.++||||+||++|+|++|+.||...+....+..+.... ++.|+ .++++++++|.+
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ 246 (331)
T cd05624 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQR 246 (331)
T ss_pred cccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHH
Confidence 999999998652 233588999999999999999999999888877777776543 33443 368999999999
Q ss_pred ccCCCCCC--cCCHHHHhcCcccccc
Q 014911 230 LLDPNPNS--RIAISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~--R~s~~eil~hp~f~~~ 253 (416)
||..++.+ |++++++++||||...
T Consensus 247 ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 247 LICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HccCchhhcCCCCHHHHhcCCCcCCC
Confidence 99976654 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=373.43 Aligned_cols=242 Identities=29% Similarity=0.478 Sum_probs=208.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H-----KHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~~~~lV~E 74 (416)
+||+|+||.|-+|.+.+|++.||||+++... ....+...|+.+|..|+ | -|+|+++++|...++.|||+|
T Consensus 193 ~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 193 VLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 5999999999999999999999999997654 55678889999999997 4 499999999999999999999
Q ss_pred ccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC--CeEEeeccccccccccccC
Q 014911 75 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--NLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~~~ 149 (416)
.+.- +|+++++. ..++...++.++.||+.||.+||+.||||+|||||||||..-+ .+||+|||.|++...
T Consensus 269 LL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q---- 343 (586)
T KOG0667|consen 269 LLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ---- 343 (586)
T ss_pred hhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC----
Confidence 9954 99999986 4589999999999999999999999999999999999997544 699999999986432
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC----------------
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---------------- 213 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---------------- 213 (416)
...+.+.+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..-.-
T Consensus 344 -~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 344 -RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred -cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 23488899999999999999996 889999999999999999999999988777766633100
Q ss_pred ------------------------------------CCCCC-----------CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 214 ------------------------------------KCPPW-----------FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 214 ------------------------------------~~p~~-----------~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
..|+. -...+.+||++||.+||.+|+|..++|+
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 01100 0245789999999999999999999999
Q ss_pred Ccccccc
Q 014911 247 SSWFKKS 253 (416)
Q Consensus 247 hp~f~~~ 253 (416)
||||...
T Consensus 502 Hpfl~~~ 508 (586)
T KOG0667|consen 502 HPFLTGT 508 (586)
T ss_pred Ccccccc
Confidence 9999843
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=363.33 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=201.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~lV~E 74 (416)
.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+ .+|+|||
T Consensus 28 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 106 (359)
T cd07876 28 PIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106 (359)
T ss_pred EeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEe
Confidence 38999999999999999999999999975532 2234567889999999999999999999986543 5799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..... ......
T Consensus 107 ~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~ 181 (359)
T cd07876 107 LMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTP 181 (359)
T ss_pred CCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc---CccCCC
Confidence 9976 5666654 3489999999999999999999999999999999999999999999999999864321 223345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh----------------------CC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------------GD 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~----------------------~~ 212 (416)
..||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.. ..
T Consensus 182 ~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (359)
T cd07876 182 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENR 260 (359)
T ss_pred CcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhC
Confidence 6789999999999887764 889999999999999999999987654332222111 00
Q ss_pred CC---------CC-----------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 FK---------CP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~~---------~p-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. .| ...++.+++||.+||++||++|||+.|+++||||....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred CCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 00 01 11357899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=356.69 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=192.6
Q ss_pred CcccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++. .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.. ...+|++|||+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 4899999999999965 4778999999865432 2457789999999999999999999854 46789999998
Q ss_pred CCCchhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe----ccCCCeEEeecccccc
Q 014911 77 KGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAF 142 (416)
Q Consensus 77 ~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll----~~~~~~kl~DFGla~~ 142 (416)
.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 65 88887742 248999999999999999999999999999999999999 4567899999999976
Q ss_pred ccccc-cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH---------HHHHHHHHhC-
Q 014911 143 SEHLK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---------VSMYRKIYRG- 211 (416)
Q Consensus 143 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~---------~~~~~~i~~~- 211 (416)
..... .........||+.|+|||++.+....+.++||||+||++|+|++|.+||..... ......+...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54321 112234567899999999998766557899999999999999999999964321 0111111110
Q ss_pred ---------------------------CCCC----------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 212 ---------------------------DFKC----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 212 ---------------------------~~~~----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.... ....+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=357.37 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=207.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+.+|+||||++||+
T Consensus 12 ~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (333)
T cd06650 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (333)
T ss_pred cccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence 4899999999999999999999999987543 22345678999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..... .......||
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~ 165 (333)
T cd06650 90 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 165 (333)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----hccccCCCC
Confidence 9999976 6799999999999999999999985 799999999999999999999999999874432 122345789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHH-------------------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK------------------------------- 207 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~------------------------------- 207 (416)
+.|+|||++.+..+ +.++|+||+||++|+|++|+.||...........
T Consensus 166 ~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (333)
T cd06650 166 RSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD 244 (333)
T ss_pred ccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhccc
Confidence 99999999977665 5899999999999999999999986544322211
Q ss_pred -------------HHhCC-CCCC-CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 208 -------------IYRGD-FKCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 208 -------------i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.... ...+ ..++.++++||.+||+.||++|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 245 SRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 11111 1111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=350.18 Aligned_cols=250 Identities=26% Similarity=0.470 Sum_probs=214.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+|+.++|+||+.+++.+..++..|++|||+.+++
T Consensus 7 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05632 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCcc
Confidence 48999999999999999999999999977654444445567889999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ........|
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g 163 (285)
T cd05632 87 LKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRGRVG 163 (285)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCcccCCCC
Confidence 9888753 3699999999999999999999999999999999999999999999999999864322 122234578
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH----HHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
++.|+|||++.+..+ +.++|+||+||++|+|++|..||....... ....+.......++.++..+.+|+.+||+.
T Consensus 164 ~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05632 164 TVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTK 242 (285)
T ss_pred CcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccC
Confidence 999999999987666 588999999999999999999998765433 233334444556777899999999999999
Q ss_pred CCCCcCC-----HHHHhcCccccccC
Q 014911 234 NPNSRIA-----ISKIMESSWFKKSA 254 (416)
Q Consensus 234 dP~~R~s-----~~eil~hp~f~~~~ 254 (416)
||.+||| +.++++||||+...
T Consensus 243 ~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 243 DPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred CHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999 88999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=344.38 Aligned_cols=248 Identities=38% Similarity=0.687 Sum_probs=219.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.++...|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876655445567899999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++....... ......+++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 568999999999999999999999999999999999999999999999999987543321 2234578999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc--HHHHHHHHH--hCCCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIY--RGDFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
|+|||.+....+ +.++|+||+|+++|+|++|..||.... ....+..+. ......|...++++.++|.+||+.||.
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877665 488999999999999999999998776 666666666 345677777899999999999999999
Q ss_pred CcCC-----HHHHhcCcccccc
Q 014911 237 SRIA-----ISKIMESSWFKKS 253 (416)
Q Consensus 237 ~R~s-----~~eil~hp~f~~~ 253 (416)
+||| +.|+++||||++.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hCcCCcccCHHHHhcChhhhCC
Confidence 9999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=348.26 Aligned_cols=249 Identities=31% Similarity=0.494 Sum_probs=205.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK---MVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 5899999999999999999999999997665433222233444544444 3479999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999999865 77999999999999999999999999999999999999999999999999998643321 223457
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
|++.|+|||.+......+.++|+||+||++|+|++|..||.... ...............|+.+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 89999999998643334589999999999999999999997532 222222233344567788999999999999999
Q ss_pred CCCCcC-----CHHHHhcCcccccc
Q 014911 234 NPNSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~R~-----s~~eil~hp~f~~~ 253 (416)
||.+|+ |+.++++||||+.-
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.87 Aligned_cols=244 Identities=28% Similarity=0.472 Sum_probs=200.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----CCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMAS-----KSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~~~~~lV 72 (416)
.||+|+||+||+|++..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. ...++++
T Consensus 7 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 3899999999999999999999999987543222 2234566788877765 79999999998754 3568999
Q ss_pred EeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC
Q 014911 73 MDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 149 (416)
|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... .
T Consensus 86 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~---~ 161 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---Q 161 (288)
T ss_pred Eccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC---c
Confidence 999985 88888865 3489999999999999999999999999999999999999999999999999875432 2
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-----------C-----
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-----------F----- 213 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-----------~----- 213 (416)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+......++.... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07863 162 MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240 (288)
T ss_pred ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccc
Confidence 22344568999999999987766 589999999999999999999998876655544443210 0
Q ss_pred -----------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 -----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 -----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
...+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=357.97 Aligned_cols=252 Identities=34% Similarity=0.629 Sum_probs=233.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+|.+|..+.+.+.+|||+++++.+.+.+..+--..|-++|... +-|.+++++.+|.+-+++|+||||+.||
T Consensus 356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG 435 (683)
T KOG0696|consen 356 VLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG 435 (683)
T ss_pred EeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence 589999999999999999999999999999888777777777888888877 5789999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|-..|++ |++.|..+..|+..|+-||-|||++||++||||..||++|.+|++||+|||++. .+.-......+.|||
T Consensus 436 DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK--Eni~~~~TTkTFCGT 513 (683)
T KOG0696|consen 436 DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIFDGVTTKTFCGT 513 (683)
T ss_pred hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccc--ccccCCcceeeecCC
Confidence 99999988 999999999999999999999999999999999999999999999999999986 233344567789999
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
|.|+|||++..++| +.++|.||+||+|||||+|.+||++.+..+++..|...+..+|..+|.++.++++.+|.+.|.+|
T Consensus 514 PdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 514 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred CcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccc
Confidence 99999999999988 58999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCH-----HHHhcCccccccCc
Q 014911 239 IAI-----SKIMESSWFKKSAP 255 (416)
Q Consensus 239 ~s~-----~eil~hp~f~~~~~ 255 (416)
..+ .+|..||||+...+
T Consensus 593 LGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 593 LGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred cCCCCccccchhhCcchhhccH
Confidence 864 78999999987544
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=364.50 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=202.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++... ..+|+|||
T Consensus 31 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e 109 (364)
T cd07875 31 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109 (364)
T ss_pred EeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEe
Confidence 48999999999999999999999999975432 223456778999999999999999999987543 46899999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 110 ~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~~ 184 (364)
T cd07875 110 LMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 184 (364)
T ss_pred CCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC---CCcccC
Confidence 9976 67777654 488999999999999999999999999999999999999999999999999975322 223345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
..||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 185 ~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (364)
T cd07875 185 YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263 (364)
T ss_pred CcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhC
Confidence 678999999999988776 4899999999999999999999988776555544432100
Q ss_pred -C--------------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 214 -K--------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 214 -~--------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
. .+...+..+++||.+||+.||.+|||+.++|+||||...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred CCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 001134678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=350.74 Aligned_cols=249 Identities=28% Similarity=0.511 Sum_probs=207.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|+||||+.+ +
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~ 89 (301)
T cd07873 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 89 (301)
T ss_pred EeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-C
Confidence 389999999999999999999999998654322 2334677899999999999999999999999999999999975 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... .........++
T Consensus 90 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~ 167 (301)
T cd07873 90 LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYSNEVVT 167 (301)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CCCccccccee
Confidence 8888864 5689999999999999999999999999999999999999999999999999864322 11223345678
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-------------------CCCCC---
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------DFKCP--- 216 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~p--- 216 (416)
+.|+|||++.+....+.++||||+||++|+|++|++||...+.......+... ....|
T Consensus 168 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (301)
T cd07873 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYR 247 (301)
T ss_pred ecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccc
Confidence 99999999876655568999999999999999999999887765444333221 00111
Q ss_pred --------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 217 --------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 217 --------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.+++.+++||.+||++||.+|||+.++++||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 24688999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=355.12 Aligned_cols=252 Identities=22% Similarity=0.384 Sum_probs=204.3
Q ss_pred CcccC--CceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+||+| +|++||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++..++..|+||||+++
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 58999 7899999999999999999999765432 24456788999999999999999999999999999999999999
Q ss_pred CchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-----CC
Q 014911 79 GELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-----DG 150 (416)
Q Consensus 79 g~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-----~~ 150 (416)
|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+........ ..
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 163 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHD 163 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccccc
Confidence 999999864 4589999999999999999999999999999999999999999999999986532211110 00
Q ss_pred cccccccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC---------------
Q 014911 151 LLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--------------- 214 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 214 (416)
......++..|+|||++.+. ...+.++||||+||++|+|++|..||..............+..+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (327)
T cd08227 164 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTM 243 (327)
T ss_pred ccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhccc
Confidence 11223567889999999753 22358999999999999999999999875543333222221110
Q ss_pred -------------------------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 215 -------------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 215 -------------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
....+++.+.+||.+||+.||++|||++++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 244 KPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred CCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 011246789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=341.63 Aligned_cols=249 Identities=30% Similarity=0.540 Sum_probs=213.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK------VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
+||.|+||.||+|.+..+++.+|+|.+....... ....+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (267)
T cd06628 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE 86 (267)
T ss_pred eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence 4899999999999999999999999986654322 1345678899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC----
Q 014911 75 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---- 149 (416)
Q Consensus 75 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~---- 149 (416)
|+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.........
T Consensus 87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06628 87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166 (267)
T ss_pred ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCcc
Confidence 9999999999976 67999999999999999999999999999999999999999999999999998755421111
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLIT 228 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 228 (416)
.......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..++..+.++|+
T Consensus 167 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06628 167 GARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLE 245 (267)
T ss_pred ccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHH
Confidence 11223468899999999987666 48899999999999999999999887665555444443 34566778999999999
Q ss_pred HccCCCCCCcCCHHHHhcCccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f 250 (416)
+||++||.+||++.++++||||
T Consensus 246 ~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 246 KTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=359.66 Aligned_cols=246 Identities=27% Similarity=0.462 Sum_probs=201.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T cd07874 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102 (355)
T ss_pred EeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhh
Confidence 38999999999999999999999999875432 223456778999999999999999999988643 35799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 103 ~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~ 177 (355)
T cd07874 103 LMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 177 (355)
T ss_pred hhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC---ccccCC
Confidence 9976 67666653 489999999999999999999999999999999999999999999999999874322 223345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC----------------------C
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------------D 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------------------~ 212 (416)
..||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+... .
T Consensus 178 ~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (355)
T cd07874 178 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256 (355)
T ss_pred ccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcC
Confidence 6789999999999877764 8999999999999999999999887654333222110 0
Q ss_pred -----CC---------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 -----FK---------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 -----~~---------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.. .+...+..+++||.+||+.||.+|||+.|+++||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred CccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 111235678999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.71 Aligned_cols=250 Identities=31% Similarity=0.498 Sum_probs=209.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHH---HHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI---SVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+||+|.+..+++.||+|.+.+..............|. ..++..+||||+.+++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 589999999999999999999999999765443222222233333 44555689999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
||+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999998865 6799999999999999999999999999999999999999999999999999864332 1223457
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
|++.|+|||.+.+....+.++|+||+||++|+|++|..||.+. ........+.......|..+|+.+.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999975433458899999999999999999999876 3334444444455677777899999999999999
Q ss_pred CCCCcC-----CHHHHhcCccccccC
Q 014911 234 NPNSRI-----AISKIMESSWFKKSA 254 (416)
Q Consensus 234 dP~~R~-----s~~eil~hp~f~~~~ 254 (416)
+|.+|| ++.++++||||+...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999 999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=338.26 Aligned_cols=246 Identities=27% Similarity=0.512 Sum_probs=213.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~gg 79 (416)
.||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. ...+|++|||++++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 489999999999999999999999999765432 2345678899999999999999999998764 45789999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. ..+++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ........
T Consensus 86 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~ 163 (257)
T cd08223 86 DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLI 163 (257)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CCcccccc
Confidence 99999864 35899999999999999999999999999999999999999999999999998755322 22334567
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP 235 (416)
+++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..|..+++.+.+++.+||++||
T Consensus 164 ~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 242 (257)
T cd08223 164 GTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRP 242 (257)
T ss_pred CCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCc
Confidence 8999999999987665 4889999999999999999999998877666666666544 4566789999999999999999
Q ss_pred CCcCCHHHHhcCccc
Q 014911 236 NSRIAISKIMESSWF 250 (416)
Q Consensus 236 ~~R~s~~eil~hp~f 250 (416)
.+|||+.++++||||
T Consensus 243 ~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 243 EKRPSVKSILRQPYI 257 (257)
T ss_pred ccCCCHHHHhcCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=373.50 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=195.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC------CCcceEEEEEEeC-CEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH------KHIVELHEVMASK-SKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~-~~~~lV~ 73 (416)
.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++... ..+|+||
T Consensus 136 ~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 3899999999999999999999999996432 223456678888777754 4588999988764 5799999
Q ss_pred eccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCC----------------CeEEe
Q 014911 74 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDG----------------NLKVT 135 (416)
Q Consensus 74 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~----------------~~kl~ 135 (416)
|++ |++|.+++.+ +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus 212 ~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~ 290 (467)
T PTZ00284 212 PKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290 (467)
T ss_pred ecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEEC
Confidence 988 6789888865 789999999999999999999998 5999999999999998766 49999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 215 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~ 215 (416)
|||.+.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|++||++.+.......+.......
T Consensus 291 DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 291 DLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred CCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 999875322 223456899999999999887774 89999999999999999999998876544333332211000
Q ss_pred C-----------------------C-------------------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 216 P-----------------------P-------------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 216 p-----------------------~-------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
| + ..++.+.+||.+||++||.+|||+.|+|+||||...
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0 0 013557799999999999999999999999999865
Q ss_pred Cc
Q 014911 254 AP 255 (416)
Q Consensus 254 ~~ 255 (416)
..
T Consensus 445 ~~ 446 (467)
T PTZ00284 445 YP 446 (467)
T ss_pred CC
Confidence 43
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=345.33 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=212.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 79999999999999999999999999765443333445667899999999999999999999999999999999999999
Q ss_pred hhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 82 FNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 82 ~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 999865 3 699999999999999999999999999999999999999999999999999875432 2223345678
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 234 (416)
..|+|||.+.+..+ +.++|+||+||++|+|++|..||..... ..+...+.......|+.+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877665 5889999999999999999999977543 233333444455667778999999999999999
Q ss_pred CCCcC-----CHHHHhcCcccccc
Q 014911 235 PNSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 235 P~~R~-----s~~eil~hp~f~~~ 253 (416)
|.+|| ++.+++.||||...
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88889999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=344.13 Aligned_cols=246 Identities=30% Similarity=0.487 Sum_probs=203.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++.+++..|+||||+. ++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred EecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 389999999999999999999999998654322 2344678899999999999999999999999999999999997 58
Q ss_pred hhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.+|.++|+|||++...... ........
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 162 (285)
T cd07861 85 LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEV 162 (285)
T ss_pred HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cccccCCc
Confidence 8888754 46899999999999999999999999999999999999999999999999998643221 12223346
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------------------------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------------ 212 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------------ 212 (416)
+++.|+|||++.+....+.++|+|||||++|+|++|.+||.+.+.......+....
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd07861 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242 (285)
T ss_pred ccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcccc
Confidence 78999999998765544689999999999999999999998765433222211100
Q ss_pred -----CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 213 -----FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 213 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
......+++++.++|++||+.||.+|||+.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.28 Aligned_cols=238 Identities=16% Similarity=0.222 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~ 76 (416)
.||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||+
T Consensus 27 ~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 27 LIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred EEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 479999999999998 789999999976654444446788899999999999999999999876 45789999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+||+|.+++.. +.+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..... ....
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~~ 179 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPFK 179 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----cccc
Confidence 99999999976 6789999999999999999999984 999999999999999999999999999875332 1134
Q ss_pred cccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 230 (416)
..|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+... .+..|..+++.+.+|+.+|
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred ccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 568999999999976 344 58999999999999999999999998888887777544 3455667899999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|+.||++|||+.++++
T Consensus 259 l~~dp~~Rps~~ell~ 274 (283)
T PHA02988 259 TSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCcccCcCHHHHHH
Confidence 9999999999999985
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=365.68 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=222.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||.|+||.||.|++..+.+.||||.++.......+-...+..|++.|++++|||++.+.++|..+...|+|||||-| +-
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SA 112 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SA 112 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cH
Confidence 89999999999999999999999999877666666778999999999999999999999999999999999999976 66
Q ss_pred hhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
.|.+. +.++.|.++..|..+.+.||+|||+.+.+|||||..|||+++.|.|||+|||.|.+.. ...+++|||
T Consensus 113 sDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTP 186 (948)
T KOG0577|consen 113 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTP 186 (948)
T ss_pred HHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCc
Confidence 67664 4679999999999999999999999999999999999999999999999999987644 346789999
Q ss_pred CCCchHHhh--hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CC-CCCCHHHHHHHHHccCCCC
Q 014911 160 AYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CP-PWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 160 ~y~aPE~~~--~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~li~~~L~~dP 235 (416)
+|||||++. ..+.++-++|||||||+..+|...++|+-..+.+..+.-|..++.+ ++ +.||..+++|+..||++-|
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKip 266 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 266 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCc
Confidence 999999986 3344457899999999999999999999998888777777666543 32 3589999999999999999
Q ss_pred CCcCCHHHHhcCccccccCccccc
Q 014911 236 NSRIAISKIMESSWFKKSAPKVVI 259 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~~~~~~~~ 259 (416)
..|||.+++++|+|.....++.++
T Consensus 267 qeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 267 QERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred ccCCcHHHHhhcchhccCCCchHH
Confidence 999999999999999887666543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.71 Aligned_cols=250 Identities=36% Similarity=0.672 Sum_probs=220.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++||||+++++.+...+..|+++||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 79999999999999999999999999766544445667899999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc------CCcccc
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ------DGLLHT 154 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~------~~~~~~ 154 (416)
.+++.+ +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 7799999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF--SSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~~L~ 232 (416)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||...........+..+....|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 567889999999877664 5899999999999999999999999888888888877776666665 8999999999999
Q ss_pred CCCCCcCCH---HHHhcCccccc
Q 014911 233 PNPNSRIAI---SKIMESSWFKK 252 (416)
Q Consensus 233 ~dP~~R~s~---~eil~hp~f~~ 252 (416)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=357.32 Aligned_cols=234 Identities=26% Similarity=0.463 Sum_probs=206.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|-||+||.|.+.. ...||+|.+...... .+.+.+|+++|++|+|+|||++++++..+..+||||||++.|+|
T Consensus 214 LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred hcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 8999999999999843 347999999765332 35677999999999999999999999998899999999999999
Q ss_pred hhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc-
Q 014911 82 FNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG- 157 (416)
Q Consensus 82 ~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g- 157 (416)
.++++. +.++......++.||++|++||+++++|||||-+.||||++++.+||+|||||+.... .......|
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d----~~Y~~~~~~ 364 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD----DEYTASEGG 364 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC----CceeecCCC
Confidence 999985 5699999999999999999999999999999999999999999999999999994321 11122222
Q ss_pred --CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 158 --TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 --t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
..-|.|||.+....+. .+|||||+||+|+||+| |+.||.+.+..+....+.+|. .+.|+.+|+.+.+++..||..
T Consensus 365 kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~ 443 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHE 443 (468)
T ss_pred CCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhC
Confidence 3349999999888774 99999999999999999 999999999999999998884 789999999999999999999
Q ss_pred CCCCcCCHHHHh
Q 014911 234 NPNSRIAISKIM 245 (416)
Q Consensus 234 dP~~R~s~~eil 245 (416)
+|++|||++.+.
T Consensus 444 ~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 444 DPEDRPTFETLR 455 (468)
T ss_pred CcccCCCHHHHH
Confidence 999999998764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=356.18 Aligned_cols=252 Identities=30% Similarity=0.498 Sum_probs=224.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||.++-..||+.+|+|.+.+.++.+.....-..+|-.||.+++.|.||.+-..|++++.+|+||..+.||+
T Consensus 192 vlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGD 271 (591)
T KOG0986|consen 192 VLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGD 271 (591)
T ss_pred EEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCc
Confidence 58999999999999999999999999988887766556677899999999999999999999999999999999999999
Q ss_pred hhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.-.|-+ | .++|..++.|+.+|+.||++||+.+||+|||||+|||+|++|+++|+|+|||.-+.. .......+|
T Consensus 272 LkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~---g~~~~~rvG 348 (591)
T KOG0986|consen 272 LKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE---GKPIRGRVG 348 (591)
T ss_pred eeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC---CCccccccC
Confidence 9777754 3 699999999999999999999999999999999999999999999999999985443 334455699
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
|.+|||||++.+..|+ ...|.|||||++|+|+.|..||.... ..++-+.+.....++|..+|+++++|++.+|+.
T Consensus 349 T~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~K 427 (591)
T KOG0986|consen 349 TVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTK 427 (591)
T ss_pred cccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHcc
Confidence 9999999999988864 89999999999999999999997642 235566677777889999999999999999999
Q ss_pred CCCCcCC-----HHHHhcCccccccCcc
Q 014911 234 NPNSRIA-----ISKIMESSWFKKSAPK 256 (416)
Q Consensus 234 dP~~R~s-----~~eil~hp~f~~~~~~ 256 (416)
||.+|.. ++++.+||||++...+
T Consensus 428 dp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 428 DPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred CHHHhccCCCcCcchhhhCcccccCCHh
Confidence 9999985 5799999999975443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=341.57 Aligned_cols=247 Identities=31% Similarity=0.478 Sum_probs=213.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||.|+||+||+|.+..++..+|+|++... .....+.+.+|+.+++.++||||+++++.+..+...|+||||+++++|
T Consensus 13 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd06611 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89 (280)
T ss_pred hcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence 89999999999999889999999998644 233456788999999999999999999999999999999999999999
Q ss_pred hhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
.+++.. ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... ........+++
T Consensus 90 ~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~ 167 (280)
T cd06611 90 DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTP 167 (280)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--ccccceeecch
Confidence 999875 46999999999999999999999999999999999999999999999999988653321 11223456899
Q ss_pred CCCchHHhhhc----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccC
Q 014911 160 AYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 160 ~y~aPE~~~~~----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~ 232 (416)
.|+|||.+... ...+.++|+||+||++|+|++|.+||...+.......+..+. +..|..++.++.++|.+||+
T Consensus 168 ~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (280)
T cd06611 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLV 247 (280)
T ss_pred hhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhc
Confidence 99999998532 223468999999999999999999999887776666666553 23466789999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+|.+|||+.++++||||...
T Consensus 248 ~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 248 KDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cChhhCcCHHHHhcChhhccc
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=386.77 Aligned_cols=253 Identities=35% Similarity=0.576 Sum_probs=227.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.|.+++.+.|++.||+|++++-...+......|..|-.||...+.+=|++++..|.++.++|+||||++||+
T Consensus 82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 59999999999999999999999999988766666667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++.+ ++++|+.++.|+..|+.||+-+|+.|+|||||||+|||||.+|++||+|||.+-..... ......+.+|||
T Consensus 162 lltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~V~s~~aVGTP 240 (1317)
T KOG0612|consen 162 LLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVRSSVAVGTP 240 (1317)
T ss_pred HHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-CcEEeccccCCC
Confidence 9999987 67999999999999999999999999999999999999999999999999987543321 122345678999
Q ss_pred CCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHcc
Q 014911 160 AYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCP--PWFSSEARRLITKLL 231 (416)
Q Consensus 160 ~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L 231 (416)
.|++||++.. .+.+|..+|.||+||++|||+.|..||...+..+.|.+|..- .+.+| ..+|+++++||.+++
T Consensus 241 DYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll 320 (1317)
T KOG0612|consen 241 DYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL 320 (1317)
T ss_pred CccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh
Confidence 9999999963 256689999999999999999999999999999999999875 67778 458999999999998
Q ss_pred CCCCCCcCC---HHHHhcCccccccCc
Q 014911 232 DPNPNSRIA---ISKIMESSWFKKSAP 255 (416)
Q Consensus 232 ~~dP~~R~s---~~eil~hp~f~~~~~ 255 (416)
. +|..|.. ++++.+||||....+
T Consensus 321 ~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 321 C-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred c-ChhhhcccccHHHHHhCccccCCCh
Confidence 7 5888888 999999999987543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=346.44 Aligned_cols=246 Identities=29% Similarity=0.456 Sum_probs=218.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||.||+|+++.+|+.+|||.+..+ ..+..+..||.||++++.|+||++|+.+-....+|||||||..|++
T Consensus 41 LGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 41 LGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred hcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 89999999999999999999999988654 3457889999999999999999999999999999999999999999
Q ss_pred hhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
.|.++. ..++|+++..+++.-+.||.|||...-+|||||..|||++.+|..||+|||.|...... .....+..|||
T Consensus 116 SDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTP 193 (502)
T KOG0574|consen 116 SDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTP 193 (502)
T ss_pred HHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCc
Confidence 999864 67999999999999999999999999999999999999999999999999998754322 12346788999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
.|||||++..-+|+ .++||||||++..||..|++||.+-.++.....|.... +.-|..+|.++.+++++||.++|+
T Consensus 194 FWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE 272 (502)
T KOG0574|consen 194 FWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPE 272 (502)
T ss_pred ccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHH
Confidence 99999999999997 88999999999999999999999988765554554432 234566899999999999999999
Q ss_pred CcCCHHHHhcCccccccCc
Q 014911 237 SRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 237 ~R~s~~eil~hp~f~~~~~ 255 (416)
+|.|+.++++|||.++...
T Consensus 273 ~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 273 ERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HHHHHHHHhhhhhhcCCCc
Confidence 9999999999999987654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.20 Aligned_cols=243 Identities=25% Similarity=0.409 Sum_probs=196.7
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-CEEEEEE
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK-SKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-~~~~lV~ 73 (416)
.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.+ +||||+++++++... ..+|+||
T Consensus 14 ~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred EeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 4899999999999752 456789999986443 223446788999999999 899999999988654 4689999
Q ss_pred eccCCCchhhHHhc---------------------------------------------------------------CCC
Q 014911 74 DLVKGGELFNKIAK---------------------------------------------------------------GRL 90 (416)
Q Consensus 74 E~~~gg~L~~~i~~---------------------------------------------------------------~~l 90 (416)
||++||+|.+++.. ..+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 99999999998864 136
Q ss_pred CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhc
Q 014911 91 REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170 (416)
Q Consensus 91 ~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 170 (416)
++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++............+..+++.|+|||++.+.
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 251 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC
Confidence 77888999999999999999999999999999999999999999999998754322111112233456789999999877
Q ss_pred CCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHH-HHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 171 GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 171 ~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+ +.++|||||||++|+|++ |..||.+.... .....+..+. ...|..+++.+.+++.+||+.||.+|||+.++++
T Consensus 252 ~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 252 VY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 66 489999999999999997 99999875543 2333333332 3456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=344.61 Aligned_cols=248 Identities=28% Similarity=0.494 Sum_probs=212.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+......|+||||++|++
T Consensus 27 ~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred EecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 389999999999999999999999999765432 34678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ........|++.
T Consensus 104 L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~ 181 (296)
T cd06654 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181 (296)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--ccccCcccCCcc
Confidence 999998888999999999999999999999999999999999999999999999999998743321 112234578999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|+.||...+.......+... ....|..++..+.++|.+||.+||.+
T Consensus 182 y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 260 (296)
T cd06654 182 WMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260 (296)
T ss_pred ccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCccc
Confidence 999999977655 58999999999999999999999887654433333222 22345668899999999999999999
Q ss_pred cCCHHHHhcCccccccC
Q 014911 238 RIAISKIMESSWFKKSA 254 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~ 254 (416)
|||+.++++||||....
T Consensus 261 Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 261 RGSAKELLQHQFLKIAK 277 (296)
T ss_pred CcCHHHHhhChhhhccC
Confidence 99999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=334.97 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=215.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 489999999999999999999999999765433 2445778899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ........|
T Consensus 86 L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~~~~~~~ 163 (256)
T cd08529 86 LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVG 163 (256)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cchhhcccc
Confidence 9999865 46899999999999999999999999999999999999999999999999998754332 222344578
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~ 236 (416)
++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+..+ .+..++..+.++|.+||+.+|+
T Consensus 164 ~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08529 164 TPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYR 242 (256)
T ss_pred CccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcc
Confidence 999999999987765 48999999999999999999999988877777777666543 3446889999999999999999
Q ss_pred CcCCHHHHhcCccc
Q 014911 237 SRIAISKIMESSWF 250 (416)
Q Consensus 237 ~R~s~~eil~hp~f 250 (416)
+||++.++++|||+
T Consensus 243 ~Rp~~~~ll~~~~~ 256 (256)
T cd08529 243 QRPDTFQLLRNPSL 256 (256)
T ss_pred cCcCHHHHhhCCCC
Confidence 99999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=346.27 Aligned_cols=246 Identities=26% Similarity=0.432 Sum_probs=207.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++..++.+|+||||++|++
T Consensus 8 ~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred eccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 4899999999999999999999999986542 23445678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++..... ......+|+
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~ 161 (308)
T cd06615 86 LDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 161 (308)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cccccCCCC
Confidence 9999976 779999999999999999999998 5999999999999999999999999999864322 223456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--------------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------------- 212 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------------- 212 (416)
+.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+....
T Consensus 162 ~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (308)
T cd06615 162 RSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240 (308)
T ss_pred cCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHH
Confidence 99999999876655 588999999999999999999997655433332221110
Q ss_pred -----------CCCCC-CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 -----------FKCPP-WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 -----------~~~p~-~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
...|. .++.++++|+.+||..||++|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 241 ELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 01111 267889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=346.94 Aligned_cols=253 Identities=34% Similarity=0.586 Sum_probs=219.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|+||||+.|++
T Consensus 8 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (316)
T cd05574 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGE 87 (316)
T ss_pred eecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCC
Confidence 48999999999999999999999999987665544456788999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC--------
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-------- 149 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-------- 149 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 88 L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (316)
T cd05574 88 LFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167 (316)
T ss_pred HHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccc
Confidence 9999865 46999999999999999999999999999999999999999999999999998644321110
Q ss_pred -------------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh
Q 014911 150 -------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 210 (416)
Q Consensus 150 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~ 210 (416)
.......||..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 246 (316)
T cd05574 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK 246 (316)
T ss_pred cccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhc
Confidence 01123467889999999987665 5899999999999999999999998887777777766
Q ss_pred CCCCCCCC--CCHHHHHHHHHccCCCCCCcCC----HHHHhcCccccccC
Q 014911 211 GDFKCPPW--FSSEARRLITKLLDPNPNSRIA----ISKIMESSWFKKSA 254 (416)
Q Consensus 211 ~~~~~p~~--~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~f~~~~ 254 (416)
.....|.. ++..++++|.+||..||.+||| ++++++||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 247 KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 65555554 6899999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.67 Aligned_cols=246 Identities=30% Similarity=0.516 Sum_probs=203.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||+||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+.+|+++||+.+ +
T Consensus 7 ~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 84 (284)
T cd07839 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-D 84 (284)
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-C
Confidence 38999999999999999999999999976432 223345677899999999999999999999999999999999975 7
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ........++
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~ 162 (284)
T cd07839 85 LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCYSAEVVT 162 (284)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCcCCCccc
Confidence 8777753 67999999999999999999999999999999999999999999999999998743321 1223345678
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCC-CCCcHHHHHHHHHhCC-------------------C-----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF-QDDNIVSMYRKIYRGD-------------------F----- 213 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf-~~~~~~~~~~~i~~~~-------------------~----- 213 (416)
+.|+|||.+.+....+.++||||+||++|+|++|..|| .+.+....+..+.... .
T Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07839 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPA 242 (284)
T ss_pred cCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCC
Confidence 99999999877655568999999999999999988875 4444444443332110 0
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
...+.+++++++||.+||+.||.+|||++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 243 TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.27 Aligned_cols=250 Identities=28% Similarity=0.458 Sum_probs=212.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||+||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..|+|+||+++++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred hcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 3899999999999999999999999986442 2345678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|...+.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ........++
T Consensus 89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~ 166 (282)
T cd06643 89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGT 166 (282)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccccccccc
Confidence 9888754 56999999999999999999999999999999999999999999999999998643221 1223345689
Q ss_pred CCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHcc
Q 014911 159 PAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 159 ~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L 231 (416)
+.|+|||++.. ....+.++|+||+||++|+|++|.+||...+.......+.... ...|..++.++.+||.+||
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (282)
T cd06643 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCL 246 (282)
T ss_pred ccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHc
Confidence 99999999842 1222478999999999999999999998877666555554432 2345668999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccCc
Q 014911 232 DPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+.||.+|||+.++++||||.....
T Consensus 247 ~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 247 EKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred cCChhhCcCHHHHhcCCCEeccCC
Confidence 999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=337.35 Aligned_cols=244 Identities=29% Similarity=0.457 Sum_probs=204.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+||||+++++
T Consensus 16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 48999999999999999999999999865432 234567899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ........|++
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~ 170 (267)
T cd06645 93 LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTP 170 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcc
Confidence 9999865 78999999999999999999999999999999999999999999999999998644321 12223457899
Q ss_pred CCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccC
Q 014911 160 AYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-----PWFSSEARRLITKLLD 232 (416)
Q Consensus 160 ~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~ 232 (416)
.|+|||++.. ....+.++|+||+||++|+|++|..||...................+ ..++..+.++|.+||+
T Consensus 171 ~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 250 (267)
T cd06645 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALT 250 (267)
T ss_pred cccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHcc
Confidence 9999999842 22235899999999999999999999976554333333333322221 2467899999999999
Q ss_pred CCCCCcCCHHHHhcCcc
Q 014911 233 PNPNSRIAISKIMESSW 249 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~ 249 (416)
.+|++|||++++++|||
T Consensus 251 ~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 251 KNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCchhCcCHHHHhcCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=338.47 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=217.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|+||+++++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 48999999999999999999999999975532 2345678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++...... .......+++.
T Consensus 86 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~ 163 (274)
T cd06609 86 CLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPF 163 (274)
T ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999987654321 22334568899
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCC-CCHHHHHHHHHccCCCCCCc
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPW-FSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li~~~L~~dP~~R 238 (416)
|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+..... ..+.. ++.++.+++.+||..+|++|
T Consensus 164 y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~R 242 (274)
T cd06609 164 WMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKER 242 (274)
T ss_pred ccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhC
Confidence 999999987765 5899999999999999999999988776665555555433 33444 78999999999999999999
Q ss_pred CCHHHHhcCccccccCc
Q 014911 239 IAISKIMESSWFKKSAP 255 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~~ 255 (416)
||++++++||||.....
T Consensus 243 pt~~~il~~~~~~~~~~ 259 (274)
T cd06609 243 PSAKELLKHKFIKKAKK 259 (274)
T ss_pred cCHHHHhhChhhcCCCc
Confidence 99999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.52 Aligned_cols=246 Identities=31% Similarity=0.601 Sum_probs=216.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.++...|+|+||+.|++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (258)
T cd05578 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD 86 (258)
T ss_pred EeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCC
Confidence 48999999999999999999999999987665554567889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++...... .......|+.
T Consensus 87 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~ 163 (258)
T cd05578 87 LRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTP 163 (258)
T ss_pred HHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---ccccccCCCh
Confidence 9999976 48999999999999999999999999999999999999999999999999998754321 1334566889
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
.|+|||.+....+ +.++|+||+|+++|+|++|..||...+ ...............|+.++..+.++|.+||+.||.
T Consensus 164 ~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (258)
T cd05578 164 GYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQ 242 (258)
T ss_pred hhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChh
Confidence 9999999987665 589999999999999999999998766 333333333355677888999999999999999999
Q ss_pred CcCCH--HHHhcCccc
Q 014911 237 SRIAI--SKIMESSWF 250 (416)
Q Consensus 237 ~R~s~--~eil~hp~f 250 (416)
+||++ .++++||||
T Consensus 243 ~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 243 KRLGDNLKDLKNHPYF 258 (258)
T ss_pred HcCCccHHHHhcCCCC
Confidence 99999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=358.36 Aligned_cols=245 Identities=33% Similarity=0.684 Sum_probs=218.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||.|-||+||-|+++++|+.||||+|++.++... ...++++|+.||+.+.||.||.+.-.|++.+++++|||.+.| +
T Consensus 571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 69999999999999999999999999999887653 348999999999999999999999999999999999999977 5
Q ss_pred hhhHH-h--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeeccccccccccccCCcccc
Q 014911 81 LFNKI-A--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 81 L~~~i-~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
....| . .|++++...+.++.||+.||.|||.+||+|+||||||||+.... .+||||||+|++... .....+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhhhh
Confidence 55555 3 38999999999999999999999999999999999999997654 599999999997654 344567
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC--C--CCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--W--FSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~li~~~ 230 (416)
..|||.|+|||++..++|+ ..-|+||.|||+|.-|+|..||.... ++-..|.+..+-+|+ | +|+++.+||..+
T Consensus 726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 8899999999999999997 78999999999999999999997754 456677777776664 3 899999999999
Q ss_pred cCCCCCCcCCHHHHhcCcccccc
Q 014911 231 LDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
|+..-.+|+|+++.+.|||+++.
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.56 Aligned_cols=250 Identities=34% Similarity=0.604 Sum_probs=233.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||-|+||.|=++........+|+|++++..+.+..+.+.+..|-.||..++.|.||++|-.|.+...+|++||-|-||+
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 58999999999999865555699999999888888888999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|+..+.. |.|.+..++.|+..+++|++|||++||++|||||||+++|.+|-+||.|||+|.... ......|+||||
T Consensus 507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~KTwTFcGTp 583 (732)
T KOG0614|consen 507 LWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGRKTWTFCGTP 583 (732)
T ss_pred hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---cCCceeeecCCc
Confidence 9999975 899999999999999999999999999999999999999999999999999998644 456778999999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
.|+|||++..++++ .++|.||||+++||||+|.+||.+.+++..|..|.+|- +.+|..++..+.+||+++...+|.+
T Consensus 584 EYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~E 662 (732)
T KOG0614|consen 584 EYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTE 662 (732)
T ss_pred ccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHh
Confidence 99999999999997 89999999999999999999999999999999999884 6789999999999999999999999
Q ss_pred cCC-----HHHHhcCccccccC
Q 014911 238 RIA-----ISKIMESSWFKKSA 254 (416)
Q Consensus 238 R~s-----~~eil~hp~f~~~~ 254 (416)
|.. +.+|.+|.||....
T Consensus 663 RLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 663 RLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred hhccccCChHHHHhhhhhhcCC
Confidence 986 89999999997643
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=344.72 Aligned_cols=250 Identities=27% Similarity=0.496 Sum_probs=214.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||||++|++
T Consensus 29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred cccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 4899999999999999999999999986432 2345678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+++++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ........|++.
T Consensus 106 L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~ 183 (292)
T cd06658 106 LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPY 183 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccCceeecCcc
Confidence 999998888999999999999999999999999999999999999999999999999998643321 222344578999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+..++..+.+++.+||..||.+
T Consensus 184 y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 262 (292)
T cd06658 184 WMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262 (292)
T ss_pred ccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhH
Confidence 999999977666 489999999999999999999998877665555544322 2223347889999999999999999
Q ss_pred cCCHHHHhcCccccccCcc
Q 014911 238 RIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~~ 256 (416)
|||++++++||||....++
T Consensus 263 Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 263 RATAQELLQHPFLKLAGPP 281 (292)
T ss_pred CcCHHHHhhChhhhccCCc
Confidence 9999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=336.81 Aligned_cols=248 Identities=28% Similarity=0.486 Sum_probs=210.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc---chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI---KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||.|+||+||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+++||++
T Consensus 7 ~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (265)
T cd06631 7 VLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85 (265)
T ss_pred eEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCC
Confidence 489999999999986 58899999998754321 12334678999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc----cCCcc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK----QDGLL 152 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~----~~~~~ 152 (416)
|++|.+++.+ +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 86 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (265)
T cd06631 86 GGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165 (265)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccc
Confidence 9999999976 779999999999999999999999999999999999999999999999999987542211 11223
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITK 229 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~ 229 (416)
....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++.++.++|++
T Consensus 166 ~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 244 (265)
T cd06631 166 KSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTS 244 (265)
T ss_pred cccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHH
Confidence 34568999999999987666 48899999999999999999999876655444343332 234566789999999999
Q ss_pred ccCCCCCCcCCHHHHhcCccc
Q 014911 230 LLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f 250 (416)
||+.+|.+|||+.++++||||
T Consensus 245 ~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 245 CLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=344.50 Aligned_cols=253 Identities=32% Similarity=0.637 Sum_probs=216.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++.+|+||||++|++
T Consensus 8 ~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (305)
T cd05609 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGD 87 (305)
T ss_pred EeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 38999999999999999999999999876654333455678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc------------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK------------ 147 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~------------ 147 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 167 (305)
T cd05609 88 CATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167 (305)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccc
Confidence 9999976 779999999999999999999999999999999999999999999999999876311000
Q ss_pred -cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC---CCCHHH
Q 014911 148 -QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP---WFSSEA 223 (416)
Q Consensus 148 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~ 223 (416)
.........+++.|+|||.+....+ +.++|+|||||++|+|++|..||.+.+.......+..+....|. .++.++
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (305)
T cd05609 168 TREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADA 246 (305)
T ss_pred hhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHH
Confidence 0011123467889999999877665 58999999999999999999999988877777777766544332 578999
Q ss_pred HHHHHHccCCCCCCcCC---HHHHhcCccccccC
Q 014911 224 RRLITKLLDPNPNSRIA---ISKIMESSWFKKSA 254 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s---~~eil~hp~f~~~~ 254 (416)
.++|.+||+.||.+||| +.++++||||....
T Consensus 247 ~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 247 QDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred HHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 99999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=338.05 Aligned_cols=250 Identities=30% Similarity=0.536 Sum_probs=209.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-------VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 73 (416)
.||.|+||+||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (272)
T cd06629 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFL 87 (272)
T ss_pred eecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEE
Confidence 4899999999999999999999999886432211 123457889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 74 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 74 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus 88 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 167 (272)
T cd06629 88 EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167 (272)
T ss_pred ecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccccccc
Confidence 99999999999976 78999999999999999999999999999999999999999999999999998754332222223
Q ss_pred cccccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCC----CCCHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPP----WFSSEARR 225 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~s~~~~~ 225 (416)
....|+..|+|||.+.... ..+.++|+||||+++|++++|..||...+.......+... ....|. .++..+.+
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (272)
T cd06629 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALD 247 (272)
T ss_pred ccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHH
Confidence 4456899999999987654 2358899999999999999999999776554444333222 222332 35889999
Q ss_pred HHHHccCCCCCCcCCHHHHhcCccc
Q 014911 226 LITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
+|.+||.++|.+|||+.++++||||
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 248 FLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHhcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.01 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=205.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+||||++++.
T Consensus 8 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 489999999999999999999999998654322 1233567899999999999999999999999999999999999988
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .......++.
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~ 164 (286)
T cd07847 87 LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATR 164 (286)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccccCccccc
Confidence 8887755 579999999999999999999999999999999999999999999999999987543321 1223445788
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------CCCC----
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FKCP---- 216 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~p---- 216 (416)
.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+..+....+.... ...|
T Consensus 165 ~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd07847 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPET 244 (286)
T ss_pred ccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCccc
Confidence 99999998765545689999999999999999999998766543332221100 0001
Q ss_pred --------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 217 --------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 217 --------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
+.++..+.+||.+||++||++|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 245 REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=340.73 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=209.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+||+ |++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred ecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 489999999999999999999999999765432 244567889999999999999999999999999999999999 999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........ .......|+
T Consensus 85 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~ 163 (286)
T cd07832 85 LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVAT 163 (286)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCc
Confidence 9999864 5699999999999999999999999999999999999999999999999999875433211 223445789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------CC-----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FK----- 214 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~----- 214 (416)
+.|+|||.+......+.++||||+||++|+|++|.+||.+.+....+..+.... ..
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd07832 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESK 243 (286)
T ss_pred ccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCC
Confidence 999999998765555689999999999999999999998776555444433210 00
Q ss_pred ------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 215 ------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 215 ------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
..+..+..+.+||.+||++||.+|||++++++||||.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 244 PIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0123578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=343.30 Aligned_cols=248 Identities=28% Similarity=0.497 Sum_probs=214.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.....+|+|+||++|++
T Consensus 26 ~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 38999999999999999999999999965432 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|..++....+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... .......+++.
T Consensus 103 L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~ 180 (296)
T cd06655 103 LTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPY 180 (296)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccCCCcCCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999887433221 12234568999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...|..+++.+.++|.+||..||.+
T Consensus 181 y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 259 (296)
T cd06655 181 WMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259 (296)
T ss_pred ccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhh
Confidence 999999877665 489999999999999999999998877655444444332 2345668899999999999999999
Q ss_pred cCCHHHHhcCccccccC
Q 014911 238 RIAISKIMESSWFKKSA 254 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~ 254 (416)
|||+.+++.||||+...
T Consensus 260 Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 260 RGSAKELLQHPFLKLAK 276 (296)
T ss_pred CCCHHHHhhChHhhhcc
Confidence 99999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.53 Aligned_cols=244 Identities=27% Similarity=0.447 Sum_probs=204.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe------CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS------KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~------~~~~~lV~ 73 (416)
.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. ...+|++|
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred heeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 4899999999999999999999999986543 2235788999999998 79999999999865 35689999
Q ss_pred eccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC
Q 014911 74 DLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 74 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 89 e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~--~~ 166 (272)
T cd06637 89 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VG 166 (272)
T ss_pred EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc--cc
Confidence 99999999999875 35899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccccCCCCCchHHhhhc----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHH
Q 014911 151 LLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--KCPPWFSSEAR 224 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 224 (416)
......|++.|+|||++... ...+.++|+||+||++|+|++|..||...........+..... ..+..++..+.
T Consensus 167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (272)
T cd06637 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 246 (272)
T ss_pred cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHH
Confidence 33456789999999998632 1235789999999999999999999987665544444433222 22345789999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
+||.+||..||.+|||+.++++||||
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 247 SFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=359.11 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=199.0
Q ss_pred CcccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++......|+|||++.
T Consensus 99 ~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 99 SLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred eecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 3899999999999764 45678999988543 234589999999999999999999999999999999996
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++................|
T Consensus 170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~g 249 (392)
T PHA03207 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249 (392)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccccc
Confidence 588888864 6799999999999999999999999999999999999999999999999999875443222222335679
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH---HHHHHHHHh----C-------------------
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---VSMYRKIYR----G------------------- 211 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~~----~------------------- 211 (416)
|+.|+|||++....|. .++||||+||++|+|++|..||.+... ...+..+.+ .
T Consensus 250 t~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (392)
T PHA03207 250 TLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY 328 (392)
T ss_pred ccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh
Confidence 9999999999877764 899999999999999999999966431 111111111 0
Q ss_pred ------CCCCCC-----CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 212 ------DFKCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 212 ------~~~~p~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+..|+ .++.++.++|++||..||.+|||+.++|.||||.+..
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 329 AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 011111 2467889999999999999999999999999998643
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=338.27 Aligned_cols=250 Identities=27% Similarity=0.485 Sum_probs=209.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc---hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.||+|.+..+++.||+|++....... ......+.+|+.++++++||||+++++++.+.+.+++|+||++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 86 (268)
T cd06630 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA 86 (268)
T ss_pred eecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence 4899999999999999999999999997544221 2245789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeecccccccccccc--CCccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQ--DGLLH 153 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~--~~~~~ 153 (416)
|++|.+++.+ +++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........ .....
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 166 (268)
T cd06630 87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166 (268)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccc
Confidence 9999999976 6799999999999999999999999999999999999998876 599999999875443211 11122
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHH---H--hCCCCCCCCCCHHHHHHHH
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---Y--RGDFKCPPWFSSEARRLIT 228 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~~~~li~ 228 (416)
...|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+ . ......|+.+++++.+++.
T Consensus 167 ~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 245 (268)
T cd06630 167 QLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL 245 (268)
T ss_pred ccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHH
Confidence 3468899999999977665 48899999999999999999999754432222222 1 1234566778999999999
Q ss_pred HccCCCCCCcCCHHHHhcCcccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
+||+.+|.+|||+.++++||||+
T Consensus 246 ~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 246 RCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=343.80 Aligned_cols=250 Identities=29% Similarity=0.502 Sum_probs=213.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 489999999999999999999999999654332 34668899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++.+..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ........+++.
T Consensus 103 L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~ 180 (297)
T cd06656 103 LTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180 (297)
T ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--ccCcCcccCCcc
Confidence 999998888999999999999999999999999999999999999999999999999998643321 112234568999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..++..+++|+.+||..||.+
T Consensus 181 y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 259 (297)
T cd06656 181 WMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDR 259 (297)
T ss_pred ccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 999999987665 58999999999999999999999876553332222222 12345568899999999999999999
Q ss_pred cCCHHHHhcCccccccCcc
Q 014911 238 RIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~~ 256 (416)
|||+.++++||||+...+.
T Consensus 260 Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 260 RGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred CcCHHHHhcCchhcccccc
Confidence 9999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=366.40 Aligned_cols=249 Identities=28% Similarity=0.508 Sum_probs=216.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||.|+|..|....|||.+.... ....+.+..||.++++|+|.|||+++|.+..++.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5899999999999999999999999985432 2445778999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-cCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK--GRL--REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~--~~l--~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.++++. |++ +|..+-.|-+||++||.|||++.|+|||||-.|+|++ ..|.+||+|||-+.-... -.....++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999986 788 8999999999999999999999999999999999996 578999999998864332 34456788
Q ss_pred ccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCCc--HHHHHHH-HHhCCCCCCCCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRK-IYRGDFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~~--~~~~~~~-i~~~~~~~p~~~s~~~~~li~~~L 231 (416)
.||.-|||||++... .-+|.++|||||||++.||.||++||-... ...+++- ..+..+++|..+|.+++.||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999999643 234799999999999999999999997643 2233322 344567888999999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccC
Q 014911 232 DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+||.+||++.++|..||++...
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred CCCcccCccHHHhccCcccccCC
Confidence 99999999999999999998763
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.70 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=213.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|+|||+++|++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 4899999999999998999999999997654332 56789999999999999999999999999999999999999999
Q ss_pred hhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC--Ccccc
Q 014911 81 LFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLLHT 154 (416)
Q Consensus 81 L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~ 154 (416)
|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++......... .....
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (267)
T cd06610 86 LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165 (267)
T ss_pred HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccccc
Confidence 9999965 35899999999999999999999999999999999999999999999999998765443222 12344
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CC-----CCCCHHHHHHHH
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CP-----PWFSSEARRLIT 228 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~~~~~li~ 228 (416)
..|++.|+|||.+......+.++|+||+||++|+|++|..||...+....+.++...... .+ ..+++.+.+++.
T Consensus 166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06610 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245 (267)
T ss_pred ccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHH
Confidence 568999999999877644568999999999999999999999887766666555544321 11 246789999999
Q ss_pred HccCCCCCCcCCHHHHhcCccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f 250 (416)
+||..||.+|||+.++++||||
T Consensus 246 ~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 246 LCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHcCCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.21 Aligned_cols=244 Identities=26% Similarity=0.422 Sum_probs=191.4
Q ss_pred CcccCCceEEEEEEEcC--CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--SKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++. ....+|+||||+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 38999999999999653 66899999986543 2245778999999999999999999884 456889999998
Q ss_pred CCCchhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe----ccCCCeEEeecccccc
Q 014911 77 KGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAF 142 (416)
Q Consensus 77 ~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll----~~~~~~kl~DFGla~~ 142 (416)
.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 75 77777641 248899999999999999999999999999999999999 5667899999999976
Q ss_pred cccccc-CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH---------HHHHHHHh--
Q 014911 143 SEHLKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------SMYRKIYR-- 210 (416)
Q Consensus 143 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~---------~~~~~i~~-- 210 (416)
...... ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543211 112344578999999999977655578999999999999999999999653211 00000000
Q ss_pred --------------------------CCC----------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 211 --------------------------GDF----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 211 --------------------------~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.73 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=204.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+++.||+|++..... ......+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 48999999999999999999999999975532 2344678899999999999999999999999999999999999998
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|..+ ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..... ......+||+.
T Consensus 86 l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~ 158 (279)
T cd06619 86 LDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNA 158 (279)
T ss_pred hHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccccCCCCChh
Confidence 8654 4588999999999999999999999999999999999999999999999999864322 23345679999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-------HHHHHHHHhCCC-CC-CCCCCHHHHHHHHHcc
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-------VSMYRKIYRGDF-KC-PPWFSSEARRLITKLL 231 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-------~~~~~~i~~~~~-~~-p~~~s~~~~~li~~~L 231 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|..||..... ......+..... .. ...++++++++|.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (279)
T cd06619 159 YMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCM 237 (279)
T ss_pred hcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHh
Confidence 999999987765 5899999999999999999999965321 122222222221 22 2347889999999999
Q ss_pred CCCCCCcCCHHHHhcCcccccc
Q 014911 232 DPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+.||.+||+++++++||||...
T Consensus 238 ~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 238 RKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred hCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=310.12 Aligned_cols=249 Identities=33% Similarity=0.543 Sum_probs=215.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+++.||+|.++.+.. +++......+||.+|+.++|.|||+++++..++..+.+|+|||.. +|
T Consensus 10 igegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dl 87 (292)
T KOG0662|consen 10 IGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87 (292)
T ss_pred hcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HH
Confidence 8999999999999999999999999987653 345667888999999999999999999999999999999999965 78
Q ss_pred hhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
..+... |.++.+.++.++.|++.||.|||++++.|||+||.|+||+.+|.+|++|||+++.+.-. -.......-|.
T Consensus 88 kkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtl 165 (292)
T KOG0662|consen 88 KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTL 165 (292)
T ss_pred HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeee
Confidence 777764 88999999999999999999999999999999999999999999999999999865432 12344556799
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC--C---C------C---------C--
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--F---K------C---------P-- 216 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~---~------~---------p-- 216 (416)
+|++|.++.+...++...|+||.|||+.|+.. |++.|++.+..+...+|.... . . . |
T Consensus 166 wyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypat 245 (292)
T KOG0662|consen 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPAT 245 (292)
T ss_pred eccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcccc
Confidence 99999999988887899999999999999986 999999999888888875421 1 0 1 1
Q ss_pred -------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 217 -------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 217 -------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
|.++..-++|+.++|.-+|.+|++++.+++||||.+..
T Consensus 246 tswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 246 TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 11345578999999999999999999999999998654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.47 Aligned_cols=249 Identities=29% Similarity=0.508 Sum_probs=207.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 76 (416)
+||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...+++++||+
T Consensus 9 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~ 88 (266)
T cd06651 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYM 88 (266)
T ss_pred eecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCC
Confidence 489999999999999999999999998755322 12345678899999999999999999998865 46889999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc-cCCcccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK-QDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-~~~~~~~ 154 (416)
++++|.+++.. +.+++.....++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... .......
T Consensus 89 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (266)
T cd06651 89 PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168 (266)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCcccc
Confidence 99999999976 678999999999999999999999999999999999999999999999999987543211 1112233
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 232 (416)
..++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..+++.++++| +||.
T Consensus 169 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~ 246 (266)
T cd06651 169 VTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIF 246 (266)
T ss_pred CCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhc
Confidence 458899999999977655 48899999999999999999999877654444443322 3455667889999999 5777
Q ss_pred CCCCCcCCHHHHhcCcccc
Q 014911 233 PNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~ 251 (416)
.+|++|||+.++++||||+
T Consensus 247 ~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 247 VEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CChhhCcCHHHHhcCcccc
Confidence 8999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=333.78 Aligned_cols=246 Identities=34% Similarity=0.576 Sum_probs=209.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+|+||++|+
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 389999999999999999999999999765433223333445555544 4568999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++..... .....++
T Consensus 83 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~ 156 (260)
T cd05611 83 DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGT 156 (260)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCC
Confidence 99999976 6799999999999999999999999999999999999999999999999998864322 2345688
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC----PPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~~L~~d 234 (416)
+.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+....+..+..+.... +..+++++.++|.+||+.|
T Consensus 157 ~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 157 PDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred cCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 99999999987664 589999999999999999999999888877777776554433 3357899999999999999
Q ss_pred CCCcC---CHHHHhcCcccccc
Q 014911 235 PNSRI---AISKIMESSWFKKS 253 (416)
Q Consensus 235 P~~R~---s~~eil~hp~f~~~ 253 (416)
|++|| +++|+++||||.+.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 99999 55899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.33 Aligned_cols=250 Identities=27% Similarity=0.543 Sum_probs=213.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++ |||++++++++......|+||||++
T Consensus 8 ~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred heeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 48999999999999999999999999865432 234567889999999996 9999999999999999999999999
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|++|.+++..+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... .......|
T Consensus 86 ~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~ 163 (277)
T cd06917 86 GGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVG 163 (277)
T ss_pred CCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccC
Confidence 9999999988889999999999999999999999999999999999999999999999999987554322 22334568
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPW-FSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~~L~~dP 235 (416)
++.|+|||.+......+.++|+||+||++|+|++|..||...+.......+.... ..++.. ++.++.+++.+||+.||
T Consensus 164 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 243 (277)
T cd06917 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243 (277)
T ss_pred CcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence 9999999998755444689999999999999999999998877655444433322 222332 78899999999999999
Q ss_pred CCcCCHHHHhcCccccccC
Q 014911 236 NSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~~~ 254 (416)
++|||+.+++.||||+...
T Consensus 244 ~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 244 KERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ccCcCHHHHhhChHhhccc
Confidence 9999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.06 Aligned_cols=249 Identities=30% Similarity=0.451 Sum_probs=211.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+...+.+|+||||++|++
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 4899999999999999999999999986542 3445778899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|...+.+ +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ........++
T Consensus 96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~ 173 (292)
T cd06644 96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGT 173 (292)
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCC
Confidence 9888754 56899999999999999999999999999999999999999999999999987643221 1222345688
Q ss_pred CCCCchHHhhhc----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHcc
Q 014911 159 PAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLL 231 (416)
Q Consensus 159 ~~y~aPE~~~~~----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L 231 (416)
+.|+|||.+... ...+.++|+|||||++|+|++|..||...+......++..... ..|..++.++.++|.+||
T Consensus 174 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (292)
T cd06644 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTAL 253 (292)
T ss_pred ccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHh
Confidence 999999998532 2224789999999999999999999988776655555544432 335568899999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccC
Q 014911 232 DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..||++||+++++++||||....
T Consensus 254 ~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 254 DKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred cCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999997543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.14 Aligned_cols=248 Identities=27% Similarity=0.499 Sum_probs=210.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+|..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||||++|++
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 4899999999999999999999999986542 22345678899999999999999999999999999999999999999
Q ss_pred hhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAKG----RLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|..++..+ .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.... .....+.
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~----~~~~~~~ 161 (286)
T cd06622 86 LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV----ASLAKTN 161 (286)
T ss_pred HHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----CCccccC
Confidence 99888763 79999999999999999999997 599999999999999999999999999986432 1233445
Q ss_pred ccCCCCCchHHhhhcCC-----CCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHH---HHhC-CCCCCCCCCHHHHHH
Q 014911 156 CGTPAYVAPEVISKKGY-----DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK---IYRG-DFKCPPWFSSEARRL 226 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~-----~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~s~~~~~l 226 (416)
.+++.|+|||.+.+... .+.++|+||+||++|+|++|..||...+....... +..+ ....|+.+++++.++
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHH
Confidence 68899999999854332 25789999999999999999999977554443332 3333 245667789999999
Q ss_pred HHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 227 ITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 227 i~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
|.+||+.+|.+||++.++++||||....
T Consensus 242 i~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 242 VAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.78 Aligned_cols=241 Identities=20% Similarity=0.320 Sum_probs=196.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++||||+++++++...+..|+|||++. ++
T Consensus 176 ~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 176 ALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 38999999999999999999999996421 235689999999999999999999999999999999995 58
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..............+||
T Consensus 246 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT 325 (461)
T PHA03211 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325 (461)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCC
Confidence 8888864 46999999999999999999999999999999999999999999999999999765432222223346799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC--------CcHHHHHHHHHhCCC-----------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--------DNIVSMYRKIYRGDF----------------- 213 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~--------~~~~~~~~~i~~~~~----------------- 213 (416)
+.|+|||++.+..+ +.++|||||||++|+|++|..|+-. .....+.+.+.....
T Consensus 326 ~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~ 404 (461)
T PHA03211 326 VDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQY 404 (461)
T ss_pred cCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHH
Confidence 99999999988776 4899999999999999998765422 112222222222111
Q ss_pred ------------CCCC-----CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 214 ------------KCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 214 ------------~~p~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
..+. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 405 RHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 14568999999999999999999999999999974
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=335.08 Aligned_cols=244 Identities=28% Similarity=0.433 Sum_probs=203.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+||||+++++
T Consensus 16 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred eeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 48999999999999999999999999965432 234568899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... ........|++
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~ 170 (267)
T cd06646 93 LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTP 170 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--ccccCccccCc
Confidence 9998865 67999999999999999999999999999999999999999999999999998754321 11223456889
Q ss_pred CCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC-----CCCCCHHHHHHHHHccC
Q 014911 160 AYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-----PPWFSSEARRLITKLLD 232 (416)
Q Consensus 160 ~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~li~~~L~ 232 (416)
.|+|||.+.. ....+.++|+||+||++|+|++|..||...+.......+....+.. +..++..+.+||++||+
T Consensus 171 ~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 250 (267)
T cd06646 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLT 250 (267)
T ss_pred cccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhh
Confidence 9999999853 2223478999999999999999999997655433332332222222 22468899999999999
Q ss_pred CCCCCcCCHHHHhcCcc
Q 014911 233 PNPNSRIAISKIMESSW 249 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~ 249 (416)
.||.+|||++++++|+|
T Consensus 251 ~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 251 KNPKKRPTAERLLTHLF 267 (267)
T ss_pred CChhhCcCHHHHhcCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.00 Aligned_cols=246 Identities=30% Similarity=0.596 Sum_probs=214.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||++.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++...+..|+|+||+.|++
T Consensus 7 ~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 4899999999999999999999999997654322 345678999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 163 (256)
T cd08218 86 LYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIG 163 (256)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hhhhhccC
Confidence 9999864 358999999999999999999999999999999999999999999999999987543221 11223458
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. +.|..++.++.++|.+||+.+|.
T Consensus 164 ~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08218 164 TPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPR 242 (256)
T ss_pred CccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChh
Confidence 889999999877665 4889999999999999999999998887777777766654 45667899999999999999999
Q ss_pred CcCCHHHHhcCccc
Q 014911 237 SRIAISKIMESSWF 250 (416)
Q Consensus 237 ~R~s~~eil~hp~f 250 (416)
+||++.++++||||
T Consensus 243 ~Rp~~~~vl~~~~~ 256 (256)
T cd08218 243 DRPSVNSILEKNFI 256 (256)
T ss_pred hCcCHHHHhhCcCC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=335.73 Aligned_cols=249 Identities=26% Similarity=0.452 Sum_probs=214.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+||||++|++
T Consensus 11 ~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 48999999999999999999999999875432 2345788999999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 89 L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 166 (277)
T cd06640 89 ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPF 166 (277)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccccccCccc
Confidence 9999988889999999999999999999999999999999999999999999999999986543221 12233467889
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..+. ...+..++..+.+++.+||+.+|.+||
T Consensus 167 y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06640 167 WMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245 (277)
T ss_pred ccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCc
Confidence 999999877665 589999999999999999999998877665554443332 234445788999999999999999999
Q ss_pred CHHHHhcCccccccC
Q 014911 240 AISKIMESSWFKKSA 254 (416)
Q Consensus 240 s~~eil~hp~f~~~~ 254 (416)
++.++++||||....
T Consensus 246 ~~~~il~~~~~~~~~ 260 (277)
T cd06640 246 TAKELLKHKFIVKNA 260 (277)
T ss_pred CHHHHHhChHhhhcc
Confidence 999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=330.03 Aligned_cols=247 Identities=31% Similarity=0.523 Sum_probs=212.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+||+|+||+||+|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++.+...+|+++||++|
T Consensus 7 ~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (258)
T cd06632 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86 (258)
T ss_pred eeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCC
Confidence 489999999999999889999999998654321 223457789999999999999999999999999999999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++|.+++.+ +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ......|
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~ 163 (258)
T cd06632 87 GSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKG 163 (258)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCC
Confidence 999999976 568999999999999999999999999999999999999999999999999987543321 2345668
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GDFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||.+......+.++|+||+||++|+|++|..||...........+.. .....|+.+++.+.+++++||+.+|
T Consensus 164 ~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 243 (258)
T cd06632 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243 (258)
T ss_pred CcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCc
Confidence 99999999987655245899999999999999999999987665444444433 2334567789999999999999999
Q ss_pred CCcCCHHHHhcCccc
Q 014911 236 NSRIAISKIMESSWF 250 (416)
Q Consensus 236 ~~R~s~~eil~hp~f 250 (416)
.+|||+.+++.|||+
T Consensus 244 ~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 244 SLRPTAAELLEHPFV 258 (258)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.05 Aligned_cols=253 Identities=31% Similarity=0.453 Sum_probs=210.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+||+|+||.||+|.+..+|+.||||.+...... .......+.+|+.+++.++||||+++++++.+.+..|+||||+ +
T Consensus 7 ~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 85 (298)
T cd07841 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-E 85 (298)
T ss_pred eeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-C
Confidence 489999999999999999999999999766543 1233456778999999999999999999999999999999999 8
Q ss_pred CchhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|+|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .......
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 163 (298)
T cd07841 86 TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQV 163 (298)
T ss_pred CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--ccccccc
Confidence 8999999763 69999999999999999999999999999999999999999999999999987543321 2223345
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-----------------------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------------------- 213 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (416)
+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+....+.++.....
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T cd07841 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFP 243 (298)
T ss_pred cceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccC
Confidence 688899999986655556899999999999999999999987766554444432100
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCcc
Q 014911 214 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 214 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 256 (416)
......+..+.++|.+||++||++|||+.++++||||.+....
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 244 PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 0012346889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.16 Aligned_cols=246 Identities=42% Similarity=0.749 Sum_probs=221.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||.|+||.||.|.+..+++.+|+|++.............+.+|+.+++.++||||+++++.+..+..+|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 79999999999999989999999999877665555677899999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 478999999999999999999999999999999999999999999999999987543321 22344568889
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s 240 (416)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+.....+.|..++..+.++|++||..||.+|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876654 5889999999999999999999988887777788877778888889999999999999999999999
Q ss_pred H---HHHhcCccc
Q 014911 241 I---SKIMESSWF 250 (416)
Q Consensus 241 ~---~eil~hp~f 250 (416)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=336.12 Aligned_cols=249 Identities=27% Similarity=0.495 Sum_probs=215.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++||++|++
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred EeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 4899999999999999999999999885432 2234568899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ........|++.
T Consensus 103 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~ 180 (285)
T cd06648 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPY 180 (285)
T ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--CcccccccCCcc
Confidence 999998888999999999999999999999999999999999999999999999999987643321 112234568999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---CPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+...... .+..++..+.+++.+||+++|++
T Consensus 181 y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (285)
T cd06648 181 WMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQ 259 (285)
T ss_pred ccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhh
Confidence 999999977665 48999999999999999999999887776666666554322 23347889999999999999999
Q ss_pred cCCHHHHhcCccccccCc
Q 014911 238 RIAISKIMESSWFKKSAP 255 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~ 255 (416)
|||+.++++||||+...+
T Consensus 260 Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 260 RATAAELLNHPFLAKAGP 277 (285)
T ss_pred CcCHHHHccCcccccCCC
Confidence 999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.94 Aligned_cols=250 Identities=31% Similarity=0.478 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++||||+++++++... +.+|+||||+.+
T Consensus 14 ~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (309)
T cd07845 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92 (309)
T ss_pred eeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC
Confidence 4899999999999999999999999997554322 2234566899999999999999999998755 579999999975
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .......
T Consensus 93 -~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 169 (309)
T cd07845 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKV 169 (309)
T ss_pred -CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--CCCCccc
Confidence 78888764 569999999999999999999999999999999999999999999999999987543221 1223334
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-------------------CCCCC-
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------DFKCP- 216 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~p- 216 (416)
+++.|+|||++.+....+.++||||+||++|+|++|.+||...+....+..+... .+..+
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (309)
T cd07845 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK 249 (309)
T ss_pred ccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccC
Confidence 6888999999876555568999999999999999999999988777666555431 01111
Q ss_pred ----------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 217 ----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 217 ----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.++++.+.+||.+||++||++|||+.+++.||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred CCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 23588999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=339.85 Aligned_cols=247 Identities=27% Similarity=0.460 Sum_probs=207.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++..+...|+|+||+++++
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 4899999999999999999999999986544322 345678899999999999999999999999999999999999998
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..+... +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... .......+++
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~ 164 (286)
T cd07846 87 LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATR 164 (286)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCccccee
Confidence 8887765 569999999999999999999999999999999999999999999999999987543221 2233456889
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------C-------
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------F------- 213 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~------- 213 (416)
.|+|||++.+....+.++||||+||++|+|++|.+||...........+.... .
T Consensus 165 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd07846 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244 (286)
T ss_pred eccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccC
Confidence 99999998765555689999999999999999999998765443333322100 0
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..++.++..+.+|+.+||+++|.+|||+.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=338.16 Aligned_cols=249 Identities=34% Similarity=0.654 Sum_probs=221.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+..|+||||+.++
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd05581 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87 (280)
T ss_pred eecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence 4899999999999999999999999998765544455578889999999998 999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC---------
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--------- 149 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--------- 149 (416)
+|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 88 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 167 (280)
T cd05581 88 ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167 (280)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcc
Confidence 99999977 58999999999999999999999999999999999999999999999999998755433211
Q ss_pred ---------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCC
Q 014911 150 ---------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS 220 (416)
Q Consensus 150 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 220 (416)
.......+++.|+|||++....+ +.++|+||||++++++++|..||...+....+..+.......|..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
T cd05581 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFP 246 (280)
T ss_pred ccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccC
Confidence 12233457889999999876654 58899999999999999999999988877777777777788888999
Q ss_pred HHHHHHHHHccCCCCCCcCCH----HHHhcCccc
Q 014911 221 SEARRLITKLLDPNPNSRIAI----SKIMESSWF 250 (416)
Q Consensus 221 ~~~~~li~~~L~~dP~~R~s~----~eil~hp~f 250 (416)
+.+.++|.+||+.+|.+|||+ +++++||||
T Consensus 247 ~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 247 PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=329.46 Aligned_cols=246 Identities=28% Similarity=0.520 Sum_probs=216.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++||||+++++++.+.+.++++|||++|++
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred EecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 4899999999999999999999999987655333 445678899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... .......+
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~ 163 (256)
T cd08221 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SMAETVVG 163 (256)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--ccccccCC
Confidence 9999975 358999999999999999999999999999999999999999999999999987543322 12345578
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. +.++.++.++.++|.+||..+|.
T Consensus 164 ~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08221 164 TPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPE 242 (256)
T ss_pred CccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcc
Confidence 999999999877665 4889999999999999999999999888777777766654 33456899999999999999999
Q ss_pred CcCCHHHHhcCccc
Q 014911 237 SRIAISKIMESSWF 250 (416)
Q Consensus 237 ~R~s~~eil~hp~f 250 (416)
+|||+.++++|||+
T Consensus 243 ~R~s~~~ll~~~~l 256 (256)
T cd08221 243 KRPTADEVLDQPLL 256 (256)
T ss_pred cCCCHHHHhhCcCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=377.37 Aligned_cols=250 Identities=29% Similarity=0.478 Sum_probs=206.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|++..++..||+|++...... ......+.+|+.+|+.|+||||++++++|.. ...+|+||||+.+
T Consensus 20 kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 389999999999999999999999999765433 2445778899999999999999999998854 4679999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-------CceeccCCCCcEEeccC-----------------
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-------GVYHRDLKPENLLLDED----------------- 129 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~-------gi~HrDlkp~NIll~~~----------------- 129 (416)
|+|.+++.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.+
T Consensus 99 GSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~ 178 (1021)
T PTZ00266 99 GDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178 (1021)
T ss_pred CcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCC
Confidence 999999864 5799999999999999999999984 49999999999999642
Q ss_pred CCeEEeeccccccccccccCCcccccccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHH
Q 014911 130 GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRK 207 (416)
Q Consensus 130 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~ 207 (416)
+.+||+|||++..... .......+||+.|+|||++... ...+.++||||||||||+|++|..||...+.. .+...
T Consensus 179 ~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~ 255 (1021)
T PTZ00266 179 PIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255 (1021)
T ss_pred CceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHH
Confidence 3489999999875432 2233456799999999998643 23468999999999999999999999865543 33333
Q ss_pred HHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 208 IYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 208 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+...........+.++.+||..||+.+|.+|||+.++|.|||++...
T Consensus 256 lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 256 LKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 33332222245789999999999999999999999999999997543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=335.65 Aligned_cols=244 Identities=22% Similarity=0.350 Sum_probs=208.3
Q ss_pred CcccCCceEEEEEEEcCCC-----cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++......|++|||
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred cccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 4899999999999976655 689999986443 223456789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecc
Q 014911 76 VKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 138 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFG 138 (416)
+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg 169 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFG 169 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCc
Confidence 999999999864 347888999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCC
Q 014911 139 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCP 216 (416)
Q Consensus 139 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p 216 (416)
++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 248 (283)
T cd05048 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP 248 (283)
T ss_pred ceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc
Confidence 9874432221222334457889999999877666 589999999999999998 999999888878877776654 3456
Q ss_pred CCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 217 PWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 217 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 249 EDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=331.72 Aligned_cols=249 Identities=29% Similarity=0.521 Sum_probs=208.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 76 (416)
+||+|+||+||.|.+..+|..||||.+...... .......+.+|+.+++.++||||+++++++.+ ...+|++|||+
T Consensus 9 ~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (265)
T cd06652 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM 88 (265)
T ss_pred EEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEec
Confidence 489999999999999999999999998654322 12345788999999999999999999998866 35789999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCcccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~ 154 (416)
+|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 168 (265)
T cd06652 89 PGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccccccccc
Confidence 99999999876 6789999999999999999999999999999999999999999999999999875432111 112234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 232 (416)
..|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|+.++..+.++|++||.
T Consensus 169 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06652 169 VTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV 247 (265)
T ss_pred CCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence 568999999999977665 58999999999999999999999876554444444322 234566788899999999995
Q ss_pred CCCCCcCCHHHHhcCcccc
Q 014911 233 PNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~ 251 (416)
+|++|||++++++|||+.
T Consensus 248 -~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 248 -EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -ChhhCCCHHHHhcCcccC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.42 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=213.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+||||++|++
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 38999999999999999999999999865432 2345688999999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 166 (277)
T cd06642 89 ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPF 166 (277)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCccc
Confidence 9999988889999999999999999999999999999999999999999999999999987543211 11223468889
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+..+. ...+..++.++.++|.+||+.+|.+||
T Consensus 167 y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06642 167 WMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245 (277)
T ss_pred ccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCc
Confidence 999999987665 489999999999999999999998766554444443332 233445788999999999999999999
Q ss_pred CHHHHhcCccccccC
Q 014911 240 AISKIMESSWFKKSA 254 (416)
Q Consensus 240 s~~eil~hp~f~~~~ 254 (416)
|+.++++||||..-.
T Consensus 246 ~~~~il~~~~~~~~~ 260 (277)
T cd06642 246 TAKELLKHKFITRYT 260 (277)
T ss_pred CHHHHHHhHHHHHHh
Confidence 999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=329.40 Aligned_cols=243 Identities=24% Similarity=0.433 Sum_probs=203.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4899999999999999999999999886432 23445778999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 9999865 45899999999999999999999999999999999999999999999999998643211100000111224
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
..|+|||.+....+ +.++|+|||||++|+|++ |.+||...+.......+... ....|..++..+.+|+.+||+.+|+
T Consensus 160 ~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 160 VKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred eeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 56999999877665 588999999999999997 99999877665555555443 3456677899999999999999999
Q ss_pred CcCCHHHHhc
Q 014911 237 SRIAISKIME 246 (416)
Q Consensus 237 ~R~s~~eil~ 246 (416)
+|||+.++++
T Consensus 239 ~Rps~~~~~~ 248 (252)
T cd05084 239 QRPSFSTVHQ 248 (252)
T ss_pred hCcCHHHHHH
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=331.92 Aligned_cols=245 Identities=29% Similarity=0.515 Sum_probs=205.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..|+|+||++|++
T Consensus 15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 4899999999999999999999999886543 2345678999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK--GRL--REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~--~~l--~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.. +.+ ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++...... .......
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 169 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETF 169 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccccC
Confidence 9999975 445 88889999999999999999999999999999999986 678999999998654321 1223334
Q ss_pred ccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCcHH--HHHHH-HHhCCCCCCCCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIV--SMYRK-IYRGDFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~li~~~L 231 (416)
.|++.|+|||.+.... ..+.++|+||+|+++|+|++|..||...... ..... ........|..+++++.+++.+||
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 249 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHc
Confidence 5899999999986543 2458999999999999999999999764322 12111 122334567788999999999999
Q ss_pred CCCCCCcCCHHHHhcCccc
Q 014911 232 DPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f 250 (416)
+++|.+|||+.+++.||||
T Consensus 250 ~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 250 EPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCCchhCCCHHHHHhCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.82 Aligned_cols=248 Identities=27% Similarity=0.520 Sum_probs=213.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++.+..++..|++|||+++++
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 48999999999999999999999999865432 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+.+....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ......+|++.
T Consensus 105 L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~ 182 (297)
T cd06659 105 LTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPY 182 (297)
T ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCcc
Confidence 9998887889999999999999999999999999999999999999999999999999986433211 12234678999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...+..++..+.++|.+||+.+|.+
T Consensus 183 y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 183 WMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred ccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCccc
Confidence 999999987665 589999999999999999999998777655555554332 2234457889999999999999999
Q ss_pred cCCHHHHhcCccccccC
Q 014911 238 RIAISKIMESSWFKKSA 254 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~ 254 (416)
|||+.++++||||.+..
T Consensus 262 Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 262 RATAQELLDHPFLLQTG 278 (297)
T ss_pred CcCHHHHhhChhhccCC
Confidence 99999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=328.87 Aligned_cols=242 Identities=29% Similarity=0.475 Sum_probs=208.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++......|+++||+++++
T Consensus 10 ~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4899999999999999889999999986542 15789999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++....... .......++
T Consensus 85 L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~ 162 (256)
T cd06612 85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRNTVIGT 162 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cccccccCC
Confidence 9999864 568999999999999999999999999999999999999999999999999987544321 122334578
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+... ....+..++..+.++|.+||+.||
T Consensus 163 ~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 241 (256)
T cd06612 163 PFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDP 241 (256)
T ss_pred ccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcCh
Confidence 99999999987766 48999999999999999999999876655443333222 223445678899999999999999
Q ss_pred CCcCCHHHHhcCccc
Q 014911 236 NSRIAISKIMESSWF 250 (416)
Q Consensus 236 ~~R~s~~eil~hp~f 250 (416)
++|||+.+++.||||
T Consensus 242 ~~Rps~~~il~~~~~ 256 (256)
T cd06612 242 EERPSAIQLLQHPFI 256 (256)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=328.48 Aligned_cols=245 Identities=31% Similarity=0.506 Sum_probs=213.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++||||++|++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 4899999999999999999999999997654332 346788999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||++...... .......
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~ 162 (256)
T cd08220 86 LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---SKAYTVV 162 (256)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---ccccccc
Confidence 9999975 2489999999999999999999999999999999999998655 5799999998754322 2223456
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+. .+.+..+++++.+++.+||..||
T Consensus 163 ~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 241 (256)
T cd08220 163 GTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDP 241 (256)
T ss_pred cCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCCh
Confidence 8999999999977655 488999999999999999999999888777776666554 35567789999999999999999
Q ss_pred CCcCCHHHHhcCccc
Q 014911 236 NSRIAISKIMESSWF 250 (416)
Q Consensus 236 ~~R~s~~eil~hp~f 250 (416)
.+|||+.+++.||||
T Consensus 242 ~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 242 SKRPQLSQIMAQPIC 256 (256)
T ss_pred hhCCCHHHHhhCCCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=332.82 Aligned_cols=250 Identities=25% Similarity=0.450 Sum_probs=216.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++.+..+...|+||||+++++
T Consensus 11 ~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred eEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 389999999999999999999999998654322 345678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|.||+++.++.++|+|||++....... .......++..
T Consensus 89 l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 166 (277)
T cd06641 89 ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPF 166 (277)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999986443211 11233468889
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
|+|||.+..... +.++|+||+||++|+|++|..||...+.......+.... ...+..++.++.++|.+||+.+|.+||
T Consensus 167 y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 245 (277)
T cd06641 167 WMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245 (277)
T ss_pred ccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 999999876655 488999999999999999999998877666665554443 335567889999999999999999999
Q ss_pred CHHHHhcCccccccCc
Q 014911 240 AISKIMESSWFKKSAP 255 (416)
Q Consensus 240 s~~eil~hp~f~~~~~ 255 (416)
++.++++||||.....
T Consensus 246 ~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 246 TAKELLKHKFIVRFAK 261 (277)
T ss_pred CHHHHHhCHHHhhhhh
Confidence 9999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.29 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=199.2
Q ss_pred CcccCCceEEEEEEEcCCC-----cEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||.||+|++..+| ..||+|++...... .....+.+|+.+++.+ +||||+++++++...+..|+|||
T Consensus 45 ~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e 122 (374)
T cd05106 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122 (374)
T ss_pred eecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence 4899999999999865443 57999999755422 3456788999999999 89999999999999999999999
Q ss_pred ccCCCchhhHHhc-------------------------------------------------------------------
Q 014911 75 LVKGGELFNKIAK------------------------------------------------------------------- 87 (416)
Q Consensus 75 ~~~gg~L~~~i~~------------------------------------------------------------------- 87 (416)
|+++|+|.+++..
T Consensus 123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (374)
T cd05106 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED 202 (374)
T ss_pred hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence 9999999998843
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCc
Q 014911 88 ----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 163 (416)
Q Consensus 88 ----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 163 (416)
.++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++............+..+++.|+|
T Consensus 203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a 282 (374)
T cd05106 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMA 282 (374)
T ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeC
Confidence 1377888999999999999999999999999999999999999999999999875432211111122334567999
Q ss_pred hHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCCCCcCC
Q 014911 164 PEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPNSRIA 240 (416)
Q Consensus 164 PE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s 240 (416)
||++.+..+ +.++||||+||++|+|++ |..||............... ....|...++++.++|.+||+.||.+|||
T Consensus 283 PE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 361 (374)
T cd05106 283 PESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361 (374)
T ss_pred HHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 999977666 589999999999999997 99999876544333333333 34556778999999999999999999999
Q ss_pred HHHHhc
Q 014911 241 ISKIME 246 (416)
Q Consensus 241 ~~eil~ 246 (416)
+.++++
T Consensus 362 ~~~l~~ 367 (374)
T cd05106 362 FSQISQ 367 (374)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=331.41 Aligned_cols=242 Identities=17% Similarity=0.260 Sum_probs=204.3
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.++++++||||+++++++..++..|+||||++
T Consensus 12 ~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 4899999999999865 4567999999875432 2334678899999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+|+|.+++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+........ ......
T Consensus 90 ~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 168 (266)
T cd05064 90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSG 168 (266)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCC
Confidence 9999999865 5789999999999999999999999999999999999999999999999998764321110 111122
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+++.|+|||.+.+..+ +.++||||+||++|++++ |..||.+.+.......+..+. .+.|..++..+.+++.+||+.
T Consensus 169 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~ 247 (266)
T cd05064 169 KSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQK 247 (266)
T ss_pred CCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 34678999999987666 589999999999999775 999999888777777776553 456777899999999999999
Q ss_pred CCCCcCCHHHHhc
Q 014911 234 NPNSRIAISKIME 246 (416)
Q Consensus 234 dP~~R~s~~eil~ 246 (416)
+|.+|||+.+|++
T Consensus 248 ~p~~RP~~~~i~~ 260 (266)
T cd05064 248 ERGERPRFSQIHS 260 (266)
T ss_pred CchhCCCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=328.76 Aligned_cols=243 Identities=30% Similarity=0.484 Sum_probs=208.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.....+|++|||+.|++
T Consensus 10 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 38999999999999999999999999975532 245788999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 87 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~ 164 (262)
T cd06613 87 LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGT 164 (262)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCC
Confidence 9998865 579999999999999999999999999999999999999999999999999987544321 122345688
Q ss_pred CCCCchHHhhhc---CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHc
Q 014911 159 PAYVAPEVISKK---GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-----CPPWFSSEARRLITKL 230 (416)
Q Consensus 159 ~~y~aPE~~~~~---~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~ 230 (416)
..|+|||.+... .+ +.++|+||+||++|+|++|.+||...+.......+....+. .+..++.++.++|.+|
T Consensus 165 ~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (262)
T cd06613 165 PYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKC 243 (262)
T ss_pred ccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHH
Confidence 999999998765 45 48899999999999999999999887655544444444222 2334678899999999
Q ss_pred cCCCCCCcCCHHHHhcCcc
Q 014911 231 LDPNPNSRIAISKIMESSW 249 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~ 249 (416)
|..+|..|||+.+++.|||
T Consensus 244 l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 244 LTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred cCCChhhCCCHHHHhcCCC
Confidence 9999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=332.67 Aligned_cols=243 Identities=31% Similarity=0.518 Sum_probs=201.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASK--SKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..+++.||+|.+....... . .....+|+.+++++. ||||+++++++.+. +.+|+||||+.
T Consensus 6 ~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred eccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 4899999999999999999999999986543221 1 223457888888885 99999999999887 89999999997
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
| +|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++. +.+||+|||++..... .......
T Consensus 84 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~~~~~~ 158 (282)
T cd07831 84 M-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KPPYTEY 158 (282)
T ss_pred c-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CCCcCCC
Confidence 5 88888764 56899999999999999999999999999999999999999 9999999999875432 1222345
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC------------------CCCCC-
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------DFKCP- 216 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~~~~p- 216 (416)
.+++.|+|||.+....+.+.++|+||+||++|+|++|.+||.+.+..+....+... .+..|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcc
Confidence 68899999998866666678999999999999999999999887765544443321 11111
Q ss_pred ----------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 217 ----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 217 ----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
+.++..+.++|.+||++||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 2467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=335.67 Aligned_cols=246 Identities=29% Similarity=0.430 Sum_probs=205.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... +..|+||||+.+
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~ 90 (293)
T cd07843 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH 90 (293)
T ss_pred hhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc
Confidence 489999999999999999999999999765433 23345677899999999999999999998877 899999999975
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... .......
T Consensus 91 -~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~ 167 (293)
T cd07843 91 -DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLV 167 (293)
T ss_pred -CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--ccccccc
Confidence 89888865 458999999999999999999999999999999999999999999999999987543321 2223456
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------------------------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------------ 212 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------------ 212 (416)
+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+......++....
T Consensus 168 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (293)
T cd07843 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTK 247 (293)
T ss_pred ccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccccccc
Confidence 78899999998766555689999999999999999999998876655554432210
Q ss_pred -------CCCCCC-CCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 213 -------FKCPPW-FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 213 -------~~~p~~-~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..+|.. +++.+.++|++||+.||++|||+.|+++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 248 YPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=335.66 Aligned_cols=246 Identities=31% Similarity=0.523 Sum_probs=203.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|++..+|+.||||.+...... ......+.+|+.++++++||||+++++++.+.+..|+||||+. ++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 389999999999999999999999998654322 2334578899999999999999999999999999999999996 58
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ........+
T Consensus 85 l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 162 (284)
T cd07860 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVV 162 (284)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccccccccc
Confidence 8888754 56899999999999999999999999999999999999999999999999998643321 122233457
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------------------C------
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------F------ 213 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------~------ 213 (416)
++.|+|||.+.+....+.++|||||||++|+|+||..||...+.......+.... .
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07860 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242 (284)
T ss_pred cccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccccc
Confidence 8899999988765555688999999999999999999998765543332222100 0
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
...+.++++++++|.+||+.||.+|||+.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 243 RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=349.35 Aligned_cols=238 Identities=22% Similarity=0.385 Sum_probs=192.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|+.... ....|+.+++.++||||+++++++......|+|||++.+ +
T Consensus 73 ~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 142 (357)
T PHA03209 73 TLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-D 142 (357)
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-c
Confidence 389999999999999999999999985432 234699999999999999999999999999999999964 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........||
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt 219 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APAFLGLAGT 219 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cccccccccc
Confidence 8888764 5699999999999999999999999999999999999999999999999999874322 1223456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCC-CCCCCCcH----------HHHHHHHHh---CCCCCC--------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNI----------VSMYRKIYR---GDFKCP-------- 216 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~-~Pf~~~~~----------~~~~~~i~~---~~~~~p-------- 216 (416)
+.|+|||++.+..+ +.++||||+||++|+|+++. ++|..... ..+...+.. ....+|
T Consensus 220 ~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 298 (357)
T PHA03209 220 VETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298 (357)
T ss_pred ccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence 99999999987776 58999999999999999854 44443211 011111110 000111
Q ss_pred ----------------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 217 ----------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 217 ----------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=335.00 Aligned_cols=245 Identities=30% Similarity=0.528 Sum_probs=199.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++.+.+..|+||||+.+ +
T Consensus 12 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 489999999999999999999999998754322 2224567899999999999999999999999999999999985 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ........++
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~ 166 (291)
T cd07844 89 LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SKTYSNEVVT 166 (291)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--Cccccccccc
Confidence 9998865 46899999999999999999999999999999999999999999999999998643221 1112233568
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHhCC---------------------C---
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRGD---------------------F--- 213 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~~---------------------~--- 213 (416)
+.|+|||++.+....+.++||||+||++|+|++|..||.+.+ .......+.+.. .
T Consensus 167 ~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T cd07844 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFY 246 (291)
T ss_pred cccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccccc
Confidence 899999998765444689999999999999999999997665 222222221100 0
Q ss_pred ------CCCCCCC--HHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 ------KCPPWFS--SEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ------~~p~~~s--~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
...+.++ .++.++|.+||+++|.+|||+.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 247 PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0001234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=337.42 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=196.5
Q ss_pred CcccCCceEEEEEEEcC----------------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ----------------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 64 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 64 (416)
.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|++++||||+++++++.
T Consensus 12 ~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred EecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 48999999999998532 34579999986543 2234567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchhhHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 014911 65 SKSKIYFAMDLVKGGELFNKIAKG--------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 124 (416)
Q Consensus 65 ~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NI 124 (416)
..+..|+||||+++|+|.+++... .++...+..++.|++.||.|||++||+||||||+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Ni 169 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNC 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhhe
Confidence 999999999999999999988542 256778899999999999999999999999999999
Q ss_pred EeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc--CCCCCCCCcHH
Q 014911 125 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIV 202 (416)
Q Consensus 125 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt--G~~Pf~~~~~~ 202 (416)
|++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ +..||...+..
T Consensus 170 ll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 248 (304)
T cd05096 170 LVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQPYGELTDE 248 (304)
T ss_pred EEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCCCCCcCCHH
Confidence 999999999999999875432211112223445788999999877665 589999999999999986 67888876655
Q ss_pred HHHHHHHh--------CCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHh
Q 014911 203 SMYRKIYR--------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIM 245 (416)
Q Consensus 203 ~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil 245 (416)
.....+.. .....|+.+++.+.+|+.+||+.||.+|||+.+|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 249 QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 44433321 11234567889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.29 Aligned_cols=244 Identities=24% Similarity=0.399 Sum_probs=213.1
Q ss_pred CcccCCceEEEEEEEcCC---CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+... +..||+|++...... .....+.+|+.+++.++||||+++++++.....+++||||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 589999999999999866 899999999765432 246789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc
Q 014911 78 GGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 78 gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 147 (416)
|++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999975 568999999999999999999999999999999999999999999999999997654332
Q ss_pred cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 014911 148 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 225 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 225 (416)
.........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+++++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence 2122344567889999999877655 589999999999999999 69999998887777777654 34667888999999
Q ss_pred HHHHccCCCCCCcCCHHHHhcC
Q 014911 226 LITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~h 247 (416)
++.+||..+|.+|||+.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=331.29 Aligned_cols=236 Identities=26% Similarity=0.423 Sum_probs=197.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||.|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+..|+||||++|++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 699999999999999999999999986543221 122222222 79999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++..... .....++
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~------~~~~~~~ 169 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT------PSCYDGT 169 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC------CccCCCC
Confidence 9999976 5899999999999999999999999999999999999999998 999999999864321 2234689
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHH----HHHHHhCCCCCCCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM----YRKIYRGDFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 234 (416)
+.|+|||++.+..+ +.++|+||+||++|+|++|..||........ ...........++.+++.+.+||.+||++|
T Consensus 170 ~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 170 LDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred CcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccC
Confidence 99999999987776 4889999999999999999999976543221 112223344556678999999999999999
Q ss_pred CCCcCC-HHHHhcCccccc
Q 014911 235 PNSRIA-ISKIMESSWFKK 252 (416)
Q Consensus 235 P~~R~s-~~eil~hp~f~~ 252 (416)
|.+||+ ++++++||||..
T Consensus 249 p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 249 INYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred hhhCCchHHHHhcCCcccC
Confidence 999996 699999999963
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=333.05 Aligned_cols=243 Identities=28% Similarity=0.452 Sum_probs=202.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE------eCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA------SKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------~~~~~~lV~ 73 (416)
.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++. ..+.+|++|
T Consensus 23 ~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 4799999999999999999999999986543 2345788899999998 7999999999984 356899999
Q ss_pred eccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC
Q 014911 74 DLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 74 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~--~~ 176 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VG 176 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc--cc
Confidence 99999999999864 45889999999999999999999999999999999999999999999999998744321 12
Q ss_pred cccccccCCCCCchHHhhh-----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-C-CCCCCCHHH
Q 014911 151 LLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-K-CPPWFSSEA 223 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~ 223 (416)
......|++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||...........+..... . .+..++.++
T Consensus 177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd06636 177 RRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKF 255 (282)
T ss_pred CCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHH
Confidence 2345678999999999863 233 4789999999999999999999977655444433333221 1 123478999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.+||.+||+.||.+|||+.++++||||
T Consensus 256 ~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.47 Aligned_cols=246 Identities=31% Similarity=0.560 Sum_probs=213.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--SKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~g 78 (416)
.||.|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++. .....|++|||+++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 489999999999999999999999999765443 344567889999999999999999999775 35678999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HcCceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCH-----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH-----~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
++|.+++.. +++++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 164 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS- 164 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc-
Confidence 999999863 56899999999999999999999 9999999999999999999999999999988654322
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLI 227 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 227 (416)
.......+++.|+|||.+....+ +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++..+.+++
T Consensus 165 -~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (265)
T cd08217 165 -SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI 242 (265)
T ss_pred -ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 11334578999999999977665 4889999999999999999999998887777777776654 45667899999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccc
Q 014911 228 TKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.+||+.+|.+|||+.++++|||+
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 243 KSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=349.61 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=199.2
Q ss_pred CcccCCceEEEEEEE-----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|.+ ..++..||||++..... ....+.+.+|+.+|+.+ +||||+++++++...+..|+|||
T Consensus 42 ~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 42 TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred eecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 489999999999974 35677899999865432 23346788999999999 89999999999999999999999
Q ss_pred ccCCCchhhHHhcC------------------------------------------------------------------
Q 014911 75 LVKGGELFNKIAKG------------------------------------------------------------------ 88 (416)
Q Consensus 75 ~~~gg~L~~~i~~~------------------------------------------------------------------ 88 (416)
|++||+|.+++...
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 99999999988531
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 89 ----------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 89 ----------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................++
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 279 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCC
Confidence 3678889999999999999999999999999999999999999999999998754332211111223346
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHH-HHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+.|+|||++.+..+ +.++|||||||++|+|++ |..||...... .....+..+. ...|...+.++.+||.+||+.||
T Consensus 280 ~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 358 (375)
T cd05104 280 VKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP 358 (375)
T ss_pred cceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCCh
Confidence 67999999987766 489999999999999998 99999876543 3333343332 34456678999999999999999
Q ss_pred CCcCCHHHHhcC
Q 014911 236 NSRIAISKIMES 247 (416)
Q Consensus 236 ~~R~s~~eil~h 247 (416)
++|||+.++++.
T Consensus 359 ~~RPs~~eil~~ 370 (375)
T cd05104 359 LKRPTFKQIVQL 370 (375)
T ss_pred hHCcCHHHHHHH
Confidence 999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.63 Aligned_cols=242 Identities=31% Similarity=0.567 Sum_probs=211.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||++.+..+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++.+.+.+.+|++|||+++|+
T Consensus 7 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 48999999999999999999999999865432 2345778899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..++++.+..++.|++.||.|||++|++|+||||+||+++.++.++++|||++...... ........|
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 162 (255)
T cd08219 85 LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVG 162 (255)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccccccccC
Confidence 9998864 45899999999999999999999999999999999999999999999999998754322 122234568
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+||+.||.
T Consensus 163 ~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 241 (255)
T cd08219 163 TPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR 241 (255)
T ss_pred CccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcc
Confidence 999999999977665 5899999999999999999999999887777777766654 45667899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.+++.-
T Consensus 242 ~Rp~~~~il~~ 252 (255)
T cd08219 242 SRPSATTILSR 252 (255)
T ss_pred cCCCHHHHhhc
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=336.19 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=199.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--------EEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--------KIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--------~~~lV 72 (416)
.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++.... ..|+|
T Consensus 19 ~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 389999999999999999999999998654322 223345678999999999999999999886543 56999
Q ss_pred EeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-
Q 014911 73 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD- 149 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 149 (416)
|||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 98 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 176 (310)
T cd07865 98 FEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176 (310)
T ss_pred EcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccC
Confidence 999965 78887765 36999999999999999999999999999999999999999999999999998754332211
Q ss_pred -CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--C--------------
Q 014911 150 -GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D-------------- 212 (416)
Q Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~-------------- 212 (416)
.......++..|+|||.+.+....+.++|+||+|+++|+|++|.+||.+.+.......+... .
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T cd07865 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL 256 (310)
T ss_pred CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhh
Confidence 12234467889999999876554468999999999999999999999887654433322220 0
Q ss_pred ---CCCC-------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 213 ---FKCP-------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 213 ---~~~p-------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
...| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 257 FKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.58 Aligned_cols=245 Identities=26% Similarity=0.448 Sum_probs=204.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-----CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK-----SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-----~~~~lV~E 74 (416)
.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++... +..|+|||
T Consensus 29 ~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 29 TIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 3899999999999999999999999986532 2235678899999998 899999999998653 46899999
Q ss_pred ccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC
Q 014911 75 LVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 149 (416)
|++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 182 (291)
T cd06639 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-- 182 (291)
T ss_pred ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc--
Confidence 9999999998752 568999999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCchHHhhhcC----CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKG----YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSE 222 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~ 222 (416)
.......|++.|+|||.+.... ..+.++|+||+||++|+|++|++||...+.......+.... ...|..++..
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRS 262 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHH
Confidence 1123456889999999986432 12588999999999999999999998876655555554432 2235567789
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
+.+||.+||+.+|.+|||+.++++||||+
T Consensus 263 l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 263 FNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 99999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.89 Aligned_cols=250 Identities=26% Similarity=0.480 Sum_probs=213.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+++++
T Consensus 27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3899999999999999999999999885432 2345678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... .......|++.
T Consensus 104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 181 (292)
T cd06657 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPY 181 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCcc
Confidence 9999888889999999999999999999999999999999999999999999999999876433211 12234568999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.... ......+++.+.+++.+||+.||.+
T Consensus 182 y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 182 WMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred ccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCccc
Confidence 999999876655 589999999999999999999998876655544443322 2233457899999999999999999
Q ss_pred cCCHHHHhcCccccccCcc
Q 014911 238 RIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~~ 256 (416)
||++.+++.||||.....+
T Consensus 261 R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 261 RATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CcCHHHHhcChHHhccCCC
Confidence 9999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=329.53 Aligned_cols=244 Identities=29% Similarity=0.480 Sum_probs=204.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC------EEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS------KIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~------~~~lV~ 73 (416)
.||+|+||.||+|.+..+++.+++|++..... ..+.+.+|+.+++.+ +||||+++++++.... .+|+||
T Consensus 13 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred eecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 48999999999999999999999999875532 346788999999998 7999999999986544 589999
Q ss_pred eccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 74 DLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 74 E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-- 166 (275)
T cd06608 89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST-- 166 (275)
T ss_pred EcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc--
Confidence 99999999988753 46999999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCchHHhhhc----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCH
Q 014911 149 DGLLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSS 221 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~ 221 (416)
........|++.|+|||++... ...+.++|||||||++|+|++|..||...+.......+..... ..+..++.
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSK 246 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCH
Confidence 1223345689999999998542 2235789999999999999999999987665555555544422 22334788
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.+++||.+||..||++|||+.++++|||+
T Consensus 247 ~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 247 KFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=333.83 Aligned_cols=248 Identities=30% Similarity=0.503 Sum_probs=207.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|++|||+.++.
T Consensus 8 ~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 48999999999999999999999999865432 22445788999999999999999999999999999999999999877
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+..+..+ ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ .......+++
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~ 165 (288)
T cd07833 87 LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATR 165 (288)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCccccc
Confidence 7666654 5699999999999999999999999999999999999999999999999999876543221 1334467889
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---------------------C-----
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------F----- 213 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------~----- 213 (416)
.|+|||++......+.++|+||+|+++|+|++|.+||.+.+.......+.... .
T Consensus 166 ~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07833 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQ 245 (288)
T ss_pred CCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCC
Confidence 99999999877445689999999999999999999998765544333222100 0
Q ss_pred ------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 ------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..|..++.++.+||++||..+|++|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 246 PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.44 Aligned_cols=245 Identities=28% Similarity=0.469 Sum_probs=210.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+++||+.|++
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 38999999999999999999999999876542 2345678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||.+....... .....+
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~ 161 (265)
T cd06605 86 LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVG 161 (265)
T ss_pred HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccC
Confidence 9999975 678999999999999999999999 999999999999999999999999999987543211 122678
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-----cHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHc
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRGD-FKCPPW-FSSEARRLITKL 230 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~~ 230 (416)
++.|+|||.+.+..+ +.++|+||+||++|+|++|..||... ........+.... ...|.. ++.++.++|.+|
T Consensus 162 ~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (265)
T cd06605 162 TSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240 (265)
T ss_pred ChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHH
Confidence 899999999987765 58999999999999999999999764 2333444443332 334444 789999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccc
Q 014911 231 LDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~ 252 (416)
|..||.+|||+.+++.||||+.
T Consensus 241 l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 241 LIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred cCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=332.43 Aligned_cols=247 Identities=30% Similarity=0.449 Sum_probs=201.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE-----EEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSK-----IYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~-----~~lV~E 74 (416)
+||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.+. ||||+++++++..... .|+|||
T Consensus 8 ~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred EecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 48999999999999999999999999865432 2233467888999999995 6999999999877665 899999
Q ss_pred ccCCCchhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeeccccccccccc
Q 014911 75 LVKGGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 75 ~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~ 147 (416)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~- 164 (295)
T cd07837 87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP- 164 (295)
T ss_pred ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCC-
Confidence 9986 78888753 24799999999999999999999999999999999999998 889999999998743221
Q ss_pred cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--------------
Q 014911 148 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------------- 213 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------------- 213 (416)
........+++.|+|||++.+....+.++|+||+||++|+|++|.+||.+.+....+..+.....
T Consensus 165 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 165 -VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred -ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence 12223345788999999987654456899999999999999999999988766554444332100
Q ss_pred ---CC-----------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 214 ---KC-----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 214 ---~~-----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
.. .+.+++.+.+||.+||++||.+|||+.+++.||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 134788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=330.38 Aligned_cols=245 Identities=33% Similarity=0.527 Sum_probs=205.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|++|+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+||||+.+ +
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 489999999999999999999999999765322 2345677899999999999999999999999999999999986 8
Q ss_pred hhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ........
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~ 161 (284)
T cd07836 84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEV 161 (284)
T ss_pred HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cccccccc
Confidence 8888764 35899999999999999999999999999999999999999999999999998744321 11223456
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------------------CC----
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------FK---- 214 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------~~---- 214 (416)
+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..+....+.... ..
T Consensus 162 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07836 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241 (284)
T ss_pred ccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCC
Confidence 78999999998765555689999999999999999999998876655544432210 00
Q ss_pred -------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 215 -------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 215 -------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..+..++.+.++|.+||+.||.+||++.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 113457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=329.49 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=206.1
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+.+++.++||||+++++++......|+||||
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred hccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 48999999999998753 467899999865432 23457889999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 76 VKGGELFNKIAK---------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 76 ~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~ 169 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccc
Confidence 999999999864 23788999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCC-CCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFK-CPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~-~p~~ 218 (416)
................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+.......+..+... .|..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
T cd05049 170 RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRT 248 (280)
T ss_pred eecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 74322111111223346788999999987766 488999999999999998 99999888877777777766553 3556
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++..+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 249 CPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=329.64 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=208.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+...+.+|+||||+++++
T Consensus 12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (284)
T cd06620 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS 89 (284)
T ss_pred HcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence 4899999999999999999999999986543 22345788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++..... ......+|+
T Consensus 90 L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~~~~~~~~~ 165 (284)
T cd06620 90 LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----SIADTFVGT 165 (284)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----hccCccccC
Confidence 9999876 679999999999999999999997 6999999999999999999999999999864322 122345789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-----------HHHHHHHhCC-CCCCCC-CCHHHHH
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-----------SMYRKIYRGD-FKCPPW-FSSEARR 225 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~-~s~~~~~ 225 (416)
..|+|||.+....+ +.++|+||+||++|+|++|..||...... .....+.... ...+.. ++.++.+
T Consensus 166 ~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd06620 166 STYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244 (284)
T ss_pred cccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHH
Confidence 99999999876655 58899999999999999999999865431 2233333322 222222 7789999
Q ss_pred HHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 226 LITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
|+.+||++||.+|||+.++++||||....
T Consensus 245 li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 245 FVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=327.57 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=203.3
Q ss_pred CcccCCceEEEEEEEcCCCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------KSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~~~lV 72 (416)
+||+|+||.||+|.+..++. .+|+|.+..... .....+.+.+|+.+++.++||||+++++++.. ....+++
T Consensus 6 ~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred ccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 48999999999999877776 699998865432 23446788899999999999999999997632 2357899
Q ss_pred EeccCCCchhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 73 MDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 164 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCc
Confidence 999999999888732 3478999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHH
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEA 223 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 223 (416)
...........+++.|+|||.+....+ +.++||||+||++|+|++ |..||.+......+..+..+. .+.++.++..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd05075 165 GDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243 (272)
T ss_pred ccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 211111123346778999999977665 589999999999999999 899999887777777776654 35566788999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcC
Q 014911 224 RRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.++|.+||+.||.+|||+.+++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 244 YSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.17 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=200.7
Q ss_pred CcccCCceEEEEEEEcC--CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~ 76 (416)
.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|+||||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 86 (316)
T cd07842 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86 (316)
T ss_pred EeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence 48999999999999988 8999999999875432334456788999999999999999999999888 8899999999
Q ss_pred CCCchhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc----CCCeEEeecccccccccc
Q 014911 77 KGGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE----DGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 77 ~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~----~~~~kl~DFGla~~~~~~ 146 (416)
.+ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++......
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~ 165 (316)
T cd07842 87 EH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165 (316)
T ss_pred Cc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCC
Confidence 75 67666642 36899999999999999999999999999999999999999 899999999998764432
Q ss_pred cc-CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH---------HHHHHHh------
Q 014911 147 KQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---------MYRKIYR------ 210 (416)
Q Consensus 147 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~---------~~~~i~~------ 210 (416)
.. .......++++.|+|||++.+....+.++|||||||++|+|++|.+||.+.+... ....+..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 245 (316)
T cd07842 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT 245 (316)
T ss_pred cccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCc
Confidence 22 1122345689999999998765544689999999999999999999997644321 0000000
Q ss_pred --------------------CCCCCC-----------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 211 --------------------GDFKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 211 --------------------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.....+ ...+..+.++|.+||++||++|||+.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 246 EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=324.82 Aligned_cols=249 Identities=32% Similarity=0.550 Sum_probs=209.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++...+.+.+++|+||+++++
T Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred EeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 489999999999999999999999999766543 3467889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-c-cccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-L-LHTTCG 157 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~-~~~~~g 157 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... . .....+
T Consensus 86 L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T cd06626 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165 (264)
T ss_pred HHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcC
Confidence 9999977 468999999999999999999999999999999999999999999999999987644322111 1 224568
Q ss_pred CCCCCchHHhhhcC--CCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHhC-CCCCCCCC--CHHHHHHHHHcc
Q 014911 158 TPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG-DFKCPPWF--SSEARRLITKLL 231 (416)
Q Consensus 158 t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~-~~~~p~~~--s~~~~~li~~~L 231 (416)
++.|+|||.+.... ..+.++||||+|+++|++++|..||.... .......+..+ ....|.+. ++.+.++|.+||
T Consensus 166 ~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (264)
T cd06626 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCL 245 (264)
T ss_pred CcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHc
Confidence 89999999987654 13588999999999999999999997653 22222222222 33455554 899999999999
Q ss_pred CCCCCCcCCHHHHhcCccc
Q 014911 232 DPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f 250 (416)
+.+|.+|||+.+++.|||+
T Consensus 246 ~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 246 ESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCCcccCCCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.17 Aligned_cols=246 Identities=35% Similarity=0.608 Sum_probs=216.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|||++++++.+......++|+||++|++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 489999999999999999999999999765432 2445678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 163 (258)
T cd08215 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTV 163 (258)
T ss_pred HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecce
Confidence 9999864 569999999999999999999999999999999999999999999999999987654322 233456
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 234 (416)
.|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+.......+.... ...|..++..+.+++.+||..+
T Consensus 164 ~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 242 (258)
T cd08215 164 VGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKD 242 (258)
T ss_pred eeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 78999999999877665 488999999999999999999999887777776666553 3456678999999999999999
Q ss_pred CCCcCCHHHHhcCccc
Q 014911 235 PNSRIAISKIMESSWF 250 (416)
Q Consensus 235 P~~R~s~~eil~hp~f 250 (416)
|.+|||+.++++||||
T Consensus 243 p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 243 PEERPSIAQILQSPFI 258 (258)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.69 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=208.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++...+..|+||||+.| +
T Consensus 22 ~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~ 100 (307)
T cd06607 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-S 100 (307)
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-C
Confidence 489999999999999999999999998755444444556788999999999999999999999999999999999975 6
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++..... .....++
T Consensus 101 l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~ 174 (307)
T cd06607 101 ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGT 174 (307)
T ss_pred HHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------CCCccCC
Confidence 7676643 5799999999999999999999999999999999999999999999999999864322 2345688
Q ss_pred CCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CC-CCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KC-PPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~li~~~L~~d 234 (416)
+.|+|||++.. ....+.++||||+|+++|+|++|..||...+.......+..... .. +..++..+.++|.+||..|
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 254 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKI 254 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCC
Confidence 89999998742 23345899999999999999999999988776655544443322 22 2347889999999999999
Q ss_pred CCCcCCHHHHhcCccccccC
Q 014911 235 PNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 235 P~~R~s~~eil~hp~f~~~~ 254 (416)
|.+|||+.+++.||||....
T Consensus 255 p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 255 PQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCcCHHHHhcChhhcccC
Confidence 99999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.21 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=204.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... ...|+++||
T Consensus 12 ~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 4899999999999999999999999986422 223456678899999999999999999987544 358999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCcccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~ 154 (416)
+.+ +|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ......
T Consensus 90 ~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (336)
T cd07849 90 MET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168 (336)
T ss_pred ccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCC
Confidence 965 888888888899999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh---------------C-------C
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------------G-------D 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~---------------~-------~ 212 (416)
.+||+.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+.. . .
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (336)
T cd07849 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKS 248 (336)
T ss_pred cCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhh
Confidence 57899999999986554456899999999999999999999987654332222110 0 0
Q ss_pred C----C-----CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 F----K-----CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~----~-----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
. . ..+..++.+.++|.+||+.||.+|||+.++++||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 249 LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 0 1134678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.16 Aligned_cols=254 Identities=28% Similarity=0.385 Sum_probs=208.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh-----------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----------MMEQIKREISVMKMVKHKHIVELHEVMASKSKI 69 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 69 (416)
+||.|+||+||+|.+..+++.||||++......... ....+.+|+.+++.++||||+++++++...+..
T Consensus 16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (335)
T PTZ00024 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI 95 (335)
T ss_pred cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence 489999999999999999999999998654332200 112577999999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc-
Q 014911 70 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK- 147 (416)
Q Consensus 70 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~- 147 (416)
|+||||+. |+|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 96 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~ 174 (335)
T PTZ00024 96 NLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174 (335)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccc
Confidence 99999997 489988865 679999999999999999999999999999999999999999999999999987543110
Q ss_pred -----------cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--C-
Q 014911 148 -----------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--F- 213 (416)
Q Consensus 148 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~- 213 (416)
.........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+....+..+.... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~ 254 (335)
T PTZ00024 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPN 254 (335)
T ss_pred cccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCc
Confidence 11122334578899999998765555689999999999999999999999877665554443210 0
Q ss_pred -------------------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 214 -------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 214 -------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
...+..+..+.++|.+||+.+|.+|||+++++.||||+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 255 EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred hhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 001235788999999999999999999999999999986543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.91 Aligned_cols=246 Identities=30% Similarity=0.567 Sum_probs=211.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+...+..|+++||+++++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 4899999999999999999999999997654322 334678899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC-eEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~-~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+...... ........
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~ 163 (257)
T cd08225 86 LMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCV 163 (257)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cccccccC
Confidence 9999865 24799999999999999999999999999999999999998865 699999998754321 11223446
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP 235 (416)
|++.|+|||.+....+ +.++|+||+||++|+|++|..||...+.......+..+.. +.++.++.++.++|.+||..+|
T Consensus 164 ~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 242 (257)
T cd08225 164 GTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSP 242 (257)
T ss_pred CCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccCh
Confidence 8999999999877665 4899999999999999999999998777666666555433 3456688999999999999999
Q ss_pred CCcCCHHHHhcCccc
Q 014911 236 NSRIAISKIMESSWF 250 (416)
Q Consensus 236 ~~R~s~~eil~hp~f 250 (416)
++|||+.++++||||
T Consensus 243 ~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 243 RDRPSITSILKRPFL 257 (257)
T ss_pred hhCcCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=341.64 Aligned_cols=247 Identities=29% Similarity=0.481 Sum_probs=202.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 23 ~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 23 PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 48999999999999999999999999865432 223446778899999999999999999988543 35799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... ......
T Consensus 102 ~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---~~~~~~ 176 (353)
T cd07850 102 LMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 176 (353)
T ss_pred ccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC---CCCCCC
Confidence 9965 888887655 99999999999999999999999999999999999999999999999999875332 222344
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 212 (416)
..+++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+....+..+....
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (353)
T cd07850 177 YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR 255 (353)
T ss_pred CcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcC
Confidence 568999999999988776 489999999999999999999998766544433332100
Q ss_pred CC--------------C-------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 FK--------------C-------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~~--------------~-------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. . +...++.++++|.+||+.||.+|||+.++|.||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 256 PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred CCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 00 0 112356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.59 Aligned_cols=244 Identities=26% Similarity=0.460 Sum_probs=201.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE-----eCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA-----SKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~~~~~~lV~E 74 (416)
.||+|+||+||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .....|+|||
T Consensus 25 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 25 TIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 4899999999999999999999999885432 2235678899999999 6999999999873 4567999999
Q ss_pred ccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC
Q 014911 75 LVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 149 (416)
|++|++|.+++.. +.+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++...... .
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~ 178 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--R 178 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccC--C
Confidence 9999999988742 46899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccccCCCCCchHHhhhc----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHH
Q 014911 150 GLLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSE 222 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~ 222 (416)
.......|++.|+|||++... ...+.++||||+||++|+|++|..||...+.......+.... ...|..++..
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNE 258 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHH
Confidence 122345689999999998532 223578999999999999999999998776544443333221 2234557889
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
+.+||.+||+.||.+|||+.++++||||
T Consensus 259 ~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 259 FNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=329.52 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=204.6
Q ss_pred CcccCCceEEEEEEE-----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||++.+ ..++..+|+|.+.... ......+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 12 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred ccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 489999999999985 2356679999886432 23456789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-C-------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 76 VKGGELFNKIAK-G-------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 76 ~~gg~L~~~i~~-~-------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
+++++|.+++.. + .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 168 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccc
Confidence 999999999863 2 38999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCC
Q 014911 142 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWF 219 (416)
Q Consensus 142 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 219 (416)
...............+++.|+|||.+....+ +.++|+|||||++|+|++ |.+||...+.......+..+.. ..+..+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (288)
T cd05093 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247 (288)
T ss_pred cccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 4432111111223345778999999977655 589999999999999998 9999998887777778877653 445668
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.++.+|+.+||++||.+|||+.+++.
T Consensus 248 ~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 248 PKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=324.07 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=203.8
Q ss_pred CcccCCceEEEEEEE--cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+ ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 489999999999964 46788999999865432 2345678899999999999999999999875 4567999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Ccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 156 (416)
|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999965 67999999999999999999999999999999999999999999999999998754322111 0112223
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 234 (416)
+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+..+. .+.|..+++++.++|.+||++|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 589999999999999998 999999887777777776654 4667789999999999999999
Q ss_pred CCCcCCHHHHhc
Q 014911 235 PNSRIAISKIME 246 (416)
Q Consensus 235 P~~R~s~~eil~ 246 (416)
|.+|||+.+|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=324.59 Aligned_cols=240 Identities=24% Similarity=0.411 Sum_probs=206.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++||||+++++++...+.++++|||+++++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred ecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 4899999999999999999999999986442 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ......+
T Consensus 89 L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~ 167 (263)
T cd05052 89 LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKF 167 (263)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCC
Confidence 9999864 35889999999999999999999999999999999999999999999999998754321111 1112234
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..++..+.++|.+||+.||
T Consensus 168 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 246 (263)
T cd05052 168 PIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNP 246 (263)
T ss_pred ccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 567999999877666 488999999999999998 99999988877777777654 356677789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
++|||+.++++
T Consensus 247 ~~Rp~~~~l~~ 257 (263)
T cd05052 247 SDRPSFAEIHQ 257 (263)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=330.19 Aligned_cols=246 Identities=30% Similarity=0.499 Sum_probs=204.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++|||++++++++.+.+..|++|||+. ++
T Consensus 6 ~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred EecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 489999999999999999999999999765432 2334567889999999999999999999999999999999995 58
Q ss_pred hhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ........+
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~ 161 (283)
T cd07835 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVV 161 (283)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--ccccCcccc
Confidence 99988653 5899999999999999999999999999999999999999999999999998643221 112233456
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------------
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------------- 212 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------------- 212 (416)
++.|+|||++.+....+.++|+||+||++|+|++|.+||...+.......+.+..
T Consensus 162 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd07835 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA 241 (283)
T ss_pred ccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccc
Confidence 8899999988765444689999999999999999999998766543333322210
Q ss_pred ----CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 213 ----FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 213 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
....+.++..+.++|.+||++||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 242 RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01124467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.93 Aligned_cols=252 Identities=19% Similarity=0.355 Sum_probs=202.8
Q ss_pred cccC--CceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||.| +||+||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.++
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 5666 99999999999999999999997654332 44578999999999999999999999999999999999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-----c
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-----L 151 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-----~ 151 (416)
+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+.......... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccc
Confidence 99999875 358999999999999999999999999999999999999999999999998654221111110 0
Q ss_pred ccccccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-----------------
Q 014911 152 LHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------------- 213 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------------- 213 (416)
.....++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd08226 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244 (328)
T ss_pred cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhc
Confidence 11123566799999987642 235899999999999999999999987654433332222111
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 ------------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 ------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.+..+++.+.+||++||+.||++|||+.++++||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01123567899999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=320.91 Aligned_cols=248 Identities=31% Similarity=0.530 Sum_probs=213.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+++++||+++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred EeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 489999999999999999999999999766432 34567899999999999999999999999988 899999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+................+
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 165 (260)
T cd06606 86 GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165 (260)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCC
Confidence 999999976 4899999999999999999999999999999999999999999999999999876544322112345678
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHh--CCCCCCCCCCHHHHHHHHHccCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYR--GDFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~d 234 (416)
+..|+|||.+....+ +.++|+||+|+++|+|++|..||.... .......+.. .....|..++..+.++|.+||+.|
T Consensus 166 ~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 244 (260)
T cd06606 166 TPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244 (260)
T ss_pred CccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCC
Confidence 999999999877654 589999999999999999999998765 3333333332 334567778999999999999999
Q ss_pred CCCcCCHHHHhcCccc
Q 014911 235 PNSRIAISKIMESSWF 250 (416)
Q Consensus 235 P~~R~s~~eil~hp~f 250 (416)
|.+|||+.+++.||||
T Consensus 245 p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 245 PKKRPTADELLQHPFL 260 (260)
T ss_pred hhhCCCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=363.29 Aligned_cols=239 Identities=34% Similarity=0.566 Sum_probs=201.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEE-EEe------CCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEV-MAS------KSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~------~~~~~lV 72 (416)
+|.+|||+.||+|.+...|..||+|.+-.. ++...+.+++||++|++|+ |+|||.+++. ... .-.++|+
T Consensus 44 vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 44 VLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 478999999999999988899999988544 5567889999999999996 9999999993 211 1357899
Q ss_pred EeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCCeEEeeccccccccccc
Q 014911 73 MDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 147 (416)
||||.||.|.|++.. .+|+|.++.+||.|++.||.+||... |+|||||-|||||+.+|+.||||||.|+-.-...
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 999999999999974 56999999999999999999999998 9999999999999999999999999987322211
Q ss_pred cC--C--c---ccccccCCCCCchHHhh---hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC
Q 014911 148 QD--G--L---LHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 217 (416)
Q Consensus 148 ~~--~--~---~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 217 (416)
.. + . --....||.|+|||.+. +.+. +.|+|||+|||+||-|+...+||++.... .|..+.+.+|+
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~ 275 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFPP 275 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCCC
Confidence 00 0 0 01224699999999974 3344 69999999999999999999999987443 46778888876
Q ss_pred --CCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 218 --WFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 218 --~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.++..+.+||+.||++||.+||++.|++.+
T Consensus 276 ~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 276 FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 689999999999999999999999998865
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.22 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=203.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--------------
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-------------- 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-------------- 66 (416)
.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 12 PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 38999999999999999999999999865543 3456788999999999999999999876543
Q ss_pred CEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeeccccccccc
Q 014911 67 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~ 145 (416)
...|+||||+.+ +|.+++..+++++..++.++.|++.||.|||++|++||||||+||+++. ++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~ 167 (342)
T cd07854 89 NSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167 (342)
T ss_pred ceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCC
Confidence 368999999974 8999888888999999999999999999999999999999999999975 45789999999875432
Q ss_pred ccc-CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------------
Q 014911 146 LKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------ 212 (416)
Q Consensus 146 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------ 212 (416)
... .+......+++.|+|||.+......+.++||||+||++|+|++|..||...+.......+....
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07854 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247 (342)
T ss_pred ccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 111 1122334678899999988665555689999999999999999999998766544443332210
Q ss_pred -------------C-----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 -------------F-----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 -------------~-----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
. ...+.++.++.+||.+||++||.+|||+.+++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123467899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=349.11 Aligned_cols=230 Identities=24% Similarity=0.445 Sum_probs=206.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||.|+.|.||+|+. .++.||||.++.- -..+|+-|++|+||||+.+.+++.....+|||||||..|.|
T Consensus 132 lGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 79999999999986 6789999987422 22578889999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
...++. ..++......|..+|+.|+.|||.+.|+|||||.-||||+.+..+||+|||.+..... ......++||..
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMSFaGTVa 276 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMSFAGTVA 276 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhhhhhhHh
Confidence 999987 5699999999999999999999999999999999999999999999999999875443 245567899999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
|||||++...+. +.|+||||+||||||||||..||.+.+...++..+-.+. ++.|..+++.++=||+.||+-.|.+|
T Consensus 277 WMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 277 WMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred hhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 999999988776 499999999999999999999999988777666655543 56788999999999999999999999
Q ss_pred CCHHHHhcC
Q 014911 239 IAISKIMES 247 (416)
Q Consensus 239 ~s~~eil~h 247 (416)
||+.+|+.|
T Consensus 356 PSFrqil~H 364 (904)
T KOG4721|consen 356 PSFRQILLH 364 (904)
T ss_pred ccHHHHHHH
Confidence 999999998
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=383.26 Aligned_cols=252 Identities=33% Similarity=0.554 Sum_probs=218.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|.||.||-|.+..+|+..|+|.+...... ......+.+|..++..|+|||+|++|++-.+.+..||.||||.||+
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 489999999999999999999999998766554 3456788999999999999999999999999999999999999999
Q ss_pred hhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc--cCCccccccc
Q 014911 81 LFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK--QDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~~~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~g 157 (416)
|.+.++.|+ .+|...+.|..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|....... -++.+....|
T Consensus 1321 La~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~G 1400 (1509)
T KOG4645|consen 1321 LASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMG 1400 (1509)
T ss_pred HHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcC
Confidence 999999865 5666778888999999999999999999999999999999999999999997654432 2244567789
Q ss_pred CCCCCchHHhhhcC--CCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRG-DFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~--~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~ 233 (416)
||.|||||++.+.. -.+-++||||||||+.||+||+.||...+. -.+...+..+ .+++|..+|++.++||..||.-
T Consensus 1401 T~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~ 1480 (1509)
T KOG4645|consen 1401 TPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQ 1480 (1509)
T ss_pred CchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhc
Confidence 99999999997643 224689999999999999999999976433 3333444444 5678889999999999999999
Q ss_pred CCCCcCCHHHHhcCcccccc
Q 014911 234 NPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~R~s~~eil~hp~f~~~ 253 (416)
||++|.++.|+++|.|-+..
T Consensus 1481 dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1481 DPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred CchhhhHHHHHHHhhccccc
Confidence 99999999999999987654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.58 Aligned_cols=243 Identities=21% Similarity=0.353 Sum_probs=202.1
Q ss_pred CcccCCceEEEEEEEcCCCcE----EEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++... ..++++||+
T Consensus 14 ~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 489999999999998766664 8999986432 223456788999999999999999999998764 578999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..............
T Consensus 91 ~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 170 (316)
T cd05108 91 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170 (316)
T ss_pred CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccC
Confidence 99999999975 4688999999999999999999999999999999999999999999999999986543222111222
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 232 (416)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.|+.++.++.+++.+||.
T Consensus 171 ~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 249 (316)
T cd05108 171 GKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 249 (316)
T ss_pred CccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 334678999999987766 489999999999999997 99999887765554444333 345567889999999999999
Q ss_pred CCCCCcCCHHHHhcC
Q 014911 233 PNPNSRIAISKIMES 247 (416)
Q Consensus 233 ~dP~~R~s~~eil~h 247 (416)
.||.+|||+.+++.+
T Consensus 250 ~~p~~Rps~~~l~~~ 264 (316)
T cd05108 250 IDADSRPKFRELIIE 264 (316)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.92 Aligned_cols=249 Identities=29% Similarity=0.502 Sum_probs=211.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+|+||++|++
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred EecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 38999999999999988999999999864432 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++.+..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ........|++.
T Consensus 103 L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~ 180 (293)
T cd06647 103 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180 (293)
T ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--ccccccccCChh
Confidence 999998878999999999999999999999999999999999999999999999999988644322 122234468899
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-C--CCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-D--FKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~--~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||.+....+ +.++|+||+||++|++++|..||...+.......+... . ...+..++..++++|.+||+.+|.+
T Consensus 181 y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (293)
T cd06647 181 WMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 259 (293)
T ss_pred hcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 999999877665 58999999999999999999999877654433333222 1 2223446789999999999999999
Q ss_pred cCCHHHHhcCccccccCc
Q 014911 238 RIAISKIMESSWFKKSAP 255 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~ 255 (416)
||++.+++.||||+...+
T Consensus 260 Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 260 RGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CcCHHHHhcCHHHhcCcc
Confidence 999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=330.00 Aligned_cols=245 Identities=28% Similarity=0.439 Sum_probs=197.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++..+...|+||||+. ++
T Consensus 12 ~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 389999999999999999999999998655322 223466789999999999999999999999999999999996 57
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ........++
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~ 166 (291)
T cd07870 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQTYSSEVVT 166 (291)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CCCCCCcccc
Confidence 7776643 56889999999999999999999999999999999999999999999999998743221 1122344678
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhC-C----------------------CC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRG-D----------------------FK 214 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~-~----------------------~~ 214 (416)
+.|+|||.+.+....+.++|+||+||++|+|++|..||...+.. +....+... . ..
T Consensus 167 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T cd07870 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246 (291)
T ss_pred ccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcccc
Confidence 99999999876544457899999999999999999999765432 222111100 0 00
Q ss_pred CCC---------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 215 CPP---------WFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 215 ~p~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.+. ..++++.+++.+||+.||.+|||+.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred CCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.32 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=204.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+||.++||++...+.+ .+|+|.+.... .+...+.-+.+||..|.+|+ |.+||+|++|-..++.+|+||||-. .
T Consensus 368 ~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~ 444 (677)
T KOG0596|consen 368 QIGSGGSSKVFKVLNSDKQ-IYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-I 444 (677)
T ss_pred hhcCCCcceeeeeecCCCc-chhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-c
Confidence 3899999999999975544 55555543322 24467889999999999995 9999999999999999999999864 4
Q ss_pred chhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+|..++.++ -++...++.|..||+.|+.++|..||||.||||.|+|+ -.|.+||+|||.|.........-...+.+|
T Consensus 445 DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvG 523 (677)
T KOG0596|consen 445 DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVG 523 (677)
T ss_pred cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccC
Confidence 899999873 34445889999999999999999999999999999998 678999999999987665555556677899
Q ss_pred CCCCCchHHhhhcCCC----------CchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHhC--CCCCCCCCCHH-H
Q 014911 158 TPAYVAPEVISKKGYD----------GAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSE-A 223 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~----------~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~-~ 223 (416)
|+.|||||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|... .+++|..-+.. +
T Consensus 524 T~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~l 603 (677)
T KOG0596|consen 524 TVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDEL 603 (677)
T ss_pred cccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHH
Confidence 9999999999654432 678999999999999999999997643 44445555554 34566554444 9
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
.++++.||+.||++|||+.++|+|||++-
T Consensus 604 i~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 604 IDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99999999999999999999999999874
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=323.78 Aligned_cols=243 Identities=32% Similarity=0.559 Sum_probs=205.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|+++||+++|+
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08228 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGD 88 (267)
T ss_pred eeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCc
Confidence 48999999999999999999999999876544444556678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ......
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 166 (267)
T cd08228 89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSL 166 (267)
T ss_pred HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcC
Confidence 9988852 348999999999999999999999999999999999999999999999999987543321 122345
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc--HHHHHHHHHhCCC-CCC-CCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIYRGDF-KCP-PWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~p-~~~s~~~~~li~~~L 231 (416)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..... +.+ ..++..+.+++.+||
T Consensus 167 ~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 245 (267)
T cd08228 167 VGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245 (267)
T ss_pred CCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHC
Confidence 68899999999987666 488999999999999999999996543 3344444443332 222 357889999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
+.+|.+|||+.++++
T Consensus 246 ~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 246 YPDPDQRPDIGYVHQ 260 (267)
T ss_pred CCCcccCcCHHHHHH
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=325.28 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=203.9
Q ss_pred CcccCCceEEEEEEEcC---CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE------EEE
Q 014911 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK------IYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~------~~l 71 (416)
+||+|+||.||.|.... ++..||+|.+..+... ......+.+|+.+++.++||||+++++++..... .++
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred ccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 48999999999998764 3478999998754432 2345678999999999999999999998765443 899
Q ss_pred EEeccCCCchhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 72 AMDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+|||+++|+|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++....
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 164 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY 164 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecc
Confidence 9999999999988842 358999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 222 (416)
............++..|+|||.+....+ +.++||||+||++|+|++ |.+||.+.+....+..+..+ ....|..+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (273)
T cd05035 165 SGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDE 243 (273)
T ss_pred ccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHH
Confidence 3221111222345678999999876655 589999999999999999 99999888777777766654 34567789999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 244 LYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=327.32 Aligned_cols=243 Identities=22% Similarity=0.328 Sum_probs=206.2
Q ss_pred CcccCCceEEEEEEEcCC-----CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|.+..+ +..||||++.... .....+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05091 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89 (283)
T ss_pred HhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence 389999999999987543 5789999997543 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecc
Q 014911 76 VKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 138 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFG 138 (416)
+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg 169 (283)
T cd05091 90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLG 169 (283)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccc
Confidence 999999999842 247888899999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCC
Q 014911 139 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCP 216 (416)
Q Consensus 139 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p 216 (416)
++................+++.|+|||.+....+ +.++||||+||++|+|++ |..||.+.+.......+..... +.|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 248 (283)
T cd05091 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248 (283)
T ss_pred cccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9874432222222233456788999999976665 588999999999999998 9999998888778888776653 457
Q ss_pred CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 217 PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 217 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
..++..+.+|+.+||+.+|.+|||+.+|+.
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 249 DDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=327.91 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=204.5
Q ss_pred CcccCCceEEEEEEEc----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 4899999999999853 456789999986433 2234567889999999999999999999999999999999999
Q ss_pred CCCchhhHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecc
Q 014911 77 KGGELFNKIAK------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 138 (416)
Q Consensus 77 ~gg~L~~~i~~------------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFG 138 (416)
++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG 169 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecccc
Confidence 99999999842 237888899999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCC
Q 014911 139 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCP 216 (416)
Q Consensus 139 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p 216 (416)
+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |.+||.+.+.......+.... .+.|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd05090 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248 (283)
T ss_pred ccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9875432222222233456778999999977665 589999999999999998 999998877666666655443 4566
Q ss_pred CCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 217 PWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 217 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..+++.+.+++.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 249 EDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=322.60 Aligned_cols=247 Identities=30% Similarity=0.524 Sum_probs=213.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.++..++||||+++++++......|+||||++|++
T Consensus 8 ~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 489999999999999999999999998765432 345788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++....... .......++
T Consensus 86 L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 163 (264)
T cd06623 86 LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGT 163 (264)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Ccccceeec
Confidence 9999976 789999999999999999999999 999999999999999999999999999987543321 122345688
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---cHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHccCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGD-FKCPPW-FSSEARRLITKLLDP 233 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~~L~~ 233 (416)
..|+|||.+....+ +.++|+||||+++|+|++|..||... ........+.... ...+.. ++..+.++|.+||.+
T Consensus 164 ~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 242 (264)
T cd06623 164 VTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQK 242 (264)
T ss_pred ccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccC
Confidence 99999999877654 58999999999999999999999876 4444555554332 344555 789999999999999
Q ss_pred CCCCcCCHHHHhcCccccc
Q 014911 234 NPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 234 dP~~R~s~~eil~hp~f~~ 252 (416)
+|++|||+.++++|||++.
T Consensus 243 ~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 243 DPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ChhhCCCHHHHHhCHHHHh
Confidence 9999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=324.00 Aligned_cols=244 Identities=21% Similarity=0.326 Sum_probs=205.8
Q ss_pred CcccCCceEEEEEEEcCC---CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+..+ ...||||.+.... .......+.+|+.+++.++||||+++++.+...+..|++|||++
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred EecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 489999999999998644 4589999986543 22345678899999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...............
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (266)
T cd05033 89 NGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG 168 (266)
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCC
Confidence 9999999865 57999999999999999999999999999999999999999999999999999865421111111122
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+++.|+|||.+....+ +.++||||||+++|+|++ |..||...........+..+ ..+.|..+++.+.+++.+||+.
T Consensus 169 ~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 247 (266)
T cd05033 169 KIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQK 247 (266)
T ss_pred CCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 34678999999877665 589999999999999998 99999887777677666654 3355667899999999999999
Q ss_pred CCCCcCCHHHHhcC
Q 014911 234 NPNSRIAISKIMES 247 (416)
Q Consensus 234 dP~~R~s~~eil~h 247 (416)
+|++|||+.+++++
T Consensus 248 ~p~~Rp~~~ei~~~ 261 (266)
T cd05033 248 DRNERPTFSQIVST 261 (266)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.21 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=211.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++.+ .||||++..+.... +.++.|++|+.++++-+|.||+-+.|++..+.. .||..+|+|-+
T Consensus 399 rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS 473 (678)
T KOG0193|consen 399 RIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS 473 (678)
T ss_pred eeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence 38999999999999955 39999998877655 488999999999999999999999999988777 99999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|+.++.- -+|.....+.|++|++.|+.|||.++|+|||||..||++.+++.|||+|||+++.-.-..........-|+
T Consensus 474 LY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gs 553 (678)
T KOG0193|consen 474 LYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGS 553 (678)
T ss_pred hhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccc
Confidence 9999963 56889999999999999999999999999999999999999999999999999876666666667777899
Q ss_pred CCCCchHHhhhc--CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHcc
Q 014911 159 PAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-----CPPWFSSEARRLITKLL 231 (416)
Q Consensus 159 ~~y~aPE~~~~~--~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L 231 (416)
..|||||++... ..++..+||||+|||+|||+||.+||...+...++..+-+|... ....++.++++|+..||
T Consensus 554 ilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~ 633 (678)
T KOG0193|consen 554 LLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCW 633 (678)
T ss_pred hhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHH
Confidence 999999998632 23368999999999999999999999987777777666666432 12346779999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
.++|++||++.+||.
T Consensus 634 ~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 634 KFDREERPLFPQLLS 648 (678)
T ss_pred hcCcccCccHHHHHH
Confidence 999999999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=337.61 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=206.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~lV~E 74 (416)
.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+|+.++||||+++++++.... .+|+|||
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 48999999999999999999999999865432 2234467889999999999999999999986543 4699999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ....
T Consensus 101 ~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~ 174 (343)
T cd07880 101 FM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMTG 174 (343)
T ss_pred cC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-----Cccc
Confidence 99 77999998888899999999999999999999999999999999999999999999999999874322 1233
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
..+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+....+..+.....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07880 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254 (343)
T ss_pred cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHh
Confidence 46789999999987644456899999999999999999999987765544444332111
Q ss_pred ----------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 ----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...+.+++.+.++|.+||+.||.+|||+.+++.||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 255 LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235688899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.05 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=208.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||||+.| +|
T Consensus 29 lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 107 (313)
T cd06633 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SA 107 (313)
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CH
Confidence 89999999999999999999999999766544444556788999999999999999999999999999999999965 77
Q ss_pred hhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
.+.+.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.... ......|++
T Consensus 108 ~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~ 181 (313)
T cd06633 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTP 181 (313)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCccccc
Confidence 777754 568999999999999999999999999999999999999999999999999876321 223457899
Q ss_pred CCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCC
Q 014911 160 AYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 160 ~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP 235 (416)
.|+|||.+.. ....+.++||||+||++|+|++|..||...+.......+.....+ ..+.++..+++|+.+||+.+|
T Consensus 182 ~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 261 (313)
T cd06633 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIP 261 (313)
T ss_pred cccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCh
Confidence 9999999852 233457899999999999999999999887765555555443322 223467889999999999999
Q ss_pred CCcCCHHHHhcCccccccC
Q 014911 236 NSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~~~ 254 (416)
.+|||+.+++.||||....
T Consensus 262 ~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 262 QERPASAELLRHDFVRRDR 280 (313)
T ss_pred hhCcCHHHHhcCcccCCCc
Confidence 9999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=327.33 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=206.0
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 13 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 48999999999997642 355899998864432 22334678899999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 76 VKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+++|+|.+++.. ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~ 170 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccc
Confidence 999999999964 124567888999999999999999999999999999999999999999999987433
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.+.......+..+. ...|...++.
T Consensus 171 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd05061 171 ETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 249 (288)
T ss_pred ccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2111111122345678999999877665 589999999999999998 899999888777777666553 4556677899
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhc------Ccccccc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIME------SSWFKKS 253 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~------hp~f~~~ 253 (416)
+.+++.+||+.||++|||+.++++ ||||+..
T Consensus 250 ~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 250 VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 999999999999999999999987 8998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=328.44 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=204.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||+||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+....|+||||+.+ +
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 86 (294)
T PLN00009 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-D 86 (294)
T ss_pred EecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-c
Confidence 489999999999999999999999998654322 23446788999999999999999999999999999999999964 7
Q ss_pred hhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+.+.. . .+++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... ........
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 164 (294)
T PLN00009 87 LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEV 164 (294)
T ss_pred HHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--ccccccCc
Confidence 8877754 2 3678899999999999999999999999999999999985 456999999998643321 11223446
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---------------------C--
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------F-- 213 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------~-- 213 (416)
+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+......++.... .
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (294)
T PLN00009 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKW 244 (294)
T ss_pred eeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccC
Confidence 78999999998765545689999999999999999999998776554444432110 0
Q ss_pred ------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 ------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...+.+++.+.+++.+||+.+|.+||++.++++||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 245 PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 01234688999999999999999999999999999998643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.18 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=207.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE------EEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK------IYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~------~~lV~E 74 (416)
.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+. .|+|+|
T Consensus 22 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 22 PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 489999999999999999999999998654322 2344667889999999999999999988765544 999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+ |++|.+++..+++++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..... ....
T Consensus 101 ~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~-----~~~~ 174 (343)
T cd07851 101 LM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTG 174 (343)
T ss_pred cC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc-----cccC
Confidence 98 66999999888899999999999999999999999999999999999999999999999999875432 1344
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
..+++.|+|||.+......+.++||||+||++|+|++|+.||.+.+....+..+.....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07851 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQS 254 (343)
T ss_pred CcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHh
Confidence 56889999999987654556899999999999999999999988776655554433210
Q ss_pred ----------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 ----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.....+++.+.++|.+||+.||.+|||+.++++||||....
T Consensus 255 ~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 255 LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred ccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 01123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.29 Aligned_cols=246 Identities=30% Similarity=0.546 Sum_probs=214.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++++.+....|++|||+++++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred EEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 489999999999999999999999999776543 2456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ......+++
T Consensus 86 L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~ 163 (254)
T cd06627 86 LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTP 163 (254)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cccccccch
Confidence 9999976 7899999999999999999999999999999999999999999999999999876543221 234456899
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-RGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
.|+|||.+....+ +.++|+||+|+++|+|++|..||...+......... ......|+.++..+.+++.+||..+|++|
T Consensus 164 ~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 242 (254)
T cd06627 164 YWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLR 242 (254)
T ss_pred hhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhC
Confidence 9999999876664 589999999999999999999998766544443433 33455677789999999999999999999
Q ss_pred CCHHHHhcCccc
Q 014911 239 IAISKIMESSWF 250 (416)
Q Consensus 239 ~s~~eil~hp~f 250 (416)
||+.+++.||||
T Consensus 243 ~~~~~~l~~~~~ 254 (254)
T cd06627 243 PTAKQLLKHPWI 254 (254)
T ss_pred cCHHHHhcCCCC
Confidence 999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.11 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=205.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA----SKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lV~E~~ 76 (416)
.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++. ....+|+||||+
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 48999999999999999999999999875432 2234567788999999999999999999875 345789999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc--CCccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLH 153 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~ 153 (416)
. ++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .....
T Consensus 91 ~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 169 (334)
T cd07855 91 E-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169 (334)
T ss_pred h-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccc
Confidence 6 589888865 6699999999999999999999999999999999999999999999999999865432211 11223
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC----------------------
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---------------------- 211 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------------- 211 (416)
...|+..|+|||.+......+.++||||+||++|+|++|++||.+.+.......+...
T Consensus 170 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 249 (334)
T cd07855 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ 249 (334)
T ss_pred cccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHh
Confidence 4578999999999876444568999999999999999999999876543332221110
Q ss_pred ----CCCC-----CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 212 ----DFKC-----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 212 ----~~~~-----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.... .+..++++.++|++||+.+|.+|||+.+++.||||....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 250 NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0011 134688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.44 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=212.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..++..||+|.+.............+.+|+.+++.++|||++++++++...+..|+||||+.| +
T Consensus 32 ~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~ 110 (317)
T cd06635 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-S 110 (317)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-C
Confidence 489999999999999999999999999765444445567889999999999999999999999999999999999976 7
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+.+.. .++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... .....|+
T Consensus 111 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~ 184 (317)
T cd06635 111 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGT 184 (317)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCC
Confidence 7777643 6689999999999999999999999999999999999999999999999998764322 2345689
Q ss_pred CCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~d 234 (416)
+.|+|||.+.. .+..+.++|+||+||++|+|++|..||...+.......+...... .+..+++.++++|.+||+.+
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 264 (317)
T cd06635 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI 264 (317)
T ss_pred ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCC
Confidence 99999999842 233458899999999999999999999887766666666554332 23357889999999999999
Q ss_pred CCCcCCHHHHhcCccccccCccc
Q 014911 235 PNSRIAISKIMESSWFKKSAPKV 257 (416)
Q Consensus 235 P~~R~s~~eil~hp~f~~~~~~~ 257 (416)
|.+|||+.++++|||+....+..
T Consensus 265 p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 265 PQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred cccCcCHHHHHhChhhhccCccc
Confidence 99999999999999997655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=332.11 Aligned_cols=241 Identities=23% Similarity=0.380 Sum_probs=200.0
Q ss_pred CcccCCceEEEEEEEcCCCcE--EEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKS--MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+.+|+||||++
T Consensus 14 ~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 489999999999998877765 466665432 2234456788999999999 89999999999999999999999999
Q ss_pred CCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 78 GGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 78 gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
+++|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~ 171 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence 99999998641 4789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 218 (416)
....... ......+++.|+|||.+....+ +.++||||+||++|+|++ |.+||...+.......+..+. ...|..
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 247 (303)
T cd05088 172 RGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247 (303)
T ss_pred cccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCC
Confidence 6322111 1111224567999999877665 589999999999999998 999998887777666665442 344556
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+++++.+||.+||+.+|.+|||+.+++.+
T Consensus 248 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 248 CDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=325.44 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=203.6
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred ECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 48999999999999977 77899999885433 223345688899999999999999999999999999999999
Q ss_pred cCCCchhhHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeecccccccc
Q 014911 76 VKGGELFNKIAKG--------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~ 144 (416)
+.|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccC
Confidence 9999999998652 488999999999999999999999999999999999998765 59999999987542
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 222 (416)
.............++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (277)
T cd05036 171 RASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGP 249 (277)
T ss_pred CccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 2111111112233567999999977666 589999999999999997 99999988777766666543 34567778999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+++.+||+.+|++|||+.++++|
T Consensus 250 ~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 250 VYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=325.67 Aligned_cols=244 Identities=21% Similarity=0.290 Sum_probs=202.0
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 13 ~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 4899999999999864 2456899999854322 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 76 VKGGELFNKIAKG-----------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~~-----------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 170 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccC
Confidence 9999999998641 24677888999999999999999999999999999999999999999999986432
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... ...|..++..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (277)
T cd05062 171 ETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM 249 (277)
T ss_pred CcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 2111111122345778999999987665 589999999999999999 799999888777776665554 3556678899
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+++.+||+.||.+|||+.+++++
T Consensus 250 ~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 250 LFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.44 Aligned_cols=248 Identities=28% Similarity=0.492 Sum_probs=209.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcc--cchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV--IKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~ 76 (416)
+||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ..+++++||+
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (264)
T cd06653 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88 (264)
T ss_pred eEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence 48999999999999999999999998854321 1223456889999999999999999999998664 5689999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCcccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~ 154 (416)
+|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 89 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (264)
T cd06653 89 PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccc
Confidence 99999999876 6789999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 232 (416)
..+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.........+... ....|+.+++.+.++|.+||+
T Consensus 169 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~ 247 (264)
T cd06653 169 VTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV 247 (264)
T ss_pred cCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc
Confidence 568999999999987665 48899999999999999999999887665555554432 245677899999999999999
Q ss_pred CCCCCcCCHHHHhcCccc
Q 014911 233 PNPNSRIAISKIMESSWF 250 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f 250 (416)
+|..|||+.+++.|||.
T Consensus 248 -~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 248 -EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -CcccCccHHHHhcCCCC
Confidence 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=325.96 Aligned_cols=248 Identities=23% Similarity=0.417 Sum_probs=199.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|++..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++...+..|++|||++ |
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 3899999999999999999999999987654322 22345556664 677799999999999999999999999997 4
Q ss_pred chhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 80 ELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 80 ~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
+|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... .....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~---~~~~~ 161 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKT 161 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc---ccccc
Confidence 77776643 3689999999999999999999998 999999999999999999999999999875432 11223
Q ss_pred ccccCCCCCchHHhhhc---CCCCchhhHHHHHHHHHHHhcCCCCCCCC-cHHHHHHHHHhC-CCCCC-CCCCHHHHHHH
Q 014911 154 TTCGTPAYVAPEVISKK---GYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRG-DFKCP-PWFSSEARRLI 227 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~-~~~~p-~~~s~~~~~li 227 (416)
...++..|+|||.+.+. ...+.++|+||+||++|+|++|..||... +.......+..+ ....| ..+|.++.++|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (283)
T cd06617 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241 (283)
T ss_pred cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 35688999999988542 12357899999999999999999999753 222223333332 23333 35789999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccccccC
Q 014911 228 TKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+||..+|.+|||+.++++||||....
T Consensus 242 ~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 242 NKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHccCChhhCcCHHHHhcCchhhhcc
Confidence 999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.21 Aligned_cols=240 Identities=24% Similarity=0.412 Sum_probs=202.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 11 ~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 11 ELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred hhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 4899999999999875 5678999998654322 3467789999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........++
T Consensus 86 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~ 164 (256)
T cd05059 86 LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFP 164 (256)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCC
Confidence 9999864 568999999999999999999999999999999999999999999999999987432211 0011111234
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
..|+|||.+.+..+ +.++|+||+||++|+|++ |..||...+.......+..+ ....|..++..+.+++.+||..+|+
T Consensus 165 ~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 243 (256)
T cd05059 165 VKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPE 243 (256)
T ss_pred ccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChh
Confidence 57999999987666 489999999999999999 89999887777777776654 3456677899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.++++.
T Consensus 244 ~Rpt~~~~l~~ 254 (256)
T cd05059 244 DRPAFKKLLSQ 254 (256)
T ss_pred hCcCHHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=326.82 Aligned_cols=253 Identities=32% Similarity=0.596 Sum_probs=212.4
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||.|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+.+++.+......|+||||
T Consensus 7 ~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (290)
T cd05613 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86 (290)
T ss_pred eeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEec
Confidence 4899999999999875 47899999999764332 223456788999999999 599999999999999999999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....... ......
T Consensus 87 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 165 (290)
T cd05613 87 INGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYS 165 (290)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-cccccc
Confidence 999999999875 678999999999999999999999999999999999999999999999999987543221 122334
Q ss_pred cccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 155 TCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
..|++.|+|||.+... ...+.++||||+|+++|+|++|..||... ....+...+.....+.|..+++.+.+++.+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 245 (290)
T cd05613 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQR 245 (290)
T ss_pred ccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHH
Confidence 5689999999998653 23357899999999999999999999743 233444555555666777899999999999
Q ss_pred ccCCCCCCcC-----CHHHHhcCccccccC
Q 014911 230 LLDPNPNSRI-----AISKIMESSWFKKSA 254 (416)
Q Consensus 230 ~L~~dP~~R~-----s~~eil~hp~f~~~~ 254 (416)
||+.||.+|| ++.+++.||||+...
T Consensus 246 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 246 LLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.93 Aligned_cols=239 Identities=23% Similarity=0.421 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..|+||||++||+
T Consensus 11 ~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 11 ELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 3899999999999874 456899998864432 23578899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....... .......++
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~ 164 (256)
T cd05114 86 LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFP 164 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCc
Confidence 9999864 5689999999999999999999999999999999999999999999999998874322111 011122345
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
..|+|||.+....+ +.++|+||+|+++|+|++ |..||...+.......+..+. ...|...+..+.+++.+||+.+|.
T Consensus 165 ~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~ 243 (256)
T cd05114 165 VKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPE 243 (256)
T ss_pred hhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcc
Confidence 67999999977666 489999999999999999 999999988877777777654 334566788999999999999999
Q ss_pred CcCCHHHHhc
Q 014911 237 SRIAISKIME 246 (416)
Q Consensus 237 ~R~s~~eil~ 246 (416)
+|||+.++++
T Consensus 244 ~Rps~~~l~~ 253 (256)
T cd05114 244 GRPTFAELLR 253 (256)
T ss_pred cCcCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=326.40 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=200.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++|||+.+
T Consensus 11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 489999999999999999999999998755432 34567889999999996 99999999999999999999999865
Q ss_pred chhh---HHh---cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 80 ELFN---KIA---KGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 80 ~L~~---~i~---~~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
++.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++..... ....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc---CCcc
Confidence 4443 322 25799999999999999999999975 999999999999999999999999999864332 1222
Q ss_pred cccccCCCCCchHHhhhc--CCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCC-CC----CCCCCHHHH
Q 014911 153 HTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDF-KC----PPWFSSEAR 224 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~-~~----p~~~s~~~~ 224 (416)
....|++.|+|||++... ...+.++||||+||++|+|++|..||..... ......+..+.. .. +..++..+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHH
Confidence 344689999999999765 2446899999999999999999999976542 122222222221 12 223788999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+||++||.+|||+.++++||||+..
T Consensus 245 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 245 NFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 99999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=337.10 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=203.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
.||+|+||+||+|++..+++.||||.+....... .....+.+|+.+++.++||||+++++++... ...|+|+||
T Consensus 12 ~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 4899999999999999999999999987543222 2345677899999999999999999987644 358999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+. ++|.+++.. +++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ......
T Consensus 91 ~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 167 (337)
T cd07858 91 MD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK--GDFMTE 167 (337)
T ss_pred CC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC--cccccc
Confidence 96 589888865 67999999999999999999999999999999999999999999999999998754321 123345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh-----------------------C
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----------------------G 211 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-----------------------~ 211 (416)
..++..|+|||.+......+.++|+||+||++|+|++|.+||.+.+.......+.. .
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (337)
T cd07858 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247 (337)
T ss_pred cccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh
Confidence 56899999999987644456899999999999999999999987654332222211 0
Q ss_pred C--------CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 212 D--------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 212 ~--------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
. ....+.+++++.+||++||++||.+|||+.++++||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 01124578999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.84 Aligned_cols=247 Identities=31% Similarity=0.531 Sum_probs=212.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++||||+++++.+...+..|+++||++|++
T Consensus 26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred hccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 48999999999999988999999999975432 35678899999999999999999999999999999999999999
Q ss_pred hhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 102 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 179 (286)
T cd06614 102 LTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGT 179 (286)
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhccccCC
Confidence 99999874 79999999999999999999999999999999999999999999999999876433221 122344578
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP 235 (416)
+.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..... ..+..++..+.++|.+||+.+|
T Consensus 180 ~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 258 (286)
T cd06614 180 PYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDP 258 (286)
T ss_pred cccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccCh
Confidence 89999999887666 4889999999999999999999988776555555443322 2233378999999999999999
Q ss_pred CCcCCHHHHhcCccccccC
Q 014911 236 NSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~~~ 254 (416)
.+|||+.++++||||....
T Consensus 259 ~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 259 EKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred hhCcCHHHHhhChHhhccC
Confidence 9999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=324.20 Aligned_cols=248 Identities=30% Similarity=0.457 Sum_probs=204.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~g 78 (416)
.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++++.. .+.+|+||||++|
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 38999999999999999999999999975432 2345778999999999999999999998854 4579999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||++..... ....
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~----~~~~ 161 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN----SLAG 161 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc----cccc
Confidence 999887642 4589999999999999999999999999999999999999999999999999864322 1122
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-----cHHHHHHHHHhCCC-CCC------CCCCH
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRGDF-KCP------PWFSS 221 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~~~-~~p------~~~s~ 221 (416)
...++..|+|||.+.+..+ +.++|+|||||++|+|++|..||... ...+....+..... ..+ ..+++
T Consensus 162 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240 (287)
T ss_pred cccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHH
Confidence 4467889999999977766 48999999999999999999999865 22333333333211 111 12467
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
.+.++|.+||..+|.+|||+.|+++||||+....
T Consensus 241 ~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 8999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.97 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=203.1
Q ss_pred CcccCCceEEEEEEEcCCC---cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 4899999999999876554 78999999765533 34567889999999999999999999876 456899999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-ccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 155 (416)
+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 9999999976 569999999999999999999999999999999999999999999999999987543221110 01111
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.++..|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+.... .+.|..++..++++|.+||.+
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 237 (257)
T cd05060 159 RWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY 237 (257)
T ss_pred cccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence 23467999999977665 589999999999999998 999999887777666665543 466778899999999999999
Q ss_pred CCCCcCCHHHHhc
Q 014911 234 NPNSRIAISKIME 246 (416)
Q Consensus 234 dP~~R~s~~eil~ 246 (416)
+|++|||+.++++
T Consensus 238 ~p~~Rp~~~~l~~ 250 (257)
T cd05060 238 RPEDRPTFSELES 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.41 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=201.6
Q ss_pred CcccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999765 455679999986543 2344567899999999999999999999875 4578999999999
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCc-cccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTT 155 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 155 (416)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999863 5799999999999999999999999999999999999999999999999999874432211111 1112
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+++.|+|||.+....+ +.++|||||||++|++++ |..||.+.........+..+. ...|+..++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23578999999876665 589999999999999996 999999887777766666543 566778899999999999999
Q ss_pred CCCCcCCHHHHhc
Q 014911 234 NPNSRIAISKIME 246 (416)
Q Consensus 234 dP~~R~s~~eil~ 246 (416)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.06 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=204.8
Q ss_pred CcccCCceEEEEEEEcCC-----CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 489999999999988644 3789999986443 223345788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 76 VKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhc
Confidence 999999999853 236788999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 222 (416)
............++..|+|||.+....+ +.++|||||||++|++++ |..||.+.+.......+..+ ....|..++..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (277)
T cd05032 171 ETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDK 249 (277)
T ss_pred cCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 3222222234456788999999876655 589999999999999998 99999888777766666644 34567778999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.++|.+||+.+|++|||+.++++
T Consensus 250 ~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 250 LLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.02 Aligned_cols=243 Identities=31% Similarity=0.559 Sum_probs=205.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|++..+|+.+|||.+.............+.+|+.+++.++||||+++++++...+..|++|||++|++
T Consensus 9 ~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08229 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 88 (267)
T ss_pred hhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCC
Confidence 48999999999999999999999998876554444455788899999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... .......
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 166 (267)
T cd08229 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSL 166 (267)
T ss_pred HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--Ccccccc
Confidence 9998852 45899999999999999999999999999999999999999999999999998754322 1223445
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH--HHHHHHHHhCCC-CC-CCCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI--VSMYRKIYRGDF-KC-PPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~~~~li~~~L 231 (416)
.|++.|+|||.+....+ +.++|+||+|+++|+|++|..||.+... ......+..... +. +..+++.+.++|.+||
T Consensus 167 ~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (267)
T cd08229 167 VGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245 (267)
T ss_pred cCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhc
Confidence 78999999999977666 4889999999999999999999976433 344444443322 22 2357899999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
+.||.+|||+.++++
T Consensus 246 ~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 246 NPDPEKRPDITYVYD 260 (267)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=324.06 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=206.6
Q ss_pred cccCCceEEEEEEEcCCCc----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 76 (416)
||+|+||.||+|....++. .+|||.+..++.. .+.....-||+.+++.|+||||+.+..+|.+ +..+++++||+
T Consensus 32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA 110 (438)
T KOG0666|consen 32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA 110 (438)
T ss_pred ecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh
Confidence 8999999999996655433 6899999766432 2444667799999999999999999999877 78999999999
Q ss_pred CCCchhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC----CCeEEeecccccccccc
Q 014911 77 KGGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED----GNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 77 ~gg~L~~~i~~------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~----~~~kl~DFGla~~~~~~ 146 (416)
+. +|+..|.- ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+++++...
T Consensus 111 Eh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p 189 (438)
T KOG0666|consen 111 EH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP 189 (438)
T ss_pred hh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence 87 89888852 358999999999999999999999999999999999999877 89999999999987654
Q ss_pred ccCC-cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH---------HHHHHHHHh--CCC-
Q 014911 147 KQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---------VSMYRKIYR--GDF- 213 (416)
Q Consensus 147 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~---------~~~~~~i~~--~~~- 213 (416)
-..- .....+-|.||+|||.+.+...++.+.|||+.|||+.||+|-.+.|.+... .+...+|.. |..
T Consensus 190 lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt 269 (438)
T KOG0666|consen 190 LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPT 269 (438)
T ss_pred ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCc
Confidence 3222 345567799999999999998889999999999999999999998865321 122333322 110
Q ss_pred --------CCCCC--------------------------CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCccc
Q 014911 214 --------KCPPW--------------------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 257 (416)
Q Consensus 214 --------~~p~~--------------------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 257 (416)
..|.+ -++.+.+|+.+||++||.+|+|++++|+|+||..+.-++
T Consensus 270 ~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 270 DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence 11211 145689999999999999999999999999999875543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.20 Aligned_cols=247 Identities=28% Similarity=0.522 Sum_probs=202.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----------EEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----------KIY 70 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----------~~~ 70 (416)
.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 14 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 92 (302)
T cd07864 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92 (302)
T ss_pred eecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence 4899999999999999999999999997654322 23456778999999999999999999886654 899
Q ss_pred EEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 71 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 71 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
+|+||+++ ++.+.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 93 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 171 (302)
T cd07864 93 LVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171 (302)
T ss_pred EEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc
Confidence 99999986 77777764 4699999999999999999999999999999999999999999999999999875433221
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CC------------
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DF------------ 213 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~------------ 213 (416)
.......+++.|+|||.+.+....+.++||||+||++|+|++|++||...+.......+... ..
T Consensus 172 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T cd07864 172 -RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY 250 (302)
T ss_pred -cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccc
Confidence 11223346788999999876544568999999999999999999999887665544444331 00
Q ss_pred ---------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 ---------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ---------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.....++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 251 FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=334.73 Aligned_cols=251 Identities=29% Similarity=0.415 Sum_probs=205.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK--SKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..+|+.+|+|.+....... .....+.+|+.+++++ +||||+++++++... ...|+||||+.
T Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 92 (337)
T cd07852 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME 92 (337)
T ss_pred hhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence 4899999999999999999999999886532222 2345677899999999 999999999988643 47899999997
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC---Ccccc
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---GLLHT 154 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~---~~~~~ 154 (416)
+ +|..++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .....
T Consensus 93 ~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 171 (337)
T cd07852 93 T-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171 (337)
T ss_pred c-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhc
Confidence 5 9999998778899999999999999999999999999999999999999999999999998754332211 23344
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 212 (416)
..||+.|+|||.+.+....+.++|+|||||++|+|++|+.||.+........++....
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (337)
T cd07852 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS 251 (337)
T ss_pred ccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh
Confidence 5689999999988765555689999999999999999999998765443333321110
Q ss_pred ---------CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 ---------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 ---------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
....+.++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 252 LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.51 Aligned_cols=247 Identities=30% Similarity=0.500 Sum_probs=206.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
.||.|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||||+++
T Consensus 6 ~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 6 QIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 3899999999999999999999999998664 2234456788999999999999999999999888 899999999975
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .......
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 162 (287)
T cd07840 85 -DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRV 162 (287)
T ss_pred -cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccc
Confidence 89888865 4799999999999999999999999999999999999999999999999999875543221 1223345
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-----------------------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------------------- 213 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (416)
++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07840 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242 (287)
T ss_pred cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccc
Confidence 788999999876554456899999999999999999999988776655554433100
Q ss_pred CC-------CCC-CCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 KC-------PPW-FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ~~-------p~~-~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.. ... +++.+.++|.+||+.+|.+|||+.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=347.71 Aligned_cols=234 Identities=35% Similarity=0.576 Sum_probs=206.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+|.|+||.|..+.+..+++..++|++.+.. ....+|+.++... +||||+.+++++.+....|+|||++.|+.
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred cCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 799999999999999999999999997762 2334677666555 79999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe-ccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL-DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll-~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ +..|+++|+|||.+..... ...+.|-|.
T Consensus 403 ll~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~-----~~~tp~~t~ 477 (612)
T KOG0603|consen 403 LLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER-----SCDTPALTL 477 (612)
T ss_pred HHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch-----hhcccchhh
Confidence 9999988665558888999999999999999999999999999999 5889999999999874332 155678899
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
.|.|||++...+|+ .++|+||||++||+||+|..||...... ++...+..+.+. .++|..+++||++||+.||.+|
T Consensus 478 ~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL~~dP~~R 554 (612)
T KOG0603|consen 478 QYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLLQVDPALR 554 (612)
T ss_pred cccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhccCChhhC
Confidence 99999999988885 9999999999999999999999775444 666666655444 8899999999999999999999
Q ss_pred CCHHHHhcCccc
Q 014911 239 IAISKIMESSWF 250 (416)
Q Consensus 239 ~s~~eil~hp~f 250 (416)
+++.+++.||||
T Consensus 555 l~~~~i~~h~w~ 566 (612)
T KOG0603|consen 555 LGADEIGAHPWF 566 (612)
T ss_pred cChhhhccCcch
Confidence 999999999999
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=321.12 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=200.3
Q ss_pred CcccCCceEEEEEEEcCCCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.++.++ +||||+++++++...+..|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999988876 46888775322 223456788999999999 89999999999999999999999999
Q ss_pred CCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 78 GGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 78 gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
+|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 99999998642 3788999999999999999999999999999999999999999999999997
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 218 (416)
....... .......++.|+|||++....+ +.++|+|||||++|+|++ |..||.+.+.......+..+. .+.+..
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 160 RGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred cccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 5222110 1112234567999999876665 589999999999999997 999998887777776665542 345566
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++.++.+++.+||..||.+|||+.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 7899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=324.59 Aligned_cols=243 Identities=27% Similarity=0.468 Sum_probs=200.7
Q ss_pred CcccCCceEEEEEEEc----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||.|+||.||+|... ..+..|+||++.... .....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 6 ~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 6 QIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred EEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 4899999999999987 456789999995432 2334688999999999999999999999999888899999999
Q ss_pred CCCchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 77 KGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 77 ~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
++|+|.+++... .++......++.|++.||.|||+++++|+||+|.||+++.++.+||+|||++.............
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~ 163 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS 163 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999764 79999999999999999999999999999999999999999999999999987552211112223
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 231 (416)
...+...|+|||.+....+ +.++||||||+++||+++ |..||.+.+.......+..+. ...|..++..+.++|..||
T Consensus 164 ~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~ 242 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCW 242 (259)
T ss_dssp TSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHc
Confidence 3456778999999987765 599999999999999999 789999988888777776554 4556778999999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
..||.+|||+.++++
T Consensus 243 ~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 243 SHDPEKRPSFQEILQ 257 (259)
T ss_dssp -SSGGGS--HHHHHH
T ss_pred CCChhhCcCHHHHHh
Confidence 999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.89 Aligned_cols=247 Identities=27% Similarity=0.439 Sum_probs=202.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++... ...|++++
T Consensus 24 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 24 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 389999999999999999999999998754322 22346678899999999999999999988543 34788888
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 103 ~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~ 176 (345)
T cd07877 103 LM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTG 176 (345)
T ss_pred hc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-----cccc
Confidence 87 77999988877899999999999999999999999999999999999999999999999999874321 2234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
..+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (345)
T cd07877 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256 (345)
T ss_pred cccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHH
Confidence 56899999999987644446899999999999999999999987655443333221100
Q ss_pred --CCC--------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 --KCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 --~~p--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..| ...++++.+||.+||++||.+|||+.+++.||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred hcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 001 12578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.30 Aligned_cols=239 Identities=25% Similarity=0.427 Sum_probs=205.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++......|+||||+++++
T Consensus 13 ~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 13 KLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred hhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCC
Confidence 48999999999999977 89999999865532 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ........+
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~ 166 (261)
T cd05148 89 LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VYLSSDKKI 166 (261)
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--cccccCCCC
Confidence 9999975 45899999999999999999999999999999999999999999999999998754321 111123345
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||.+....+ +.++|+||||+++|+|++ |..||...+....+..+..+ ..+.|..+++.+.+++.+||+.||
T Consensus 167 ~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 245 (261)
T cd05148 167 PYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEP 245 (261)
T ss_pred ceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCc
Confidence 678999999977665 488999999999999998 89999888777777776654 345567789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 246 ~~Rpt~~~l~~ 256 (261)
T cd05148 246 EDRPSFKALRE 256 (261)
T ss_pred hhCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=317.96 Aligned_cols=243 Identities=31% Similarity=0.576 Sum_probs=206.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++++++|+||+++++++...+..++||||++|++
T Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (267)
T cd08224 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD 88 (267)
T ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCC
Confidence 48999999999999999999999999876554444456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .......
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~ 166 (267)
T cd08224 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSL 166 (267)
T ss_pred HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--Cccccee
Confidence 9998853 45899999999999999999999999999999999999999999999999998754321 1223345
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc--HHHHHHHHHhCCC-CCCC-CCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIYRGDF-KCPP-WFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~~li~~~L 231 (416)
.+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.... .......+..+.. +.|. .++..+.++|.+||
T Consensus 167 ~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 245 (267)
T cd08224 167 VGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245 (267)
T ss_pred cCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHc
Confidence 68999999999987766 488999999999999999999996543 3344444444432 3444 68889999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
.++|.+|||+.++++
T Consensus 246 ~~~p~~Rp~~~~il~ 260 (267)
T cd08224 246 NPDPEKRPDISYVLQ 260 (267)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.42 Aligned_cols=244 Identities=30% Similarity=0.497 Sum_probs=214.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|+||+++++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 4899999999999999999999999997654332 345677889999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++...... .....
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~ 161 (256)
T cd08530 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQ 161 (256)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----Ccccc
Confidence 9998865 46899999999999999999999999999999999999999999999999998755432 33345
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~d 234 (416)
.+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. ..+..++.++++++.+||..+
T Consensus 162 ~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 162 IGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred cCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCC
Confidence 68999999999977665 4789999999999999999999999887777666665554 455668899999999999999
Q ss_pred CCCcCCHHHHhcCccc
Q 014911 235 PNSRIAISKIMESSWF 250 (416)
Q Consensus 235 P~~R~s~~eil~hp~f 250 (416)
|.+|||+.++++||+.
T Consensus 241 p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 241 PKLRPNCDKILASPAV 256 (256)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.98 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=203.5
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+. .++..+++|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 4899999999999854 3456799998854432 3346788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecc
Q 014911 76 VKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 138 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFG 138 (416)
+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg 168 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 168 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCC
Confidence 999999999854 237899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCC
Q 014911 139 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCP 216 (416)
Q Consensus 139 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p 216 (416)
++................+++.|+|||.+....+ +.++||||+||++|+|++ |..||...+.......+..+.. ..+
T Consensus 169 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T cd05094 169 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247 (291)
T ss_pred cccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCC
Confidence 9874432211112233456788999999887665 488999999999999998 9999988877777777766544 345
Q ss_pred CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 217 PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 217 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
..++..+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 248 RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=313.47 Aligned_cols=242 Identities=33% Similarity=0.535 Sum_probs=208.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++||++|++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 48999999999999998999999999976543 345788999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .....++
T Consensus 84 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~ 160 (253)
T cd05122 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGT 160 (253)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecC
Confidence 9999876 4799999999999999999999999999999999999999999999999999875443221 3456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-CCCCC--CCCCHHHHHHHHHccCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-DFKCP--PWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p--~~~s~~~~~li~~~L~~dP 235 (416)
..|+|||.+....+ +.++|+||+|+++|+|++|..||...+........... ....+ ..++..+.++|.+||+.||
T Consensus 161 ~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (253)
T cd05122 161 PYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP 239 (253)
T ss_pred CcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCCh
Confidence 99999999876654 58899999999999999999999887544433333322 22222 2348999999999999999
Q ss_pred CCcCCHHHHhcCcc
Q 014911 236 NSRIAISKIMESSW 249 (416)
Q Consensus 236 ~~R~s~~eil~hp~ 249 (416)
.+|||+.++++|||
T Consensus 240 ~~R~t~~~~l~~~~ 253 (253)
T cd05122 240 EKRPTAEQLLKHPF 253 (253)
T ss_pred hhCCCHHHHhcCCC
Confidence 99999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.63 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=201.6
Q ss_pred cccC--CceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+| ++|.||.+++..+++.||||++...... ......+.+|+.+++.++||||+++++++...+..|++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 4444 6778888888889999999999765332 245678999999999999999999999999999999999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-----CCc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-----DGL 151 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-----~~~ 151 (416)
+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........ ...
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 99999874 4589999999999999999999999999999999999999999999999998864322111 111
Q ss_pred ccccccCCCCCchHHhhhc--CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC----------------
Q 014911 152 LHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---------------- 213 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---------------- 213 (416)
.....++..|+|||++... .+ +.++|+||+||++|+|++|..||..............+..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 2334578889999998653 34 5889999999999999999999987654332221111100
Q ss_pred ------------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 214 ------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 214 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..+..++.++.+|+.+||+.||++|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0111235678999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.25 Aligned_cols=244 Identities=24% Similarity=0.426 Sum_probs=205.0
Q ss_pred CcccCCceEEEEEEEcCC-----CcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||.||+|.+... ...+|+|.+..... ......+.+|+.+++++ +||||+++++++...+.+|++||
T Consensus 19 ~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred EecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 489999999999988644 37899999875432 23346788999999999 89999999999999999999999
Q ss_pred ccCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeec
Q 014911 75 LVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 137 (416)
Q Consensus 75 ~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DF 137 (416)
|+++|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Df 176 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADF 176 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCcc
Confidence 9999999999853 35889999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCC
Q 014911 138 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKC 215 (416)
Q Consensus 138 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~ 215 (416)
|++................+++.|+|||.+....+ +.++||||+||++|+|++ |..||...+.......+..+. ...
T Consensus 177 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (293)
T cd05053 177 GLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEK 255 (293)
T ss_pred ccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99875443221111222334667999999877666 488999999999999998 999999888777777666553 355
Q ss_pred CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 216 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 216 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
|...+..+.+|+.+||.+||++|||+.+++++
T Consensus 256 ~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 256 PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.33 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=201.7
Q ss_pred CcccCCceEEEEEEEcCCCc----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..+|+ .||+|++.... .......+.+|+.+++.++||||+++++++.. ...++++||+
T Consensus 14 ~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred ecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 48999999999999877776 48999986543 22345678899999999999999999998865 4578999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..............
T Consensus 91 ~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~ 170 (279)
T cd05109 91 PYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170 (279)
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCC
Confidence 99999999965 5699999999999999999999999999999999999999999999999999875543211111122
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.++.++.++.+++.+||.
T Consensus 171 ~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 249 (279)
T cd05109 171 GKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM 249 (279)
T ss_pred CccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcC
Confidence 234678999999977766 489999999999999998 999998877666665555443 45566789999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.||++|||+.++++
T Consensus 250 ~dp~~Rp~~~~l~~ 263 (279)
T cd05109 250 IDSECRPRFRELVD 263 (279)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=325.73 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=207.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+||||+.| +
T Consensus 22 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 100 (308)
T cd06634 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-S 100 (308)
T ss_pred heeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-C
Confidence 389999999999999999999999998754433334456788999999999999999999999999999999999974 7
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+.+.. ..+++..+..++.|++.||.|||++|++||||+|.||+++.++.++|+|||++..... .....++
T Consensus 101 l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~ 174 (308)
T cd06634 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGT 174 (308)
T ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCC
Confidence 7777643 5689999999999999999999999999999999999999999999999999865332 2345688
Q ss_pred CCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~d 234 (416)
+.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..+..+ .+..++..+.+||++||+.+
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 254 (308)
T cd06634 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254 (308)
T ss_pred ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCC
Confidence 99999999853 223357899999999999999999999876655444444444332 23457889999999999999
Q ss_pred CCCcCCHHHHhcCccccccC
Q 014911 235 PNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 235 P~~R~s~~eil~hp~f~~~~ 254 (416)
|.+||++.++++|||+....
T Consensus 255 P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 255 PQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cccCCCHHHHhhCccccccC
Confidence 99999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=322.19 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=203.0
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..|++|||
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred ccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 4899999999999743 356789999875432 24457899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 76 VKGGELFNKIAKG----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 76 ~~gg~L~~~i~~~----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~ 168 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCc
Confidence 9999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCC
Q 014911 140 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPP 217 (416)
Q Consensus 140 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 217 (416)
+................+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+ ....|.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
T cd05092 169 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247 (280)
T ss_pred eeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCC
Confidence 864332111111223345778999999987766 489999999999999998 99999887766666666554 345567
Q ss_pred CCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 218 WFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 218 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+++.+.++|.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 248 TCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 78999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.72 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=198.7
Q ss_pred CcccCCceEEEEEEEcCC-----CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|.+... +..||||++.... .....+.+.+|+.+|+.++ ||||+++++++...+.+|+|||
T Consensus 44 ~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred eecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 489999999999987543 3469999996543 2234567899999999996 9999999999999999999999
Q ss_pred ccCCCchhhHHhc-------------------------------------------------------------------
Q 014911 75 LVKGGELFNKIAK------------------------------------------------------------------- 87 (416)
Q Consensus 75 ~~~gg~L~~~i~~------------------------------------------------------------------- 87 (416)
|+++|+|.+++..
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 9999999988753
Q ss_pred ------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeec
Q 014911 88 ------------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 137 (416)
Q Consensus 88 ------------------------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DF 137 (416)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~Df 281 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDF 281 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeC
Confidence 13677888899999999999999999999999999999999999999999
Q ss_pred cccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHH-HHHHHHHhC-CCC
Q 014911 138 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRG-DFK 214 (416)
Q Consensus 138 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~ 214 (416)
|++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...... ..+..+..+ ...
T Consensus 282 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~ 360 (400)
T cd05105 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360 (400)
T ss_pred CcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC
Confidence 99875433222222233456788999999977666 589999999999999997 99999875443 333344333 244
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 215 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.|..++..+.+++.+||+.||++|||+.++.+
T Consensus 361 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 361 KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 56678999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.80 Aligned_cols=242 Identities=23% Similarity=0.406 Sum_probs=204.7
Q ss_pred CcccCCceEEEEEEEcC-CCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQ-TGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.||+|.+.. +++ .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 58999999999999865 333 6999999776543 556789999999999999999999999988 89999999999
Q ss_pred CCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccc
Q 014911 78 GGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLH 153 (416)
Q Consensus 78 gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 153 (416)
+++|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++......... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 9999999976 35899999999999999999999999999999999999999999999999998755332111 1112
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 230 (416)
...++..|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+... ....|..++..+.+++.+|
T Consensus 159 ~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred CCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 3456788999999877666 488999999999999998 99999887777666666532 2344566789999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|+.+|.+|||+.++++
T Consensus 238 l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 238 WAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCcccCCCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.33 Aligned_cols=253 Identities=32% Similarity=0.610 Sum_probs=227.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+|++|-+++.++|.+.+|+|+++++-....+.++-+..|-.+..+- +||.+|-++.+|.+++.+++|.||++||
T Consensus 257 vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg 336 (593)
T KOG0695|consen 257 VIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG 336 (593)
T ss_pred eecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc
Confidence 589999999999999999999999999988877767777788888887765 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.-.+++ .+++|+.++.|...|+.||+|||++||++||||..|+|+|..|++||+|+|++. ..........+.|||
T Consensus 337 dlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck--e~l~~gd~tstfcgt 414 (593)
T KOG0695|consen 337 DLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGLGPGDTTSTFCGT 414 (593)
T ss_pred ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh--cCCCCCcccccccCC
Confidence 99777765 789999999999999999999999999999999999999999999999999986 344556678899999
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC--------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--------DNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~--------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 230 (416)
|.|+|||++.+..| +..+|.|+|||+++||++|+.||+- .+...+++-|....+.+|..+|-.+..+++..
T Consensus 415 pnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgf 493 (593)
T KOG0695|consen 415 PNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGF 493 (593)
T ss_pred Ccccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHh
Confidence 99999999998877 6999999999999999999999952 33456777788888999999999999999999
Q ss_pred cCCCCCCcCC------HHHHhcCccccccCcc
Q 014911 231 LDPNPNSRIA------ISKIMESSWFKKSAPK 256 (416)
Q Consensus 231 L~~dP~~R~s------~~eil~hp~f~~~~~~ 256 (416)
|.+||.+|.. +.++..||||+.....
T Consensus 494 lnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 494 LNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred hcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 9999999975 6899999999965443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.63 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=204.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++......|+||||+.|++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 48999999999999877 999999998665432 345688999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++................++
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 9999964 56899999999999999999999999999999999999999999999999998743321111111122335
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+... ....|..++..+.+++.+||..+|.
T Consensus 159 ~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 237 (251)
T cd05041 159 IKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237 (251)
T ss_pred eccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence 67999999876655 589999999999999998 89999887776666666544 2445667889999999999999999
Q ss_pred CcCCHHHHhc
Q 014911 237 SRIAISKIME 246 (416)
Q Consensus 237 ~R~s~~eil~ 246 (416)
+|||+.++++
T Consensus 238 ~Rp~~~ell~ 247 (251)
T cd05041 238 NRPSFSEIYN 247 (251)
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=325.31 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=201.1
Q ss_pred CcccCCceEEEEEEEcCCCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+|++|||++
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 58999999999999877765 46888775322 223456788999999999 79999999999999999999999999
Q ss_pred CCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 78 GGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 78 gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
+++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 166 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCC
Confidence 9999999864 24788999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 218 (416)
....... .......+..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..
T Consensus 167 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd05089 167 RGEEVYV---KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN 242 (297)
T ss_pred cccccee---ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 6322110 0111223456999999877665 489999999999999997 999999888877777776553 345667
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
++..+.+||.+||+.+|.+|||++++++.
T Consensus 243 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 243 CDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.67 Aligned_cols=244 Identities=23% Similarity=0.410 Sum_probs=203.4
Q ss_pred CcccCCceEEEEEEEcC-------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||.||+|++.. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 25 PLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 38999999999998643 33579999997543 223456788999999999 799999999999999999999
Q ss_pred EeccCCCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+++|+|.+++... .++...+..++.|++.||+|||++|++||||||+||+++.++.+||+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~ 182 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEEC
Confidence 9999999999999642 37888999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 213 (416)
|||++................+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. .
T Consensus 183 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (307)
T cd05098 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 261 (307)
T ss_pred CCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCC
Confidence 9999875432111111122234578999999977665 589999999999999998 999998888777777666554 3
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 262 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=322.59 Aligned_cols=243 Identities=21% Similarity=0.337 Sum_probs=202.7
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|+||+||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+++||
T Consensus 7 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 58999999999998753 335799998865432 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC
Q 014911 76 VKGGELFNKIAK-------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 76 ~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~ 164 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR 164 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCC
Confidence 999999998753 2477889999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 014911 131 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 209 (416)
Q Consensus 131 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 209 (416)
.+||+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.....+...+.
T Consensus 165 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 243 (290)
T cd05045 165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243 (290)
T ss_pred cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 999999999875432221111223345778999999876665 589999999999999998 999999888777666655
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 210 RG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 210 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.. ..+.|..++.++.+++.+||+.+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 244 TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 43 33456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.45 Aligned_cols=248 Identities=26% Similarity=0.454 Sum_probs=200.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--------CEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--------SKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--------~~~~lV 72 (416)
.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 15 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 3899999999999999999999999987654322 2234667899999999999999999987443 357999
Q ss_pred EeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-
Q 014911 73 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD- 149 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 149 (416)
|||+.+ +|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 94 ~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 172 (311)
T cd07866 94 TPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172 (311)
T ss_pred EecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCccc
Confidence 999975 67776653 57999999999999999999999999999999999999999999999999998754322111
Q ss_pred --------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--------
Q 014911 150 --------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------- 213 (416)
Q Consensus 150 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------- 213 (416)
.......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (311)
T cd07866 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWP 252 (311)
T ss_pred ccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhch
Confidence 1112345788999999987655456899999999999999999999998776655554432100
Q ss_pred ---------------CCC-------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 ---------------KCP-------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ---------------~~p-------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..| ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 253 GWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 001 1245688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=313.09 Aligned_cols=241 Identities=23% Similarity=0.437 Sum_probs=203.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++|++
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 589999999999986 478899999986543 22334568899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........++
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIP 157 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCc
Confidence 9999864 458899999999999999999999999999999999999999999999999986432111 1111122346
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....+ +.++||||+|+++|++++ |..||.+.+.......+..+. ...|..++..+.+++.+||+.+|.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999976655 589999999999999998 999998887766666665543 355677899999999999999999
Q ss_pred CcCCHHHHhc
Q 014911 237 SRIAISKIME 246 (416)
Q Consensus 237 ~R~s~~eil~ 246 (416)
+|||+.++++
T Consensus 237 ~Rp~~~~l~~ 246 (250)
T cd05085 237 NRPKFSELQK 246 (250)
T ss_pred cCCCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=321.81 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=197.8
Q ss_pred CcccCCceEEEEEEEcCCCcE-------EEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||+||+|.+..++.. +|+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 489999999999998665543 8888875432 234567888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC--------eEEeeccccccc
Q 014911 74 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--------LKVTDFGLSAFS 143 (416)
Q Consensus 74 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~--------~kl~DFGla~~~ 143 (416)
||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++. ++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 99999999999975 35899999999999999999999999999999999999988765 699999987632
Q ss_pred cccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC-CCCCCCCcHHHHHHHHHhCCCCCCCCCCHH
Q 014911 144 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRGDFKCPPWFSSE 222 (416)
Q Consensus 144 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 222 (416)
. ......+++.|+|||++.+....+.++||||+||++|+|++| .+||...+..... .........|...+.+
T Consensus 159 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (258)
T cd05078 159 L------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTE 231 (258)
T ss_pred C------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHH
Confidence 2 123456889999999997655456899999999999999998 5777665554332 2344456677777899
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+||.+||+.||++|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.10 Aligned_cols=246 Identities=32% Similarity=0.523 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++..++..|+|+||+.+ +
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 389999999999999999999999998765432 23456788999999999999999999999999999999999976 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||.+....... .......++
T Consensus 84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 161 (283)
T cd05118 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVT 161 (283)
T ss_pred HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCc
Confidence 8888765 479999999999999999999999999999999999999999999999999987544322 122334578
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------CC-----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FK----- 214 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~----- 214 (416)
..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+....+.... ..
T Consensus 162 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05118 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241 (283)
T ss_pred ccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcccc
Confidence 899999998776445689999999999999999999998877655544432210 00
Q ss_pred ------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 215 ------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 215 ------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..+.++..+.++|.+||++||.+||++.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=324.94 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=200.9
Q ss_pred CcccCCceEEEEEEE-----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|.+ ..++..||+|.+..... ....+.+.+|+.+++++ +||||+++++++...+..|+|||
T Consensus 42 ~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred eeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 489999999999975 34566899999865432 23456789999999999 79999999999999999999999
Q ss_pred ccCCCchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCc
Q 014911 75 LVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 151 (416)
|+++|+|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus 120 ~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (302)
T cd05055 120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199 (302)
T ss_pred cCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceee
Confidence 99999999999652 389999999999999999999999999999999999999999999999999875433211111
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHH
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLIT 228 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 228 (416)
.....+++.|+|||.+....+ +.++||||+||++|+|++ |..||...+............ ...|...++.+.+++.
T Consensus 200 ~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (302)
T cd05055 200 KGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278 (302)
T ss_pred cCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 222345778999999977665 589999999999999998 999998876554444443332 2345678999999999
Q ss_pred HccCCCCCCcCCHHHHhc
Q 014911 229 KLLDPNPNSRIAISKIME 246 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~ 246 (416)
+||.++|++|||+.++++
T Consensus 279 ~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 279 TCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=323.36 Aligned_cols=243 Identities=20% Similarity=0.259 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCC----------------cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTG----------------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 64 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 64 (416)
.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4899999999999876544 56899998755322 45678899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchhhHHhc-C-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCe
Q 014911 65 SKSKIYFAMDLVKGGELFNKIAK-G-----------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 132 (416)
Q Consensus 65 ~~~~~~lV~E~~~gg~L~~~i~~-~-----------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~ 132 (416)
..+..+++|||+.+++|.+++.. . .+++..++.++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCce
Confidence 99999999999999999999865 2 58999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc--CCCCCCCCcHHHHHHHHHh
Q 014911 133 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIVSMYRKIYR 210 (416)
Q Consensus 133 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt--G~~Pf~~~~~~~~~~~i~~ 210 (416)
+|+|||++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05051 170 KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGH 248 (296)
T ss_pred EEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHh
Confidence 9999999875432221222234456788999999876555 589999999999999998 7899987766655555432
Q ss_pred C--------CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 211 G--------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 211 ~--------~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
. ..+.|+.++.++.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 249 FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 2 12345567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=319.76 Aligned_cols=242 Identities=19% Similarity=0.321 Sum_probs=199.5
Q ss_pred CcccCCceEEEEEEEcCCCcE----EEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. ....++++||+
T Consensus 14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 489999999999999877774 6667664321 1233467888899999999999999999875 45678999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..............
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T cd05111 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170 (279)
T ss_pred CCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCC
Confidence 99999999964 5689999999999999999999999999999999999999999999999999975432222222334
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..++..|+|||.+....+ +.++||||+||++|+|++ |..||.+.........+..+. ...|..++.++.+++.+||.
T Consensus 171 ~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~ 249 (279)
T cd05111 171 HKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWM 249 (279)
T ss_pred CCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcC
Confidence 456778999999977666 589999999999999998 999998877666555555444 34455678899999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.||.+|||+.++++
T Consensus 250 ~~p~~Rps~~el~~ 263 (279)
T cd05111 250 IDENVRPTFKELAN 263 (279)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.67 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=197.3
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe-CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS-KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~~~~~lV~ 73 (416)
+||+|+||.||+|.+.. +++.||+|++..... ......+.+|+.+++++ +||||+++++++.. ...+|++|
T Consensus 14 ~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred ccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 48999999999997543 457899999865432 23346778899999999 89999999998754 46789999
Q ss_pred eccCCCchhhHHhc--------------------------------------------------------------CCCC
Q 014911 74 DLVKGGELFNKIAK--------------------------------------------------------------GRLR 91 (416)
Q Consensus 74 E~~~gg~L~~~i~~--------------------------------------------------------------~~l~ 91 (416)
||+++++|.+++.. .+++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 99999999998843 2578
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcC
Q 014911 92 EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171 (416)
Q Consensus 92 e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 171 (416)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++................+++.|+|||++.+..
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 251 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC
Confidence 89999999999999999999999999999999999999999999999997543222111122334567899999998877
Q ss_pred CCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 172 YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 172 ~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+. .++||||+||++|+|++ |..||.+..... ....+..+ ....|..+++++.+++.+||+.+|.+|||+.++++|
T Consensus 252 ~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 252 YT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 64 88999999999999998 999998754333 23333332 234466688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=325.38 Aligned_cols=243 Identities=22% Similarity=0.397 Sum_probs=202.8
Q ss_pred CcccCCceEEEEEEEcC-------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+ +||||+++++++...+.+|++
T Consensus 19 ~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 19 PLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 48999999999998642 345799999865432 23456788999999999 699999999999999999999
Q ss_pred EeccCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+++|+|.+++.. ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~ 176 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIA 176 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEc
Confidence 999999999999854 237888999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 213 (416)
|||++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+....+..+..+. .
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 255 (314)
T cd05099 177 DFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM 255 (314)
T ss_pred cccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875432211111222234567999999977665 589999999999999999 999999888777777776553 3
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
..|..++.++.+++.+||..||.+|||+.++++
T Consensus 256 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 256 DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 556778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=316.24 Aligned_cols=240 Identities=22% Similarity=0.373 Sum_probs=201.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||.|.+.. +..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..|++|||+.+|+
T Consensus 11 ~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 11 ELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 38999999999998743 45699998865432 23568899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++|+||||.||+++.++.+||+|||++........ .......++
T Consensus 86 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~ 164 (256)
T cd05113 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFP 164 (256)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccC
Confidence 9999965 4689999999999999999999999999999999999999999999999999864322110 011112345
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+++++.+||++||.
T Consensus 165 ~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 243 (256)
T cd05113 165 VRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE 243 (256)
T ss_pred hhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 67999999977665 489999999999999998 9999988777777777766543 34556789999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.+++.+
T Consensus 244 ~Rp~~~~ll~~ 254 (256)
T cd05113 244 ERPTFQQLLSS 254 (256)
T ss_pred cCCCHHHHHHh
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=317.17 Aligned_cols=239 Identities=22% Similarity=0.372 Sum_probs=201.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|++|||++|++
T Consensus 13 ~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 13 KLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred EecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence 4899999999999974 457899999865432 23568899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ........
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 166 (261)
T cd05068 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKF 166 (261)
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcC
Confidence 9999975 2589999999999999999999999999999999999999999999999999876542111 11111122
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++|+||||+++|+|++ |..||.+.+.......+... ..+.+..++..+.+++.+||+.+|
T Consensus 167 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 245 (261)
T cd05068 167 PIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDP 245 (261)
T ss_pred ceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCc
Confidence 457999999876665 589999999999999999 99999988877777666554 234566789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+||++.++++
T Consensus 246 ~~Rp~~~~l~~ 256 (261)
T cd05068 246 DDRPTFETLQW 256 (261)
T ss_pred ccCCCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=318.13 Aligned_cols=228 Identities=28% Similarity=0.444 Sum_probs=193.7
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchhhH
Q 014911 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNK 84 (416)
Q Consensus 5 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 84 (416)
|+||+||+|++..+++.||+|.+.... ...+|...+....||||+++++++...+..|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999996543 223455555566799999999999999999999999999999999
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCc
Q 014911 85 IAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 163 (416)
Q Consensus 85 i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 163 (416)
+.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+..... ......+++.|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 865 5799999999999999999999999999999999999999999999999998754332 1233456788999
Q ss_pred hHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCH--
Q 014911 164 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAI-- 241 (416)
Q Consensus 164 PE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~-- 241 (416)
||.+....+ +.++|+||+||++|+|++|..||....... ........|+++++.++++|.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876666 588999999999999999999986543210 0112345788899999999999999999999985
Q ss_pred ---HHHhcCccc
Q 014911 242 ---SKIMESSWF 250 (416)
Q Consensus 242 ---~eil~hp~f 250 (416)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=315.76 Aligned_cols=239 Identities=21% Similarity=0.371 Sum_probs=201.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|++|||+++++
T Consensus 13 ~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 13 KLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred ecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 4899999999999864 567799998764332 24678899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........ .......+
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 166 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKF 166 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-eccCCCcc
Confidence 9999864 4688999999999999999999999999999999999999999999999999975432111 11122335
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. .+.+..++.++.+++.+||..+|
T Consensus 167 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 245 (261)
T cd05072 167 PIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245 (261)
T ss_pred ceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 678999999877665 588999999999999998 999998887777666665542 34445688999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
++|||++++++
T Consensus 246 ~~Rp~~~~i~~ 256 (261)
T cd05072 246 EERPTFDYLQS 256 (261)
T ss_pred ccCcCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.16 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=210.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E~ 75 (416)
.||.|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++.... .+|++|||
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 48999999999999999999999999875432 1234567889999999999999999999987765 89999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLH 153 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~ 153 (416)
+.+ +|.+++.+ +.+++..+..++.||+.||+|||++||+||||||.||+++.++.++|+|||++........ .....
T Consensus 86 ~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 164 (330)
T cd07834 86 MET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164 (330)
T ss_pred hhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccc
Confidence 975 89888876 5799999999999999999999999999999999999999999999999999986543221 01234
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-------------------
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK------------------- 214 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 214 (416)
...+++.|+|||++.+....+.++|+||+||++|+|++|.+||.+.+....+..+......
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
T cd07834 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLK 244 (330)
T ss_pred ccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHh
Confidence 4568999999999987744468999999999999999999999988776655554431100
Q ss_pred ------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 215 ------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 215 ------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..+.++..+.++|.+||+.+|.+|||+++++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1123678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.82 Aligned_cols=246 Identities=31% Similarity=0.519 Sum_probs=206.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+....|+|+||+.+ +
T Consensus 6 ~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (282)
T cd07829 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-D 83 (282)
T ss_pred cccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-C
Confidence 4899999999999999999999999997654 2223456778899999999999999999999999999999999985 8
Q ss_pred hhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+. .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .......++
T Consensus 84 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~ 161 (282)
T cd07829 84 LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYTHEVVT 161 (282)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccCccccC
Confidence 99999764 79999999999999999999999999999999999999999999999999987543321 122334567
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC------------------CCCC-----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------DFKC----- 215 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~~~~----- 215 (416)
..|+|||.+......+.++|+||+||++|+|++|.+||...+....+.++... ....
T Consensus 162 ~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
T cd07829 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPP 241 (282)
T ss_pred cCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCc
Confidence 88999999876644568999999999999999999999887765554443221 0001
Q ss_pred ------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 216 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 216 ------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.+.++..+.++|.+||+.||.+||++.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 242 KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 12247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.87 Aligned_cols=253 Identities=35% Similarity=0.592 Sum_probs=210.9
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.++..+ +||||+++++.+......|+||||
T Consensus 7 ~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (288)
T cd05583 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDY 86 (288)
T ss_pred EeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEec
Confidence 4899999999999864 46789999999754332 223446788999999999 699999999999999999999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+.||+|.+++.. +.+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++....... ......
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 165 (288)
T cd05583 87 VNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYS 165 (288)
T ss_pred CCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-cccccc
Confidence 999999999875 679999999999999999999999999999999999999999999999999987543321 112233
Q ss_pred cccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 155 TCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
.+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+ .......+.....+.|..++.++.++|.+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 245 (288)
T cd05583 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQK 245 (288)
T ss_pred ccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHH
Confidence 56899999999986543 23588999999999999999999996432 23444555556667788899999999999
Q ss_pred ccCCCCCCcCC---HHHHhcCccccccC
Q 014911 230 LLDPNPNSRIA---ISKIMESSWFKKSA 254 (416)
Q Consensus 230 ~L~~dP~~R~s---~~eil~hp~f~~~~ 254 (416)
||+.||++||| +.++++||||+...
T Consensus 246 ~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 246 LLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999998 56779999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=323.48 Aligned_cols=244 Identities=22% Similarity=0.407 Sum_probs=204.4
Q ss_pred CcccCCceEEEEEEEc-------CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNL-------QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++......|++
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 99 (304)
T cd05101 22 PLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99 (304)
T ss_pred eeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence 3899999999999753 244579999986442 223456789999999999 899999999999999999999
Q ss_pred EeccCCCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~ 179 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEEC
Confidence 9999999999998642 36778889999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 213 (416)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. .
T Consensus 180 D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (304)
T cd05101 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 258 (304)
T ss_pred CCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC
Confidence 9999875543222222233446778999999977666 488999999999999998 899999888877777776543 3
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..|..++..+.+||.+||.++|.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 259 DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=320.50 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=193.6
Q ss_pred CcccCCceEEEEEEEcCC------------------------CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc
Q 014911 1 MLGHGTFAKVYLARNLQT------------------------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 56 (416)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 489999999999975322 2358889885432 2334678889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----
Q 014911 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---- 130 (416)
Q Consensus 57 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---- 130 (416)
+++++++...+..|+||||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||.||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999864 6789999999999999999999999999999999999998654
Q ss_pred ---CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHh-cCCCCCCCCcHHHHHH
Q 014911 131 ---NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYR 206 (416)
Q Consensus 131 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~ll-tG~~Pf~~~~~~~~~~ 206 (416)
.+|++|||++..... .....+++.|+|||.+.+....+.++||||+||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 123357888999999876544568999999999999985 7999998766544332
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 207 KIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 207 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
........|...++.+.++|.+||+.+|.+|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2233444555567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=317.30 Aligned_cols=243 Identities=21% Similarity=0.358 Sum_probs=203.8
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..+++ .||||++.... .......+.+|+.+++.++||||+++++++......++||||++
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 48999999999999877665 69999986542 23445789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (269)
T cd05065 89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168 (269)
T ss_pred CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccc
Confidence 9999999864 56899999999999999999999999999999999999999999999999998754332211111111
Q ss_pred c---cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHc
Q 014911 156 C---GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 156 ~---gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 230 (416)
. .+..|+|||.+....+ +.++||||+||++|++++ |..||...+.......+... ..+.|+.++..+.+++.+|
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~ 247 (269)
T cd05065 169 LGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDC 247 (269)
T ss_pred cCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHH
Confidence 1 1457999999987766 489999999999999886 99999888777666666543 2345567889999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|..+|.+||++.+++.
T Consensus 248 l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 248 WQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=357.16 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=199.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+
T Consensus 9 ~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGS 88 (932)
T PRK13184 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88 (932)
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCC
Confidence 48999999999999999999999999976544333455678999999999999999999999999999999999999999
Q ss_pred hhhHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 81 LFNKIAK------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 81 L~~~i~~------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
|.+++.. ..++...+..++.|++.||+|||++||+||||||+||+++.+|.++|+|||++........
T Consensus 89 L~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~ 168 (932)
T PRK13184 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168 (932)
T ss_pred HHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccc
Confidence 9998853 1245567788999999999999999999999999999999999999999999975521110
Q ss_pred ----------------CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHH-HhC
Q 014911 149 ----------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI-YRG 211 (416)
Q Consensus 149 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i-~~~ 211 (416)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+........ ...
T Consensus 169 ~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~ 247 (932)
T PRK13184 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILS 247 (932)
T ss_pred cccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccC
Confidence 001123469999999999987776 58999999999999999999999876544332221 111
Q ss_pred CCCCC--CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 212 DFKCP--PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 212 ~~~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
....+ ..+++.+.+++.+||+.||++|++..+.+.
T Consensus 248 P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 248 PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111 347889999999999999999988665553
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=330.75 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=201.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++... ..+|+|+|
T Consensus 22 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 48999999999999999999999999875432 223345688999999999999999999998654 35799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.+ +|.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ....
T Consensus 101 ~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~ 173 (342)
T cd07879 101 YMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTG 173 (342)
T ss_pred cccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCC
Confidence 9964 666654 34689999999999999999999999999999999999999999999999999864321 2234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 212 (416)
..+++.|+|||.+.+....+.++|+||+||++|+|++|+.||.+.+....+..+....
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (342)
T cd07879 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253 (342)
T ss_pred ceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhh
Confidence 5678999999998764444689999999999999999999998876554444332210
Q ss_pred -CCC--------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 -FKC--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 -~~~--------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
... .+..++.+.+||.+||+.||.+|||+.+++.||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 124678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=320.02 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=203.8
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++......|++|||
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 48999999999998753 67899999986543 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCe
Q 014911 76 VKGGELFNKIAKG-----------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 132 (416)
Q Consensus 76 ~~gg~L~~~i~~~-----------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~ 132 (416)
+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||.||+++.++.+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 169 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 169 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCce
Confidence 9999999998631 36788889999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC
Q 014911 133 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG 211 (416)
Q Consensus 133 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 211 (416)
+|+|||++.................++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~ 248 (288)
T cd05050 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248 (288)
T ss_pred EECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999864322211111222334677999999877766 489999999999999997 88999887777777777665
Q ss_pred CC-CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 212 DF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 212 ~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.. +.|..++..+.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 249 NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 43 456778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=316.68 Aligned_cols=237 Identities=23% Similarity=0.318 Sum_probs=194.0
Q ss_pred CcccCCceEEEEEEEcC------------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014911 1 MLGHGTFAKVYLARNLQ------------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 68 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 68 (416)
.||+|+||.||+|+... ....||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 48999999999998532 22368889875432 2345678889999999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC-------eEEeeccc
Q 014911 69 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-------LKVTDFGL 139 (416)
Q Consensus 69 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~-------~kl~DFGl 139 (416)
.++||||+++|+|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999888864 56999999999999999999999999999999999999987664 89999998
Q ss_pred cccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHh-cCCCCCCCCcHHHHHHHHHhCCCCCCCC
Q 014911 140 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYRGDFKCPPW 218 (416)
Q Consensus 140 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~ll-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 218 (416)
+..... .....++..|+|||.+......+.++||||+||++|+|+ +|..||......... ............
T Consensus 159 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~ 231 (262)
T cd05077 159 PITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTP 231 (262)
T ss_pred CccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCC
Confidence 864321 223457889999999875454568999999999999997 599999876654332 233334444444
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.++++.+||.+||+.||.+||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 57889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.15 Aligned_cols=243 Identities=19% Similarity=0.260 Sum_probs=191.6
Q ss_pred CcccCCceEEEEEEEcC--CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 48999999999996432 44578888775432 223346788899999999999999999999999999999999999
Q ss_pred CchhhHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 79 GELFNKIAKG------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 79 g~L~~~i~~~------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|+|.+++... ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++............
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 9999998652 2467888999999999999999999999999999999999999999999998632211111111
Q ss_pred cccccCCCCCchHHhhhc------CCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHh-CCCC-----CCCCC
Q 014911 153 HTTCGTPAYVAPEVISKK------GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYR-GDFK-----CPPWF 219 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~~ 219 (416)
....+++.|+|||++... ...+.++||||+||++|+|++ |..||.............. .... .+..+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 233456789999998542 233578999999999999999 8999988765555444433 2222 23357
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++...+++..|+ .||++|||++++++
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=340.62 Aligned_cols=251 Identities=35% Similarity=0.604 Sum_probs=217.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||-|+||+|.+++..+|...+|+|.+++......+....++.|-.||..-+.+-||+||..|.+++.+|+||+|++||+
T Consensus 636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD 715 (1034)
T KOG0608|consen 636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 715 (1034)
T ss_pred eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence 48999999999999999999999999999888888889999999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC----------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---------- 149 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~---------- 149 (416)
+-.++-+ |-|.|+.++.|+..|.+|+++.|+.|++||||||.|||||.+|++||+||||++-+.+....
T Consensus 716 mMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~R 795 (1034)
T KOG0608|consen 716 MMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHR 795 (1034)
T ss_pred HHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccc
Confidence 9998866 88999999999999999999999999999999999999999999999999999754322110
Q ss_pred ------------------------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC
Q 014911 150 ------------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD 199 (416)
Q Consensus 150 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~ 199 (416)
-..+..+||+.|+|||++.+.+|. ..+|.||.|||||+|+.|.+||...
T Consensus 796 qDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 796 QDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred cccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCCCCccCC
Confidence 012345799999999999999986 8899999999999999999999887
Q ss_pred cHHHHHHHHHh--CCCCCC--CCCCHHHHHHHHHccCCCCCCcCC---HHHHhcCcccccc
Q 014911 200 NIVSMYRKIYR--GDFKCP--PWFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKS 253 (416)
Q Consensus 200 ~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~f~~~ 253 (416)
++.+...++.+ ..+.+| ..+|+++.+||.++.. +++.|+. ++++..||||+..
T Consensus 875 tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 875 TPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 76544444322 233343 4589999999999665 5777774 6789999999864
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=335.37 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=200.2
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||.||+|++. .+++.||+|++..... ......+.+|+.+|..+. ||||+++++++...+..|+|||
T Consensus 44 ~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 44 TLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 4899999999999864 3556899999975432 233457889999999997 9999999999999999999999
Q ss_pred ccCCCchhhHHhcC------------------------------------------------------------------
Q 014911 75 LVKGGELFNKIAKG------------------------------------------------------------------ 88 (416)
Q Consensus 75 ~~~gg~L~~~i~~~------------------------------------------------------------------ 88 (416)
|+++|+|.+++.+.
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 99999999998541
Q ss_pred ---------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 89 ---------------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 89 ---------------------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
.++...+..++.|++.||.|||++|++||||||+|||++.++.+||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~ 281 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEE
Confidence 25666788899999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHH-HHHHhC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMY-RKIYRG-D 212 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~-~~i~~~-~ 212 (416)
|||++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||......+.. ..+..+ .
T Consensus 282 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~ 360 (401)
T cd05107 282 DFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360 (401)
T ss_pred ecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC
Confidence 9999875432211112223457888999999977665 589999999999999998 89999875544433 333333 2
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 213 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 213 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
...|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 361 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 45677789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=354.62 Aligned_cols=141 Identities=35% Similarity=0.642 Sum_probs=131.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+.+|+||||+.|++
T Consensus 11 ~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~ 90 (669)
T cd05610 11 PISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGD 90 (669)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCC
Confidence 38999999999999999999999999987665555566789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 91 L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 91 VKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999975 678999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.16 Aligned_cols=247 Identities=28% Similarity=0.468 Sum_probs=203.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~gg 79 (416)
.||.|+||.||+|.+..+|+.||+|.+.+.... ......+.+|+.+++.++||||+++++++.. ....|+++||+ ++
T Consensus 17 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 17 PVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred eecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 489999999999999999999999998654322 2344678899999999999999999999865 56899999998 56
Q ss_pred chhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 80 ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 80 ~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+|.+++..+++++..+..++.|++.||.|||++|++||||+|.||+++.++.++|+|||++..... ......+++
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~ 169 (328)
T cd07856 95 DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTR 169 (328)
T ss_pred CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccc
Confidence 899888878899999999999999999999999999999999999999999999999999874321 223456788
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh--------------------------CCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--------------------------GDF 213 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--------------------------~~~ 213 (416)
.|+|||.+.+....+.++|+||+||++|+|++|.+||...+.......+.+ ...
T Consensus 170 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd07856 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249 (328)
T ss_pred cccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccC
Confidence 999999986644446899999999999999999999987654322211110 000
Q ss_pred CC-----CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 KC-----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 ~~-----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. .+.+++.+.++|++||+.+|.+|||+++++.||||....
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred CCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 11 134678999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=316.28 Aligned_cols=242 Identities=24% Similarity=0.397 Sum_probs=204.4
Q ss_pred CcccCCceEEEEEEEcCCCc----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 14 ~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred eecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 48999999999999877665 589998865532 2345678899999999999999999999887 7899999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..............
T Consensus 91 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 170 (279)
T cd05057 91 PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170 (279)
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCC
Confidence 99999999975 4699999999999999999999999999999999999999999999999999875442211111112
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..++..|+|||.+....+ +.++|+||+||++|++++ |..||.+.+.......+..+. .+.|...+..+.+++.+||.
T Consensus 171 ~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 249 (279)
T cd05057 171 GKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWM 249 (279)
T ss_pred CcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 223567999999876665 489999999999999998 999999988777777766553 46677789999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.||+.|||+.++++
T Consensus 250 ~~p~~Rp~~~~l~~ 263 (279)
T cd05057 250 IDAESRPTFKELIN 263 (279)
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.71 Aligned_cols=238 Identities=22% Similarity=0.384 Sum_probs=199.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.++++++||||+++++++. .+..|++|||+++++
T Consensus 13 ~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 13 KLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred eeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 4899999999999875 5667999998764432 356889999999999999999999875 566899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ........+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 165 (260)
T cd05070 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKF 165 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-cccccCCCC
Confidence 9999864 358999999999999999999999999999999999999999999999999987543211 111112234
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++|+||||+++|+|++ |.+||.+.+.......+..+ ..+.|...+..+.+|+.+||.++|
T Consensus 166 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05070 166 PIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDP 244 (260)
T ss_pred CccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCc
Confidence 567999999876655 489999999999999999 99999888777777776654 345667789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++.+
T Consensus 245 ~~Rpt~~~l~~ 255 (260)
T cd05070 245 EERPTFEYLQS 255 (260)
T ss_pred ccCcCHHHHHH
Confidence 99999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.14 Aligned_cols=243 Identities=20% Similarity=0.337 Sum_probs=202.8
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++||||+++.+++...+..|+||||++
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred EecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 48999999999999876655 799999865432 2345678899999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc-cc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HT 154 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-~~ 154 (416)
+++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............ ..
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 169 (268)
T cd05063 90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169 (268)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccC
Confidence 9999999864 57899999999999999999999999999999999999999999999999998754332111111 11
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
...++.|+|||.+....+ +.++||||+||++|+|++ |..||...+.......+..+. .+.+..++..+.+++.+||+
T Consensus 170 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~ 248 (268)
T cd05063 170 GKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQ 248 (268)
T ss_pred CCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 123457999999977665 589999999999999997 999998877777777776542 23344578999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.+|++||++.++++
T Consensus 249 ~~p~~Rp~~~~i~~ 262 (268)
T cd05063 249 QDRARRPRFVDIVN 262 (268)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.38 Aligned_cols=238 Identities=25% Similarity=0.396 Sum_probs=199.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+ ..||+|++..... ..+.+.+|+.+++.++||||+++++.+. .+..|+||||+++|+
T Consensus 13 ~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 13 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred ecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 389999999999998665 4699999875432 2356889999999999999999999874 456899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ........+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~ 165 (262)
T cd05071 87 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKF 165 (262)
T ss_pred HHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-cccccCCcc
Confidence 9999975 358899999999999999999999999999999999999999999999999987543221 111223346
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||.+.........+..+ ..+.+..++..+.+++.+||+.||
T Consensus 166 ~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 244 (262)
T cd05071 166 PIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 244 (262)
T ss_pred cceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCc
Confidence 678999999877666 589999999999999999 89999888776666666544 244566789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 245 ~~Rp~~~~~~~ 255 (262)
T cd05071 245 EERPTFEYLQA 255 (262)
T ss_pred ccCCCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.99 Aligned_cols=242 Identities=24% Similarity=0.396 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCC----cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTG----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||.|+||.||+|.+..++ ..||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|++|||+
T Consensus 6 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 6 KLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred eeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4899999999999998766 89999999654321 25678899999999999999999999999999999999999
Q ss_pred CCCchhhHHhc-CC--CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 77 KGGELFNKIAK-GR--LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 77 ~gg~L~~~i~~-~~--l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
+|++|.+++.. .. +++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........... .
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~ 162 (258)
T smart00219 84 EGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-K 162 (258)
T ss_pred CCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc-c
Confidence 99999999975 22 99999999999999999999999999999999999999999999999999875543211111 1
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 231 (416)
...+++.|+|||.+....+ +.++|+||+||++|+|++ |.+||...+.......+.... ...+..++..+.+++.+||
T Consensus 163 ~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 241 (258)
T smart00219 163 GGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCW 241 (258)
T ss_pred cCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHC
Confidence 1236788999999865544 589999999999999998 899999887777777776554 3456678999999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
..||.+|||+.++++
T Consensus 242 ~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 242 AEDPEDRPTFSELVE 256 (258)
T ss_pred cCChhhCcCHHHHHh
Confidence 999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.19 Aligned_cols=244 Identities=31% Similarity=0.485 Sum_probs=201.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE-----EEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMASKSK-----IYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~-----~~lV 72 (416)
.||.|+||.||+|++..+++.||+|++...... ......+.+|+.+++++ +||||+++++++..... +|++
T Consensus 6 ~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 489999999999999889999999999754432 23334566788877766 59999999999988776 9999
Q ss_pred EeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC
Q 014911 73 MDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 149 (416)
|||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~--- 160 (287)
T cd07838 85 FEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--- 160 (287)
T ss_pred ehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC---
Confidence 999975 79888865 35899999999999999999999999999999999999999999999999998754332
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-----C----------
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-----K---------- 214 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-----~---------- 214 (416)
.......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++..... .
T Consensus 161 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 22233457889999999987665 5889999999999999999999998877666655543110 0
Q ss_pred ------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 215 ------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 215 ------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001245788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.88 Aligned_cols=243 Identities=25% Similarity=0.358 Sum_probs=194.9
Q ss_pred CcccCCceEEEEEE----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 74 (416)
.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++.. ....|++||
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 48999999998865 345788999999865432 1234678899999999999999999998765 346899999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLH 153 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 153 (416)
|+++++|.+++....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......... ....
T Consensus 89 ~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 168 (283)
T cd05080 89 YVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168 (283)
T ss_pred CCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCC
Confidence 999999999998888999999999999999999999999999999999999999999999999998754322111 1112
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH--H-------------HHHHHHh-CCCCCCC
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV--S-------------MYRKIYR-GDFKCPP 217 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~--~-------------~~~~i~~-~~~~~p~ 217 (416)
...++..|+|||.+....+ +.++|||||||++|+|++|..||...... . ....+.. ...+.|.
T Consensus 169 ~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd05080 169 DGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK 247 (283)
T ss_pred CCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCC
Confidence 2345667999999876655 58999999999999999999998653311 0 0011111 1123456
Q ss_pred CCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 218 WFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 218 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.++..+.+++.+||++||++|||+.++++
T Consensus 248 ~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 248 NCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 68899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.50 Aligned_cols=243 Identities=20% Similarity=0.253 Sum_probs=197.3
Q ss_pred CcccCCceEEEEEEEcCCC--------------cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014911 1 MLGHGTFAKVYLARNLQTG--------------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 66 (416)
.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|++++++++||||+++++++...
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred ccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4899999999999875432 358999987543 223456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchhhHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeE
Q 014911 67 SKIYFAMDLVKGGELFNKIAKG-------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLK 133 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~k 133 (416)
+..|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~k 169 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIK 169 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEE
Confidence 9999999999999999988542 367888999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc--CCCCCCCCcHHHHHHHHHh-
Q 014911 134 VTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIVSMYRKIYR- 210 (416)
Q Consensus 134 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt--G~~Pf~~~~~~~~~~~i~~- 210 (416)
|+|||++................+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+..
T Consensus 170 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 248 (295)
T cd05097 170 IADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248 (295)
T ss_pred ecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHh
Confidence 999999874332111111222345678999999877665 589999999999999988 7789987665554443321
Q ss_pred -------CCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 211 -------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 211 -------~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.....++.+++.+.+|+.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112345567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.39 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=202.5
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 48999999999999865543 799999865432 2345688999999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCc-ccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHT 154 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 154 (416)
|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........... ...
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd05066 89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168 (267)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCC
Confidence 9999999975 5689999999999999999999999999999999999999999999999999876543221111 111
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..+++.|+|||.+....+ +.++|+|||||++|++++ |..||.+.+.......+..+. .+.+..+++.+.+++.+||+
T Consensus 169 ~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (267)
T cd05066 169 GKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQ 247 (267)
T ss_pred CccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcc
Confidence 223567999999987665 589999999999999886 999998877666666665542 34455678999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.+|.+|||+.++++
T Consensus 248 ~~p~~Rp~~~~i~~ 261 (267)
T cd05066 248 KDRNERPKFEQIVS 261 (267)
T ss_pred cCchhCCCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=347.01 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=187.9
Q ss_pred CcccCCceEEEEEEEcCC-CcEEEEEEe--------------ecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQT-GKSMAMKVV--------------GKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-~~~vAiK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 65 (416)
.||+|+||+||+|..... +...+.|.+ .+...........+.+|+.+|+.++||||+++++++..
T Consensus 155 ~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 234 (501)
T PHA03210 155 DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS 234 (501)
T ss_pred EecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEE
Confidence 389999999999876432 222222211 11111112334678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchhhHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 66 KSKIYFAMDLVKGGELFNKIAKG------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 66 ~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
.+..|+|++++. ++|.+++..+ ......++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 235 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGl 313 (501)
T PHA03210 235 EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGT 313 (501)
T ss_pred CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999995 4787776542 234677889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCC-CCCCC--cHHHHHHHHHhC----C
Q 014911 140 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL-PFQDD--NIVSMYRKIYRG----D 212 (416)
Q Consensus 140 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~-Pf~~~--~~~~~~~~i~~~----~ 212 (416)
+....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|.. ||... +....+..+... .
T Consensus 314 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 391 (501)
T PHA03210 314 AMPFEKER-EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391 (501)
T ss_pred ceecCccc-ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccCh
Confidence 97543221 112234679999999999988777 489999999999999999865 45332 111122111110 0
Q ss_pred CCCC----------------------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 FKCP----------------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~~~p----------------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..+| ..++.++.++|.+||++||.+|||+.|+|.||||....
T Consensus 392 ~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 392 EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred hhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 0000 12456788899999999999999999999999998653
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.68 Aligned_cols=234 Identities=23% Similarity=0.443 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||.|+||.||+|.. .|+.||+|.+..... ...++.+|+.+++.++||||+++++++.+.+..|+||||+++++
T Consensus 13 ~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 13 TIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred eeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 489999999999987 588999999965532 45778899999999999999999999999999999999999999
Q ss_pred hhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .....+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-----~~~~~~ 161 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKL 161 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-----cccCCC
Confidence 9999975 2 5899999999999999999999999999999999999999999999999998754221 112334
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++|+||||+++|+|++ |..||...+.......+..+ ....|..+++.+.++|.+||..+|
T Consensus 162 ~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05039 162 PVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDP 240 (256)
T ss_pred cccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccCh
Confidence 567999999876555 589999999999999997 99999988877776666544 345567789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 241 ~~Rp~~~~l~~ 251 (256)
T cd05039 241 AKRPTFKQLRE 251 (256)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=316.17 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=202.0
Q ss_pred CcccCCceEEEEEEEcCCC------cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTG------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||.||+|++.... +.+|+|.+..... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 4899999999999986544 6899998864421 2335678899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-----CeEEeeccccc
Q 014911 75 LVKGGELFNKIAK--------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-----NLKVTDFGLSA 141 (416)
Q Consensus 75 ~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-----~~kl~DFGla~ 141 (416)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9999999999863 2378899999999999999999999999999999999999887 89999999986
Q ss_pred cccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCC
Q 014911 142 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWF 219 (416)
Q Consensus 142 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 219 (416)
...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 4432211111223345778999999977665 589999999999999998 99999887766666665443 34566778
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+..+.++|.+||..+|.+|||+.++++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.27 Aligned_cols=238 Identities=23% Similarity=0.395 Sum_probs=198.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|++|||+.+++
T Consensus 13 ~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 13 KLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred eecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 389999999999988655 4699998865432 2356788999999999999999999875 456899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++....... ........+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 165 (260)
T cd05069 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKF 165 (260)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccccCCCcc
Confidence 9999965 348899999999999999999999999999999999999999999999999987543211 111122345
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||.+.+.......+..+ ..+.|..++..+.+++++||.+||
T Consensus 166 ~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05069 166 PIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244 (260)
T ss_pred chhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 678999999876655 589999999999999999 99999988777766666554 234566789999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||++++++
T Consensus 245 ~~Rp~~~~i~~ 255 (260)
T cd05069 245 DERPTFEYIQS 255 (260)
T ss_pred ccCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=339.22 Aligned_cols=247 Identities=24% Similarity=0.483 Sum_probs=215.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--EEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK--IYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~lV~E~~~ 77 (416)
+||+|+|-+||+|.|..+|..||--.+...... .....+++..|+.+|+.|+||||+++|+.+.+..+ +-+|.|++.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 589999999999999999999997655544433 34557899999999999999999999999987665 889999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccC-CCeEEeeccccccccccccCCccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
+|+|+.|+++ ++++...++.|++||+.||.|||++. |+|||||-.||+|+.+ |.|||+|+|||++... ....
T Consensus 127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~----s~ak 202 (632)
T KOG0584|consen 127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK----SHAK 202 (632)
T ss_pred CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc----cccc
Confidence 9999999987 88999999999999999999999985 9999999999999854 7899999999996543 2234
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKC--PPWFSSEARRLITKL 230 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~ 230 (416)
...|||.|||||++. ..|+ ..+||||||+.|.||.|+..||.. .+...+|+++..|..+- ..--.+++++||.+|
T Consensus 203 svIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC 280 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC 280 (632)
T ss_pred eeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence 478999999999986 5675 899999999999999999999975 78889999998875432 122368999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccccC
Q 014911 231 LDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
|.. .+.|+|+.|+|+||||....
T Consensus 281 l~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 281 LAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred hcC-chhccCHHHHhhChhhcccc
Confidence 999 99999999999999998753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=311.76 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=197.8
Q ss_pred CcccCCceEEEEEEEcC---CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA-SKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~~ 76 (416)
+||+|+||.||+|.+.. .+..+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..|++|||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 58999999999998753 34579999875332 2234578889999999999999999999764 456789999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc--CCcc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~ 152 (416)
.+|+|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 99999999975 4467788889999999999999999999999999999999999999999999864322110 0111
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHc
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 230 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 230 (416)
....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+..+. ...|..+++.+.+++.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred ccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 22345678999999877665 589999999999999999 677888777766666665543 344556789999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|.++|++||++.++++
T Consensus 239 l~~~p~~Rp~~~~il~ 254 (262)
T cd05058 239 WHPKPEMRPTFSELVS 254 (262)
T ss_pred cCCChhhCCCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.66 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=200.1
Q ss_pred CcccCCceEEEEEEEcCC--CcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQT--GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS----KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~~~~lV~ 73 (416)
+||+|+||.||+|.+..+ +..||+|.+..... .......+.+|+.+++.+ +||||+++++.... ...+|+++
T Consensus 7 ~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 489999999999999888 89999999864322 223345678899999999 59999999987532 25688999
Q ss_pred eccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc--CC
Q 014911 74 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DG 150 (416)
Q Consensus 74 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~ 150 (416)
||+. ++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 86 e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (332)
T cd07857 86 ELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164 (332)
T ss_pred eccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccc
Confidence 9986 589888865 6799999999999999999999999999999999999999999999999999875432211 11
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-------------------
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------- 211 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------- 211 (416)
......||+.|+|||.+.+....+.++|+||+||++|+|++|.+||...+.......+...
T Consensus 165 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (332)
T cd07857 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN 244 (332)
T ss_pred cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHH
Confidence 2234578999999998865433468999999999999999999999876543333222110
Q ss_pred ------C---CC---CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 212 ------D---FK---CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 212 ------~---~~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
. .. ..+..+..+.+++.+||+.||.+|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 112357899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=328.41 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=196.1
Q ss_pred CcccCCceEEEEEEE-----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe-CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS-KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~~~~~lV~ 73 (416)
.||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++.. +..+|++|
T Consensus 14 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 14 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred cccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEE
Confidence 489999999999985 35678999999965432 23356788999999999 68999999998754 45789999
Q ss_pred eccCCCchhhHHhcC-----------------------------------------------------------------
Q 014911 74 DLVKGGELFNKIAKG----------------------------------------------------------------- 88 (416)
Q Consensus 74 E~~~gg~L~~~i~~~----------------------------------------------------------------- 88 (416)
||+++|+|.+++...
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 999999999988531
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchH
Q 014911 89 ---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 165 (416)
Q Consensus 89 ---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 165 (416)
.++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.............+..+++.|+|||
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 25677888999999999999999999999999999999999999999999987542211111112234567799999
Q ss_pred HhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCCCcCCHH
Q 014911 166 VISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAIS 242 (416)
Q Consensus 166 ~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~ 242 (416)
.+....+ +.++||||+||++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.||.+|||+.
T Consensus 252 ~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~ 330 (343)
T cd05103 252 TIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330 (343)
T ss_pred HhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 9877666 489999999999999997 99999875433 233333333 3455677889999999999999999999999
Q ss_pred HHhcC
Q 014911 243 KIMES 247 (416)
Q Consensus 243 eil~h 247 (416)
++++|
T Consensus 331 eil~~ 335 (343)
T cd05103 331 ELVEH 335 (343)
T ss_pred HHHHH
Confidence 99876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=313.53 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=211.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--------CCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--------KSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------~~~~~lV 72 (416)
.||+|.||+||+|+...+|+.||+|.+-.+.. +.+......+|+++|..|+|+|++.+++++.. ...+|+|
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 48999999999999999999999997755432 34666778899999999999999999887632 3459999
Q ss_pred EeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc--
Q 014911 73 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-- 148 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-- 148 (416)
+.+|+. +|+..+.. .+++..++.++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.++....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~ 181 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVV 181 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccC
Confidence 999987 89888865 5799999999999999999999999999999999999999999999999999965543321
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh--CCC-------------
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GDF------------- 213 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--~~~------------- 213 (416)
....+..+-|.+|++||.+.+...++++.|||+.|||+.+|++|.+-+.+.+.......|.. |.+
T Consensus 182 kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL 261 (376)
T KOG0669|consen 182 KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPL 261 (376)
T ss_pred CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchH
Confidence 12244556799999999999888788999999999999999999999998877665555422 111
Q ss_pred ----C---CCCC-------------CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCcc
Q 014911 214 ----K---CPPW-------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 214 ----~---~p~~-------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 256 (416)
+ .|.. -++++.+|+.++|..||.+|+++.++++|.||.+...+
T Consensus 262 ~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 262 YQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred HHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0 1110 14578999999999999999999999999999876544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.45 Aligned_cols=238 Identities=23% Similarity=0.375 Sum_probs=199.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+..|++|||+.+++
T Consensus 13 ~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05067 13 KLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGS 86 (260)
T ss_pred eeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCC
Confidence 489999999999986 4678899999875443 2357889999999999999999999874 567899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... ........+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 165 (260)
T cd05067 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKF 165 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cccccCCcc
Confidence 9999864 468999999999999999999999999999999999999999999999999987543211 111122345
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++||||+|+++|++++ |++||.+.+.......+..+ ..+.+...+.++.+++.+||+.+|
T Consensus 166 ~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05067 166 PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKP 244 (260)
T ss_pred cccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 678999999876665 589999999999999999 99999988777766666544 235566788999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
++|||+++++.
T Consensus 245 ~~Rp~~~~l~~ 255 (260)
T cd05067 245 EERPTFEYLRS 255 (260)
T ss_pred hhCCCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.08 Aligned_cols=244 Identities=23% Similarity=0.404 Sum_probs=203.5
Q ss_pred CcccCCceEEEEEEEcCC-------CcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQT-------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +||||+++++++...+.+|++
T Consensus 19 ~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 19 PLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred eeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 389999999999986432 2368999886432 223457889999999999 799999999999999999999
Q ss_pred EeccCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+++|+|.+++.. ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~ 176 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEEC
Confidence 999999999999864 136778888999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 213 (416)
|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 255 (334)
T cd05100 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM 255 (334)
T ss_pred CcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875433221111222334567999999977666 488999999999999998 899999988888777776543 3
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.|..++..+.+++.+||+.+|.+|||+.+++++
T Consensus 256 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 256 DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5566788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=314.95 Aligned_cols=246 Identities=29% Similarity=0.511 Sum_probs=207.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+..++..+++|++...... .......+.+|+.+++.++||||+++++++.+....++|+||+++
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (260)
T cd08222 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86 (260)
T ss_pred eecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCC
Confidence 489999999999999888888888877543321 122334677899999999999999999999999999999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++..... ......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~--~~~~~~ 163 (260)
T cd08222 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG--SCDLAT 163 (260)
T ss_pred CCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--Cccccc
Confidence 999988752 46899999999999999999999999999999999999975 6799999999875432 122233
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccC
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~ 232 (416)
...|++.|+|||.+....++ .++|+||+|+++|+|++|..||...+.......+..+.. ..|..++.++.++|.+||.
T Consensus 164 ~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 242 (260)
T cd08222 164 TFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLN 242 (260)
T ss_pred CCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhc
Confidence 45688999999998766664 789999999999999999999988777666666655543 4456788999999999999
Q ss_pred CCCCCcCCHHHHhcCccc
Q 014911 233 PNPNSRIAISKIMESSWF 250 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f 250 (416)
.||.+||++.++++||||
T Consensus 243 ~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 243 KDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CChhhCcCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.37 Aligned_cols=242 Identities=22% Similarity=0.394 Sum_probs=208.4
Q ss_pred CcccCCceEEEEEEEcCCCc---E-EEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK---S-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||.||+|.....+. . ||+|....+..........+.+|+++|++++|||||++||+......+|+|||+|
T Consensus 164 kLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~ 243 (474)
T KOG0194|consen 164 KLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELC 243 (474)
T ss_pred eeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEec
Confidence 48999999999998765422 3 8999987644445567889999999999999999999999999999999999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+||+|.+++++ +.++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.... ......
T Consensus 244 ~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---~~~~~~ 320 (474)
T KOG0194|consen 244 NGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---YVMKKF 320 (474)
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc---eeeccc
Confidence 99999999987 3499999999999999999999999999999999999999999999999999874331 111111
Q ss_pred cc-cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHc
Q 014911 155 TC-GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF--KCPPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~-gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 230 (416)
.+ -...|+|||.+...-| +.++||||+||++||+++ |..||.+........+|....+ +.|+..+..+..++.+|
T Consensus 321 ~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c 399 (474)
T KOG0194|consen 321 LKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQC 399 (474)
T ss_pred cccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHh
Confidence 22 2456999999987755 599999999999999999 8999999999999999955443 55667788999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
+..||+.|||+.++.+
T Consensus 400 ~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 400 WKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCChhhccCHHHHHH
Confidence 9999999999999864
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.79 Aligned_cols=243 Identities=19% Similarity=0.275 Sum_probs=196.8
Q ss_pred CcccCCceEEEEEEEcC----------------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ----------------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 64 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 64 (416)
.||+|+||+||+|.+.. ++..+|+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 48999999999986532 34579999986543 2234568899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchhhHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCe
Q 014911 65 SKSKIYFAMDLVKGGELFNKIAKG------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 132 (416)
Q Consensus 65 ~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~ 132 (416)
..+..|++|||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCE
Confidence 999999999999999999998652 26677899999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc--CCCCCCCCcHHHHHHHHH-
Q 014911 133 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIVSMYRKIY- 209 (416)
Q Consensus 133 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt--G~~Pf~~~~~~~~~~~i~- 209 (416)
+|+|||++................+++.|+|||......+ +.++|+|||||++|+|++ |..||...+.........
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05095 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248 (296)
T ss_pred EeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHH
Confidence 9999999874432211111222344678999998876665 589999999999999998 789998766554443321
Q ss_pred -------hCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 210 -------RGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 210 -------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
....+.|..+++.+.+|+.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 249 FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1123445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=356.17 Aligned_cols=247 Identities=28% Similarity=0.504 Sum_probs=205.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE----------------
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA---------------- 64 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~---------------- 64 (416)
+||+||||.||+++++-+|+.||||.|.... .......+.+|+..|.+|+|||||++|..+.
T Consensus 486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 5899999999999999999999999997665 3355678999999999999999999975320
Q ss_pred ----------------------------------------e----------------------C----------------
Q 014911 65 ----------------------------------------S----------------------K---------------- 66 (416)
Q Consensus 65 ----------------------------------------~----------------------~---------------- 66 (416)
. .
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence 0 0
Q ss_pred -------------------------CEEEEEEeccCCCchhhHHhcCCCC--HHHHHHHHHHHHHHHHHHHHcCceeccC
Q 014911 67 -------------------------SKIYFAMDLVKGGELFNKIAKGRLR--EDVARVYFQQLISAVDFCHSRGVYHRDL 119 (416)
Q Consensus 67 -------------------------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~~~~qll~aL~ylH~~gi~HrDl 119 (416)
..+||-||||+..+|.+.+.++.+. .+.++++|+||++||.|+|+.||+||||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDL 723 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDL 723 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccC
Confidence 1378999999998888888887664 8899999999999999999999999999
Q ss_pred CCCcEEeccCCCeEEeecccccccc----------------ccccCCcccccccCCCCCchHHhhhcC--CCCchhhHHH
Q 014911 120 KPENLLLDEDGNLKVTDFGLSAFSE----------------HLKQDGLLHTTCGTPAYVAPEVISKKG--YDGAKADIWS 181 (416)
Q Consensus 120 kp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwS 181 (416)
||.||++|++++|||+|||+|+... .....+..+...||.-|+|||++.+.. .++.|+|+||
T Consensus 724 KP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYS 803 (1351)
T KOG1035|consen 724 KPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYS 803 (1351)
T ss_pred CcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHH
Confidence 9999999999999999999998621 001122456678999999999998766 3459999999
Q ss_pred HHHHHHHHhcCCCCCCC-CcHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 182 CGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPWF----SSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 182 lGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
||||||||+ .||.. .........+.++.++.|+.+ -+.-..+|++||+.||++|||+.|+|++.||..
T Consensus 804 LGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 804 LGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 999999999 45754 344566777777777777433 245679999999999999999999999999964
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=310.43 Aligned_cols=233 Identities=24% Similarity=0.451 Sum_probs=198.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM-ASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~lV~E~~~gg 79 (416)
+||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.+++.++|||++++++++ ...+..|++|||++++
T Consensus 13 ~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 13 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 489999999999986 57889999985432 245788999999999999999999975 4567899999999999
Q ss_pred chhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. + .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~ 160 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGK 160 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-----cCCCCc
Confidence 99999875 2 488999999999999999999999999999999999999999999999998864322 112334
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 234 (416)
++..|+|||++....+ +.++||||+||++|+|++ |..||...+.......+..+. ...++.+++.+.+++.+||+.+
T Consensus 161 ~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (256)
T cd05082 161 LPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLD 239 (256)
T ss_pred cceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCC
Confidence 5668999999877665 488999999999999997 999999888777776665542 3456678999999999999999
Q ss_pred CCCcCCHHHHhc
Q 014911 235 PNSRIAISKIME 246 (416)
Q Consensus 235 P~~R~s~~eil~ 246 (416)
|++|||+.++++
T Consensus 240 p~~Rpt~~~l~~ 251 (256)
T cd05082 240 AATRPSFLQLRE 251 (256)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=310.14 Aligned_cols=239 Identities=24% Similarity=0.394 Sum_probs=202.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. ++..||||.+..... ....+.+|+.+++.++||||+++++++......|+||||+++++
T Consensus 13 ~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 13 KLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 4899999999999975 557899999875432 23578899999999999999999999999899999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... ........+
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 166 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKF 166 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCC
Confidence 9999965 368999999999999999999999999999999999999999999999999987543211 111112234
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+.+..+ +.++|+||+||++|+|++ |+.||.+.+.......+..+ ..+.|...+..+.+++.+||+.+|
T Consensus 167 ~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 245 (261)
T cd05034 167 PIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDP 245 (261)
T ss_pred CccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 568999999976655 589999999999999998 99999888777777777654 345566788999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 246 ~~Rp~~~~l~~ 256 (261)
T cd05034 246 EERPTFEYLQS 256 (261)
T ss_pred ccCCCHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=313.12 Aligned_cols=243 Identities=17% Similarity=0.217 Sum_probs=192.0
Q ss_pred CcccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 4899999999999864 35568999988655322 2335788899999999999999999999999999999999999
Q ss_pred CchhhHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 79 GELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 79 g~L~~~i~~------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|+|.+++.. ...++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 999999864 13567788899999999999999999999999999999999999999999998643221111112
Q ss_pred cccccCCCCCchHHhhhcC------CCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCC--C---CCC
Q 014911 153 HTTCGTPAYVAPEVISKKG------YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKC--P---PWF 219 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~------~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~--p---~~~ 219 (416)
....+++.|+|||++.... ..+.++|+||+||++|+|++ |..||...+........... .... | ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 2345788899999986432 12578999999999999996 99999876655443332222 2211 2 236
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++.+.+++..|+ .+|.+|||+++|+.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=309.22 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=202.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.++++++||||+++++++......|+||||+.|++
T Consensus 11 ~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 11 EIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 4899999999999874 4778999998654322 3568899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.++++.+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ........++
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~ 164 (256)
T cd05112 86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFP 164 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccc
Confidence 9999864 568999999999999999999999999999999999999999999999999987432211 1111122345
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. ...|...+..+.+|+.+||+.+|.
T Consensus 165 ~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~ 243 (256)
T cd05112 165 VKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPE 243 (256)
T ss_pred hhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChh
Confidence 68999999976665 489999999999999998 999999888777777776553 334556789999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.+++++
T Consensus 244 ~Rp~~~~~l~~ 254 (256)
T cd05112 244 DRPSFSLLLHQ 254 (256)
T ss_pred hCCCHHHHHHh
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=307.45 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=200.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-----KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~lV~E~ 75 (416)
.||+|+|+.||++++..++..+|+|.+.... ....+...+|++..++++||||++++++... ....|+++.|
T Consensus 28 ~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 28 LLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred eecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 4899999999999999999999999996654 3556889999999999999999999887533 3459999999
Q ss_pred cCCCchhhHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 76 VKGGELFNKIAK----G-RLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 76 ~~gg~L~~~i~~----~-~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
...|+|.+.++. | .++|.++..|+.++++||.+||+.. ++||||||.|||+++.+..+|.|||.++...-.-.
T Consensus 105 y~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~ 184 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE 184 (302)
T ss_pred hccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence 999999999974 3 5999999999999999999999999 99999999999999999999999999875432211
Q ss_pred CCc-------ccccccCCCCCchHHhhhcCCC--CchhhHHHHHHHHHHHhcCCCCCCCCcH--HHHHHHHHhCCCCCCC
Q 014911 149 DGL-------LHTTCGTPAYVAPEVISKKGYD--GAKADIWSCGVILYVLLAGFLPFQDDNI--VSMYRKIYRGDFKCPP 217 (416)
Q Consensus 149 ~~~-------~~~~~gt~~y~aPE~~~~~~~~--~~~~DvwSlGvil~~lltG~~Pf~~~~~--~~~~~~i~~~~~~~p~ 217 (416)
... ......|..|+|||.+.-+.+. +.++|||||||+||.|+.|..||+..-. ..+.-.+.++.+.+|.
T Consensus 185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~ 264 (302)
T KOG2345|consen 185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN 264 (302)
T ss_pred chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC
Confidence 110 1122468899999998654332 5789999999999999999999964211 1122234445555553
Q ss_pred --CCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 218 --WFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 218 --~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 265 ~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 265 SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 489999999999999999999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.68 Aligned_cols=244 Identities=31% Similarity=0.468 Sum_probs=201.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||.|+||+||+|.+..+++.||||.+...... .......+|+..++.++ ||||+++++++..++..|+||||+ +|
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 489999999999999999999999998654322 11234457999999999 999999999999999999999999 77
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++..... ........
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~~~~~~ 159 (283)
T cd07830 83 NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPPYTDYV 159 (283)
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCCcCCCC
Confidence 99988865 2689999999999999999999999999999999999999999999999999875432 12223456
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------CC---
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FK--- 214 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~--- 214 (416)
++..|+|||++......+.++|+||+|+++++|++|.+||...+....+.++.... ..
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence 88999999998655444689999999999999999999998776554444332100 00
Q ss_pred --------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 215 --------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 215 --------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
..+..+.++.++|++||+.||.+|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 012236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=314.18 Aligned_cols=243 Identities=20% Similarity=0.310 Sum_probs=201.9
Q ss_pred CcccCCceEEEEEEEcC----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~ 75 (416)
+||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. +...++++||
T Consensus 13 ~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 48999999999999875 36889999886432 33456778899999999999999999998655 5789999999
Q ss_pred cCCCchhhHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 76 VKGGELFNKIAK---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 76 ~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||+++.....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~ 170 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCC
Confidence 999999999864 34889999999999999999999999999999999999999999999999998743221
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHH
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 224 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 224 (416)
..........++..|+|||.+....+ +.++|||||||++|++++ |.+||...+.......+..+. +..+..+++++.
T Consensus 171 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
T cd05043 171 DYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELF 249 (280)
T ss_pred ceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11111122345677999999977665 589999999999999999 999999887777666665542 344566789999
Q ss_pred HHHHHccCCCCCCcCCHHHHhc
Q 014911 225 RLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~ 246 (416)
+++.+||..||++|||+.++++
T Consensus 250 ~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 250 AVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=304.96 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=206.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||.|+-|.|++++.+.+|...|||.+.+.. +.+...++.+.++++-+.+ .|+||+.+++|..+..+++.||.+.. -
T Consensus 100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred hcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 899999999999999999999999997654 3345677888888887775 89999999999999999999999853 3
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+..++.+ ++++|..+-++...+++||.||-. +||+|||+||.|||+|+.|++|+||||.+...-. ....+...|
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtrsAG 253 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTRSAG 253 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---ccccccccC
Confidence 3334433 779999999999999999999975 5899999999999999999999999999975432 223345579
Q ss_pred CCCCCchHHhhh---cCCCCchhhHHHHHHHHHHHhcCCCCCCCC-cHHHHHHHHHhCCCCC-CC--CCCHHHHHHHHHc
Q 014911 158 TPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDFKC-PP--WFSSEARRLITKL 230 (416)
Q Consensus 158 t~~y~aPE~~~~---~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~~~-p~--~~s~~~~~li~~~ 230 (416)
.+.|||||.+.- ..| ...+||||||+.++||.||..||.+. ...+..-++.+.+.+. |. .+|+++.+|+..|
T Consensus 254 C~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 254 CAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDC 332 (391)
T ss_pred CccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHH
Confidence 999999999853 245 48999999999999999999999884 3446666777655433 22 3899999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccccCc
Q 014911 231 LDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
|+.|+.+||...++|+|||+....+
T Consensus 333 L~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 333 LTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred hhcCcccCcchHHHhcCcceeecch
Confidence 9999999999999999999986543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=312.77 Aligned_cols=243 Identities=23% Similarity=0.385 Sum_probs=203.7
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|+... +.+.+|+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 48999999999999754 35689999886543 223457789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 76 VKGGELFNKIAK-G---------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 76 ~~gg~L~~~i~~-~---------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
+++|+|.+++.. . .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++.....
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~ 169 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCc
Confidence 999999999975 3 589999999999999999999999999999999999999999999999999863321
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHH
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF--KCPPWFSSE 222 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~ 222 (416)
. .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+.. +.+..++..
T Consensus 170 ~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (275)
T cd05046 170 S-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247 (275)
T ss_pred c-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHH
Confidence 1 1112233456778999999876665 488999999999999998 8999987766666666665543 345568899
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+++.+||+.+|.+|||+.+++..
T Consensus 248 l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 248 LYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=316.72 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=199.6
Q ss_pred CcccCCceEEEEEEEcCCCc----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++... ..++++||+
T Consensus 14 ~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 48999999999999887776 468888764432 23345688999999999999999999988654 467999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..............
T Consensus 91 ~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 170 (303)
T cd05110 91 PHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170 (303)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCC
Confidence 99999999875 3689999999999999999999999999999999999999999999999999975443222112223
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+. .+.++.++..+.+++.+||.
T Consensus 171 ~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~ 249 (303)
T cd05110 171 GKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWM 249 (303)
T ss_pred CccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 345778999999877665 589999999999999997 999998876555544444332 34456688999999999999
Q ss_pred CCCCCcCCHHHHhcC
Q 014911 233 PNPNSRIAISKIMES 247 (416)
Q Consensus 233 ~dP~~R~s~~eil~h 247 (416)
.+|.+||++.++++.
T Consensus 250 ~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 250 IDADSRPKFKELAAE 264 (303)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.98 Aligned_cols=241 Identities=25% Similarity=0.403 Sum_probs=200.5
Q ss_pred CcccCCceEEEEEEEcCC---CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++.+ ...|+||||++
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 489999999999987544 3579999885443 12445688999999999999999999998875 45789999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......... .....
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 168 (270)
T cd05056 90 LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKG 168 (270)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce-ecCCC
Confidence 9999999975 35899999999999999999999999999999999999999999999999998754332111 11122
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+++.|+|||.+....+ +.++|||||||++|++++ |..||...+.......+..+. .+.|+.++..+.++|.+||..
T Consensus 169 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (270)
T cd05056 169 KLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 247 (270)
T ss_pred CccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 34567999999876665 589999999999999986 999998887766666665543 456778899999999999999
Q ss_pred CCCCcCCHHHHhc
Q 014911 234 NPNSRIAISKIME 246 (416)
Q Consensus 234 dP~~R~s~~eil~ 246 (416)
+|.+|||+.+++.
T Consensus 248 ~P~~Rpt~~~~~~ 260 (270)
T cd05056 248 DPSKRPRFTELKA 260 (270)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=315.84 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=199.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++.++ .||||+++++++.+....|++|||+.+
T Consensus 22 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~- 98 (296)
T cd06618 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST- 98 (296)
T ss_pred EeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-
Confidence 489999999999999988999999999754322 2334566677766666 499999999999999999999999854
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+.+.. +.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..... ........
T Consensus 99 ~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~---~~~~~~~~ 175 (296)
T cd06618 99 CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSA 175 (296)
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC---CCcccCCC
Confidence 67776654 579999999999999999999997 5999999999999999999999999999865432 11223345
Q ss_pred cCCCCCchHHhhhcC---CCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCC-CCC--CCCCHHHHHHHHH
Q 014911 157 GTPAYVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDF-KCP--PWFSSEARRLITK 229 (416)
Q Consensus 157 gt~~y~aPE~~~~~~---~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~-~~p--~~~s~~~~~li~~ 229 (416)
+++.|+|||.+.... ..+.++|+||||+++|+|++|+.||..... .+.+..+..... ..+ ..++.++.+||.+
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (296)
T cd06618 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDL 255 (296)
T ss_pred CCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Confidence 788999999986543 235789999999999999999999976432 234444444332 222 2368899999999
Q ss_pred ccCCCCCCcCCHHHHhcCcccccc
Q 014911 230 LLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
||..||.+|||+.+++.||||...
T Consensus 256 ~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 256 CLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HccCChhhCCCHHHHhcChhhhcc
Confidence 999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=308.82 Aligned_cols=234 Identities=23% Similarity=0.276 Sum_probs=192.2
Q ss_pred CcccCCceEEEEEEEcCCC----------cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014911 1 MLGHGTFAKVYLARNLQTG----------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 70 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 70 (416)
.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...|
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 4899999999999998776 3578887754421 15678899999999999999999999887 7789
Q ss_pred EEEeccCCCchhhHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-------CeEEeeccccc
Q 014911 71 FAMDLVKGGELFNKIAK-G-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-------NLKVTDFGLSA 141 (416)
Q Consensus 71 lV~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-------~~kl~DFGla~ 141 (416)
+||||+++|+|.+++.. + .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999975 3 589999999999999999999999999999999999999888 79999999987
Q ss_pred cccccccCCcccccccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCCCC
Q 014911 142 FSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPWF 219 (416)
Q Consensus 142 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 219 (416)
.... .....++..|+|||.+... ...+.++||||+||++|+|++ |..||...+......... .....|...
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 229 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPD 229 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCC
Confidence 4322 2234567889999998765 344689999999999999999 688887765433332222 222223323
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+..+.++|.+||+.+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 489999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=310.12 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=200.8
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEE
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~l 71 (416)
+||+|+||+||+|.+. .+++.||||++..+... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred cccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 5899999999999864 46789999999655432 234677889999999999999999999875432 3578
Q ss_pred EEeccCCCchhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 72 AMDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+++|+.+|+|.+++.. ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~ 164 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccccccc
Confidence 9999999999887642 247899999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............+++.|++||.+....+ +.++|||||||++|+|++ |.+||.+.+....+..+..+. ...++.++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (273)
T cd05074 165 SGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLED 243 (273)
T ss_pred CCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 2111111223345678999999877666 488999999999999999 999998887777776665543 4556778899
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.+++.+||+.+|+.|||+.+++.
T Consensus 244 ~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 244 VYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=312.63 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=195.8
Q ss_pred CcccCCceEEEEEEE----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARN----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E 74 (416)
.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 489999999999974 4578899999986543 223456789999999999999999999998765 67899999
Q ss_pred ccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cc
Q 014911 75 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~ 151 (416)
|++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......... ..
T Consensus 89 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (284)
T cd05079 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168 (284)
T ss_pred ccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceee
Confidence 9999999999865 35899999999999999999999999999999999999999999999999998754322111 11
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---------------HHHHHHHHHhC-CCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---------------IVSMYRKIYRG-DFKC 215 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---------------~~~~~~~i~~~-~~~~ 215 (416)
.....++..|+|||.+.+..+ +.++||||+||++|+|+++..|+.... .......+..+ ..+.
T Consensus 169 ~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05079 169 KDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247 (284)
T ss_pred cCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC
Confidence 223456778999999877665 488999999999999999877653211 11111112222 2344
Q ss_pred CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 216 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 216 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 56689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.55 Aligned_cols=243 Identities=15% Similarity=0.236 Sum_probs=192.0
Q ss_pred CcccCCceEEEEEEEcCC--CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQT--GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|....+ ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 489999999999975433 33566776654332 23456889999999999999999999999999999999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
|+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 999999864 235677788999999999999999999999999999999999999999999875322111111223
Q ss_pred ccccCCCCCchHHhhhcC------CCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C-----CCCCCCC
Q 014911 154 TTCGTPAYVAPEVISKKG------YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F-----KCPPWFS 220 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~------~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~s 220 (416)
..++++.|+|||++.... ..+.++|||||||++|+|++ |..||...+....+..+..+. . ..+..++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 457889999999985321 12478999999999999997 688998777666666544332 1 2234478
Q ss_pred HHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 221 SEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 221 ~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.+.+++..|+ .+|.+|||+.++++
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 89999999999 67999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.48 Aligned_cols=242 Identities=24% Similarity=0.405 Sum_probs=192.4
Q ss_pred CcccCCceEEEEEE----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 74 (416)
+||+|+||+||.|. +..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 48999999999997 44678899999986442 2345678999999999999999999998643 457899999
Q ss_pred ccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 75 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 75 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++............
T Consensus 88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 167 (284)
T cd05081 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167 (284)
T ss_pred ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceee
Confidence 9999999999965 46899999999999999999999999999999999999999999999999998754322111111
Q ss_pred -cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH----------------HHHHHHhC-CCC
Q 014911 153 -HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----------------MYRKIYRG-DFK 214 (416)
Q Consensus 153 -~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~----------------~~~~i~~~-~~~ 214 (416)
....++..|+|||.+.+..+ +.++|+||+||++|+|++|..|+....... +...+... ..+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd05081 168 REPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246 (284)
T ss_pred cCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC
Confidence 11123446999999977665 589999999999999999887765432110 11111111 234
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 215 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+..++..+.+||.+||+.+|++|||+.++++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 247 APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 45668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=305.12 Aligned_cols=238 Identities=24% Similarity=0.393 Sum_probs=198.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...|++|||+++++
T Consensus 13 ~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 13 KLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred EecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 3899999999999864 55679999886432 234678899999999999999999999887 78899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..++...+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....... ........+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 165 (260)
T cd05073 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKF 165 (260)
T ss_pred HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cccccCCcc
Confidence 9999965 357888999999999999999999999999999999999999999999999987543211 111122335
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++|+||+||++|++++ |..||...+.......+..+. .+.+...+.++.+++.+||+++|
T Consensus 166 ~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 244 (260)
T cd05073 166 PIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244 (260)
T ss_pred cccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCc
Confidence 667999999976555 588999999999999998 999999887766666665542 34566788999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
++||++.+++.
T Consensus 245 ~~Rp~~~~l~~ 255 (260)
T cd05073 245 EERPTFEYIQS 255 (260)
T ss_pred ccCcCHHHHHH
Confidence 99999988863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=305.06 Aligned_cols=243 Identities=29% Similarity=0.539 Sum_probs=204.4
Q ss_pred CcccCCceEEEEEEEcC-CCcEEEEEEeecCcc-------cchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKV-------IKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~l 71 (416)
.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+ ++||||+++++++...+..|+
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 48999999999999987 788999998864321 122345667788888875 799999999999999999999
Q ss_pred EEeccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 72 AMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
+|||++|++|.+++.. ..+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 166 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence 9999999999988732 468999999999999999999996 7899999999999999999999999999875433
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CCC-CCCHHH
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPP-WFSSEA 223 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~-~~s~~~ 223 (416)
. .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+. .+++.+
T Consensus 167 ~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (269)
T cd08528 167 E---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDV 242 (269)
T ss_pred c---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHH
Confidence 2 13345678999999999987655 68999999999999999999999888777666666655433 222 578999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcC
Q 014911 224 RRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.++|.+||+.||++|||+.++..+
T Consensus 243 ~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 243 TDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.82 Aligned_cols=232 Identities=26% Similarity=0.463 Sum_probs=196.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|++|||+.|++
T Consensus 13 ~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 13 IIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred eeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 489999999999974 78899999985432 235788999999999999999999998654 4799999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ......
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~ 159 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKL 159 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCC
Confidence 9999964 35899999999999999999999999999999999999999999999999998643211 122234
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+..|+|||.+....+ +.++|+||+||++|+|++ |.+||...+.......+..+. ...+..++..+.+++.+||+.+|
T Consensus 160 ~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (254)
T cd05083 160 PVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEP 238 (254)
T ss_pred CceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCCh
Confidence 567999999876655 589999999999999997 999999888777766665543 33455688999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.+++.
T Consensus 239 ~~Rp~~~~l~~ 249 (254)
T cd05083 239 KKRPSFHKLRE 249 (254)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.19 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=208.8
Q ss_pred cccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
||+|+||+||+|+... ....||||.++... ...+..+|+||+++|..++|||||+|+|++..++.+|+|+||+
T Consensus 494 LGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm 571 (774)
T KOG1026|consen 494 LGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYM 571 (774)
T ss_pred hcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEec
Confidence 8999999999998643 34579999996554 2246789999999999999999999999999999999999999
Q ss_pred CCCchhhHHhc-----------CC----CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 77 KGGELFNKIAK-----------GR----LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 77 ~gg~L~~~i~~-----------~~----l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
..|||..++.. .. ++..+...++.||+.|+.||-++.+|||||-..|+||.++..|||+|||+++
T Consensus 572 ~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsR 651 (774)
T KOG1026|consen 572 DHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSR 651 (774)
T ss_pred ccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccch
Confidence 99999999852 12 7788999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCC
Q 014911 142 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWF 219 (416)
Q Consensus 142 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~ 219 (416)
..-...-........-..+|||||.+....|. .+|||||+||+|||+++ |..||.+...++..+.|..+. +++|..+
T Consensus 652 diYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~C 730 (774)
T KOG1026|consen 652 DIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENC 730 (774)
T ss_pred hhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCC
Confidence 43322111111122235579999999988885 89999999999999999 999999999999999998876 5889999
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHh
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIM 245 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil 245 (416)
+.++.+|+..||+.+|.+|||+.||-
T Consensus 731 P~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 731 PTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999999999999983
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=315.15 Aligned_cols=242 Identities=29% Similarity=0.457 Sum_probs=198.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC--C----CcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--K----HIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~~~~~~~~~~lV~E 74 (416)
+||+|+||+|-.+.+.+++..||||+++.-. ...+..+-|+.+|.++++ | -++++.++|...+++|||+|
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe 171 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE 171 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence 5899999999999999999999999996432 234566779999999942 3 37788888999999999999
Q ss_pred ccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc--------------------CCC
Q 014911 75 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--------------------DGN 131 (416)
Q Consensus 75 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~--------------------~~~ 131 (416)
.+ |-++++++.+ .+++-+.++.+..||+.+++|||+.+++|.||||||||+.. +..
T Consensus 172 ll-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~ 250 (415)
T KOG0671|consen 172 LL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTA 250 (415)
T ss_pred cc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcc
Confidence 98 6699999986 46999999999999999999999999999999999999831 335
Q ss_pred eEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH---HHHHH
Q 014911 132 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---MYRKI 208 (416)
Q Consensus 132 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~---~~~~i 208 (416)
++++|||.|++.... -.+.+.|..|+|||++.+-++. .++||||+||||+||.+|...|...+..+ +.+.|
T Consensus 251 I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 251 IKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred eEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 899999999864432 2567789999999999999995 89999999999999999999997755332 33333
Q ss_pred Hh------------------CCCCCCCCC-------------------------CHHHHHHHHHccCCCCCCcCCHHHHh
Q 014911 209 YR------------------GDFKCPPWF-------------------------SSEARRLITKLLDPNPNSRIAISKIM 245 (416)
Q Consensus 209 ~~------------------~~~~~p~~~-------------------------s~~~~~li~~~L~~dP~~R~s~~eil 245 (416)
.. +.+..|... -..+.|||++||.+||.+|+|+.|+|
T Consensus 325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 21 111111110 13578999999999999999999999
Q ss_pred cCcccccc
Q 014911 246 ESSWFKKS 253 (416)
Q Consensus 246 ~hp~f~~~ 253 (416)
.||||...
T Consensus 405 ~HpFF~~~ 412 (415)
T KOG0671|consen 405 SHPFFARL 412 (415)
T ss_pred cCHHhhcC
Confidence 99999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=306.24 Aligned_cols=243 Identities=23% Similarity=0.391 Sum_probs=196.9
Q ss_pred CcccCCceEEEEEEEc----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNL----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 74 (416)
.||+|+||.||+|... .++..+|+|++...... .....+.+|+.+++.++||||+++++++.. ....|++||
T Consensus 11 ~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred eeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 3899999999999864 35889999999755432 345789999999999999999999999877 668999999
Q ss_pred ccCCCchhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-c
Q 014911 75 LVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-L 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~ 151 (416)
|+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......... .
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (284)
T cd05038 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168 (284)
T ss_pred cCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceec
Confidence 99999999999763 49999999999999999999999999999999999999999999999999987544211111 1
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH---------------HHHHHHhC-CCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---------------MYRKIYRG-DFKC 215 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~---------------~~~~i~~~-~~~~ 215 (416)
.....++..|+|||.+....+ +.++|+||+||++|+|++|..||....... ....+... ..+.
T Consensus 169 ~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05038 169 KEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247 (284)
T ss_pred cCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCC
Confidence 112234566999999876655 588999999999999999999986542211 12222221 2344
Q ss_pred CCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 216 PPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 216 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
|..++..+.+++.+||+++|.+|||+.++++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 248 PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 5667889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.16 Aligned_cols=241 Identities=22% Similarity=0.391 Sum_probs=206.0
Q ss_pred CcccCCceEEEEEEEcCCCc-----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGK-----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|+||.||.|....... .||||.+.+. .+.+....+.+|..+|+.++|||||+++|++.+....+|++||
T Consensus 699 ~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 699 VLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 48999999999998764333 3788877544 4556778999999999999999999999999999999999999
Q ss_pred cCCCchhhHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc
Q 014911 76 VKGGELFNKIAKG--------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 76 ~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 147 (416)
+.||+|..+|++. .++..+...++.|+++|++||+++++|||||...|+||+....+||+|||+|+....
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~-- 854 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYD-- 854 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhh--
Confidence 9999999999753 388899999999999999999999999999999999999999999999999983221
Q ss_pred cCCccccccc--CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHH-HhCCCCCCCCCCHHH
Q 014911 148 QDGLLHTTCG--TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKI-YRGDFKCPPWFSSEA 223 (416)
Q Consensus 148 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~ 223 (416)
.+.......+ ...|||||.+....+ +.++|||||||+|||++| |..||.+.+..++.... ..+.++.|..++..+
T Consensus 855 ~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~l 933 (1025)
T KOG1095|consen 855 KDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKL 933 (1025)
T ss_pred chheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHH
Confidence 1111111112 245999999988666 599999999999999999 99999998887777744 455788899999999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhc
Q 014911 224 RRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+++..||+.+|++||++..|++
T Consensus 934 y~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 934 YQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=331.86 Aligned_cols=234 Identities=32% Similarity=0.502 Sum_probs=191.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~lV~E 74 (416)
.||+||||.||+++++.+|+.||||.++..... ...+..-+|+++|++|+|||||+++++-++.. ...+|||
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 489999999999999999999999999876533 34577889999999999999999999865443 5689999
Q ss_pred ccCCCchhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc--CCC--eEEeecccccccccc
Q 014911 75 LVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGN--LKVTDFGLSAFSEHL 146 (416)
Q Consensus 75 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~--~~~--~kl~DFGla~~~~~~ 146 (416)
||+||+|+..+.+ ..++|.+...++..+..||.|||.+||+||||||.||++-. +|. .||+|||.|+-.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~-- 175 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD-- 175 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC--
Confidence 9999999999975 35999999999999999999999999999999999999843 343 7999999998544
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-----HHHHHHHHHh-----------
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-----IVSMYRKIYR----------- 210 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-----~~~~~~~i~~----------- 210 (416)
.+....+..||+.|.+||++.+..+++..+|.||+||++|++.||..||-... ..-++..+.+
T Consensus 176 -d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 176 -DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred -CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 34577888999999999999876667799999999999999999999995421 1122322211
Q ss_pred ---------CCCCCCCCCCHH----HHHHHHHccCCCCCCcC
Q 014911 211 ---------GDFKCPPWFSSE----ARRLITKLLDPNPNSRI 239 (416)
Q Consensus 211 ---------~~~~~p~~~s~~----~~~li~~~L~~dP~~R~ 239 (416)
..++.|..+++. +-.++..+|..+|.+|.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 112334444444 44678889999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=311.16 Aligned_cols=239 Identities=25% Similarity=0.404 Sum_probs=189.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-KIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~~~gg 79 (416)
+||+|+||.||+|.- .+|..||||.+....... ..++.+|+.++.+++|||+|+|+|+|.+.+ ..++|+||++.|
T Consensus 82 ~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nG 157 (361)
T KOG1187|consen 82 LIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNG 157 (361)
T ss_pred ceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCC
Confidence 589999999999986 445899999776554321 355999999999999999999999999988 599999999999
Q ss_pred chhhHHhc--C-CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 80 ELFNKIAK--G-RLREDVARVYFQQLISAVDFCHSRG---VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 80 ~L~~~i~~--~-~l~e~~~~~~~~qll~aL~ylH~~g---i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
+|.+.+.. + .+++....+|+.+++.||+|||... |+||||||.|||||++.+.||+|||+|...... .....
T Consensus 158 sL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~ 235 (361)
T KOG1187|consen 158 SLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVS 235 (361)
T ss_pred CHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--cccee
Confidence 99999975 3 7899999999999999999999854 999999999999999999999999999643321 11222
Q ss_pred cc-ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc------HHHH-HHHHHhCCC------CCC-CC
Q 014911 154 TT-CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN------IVSM-YRKIYRGDF------KCP-PW 218 (416)
Q Consensus 154 ~~-~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~------~~~~-~~~i~~~~~------~~p-~~ 218 (416)
+. .||.+|+|||.+... ..+.++||||+||+|.||+||+.|.+... .... ...+.++.. .+. ..
T Consensus 236 ~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~ 314 (361)
T KOG1187|consen 236 TTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGE 314 (361)
T ss_pred eecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCC
Confidence 22 899999999999764 34689999999999999999999887532 1111 112222211 111 12
Q ss_pred CC--HH---HHHHHHHccCCCCCCcCCHHHHhc
Q 014911 219 FS--SE---ARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 219 ~s--~~---~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++ .. +..+..+|++.+|..||++.++++
T Consensus 315 ~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 315 YPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 23 22 456778899999999999999753
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.42 Aligned_cols=243 Identities=13% Similarity=0.172 Sum_probs=183.4
Q ss_pred CcccCCceEEEEEEEcCC---CcEEEEEEeecCcccchhh--------HHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 014911 1 MLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGM--------MEQIKREISVMKMVKHKHIVELHEVMASKS-- 67 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 67 (416)
+||+|+||+||+|.+..+ +..+|+|+........... ......+...+..+.|+||++++++.....
T Consensus 19 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 98 (294)
T PHA02882 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCR 98 (294)
T ss_pred EEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCC
Confidence 489999999999998877 6778888654332110000 011223344556778999999999765443
Q ss_pred --EEEEEEeccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 68 --KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 68 --~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
..|+++|++.. ++.+.+.. ...++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+|+...
T Consensus 99 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 99 MYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177 (294)
T ss_pred ceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence 45788888754 66666655 447889999999999999999999999999999999999999999999999997543
Q ss_pred cccc-----CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-H--------HHHHHHHh
Q 014911 145 HLKQ-----DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-V--------SMYRKIYR 210 (416)
Q Consensus 145 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~--------~~~~~i~~ 210 (416)
.... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+. . +....+..
T Consensus 178 ~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 256 (294)
T PHA02882 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE 256 (294)
T ss_pred cCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh
Confidence 2111 111233469999999999987776 5999999999999999999999987632 1 12233333
Q ss_pred CCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 211 GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 211 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+... ++..++.+.+++..|+..+|.+||+++++++
T Consensus 257 ~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 257 GKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3333 3446889999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=289.68 Aligned_cols=239 Identities=48% Similarity=0.823 Sum_probs=207.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchhhHH
Q 014911 6 TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI 85 (416)
Q Consensus 6 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 85 (416)
+||.||+|.+..+|+.+|+|++....... ..+.+.+|+..++.++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 68999999999899999999997654322 1578999999999999999999999999999999999999999999999
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCch
Q 014911 86 AKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 164 (416)
Q Consensus 86 ~~~-~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 164 (416)
... .++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......+++.|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 764 4899999999999999999999999999999999999999999999999998754432 134456688999999
Q ss_pred HHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHccCCCCCCcCC
Q 014911 165 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW---FSSEARRLITKLLDPNPNSRIA 240 (416)
Q Consensus 165 E~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~s 240 (416)
|.+....+ +.++|+||+|++++++++|..||.. .+.......+.......+.. ++..+.+++.+||..+|++||+
T Consensus 156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99986666 4799999999999999999999988 55556666655554443332 8899999999999999999999
Q ss_pred HHHHhcCccc
Q 014911 241 ISKIMESSWF 250 (416)
Q Consensus 241 ~~eil~hp~f 250 (416)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=327.52 Aligned_cols=247 Identities=26% Similarity=0.468 Sum_probs=216.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS-----KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-----~~~~~lV~E 74 (416)
+||.|.+|+||+++++++++.+|+|+...... .-+.++-|..||+.+ +|||++.+|+++.- ++.+|+|||
T Consensus 26 vig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 26 VIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 58999999999999999999999999976653 336788899999987 69999999999853 578999999
Q ss_pred ccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCc
Q 014911 75 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 151 (416)
||.||+..|+++. +++.|+.+..|++.++.|+.+||++.++|||||-.|||++.+|.|||+|||++..... .-+.
T Consensus 102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds--T~gr 179 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS--TVGR 179 (953)
T ss_pred ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec--cccc
Confidence 9999999999975 6799999999999999999999999999999999999999999999999999975443 2344
Q ss_pred ccccccCCCCCchHHhhhc-----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHH
Q 014911 152 LHTTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEA 223 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 223 (416)
..+..|||.|||||++... .| +..+|+||||++..||..|.+|+-+..++..+-.|.++.. ..|..++..+
T Consensus 180 RnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~F 258 (953)
T KOG0587|consen 180 RNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKF 258 (953)
T ss_pred ccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHH
Confidence 5678899999999999643 24 4789999999999999999999999998877767665543 2355689999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.++|..||.+|-.+||+..++++|||.....
T Consensus 259 ndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 259 NDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred HHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 9999999999999999999999999998543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=305.62 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=209.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc----chhhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI----KVGMMEQIKREISVMKMVKHKHIVELHEVMA-SKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 75 (416)
+||+|+|+.||+|.|...++.||+|+-...+.. +.+.....-+|.+|.+.|.||.||++|++|. +.+.+|-|+||
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY 549 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY 549 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence 589999999999999999999999987655443 3345677889999999999999999999995 55779999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEecc---CCCeEEeeccccccccccccC
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR--GVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~--gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 149 (416)
|+|.+|.-+++. ..++|.+++.|+-||+.||.||... .|+|-||||.|||+-. -|.+||+|||++.+.+....+
T Consensus 550 ceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~ 629 (775)
T KOG1151|consen 550 CEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYN 629 (775)
T ss_pred cCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccC
Confidence 999999988876 6699999999999999999999976 5999999999999943 467999999999987654322
Q ss_pred -----CcccccccCCCCCchHHhhh---cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHH--HHHhC-CCCCC-
Q 014911 150 -----GLLHTTCGTPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYR--KIYRG-DFKCP- 216 (416)
Q Consensus 150 -----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~--~i~~~-~~~~p- 216 (416)
.+.....||.||++||.+.- .+-.+.++||||+|||+|..+.|+.||...... +++. .|.+. +..+|
T Consensus 630 ~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~ 709 (775)
T KOG1151|consen 630 SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPP 709 (775)
T ss_pred cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCC
Confidence 23445679999999998752 344468999999999999999999999875332 2222 23322 33444
Q ss_pred -CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 217 -PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 217 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
|.+|+++++||++||++--+.|+...++-.||+|...
T Consensus 710 KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 710 KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 5699999999999999999999999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.00 Aligned_cols=246 Identities=19% Similarity=0.293 Sum_probs=171.8
Q ss_pred CcccCCceEEEEEEEcCC----CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEE------EEeCCEEE
Q 014911 1 MLGHGTFAKVYLARNLQT----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV------MASKSKIY 70 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~------~~~~~~~~ 70 (416)
.||+|+||+||+|.+..+ +..||+|.+..... .+....+ .++...+.++..+... ......++
T Consensus 139 ~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 489999999999999988 99999998754321 1111111 1122222233222211 24567899
Q ss_pred EEEeccCCCchhhHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-
Q 014911 71 FAMDLVKGGELFNKIAKGRL---------------------REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE- 128 (416)
Q Consensus 71 lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~- 128 (416)
+|+||+.+++|.+++....+ .+..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence 99999999999998865321 13446789999999999999999999999999999986
Q ss_pred CCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCC---------------------CchhhHHHHHHHHH
Q 014911 129 DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD---------------------GAKADIWSCGVILY 187 (416)
Q Consensus 129 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DvwSlGvil~ 187 (416)
++.+||+|||+|+..... ........++|+.|+|||.+...... +.++||||+||+||
T Consensus 292 ~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~ 370 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370 (566)
T ss_pred CCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence 578999999999754321 12233566899999999976432211 24569999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCCCC-------C--------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 188 VLLAGFLPFQDDNIVSMYRKIYRGDFKC-------P--------------PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 188 ~lltG~~Pf~~~~~~~~~~~i~~~~~~~-------p--------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+|+++..|++... ......+....... + ...+....+||.+||++||.+|||+.++|+
T Consensus 371 el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 371 QMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 9999877765431 11222221111110 1 111234568999999999999999999999
Q ss_pred CccccccCc
Q 014911 247 SSWFKKSAP 255 (416)
Q Consensus 247 hp~f~~~~~ 255 (416)
||||+....
T Consensus 450 Hpff~~~~~ 458 (566)
T PLN03225 450 HPYFDREGL 458 (566)
T ss_pred CcCcCCCCc
Confidence 999987544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=278.05 Aligned_cols=240 Identities=25% Similarity=0.479 Sum_probs=197.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
+|+|.|++||.|++..+++.++||+++.-+ ...++||+.||+.|. ||||+.++++..++ ....+++||+..
T Consensus 46 ~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 46 VGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 799999999999999999999999985432 368999999999996 99999999998765 457899999987
Q ss_pred CchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
.+...+. ..++.-.++.|+.+++.||.||||.||.|||+||.|++||... .++|+|+|+|.++.. .........
T Consensus 120 ~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp---~~eYnVRVA 194 (338)
T KOG0668|consen 120 TDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVA 194 (338)
T ss_pred ccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC---Cceeeeeee
Confidence 6554443 3488889999999999999999999999999999999999654 599999999987654 334556778
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCC-CCcHHHHHHHH-------------HhCCCCCCC------
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ-DDNIVSMYRKI-------------YRGDFKCPP------ 217 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~-~~~~~~~~~~i-------------~~~~~~~p~------ 217 (416)
+..|--||.+.....++.+-|+||+||+|..|+..+-||- +.+..+..-+| .+-.+.+++
T Consensus 195 SRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~ 274 (338)
T KOG0668|consen 195 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDIL 274 (338)
T ss_pred hhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHh
Confidence 9999999999887777799999999999999999988873 33222222222 111122221
Q ss_pred -------C-----------CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 218 -------W-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 218 -------~-----------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
| .++++.||+.++|.+|..+|+|+.|++.||||..
T Consensus 275 ~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 275 GRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1 4799999999999999999999999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=311.81 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=210.8
Q ss_pred CcccCCceEEEEEEEcC-CCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQ-TGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||.|++|.+.. +|+ .||||.+....... ....|.+|+.+|.+|+|||+++||++..+ ..+.+|+|+++
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 48999999999998763 333 69999997766542 67899999999999999999999999987 78899999999
Q ss_pred CCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 78 GGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 78 gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+|+|.+.+.+ ..|....+..|+.||+.|+.||.+++.|||||-..|+|+-....+||+||||.+-.........+..
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p 273 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAP 273 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecC
Confidence 9999999975 5688899999999999999999999999999999999999988999999999986544322211111
Q ss_pred c-ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014911 155 T-CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 155 ~-~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 231 (416)
. --...|+|||.+....+. .++|||++||++|||++ |+.||.+-....++++|-.++ ++.|+.+++++.+++..||
T Consensus 274 ~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cW 352 (1039)
T KOG0199|consen 274 QRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCW 352 (1039)
T ss_pred CCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhc
Confidence 1 123359999999888774 89999999999999999 999999999999999887654 6788999999999999999
Q ss_pred CCCCCCcCCHHHHhcCccc
Q 014911 232 DPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f 250 (416)
..+|.+|||+..|.+.-+.
T Consensus 353 ah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 353 AHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cCCccccccHHHHHHhHHH
Confidence 9999999999998754333
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=289.07 Aligned_cols=246 Identities=25% Similarity=0.423 Sum_probs=202.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||.|+||+|++..++.+|+..|||.++.... +....++..|..... .-+.||||++|+..-.++..||.||++.- +
T Consensus 72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred hcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 8999999999999999999999999987664 234567788887654 45799999999999999999999999954 4
Q ss_pred hhhHH------hcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 81 LFNKI------AKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 81 L~~~i------~~~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
|..+. ++.+++|+.+-.+.-..+.||+||-. ..|+|||+||+|||++..|.+||||||.+..... .-..+
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---SiAkT 225 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SIAKT 225 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---HHHhh
Confidence 43322 23679999999999999999999975 5899999999999999999999999999864322 22234
Q ss_pred ccccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHhCCCCC---CC---CCCHHHH
Q 014911 154 TTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRGDFKC---PP---WFSSEAR 224 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~~~~~---p~---~~s~~~~ 224 (416)
.-.|..+|||||.+.. .+|+ .+||+||||++|||+.||..||..-+ ..+....+..+.++. +. .+|..+.
T Consensus 226 ~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~ 304 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMV 304 (361)
T ss_pred hccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHH
Confidence 4578999999999863 3565 89999999999999999999998754 345555666665543 22 2789999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+|..||.+|-+.||+..+++++||++...
T Consensus 305 ~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 305 RFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999999999999999999999999998543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=290.80 Aligned_cols=242 Identities=30% Similarity=0.505 Sum_probs=202.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEec
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMDL 75 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E~ 75 (416)
+|.|+- .|-.|.|.-++++||+|.+..+. .......+..+|..++..++|+||++++.+|.-. ...|+|||+
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 577777 78888999999999999987773 3344567888999999999999999999998543 458999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+.. +|...+. -.++...+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|.-.. ..-.++..
T Consensus 103 m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~---~~~~mtpy 177 (369)
T KOG0665|consen 103 MDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED---TDFMMTPY 177 (369)
T ss_pred hhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC---cccccCch
Confidence 965 8888776 458888999999999999999999999999999999999999999999999997322 22356677
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-----------------------
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----------------------- 212 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------------------- 212 (416)
..|..|.|||++.+.+| ...+||||+||++.||++|...|.+.+..+.+.++....
T Consensus 178 VvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~ 256 (369)
T KOG0665|consen 178 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP 256 (369)
T ss_pred hheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh
Confidence 89999999999999886 488999999999999999999999877666655553210
Q ss_pred ----CC----CCC-----------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 213 ----FK----CPP-----------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 213 ----~~----~p~-----------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
+. +|. .-+..+++|+.+||..||++|+|++++|+|||++
T Consensus 257 ~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 257 QYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00 111 1135689999999999999999999999999997
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=303.86 Aligned_cols=238 Identities=27% Similarity=0.485 Sum_probs=201.5
Q ss_pred CcccCCceEEEEEEEcC--CCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQ--TGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~--~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||.|-||.||.|.... .|+ .||||..+.+-.. +..+.+..|..+|+.++||||++++|++.+ ...|||||++
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~ 472 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELA 472 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecc
Confidence 48999999999998653 233 6889988664433 346889999999999999999999999864 5789999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+-|+|..+++. ..++......|+.||+.||.|||++..+||||-..|||+....-+||+|||+++..+.. ...+.
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~---~yYka 549 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD---AYYKA 549 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc---chhhc
Confidence 99999999986 56888899999999999999999999999999999999999999999999999865542 22222
Q ss_pred cccC--CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHc
Q 014911 155 TCGT--PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt--~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 230 (416)
..|. .-|||||-++-..+ +.+||||-|||.+||++. |..||.+-...+..-.+.+|+ +++|+.+++.+..|+.+|
T Consensus 550 S~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred cccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence 2333 34999999987766 488999999999999887 999999876666666666664 789999999999999999
Q ss_pred cCCCCCCcCCHHHHh
Q 014911 231 LDPNPNSRIAISKIM 245 (416)
Q Consensus 231 L~~dP~~R~s~~eil 245 (416)
|+++|.+||.+.+|.
T Consensus 629 WayeP~kRPrftei~ 643 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIK 643 (974)
T ss_pred hccCcccCCcHHHHH
Confidence 999999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=305.26 Aligned_cols=241 Identities=29% Similarity=0.481 Sum_probs=204.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC------CCCcceEEEEEEeCCEEEEEEec
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK------HKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.|+|-||+|-.|.+..-|..||||+|..... +...=.+|+.||++|+ --|+++|+-.|...+++|+|+|.
T Consensus 440 ~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~ 515 (752)
T KOG0670|consen 440 TGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEP 515 (752)
T ss_pred cccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehh
Confidence 6999999999999999999999999976643 3456678999999996 35899999999999999999999
Q ss_pred cCCCchhhHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC-eEEeeccccccccccccCC
Q 014911 76 VKGGELFNKIAK-G---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 76 ~~gg~L~~~i~~-~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~-~kl~DFGla~~~~~~~~~~ 150 (416)
+. ..|.+.+.+ | .|....++.|+.||+.||..|-..||+|.||||.|||+++..+ +||||||.|.+... .
T Consensus 516 Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e----n 590 (752)
T KOG0670|consen 516 LS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE----N 590 (752)
T ss_pred hh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc----c
Confidence 85 489999976 3 3888999999999999999999999999999999999987654 89999999876543 3
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC------------
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW------------ 218 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~------------ 218 (416)
..+.+.-+..|.|||++.+.+|+ ...|+||.||+||||.||+..|++.+...+++..+...-++|..
T Consensus 591 eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF 669 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF 669 (752)
T ss_pred cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence 34555667789999999999997 89999999999999999999999988777766554433333311
Q ss_pred -----------------------------------------CC-------HHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 219 -----------------------------------------FS-------SEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 219 -----------------------------------------~s-------~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
++ ..+++||.+||..||.+|.|+.++|.||||
T Consensus 670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcc
Confidence 11 357899999999999999999999999999
Q ss_pred cc
Q 014911 251 KK 252 (416)
Q Consensus 251 ~~ 252 (416)
..
T Consensus 750 ~~ 751 (752)
T KOG0670|consen 750 TE 751 (752)
T ss_pred cC
Confidence 64
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.75 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=215.5
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||.|.||.||+|+.+..|+ .||||.++.... +.+...|..|+.||-+..||||++|.++......++||.||++
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 58999999999999886664 799999976543 3456789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
.|+|..+++. |.|+..++.-+++.|+.|++||-+.|+|||||-..|||++.+-.+|++|||++++..... ....++.
T Consensus 714 NGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~ 792 (996)
T KOG0196|consen 714 NGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTL 792 (996)
T ss_pred CCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-Ccccccc
Confidence 9999999975 789999999999999999999999999999999999999999999999999999776543 2333444
Q ss_pred ccC--CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014911 156 CGT--PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt--~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 231 (416)
-|. ..|.|||.+....+. .+|||||+||+|||.++ |.-||.+.+.++..+.|..+. ++.|..++..+..|+..||
T Consensus 793 GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCW 871 (996)
T KOG0196|consen 793 GGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCW 871 (996)
T ss_pred CCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHH
Confidence 443 469999999988885 88999999999999887 999999999999999998774 5667789999999999999
Q ss_pred CCCCCCcCCHHHHhcC
Q 014911 232 DPNPNSRIAISKIMES 247 (416)
Q Consensus 232 ~~dP~~R~s~~eil~h 247 (416)
++|-..||.+.||+.+
T Consensus 872 qkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 872 QKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHhhcCCCHHHHHHH
Confidence 9999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=284.06 Aligned_cols=249 Identities=25% Similarity=0.459 Sum_probs=205.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~ 76 (416)
||.|+||.||.+.|..+|+.||+|.+..-. .+......+.+|+.+|.-.+|.||+..+++..... .+|++.|++
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm 139 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM 139 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence 899999999999999999999999884322 22234567889999999999999999999876544 467888888
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
.. +|...|.. ..++.+.++.++.||+.||+|||+.||.||||||.|+|++.|..+||||||+++..+.. ....++..
T Consensus 140 QS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~~hMTqE 217 (449)
T KOG0664|consen 140 QS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DRLNMTHE 217 (449)
T ss_pred Hh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hhhhhHHH
Confidence 65 77777765 77999999999999999999999999999999999999999999999999999865432 23344555
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHh-----------------------CC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----------------------GD 212 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-----------------------~~ 212 (416)
.-|.+|+|||++.+...++...||||.|||+.||+..+..|...++.+..+.|.. +.
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~ 297 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAG 297 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccC
Confidence 6799999999999988888999999999999999999999988776655555422 11
Q ss_pred CCCCC-----------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 FKCPP-----------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 ~~~p~-----------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
...|. .-..+..+++.++|.+||++|++.++++.|++....
T Consensus 298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11121 123467899999999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.17 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=179.8
Q ss_pred CcccCCceEEEEEEEc----------------CCCcEEEEEEeecCcccc-----------hhhHHHHHHHHHHHHhCCC
Q 014911 1 MLGHGTFAKVYLARNL----------------QTGKSMAMKVVGKDKVIK-----------VGMMEQIKREISVMKMVKH 53 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~----------------~~~~~vAiK~i~~~~~~~-----------~~~~~~~~~Ei~il~~l~h 53 (416)
.||+|+||+||+|.+. ..++.||||.+....... ....+....|+.++.+++|
T Consensus 152 ~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~ 231 (507)
T PLN03224 152 KLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKR 231 (507)
T ss_pred EeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhc
Confidence 4899999999999752 345689999986432110 0011233457777777776
Q ss_pred CCc-----ceEEEEEEe--------CCEEEEEEeccCCCchhhHHhc--C-----------------------CCCHHHH
Q 014911 54 KHI-----VELHEVMAS--------KSKIYFAMDLVKGGELFNKIAK--G-----------------------RLREDVA 95 (416)
Q Consensus 54 pnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~--~-----------------------~l~e~~~ 95 (416)
.++ +++++++.. .+..|+||||+++++|.+++.. + .++...+
T Consensus 232 ~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~ 311 (507)
T PLN03224 232 NPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVI 311 (507)
T ss_pred ccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHH
Confidence 654 566666542 3568999999999999888753 1 1345678
Q ss_pred HHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcC----
Q 014911 96 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG---- 171 (416)
Q Consensus 96 ~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---- 171 (416)
+.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......+||.|+|||.+....
T Consensus 312 ~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~ 390 (507)
T PLN03224 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPR 390 (507)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCc
Confidence 88999999999999999999999999999999999999999999864322111 1111223489999999985322
Q ss_pred ----------------CC-CchhhHHHHHHHHHHHhcCCC-CCCCCcH-----------HHHHHHHHhCCCCCC--CCCC
Q 014911 172 ----------------YD-GAKADIWSCGVILYVLLAGFL-PFQDDNI-----------VSMYRKIYRGDFKCP--PWFS 220 (416)
Q Consensus 172 ----------------~~-~~~~DvwSlGvil~~lltG~~-Pf~~~~~-----------~~~~~~i~~~~~~~p--~~~s 220 (416)
|. ..+.|+||+||++|+|++|.+ ||.+... ...++.+....+.++ +..+
T Consensus 391 ~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s 470 (507)
T PLN03224 391 APAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNK 470 (507)
T ss_pred cchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccC
Confidence 11 124799999999999999876 7754211 111122222333333 4578
Q ss_pred HHHHHHHHHccCCCC---CCcCCHHHHhcCccccc
Q 014911 221 SEARRLITKLLDPNP---NSRIAISKIMESSWFKK 252 (416)
Q Consensus 221 ~~~~~li~~~L~~dP---~~R~s~~eil~hp~f~~ 252 (416)
+.+++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 471 ~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 471 EAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 999999999999766 68999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=296.76 Aligned_cols=236 Identities=25% Similarity=0.444 Sum_probs=208.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||-|-||.||.|.+++..-.||||.++.+.. ..+++..|..+|+.++|||+|+|+++|..+..+|||.||+..|.
T Consensus 274 KLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 274 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred ccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 38999999999999999999999999865532 35789999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.+ ..++.-.+..++.||.+|++||..++++||||-..|+|+.++..+|++||||+++... ...+...|
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYTAHAG 425 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYTAHAG 425 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----CceecccC
Confidence 9999976 3477777888899999999999999999999999999999999999999999997543 22222233
Q ss_pred ---CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 158 ---TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 158 ---t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..-|.|||-+....+ +.++|||+|||+|||+.| |-.||.+.+....|..+.++. ..-|..+++.+.+|++.||+
T Consensus 426 AKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred ccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 345999999987766 489999999999999999 999999999988888877763 57799999999999999999
Q ss_pred CCCCCcCCHHHHh
Q 014911 233 PNPNSRIAISKIM 245 (416)
Q Consensus 233 ~dP~~R~s~~eil 245 (416)
++|.+||++.++-
T Consensus 505 WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 505 WSPSDRPSFAEIH 517 (1157)
T ss_pred CCcccCccHHHHH
Confidence 9999999998873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.29 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=196.9
Q ss_pred CcccCCceE-EEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAK-VYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
++|.|+-|+ ||+|.. .|+.||||.+-. +..+.+.|||..|+.. .|||||++|+.-.+.+..||..|.|..
T Consensus 516 ilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 478888864 899987 789999998743 3446788999999998 599999999999999999999999976
Q ss_pred CchhhHHhcC-C----CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CC--CeEEeecccccccccccc
Q 014911 79 GELFNKIAKG-R----LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DG--NLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 79 g~L~~~i~~~-~----l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~--~~kl~DFGla~~~~~~~~ 148 (416)
+|.++++.. . ......+..+.|+++||++||+.+|+||||||.||||+. ++ .++|+|||++........
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999999762 1 112455788999999999999999999999999999986 34 589999999975543322
Q ss_pred C-CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCC---CCCCHHH
Q 014911 149 D-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCP---PWFSSEA 223 (416)
Q Consensus 149 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~ 223 (416)
. ....+..||-+|+|||++..... ..++||||+|||+|+.++ |.+||.+.-.. ...|.++....- +.-..++
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchHHH
Confidence 1 22455679999999999987655 478999999999999988 59999875432 234555554321 1112289
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccccccCccccc
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVI 259 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~ 259 (416)
.+||.+||.++|..||++.++|.||+|....++..+
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~F 779 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSF 779 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHH
Confidence 999999999999999999999999999987655433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.92 Aligned_cols=230 Identities=23% Similarity=0.327 Sum_probs=182.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|..||||.+..... ....|+.++++++||||+++++++.+.+..|+||||++||+
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 48999999999999999999999998864321 12356889999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCH---SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH---~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+..... .....+
T Consensus 770 L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~ 840 (968)
T PLN00113 770 LSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFI 840 (968)
T ss_pred HHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccc
Confidence 9999963 889999999999999999999 6799999999999999998887775 665542211 123368
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-----HHHHHHHHHh---------CCC----CCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-----IVSMYRKIYR---------GDF----KCPPWF 219 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-----~~~~~~~i~~---------~~~----~~p~~~ 219 (416)
|+.|+|||++....+ +.++||||+||++|||++|+.||+... .....+.... ... ..+...
T Consensus 841 t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (968)
T PLN00113 841 SSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919 (968)
T ss_pred cccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHH
Confidence 899999999987766 589999999999999999999996431 1111111100 000 001111
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..++.+++.+||+.||.+|||+.++++.
T Consensus 920 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 920 IVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 2356789999999999999999999853
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=288.86 Aligned_cols=241 Identities=20% Similarity=0.283 Sum_probs=198.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|-||.|.+|.- ..+..||+|.++.+... .....+.+||++|.+|+||||+++++++..++.+++++||++.|+|
T Consensus 546 iGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 546 IGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 89999999999985 45789999999776543 3457899999999999999999999999999999999999999999
Q ss_pred hhHHhcC--C-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 82 FNKIAKG--R-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 82 ~~~i~~~--~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
..++.+. + +.-....+++.||++|++||.+.+++||||.+.|+|++.++++||+|||+++-.-.......--...-.
T Consensus 623 nqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlp 702 (807)
T KOG1094|consen 623 NQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLP 702 (807)
T ss_pred HHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeee
Confidence 9999763 2 234455679999999999999999999999999999999999999999999732211111111112335
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHh--cCCCCCCCCcHHHHHHHHHh---C-----CCCCCCCCCHHHHHHHH
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLL--AGFLPFQDDNIVSMYRKIYR---G-----DFKCPPWFSSEARRLIT 228 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~ll--tG~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~s~~~~~li~ 228 (416)
..|||||.+....+. .++|+|++|+++||++ +...||...+.++..+.... . .+..|+-++..+.+|+.
T Consensus 703 iRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml 781 (807)
T KOG1094|consen 703 IRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELML 781 (807)
T ss_pred eeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHH
Confidence 679999999887774 8999999999999876 48999998877666555422 1 23567789999999999
Q ss_pred HccCCCCCCcCCHHHHhc
Q 014911 229 KLLDPNPNSRIAISKIME 246 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~ 246 (416)
+|+..|..+|||++++-.
T Consensus 782 ~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 782 RCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHhchhhhcCCCHHHHHH
Confidence 999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.97 Aligned_cols=192 Identities=29% Similarity=0.598 Sum_probs=175.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchh-----hHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----MMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 73 (416)
||.|+||+|++|.++.+...|+||.|.++++.-.. .+-.+-.||+||..|+ |+||++++++|++.+.+|++|
T Consensus 569 lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~t 648 (772)
T KOG1152|consen 569 LGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLET 648 (772)
T ss_pred ccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEe
Confidence 89999999999999999999999999988765211 1234667999999998 999999999999999999999
Q ss_pred ecc-CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCc
Q 014911 74 DLV-KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 151 (416)
Q Consensus 74 E~~-~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 151 (416)
|.- +|.+||++|+. .+++|.++..+|+|++.|+++||+.||+|||||-||+.++.+|-+||+|||.|.... .+.
T Consensus 649 e~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k----sgp 724 (772)
T KOG1152|consen 649 EVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK----SGP 724 (772)
T ss_pred cCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc----CCC
Confidence 974 56799999986 679999999999999999999999999999999999999999999999999987543 577
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 197 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~ 197 (416)
..+..||..|.|||++.+.+|.|.+-|||++|++||-+.....||-
T Consensus 725 fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 725 FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8899999999999999999999999999999999999998888874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=280.66 Aligned_cols=245 Identities=26% Similarity=0.495 Sum_probs=189.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-----C---CCcceEEEEEE----eCCE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----H---KHIVELHEVMA----SKSK 68 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~----~~~~ 68 (416)
.||.|-|++||+|.|..+.+.||+|+++... ...+....||++|++++ | .+||+|++.|. ++.+
T Consensus 85 KLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 85 KLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred eccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 3899999999999999999999999996543 34577889999999884 3 37999999995 4578
Q ss_pred EEEEEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEecc----------------
Q 014911 69 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDE---------------- 128 (416)
Q Consensus 69 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~---------------- 128 (416)
+|||+|++ |..|..+|.. ..++...++.|++|++.||.|||. .||+|.||||+|||+..
T Consensus 161 VCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~ 239 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEAT 239 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhcccc
Confidence 99999999 6799999975 459999999999999999999996 59999999999999810
Q ss_pred --------------------------------------------------------------------------------
Q 014911 129 -------------------------------------------------------------------------------- 128 (416)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (416)
T Consensus 240 ~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~ 319 (590)
T KOG1290|consen 240 TSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERS 319 (590)
T ss_pred ccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhc
Confidence
Q ss_pred ------------------C----------------------------------------------------CCeEEeecc
Q 014911 129 ------------------D----------------------------------------------------GNLKVTDFG 138 (416)
Q Consensus 129 ------------------~----------------------------------------------------~~~kl~DFG 138 (416)
+ -.+||+|||
T Consensus 320 ~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlG 399 (590)
T KOG1290|consen 320 TLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLG 399 (590)
T ss_pred ccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeecc
Confidence 0 014566666
Q ss_pred ccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc------HHHHHHHHH---
Q 014911 139 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN------IVSMYRKIY--- 209 (416)
Q Consensus 139 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~------~~~~~~~i~--- 209 (416)
-|+.... .++.-..|..|+|||++.+.+|. ..+||||++|++|||+||...|+..+ .++-+..|.
T Consensus 400 NACW~~k-----hFT~DIQTRQYRapEVllGsgY~-~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL 473 (590)
T KOG1290|consen 400 NACWVHK-----HFTEDIQTRQYRAPEVLLGSGYS-TSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL 473 (590)
T ss_pred chhhhhh-----hhchhhhhhhccCcceeecCCCC-CchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence 5553221 12333468889999999999995 88999999999999999999996421 011111111
Q ss_pred ---------hC-----------CC----CCCCC-----------C----CHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 210 ---------RG-----------DF----KCPPW-----------F----SSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 210 ---------~~-----------~~----~~p~~-----------~----s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
.| .+ .+.+| + ..++.+||.-||+.+|.+|||+.++|+|||+
T Consensus 474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence 11 11 11122 1 3567899999999999999999999999999
Q ss_pred cccCcc
Q 014911 251 KKSAPK 256 (416)
Q Consensus 251 ~~~~~~ 256 (416)
+....+
T Consensus 554 n~~~~~ 559 (590)
T KOG1290|consen 554 NPVAGP 559 (590)
T ss_pred cCCCCC
Confidence 976544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.33 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=209.1
Q ss_pred CcccCCceEEEEEEEcCCCc----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
+||+|+||+||+|.+...|+ +||||++...... .....+.+|+-+|..|+|||++++++++.... +.||++|+
T Consensus 703 vLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 703 VLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred eeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 58999999999999886666 6888888655433 34578889999999999999999999987666 88999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++|.|.|+++. +.+.......|..||++|+.|||.++++||||-..|||+..-..+||+|||++.+............
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~ 859 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPG 859 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccc
Confidence 99999999975 6788999999999999999999999999999999999999999999999999997765443332222
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..-.+.|+|=|.+....| +.++||||+||++||++| |..|+++....++-..+..++ ++.|+.++.++.-++.+||.
T Consensus 860 gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwm 938 (1177)
T KOG1025|consen 860 GKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWM 938 (1177)
T ss_pred cccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhc
Confidence 233456999999988877 499999999999999999 999999988877777766654 78899999999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.|+..||+++++..
T Consensus 939 id~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 939 IDADSRPTFKELAE 952 (1177)
T ss_pred cCcccCccHHHHHH
Confidence 99999999988754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.10 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=214.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.+|.|+||.||+|+++.+++..|+|+++.+.. ....-+.+||-+++.++||||+.+++.+...+..++.||||.||+
T Consensus 22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred eecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 37999999999999999999999999977653 345678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+.-.- |.++|.++....+..+.||+|||+.|-+|||||-.||++++.|.+|++|||.+..+.. .-.....+.|||
T Consensus 99 lQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtp 176 (829)
T KOG0576|consen 99 LQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTP 176 (829)
T ss_pred ccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhhhhhcccCCc
Confidence 9988764 9999999999999999999999999999999999999999999999999999864332 122345678999
Q ss_pred CCCchHHhh--hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccC
Q 014911 160 AYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-----PWFSSEARRLITKLLD 232 (416)
Q Consensus 160 ~y~aPE~~~--~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~ 232 (416)
+|||||+-. +.+-+...+|+|++|+...|+---.+|-.+..++.......+..+..| ..+++.+-+|++.+|.
T Consensus 177 ywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~alt 256 (829)
T KOG0576|consen 177 YWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALT 256 (829)
T ss_pred cccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhc
Confidence 999999864 333335899999999999999998888777777666555555544433 3478999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
++|++|||++.+|.|||....
T Consensus 257 knpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 257 KNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCCccCCChhhheeceeeccc
Confidence 999999999999999998754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.71 Aligned_cols=242 Identities=24% Similarity=0.423 Sum_probs=204.5
Q ss_pred CcccCCceEEEEEEEc---C----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNL---Q----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||.|++|.-. . ....||||........ ...+.+..|+.+|+.+ +||||+.+.+++...+.+++|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v 380 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVI 380 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEE
Confidence 4899999999999643 1 1457999998765543 4567899999999998 599999999999999999999
Q ss_pred EeccCCCchhhHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAKGR-----------------LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
+||+..|+|.+++...+ ++......++.||+.|++||+++.++||||-..|||+..+..+||+
T Consensus 381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIa 460 (609)
T KOG0200|consen 381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIA 460 (609)
T ss_pred EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEc
Confidence 99999999999998766 8999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCC--CCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCc-HHHHHHHHHhC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPA--YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDN-IVSMYRKIYRG 211 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~--y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~-~~~~~~~i~~~ 211 (416)
|||+|+......... .....|+.+ |||||.+....| +.++||||+||+|||+++ |..||.+.. ..+++..+..|
T Consensus 461 DFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G 538 (609)
T KOG0200|consen 461 DFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG 538 (609)
T ss_pred cccceeccCCCCceE-ecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC
Confidence 999998433211111 111222233 999999988665 599999999999999999 999999854 55667777777
Q ss_pred C-CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 212 D-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 212 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
. .+.|..+++++.++++.||+.+|.+||++.++.+
T Consensus 539 ~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 539 NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 5 4789999999999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=248.84 Aligned_cols=212 Identities=43% Similarity=0.762 Sum_probs=186.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 799999999999998889999999997654321 346789999999999999999999999999999999999999999
Q ss_pred hhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeeccccccccccccCCcccccccC
Q 014911 82 FNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 82 ~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
.+++... .++...+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999764 7999999999999999999999999999999999999999 89999999999875433211 23345578
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
..|++||.+......+.++|+|++|++++++ ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987653446899999999999999 678899999999999999
Q ss_pred CCHHHHhcCc
Q 014911 239 IAISKIMESS 248 (416)
Q Consensus 239 ~s~~eil~hp 248 (416)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=273.62 Aligned_cols=234 Identities=21% Similarity=0.364 Sum_probs=191.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMASKS----KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~----~~~lV~E 74 (416)
+||+|.||.||+|.. +++.||||++... ..+.+..|-+|.+. +.|+||+++++.-...+ .+++|++
T Consensus 217 li~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 589999999999987 6799999999543 34677888888776 47999999999876555 8999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS---------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~---------~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
|-+.|+|.+++....++.....+++..++.||+|||+ ..|+|||||..||||..|+...|+|||+|-.+..
T Consensus 289 fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred eccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 9999999999999999999999999999999999995 3599999999999999999999999999988887
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCC-----chhhHHHHHHHHHHHhcCC------------CCCC-----CCcHHH
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDG-----AKADIWSCGVILYVLLAGF------------LPFQ-----DDNIVS 203 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwSlGvil~~lltG~------------~Pf~-----~~~~~~ 203 (416)
....+.....+||.+|||||++.+.-... .+.||||+|.||||+++.- +||. .++..+
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 77777778889999999999997542211 3589999999999999742 2332 133444
Q ss_pred HHHHHHh--CCCCCCCCC-----CHHHHHHHHHccCCCCCCcCCHH
Q 014911 204 MYRKIYR--GDFKCPPWF-----SSEARRLITKLLDPNPNSRIAIS 242 (416)
Q Consensus 204 ~~~~i~~--~~~~~p~~~-----s~~~~~li~~~L~~dP~~R~s~~ 242 (416)
+...+.. ..+.+|..+ -..+.+.+..||+.||+.|+|+.
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 4444432 334445432 35688999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=243.61 Aligned_cols=203 Identities=27% Similarity=0.488 Sum_probs=167.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||+|+||.|-+.++..+|...|+|.+..... .....++.+|+.+..+ ...|.+|.+|+.+.....++|.||.+.. +
T Consensus 54 lGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 54 LGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 8999999999999999999999999965542 3445677788887555 4799999999999999999999999854 6
Q ss_pred hhhHHh----c-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 81 LFNKIA----K-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 81 L~~~i~----~-~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|..+-. . +.++|..+-+++..++.||.|||++ .++|||+||.|||++.+|++|+||||.+..... .-..+.
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiAkt~ 207 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIAKTM 207 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh---hhHHHH
Confidence 654443 2 6799999999999999999999986 899999999999999999999999999875432 112223
Q ss_pred cccCCCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhC
Q 014911 155 TCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRG 211 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~ 211 (416)
..|...|+|||.+.. .+| +.+|||||||++++||.+++.||+. .++.+.++.+...
T Consensus 208 daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 568889999999853 355 4899999999999999999999976 3455556666544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.57 Aligned_cols=245 Identities=25% Similarity=0.461 Sum_probs=194.8
Q ss_pred CcccCCceEEEEEEEcC---CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+|++||+|.+.. .++.||+|.+..... ...+.+|+++|..+ .+.||+.+.+++..++...+||||.
T Consensus 43 kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 43 KIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred cccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 48999999999999887 788999999866543 35788999999998 5999999999999999999999999
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccc--------
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLK-------- 147 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~-------- 147 (416)
+..+..++... ++-.+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|.|||+|.-.+...
T Consensus 118 ~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~ 195 (418)
T KOG1167|consen 118 EHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSY 195 (418)
T ss_pred CccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhh
Confidence 99888777754 6788999999999999999999999999999999999854 568999999996211000
Q ss_pred ------c-----------------CC-----------cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCC
Q 014911 148 ------Q-----------------DG-----------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF 193 (416)
Q Consensus 148 ------~-----------------~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~ 193 (416)
. .+ ......|||+|+|||++.+.+-.+.++||||.|||+..++++.
T Consensus 196 ~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~ 275 (418)
T KOG1167|consen 196 SGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRR 275 (418)
T ss_pred hcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccc
Confidence 0 00 0113359999999999999888889999999999999999999
Q ss_pred CCCCCCc-----HH---------HHHHHH-HhCC---------------------------CCCC----------CCCCH
Q 014911 194 LPFQDDN-----IV---------SMYRKI-YRGD---------------------------FKCP----------PWFSS 221 (416)
Q Consensus 194 ~Pf~~~~-----~~---------~~~~~i-~~~~---------------------------~~~p----------~~~s~ 221 (416)
.||-... .. .+.+.- .-+. .+.+ ..++.
T Consensus 276 ~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~ 355 (418)
T KOG1167|consen 276 YPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPA 355 (418)
T ss_pred cccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccH
Confidence 9983210 00 000000 0000 0000 11356
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
.+.+|+.+||..||.+|+|++++|+||||..
T Consensus 356 ~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 356 LLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 8999999999999999999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=264.30 Aligned_cols=237 Identities=22% Similarity=0.427 Sum_probs=186.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeC----CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMASK----SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~----~~~~lV~E 74 (416)
.||+|.||+||+|.+ .|+.||||++.... .....||.+|.+. |+|+||+.+++.-... ..+|+|.+
T Consensus 218 ~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 218 IIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 389999999999999 78999999996443 2567788998875 6999999998864322 36999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----c---CceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS-----R---GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~-----~---gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
|-+.|+|+|++.+..++-+...+++..+++||++||. + .|+|||||..|||+..+|.+-|+|+|||......
T Consensus 290 YHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred cccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 9999999999999999999999999999999999994 2 4999999999999999999999999999755443
Q ss_pred c--cCCcccccccCCCCCchHHhhhcC----CCC-chhhHHHHHHHHHHHhcC----------CCCCCC-----CcHHHH
Q 014911 147 K--QDGLLHTTCGTPAYVAPEVISKKG----YDG-AKADIWSCGVILYVLLAG----------FLPFQD-----DNIVSM 204 (416)
Q Consensus 147 ~--~~~~~~~~~gt~~y~aPE~~~~~~----~~~-~~~DvwSlGvil~~lltG----------~~Pf~~-----~~~~~~ 204 (416)
. -+-..+..+||.+|||||++...- +.+ ..+||||+|.|+||++.. .+||.+ ++.+++
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 2 122356779999999999985421 111 358999999999999752 778854 344455
Q ss_pred HHHHH--hCCCCCCCCC-CH----HHHHHHHHccCCCCCCcCCHHHHh
Q 014911 205 YRKIY--RGDFKCPPWF-SS----EARRLITKLLDPNPNSRIAISKIM 245 (416)
Q Consensus 205 ~~~i~--~~~~~~p~~~-s~----~~~~li~~~L~~dP~~R~s~~eil 245 (416)
.+-+. +-.+..|+++ |. .+..+++.||..||.-|.|+--|.
T Consensus 450 rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 450 RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 44432 2234555544 32 355789999999999999986653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-31 Score=243.28 Aligned_cols=214 Identities=44% Similarity=0.719 Sum_probs=181.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||.|++|+||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+......++++|++.+++
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 6 KLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred EeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 379999999999999888999999999765432 246788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. .. +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+....... ........++
T Consensus 84 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~ 162 (225)
T smart00221 84 LFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLKTVKGT 162 (225)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cccccceecc
Confidence 9999976 34 8999999999999999999999999999999999999999999999999987654322 1133455788
Q ss_pred CCCCchHHh-hhcCCCCchhhHHHHHHHHHHHhcCCCCCCC--CcHHHHHHHHHhCCCCCCCC
Q 014911 159 PAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRGDFKCPPW 218 (416)
Q Consensus 159 ~~y~aPE~~-~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~--~~~~~~~~~i~~~~~~~p~~ 218 (416)
..|++||.+ ....+ +.++|+||||+++++|++|+.||.. .+...+.+.+..+.....+|
T Consensus 163 ~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 163 PFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred CCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 899999998 44444 4699999999999999999999987 44457777787776544443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=246.16 Aligned_cols=243 Identities=28% Similarity=0.452 Sum_probs=192.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEV-MASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~~~lV~E~~~g 78 (416)
.||+|.||++.+|.++.++..+++|.+.++... ...+.+|..---.| .|.||+.-|++ |.+.+.+.++|||++-
T Consensus 31 ~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~ 106 (378)
T KOG1345|consen 31 QLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPR 106 (378)
T ss_pred HhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCcc
Confidence 489999999999999999999999999876543 46777887764444 59999998876 6778899999999999
Q ss_pred CchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC--CCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED--GNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|+|..-+....+.|....+++.|+++|+.|||++++||||||.+||||-.. -.+||||||+++... .......
T Consensus 107 gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-----~tV~~~~ 181 (378)
T KOG1345|consen 107 GDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-----TTVKYLE 181 (378)
T ss_pred chhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC-----ceehhhh
Confidence 999999988779999999999999999999999999999999999999533 369999999876322 2223334
Q ss_pred cCCCCCchHHhhhcC----CCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCC-CCCCC---CCCHHHH
Q 014911 157 GTPAYVAPEVISKKG----YDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGD-FKCPP---WFSSEAR 224 (416)
Q Consensus 157 gt~~y~aPE~~~~~~----~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~-~~~p~---~~s~~~~ 224 (416)
-+..|.|||++.... ...+.+|+|.||+|+|.+|||.+||.... ....+.++..+. ...|. .+|+.+.
T Consensus 182 ~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~ 261 (378)
T KOG1345|consen 182 YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKAL 261 (378)
T ss_pred hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHH
Confidence 567799999875332 11367899999999999999999997532 223344444332 34443 3789999
Q ss_pred HHHHHccCCCCCCc---CCHHHHhcCccccc
Q 014911 225 RLITKLLDPNPNSR---IAISKIMESSWFKK 252 (416)
Q Consensus 225 ~li~~~L~~dP~~R---~s~~eil~hp~f~~ 252 (416)
.+.++-|.++|++| .++......-|...
T Consensus 262 r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 262 RLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred HHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 99999999999999 56666666777643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=290.20 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=205.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecC---cccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKD---KVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
++|.|++|.|+.+......+.++.|.+... ..........+..|..+-..+.|||++.....+......+-.||||+
T Consensus 325 ~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~ 404 (601)
T KOG0590|consen 325 VLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCP 404 (601)
T ss_pred eeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhccc
Confidence 479999999999988877777777766522 11111222337778888889999999888777766666666699999
Q ss_pred CCchhhHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC--Ccccc
Q 014911 78 GGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLLHT 154 (416)
Q Consensus 78 gg~L~~~i~~~-~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~ 154 (416)
+ +|+.++... +++..++..+++||+.||+|||+.||.|||+||+|++++.+|.+||+|||.+..+...... .....
T Consensus 405 ~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g 483 (601)
T KOG0590|consen 405 Y-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSG 483 (601)
T ss_pred H-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcC
Confidence 9 999999884 8999999999999999999999999999999999999999999999999999877665554 55677
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHH--HHHHhCC-------CCCCCCCCHHHHH
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY--RKIYRGD-------FKCPPWFSSEARR 225 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~--~~i~~~~-------~~~p~~~s~~~~~ 225 (416)
.+|+.+|+|||++....|+....||||+|++++.|.+|+.||......+.. ....... ..+-..++...+.
T Consensus 484 ~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~ 563 (601)
T KOG0590|consen 484 IVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRI 563 (601)
T ss_pred cccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHH
Confidence 899999999999999999999999999999999999999999765433221 1111111 1111236788999
Q ss_pred HHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 226 LITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+|.+||++||.+|+|+++|++.+||+..
T Consensus 564 ~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 564 IIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHccCChhheecHHHHhhChHhhhc
Confidence 9999999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=292.47 Aligned_cols=200 Identities=16% Similarity=0.216 Sum_probs=147.9
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccC
Q 014911 50 MVKH-KHIVELHEVM-------ASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119 (416)
Q Consensus 50 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDl 119 (416)
.+.| +||+++++.+ .....++.++|++ +++|.+++.. +.+++.++..++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 6888888877 2334677888887 5699999965 45999999999999999999999999999999
Q ss_pred CCCcEEeccC-------------------CCeEEeecccccccccccc--------------CCcccccccCCCCCchHH
Q 014911 120 KPENLLLDED-------------------GNLKVTDFGLSAFSEHLKQ--------------DGLLHTTCGTPAYVAPEV 166 (416)
Q Consensus 120 kp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPE~ 166 (416)
||+||||+.. +.+|++|||+++....... .......+||++|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 4456666666643211000 000112468999999999
Q ss_pred hhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHh
Q 014911 167 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIM 245 (416)
Q Consensus 167 ~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil 245 (416)
+.+..| +.++|||||||+||||++|.+|+..... ....+..... +.+....+...+++.+||++||.+|||+.+++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988777 5899999999999999999999864321 1222221111 11111245678999999999999999999999
Q ss_pred cCcccccc
Q 014911 246 ESSWFKKS 253 (416)
Q Consensus 246 ~hp~f~~~ 253 (416)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=233.62 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=198.6
Q ss_pred cccCCceEEEEEEEcCCC-----cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 014911 2 LGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA-SKSKIYFAMDL 75 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 75 (416)
+-+|+||.||.|++.+.. +.|-+|.+.... ++-+...+..|...+..+.|||+....++.. +....+.++.+
T Consensus 292 lqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 292 LQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 568999999999776432 345556554332 2234567888999999999999999999864 55678888888
Q ss_pred cCCCchhhHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 76 VKGGELFNKIAK---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 76 ~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
..-|+|..++.. ..++..+...++.|+..|++|||++||+|.||-..|++||+.-.+||+|=.+++...+.
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPG 449 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcc
Confidence 888999998861 23677788889999999999999999999999999999999999999999998754332
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHH
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 224 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 224 (416)
.-.-.-........||+||.+....|. ..+|+|||||+||||+| |+.||.+-++.++...+.+|. +..|-.+++++.
T Consensus 450 DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf 528 (563)
T KOG1024|consen 450 DYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELF 528 (563)
T ss_pred cccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHH
Confidence 222122233345679999999988775 88999999999999999 999999999999999998874 577889999999
Q ss_pred HHHHHccCCCCCCcCCHHHHhc
Q 014911 225 RLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~ 246 (416)
.++.-||+.+|++||+++|+..
T Consensus 529 ~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 529 TVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=221.76 Aligned_cols=157 Identities=25% Similarity=0.292 Sum_probs=128.1
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|+|.+++.. +.+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 689999974 45999999999999999999999999 999999999999999 9998754331 236
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCCCC-------CCCCCH--HHHHH
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFKC-------PPWFSS--EARRL 226 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~l 226 (416)
||+.|+|||++.+..+. .++||||+||++|+|++|..||..... ......+....... +..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887774 899999999999999999999976543 23333333221111 122344 69999
Q ss_pred HHHccCCCCCCcCCHHHHhcCcccc
Q 014911 227 ITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 227 i~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
|.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-27 Score=224.02 Aligned_cols=249 Identities=36% Similarity=0.604 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||.|+||.||++.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++++.++
T Consensus 7 ~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 7 KLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred eecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 3799999999999986 78999999877655433577899999999999988 7999999998888899999999999
Q ss_pred chhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCC----
Q 014911 80 ELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDG---- 150 (416)
Q Consensus 80 ~L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~---- 150 (416)
++.+.+... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+..........
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (384)
T COG0515 84 SLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163 (384)
T ss_pred cHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccc
Confidence 999777653 699999999999999999999999999999999999999998 69999999987443322221
Q ss_pred cccccccCCCCCchHHhhhc--CCCCchhhHHHHHHHHHHHhcCCCCCCCCcH----HHHHHHHHhCCCC-CCCCCC---
Q 014911 151 LLHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFK-CPPWFS--- 220 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~~s--- 220 (416)
.....+||+.|+|||.+... .+.....|+||+|++++++++|..||..... ......+.....+ ......
T Consensus 164 ~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (384)
T COG0515 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243 (384)
T ss_pred cccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccc
Confidence 34677899999999999874 4556899999999999999999999987763 4555555544433 222222
Q ss_pred -----HHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 221 -----SEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 221 -----~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
..+.+++..++..+|..|.+..+...++|...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 244 PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 47899999999999999999999988866543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-30 Score=254.50 Aligned_cols=239 Identities=35% Similarity=0.621 Sum_probs=209.2
Q ss_pred CcccCCceEEEEEEE---cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARN---LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
++|.|+||+|++++. .+.|..+|+|+..+......... ....|..++..++ ||.+++++..+..+...|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 689999999998853 35677899999977665432222 5667888888887 999999999999999999999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
.||+|+..+.. ..+.+...+.+...++-+++++|+.||+|||+|++||+++.+|++++.|||++...-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999999876 56888889999999999999999999999999999999999999999999998754322 222
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|||..|||||++. ++ ...+|.||+|+++|+|++|..||.. +....|.+..+..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 44 3789999999999999999999998 677788888999999999999999999999999
Q ss_pred CCcCC-----HHHHhcCcccccc
Q 014911 236 NSRIA-----ISKIMESSWFKKS 253 (416)
Q Consensus 236 ~~R~s-----~~eil~hp~f~~~ 253 (416)
.+|.- ..++++|+||+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99986 4799999999764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=229.26 Aligned_cols=159 Identities=23% Similarity=0.226 Sum_probs=125.2
Q ss_pred CcccCCceEEEEEEEcC-CCcEEEEEEeecCcc--cchhhHHHHHHHHHHHHhCCCCCcce-EEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKV--IKVGMMEQIKREISVMKMVKHKHIVE-LHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++.. +++.||||++..... ........+.+|+.+|+.++|+||+. +++. +..|+||||+
T Consensus 25 ~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~ 100 (365)
T PRK09188 25 VLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWT 100 (365)
T ss_pred EEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEcc
Confidence 48999999999999876 788889998753311 12234567999999999999999985 5442 4589999999
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccC-CCCcEEeccCCCeEEeeccccccccccccCCc----
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL-KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL---- 151 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDl-kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~---- 151 (416)
+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|...........
T Consensus 101 ~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~ 174 (365)
T PRK09188 101 EGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAY 174 (365)
T ss_pred CCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhh
Confidence 99999732 21 11 1568899999999999999999999 99999999999999999999986654332222
Q ss_pred --ccccccCCCCCchHHhhh
Q 014911 152 --LHTTCGTPAYVAPEVISK 169 (416)
Q Consensus 152 --~~~~~gt~~y~aPE~~~~ 169 (416)
..+.++++.|+|||.+..
T Consensus 175 ~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 175 EDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhccCccCCcccCCh
Confidence 246678999999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=212.80 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=187.6
Q ss_pred CcccCCceEEEEEEEcCCC-cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH----KHIVELHEVM-ASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~~~lV~E 74 (416)
.||+|+||.||.|.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.. ..+...|+||+
T Consensus 25 ~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 25 KIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred eccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 4899999999999997775 6899998866543221 267889999998873 6999999999 57889999999
Q ss_pred ccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-----CeEEeecccccccccc
Q 014911 75 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-----NLKVTDFGLSAFSEHL 146 (416)
Q Consensus 75 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-----~~kl~DFGla~~~~~~ 146 (416)
.+ |.+|.++... ++++...+..++.|++.+|.+||+.|++||||||.|+++...+ .+.|.|||+++.+...
T Consensus 102 l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~ 180 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYV 180 (322)
T ss_pred cc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccccc
Confidence 98 7799998753 6799999999999999999999999999999999999998653 5999999999833321
Q ss_pred ccCC-------c-ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH---HHHHHHHhCCC-C
Q 014911 147 KQDG-------L-LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---SMYRKIYRGDF-K 214 (416)
Q Consensus 147 ~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~---~~~~~i~~~~~-~ 214 (416)
...+ . .....||..|.++.+..+... +.+.|+||++.++.+|+.|.+||...... ..+........ .
T Consensus 181 ~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T KOG1164|consen 181 GDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD 259 (322)
T ss_pred CCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc
Confidence 1111 1 123459999999999887765 58999999999999999999999765432 22222222211 1
Q ss_pred -CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 215 -CPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 215 -~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.....+..+..+...+-..+...+|....+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 260 RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 223345677777777777899999998877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=234.77 Aligned_cols=215 Identities=35% Similarity=0.661 Sum_probs=170.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+|..|+||.||+++++.+.+.+|+|+ +++.+. +++ |+.....|.+| |+
T Consensus 90 lisngAygavylvrh~~trqrfa~ki-Nkq~li-------lRn---ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 90 LISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-------LRN---ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeccCCCCceeeeeccccccchhhcc-cccchh-------hhc---cccccCCccee---------------------ch
Confidence 46789999999999999999999954 333221 111 34444455444 45
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc------------
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK------------ 147 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~------------ 147 (416)
-...++. |.++.+. +.+++|+|+.||+|||+||+|++|+.-|++|++|||++..--...
T Consensus 138 c~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~ 209 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKD 209 (1205)
T ss_pred hhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHH
Confidence 5555554 5666544 779999999999999999999999999999999999985321110
Q ss_pred -cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC---CCHHH
Q 014911 148 -QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---FSSEA 223 (416)
Q Consensus 148 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~~~ 223 (416)
..-.....||||.|+|||++..++| |..+|+|++|+|+|+++-|..||.++++++++..........|.. +++++
T Consensus 210 t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea 288 (1205)
T KOG0606|consen 210 THEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEA 288 (1205)
T ss_pred HHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHH
Confidence 1112234599999999999999998 699999999999999999999999999999999988877777654 68999
Q ss_pred HHHHHHccCCCCCCcC---CHHHHhcCccccccCcc
Q 014911 224 RRLITKLLDPNPNSRI---AISKIMESSWFKKSAPK 256 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~---s~~eil~hp~f~~~~~~ 256 (416)
+++|.++|+.+|..|. .+-++.+|+||+.-...
T Consensus 289 ~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 289 QDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 9999999999999996 46788899999875544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=197.60 Aligned_cols=139 Identities=21% Similarity=0.273 Sum_probs=111.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh-----------------------hHHHHHHHHHHHHhCCCCCcc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----------------------MMEQIKREISVMKMVKHKHIV 57 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpnIv 57 (416)
.||+|+||.||+|.+. +|+.||||+++........ ......+|+.++..+.++++.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 4 CISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred ccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4899999999999986 8999999999765321111 012345699999999888775
Q ss_pred eEEEEEEeCCEEEEEEeccCCCchhhH-HhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEeccCCCeEEe
Q 014911 58 ELHEVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 58 ~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~~~~qll~aL~yl-H~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
....+.... .++||||++|+++... +..+.+++..+..++.|++.+|.|+ |+.||+||||||+||+++ ++.++|+
T Consensus 83 ~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~Li 159 (190)
T cd05147 83 CPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYII 159 (190)
T ss_pred CCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEE
Confidence 544332222 3899999999877655 4457899999999999999999999 799999999999999998 5789999
Q ss_pred eccccccc
Q 014911 136 DFGLSAFS 143 (416)
Q Consensus 136 DFGla~~~ 143 (416)
|||+|...
T Consensus 160 DFG~a~~~ 167 (190)
T cd05147 160 DVSQSVEH 167 (190)
T ss_pred EccccccC
Confidence 99998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=202.33 Aligned_cols=228 Identities=27% Similarity=0.361 Sum_probs=150.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC----------CCcceEEEEEEe-----
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH----------KHIVELHEVMAS----- 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~~----- 65 (416)
.||.|+++.||.+.+..||+.+|+|++...........+.+++|.-....+.+ -.++..++...-
T Consensus 19 ~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~ 98 (288)
T PF14531_consen 19 IIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPP 98 (288)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-S
T ss_pred ccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCc
Confidence 48999999999999999999999999987765455567888888866655432 234444443321
Q ss_pred -------CCE-----EEEEEeccCCCchhhHHhc----CCC---CHHHHH-HHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 014911 66 -------KSK-----IYFAMDLVKGGELFNKIAK----GRL---REDVAR-VYFQQLISAVDFCHSRGVYHRDLKPENLL 125 (416)
Q Consensus 66 -------~~~-----~~lV~E~~~gg~L~~~i~~----~~l---~e~~~~-~~~~qll~aL~ylH~~gi~HrDlkp~NIl 125 (416)
.+. .+++|.-+. ++|.+.+.- ... ....++ .+..|++..+++||+.|++|+||+|+|++
T Consensus 99 ~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfl 177 (288)
T PF14531_consen 99 FFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFL 177 (288)
T ss_dssp EEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred ceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEE
Confidence 112 356777764 488777642 222 122333 34489999999999999999999999999
Q ss_pred eccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcC-------CCCchhhHHHHHHHHHHHhcCCCCCCC
Q 014911 126 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG-------YDGAKADIWSCGVILYVLLAGFLPFQD 198 (416)
Q Consensus 126 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DvwSlGvil~~lltG~~Pf~~ 198 (416)
++.+|.+.|+||+...-.... ......+..|.+||...... ..+.+.|.|+||+++|.|+||..||+.
T Consensus 178 l~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 178 LDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp E-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred EcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 999999999999876532221 11133457799999875531 125789999999999999999999987
Q ss_pred CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 199 DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 199 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
......... .--.+. .+++.++.||+.+|++||.+|
T Consensus 253 ~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 654321110 111344 788999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=231.27 Aligned_cols=232 Identities=25% Similarity=0.357 Sum_probs=177.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCc-ccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDK-VIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||.+.|=+|.+|++. .|. |+||++-+.. ...-....+..+|++ ...++|||.+.+.-+.......|+|-+|+.. +
T Consensus 31 LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-n 106 (1431)
T KOG1240|consen 31 LGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-N 106 (1431)
T ss_pred cCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-h
Confidence 899999999999984 454 8999997654 222222333444555 5667999999999998888899999999987 9
Q ss_pred hhhHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccc--cccccCC---cccc
Q 014911 81 LFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS--EHLKQDG---LLHT 154 (416)
Q Consensus 81 L~~~i~~~~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~--~~~~~~~---~~~~ 154 (416)
|+|++..++ +..-+.+.|+.||+.||.-||..||+|||||.|||||+.-+-+.|+||..-... .+.++.. .+.|
T Consensus 107 LyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDT 186 (1431)
T KOG1240|consen 107 LYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDT 186 (1431)
T ss_pred hhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEec
Confidence 999998755 667788889999999999999999999999999999999888999999854321 1111111 1233
Q ss_pred cccCCCCCchHHhhhcC----------CCCchhhHHHHHHHHHHHhc-CCCCCCCCc-----------HHHHHHHHHhCC
Q 014911 155 TCGTPAYVAPEVISKKG----------YDGAKADIWSCGVILYVLLA-GFLPFQDDN-----------IVSMYRKIYRGD 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~----------~~~~~~DvwSlGvil~~llt-G~~Pf~~~~-----------~~~~~~~i~~~~ 212 (416)
...-.+|+|||.+.... .-+++.||||+||++.||++ |.+||.-.. .....++|
T Consensus 187 SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I---- 262 (1431)
T KOG1240|consen 187 SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI---- 262 (1431)
T ss_pred CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC----
Confidence 33445699999986522 12568999999999999998 899996432 12222222
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 213 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 213 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
-+..+++||..|++.||++|.|+++.|+.
T Consensus 263 ------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 263 ------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 14578999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=190.23 Aligned_cols=139 Identities=19% Similarity=0.262 Sum_probs=113.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh-----------------------hHHHHHHHHHHHHhCCCCCcc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----------------------MMEQIKREISVMKMVKHKHIV 57 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpnIv 57 (416)
.||+|+||.||+|.+. +|+.||||+++........ ....+.+|+..+.++.|++|.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 4 CISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred eeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4899999999999986 8999999999865321000 023356899999999999886
Q ss_pred eEEEEEEeCCEEEEEEeccCCCchhh-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEe
Q 014911 58 ELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 58 ~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
....+.... .|+||||++|+++.. .+..+++++..+..++.|++.+|.++|+ +||+||||||+||+++ ++.++|+
T Consensus 83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~li 159 (190)
T cd05145 83 VPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYII 159 (190)
T ss_pred CceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEE
Confidence 655544333 489999999886544 3556778999999999999999999999 9999999999999998 8899999
Q ss_pred eccccccc
Q 014911 136 DFGLSAFS 143 (416)
Q Consensus 136 DFGla~~~ 143 (416)
|||+++..
T Consensus 160 DFG~a~~~ 167 (190)
T cd05145 160 DVSQAVEL 167 (190)
T ss_pred Ecccceec
Confidence 99998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-24 Score=194.20 Aligned_cols=165 Identities=16% Similarity=0.229 Sum_probs=128.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHH------HHHHHHHHHhCCCCCcceEEEEEEeC--------
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ------IKREISVMKMVKHKHIVELHEVMASK-------- 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~~-------- 66 (416)
+||.|+||.||++.+ ++..+|||++............. +.+|+..+.++.||+|..+.+++...
T Consensus 38 ~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~ 115 (232)
T PRK10359 38 VFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYA 115 (232)
T ss_pred EecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccccc
Confidence 489999999999755 57789999997665444444334 68999999999999999999986543
Q ss_pred CEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 67 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
+..+++|||++|.+|.+... ++++ ...+++.+|..||+.|++|||+||.||+++++| ++|+|||.+......
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~---~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE---ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred CCeEEEEEEECCccHHHhhh---ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccch
Confidence 35899999999999988732 3432 456999999999999999999999999999998 999999987633211
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHh
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 190 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~ll 190 (416)
. ....++....|. .++|+||||+++..+.
T Consensus 188 ~--------------a~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 188 K--------------AKDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred h--------------hHHHHHHHhHhc-ccccccceeEeehHHH
Confidence 1 011144455666 7899999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-25 Score=233.35 Aligned_cols=250 Identities=32% Similarity=0.523 Sum_probs=212.5
Q ss_pred cccCCceEEEEEEEcC-CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+|+|+.|-.+.... +...+|+|.+.... ........+..|..+-+.+. |+|++.+++........++.++|..|+
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 7999999999998754 44467777765543 23355677888999999997 999999999999999999999999999
Q ss_pred chhhHH-hcC--CCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEeccCC-CeEEeeccccccccc-cccCCccc
Q 014911 80 ELFNKI-AKG--RLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEH-LKQDGLLH 153 (416)
Q Consensus 80 ~L~~~i-~~~--~l~e~~~~~~~~qll~aL~ylH-~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~-~~~~~~~~ 153 (416)
++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ +++++|||+|+.+.. .+......
T Consensus 107 ~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~ 186 (601)
T KOG0590|consen 107 SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLK 186 (601)
T ss_pred ccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeee
Confidence 999999 552 5888999999999999999999 99999999999999999999 999999999998777 56666777
Q ss_pred cccc-CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHH-HHHHHhC--C--CCCCCCCCHHHHHHH
Q 014911 154 TTCG-TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM-YRKIYRG--D--FKCPPWFSSEARRLI 227 (416)
Q Consensus 154 ~~~g-t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~-~~~i~~~--~--~~~p~~~s~~~~~li 227 (416)
..|| ++.|+|||...+..|.+...|+||+|+++..+++|..||........ +..+... . ......++....+++
T Consensus 187 ~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (601)
T KOG0590|consen 187 DRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLL 266 (601)
T ss_pred cccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcc
Confidence 8899 99999999999888889999999999999999999999987654322 1222222 1 222334788999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccccc
Q 014911 228 TKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
.++|..+|..|.+.+++..+||+..
T Consensus 267 ~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 267 HKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccCCchhccccccccccccccc
Confidence 9999999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-23 Score=182.69 Aligned_cols=233 Identities=22% Similarity=0.343 Sum_probs=184.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||.|+||.+|+|....+|+.||||+-+...- ..++..|..+.+.|++ +.|..+..+..++..-.+||+.. |.+
T Consensus 23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 23 IGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred ecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 8999999999999999999999998754432 2467789999999974 78888888888899999999998 778
Q ss_pred hhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC---CCeEEeeccccccccccccC-----C
Q 014911 81 LFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHLKQD-----G 150 (416)
Q Consensus 81 L~~~i~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~-----~ 150 (416)
|.++.. ..+++-..+.-++-|++.-++|+|.++.+||||||+|+|..-+ ..+-++|||+|..+...... .
T Consensus 97 LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyr 176 (341)
T KOG1163|consen 97 LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYR 176 (341)
T ss_pred HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccc
Confidence 988875 4779999999999999999999999999999999999999644 35899999999866543322 1
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---cHHHHHHHHHhCCCCCC-----CCCCHH
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCP-----PWFSSE 222 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~~~p-----~~~s~~ 222 (416)
......||..|.+--...+... +..-|+=|+|.+|.++.-|.+||.+- +...-+++|.....+.| ..++.+
T Consensus 177 e~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~E 255 (341)
T KOG1163|consen 177 EDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAE 255 (341)
T ss_pred cCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHH
Confidence 2234568999988666554433 46789999999999999999999884 44466777776666555 347788
Q ss_pred HHHHHHHccCCCCCCcCCH
Q 014911 223 ARRLITKLLDPNPNSRIAI 241 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~ 241 (416)
+.-.+.-|=..--.+-|..
T Consensus 256 F~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 256 FAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHHHHHHHhhcCCCCCCcH
Confidence 8877777765555555553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=183.11 Aligned_cols=188 Identities=20% Similarity=0.256 Sum_probs=140.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh-hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-MMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+|++|+||+||++.. .+.+++.+.+......... ....+.+|+++|++|+ |++|++++++ +..|++|||+.|
T Consensus 9 ~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 9 PLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 489999999998875 6777887766544322111 1225789999999995 5889999886 457999999999
Q ss_pred CchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccC-CCCcEEeccCCCeEEeeccccccccccccC------C-
Q 014911 79 GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL-KPENLLLDEDGNLKVTDFGLSAFSEHLKQD------G- 150 (416)
Q Consensus 79 g~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDl-kp~NIll~~~~~~kl~DFGla~~~~~~~~~------~- 150 (416)
.+|...+..+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|......... .
T Consensus 83 ~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 83 AAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred ccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 9987654222 1357889999999999999999999 799999999999999999999854432210 0
Q ss_pred ----cccccccCCCCCchHHhhhcCCCC-chhhHHHHHHHHHHHhcCCCCCCCCc
Q 014911 151 ----LLHTTCGTPAYVAPEVISKKGYDG-AKADIWSCGVILYVLLAGFLPFQDDN 200 (416)
Q Consensus 151 ----~~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwSlGvil~~lltG~~Pf~~~~ 200 (416)
...-...++.|++|+...-....+ ...+.++.|+-+|.++|+..|+.+++
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 011123688999998754321112 56799999999999999999876544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=185.11 Aligned_cols=132 Identities=20% Similarity=0.241 Sum_probs=108.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE-E
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-----KHKHIVELHEVMASKS---KIY-F 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~-l 71 (416)
+||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||+++++++.++. .++ +
T Consensus 9 ~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 9 PLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred eecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 589999999995 7777766 6999866432 2346789999999999 5799999999998874 444 7
Q ss_pred EEec--cCCCchhhHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCceeccCCCCcEEeccC----CCeEEeecccc
Q 014911 72 AMDL--VKGGELFNKIAKGRLREDVARVYFQQLISAV-DFCHSRGVYHRDLKPENLLLDED----GNLKVTDFGLS 140 (416)
Q Consensus 72 V~E~--~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL-~ylH~~gi~HrDlkp~NIll~~~----~~~kl~DFGla 140 (416)
|+|| +.+|+|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 557999999988777776 35678888777 99999999999999999999743 37999995433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=185.91 Aligned_cols=233 Identities=21% Similarity=0.336 Sum_probs=181.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+.+.|.+.-++++||||.-... ..+.+++.|.+..+.|. .++|...|.+...+-+-.+|||++ |-
T Consensus 35 KIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 35 KIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred ccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 389999999999999999999999976433 23468999999999985 799999999988888899999998 66
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-----CeEEeeccccccccccccC---
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-----NLKVTDFGLSAFSEHLKQD--- 149 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-----~~kl~DFGla~~~~~~~~~--- 149 (416)
+|.|+..- .+|+...+.-++.|++.-++|+|++.+|+|||||+|+||..-+ .+-++|||+|..+......
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI 188 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI 188 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence 88888753 6799999999999999999999999999999999999997443 4899999999866543221
Q ss_pred --CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC---CcHHHHHHHHHhCCCCCC-----CCC
Q 014911 150 --GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDFKCP-----PWF 219 (416)
Q Consensus 150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~~p-----~~~ 219 (416)
+......||..||+=-...+..- +..-|+=|||-+++++|-|.+||.+ ++...-|++|-...-..| ..+
T Consensus 189 PYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~ 267 (449)
T KOG1165|consen 189 PYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGF 267 (449)
T ss_pred ccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcC
Confidence 22345579999999766666554 4788999999999999999999987 455667777754433222 234
Q ss_pred CHHHHHHHHHccCCCCCCcCC
Q 014911 220 SSEARRLITKLLDPNPNSRIA 240 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s 240 (416)
+.++..-++-.=..+-.+-|.
T Consensus 268 P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 268 PEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred HHHHHHHHHHHHhcCcccCCC
Confidence 555544444433333333343
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=184.25 Aligned_cols=198 Identities=26% Similarity=0.414 Sum_probs=148.5
Q ss_pred CCCCcceEEEEEEe---------------------------CCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHH
Q 014911 52 KHKHIVELHEVMAS---------------------------KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 104 (416)
Q Consensus 52 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~ 104 (416)
+|||||++...|.+ +..+|+||..... +|..++.....+....+-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999887632 2358999987755 9999998888889999999999999
Q ss_pred HHHHHHHcCceeccCCCCcEEecc--CC--CeEEeeccccccccccccC----CcccccccCCCCCchHHhhhcC-----
Q 014911 105 AVDFCHSRGVYHRDLKPENLLLDE--DG--NLKVTDFGLSAFSEHLKQD----GLLHTTCGTPAYVAPEVISKKG----- 171 (416)
Q Consensus 105 aL~ylH~~gi~HrDlkp~NIll~~--~~--~~kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----- 171 (416)
|+.|||++||.|||+|..|||+.- |+ .+.|+|||.+--.+...-. ...-..-|.-.-||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 999999999999999999999953 33 3899999976422221100 0111234677899999986432
Q ss_pred CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHccCCCCCCcCCH---HHHhc
Q 014911 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--RGDFKCPPWFSSEARRLITKLLDPNPNSRIAI---SKIME 246 (416)
Q Consensus 172 ~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~---~eil~ 246 (416)
.+-.++|.|++|.+.||+++...||.....+-+-..-+ ......|..+++.+++|+..+|+.||++|+|. ..+++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11258999999999999999999998754332211111 12346788899999999999999999999994 45555
Q ss_pred Cccc
Q 014911 247 SSWF 250 (416)
Q Consensus 247 hp~f 250 (416)
-..|
T Consensus 513 LsLw 516 (598)
T KOG4158|consen 513 LSLW 516 (598)
T ss_pred HHHh
Confidence 4333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=177.54 Aligned_cols=232 Identities=19% Similarity=0.326 Sum_probs=185.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
|.+.-.|+.|+|++.+ ..++.|++....... .....+..|.-.|+...||||+.+++.+..+.++.++..|++-|+|
T Consensus 198 l~e~hsgelwrgrwqg--ndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 198 LAESHSGELWRGRWQG--NDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hccCCCcccccccccC--cchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4556679999999944 456668776544332 2335677888889999999999999999999999999999999999
Q ss_pred hhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCCeEEe--eccccccccccccCCcccc
Q 014911 82 FNKIAKG---RLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVT--DFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 82 ~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~ 154 (416)
+..+..+ -.+..++.+++.+++.|++|||+.. |..--|....+++|++...+|+ |--++. .. ..
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--qe-------~g 345 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE-------VG 345 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--ec-------cc
Confidence 9999864 3678899999999999999999875 5555688999999998876654 332221 11 11
Q ss_pred cccCCCCCchHHhhhcCCCC--chhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVISKKGYDG--AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~--~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 230 (416)
..-+|.|++||.+.+.+.+. ..+|+||+.++++||-|...||.+-.+++.--+|.-. ...+||.+|..+..|++-|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ic 425 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNIC 425 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHH
Confidence 23488999999998876543 4689999999999999999999998877655555432 4678999999999999999
Q ss_pred cCCCCCCcCCHHHHh
Q 014911 231 LDPNPNSRIAISKIM 245 (416)
Q Consensus 231 L~~dP~~R~s~~eil 245 (416)
+..||.+||.+..++
T Consensus 426 mnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 426 MNEDPGKRPKFDMIV 440 (448)
T ss_pred hcCCCCcCCCcceeh
Confidence 999999999987664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-20 Score=168.08 Aligned_cols=136 Identities=21% Similarity=0.320 Sum_probs=115.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+.|++|.....++...+..+++|||
T Consensus 3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 489999999999987 778899998654332211 1234678899999999999998888777778889999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999865322 7889999999999999999999999999999999 78999999998874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=174.22 Aligned_cols=137 Identities=18% Similarity=0.191 Sum_probs=109.5
Q ss_pred CcccCCceEEEEEE-EcCCCcEEEEEEeecCcccch---------------------hhHHHHHHHHHHHHhCCCC--Cc
Q 014911 1 MLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKV---------------------GMMEQIKREISVMKMVKHK--HI 56 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~-~~~~~~~vAiK~i~~~~~~~~---------------------~~~~~~~~Ei~il~~l~hp--nI 56 (416)
.||+|+||.||+|. +..+|+.||||++........ .....+.+|+.+++.+.+. .+
T Consensus 35 ~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~ 114 (237)
T smart00090 35 CISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPV 114 (237)
T ss_pred eeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48999999999999 668999999999976432100 0113467899999999753 34
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchhhHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEeccCCCeEE
Q 014911 57 VELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG-VYHRDLKPENLLLDEDGNLKV 134 (416)
Q Consensus 57 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~~~~qll~aL~ylH~~g-i~HrDlkp~NIll~~~~~~kl 134 (416)
.++++. ...|+||||+.|++|.... ....+.+..+..++.|++.+|.+||++| ++||||||+||+++ ++.++|
T Consensus 115 p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~L 189 (237)
T smart00090 115 PKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVI 189 (237)
T ss_pred CeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEE
Confidence 455543 2358999999998887765 3455677778899999999999999999 99999999999999 889999
Q ss_pred eecccccc
Q 014911 135 TDFGLSAF 142 (416)
Q Consensus 135 ~DFGla~~ 142 (416)
+|||.+..
T Consensus 190 iDFg~a~~ 197 (237)
T smart00090 190 IDVSQSVE 197 (237)
T ss_pred EEChhhhc
Confidence 99998874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=166.78 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=109.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|+||+||+|.. +|..+++|......... ......+.+|+.+++.+.|+++....-+....+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 589999999999985 67889999865432211 11236778999999999988766655555667778999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988755321 7899999999999999999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=193.73 Aligned_cols=186 Identities=22% Similarity=0.321 Sum_probs=150.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||.|.+.. |+.||||+-.......-.... +++.+|+ -+.|..+.....-.+.-++|+||.+
T Consensus 705 e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 705 EIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred eeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 48999999999999866 999999987655443221122 2333333 2445555555666788899999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-------CCCeEEeeccccccccccccC
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------DGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-------~~~~kl~DFGla~~~~~~~~~ 149 (416)
-|+|.+++.. +.+++..+..+..|++..|+.||..+|||+||||.|+||.. .--++|+|||.|-........
T Consensus 778 ~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~ 857 (974)
T KOG1166|consen 778 YGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG 857 (974)
T ss_pred cccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC
Confidence 9999999986 66999999999999999999999999999999999999942 224899999998655544444
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCC
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 194 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~ 194 (416)
..+...++|-.+-.+|...+.++. +.+|.|.++.+++.||.|+.
T Consensus 858 ~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 858 TKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 466778899999999999999995 99999999999999999853
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=180.44 Aligned_cols=199 Identities=21% Similarity=0.349 Sum_probs=156.9
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCc-eeccCCCCcE
Q 014911 48 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGV-YHRDLKPENL 124 (416)
Q Consensus 48 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi-~HrDlkp~NI 124 (416)
|+.+.|.|+.++++...++...++|.+||.-|+|.|.+... .++.--...+++.++.||.|+|+..| +|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46789999999999999999999999999999999999863 46666677788999999999998876 9999999999
Q ss_pred EeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCC------CCchhhHHHHHHHHHHHhcCCCCCCC
Q 014911 125 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY------DGAKADIWSCGVILYVLLAGFLPFQD 198 (416)
Q Consensus 125 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwSlGvil~~lltG~~Pf~~ 198 (416)
++|....+||+|||+..+..............-...|.|||.+..... -+.++|+||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876542111111222234556999999976422 24679999999999999999999976
Q ss_pred C----cHHHHHHHHHh-CCCCCCCC------CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 199 D----NIVSMYRKIYR-GDFKCPPW------FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 199 ~----~~~~~~~~i~~-~~~~~p~~------~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
. ...++...+.+ +...+.|. +.+++..++..|+..+|..||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 3 22345555555 33223222 3457899999999999999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-19 Score=160.47 Aligned_cols=132 Identities=18% Similarity=0.277 Sum_probs=104.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch-------------------hhHHHHHHHHHHHHhCCCC--CcceE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------------------GMMEQIKREISVMKMVKHK--HIVEL 59 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hp--nIv~l 59 (416)
.||+|+||.||+|.+ .+|+.||||++........ .......+|+.++..+.|+ .++..
T Consensus 22 ~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~ 100 (198)
T cd05144 22 QIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKP 100 (198)
T ss_pred ccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCce
Confidence 489999999999987 4899999999865431000 0112367899999999887 44444
Q ss_pred EEEEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 60 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||||+||+++.++.++|+|||+
T Consensus 101 ~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 101 ID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred ee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 43 2456899999999988765431 34567889999999999999999999999999999999999999999
Q ss_pred ccc
Q 014911 140 SAF 142 (416)
Q Consensus 140 a~~ 142 (416)
+.-
T Consensus 172 ~~~ 174 (198)
T cd05144 172 MVS 174 (198)
T ss_pred ccc
Confidence 863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=180.66 Aligned_cols=132 Identities=17% Similarity=0.251 Sum_probs=108.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-----chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|+||+||+|.+.. ..+++|+....... .....+.+.+|+.+++.++|++++....+.......++||||
T Consensus 340 ~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 340 LIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred eeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 48999999999998743 34455543222111 111235688999999999999999988877777788999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
++|++|.+++. ....++.|++.+|.|||+.|++||||||+||++ .++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999998875 456789999999999999999999999999999 678999999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=155.42 Aligned_cols=135 Identities=20% Similarity=0.299 Sum_probs=99.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHH---------------------HHHHHHHHHHhCCCC--Ccc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME---------------------QIKREISVMKMVKHK--HIV 57 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp--nIv 57 (416)
.||+|+||+||+|.+. +|+.||||++............ ....|...+..+.+. .+.
T Consensus 4 ~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 4 PIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred ccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 4899999999999986 8999999998764322111111 124566777766544 355
Q ss_pred eEEEEEEeCCEEEEEEeccCCCchhhH-HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEe
Q 014911 58 ELHEVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 58 ~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
+++++ ...++||||++|+.+... +..... ...++.++.+++.++.++|+ .||+||||||+||+++ ++.++|+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 55553 235899999999644322 222111 16788999999999999999 9999999999999999 8999999
Q ss_pred ecccccc
Q 014911 136 DFGLSAF 142 (416)
Q Consensus 136 DFGla~~ 142 (416)
|||.+..
T Consensus 157 Dfg~a~~ 163 (187)
T cd05119 157 DVPQAVE 163 (187)
T ss_pred ECccccc
Confidence 9999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=178.23 Aligned_cols=177 Identities=27% Similarity=0.443 Sum_probs=136.2
Q ss_pred CEEEEEEeccCCCchhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 67 SKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
..+||.|++|.-.+|.+++.+ ...+......++.|+..|++| +|.+|||+||.||+...++.+||.|||+.+-
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 358999999999999999974 246678889999999999999 9999999999999999999999999999875
Q ss_pred ccccc----cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCC
Q 014911 143 SEHLK----QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPP 217 (416)
Q Consensus 143 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 217 (416)
..... .....+...||++||+||.+.+..|. .++||||||+||+||+. =..+|.. ......+..+.++...
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHH
Confidence 44332 11234556799999999999988884 99999999999999996 2222221 1222333334333111
Q ss_pred CC-CHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 218 WF-SSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 218 ~~-s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
+. .+.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22 2455699999999999999987777677664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=157.50 Aligned_cols=136 Identities=17% Similarity=0.300 Sum_probs=108.0
Q ss_pred Ccc-cCCceEEEEEEEcCCCcEEEEEEeecCcc----c------chhhHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC-
Q 014911 1 MLG-HGTFAKVYLARNLQTGKSMAMKVVGKDKV----I------KVGMMEQIKREISVMKMVKHKHI--VELHEVMASK- 66 (416)
Q Consensus 1 ~LG-~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~- 66 (416)
+|| .|+.|+||.+.. .+..++||.+..... . .......+.+|+.++..|.|++| ++.+++....
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 367 899999999987 478899998864321 0 11223568899999999998875 6777764332
Q ss_pred C---EEEEEEeccCC-CchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 67 S---KIYFAMDLVKG-GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 67 ~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
. ..++|||+++| .+|.+++..+.+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 23599999998 6899888777777654 56899999999999999999999999999999999999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=135.67 Aligned_cols=129 Identities=20% Similarity=0.324 Sum_probs=110.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||.|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| +++++++.+....+..|++|||+.|
T Consensus 5 ~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 5 LLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3899999999999973 37899999865432 3578899999999976 5999999998888899999999999
Q ss_pred CchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 79 GELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---GVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 79 g~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~---gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
+++... +......++.+++.+|+++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 5566677889999999999984 799999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.2e-18 Score=178.08 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=205.4
Q ss_pred ccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchh
Q 014911 3 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELF 82 (416)
Q Consensus 3 G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~ 82 (416)
-.|+++.++.+.-..+|...++|+............+.+.++-.++-...+|-+++....+......+++++|..|++|.
T Consensus 813 qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~ 892 (1205)
T KOG0606|consen 813 QSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLP 892 (1205)
T ss_pred cCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCch
Confidence 46889999999888888777777765544333333445555555555556677777666666788899999999999999
Q ss_pred hHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc---------------
Q 014911 83 NKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL--------------- 146 (416)
Q Consensus 83 ~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~--------------- 146 (416)
..+.. +..+++.++.++..+..+++|||+..+.|||++|.|+++..+|..+++|||........
T Consensus 893 Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~ 972 (1205)
T KOG0606|consen 893 SKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTP 972 (1205)
T ss_pred hhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcc
Confidence 99987 66889999999999999999999999999999999999999999999999833211100
Q ss_pred -------ccC-------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC
Q 014911 147 -------KQD-------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD 212 (416)
Q Consensus 147 -------~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~ 212 (416)
... .......||+.|.+||...+... +..+|.|+.|+++++.++|.+||........++.|.+..
T Consensus 973 ~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen 973 RRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRD 1051 (1205)
T ss_pred ccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCC
Confidence 000 11234468999999999988776 588999999999999999999999999999999998887
Q ss_pred CCCCC---CCCHHHHHHHHHccCCCCCCcCCHH---HHhcCccccccCccc
Q 014911 213 FKCPP---WFSSEARRLITKLLDPNPNSRIAIS---KIMESSWFKKSAPKV 257 (416)
Q Consensus 213 ~~~p~---~~s~~~~~li~~~L~~dP~~R~s~~---eil~hp~f~~~~~~~ 257 (416)
.+.|. ..+..+++++..+|..+|.+|..+. ++-.||||+...+..
T Consensus 1052 ~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1052 IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 76654 4789999999999999999999987 889999999765543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.8e-15 Score=149.96 Aligned_cols=141 Identities=21% Similarity=0.267 Sum_probs=95.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccch-------------------------------hhHH------HHHHH
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------------------------------GMME------QIKRE 44 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------------------~~~~------~~~~E 44 (416)
||.|++|.||+|+. .+|+.||||+......... +... .+.+|
T Consensus 125 lasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 125 LAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred eeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 78999999999986 5799999999854321000 0001 23445
Q ss_pred HHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHH-HHHHHHHcCceecc
Q 014911 45 ISVMKMVK-----HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCHSRGVYHRD 118 (416)
Q Consensus 45 i~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~-aL~ylH~~gi~HrD 118 (416)
...+.++. +|+|.-..-+....+..++||||++|++|.+......... ....++.+++. .+..+|..|++|+|
T Consensus 204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H~D 282 (437)
T TIGR01982 204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFHAD 282 (437)
T ss_pred HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 55555542 3443322222233455799999999999988764321111 22345555555 46889999999999
Q ss_pred CCCCcEEeccCCCeEEeecccccccc
Q 014911 119 LKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 119 lkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+||.||+++.+|.++++|||++....
T Consensus 283 ~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 283 LHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.7e-16 Score=153.81 Aligned_cols=245 Identities=20% Similarity=0.222 Sum_probs=184.8
Q ss_pred ccc--CCceEEEEEEE--cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGH--GTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~--G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
+|. |.+|.||.+.. ..++..+|+|.-....... .....=.+|+...++++ |+|.++.+..++..+..|+-+|+|
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~ 200 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC 200 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence 688 99999999998 8899999999743222111 11122336777777774 999999999999999999999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHH----HHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccccC
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLIS----AVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~----aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~ 149 (416)
. .+|..+... .-+++..++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++|||+........-.
T Consensus 201 ~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~ 279 (524)
T KOG0601|consen 201 G-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFS 279 (524)
T ss_pred c-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccc
Confidence 5 588887765 34899999999999999 9999999999999999999999999 78999999998755433211
Q ss_pred Cc---ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC--cHHHHHHHHHhCCCCCCCCCCHHHH
Q 014911 150 GL---LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPWFSSEAR 224 (416)
Q Consensus 150 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~ 224 (416)
.. .....|...|++||...+. .+...|++++|.++.+..+|..+.... +.....+.+. -..++-...+..+.
T Consensus 280 ~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~~~s~~l~ 356 (524)
T KOG0601|consen 280 SVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCEGGSSSLR 356 (524)
T ss_pred cceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-CchhhhcCcchhhh
Confidence 11 1222567789999998643 468899999999999988876665432 1111111111 01112223466777
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
..+..|++.+|..|++++.+++|++..
T Consensus 357 ~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 357 SVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hHHHHhcCcchhhhhHHHHHhcccccc
Confidence 799999999999999999999999986
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-15 Score=154.55 Aligned_cols=137 Identities=23% Similarity=0.358 Sum_probs=94.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCccc--------------------------c-h----hhHHHHHH------H
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--------------------------K-V----GMMEQIKR------E 44 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------------------------~-~----~~~~~~~~------E 44 (416)
||.|++|.||+|+...+|+.||||+.+..... + . +..+.+.+ |
T Consensus 127 lasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~E 206 (537)
T PRK04750 127 LASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMRE 206 (537)
T ss_pred hcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHH
Confidence 79999999999999888999999999754210 0 0 11223333 3
Q ss_pred HHHHHhCC----CCCcceEEEEEE-eCCEEEEEEeccCCCchhhH--Hhc-C----CCCHHHHHHHHHHHHHHHHHHHHc
Q 014911 45 ISVMKMVK----HKHIVELHEVMA-SKSKIYFAMDLVKGGELFNK--IAK-G----RLREDVARVYFQQLISAVDFCHSR 112 (416)
Q Consensus 45 i~il~~l~----hpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~~~~qll~aL~ylH~~ 112 (416)
...+.++. +.+.+.+-.++. -.+..++||||+.|+.+.+. +.. + .+.+..+..++.|++ ..
T Consensus 207 a~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~ 279 (537)
T PRK04750 207 AANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RD 279 (537)
T ss_pred HHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hC
Confidence 33333332 333333333332 24567899999999999774 332 3 355666666777765 58
Q ss_pred CceeccCCCCcEEeccCC----CeEEeeccccccccc
Q 014911 113 GVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEH 145 (416)
Q Consensus 113 gi~HrDlkp~NIll~~~~----~~kl~DFGla~~~~~ 145 (416)
|++|+|+||.||+++.+| .++++|||++...+.
T Consensus 280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 999999999999999988 899999999875443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-13 Score=139.73 Aligned_cols=169 Identities=17% Similarity=0.305 Sum_probs=131.4
Q ss_pred EEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchhhHHhcCCCC
Q 014911 12 LARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR 91 (416)
Q Consensus 12 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 91 (416)
.|..+.++.+|.|.+.+.... ...+.+++-+.-|+.++||||+++++.++..+.+|+|+|-+. .|..++.+ ++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--hH
Confidence 355667899999999876543 345678888999999999999999999999999999999985 46666654 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhc
Q 014911 92 EDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170 (416)
Q Consensus 92 e~~~~~~~~qll~aL~ylH-~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 170 (416)
...+..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++.-...... ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 7777788899999999997 67899999999999999999999999998764332211 11111122236777765332
Q ss_pred CCCCchhhHHHHHHHHHHHhcC
Q 014911 171 GYDGAKADIWSCGVILYVLLAG 192 (416)
Q Consensus 171 ~~~~~~~DvwSlGvil~~lltG 192 (416)
. -..|.|.|||++++++.|
T Consensus 181 ~---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c---cchhhhhHHHHHHHHhCc
Confidence 2 347999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.9e-13 Score=121.62 Aligned_cols=138 Identities=18% Similarity=0.211 Sum_probs=103.4
Q ss_pred CcccCCceEEEEEEEcC------CCcEEEEEEeecCccc-------------------chhhHHH----HHHHHHHHHhC
Q 014911 1 MLGHGTFAKVYLARNLQ------TGKSMAMKVVGKDKVI-------------------KVGMMEQ----IKREISVMKMV 51 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~-------------------~~~~~~~----~~~Ei~il~~l 51 (416)
.||.|--+.||.|.... .+..+|||+.+..... +.+.... .++|++.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 48999999999998653 3579999988542210 0111223 34899999998
Q ss_pred CC--CCcceEEEEEEeCCEEEEEEeccCCCchhh-HHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEec
Q 014911 52 KH--KHIVELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLD 127 (416)
Q Consensus 52 ~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~aL~yl-H~~gi~HrDlkp~NIll~ 127 (416)
.. -++..++++ ..-++||||+.|..+.. .+....++++.+..++.|++.+|..| |+.|++|+||+|.||+++
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~ 159 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH 159 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE
Confidence 53 567777764 46789999997754432 33344566777788899999999999 899999999999999996
Q ss_pred cCCCeEEeeccccccc
Q 014911 128 EDGNLKVTDFGLSAFS 143 (416)
Q Consensus 128 ~~~~~kl~DFGla~~~ 143 (416)
++.+.|+|||.+...
T Consensus 160 -~~~v~iIDF~qav~~ 174 (197)
T cd05146 160 -DGKVWFIDVSQSVEP 174 (197)
T ss_pred -CCcEEEEECCCceeC
Confidence 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=119.96 Aligned_cols=124 Identities=21% Similarity=0.298 Sum_probs=94.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
|+.|.++.||++.. .+..|++|+...... ......+|+.+++.+.+.+ +.+++.... +..++||||++|.+
T Consensus 6 l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 6 LKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred cCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 68899999999987 478899998754421 1234578999999886544 345555433 34589999999988
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeccCCCCcEEeccCCCeEEeeccccc
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV-----YHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi-----~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
+.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7653 11123456799999999999985 9999999999998 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.42 E-value=9e-14 Score=99.57 Aligned_cols=61 Identities=56% Similarity=0.904 Sum_probs=48.6
Q ss_pred ccccchhhhhccCCCCCCCchhHHhhHH-HhhhhcccccCChhhhHHHHHHHHhhcccEEEe
Q 014911 275 PETLNAFHIISLSEGFDLSPLFEEKKRA-EREELRFATTRPASSVISRFEEVAKAVKFNVKT 335 (416)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (416)
|..+|||++|++|+|+|||+||++.... .++++||+++.||+.|++++|++|+.++++|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 5689999999999999999999876543 457899999999999999999999999999974
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-13 Score=137.96 Aligned_cols=240 Identities=19% Similarity=0.190 Sum_probs=181.1
Q ss_pred cccCCceEEEEEEEc-CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNL-QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||.|.|+.|+.+... .++..+++|...+......+.+ .-..|+-+...+ .|.++++++..+......|+-.|||.|+
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~ 351 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGG 351 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCc
Confidence 788999999988655 7888999998866554432222 223456666555 5999999999988888889999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++...+.- ..+.+...++...|++.++.++|+..++|+|++|.||++..+ +..++.|||..+-... .......
T Consensus 352 s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-----~~~~~~~ 426 (524)
T KOG0601|consen 352 SSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-----SSGVFHH 426 (524)
T ss_pred chhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-----ecccccc
Confidence 88777643 558899999999999999999999999999999999999876 7889999998762111 0111122
Q ss_pred CCCCC-chHHhhhcCCCCchhhHHHHHHHHHHHhcCCCC-CCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYV-APEVISKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~-aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
.-++. .+|++........++|++|||.-+++.++|..- +... ....|..+..+..+..+..+..+.+.++.+++
T Consensus 427 ~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~ 502 (524)
T KOG0601|consen 427 IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQLQVLLKVMINPDR 502 (524)
T ss_pred cccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhhhhhhhhhcCCcc
Confidence 33344 355555444446899999999999999988543 2222 23345566666667667899999999999999
Q ss_pred CCcCCHHHHhcCcccc
Q 014911 236 NSRIAISKIMESSWFK 251 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~ 251 (416)
..|+++.++..|+=|.
T Consensus 503 ~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 503 KRRPSAVELSLHSEFY 518 (524)
T ss_pred ccchhhhhhcccchhh
Confidence 9999999998877654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5e-12 Score=110.38 Aligned_cols=134 Identities=19% Similarity=0.280 Sum_probs=101.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----MMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
++++|+-+.+|.+.. -|..+.+|.=.+....... ......+|.+++.+++--.|.-..=+..+++...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 478999999999966 4445666643322222211 235677899999998766666655566678888999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 143 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~ 143 (416)
++|-.|.+.+... ...+++.+-.-+.-||..||+|+||.+.||++..+ ++.++|||++.+.
T Consensus 81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 9998888888765 24566677778889999999999999999999665 4999999998743
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-13 Score=125.83 Aligned_cols=202 Identities=17% Similarity=0.268 Sum_probs=142.1
Q ss_pred HHHhCCCCCcceEEEEEEe-----CCEEEEEEeccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC--c
Q 014911 47 VMKMVKHKHIVELHEVMAS-----KSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRG--V 114 (416)
Q Consensus 47 il~~l~hpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~g--i 114 (416)
-|-++-|.|||+++.++.+ .....++.||++.|++..++++ ..+....-.+|+.||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3445679999999998854 3458899999999999999975 35888888999999999999999885 9
Q ss_pred eeccCCCCcEEeccCCCeEEeeccccccccccccCCc--ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC
Q 014911 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL--LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG 192 (416)
Q Consensus 115 ~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG 192 (416)
+|+++.-.-|++..+|-+|+.---............. .....+-++|.|||.=...+. +.++|||++|....+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence 9999999999999998888753222211111111111 112246788999986433333 3579999999999999887
Q ss_pred CCCCCC-CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 193 FLPFQD-DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 193 ~~Pf~~-~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
...-.. ......-..+.+.-+... ...-++++.+||+..|..||++.+++.||..-+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 665322 211111122222111111 123357899999999999999999999998654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-11 Score=107.69 Aligned_cols=139 Identities=19% Similarity=0.227 Sum_probs=106.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccc-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
|-+|+-+.|+.+.+ .|+...||.=....... .-...+.++|+++|.++.--.|.-..=++.+...-.|+|||+
T Consensus 15 ikQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 15 IKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 56899999999987 78888888432222211 112457889999999997667766666677777788999999
Q ss_pred CC-CchhhHHhc--CC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeecccccc
Q 014911 77 KG-GELFNKIAK--GR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAF 142 (416)
Q Consensus 77 ~g-g~L~~~i~~--~~-l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~ 142 (416)
+| .++.+++.. .. ........+++++-..+.-||.++|+|+||..+||++.++|+ +-++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 87 477888764 22 333334788999999999999999999999999999987764 58999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=113.21 Aligned_cols=138 Identities=18% Similarity=0.315 Sum_probs=107.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASK---SKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E~~ 76 (416)
||.|.++.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+||||+
T Consensus 6 l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 6 LSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred cCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 789999999999873 4688999998654321 124578899999999975 4567777776554 3678999999
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS--------------------------------------------- 111 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~--------------------------------------------- 111 (416)
+|.++.+.+..+.++++....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 99888776643457777788888888888888883
Q ss_pred -----------cCceeccCCCCcEEecc--CCCeEEeecccccc
Q 014911 112 -----------RGVYHRDLKPENLLLDE--DGNLKVTDFGLSAF 142 (416)
Q Consensus 112 -----------~gi~HrDlkp~NIll~~--~~~~kl~DFGla~~ 142 (416)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.7e-10 Score=110.66 Aligned_cols=209 Identities=18% Similarity=0.271 Sum_probs=157.4
Q ss_pred eEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCC-Cchh
Q 014911 8 AKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLVKG-GELF 82 (416)
Q Consensus 8 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L~ 82 (416)
.+.|+|....+|..|++|.+...+.... .....-+++++++.|+|||.+.++|.. ...+++|++|.++ ++|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 5789999999999999999955443322 223345788999999999999999863 4579999999886 5776
Q ss_pred hHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 83 NKIA----------------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 83 ~~i~----------------~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
++.- ..+.+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|+..|...+....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 6541 123778999999999999999999999999999999999999889999888876543321
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCC-CCCCcHHHH-HHHHHhCCCCCCCCCCHHHH
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSM-YRKIYRGDFKCPPWFSSEAR 224 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~~ 224 (416)
. . |-+... .+-|.=.||.++..|.||..- |.....+.. ...| -..+|.+++
T Consensus 447 ~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~r 499 (655)
T KOG3741|consen 447 P--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDLR 499 (655)
T ss_pred C--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHHH
Confidence 1 1 112221 457999999999999999544 222222222 2222 245789999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcC
Q 014911 225 RLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~h 247 (416)
++|.-+...+++. -++.+++.+
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHH
Confidence 9999999999987 688898865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.5e-11 Score=104.89 Aligned_cols=127 Identities=20% Similarity=0.324 Sum_probs=85.8
Q ss_pred EEEEEEEcCCCcEEEEEEeecCccc-----------------------chhhHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 014911 9 KVYLARNLQTGKSMAMKVVGKDKVI-----------------------KVGMMEQIKREISVMKMVKHK--HIVELHEVM 63 (416)
Q Consensus 9 ~Vy~a~~~~~~~~vAiK~i~~~~~~-----------------------~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 63 (416)
.||.|.. .+|+.+|||+....... ..-.....++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 56789999988542110 001235678899999999765 567777653
Q ss_pred EeCCEEEEEEeccC--CCchhhHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 64 ASKSKIYFAMDLVK--GGELFNKIAKGRLREDVARVYFQQLISAVDF-CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 64 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~~~~qll~aL~y-lH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
.-++||||+. |..+. .+....++.+....++.+++..+.. +|+.||+|+||.+.||+++++ .+.++|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 54453 3444334456677788888886555 579999999999999999877 9999999988
Q ss_pred cc
Q 014911 141 AF 142 (416)
Q Consensus 141 ~~ 142 (416)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 63
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.9e-11 Score=121.89 Aligned_cols=154 Identities=19% Similarity=0.353 Sum_probs=114.9
Q ss_pred HHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeecccccccccccc-----C--CcccccccCCCCCchHHhhhcC
Q 014911 100 QQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-----D--GLLHTTCGTPAYVAPEVISKKG 171 (416)
Q Consensus 100 ~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-----~--~~~~~~~gt~~y~aPE~~~~~~ 171 (416)
.+...|+.|+|.. +++|++|.|++|.++.+|..||+.|+++........ . ...........|.|||++.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3455999999965 899999999999999999999999998764332111 0 11111224567999999987 4
Q ss_pred CCCchhhHHHHHHHHHHHh-cCCCCCCCCcHHHHHHHHHh----CCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 172 YDGAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYR----GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 172 ~~~~~~DvwSlGvil~~ll-tG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
..+.++|++|+||++|.+. .|+.-+...+....+..-.. +....+..+++++++=|.++|..++..||++..++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4568999999999999999 56666655433222222111 123445678999999999999999999999999999
Q ss_pred CccccccC
Q 014911 247 SSWFKKSA 254 (416)
Q Consensus 247 hp~f~~~~ 254 (416)
.|||.+..
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99998754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-09 Score=100.51 Aligned_cols=130 Identities=17% Similarity=0.096 Sum_probs=92.9
Q ss_pred EEEEEEcCCCcEEEEEEeecCccc---ch-----hhHHHHHHHHHHHHhCCCCC--cceEEEEEEe-----CCEEEEEEe
Q 014911 10 VYLARNLQTGKSMAMKVVGKDKVI---KV-----GMMEQIKREISVMKMVKHKH--IVELHEVMAS-----KSKIYFAMD 74 (416)
Q Consensus 10 Vy~a~~~~~~~~vAiK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~lV~E 74 (416)
|.++.. .|+.|.||........ +. .....+.+|...+..|..-+ ++.+..+... ....++|+|
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 445543 6778999976332210 00 01124778999888874322 2333334332 245789999
Q ss_pred ccCCC-chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-------CCCeEEeeccccc
Q 014911 75 LVKGG-ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------DGNLKVTDFGLSA 141 (416)
Q Consensus 75 ~~~gg-~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-------~~~~kl~DFGla~ 141 (416)
+++|. +|.+++.. ...++.....++.+++..+.-||+.||+|+|+++.|||++. ++.+.++||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 78888753 45677788899999999999999999999999999999975 4579999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.8e-09 Score=96.12 Aligned_cols=132 Identities=21% Similarity=0.325 Sum_probs=100.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-----------------c--hhhHHHHHHHHHHHHhCCCC--CcceE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----------------K--VGMMEQIKREISVMKMVKHK--HIVEL 59 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----------------~--~~~~~~~~~Ei~il~~l~hp--nIv~l 59 (416)
.||.|--|.||.|.+. .|.++|||.=+..... + .-.....++|..+|.+|... .|.+.
T Consensus 98 ~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 98 KIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred ccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 4899999999999974 7899999954221110 0 01234578999999999654 77777
Q ss_pred EEEEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 60 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
+++ +.-.+||||+.|-+|...- ++.+.+..++..|+.-+.-.-..||+|+|+.+-||+++++|.+.++||--
T Consensus 177 ~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 177 IAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred ccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence 764 5678999999997775542 24555566666677766666699999999999999999999999999986
Q ss_pred cc
Q 014911 140 SA 141 (416)
Q Consensus 140 a~ 141 (416)
+.
T Consensus 249 ~v 250 (304)
T COG0478 249 AV 250 (304)
T ss_pred cc
Confidence 65
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.8e-08 Score=95.76 Aligned_cols=228 Identities=18% Similarity=0.227 Sum_probs=146.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcce----EEEEE--EeCC-EEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE----LHEVM--ASKS-KIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~----l~~~~--~~~~-~~~lV~ 73 (416)
||+|+-+.+|-.-. -+..|| |+........ .. +.+..|... .||-+-. ..... .+.+ .+-++|
T Consensus 19 LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 19 LGQGGEADLYTLGE--VRDQVA-KIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred ccCCccceeeecch--hhchhh-eeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 79999999996643 222344 8876654321 11 122223333 4654333 11111 2223 378899
Q ss_pred eccCCCch-hhHHhc----C---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 74 DLVKGGEL-FNKIAK----G---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 74 E~~~gg~L-~~~i~~----~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
..++|..- .++... . ....+-+.+..+.|+.+.+.||..|.+-+|+.++|+|+++++.+.|.|=..-.+.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-- 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-- 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec--
Confidence 98888532 233221 1 2567888899999999999999999999999999999999999999986643322
Q ss_pred cccCCcccccccCCCCCchHHhh-----hcCCCCchhhHHHHHHHHHHHhcC-CCCCCCCcH----HHHHH-HHHhCC--
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVIS-----KKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNI----VSMYR-KIYRGD-- 212 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlGvil~~lltG-~~Pf~~~~~----~~~~~-~i~~~~-- 212 (416)
..+.......|.+.|.+||.-. +... +...|.|.||+++|++|.| +.||.+-.. ...++ .|..+.
T Consensus 168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred -cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2233444567999999999854 2222 3668999999999999885 999976210 00111 222221
Q ss_pred ---------CCCC---CC--CCHHHHHHHHHccCC--CCCCcCCHH
Q 014911 213 ---------FKCP---PW--FSSEARRLITKLLDP--NPNSRIAIS 242 (416)
Q Consensus 213 ---------~~~p---~~--~s~~~~~li~~~L~~--dP~~R~s~~ 242 (416)
.+-| || +++++..|..+|+.. +|.-|||++
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1112 22 678999999999876 356899964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=4e-08 Score=89.62 Aligned_cols=104 Identities=22% Similarity=0.381 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhCCC--CCcceEEEEEEeC----CEEEEEEeccCCC-chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 014911 39 EQIKREISVMKMVKH--KHIVELHEVMASK----SKIYFAMDLVKGG-ELFNKIAK-GRLREDVARVYFQQLISAVDFCH 110 (416)
Q Consensus 39 ~~~~~Ei~il~~l~h--pnIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH 110 (416)
....+|...+..|.. =.+++.+.+.... ...++|+|+++|. +|.+++.. ...+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 467788888877742 2344455554432 3568999999984 78888876 44777888899999999999999
Q ss_pred HcCceeccCCCCcEEeccCC---CeEEeecccccc
Q 014911 111 SRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAF 142 (416)
Q Consensus 111 ~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~ 142 (416)
.+||+|+|++|.|||++.++ .+.++||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 799999997763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.3e-08 Score=88.63 Aligned_cols=137 Identities=14% Similarity=0.116 Sum_probs=100.7
Q ss_pred ccCCceEEEEEEEcCCCcEEEEEEeecCcccc---hhhHHHHHHHHHHHHhCCCC--CcceEEEEE--Ee--CCEEEEEE
Q 014911 3 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVKHK--HIVELHEVM--AS--KSKIYFAM 73 (416)
Q Consensus 3 G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~--~~--~~~~~lV~ 73 (416)
|+|+-|.|+.... .|+.+-+|.-....... ..-...+.+|+..+..|..- .+.++.... .. .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6789999999775 44468888653111110 12346889999999988532 244444221 11 23478999
Q ss_pred eccCC-CchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC--eEEeeccccc
Q 014911 74 DLVKG-GELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--LKVTDFGLSA 141 (416)
Q Consensus 74 E~~~g-g~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~--~kl~DFGla~ 141 (416)
|-+.| -+|.+++..+ +.++.....++.++...+.-||+.|+.|+|+.+.||+++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98765 4888888663 4577888899999999999999999999999999999987777 9999998665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-09 Score=110.00 Aligned_cols=232 Identities=20% Similarity=0.193 Sum_probs=163.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEeccCCC-
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFAMDLVKGG- 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~gg- 79 (416)
+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..++..+++|+++.++
T Consensus 250 fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 468899999999876665544 5655332 45567899999999999 777777778889999999999887
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+....+.. -.+.+-+.....+.-..+++++|+.--+||| ||+..+ +..+..||+........ ....+..+
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---~~~~t~~~ 392 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT---MKPRTAIG 392 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc---cccccCCC
Confidence 32222211 2244445555667778899999999889999 777654 68999999987643322 23456789
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC------CCCCHHHHHHHHHcc
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP------PWFSSEARRLITKLL 231 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p------~~~s~~~~~li~~~L 231 (416)
++.++|||+.....++ ...|.|++|+--.++.-|.+|-..+-. ....+-.+. ..| .|-...-+++...|+
T Consensus 393 ~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~ 468 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCL 468 (829)
T ss_pred CCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCC-CccccchhhhcCcccccCCccccc
Confidence 9999999999888776 779999999877788888877654211 000110000 011 111122235788899
Q ss_pred CCCCCCcCCHHHHhcCccccccC
Q 014911 232 DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..-|..|+....++.|.+|....
T Consensus 469 ~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 469 NGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCCCCCCcchhhHHHHHHhccCc
Confidence 99999999999999998887543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.2e-07 Score=84.93 Aligned_cols=130 Identities=16% Similarity=0.164 Sum_probs=82.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC--CcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+|..+.||+. .|..+++|...... ....+.+|.++++.+..- .+.+.+++....+...+|||+++|.
T Consensus 9 i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 9 TGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred ecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 799999999984 24467788875422 235678999999988643 3577788887888889999999996
Q ss_pred c-hh--------------hHHh-------cC---CCCHHH-HHHHHHHH----------HHH-HHHHH----HcCceecc
Q 014911 80 E-LF--------------NKIA-------KG---RLREDV-ARVYFQQL----------ISA-VDFCH----SRGVYHRD 118 (416)
Q Consensus 80 ~-L~--------------~~i~-------~~---~l~e~~-~~~~~~ql----------l~a-L~ylH----~~gi~HrD 118 (416)
+ +. ..+. .- ..+... ...+..++ ... ..+|. ...++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 11 1110 00 011000 01111111 111 11222 12478999
Q ss_pred CCCCcEEeccCCCeEEeeccccc
Q 014911 119 LKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 119 lkp~NIll~~~~~~kl~DFGla~ 141 (416)
++|.||++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.9e-07 Score=95.75 Aligned_cols=135 Identities=19% Similarity=0.337 Sum_probs=90.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccc---------------------------hh----hHH------HHHHH
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---------------------------VG----MME------QIKRE 44 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---------------------------~~----~~~------~~~~E 44 (416)
|+.++-|.||+|+. .+|+.||||+.+..-... .+ ..+ .+.+|
T Consensus 133 iAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 133 IASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred hhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 56789999999997 459999999985522110 00 011 13345
Q ss_pred HHHHHhC-----CCCCcceEEEEEEeCCEEEEEEeccCCCchhhHH--hcCCCCH-----HHHHHHHHHHHHHHHHHHHc
Q 014911 45 ISVMKMV-----KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI--AKGRLRE-----DVARVYFQQLISAVDFCHSR 112 (416)
Q Consensus 45 i~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i--~~~~l~e-----~~~~~~~~qll~aL~ylH~~ 112 (416)
...+.++ +.|+|.-..=+.+-.+.-.++|||+.|-.+.+.. ....++. ..+..++.|++ ..
T Consensus 212 A~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~-------~d 284 (517)
T COG0661 212 AANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-------RD 284 (517)
T ss_pred HHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hc
Confidence 5555444 2454444444444556778999999998887774 3433553 22333333333 48
Q ss_pred CceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 113 gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
|++|.|.+|.||+++.+|.+.+.|||+....+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999987544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.6e-07 Score=81.83 Aligned_cols=137 Identities=18% Similarity=0.232 Sum_probs=98.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchh---------------------hHHHHHHHHHHHHhCC--CCCcce
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG---------------------MMEQIKREISVMKMVK--HKHIVE 58 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--hpnIv~ 58 (416)
|+.|--+.||+|.. .++..+|+|++......-.. ...-..+|..-|+++. +-.+.+
T Consensus 56 istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 56 ISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred ecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 67888999999985 67899999999654322110 0122456888888874 455666
Q ss_pred EEEEEEeCCEEEEEEeccCCC-chhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEee
Q 014911 59 LHEVMASKSKIYFAMDLVKGG-ELFNKIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTD 136 (416)
Q Consensus 59 l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~D 136 (416)
.+.+. .-.+||||+... .-.-.+..-.+..+++..+..+++..+.-|-. .|+||+||+.-|||+. ++.+.|+|
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID 209 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIID 209 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEE
Confidence 66654 346999999653 11112222234455788899999999998877 8999999999999998 88999999
Q ss_pred cccccccc
Q 014911 137 FGLSAFSE 144 (416)
Q Consensus 137 FGla~~~~ 144 (416)
||-|....
T Consensus 210 ~~QaV~~~ 217 (268)
T COG1718 210 VSQAVTID 217 (268)
T ss_pred CccccccC
Confidence 99887443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-06 Score=79.57 Aligned_cols=133 Identities=20% Similarity=0.308 Sum_probs=80.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEVM---ASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV~E~~ 76 (416)
|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|+++
T Consensus 5 l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 5 LSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 6789999999999744 58999987433 3456788999998888532 356666644 3344689999999
Q ss_pred CCCchhh----------------HHhc---C--C---CCHHH---H---HHH---------------HHHHHH-HHHHHH
Q 014911 77 KGGELFN----------------KIAK---G--R---LREDV---A---RVY---------------FQQLIS-AVDFCH 110 (416)
Q Consensus 77 ~gg~L~~----------------~i~~---~--~---l~e~~---~---~~~---------------~~qll~-aL~ylH 110 (416)
+|..+.. .+.. . . +.... . ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987766 1111 0 0 01000 0 000 011222 233333
Q ss_pred -------HcCceeccCCCCcEEec-cCCCeEEeeccccc
Q 014911 111 -------SRGVYHRDLKPENLLLD-EDGNLKVTDFGLSA 141 (416)
Q Consensus 111 -------~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~ 141 (416)
...++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 24599999999999999 55666899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.4e-07 Score=80.97 Aligned_cols=67 Identities=25% Similarity=0.466 Sum_probs=53.2
Q ss_pred CEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 67 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
...+++|||++|.+|.+... ++++ +...+.+++.-+|+.|++|+|.+|.|++++.+ .++++||+...
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~---i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED---IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh---cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 45668999999988876632 3332 44567788999999999999999999999855 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.3e-06 Score=80.01 Aligned_cols=130 Identities=15% Similarity=0.130 Sum_probs=82.4
Q ss_pred cCCc-eEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 4 HGTF-AKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 4 ~G~f-g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
.|.+ +.||++.. .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 8 ~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 8 EGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred CCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 4555 88999975 34678888875432 235678999988884 34567788877777788999999999766
Q ss_pred hhHH----------------hc-CCCCH-----H-HHHHHHHH-----------------------HHHHHHHH------
Q 014911 82 FNKI----------------AK-GRLRE-----D-VARVYFQQ-----------------------LISAVDFC------ 109 (416)
Q Consensus 82 ~~~i----------------~~-~~l~e-----~-~~~~~~~q-----------------------ll~aL~yl------ 109 (416)
.... .+ ..++. . .....+.+ +...+..|
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 4321 00 00110 0 00000000 11111222
Q ss_pred -HHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 110 -HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 110 -H~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
....++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12348999999999999987778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.8e-06 Score=93.59 Aligned_cols=203 Identities=15% Similarity=0.209 Sum_probs=142.2
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEeccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 014911 39 EQIKREISVMKMVKHKHIVELHEVMASKSK----IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 113 (416)
Q Consensus 39 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~g 113 (416)
....-|...+.++.|+|++.++.+-...-. ..+..++|++-++.+.+.. +..+.+.++.+..++++||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344456667888899999999998654332 3455689999999999987 88999999999999999999999996
Q ss_pred ceeccCCCC---cEEeccCCCeEEe--eccccccccccccCCcccccccCCCCCchHHhhhcCCC-CchhhHHHHHHHHH
Q 014911 114 VYHRDLKPE---NLLLDEDGNLKVT--DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILY 187 (416)
Q Consensus 114 i~HrDlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DvwSlGvil~ 187 (416)
..|.-+... +-..+..+...++ ||+.+....... ......-+..+.|||......+. +...|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666655554 4444556666666 888776433221 12223345668888887655443 12369999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 188 VLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 188 ~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+..|..+-...... ..+ .+........+++.+|+..++++|+++.+++.|||.+..
T Consensus 384 ~~~~~~~i~~~~~~~---~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVP---VSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhcCcccccccch---hhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 888875442211100 000 111122267889999999999999999999999998753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.5e-06 Score=90.28 Aligned_cols=77 Identities=17% Similarity=0.362 Sum_probs=54.6
Q ss_pred cccCCceEEEEEEEcCCC--cEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTG--KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHI--VELHEVMASK---SKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~lV~ 73 (416)
|+.|.++.+|+......+ ..+++|+....... .....+.+|+.+|+.+. |++| .+++.++.+. +..|+||
T Consensus 46 l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 46 FGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred eCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 678899999998764332 36777776443221 12356889999999995 6665 7777777654 4689999
Q ss_pred eccCCCc
Q 014911 74 DLVKGGE 80 (416)
Q Consensus 74 E~~~gg~ 80 (416)
||++|..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-05 Score=71.08 Aligned_cols=131 Identities=21% Similarity=0.334 Sum_probs=97.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcc-------------cchhhHHHHHHHHHHHHhCC------CCCcceEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-------------IKVGMMEQIKREISVMKMVK------HKHIVELHE 61 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~ 61 (416)
.||+|+.=.||.-- ......||+...... .......+..+|+.....+. +.+|.+++|
T Consensus 8 ~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 8 LIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred ccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 48999999998543 344567899876650 01123467778888777766 789999999
Q ss_pred EEEeCCEEEEEEeccCC------CchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----C
Q 014911 62 VMASKSKIYFAMDLVKG------GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----N 131 (416)
Q Consensus 62 ~~~~~~~~~lV~E~~~g------g~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~----~ 131 (416)
+.++.-..-+|+|.+.+ -+|.+++..+.+++ .+. ..+-.-..||-+.+|+.+|++|.||++...+ .
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence 99999999999998743 47888888877877 333 3444556788999999999999999996543 4
Q ss_pred eEEee-cc
Q 014911 132 LKVTD-FG 138 (416)
Q Consensus 132 ~kl~D-FG 138 (416)
+.|+| ||
T Consensus 161 lvlIDG~G 168 (199)
T PF10707_consen 161 LVLIDGLG 168 (199)
T ss_pred EEEEeCCC
Confidence 77777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1e-05 Score=70.69 Aligned_cols=124 Identities=23% Similarity=0.380 Sum_probs=89.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV-ELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|.+|.||+|.+ .|..+|+|+-..+. ....+..|+++|..+.-.++. ++|.+. ..++.|||+.|-
T Consensus 29 ~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 29 ELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 389999999999998 66799999876553 346788999999999866654 445443 334559999997
Q ss_pred chhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC-C-CcEEeccCCCeEEeecccccc
Q 014911 80 ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK-P-ENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 80 ~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlk-p-~NIll~~~~~~kl~DFGla~~ 142 (416)
+|.+.-..+ + ++-+..+++.---|-..||-|+.|. | .||++ .++.+.|+||..|++
T Consensus 98 ~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence 776664332 2 2333445666556678899999996 4 45555 555999999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.8e-05 Score=81.23 Aligned_cols=138 Identities=20% Similarity=0.213 Sum_probs=86.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccc----------------------------hhhHHH------HHHHHHH
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK----------------------------VGMMEQ------IKREISV 47 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~----------------------------~~~~~~------~~~Ei~i 47 (416)
||.-+.|.||+|+.+ +|+.||||+-+..-... .+..+. +.+|.+-
T Consensus 169 iaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 169 IAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 677789999999975 49999999875421100 000111 2223332
Q ss_pred H----HhCCCCC------cceEEEEEEeCCEEEEEEeccCCCchhhH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 014911 48 M----KMVKHKH------IVELHEVMASKSKIYFAMDLVKGGELFNK--IAKGRLREDVARVYFQQLISAVDFCHSRGVY 115 (416)
Q Consensus 48 l----~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~ 115 (416)
. +.+.|-+ |.++|-. ..+...++|||+.|..+.|. +.+..++...+...+.+... .-+-..|.+
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gff 323 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFF 323 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCc
Confidence 2 2233444 4444432 24567899999999877554 45555776654443333322 223357899
Q ss_pred eccCCCCcEEecc----CCCeEEeecccccccc
Q 014911 116 HRDLKPENLLLDE----DGNLKVTDFGLSAFSE 144 (416)
Q Consensus 116 HrDlkp~NIll~~----~~~~kl~DFGla~~~~ 144 (416)
|+|-+|.||++.. ++.+.+.|||+.....
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 9999999999984 5679999999987544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.1e-05 Score=68.26 Aligned_cols=121 Identities=22% Similarity=0.303 Sum_probs=86.1
Q ss_pred CcccCCc-eEEEEEEEcCCCcEEEEEEeecCcc----------cc--------hhhHHHHHHHHHHHHhCC---CCCc--
Q 014911 1 MLGHGTF-AKVYLARNLQTGKSMAMKVVGKDKV----------IK--------VGMMEQIKREISVMKMVK---HKHI-- 56 (416)
Q Consensus 1 ~LG~G~f-g~Vy~a~~~~~~~~vAiK~i~~~~~----------~~--------~~~~~~~~~Ei~il~~l~---hpnI-- 56 (416)
.||.|+- |.||+++- .|+.+|+|++..-.. .. ....+.+..|-++..+|+ +.++
T Consensus 44 fLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~A 121 (207)
T PF13095_consen 44 FLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWA 121 (207)
T ss_pred ecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceE
Confidence 3899999 99999987 788999999422110 00 022346778888877764 5566
Q ss_pred ceEEEEEEeC------------------CEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecc
Q 014911 57 VELHEVMASK------------------SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118 (416)
Q Consensus 57 v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrD 118 (416)
+++++++.-. ....||-||++... .++ ..-+.+|++-+..+|..||+-+|
T Consensus 122 vkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~~k~gI~~~D 189 (207)
T PF13095_consen 122 VKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKILHKLGIVPRD 189 (207)
T ss_pred EEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHHHHCCeeecc
Confidence 9999987321 12467888776643 122 23355788888999999999999
Q ss_pred CCCCcEEeccCCCeEEeecccc
Q 014911 119 LKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 119 lkp~NIll~~~~~~kl~DFGla 140 (416)
+++.|.. +-+|+|||.+
T Consensus 190 v~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 190 VKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred Ccccccc-----CCEEEecccC
Confidence 9999986 4589999964
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.2e-05 Score=72.98 Aligned_cols=70 Identities=10% Similarity=0.129 Sum_probs=43.4
Q ss_pred cccCCce-EEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEEEe
Q 014911 2 LGHGTFA-KVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK---HIVELHEVMASK---SKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~lV~E 74 (416)
|+.|+.. .||+.. ..+.+|+.... .....+.+|..+++.+... .+.++++..... ...|++|+
T Consensus 5 ~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 5 VDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 4555555 599762 34667865432 1245788999999887531 344555443322 24589999
Q ss_pred ccCCCch
Q 014911 75 LVKGGEL 81 (416)
Q Consensus 75 ~~~gg~L 81 (416)
+++|.++
T Consensus 75 ~i~G~~l 81 (235)
T cd05155 75 WLEGETA 81 (235)
T ss_pred eecCCCC
Confidence 9998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.6e-07 Score=98.23 Aligned_cols=208 Identities=16% Similarity=0.091 Sum_probs=145.3
Q ss_pred HHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCchhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC
Q 014911 41 IKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKGGELFNKIAKG-----RLREDVARVYFQQLISAVDFCHSRG 113 (416)
Q Consensus 41 ~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~aL~ylH~~g 113 (416)
...|..-++...|+++...+.-... ....|.+++|+.+|.+++.|-+| .+.+.-+....++.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3345555666789999887765533 34578999999999999999653 2444445555555577888877642
Q ss_pred -----ceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHH
Q 014911 114 -----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYV 188 (416)
Q Consensus 114 -----i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~ 188 (416)
.+|+++|+-|.+|..+-++|+.++|+.++..+ .........++|.|++|++.+.-.+. .++|+|..|+-+|.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYL 1432 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHH
Confidence 79999999999999999999999999883222 12233456788899999999888774 66999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 189 LLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 189 lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
+..|..||-.-....+...+.++. .+.+...|.++-.....+|-..-..||.-...+.-+.|-
T Consensus 1433 rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 999988875433322222222222 234444455555555555556667788877777666553
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00032 Score=70.07 Aligned_cols=77 Identities=13% Similarity=0.184 Sum_probs=54.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcc-c-c--hhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-I-K--VGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~-~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 74 (416)
||.|.+..||++.+...++.+.||.-..... . . .-..++...|...|+.+. ..++++++.+ +....++|||
T Consensus 34 lggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME 111 (401)
T PRK09550 34 IGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVME 111 (401)
T ss_pred cCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEe
Confidence 6889999999999854446899997532110 0 0 123567788888888763 3567888876 4466889999
Q ss_pred ccCCCc
Q 014911 75 LVKGGE 80 (416)
Q Consensus 75 ~~~gg~ 80 (416)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0002 Score=66.37 Aligned_cols=132 Identities=17% Similarity=0.269 Sum_probs=77.7
Q ss_pred cccCCceEEEEEEEcC-CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
|+.|-...||++.... .++.|++|+...... ..-...+|+.+++.+... -.++++.... + .++|||++|.
T Consensus 6 l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 6 FTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred cCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 5667888999997533 357888997754321 112345789999888532 3444544332 2 3799999986
Q ss_pred chhhH----------H----h---c--CCCC-----------HHHHHHHHHH----------------------HHHHHH
Q 014911 80 ELFNK----------I----A---K--GRLR-----------EDVARVYFQQ----------------------LISAVD 107 (416)
Q Consensus 80 ~L~~~----------i----~---~--~~l~-----------e~~~~~~~~q----------------------ll~aL~ 107 (416)
++... + . . .... .+.+..+... +...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 55211 1 1 1 0110 1122222211 111111
Q ss_pred HH----H----HcCceeccCCCCcEEecc-CCCeEEeeccccc
Q 014911 108 FC----H----SRGVYHRDLKPENLLLDE-DGNLKVTDFGLSA 141 (416)
Q Consensus 108 yl----H----~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~ 141 (416)
.| . ..+++|+|+.|.|||++. ++.+.++||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 1 236999999999999998 5789999999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00032 Score=67.73 Aligned_cols=73 Identities=10% Similarity=0.142 Sum_probs=52.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEEEEec
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH---KHIVELHEVMAS---KSKIYFAMDL 75 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~lV~E~ 75 (416)
||.|..+.||.... .++ .+.+|... .. .....+..|...|+.|.- ..|.++++++.. .+..++|||+
T Consensus 22 i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 22 ISEQPYAALWALYD-SQG-NPMPLMAR-SF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred cCCccceeEEEEEc-CCC-CEEEEEec-cc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 78999999999965 223 46677743 21 112578899999998843 467888877654 3678999999
Q ss_pred cCCCch
Q 014911 76 VKGGEL 81 (416)
Q Consensus 76 ~~gg~L 81 (416)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00011 Score=69.21 Aligned_cols=131 Identities=15% Similarity=0.197 Sum_probs=77.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+..|-.+.+|+... +++.+++|+...... ...-...+|..+++.+...++ .+++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 45688889999873 567888887643211 110134689999998854322 34444432 368999999865
Q ss_pred hhh--------------HHh---cCC-----CC-HHHHHHHHHHH---------HHHHHHHHH--------cCceeccCC
Q 014911 81 LFN--------------KIA---KGR-----LR-EDVARVYFQQL---------ISAVDFCHS--------RGVYHRDLK 120 (416)
Q Consensus 81 L~~--------------~i~---~~~-----l~-e~~~~~~~~ql---------l~aL~ylH~--------~gi~HrDlk 120 (416)
+.. .+. ..+ ++ ...+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 111 111 11 12222332222 111222221 258999999
Q ss_pred CCcEEeccCCCeEEeecccccc
Q 014911 121 PENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 121 p~NIll~~~~~~kl~DFGla~~ 142 (416)
|.||++++++ +.++||..|..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00015 Score=69.65 Aligned_cols=132 Identities=17% Similarity=0.183 Sum_probs=80.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEV------MASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~lV~ 73 (416)
|..|....+|+... .+..+++|+.... ....+..|+.++..|.+- .+.+++.. ....+..++|+
T Consensus 22 i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 22 ISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677789999865 3446888987531 124677788888877432 24554432 23355678999
Q ss_pred eccCCCchhh-----------HH---hc--CCCCH--------HHHH------------HHHHHHHHHHHHHHH------
Q 014911 74 DLVKGGELFN-----------KI---AK--GRLRE--------DVAR------------VYFQQLISAVDFCHS------ 111 (416)
Q Consensus 74 E~~~gg~L~~-----------~i---~~--~~l~e--------~~~~------------~~~~qll~aL~ylH~------ 111 (416)
++++|..+.. .+ .. ..+.. .... .....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999865421 00 00 00100 0000 001112233444443
Q ss_pred -cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 -RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 -~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.79 E-value=9.7e-05 Score=66.29 Aligned_cols=97 Identities=16% Similarity=0.235 Sum_probs=79.4
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCchhhH----HhcCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 014911 43 REISVMKMVKH-KHIVELHEVMASKSKIYFAMDLVKGGELFNK----IAKGRLREDVARVYFQQLISAVDFCHS---RGV 114 (416)
Q Consensus 43 ~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----i~~~~l~e~~~~~~~~qll~aL~ylH~---~gi 114 (416)
.|.-+|+.+.+ +++++++|.+- -++|.||...+++... ..--..+.....+++.+++..+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999976 69999999873 3678899987766532 111346788999999999999999997 458
Q ss_pred eeccCCCCcEEeccCCCeEEeeccccccc
Q 014911 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFS 143 (416)
Q Consensus 115 ~HrDlkp~NIll~~~~~~kl~DFGla~~~ 143 (416)
.-.|++|+|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00032 Score=67.96 Aligned_cols=133 Identities=20% Similarity=0.251 Sum_probs=78.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEV------MASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~lV~ 73 (416)
++.|....+|++.. .+| .+++|+..... ..+.+..|+.++..|... .+.+++.. ....+..++++
T Consensus 30 ~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 30 IAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45666789999864 344 57789875421 124556677777777422 24444432 12346789999
Q ss_pred eccCCCchh-----------hH---Hhc--CCCCH-------HHHH----------------HHHHHHHHHHHHHH----
Q 014911 74 DLVKGGELF-----------NK---IAK--GRLRE-------DVAR----------------VYFQQLISAVDFCH---- 110 (416)
Q Consensus 74 E~~~gg~L~-----------~~---i~~--~~l~e-------~~~~----------------~~~~qll~aL~ylH---- 110 (416)
+|++|.++. .. +.. ..++. ...+ .....+...++++.
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999985431 11 110 00100 0000 00112233455553
Q ss_pred ---HcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 111 ---SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 111 ---~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2689999999999999988877899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00092 Score=65.00 Aligned_cols=30 Identities=37% Similarity=0.538 Sum_probs=25.8
Q ss_pred cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 ~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
.|+||+|++|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866556899999775
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00011 Score=70.17 Aligned_cols=130 Identities=18% Similarity=0.318 Sum_probs=93.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--------------chh---h--HHHHHHHHHHHHhCCC--CCcceE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--------------KVG---M--MEQIKREISVMKMVKH--KHIVEL 59 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------------~~~---~--~~~~~~Ei~il~~l~h--pnIv~l 59 (416)
.||-|.-+-||.+-+ ..|++.++|.=+..+.. +.. . .-...+|...|+.|.. --|.+.
T Consensus 99 qIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkp 177 (465)
T KOG2268|consen 99 QIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKP 177 (465)
T ss_pred ccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence 378999999999987 56888999854322110 000 0 1235578999998853 345555
Q ss_pred EEEEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 60 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
++ .+..++|||++.|..|...-. ...+..+...++.-+--|-.+|++|+|..-=||++++++.++++||--
T Consensus 178 iD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 178 ID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred cc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 54 457789999999977755432 122344556677777888999999999999999999999999999975
Q ss_pred c
Q 014911 140 S 140 (416)
Q Consensus 140 a 140 (416)
.
T Consensus 249 m 249 (465)
T KOG2268|consen 249 M 249 (465)
T ss_pred h
Confidence 4
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0008 Score=64.90 Aligned_cols=72 Identities=14% Similarity=0.225 Sum_probs=46.1
Q ss_pred cccCCceEEEEEEEcC------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQ------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E 74 (416)
|..|-...||++.... +++.+++|+..... .......+|..+++.+...+ ..+++..+.. .+|+|
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 3456677999987533 25789999975432 12235678888888885322 3455555532 35889
Q ss_pred ccCCCch
Q 014911 75 LVKGGEL 81 (416)
Q Consensus 75 ~~~gg~L 81 (416)
|++|..+
T Consensus 78 ~i~G~~l 84 (302)
T cd05156 78 FIPSRTL 84 (302)
T ss_pred eeCCCcC
Confidence 9888655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00034 Score=47.50 Aligned_cols=42 Identities=21% Similarity=0.464 Sum_probs=35.2
Q ss_pred ceeEEEEEEEEee-CCeEEEEEEecCCChhhHHHHhhhhhhhhc
Q 014911 351 GKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFCSNELRPAL 393 (416)
Q Consensus 351 ~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~le~~~~~~~~l~~~l 393 (416)
..+.|++||+.+. ++++.|+|+|.+||...|+++|. +|-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~-~il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCS-KILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHH-HHHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHH-HHHHHc
Confidence 4588999999997 89999999999999999999997 465544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00099 Score=64.44 Aligned_cols=131 Identities=19% Similarity=0.282 Sum_probs=83.0
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEEEEeccCCCc
Q 014911 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKS--KIYFAMDLVKGGE 80 (416)
Q Consensus 5 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lV~E~~~gg~ 80 (416)
|....+|...+ +++.+++. ... ............+|..+++.+.- .-+.+.++++.++. ..|.||+|+.|..
T Consensus 36 G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~ 111 (321)
T COG3173 36 GWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV 111 (321)
T ss_pred CcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence 33344555544 37778877 321 22233456778899999998753 23444455555554 7799999999854
Q ss_pred hhhHHhcCCCCHHHHHHHHH-HHHHHHHHHHH------------------------------------------------
Q 014911 81 LFNKIAKGRLREDVARVYFQ-QLISAVDFCHS------------------------------------------------ 111 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~-qll~aL~ylH~------------------------------------------------ 111 (416)
+.+.......+ ..++. .+...|.-||+
T Consensus 112 ~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 112 VWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred ccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 43333222111 12222 44444555553
Q ss_pred ----------cCceeccCCCCcEEeccCCCeEEeeccccccc
Q 014911 112 ----------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 143 (416)
Q Consensus 112 ----------~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~ 143 (416)
..++|+|+++.|++++.++-+-+.||+++++-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 24899999999999999999999999999753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0018 Score=63.68 Aligned_cols=75 Identities=9% Similarity=0.080 Sum_probs=50.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcc-cc---hhhHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IK---VGMMEQIKREISVMKMVK--HK-HIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~E 74 (416)
||-|...-||++.+...++.|+||--....- .. .-..++..-|..+|+... -| .++++|.+ ++....+|||
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vME 80 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVME 80 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHh
Confidence 7899999999999854446899995431111 00 123466778888887763 24 56666654 5566679999
Q ss_pred ccCC
Q 014911 75 LVKG 78 (416)
Q Consensus 75 ~~~g 78 (416)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0023 Score=62.43 Aligned_cols=138 Identities=22% Similarity=0.304 Sum_probs=96.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCccc----------------------chhhH-HHHHHHHHHHHhCCCCCcce
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI----------------------KVGMM-EQIKREISVMKMVKHKHIVE 58 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------------------~~~~~-~~~~~Ei~il~~l~hpnIv~ 58 (416)
|..|--+-||.|.. .+|..+|||++...-+. ...++ --...|++-|++|+...|.-
T Consensus 152 iSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 152 ISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred cccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 56688889999985 67888999988542211 01111 12557888888887655443
Q ss_pred EEEEEEeCCEEEEEEeccCC-CchhhHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEeccCCCeEEee
Q 014911 59 LHEVMASKSKIYFAMDLVKG-GELFNKIAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLDEDGNLKVTD 136 (416)
Q Consensus 59 l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~~~~qll~aL~yl-H~~gi~HrDlkp~NIll~~~~~~kl~D 136 (416)
.--+... .-.+||+++.+ |--.-.+..-.++...+..+-.|++.-+.-| |.+++||.||.--|+|+ .+|.+.|+|
T Consensus 231 PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiID 307 (520)
T KOG2270|consen 231 PEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIID 307 (520)
T ss_pred CCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEE
Confidence 3222221 23689999953 2223334445688889999999998888877 57799999999999998 568999999
Q ss_pred ccccccc
Q 014911 137 FGLSAFS 143 (416)
Q Consensus 137 FGla~~~ 143 (416)
-+-|.-.
T Consensus 308 VSQSVE~ 314 (520)
T KOG2270|consen 308 VSQSVEH 314 (520)
T ss_pred ccccccC
Confidence 9977633
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00098 Score=67.35 Aligned_cols=161 Identities=20% Similarity=0.276 Sum_probs=106.5
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceec
Q 014911 39 EQIKREISVMKMVKHKHIVELHEVMASK-SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117 (416)
Q Consensus 39 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~Hr 117 (416)
.++.-...+++.+.|+|...++++.... ....+|||++ +.+|.+....+.+-.... . .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~-------~-------~~~~~~- 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESL-------L-------AHGVLH- 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhh-------c-------ccccce-
Confidence 4556677889999999999999987543 4588999999 458999887654221111 1 122221
Q ss_pred cCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCC
Q 014911 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 197 (416)
Q Consensus 118 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~ 197 (416)
-|+ .+.+| -+++ . | | ...++|+||||+|.++.++.-|...|.
T Consensus 91 ----~~~-------~~~td-~~~t---~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 ----LNI-------IYITD-HFLT---K---------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ----ehh-------hhccc-cccc---c---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 122 23333 1111 0 0 0 011258999999999999999988887
Q ss_pred CCcHHHHHHHHHhCCCCCCC-------------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 198 DDNIVSMYRKIYRGDFKCPP-------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 198 ~~~~~~~~~~i~~~~~~~p~-------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.....+....+.+-.. .+. .++.-...+..+|+...|..||...++++++-|....
T Consensus 133 ~~~~s~~l~~i~k~~~-~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYT-DDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHHhcc-CchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 6655555554443211 111 1456678899999999999999999999999987653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0055 Score=61.30 Aligned_cols=81 Identities=16% Similarity=0.134 Sum_probs=52.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcc-cch---hhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKV---GMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 74 (416)
||-|....||+..+ .+..++||.-..... ... -...+...|...|+.+. ..++.+++.+.. +..+++||
T Consensus 40 iggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME 115 (418)
T PLN02756 40 VGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMR 115 (418)
T ss_pred cCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEe
Confidence 68899999999987 345688997642221 111 13455566777777664 357888888765 45678899
Q ss_pred ccCC--CchhhHHh
Q 014911 75 LVKG--GELFNKIA 86 (416)
Q Consensus 75 ~~~g--g~L~~~i~ 86 (416)
++++ ..+.+.+.
T Consensus 116 ~L~~~~~ilr~~Ll 129 (418)
T PLN02756 116 YLEPPHIILRKGLI 129 (418)
T ss_pred ecCCcceehhhhhc
Confidence 9977 23444443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0084 Score=57.86 Aligned_cols=29 Identities=34% Similarity=0.622 Sum_probs=25.6
Q ss_pred cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 ~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.004 Score=59.43 Aligned_cols=30 Identities=30% Similarity=0.524 Sum_probs=25.5
Q ss_pred CceeccCCCCcEEeccCCC-eEEeecccccc
Q 014911 113 GVYHRDLKPENLLLDEDGN-LKVTDFGLSAF 142 (416)
Q Consensus 113 gi~HrDlkp~NIll~~~~~-~kl~DFGla~~ 142 (416)
.++|+|++|.||+++.++. .-|+||+.++.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0093 Score=58.80 Aligned_cols=130 Identities=14% Similarity=0.239 Sum_probs=76.3
Q ss_pred cCCceEEEEEEEcC----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCC
Q 014911 4 HGTFAKVYLARNLQ----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 4 ~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~g 78 (416)
.|-...+|++.... +++.|.+|+..... ....+ -.+|..+++.+..-++ .++++.+..+ .|.+|++|
T Consensus 46 gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 46 GAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred CcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 47778899986432 34688999885542 12223 3679999988854333 3455665432 57888877
Q ss_pred Cchhh----------HH----h---cCC------CC-HHHHHHHHHHHH-----------------HHHHHH--------
Q 014911 79 GELFN----------KI----A---KGR------LR-EDVARVYFQQLI-----------------SAVDFC-------- 109 (416)
Q Consensus 79 g~L~~----------~i----~---~~~------l~-e~~~~~~~~qll-----------------~aL~yl-------- 109 (416)
.+|.. .+ . ... .. .+.+..++.++. ..+..|
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 55531 11 1 101 11 222333332221 111111
Q ss_pred HHcCceeccCCCCcEEecc-CCCeEEeeccccc
Q 014911 110 HSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSA 141 (416)
Q Consensus 110 H~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~ 141 (416)
+...++|+|+++.||++++ ++.+.++||..|.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1235899999999999986 4679999999876
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0089 Score=58.58 Aligned_cols=130 Identities=17% Similarity=0.237 Sum_probs=74.5
Q ss_pred cCCceEEEEEEEcCC---CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 014911 4 HGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 4 ~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.|--..+|++..... +..|.+|+...... . .-.-.+|..+++.+..-++ .++++++.. + +|.+|++|.
T Consensus 24 gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~ 95 (330)
T PLN02421 24 GGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR 95 (330)
T ss_pred CcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence 366677888865332 34788998754321 1 1223578889888865444 355555532 2 488898775
Q ss_pred chhh----------HH----h---cCCCC-------HHHHHHHHHHH----------------------HHHHHHHH---
Q 014911 80 ELFN----------KI----A---KGRLR-------EDVARVYFQQL----------------------ISAVDFCH--- 110 (416)
Q Consensus 80 ~L~~----------~i----~---~~~l~-------e~~~~~~~~ql----------------------l~aL~ylH--- 110 (416)
+|.. .+ . ...++ ...+..++.++ ..-+..+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5411 11 1 11111 22333333222 11122221
Q ss_pred -HcC----ceeccCCCCcEEecc-CCCeEEeeccccc
Q 014911 111 -SRG----VYHRDLKPENLLLDE-DGNLKVTDFGLSA 141 (416)
Q Consensus 111 -~~g----i~HrDlkp~NIll~~-~~~~kl~DFGla~ 141 (416)
+.+ .+|+|+.|.||++++ ++.++++||..|.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 122 799999999999975 4689999999876
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0096 Score=54.23 Aligned_cols=31 Identities=35% Similarity=0.747 Sum_probs=22.1
Q ss_pred cCceeccCCCCcEEe-ccCCCeEEeecccccc
Q 014911 112 RGVYHRDLKPENLLL-DEDGNLKVTDFGLSAF 142 (416)
Q Consensus 112 ~gi~HrDlkp~NIll-~~~~~~kl~DFGla~~ 142 (416)
..++|+|+.|.||++ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.013 Score=58.37 Aligned_cols=75 Identities=16% Similarity=0.193 Sum_probs=51.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccc---hhhHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEEec
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVK--HK-HIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~E~ 75 (416)
||-|.-.-||++.+...++.|+||--....-.. .-..++..-|..+|+... -| +++++|.+ ++....+|||+
T Consensus 37 igdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vMEd 114 (409)
T PRK12396 37 IGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVMED 114 (409)
T ss_pred cCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHHh
Confidence 788999999999984445779998542211111 123577788999988764 34 56667664 55667789999
Q ss_pred cCC
Q 014911 76 VKG 78 (416)
Q Consensus 76 ~~g 78 (416)
++.
T Consensus 115 L~~ 117 (409)
T PRK12396 115 LSD 117 (409)
T ss_pred Ccc
Confidence 864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.068 Score=51.74 Aligned_cols=29 Identities=21% Similarity=0.247 Sum_probs=27.3
Q ss_pred CceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 113 gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
++||+|+.+.|+++++++.+-++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.044 Score=54.78 Aligned_cols=29 Identities=24% Similarity=0.220 Sum_probs=24.6
Q ss_pred cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 ~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
...||.|+-+.||+.++ +.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 46899999999999754 569999999775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.038 Score=54.81 Aligned_cols=62 Identities=15% Similarity=0.151 Sum_probs=48.2
Q ss_pred EEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEeccC
Q 014911 68 KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLDED 129 (416)
Q Consensus 68 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~yl-H~~gi~HrDlkp~NIll~~~ 129 (416)
...++-+|..|.++..++.....+|....+++.-...|+--| --.+.+|.|++|.||++-.+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 345777899999999999876678877777777666665544 45689999999999999543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.069 Score=51.20 Aligned_cols=70 Identities=13% Similarity=0.205 Sum_probs=45.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+|.|..+.+|... .+++.+.||+-... ....+..|..-|+.|. .-.+++.+.+....+..|+||||++.
T Consensus 25 v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 25 VSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp E--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred cCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 5678889999987 57888999987622 1245677888888773 44677888888877778999999876
Q ss_pred C
Q 014911 79 G 79 (416)
Q Consensus 79 g 79 (416)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.26 Score=48.13 Aligned_cols=70 Identities=13% Similarity=0.097 Sum_probs=42.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC--CcceEE---E--EEEeCCEEEEEEeccCC
Q 014911 6 TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELH---E--VMASKSKIYFAMDLVKG 78 (416)
Q Consensus 6 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~---~--~~~~~~~~~lV~E~~~g 78 (416)
.-..||+... .+|..+++|+.+.... ....+..|+..+..|... .++... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 4467888875 4567799998854331 235677788887766321 122211 1 12335678889999987
Q ss_pred Cc
Q 014911 79 GE 80 (416)
Q Consensus 79 g~ 80 (416)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 53
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.36 Score=54.52 Aligned_cols=30 Identities=33% Similarity=0.557 Sum_probs=25.9
Q ss_pred cCceeccCCCCcEEeccCC--CeE-Eeeccccc
Q 014911 112 RGVYHRDLKPENLLLDEDG--NLK-VTDFGLSA 141 (416)
Q Consensus 112 ~gi~HrDlkp~NIll~~~~--~~k-l~DFGla~ 141 (416)
.+++|+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 554 99999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.051 Score=53.16 Aligned_cols=87 Identities=25% Similarity=0.392 Sum_probs=61.2
Q ss_pred CCCCCcceEEEEEE-eCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEecc
Q 014911 51 VKHKHIVELHEVMA-SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDE 128 (416)
Q Consensus 51 l~hpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~ 128 (416)
...++..+.+-+-. ..-..|++|++- |+.+ ..+.. -..+++..++.+.+..++-+..+ ..-|||+.-.||||+
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId- 356 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID- 356 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Ccee-eeeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence 34455555544442 234567777774 3333 22221 34567788999998888777765 689999999999999
Q ss_pred CCCeEEeecccccc
Q 014911 129 DGNLKVTDFGLSAF 142 (416)
Q Consensus 129 ~~~~kl~DFGla~~ 142 (416)
+|++-|+||-++++
T Consensus 357 ~GnvtLIDfklsRl 370 (488)
T COG5072 357 EGNVTLIDFKLSRL 370 (488)
T ss_pred cCceEEEEeeeeec
Confidence 99999999999984
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.17 Score=48.44 Aligned_cols=75 Identities=13% Similarity=0.152 Sum_probs=46.5
Q ss_pred ccCCceEEEEEEEcC----CC----cEEEEEEeecCcccc--hhhHHHHHHHHHHHHhCC-------------CCCcceE
Q 014911 3 GHGTFAKVYLARNLQ----TG----KSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVK-------------HKHIVEL 59 (416)
Q Consensus 3 G~G~fg~Vy~a~~~~----~~----~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-------------hpnIv~l 59 (416)
|.|-.|.+|++.-.. ++ ..+.||......... ......+.+|+.+.+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 778889999886532 22 357888875222111 123456788888877551 1235666
Q ss_pred EEEEEeCCEEEEEEeccC
Q 014911 60 HEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 60 ~~~~~~~~~~~lV~E~~~ 77 (416)
+..-..+...+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 666655567889998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 416 | ||||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-57 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-57 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-57 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-57 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-57 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-57 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-56 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-55 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-55 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-54 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-54 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-54 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-53 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-53 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-53 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-53 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-53 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-50 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-50 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-47 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-46 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-46 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-46 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-46 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-43 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-43 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-43 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-43 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-42 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-42 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-41 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-41 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-40 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-40 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-40 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-39 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-39 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-39 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-39 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-39 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-39 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-39 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-39 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-39 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-39 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-39 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-39 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-39 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-39 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-39 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-39 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-39 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-39 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-39 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-39 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-39 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-39 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-39 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-39 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-39 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-39 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-39 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-39 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-39 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-39 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-39 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-39 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-39 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-39 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-39 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-39 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-39 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-38 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-38 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-38 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-38 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-38 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-38 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-38 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-38 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-38 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-38 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-38 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-38 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-38 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-38 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-38 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-38 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-38 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-38 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-38 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-38 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-38 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-38 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-38 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-38 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-38 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-38 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-38 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-38 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-38 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-38 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-38 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-38 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-38 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-38 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-38 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-38 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-38 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-38 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-38 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-38 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-38 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-38 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-38 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-38 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-38 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-38 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-38 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-38 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-38 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-38 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-38 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-38 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-38 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-38 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-38 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-38 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-38 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-38 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-38 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-38 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-38 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-38 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-38 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-38 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-37 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-37 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-37 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-37 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-37 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-37 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-37 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-37 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-37 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-37 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-37 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-37 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-37 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-37 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-37 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-37 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-37 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-37 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-37 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-37 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-37 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-37 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-37 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-37 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-37 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-37 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-36 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-36 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-36 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-36 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-36 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-36 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-36 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-36 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-36 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-36 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-36 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-36 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-36 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-36 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-36 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-36 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-36 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-36 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-36 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-36 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-36 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-36 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-35 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-35 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-35 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-35 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-35 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-34 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-33 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-33 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-33 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-33 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-33 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-33 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-33 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-33 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-33 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-33 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-32 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-32 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-32 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-32 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-32 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-32 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-31 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-31 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-31 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-31 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-31 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-31 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-31 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-31 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-31 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-31 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-31 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-31 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-31 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-31 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-31 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-31 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-30 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-30 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-30 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-30 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-29 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-29 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-29 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-28 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-28 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-28 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-28 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-28 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-27 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-27 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-25 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-25 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-24 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-23 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-22 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-22 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-22 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-22 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-21 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-21 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-21 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-21 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-20 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-20 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-20 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-16 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 6e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-06 |
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-161
Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 6/259 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + +V LA N T +++A+K+V + + E IK+EI + KM+ H+++V+ +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ Y ++ GGELF++I + E A+ +F QL++ V + H G+ HRD+K
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE NLK++DFGL+ + ++ LL+ CGT YVAPE++ ++ + D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 181 SCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW--FSSEARRLITKLLDPNPNS 237
SCG++L +LAG LP+ + Y PW S L+ K+L NP++
Sbjct: 193 SCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 238 RIAISKIMESSWFKKSAPK 256
RI I I + W+ K K
Sbjct: 253 RITIPDIKKDRWYNKPLKK 271
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 455 bits (1173), Expect = e-161
Identities = 96/303 (31%), Positives = 157/303 (51%), Gaps = 13/303 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + +V LA N T +++A+K+V + + E IK+EI + KM+ H+++V+ +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ Y ++ GGELF++I + E A+ +F QL++ V + H G+ HRD+K
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE NLK++DFGL+ + ++ LL+ CGT YVAPE++ ++ + D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 181 SCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW--FSSEARRLITKLLDPNPNS 237
SCG++L +LAG LP+ + Y PW S L+ K+L NP++
Sbjct: 193 SCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 238 RIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLSPLFE 297
RI I I + W+ K K + + S+ P + + D SP+
Sbjct: 253 RITIPDIKKDRWYNKPLKKGA---KRPRVTSGGVSESPSGFSK----HIQSNLDFSPVNS 305
Query: 298 EKK 300
+
Sbjct: 306 ASR 308
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 453 bits (1169), Expect = e-161
Identities = 111/259 (42%), Positives = 162/259 (62%), Gaps = 4/259 (1%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG GTF KV + + TG +A+K++ + K+ + ++ +IKREI +K+ +H HI++L++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+++ + + M+ V GGELF+ I GR+ E AR FQQ++SAVD+CH V HRDLK
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLD N K+ DFGLS + L T+CG+P Y APEVIS + Y G + DIW
Sbjct: 139 PENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCGVILY LL G LPF D+++ ++++KI G F P + + L+ +L +P R
Sbjct: 196 SCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRAT 255
Query: 241 ISKIMESSWFKKSAPKVVI 259
I I E WFK+ P +
Sbjct: 256 IKDIREHEWFKQDLPSYLF 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-161
Identities = 83/262 (31%), Positives = 142/262 (54%), Gaps = 6/262 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-QIKREISVMKMVKHKHIVELH 60
LG G++ KV + +T A+K++ K K+ ++ E +K+EI +++ ++HK++++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 61 EVM--ASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+V+ K K+Y M+ G E+ + + + R A YF QLI +++ HS+G+ H
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS-KKGYDGA 175
+D+KP NLLL G LK++ G++ D T+ G+PA+ PE+ + + G
Sbjct: 133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGF 192
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235
K DIWS GV LY + G PF+ DNI ++ I +G + P L+ +L+ P
Sbjct: 193 KVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEP 252
Query: 236 NSRIAISKIMESSWFKKSAPKV 257
R +I +I + SWF+K P
Sbjct: 253 AKRFSIRQIRQHSWFRKKHPPA 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 453 bits (1167), Expect = e-158
Identities = 127/455 (27%), Positives = 208/455 (45%), Gaps = 78/455 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG GTF KV + ++ TG +A+K++ + K+ + ++ +I+REI +K+ +H HI++L++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+++ S I+ M+ V GGELF+ I GRL E +R FQQ++S VD+CH V HRDLK
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLD N K+ DFGLS + L T+CG+P Y APEVIS + Y G + DIW
Sbjct: 144 PENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
S GVILY LL G LPF DD++ ++++KI G F P + + L+ +L +P R
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRAT 260
Query: 241 ISKIMESSWFKKSAPKVV-------------------------ITKQEMEFEADKSSKQP 275
I I E WFK+ PK + +++E+ + Q
Sbjct: 261 IKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQD 320
Query: 276 ETLNAFHII--------SLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFE---- 323
A+H+I + + + + P +
Sbjct: 321 PLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTL 380
Query: 324 ---------------------------------EVAKAVK---FNVK-TSESRVRLQGQE 346
EV +A+K + K + +R++ +
Sbjct: 381 DELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKN 440
Query: 347 SGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEY 381
++ ++ V +++ + + + LE
Sbjct: 441 PVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 443 bits (1142), Expect = e-156
Identities = 108/336 (32%), Positives = 163/336 (48%), Gaps = 34/336 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F L R+ T + +A+K + + I E ++REI + ++H +IV E
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83
Query: 62 VMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+ + + + M+ GGEL+ +I GR ED AR +FQQL+S V +CHS + HRDLK
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143
Query: 121 PENLLLDED--GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
EN LLD LK+ DFG S S +T GTPAY+APEV+ ++ YDG AD
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRK----IYRGDFKCPP--WFSSEARRLITKLLD 232
+WSCGV LYV+L G PF+D YRK I + P S E LI+++
Sbjct: 201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFV 260
Query: 233 PNPNSRIAISKIMESSWFKKSAPKVVITKQEME----------------FEADKSSKQPE 276
+P +RI+I +I SWF K+ P ++ + + + P
Sbjct: 261 ADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPA 320
Query: 277 TLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATT 312
N +++ DL ++ E+ ++
Sbjct: 321 VRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDSS 354
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-154
Identities = 82/253 (32%), Positives = 131/253 (51%), Gaps = 4/253 (1%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G FAK + + T + A K+V K ++K E++ EIS+ + + H+H+V H
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ ++L + L + L E AR Y +Q++ + H V HRDL
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K NL L+ED +K+ DFGL+ E+ CGTP Y+APEV+SKKG+ + D+
Sbjct: 142 KLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSF-EVDV 198
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
WS G I+Y LL G PF+ + Y +I + ++ P + A LI K+L +P +R
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 258
Query: 240 AISKIMESSWFKK 252
I++++ +F
Sbjct: 259 TINELLNDEFFTS 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-154
Identities = 81/257 (31%), Positives = 147/257 (57%), Gaps = 5/257 (1%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+FA VY A ++ TG +A+K++ K + K GM+++++ E+ + +KH I+EL+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ +Y +++ GE+ + E+ AR + Q+I+ + + HS G+ HRDL
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
NLLL + N+K+ DFGL+ + +T CGTP Y++PE+ ++ + G ++D+
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSAH-GLESDV 195
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
WS G + Y LL G PF D + + K+ D++ P + S EA+ LI +LL NP R+
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRL 255
Query: 240 AISKIMESSWFKKSAPK 256
++S +++ + +++
Sbjct: 256 SLSSVLDHPFMSRNSST 272
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 437 bits (1126), Expect = e-154
Identities = 105/267 (39%), Positives = 170/267 (63%), Gaps = 5/267 (1%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F KV LA + +T + +A+K + + + K M +++REIS +K+++H HI++L++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+ + + I ++ GGELF+ I K R+ ED R +FQQ+I A+++CH + HRDLK
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLD++ N+K+ DFGLS + L T+CG+P Y APEVI+ K Y G + D+W
Sbjct: 136 PENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
SCG++LYV+L G LPF D+ I ++++K+ + P + S A+ LI +++ +P RI
Sbjct: 193 SCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRIT 252
Query: 241 ISKIMESSWFKKSAPKVVITKQEMEFE 267
I +I WF + P + +E++
Sbjct: 253 IQEIRRDPWFNVNLPDYLRPMEEVQGS 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-153
Identities = 82/253 (32%), Positives = 131/253 (51%), Gaps = 4/253 (1%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G FAK + + T + A K+V K ++K E++ EIS+ + + H+H+V H
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ ++L + L + L E AR Y +Q++ + H V HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K NL L+ED +K+ DFGL+ E+ CGTP Y+APEV+SKKG+ + D+
Sbjct: 168 KLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSF-EVDV 224
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
WS G I+Y LL G PF+ + Y +I + ++ P + A LI K+L +P +R
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 284
Query: 240 AISKIMESSWFKK 252
I++++ +F
Sbjct: 285 TINELLNDEFFTS 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-152
Identities = 94/257 (36%), Positives = 145/257 (56%), Gaps = 6/257 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F VYLAR Q MA+KV+ K ++ K G+ Q++REI + ++H +I+ ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ +IY ++ GEL+ ++ K GR E + + ++L A+ +CH R V HRD+K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLL+ G LK+ DFG S + L+ T CGT Y+ PE+I K +D K D+W
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHD-EKVDLW 196
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
GV+ Y L G PF + +R+I D K PP+ S ++ LI+KLL +P R+
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLP 256
Query: 241 ISKIMESSWFKKSAPKV 257
+ +ME W K ++ +V
Sbjct: 257 LKGVMEHPWVKANSRRV 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-152
Identities = 96/280 (34%), Positives = 151/280 (53%), Gaps = 31/280 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----------------------GMM 38
+G G++ V LA N AMKV+ K K+I+ G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 39 EQIKREISVMKMVKHKHIVELHEVM--ASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR 96
EQ+ +EI+++K + H ++V+L EV+ ++ +Y +LV G + L ED AR
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
YFQ LI +++ H + + HRD+KP NLL+ EDG++K+ DFG+S + D LL T
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--GSDALLSNTV 198
Query: 157 GTPAYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK 214
GTPA++APE +S +K + G D+W+ GV LY + G PF D+ I+ ++ KI +
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE 258
Query: 215 CP--PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
P P + + + LIT++LD NP SRI + +I W +
Sbjct: 259 FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 422 bits (1087), Expect = e-149
Identities = 86/265 (32%), Positives = 145/265 (54%), Gaps = 6/265 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F VYLAR Q+ +A+KV+ K ++ K G+ Q++RE+ + ++H +I+ L+
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+++Y ++ G ++ ++ K + E Y +L +A+ +CHS+ V HRD+K
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLL G LK+ DFG S + + CGT Y+ PE+I + +D K D+W
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHD-EKVDLW 191
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
S GV+ Y L G PF+ + Y++I R +F P + + AR LI++LL NP+ R
Sbjct: 192 SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 251
Query: 241 ISKIMESSWFKKSAPKVVITKQEME 265
+ +++E W ++ K + +
Sbjct: 252 LREVLEHPWITANSSKPSNCQNKES 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-139
Identities = 100/260 (38%), Positives = 159/260 (61%), Gaps = 5/260 (1%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G FAKV LAR++ TG+ +A+K++ K + + ++++ RE+ +MK++ H +IV+L E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+ ++ +Y M+ GGE+F+ + A GR++E AR F+Q++SAV +CH + + HRDLK
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
ENLLLD D N+K+ DFG S G L CG P Y APE+ K YDG + D+W
Sbjct: 142 AENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVW 198
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
S GVILY L++G LPF N+ + ++ RG ++ P + S++ L+ + L NP R
Sbjct: 199 SLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGT 258
Query: 241 ISKIMESSWFKKSAPKVVIT 260
+ +IM+ W + +
Sbjct: 259 LEQIMKDRWINAGHEEDELK 278
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 398 bits (1026), Expect = e-139
Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 20/285 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ---IKREISVMKMV----KH 53
+LG G F V+ L +A+KV+ +++V+ + E++++ V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 54 KHIVELHEVMASKSKIYFAMDL-VKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHS 111
++ L + ++ ++ + +LF+ I KG L E +R +F Q+++A+ CHS
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 112 RGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
RGV HRD+K EN+L+D G K+ DFG A D GT Y PE IS+
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFDGTRVYSPPEWISRH 213
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 230
Y A +WS G++LY ++ G +PF+ D ++I + P S + LI +
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRC 267
Query: 231 LDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQP 275
L P P+SR ++ +I+ W + A V + + S P
Sbjct: 268 LAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP 312
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-137
Identities = 80/270 (29%), Positives = 138/270 (51%), Gaps = 16/270 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-----QIKREISVMKMVKHKHI 56
LG G F V+ A + + K + +K + K+KV++ +E ++ EI+++ V+H +I
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 57 VELHEVMASKSKIYFAMDL-VKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 114
+++ ++ ++ M+ G +LF I RL E +A F+QL+SAV + + +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
HRD+K EN+++ ED +K+ DFG +A+ L++ L +T CGT Y APEV+ Y G
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTIEYCAPEVLMGNPYRG 208
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 234
+ ++WS GV LY L+ PF + + P S E L++ LL P
Sbjct: 209 PELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGLLQPV 262
Query: 235 PNSRIAISKIMESSWFKKSAPKVVITKQEM 264
P R + K++ W + T +E+
Sbjct: 263 PERRTTLEKLVTDPWVTQPVNLADYTWEEV 292
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-135
Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 18/280 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM---EQIKREISVMKMVKHK--HI 56
LG G F VY + +A+K V KD++ G + ++ E+ ++K V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 57 VELHEVMASKSKIYFAMDLVKG-GELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGV 114
+ L + ++ + +LF+ I +G L+E++AR +F Q++ AV CH+ GV
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 170
Query: 115 YHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
HRD+K EN+L+D + G LK+ DFG A +D + GT Y PE I Y
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233
G A +WS G++LY ++ G +PF+ D +I RG SSE + LI L
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLAL 280
Query: 234 NPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSK 273
P+ R +I W + + + + SK
Sbjct: 281 RPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-130
Identities = 61/300 (20%), Positives = 124/300 (41%), Gaps = 51/300 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--------------VGMMEQIKREISV 47
L G F K+ L K A+K K + K + K E+ +
Sbjct: 39 LNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 48 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---------GRLREDVARVY 98
+ +K+++ + ++ + ++Y + ++ + + V +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 99 FQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157
+ ++++ + H+ + + HRD+KP N+L+D++G +K++DFG S + D + + G
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----DKKIKGSRG 212
Query: 158 TPAYVAPEVIS-KKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDFKC 215
T ++ PE S + Y+GAK DIWS G+ LYV+ +PF ++V ++ I + +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272
Query: 216 P-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
P + S+E + L NP RI ++ W + +
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-111
Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 37/292 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V ARN + A+K + + + I E+ ++ + H+++V +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYY 68
Query: 61 EV-------------MASKSKIYFAMDLVKGGELFNKIAKGR--LREDVARVYFQQLISA 105
+ KS ++ M+ + G L++ I + D F+Q++ A
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 106 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------------LKQDGLLH 153
+ + HS+G+ HRDLKP N+ +DE N+K+ DFGL+ L
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 213
+ GT YVA EV+ G+ K D++S G+I + ++ V++ +K+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSI 246
Query: 214 KCPPWF----SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITK 261
+ PP F +++I L+D +PN R ++ S W VI +
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-107
Identities = 96/290 (33%), Positives = 150/290 (51%), Gaps = 22/290 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVKHKHI 56
LG G +V LA +T K +A+K++ K K + ++ EI ++K + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+++ ++ Y ++L++GGELF+K+ RL+E ++YF Q++ AV + H G+
Sbjct: 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 116 HRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS---K 169
HRDLKPEN+LL +ED +K+TDFG S L + L+ T CGTP Y+APEV+
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGT 193
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRG--DFKCPPWF--SSEAR 224
GY D WS GVIL++ L+G+ PF + VS+ +I G +F W S +A
Sbjct: 194 AGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQ 274
L+ KLL +P +R + + W + K E + Q
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQ 302
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-106
Identities = 93/262 (35%), Positives = 140/262 (53%), Gaps = 13/262 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F+ V + TG A K++ K+ ++++RE + + ++H +IV LH+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHD 72
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ +S Y DLV GGELF I A+ E A QQ++ ++ +CHS G+ HR+LK
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PENLLL + +K+ DFGL+ + H GTP Y++PEV+ K Y
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPV 188
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
DIW+CGVILY+LL G+ PF D++ +Y +I G D+ P W + EA+ LI +L
Sbjct: 189 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248
Query: 234 NPNSRIAISKIMESSWFKKSAP 255
NP RI + ++ W
Sbjct: 249 NPKKRITADQALKVPWICNRER 270
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-103
Identities = 93/262 (35%), Positives = 140/262 (53%), Gaps = 13/262 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F+ V + TG A K++ K+ ++++RE + + ++H +IV LH+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHD 95
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ +S Y DLV GGELF I A+ E A QQ++ ++ +CHS G+ HR+LK
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PENLLL + +K+ DFGL+ + H GTP Y++PEV+ K Y
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPV 211
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
DIW+CGVILY+LL G+ PF D++ +Y +I G D+ P W + EA+ LI +L
Sbjct: 212 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 271
Query: 234 NPNSRIAISKIMESSWFKKSAP 255
NP RI + ++ W
Sbjct: 272 NPKKRITADQALKVPWICNRER 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-103
Identities = 96/263 (36%), Positives = 137/263 (52%), Gaps = 16/263 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G++ +V +A T A K + K V V ++ K+EI +MK + H +I+ L+E
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDHPNIIRLYE 73
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ IY M+L GGELF ++ K RE A + ++SAV +CH V HRDLK
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PEN L D LK+ DFGL+A K ++ T GTP YV+P+V+ + Y G +
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVL-EGLY-GPEC 188
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D WS GV++YVLL G+ PF + KI G F W S +A LI +LL
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248
Query: 234 NPNSRIAISKIMESSWFKKSAPK 256
+P RI + +E WF+K
Sbjct: 249 SPKQRITSLQALEHEWFEKQLSS 271
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 22/273 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV------GMMEQIKREISVMKMVK-HK 54
LG G + V + T K A+K++ + E +E+ +++ V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 113
+I++L + + + + DL+K GELF+ + K L E R + L+ + H
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI------ 167
+ HRDLKPEN+LLD+D N+K+TDFG S L L CGTP+Y+APE+I
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 223
+ GY G + D+WS GVI+Y LLAG PF + M R I G F P W +S
Sbjct: 202 NHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260
Query: 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
+ L+++ L P R + + +F++ +
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-103
Identities = 93/272 (34%), Positives = 147/272 (54%), Gaps = 22/272 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVKHKHI 56
LG G +V LA +T K +A++++ K K + ++ EI ++K + H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+++ ++ Y ++L++GGELF+K+ RL+E ++YF Q++ AV + H G+
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 116 HRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS---K 169
HRDLKPEN+LL +ED +K+TDFG S L + L+ T CGTP Y+APEV+
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGT 318
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRG--DFKCPPWF--SSEAR 224
GY D WS GVIL++ L+G+ PF + VS+ +I G +F W S +A
Sbjct: 319 AGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
L+ KLL +P +R + + W + K
Sbjct: 378 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-103
Identities = 89/268 (33%), Positives = 141/268 (52%), Gaps = 21/268 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVK-HKH 55
+G G + V + TG A+K++ + E +RE +++ V H H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 114
I+ L + S S ++ DL++ GELF+ + K L E R + L+ AV F H+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI------S 168
HRDLKPEN+LLD++ ++++DFG S L+ L CGTP Y+APE++ +
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEAR 224
GY G + D+W+CGVIL+ LLAG PF + M R I G F P W SS +
Sbjct: 279 HPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKK 252
LI++LL +P +R+ + ++ +F++
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-102
Identities = 101/262 (38%), Positives = 150/262 (57%), Gaps = 16/262 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F++V+L + TGK A+K + K + ++ EI+V+K +KH++IV L +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ S + Y M LV GGELF++I +G E A + QQ++SAV + H G+ HRDLK
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PENLL +E+ + +TDFGLS + +G++ T CGTP YVAPEV+++K Y
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPY-SKAV 188
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D WS GVI Y+LL G+ PF ++ ++ KI G +F+ P W S A+ I LL+
Sbjct: 189 DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEK 248
Query: 234 NPNSRIAISKIMESSWFKKSAP 255
+PN R K + W +
Sbjct: 249 DPNERYTCEKALSHPWIDGNTA 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-102
Identities = 90/263 (34%), Positives = 145/263 (55%), Gaps = 14/263 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V ++ T + A+KV+ K I RE+ ++K + H +I++L E
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFE 88
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++ S Y +L GGELF++I + R E A +Q+ S + + H + HRDLK
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PEN+LL ++D ++K+ DFGLS +Q+ + GT Y+APEV+ + Y K
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RGTY-DEKC 203
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS GVILY+LL+G PF N + +++ G F P W S +A+ LI K+L
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 234 NPNSRIAISKIMESSWFKKSAPK 256
+P+ RI ++ +E W +K + +
Sbjct: 264 HPSLRITATQCLEHPWIQKYSSE 286
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-101
Identities = 82/263 (31%), Positives = 133/263 (50%), Gaps = 18/263 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+L +G +K + KD+ MEQI+ EI V+K + H +I+++ E
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V +Y M+ +GGEL +I L E +Q+++A+ + HS+ V H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 117 RDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
+DLKPEN+L +K+ DFGL+ K D GT Y+APEV K+
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVF-KRDV- 202
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWF-SSEARRLITKL 230
K DIWS GV++Y LL G LPF ++ + +K ++ + +A L+ ++
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQM 262
Query: 231 LDPNPNSRIAISKIMESSWFKKS 253
L +P R + ++++ WFK++
Sbjct: 263 LTKDPERRPSAAQVLHHEWFKQA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 8e-99
Identities = 94/263 (35%), Positives = 145/263 (55%), Gaps = 14/263 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F+ V + G+ A ++ K+ ++++RE + +++KH +IV LH+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHPNIVRLHD 77
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++ + Y DLV GGELF I A+ E A QQ++ AV CH GV HR+LK
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLK 137
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDG-LLHTTCGTPAYVAPEVISKKGYDGAK 176
PENLLL + +K+ DFGL+ ++ + GTP Y++PEV+ K Y G
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIE---VEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKP 193
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLD 232
D+W+CGVILY+LL G+ PF D++ +Y++I G DF P W + EA+ LI K+L
Sbjct: 194 VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLT 253
Query: 233 PNPNSRIAISKIMESSWFKKSAP 255
NP+ RI ++ ++ W +
Sbjct: 254 INPSKRITAAEALKHPWISHRST 276
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 1e-97
Identities = 86/267 (32%), Positives = 144/267 (53%), Gaps = 16/267 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVKHKHIVE 58
LG G FA V R TGK A K + K ++ E+I+RE+++++ ++H +I+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
LH++ +K+ + ++LV GGELF+ + K L ED A + +Q++ V + HS+ + H
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 118 DLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
DLKPEN++L + +K+ DFG++ ++ GTP +VAPE+++ +
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPL- 188
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITK 229
G +AD+WS GVI Y+LL+G PF + I DF + S A+ I +
Sbjct: 189 GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRR 248
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPK 256
LL +P R+ I++ +E SW K +
Sbjct: 249 LLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 1e-97
Identities = 95/267 (35%), Positives = 141/267 (52%), Gaps = 18/267 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + VY + T K A+KV+ K + ++ EI V+ + H +I++L E
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-----KIVRTEIGVLLRLSHPNIIKLKE 115
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ + ++I ++LV GGELF++I KG E A +Q++ AV + H G+ HRDLK
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PENLL D LK+ DFGLS ++ L+ T CGTP Y APE++ Y G +
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCAY-GPEV 231
Query: 178 DIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLD 232
D+WS G+I Y+LL GF PF D+ M+R+I F P W S A+ L+ KL+
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIV 291
Query: 233 PNPNSRIAISKIMESSWFKKSAPKVVI 259
+P R+ + ++ W A V
Sbjct: 292 LDPKKRLTTFQALQHPWVTGKAANFVH 318
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 1e-96
Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 18/265 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 59
+G G F+ V N +TG+ A+K+V K + E +KRE S+ M+KH HIVEL
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKI-AKGRLR----EDVARVYFQQLISAVDFCHSRGV 114
E +S +Y + + G +L +I + E VA Y +Q++ A+ +CH +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 115 YHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
HRD+KP +LL + +K+ FG++ + + GTP ++APEV+ ++
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLI 227
Y G D+W CGVIL++LL+G LPF ++ I +G W S A+ L+
Sbjct: 210 Y-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLV 267
Query: 228 TKLLDPNPNSRIAISKIMESSWFKK 252
++L +P RI + + + W K+
Sbjct: 268 RRMLMLDPAERITVYEALNHPWLKE 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 6e-96
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 51/303 (16%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G A V+ R+ +TG A+KV ++ ++ RE V+K + HK+IV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 61 EVM--ASKSKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGV 114
+ + M+ G L+ + + L E + + ++ ++ G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 115 YHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
HR++KP N++ D K+TDFG + L+ D + GT Y+ P++ +
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 171 GYD-------GAKADIWSCGVILYVLLAGFLPFQD----DNIVSMYRKIYRGDF------ 213
GA D+WS GV Y G LPF+ + KI G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 214 -------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254
++ +L+ + + +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
Query: 255 PKV 257
Sbjct: 311 GNS 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 7e-96
Identities = 94/301 (31%), Positives = 155/301 (51%), Gaps = 29/301 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELH 60
LG G+F+ + ++ ++ A+K++ K ++EI+ +K+ + H +IV+LH
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLH 72
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
EV + + M+L+ GGELF +I K E A ++L+SAV H GV HRDL
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 120 KPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
KPENLL +++ +K+ DFG + + L T C T Y APE++++ GYD
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ES 189
Query: 177 ADIWSCGVILYVLLAGFLPFQDDN-------IVSMYRKIYRG--DFKCPPW--FSSEARR 225
D+WS GVILY +L+G +PFQ + V + +KI +G F+ W S EA+
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249
Query: 226 LITKLLDPNPNSRIAISKIMESSWFKK--SAPKVVITKQEMEFEADKS--SKQPETLNAF 281
LI LL +PN R+ +S + + W + + ++ + + + T +AF
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAF 309
Query: 282 H 282
+
Sbjct: 310 N 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 7e-96
Identities = 85/274 (31%), Positives = 142/274 (51%), Gaps = 16/274 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM---EQIKREISVMKMVKHKHIVE 58
LG G FA V R TG A K + K + E I+RE+S++K ++H +++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
LHEV +K+ + ++LV GGELF+ + K L E+ A + +Q+++ V + HS + H
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 118 DLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
DLKPEN++L +K+ DFGL+ + GTP +VAPE+++ +
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIVNYEPL- 194
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITK 229
G +AD+WS GVI Y+LL+G PF D + +F+ + S+ A+ I +
Sbjct: 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 263
LL +P R+ I ++ W K + ++++
Sbjct: 255 LLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKA 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 8e-96
Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 20/273 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVE 58
+G G +KV+ N + + A+K V ++ ++ + EI+ + ++ I+
Sbjct: 35 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
L++ + IY M+ +L + + K + + Y++ ++ AV H G+ H
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD---- 173
DLKP N L+ DG LK+ DFG++ + + + GT Y+ PE I
Sbjct: 152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 174 ------GAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG-DFKCPPWFSSEAR 224
K+D+WS G ILY + G PFQ + I ++ I + + P + +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 257
++ L +P RI+I +++ + + V
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 3e-95
Identities = 85/308 (27%), Positives = 143/308 (46%), Gaps = 52/308 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV--GMMEQIKREISVMKMVKHKHIVEL 59
+G G++ V +A QT A+K++ K+K+ ++ +E+IK E+ +MK + H +I L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-------------------------------- 87
+EV + I M+L GG L +K+
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 88 ---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL--DEDGNLKVTD 136
RE + +Q+ SA+ + H++G+ HRD+KPEN L ++ +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 137 FGLSAFSEHLK--QDGLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGF 193
FGLS L + + T GTP +VAPEV++ G K D WS GV+L++LL G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 194 LPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSW 249
+PF N ++ F+ P + S AR L++ LL+ N + R + ++ W
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333
Query: 250 FKKSAPKV 257
+ + K+
Sbjct: 334 ISQFSDKI 341
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 4e-95
Identities = 86/326 (26%), Positives = 153/326 (46%), Gaps = 31/326 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELH 60
+G G+++ + T A+K++ K K EI ++ + +H +I+ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLK 82
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+V +Y +L+KGGEL +KI + E A + V++ H++GV HRDL
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142
Query: 120 KPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
KP N+L ++++ DFG + ++GLL T C T +VAPEV+ ++GYD A
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLERQGYD-A 199
Query: 176 KADIWSCGVILYVLLAGFLPF---QDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLIT 228
DIWS GV+LY +L G+ PF DD + +I G W S A+ L++
Sbjct: 200 ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVS 259
Query: 229 KLLDPNPNSRIAISKIMESSWFKK--SAPKVVITKQEMEFEADKSSKQPETLNAFHIISL 286
K+L +P+ R+ + ++ W P+ + +Q+ + + ++
Sbjct: 260 KMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD-----APHLVKGAMAATYSALNR 314
Query: 287 SEGFDLSPLFEEKKRAEREELRFATT 312
++ L P+ A+R ++ T+
Sbjct: 315 NQSPVLEPV-GRSTLAQRRGIKKITS 339
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 6e-95
Identities = 84/274 (30%), Positives = 140/274 (51%), Gaps = 16/274 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVKHKHIVE 58
LG G FA V R TG A K + K + E+I+RE+S+++ V H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
LH+V +++ + ++LV GGELF+ + K L E+ A + +Q++ V++ H++ + H
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 118 DLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
DLKPEN++L ++K+ DFGL+ ++ GTP +VAPE+++ +
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPL- 195
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITK 229
G +AD+WS GVI Y+LL+G PF D I DF + S A+ I K
Sbjct: 196 GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK 255
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 263
LL R+ I + + W + + ++E
Sbjct: 256 LLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-94
Identities = 70/329 (21%), Positives = 132/329 (40%), Gaps = 20/329 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVE 58
+G G +KV+ N + + A+K V ++ ++ + EI+ + ++ I+
Sbjct: 16 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
L++ + IY M+ +L + + K + + Y++ ++ AV H G+ H
Sbjct: 74 LYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD---- 173
DLKP N L+ DG LK+ DFG++ + + + GT Y+ PE I
Sbjct: 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191
Query: 174 ------GAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG-DFKCPPWFSSEAR 224
K+D+WS G ILY + G PFQ + I ++ I + + P + +
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHII 284
++ L +P RI+I +++ + + V + E Q LN+ + I
Sbjct: 252 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 311
Query: 285 SLSEGFDLSPLFEEKKRAEREELRFATTR 313
+ + F R
Sbjct: 312 LKAAKTLYEHYSGGESHNSSSSKTFEKKR 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 3e-94
Identities = 85/274 (31%), Positives = 140/274 (51%), Gaps = 16/274 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVKHKHIVE 58
LG G FA V R TG A K + K + E+I+RE+S+++ V H +I+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
LH+V +++ + ++LV GGELF+ + K L E+ A + +Q++ V++ H++ + H
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 118 DLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
DLKPEN++L ++K+ DFGL+ ++ GTP +VAPE+++ +
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPL- 195
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITK 229
G +AD+WS GVI Y+LL+G PF D I DF + S A+ I K
Sbjct: 196 GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK 255
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 263
LL R+ I + + W + + ++E
Sbjct: 256 LLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-94
Identities = 90/263 (34%), Positives = 145/263 (55%), Gaps = 14/263 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V ++ T + A+KV+ K I RE+ ++K + H +I++L E
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFE 88
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
++ S Y +L GGELF++I + R E A +Q+ S + + H + HRDLK
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PEN+LL ++D ++K+ DFGLS +Q+ + GT Y+APEV+ + Y K
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RGTY-DEKC 203
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS GVILY+LL+G PF N + +++ G F P W S +A+ LI K+L
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 234 NPNSRIAISKIMESSWFKKSAPK 256
+P+ RI ++ +E W +K + +
Sbjct: 264 HPSLRITATQCLEHPWIQKYSSE 286
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-93
Identities = 67/301 (22%), Positives = 127/301 (42%), Gaps = 20/301 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVE 58
+G G +KV+ N + + A+K V ++ ++ + EI+ + ++ I+
Sbjct: 63 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
L++ + IY M+ +L + + K + + Y++ ++ AV H G+ H
Sbjct: 121 LYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD---- 173
DLKP N L+ DG LK+ DFG++ + + + G Y+ PE I
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238
Query: 174 ------GAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG-DFKCPPWFSSEAR 224
K+D+WS G ILY + G PFQ + I ++ I + + P + +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHII 284
++ L +P RI+I +++ + + V + E Q LN+ + I
Sbjct: 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 358
Query: 285 S 285
Sbjct: 359 L 359
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-93
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 16/273 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELH 60
LG G FA V + TG+ A K + K + + +I EI+V+++ K ++ LH
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLH 95
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHR 117
EV + S+I ++ GGE+F+ + E+ +Q++ V + H + H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 118 DLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
DLKP+N+LL G++K+ DFG+S + L GTP Y+APE+++
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILNYDPI-T 211
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKL 230
D+W+ G+I Y+LL PF ++ Y I + D+ + S A I L
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 231 LDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 263
L NP R + SW ++ + + +E
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 2e-93
Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 38/290 (13%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVEL 59
+LG G A+V NL T + A+K++ K ++ RE+ ++ + H++++EL
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
E + + Y + ++GG + + I + E A V Q + SA+DF H++G+ HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 119 LKPENLLL---DEDGNLKVTDFGLSAFSE-----HLKQDGLLHTTCGTPAYVAPEVISK- 169
LKPEN+L ++ +K+ DF L + + L T CG+ Y+APEV+
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 170 ----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---------------MYRKIYR 210
YD + D+WS GVILY+LL+G+ PF ++ I
Sbjct: 197 SEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 211 G--DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
G +F W S A+ LI+KLL + R++ +++++ W + AP+
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 3e-93
Identities = 91/263 (34%), Positives = 145/263 (55%), Gaps = 13/263 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V L ++ TG+ A+KV+ K +V + E + RE+ ++K + H +I++L+E
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K Y ++ GGELF++I ++ R E A +Q++S + + H + HRDLK
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PENLLL +D N+++ DFGLS + + GT Y+APEV+ Y K
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVL-HGTY-DEKC 208
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS GVILY+LL+G PF N + +K+ +G F+ P W S A+ LI K+L
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY 268
Query: 234 NPNSRIAISKIMESSWFKKSAPK 256
P+ RI+ ++ W + +
Sbjct: 269 VPSMRISARDALDHEWIQTYTKE 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 284 bits (727), Expect = 7e-93
Identities = 59/305 (19%), Positives = 109/305 (35%), Gaps = 51/305 (16%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G A V+ R+ +TG A+KV ++ ++ RE V+K + HK+IV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 61 EVM--ASKSKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGV 114
+ + M+ G L+ + + L E + + ++ ++ G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 115 YHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
HR++KP N++ D K+TDFG + L+ D + GT Y+ P++ +
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 171 GYD-------GAKADIWSCGVILYVLLAGFLPFQD----DNIVSMYRKIYRGDF------ 213
GA D+WS GV Y G LPF+ + KI G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 214 -------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254
++ +L+ + + +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
Query: 255 PKVVI 259
+ +
Sbjct: 311 MVIHV 315
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 6e-92
Identities = 96/291 (32%), Positives = 149/291 (51%), Gaps = 23/291 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM----------MEQIKREISVMKMV 51
LG G + +V L + A+KV+ K + K E+I EIS++K +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 52 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 110
H +I++L +V K Y + +GGELF +I + + E A +Q++S + + H
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 111 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 167
+ HRD+KPEN+LL + N+K+ DFGLS+F +D L GT Y+APEV+
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPEVL 220
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 223
KK Y K D+WSCGVI+Y+LL G+ PF N + +K+ +G F W S EA
Sbjct: 221 -KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEA 278
Query: 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQ 274
+ LI +L + N R + + S W KK A + + Q+ A + ++
Sbjct: 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 1e-91
Identities = 73/320 (22%), Positives = 126/320 (39%), Gaps = 22/320 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G F V + TG+ +A+K ++ K E+ EI +MK + H ++V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHPNVVSAR 78
Query: 61 EVMASKSKI------YFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCH 110
EV K+ AM+ +GG+L + + L+E R + SA+ + H
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 111 SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 167
+ HRDLKPEN++L K+ D G +++ L Q L GT Y+APE++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGELCTEFVGTLQYLAPELL 195
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFKCPPWFSSEARRL 226
+K Y D WS G + + + GF PF + V + K+ + + +
Sbjct: 196 EQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 227 ITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISL 286
+ P PN I W + + +Q + + + L++ + L
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQC--MLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312
Query: 287 SEGFDLSPLFEEKKRAEREE 306
++ E
Sbjct: 313 LSVMNMVSGRVHTYPVTENE 332
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-91
Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 15/280 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V+ TG +A K++ + E++K EISVM + H ++++L++
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQLYD 153
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
SK+ I M+ V GGELF++I + L E ++ +Q+ + H + H DL
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 120 KPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
KPEN+L + +K+ DFGL+ K L GTP ++APEV++
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARR---YKPREKLKVNFGTPEFLAPEVVNYDFV-SFPT 269
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS GVI Y+LL+G PF DN I D + + S EA+ I+KLL
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK 329
Query: 234 NPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSK 273
+ RI+ S+ ++ W ++ Q+ + +
Sbjct: 330 EKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQD 369
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 4e-91
Identities = 93/263 (35%), Positives = 145/263 (55%), Gaps = 14/263 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + +V L R+ T A+K++ K V ++ E++V+K++ H +I++L++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K Y M+ KGGELF++I + + E A V +Q++S V + H + HRDLK
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163
Query: 121 PENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
PENLLL ++D +K+ DFGLSA + + GT Y+APEV+ +K Y K
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVL-RKKY-DEKC 218
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS GVIL++LLAG+ PF + RK+ +G F P W S A+ LI ++L
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 234 NPNSRIAISKIMESSWFKKSAPK 256
+ RI+ + +E W K+ K
Sbjct: 279 DSQRRISAQQALEHPWIKEMCSK 301
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 9e-91
Identities = 69/264 (26%), Positives = 115/264 (43%), Gaps = 16/264 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+ + K+ K V + +K+EIS++ + +H++I+ LHE
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHE 68
Query: 62 VMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
S ++ + + G ++F +I L E Y Q+ A+ F HS + H D+
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 120 KPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
+PEN++ +K+ +FG + LK P Y APEV
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQHDVV-STAT 184
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS G ++YVLL+G PF + + I F + S EA + +LL
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 234 NPNSRIAISKIMESSWFKKSAPKV 257
SR+ S+ ++ W K+ +V
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERV 268
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 5e-90
Identities = 85/258 (32%), Positives = 142/258 (55%), Gaps = 8/258 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F+ V LAR L T + A+K++ K +IK + + RE VM + H V+L+
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
K+YF + K GEL I K G E R Y +++SA+++ H +G+ HRDLK
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LL+ED ++++TDFG + + ++ GT YV+PE++++K + +D+W
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLW 216
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI- 239
+ G I+Y L+AG PF+ N +++KI + ++ P F +AR L+ KLL + R+
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLG 276
Query: 240 -----AISKIMESSWFKK 252
+ +F+
Sbjct: 277 CEEMEGYGPLKAHPFFES 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 6e-90
Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+ TG+ K + + +K EIS+M + H ++ LH+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
K ++ ++ + GGELF++IA ++ E Y +Q + H + H D+
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 120 KPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
KPEN++ + ++K+ DFGL+ L D ++ T T + APE++ ++ G
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPV-GFYT 231
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+W+ GV+ YVLL+G PF ++ + + + R +F + S EA+ I LL
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 291
Query: 234 NPNSRIAISKIMESSWFKKSAPK 256
P R+ + +E W K
Sbjct: 292 EPRKRLTVHDALEHPWLKGDHSN 314
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 9e-90
Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 32/273 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G KV + +TG+ A+K++ + ++E+ HIV +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCI 87
Query: 60 HEV----MASKSKIYFAMDLVKGGELFNKI-AKGRLR--EDVARVYFQQLISAVDFCHSR 112
+V K + M+ ++GGELF++I +G E A + + +A+ F HS
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 113 GVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 169
+ HRD+KPENLL ++D LK+TDFG + + L T C TP YVAPEV+
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGP 203
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRG--DFKCPPW--FSS 221
+ YD D+WS GVI+Y+LL GF PF + M R+I G F P W S
Sbjct: 204 EKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262
Query: 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254
+A++LI LL +P R+ I++ M W +S
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-89
Identities = 91/349 (26%), Positives = 141/349 (40%), Gaps = 24/349 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+ TG + A K V E +++EI M +++H +V LH+
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHD 221
Query: 62 VMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+++ + + GGELF K+A ++ ED A Y +Q+ + H H DL
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 281
Query: 120 KPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
KPEN++ LK+ DFGL+A L + T GT + APEV K G
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYT 337
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDP 233
D+WS GV+ Y+LL+G PF +N R + + + S + + I KLL
Sbjct: 338 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 397
Query: 234 NPNSRIAISKIMESSWFKKSAPKVVIT-------KQEMEFEADKSSKQPETLNAF-HIIS 285
+PN+R+ I + +E W + + + K PE L I +
Sbjct: 398 DPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISN 457
Query: 286 LSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 334
S P E R + A R ++ F +
Sbjct: 458 YSSLRKHRPQ-EYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSANFYCR 505
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 4e-89
Identities = 47/301 (15%), Positives = 106/301 (35%), Gaps = 54/301 (17%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-------- 52
+LG A + +TG+S + V + ++Q+K E+ +++++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 53 -----------------HKHIVELHEVMASKS--KIYFAMDLVK------GGELFNKIAK 87
K ++ + +F ++ G L + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 88 GRLREDVARVY-FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146
+ AR+ Q+I + H G+ H L+P +++LD+ G + +T F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL------ 253
Query: 147 KQDGLLHTTCGTPAYVAPEVIS----------KKGYDGAKADIWSCGVILYVLLAGFLPF 196
+DG + + + PE+ + ++ D W+ G+++Y + LP
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 197 QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
D + I+R R L+ L R+ + ME+ +++ +
Sbjct: 314 TKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369
Query: 257 V 257
+
Sbjct: 370 L 370
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 5e-89
Identities = 89/317 (28%), Positives = 147/317 (46%), Gaps = 33/317 (10%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELH 60
LG G KV N +T + A+K++ + +RE+ + + HIV +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 121
Query: 61 EV----MASKSKIYFAMDLVKGGELFNKI-AKGRLR--EDVARVYFQQLISAVDFCHSRG 113
+V A + + M+ + GGELF++I +G E A + + A+ + HS
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 114 VYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
+ HRD+KPENLL + LK+TDFG + L T C TP YVAPEV+ +
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAPEVLGPE 238
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRG--DFKCPPW--FSSE 222
YD D+WS GVI+Y+LL G+ PF ++ ++ M +I G +F P W S E
Sbjct: 239 KYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297
Query: 223 ARRLITKLLDPNPNSRIAISKIMESSWFKKS--APKVVITKQEMEFEADKSSKQPETLNA 280
+ LI LL P R+ I++ M W +S P+ + + E + + +
Sbjct: 298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 357
Query: 281 FHIISLSEGFDLSPLFE 297
+ ++ ++ + +
Sbjct: 358 SALATMRVDYEQIKIKK 374
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 8e-85
Identities = 89/258 (34%), Positives = 154/258 (59%), Gaps = 14/258 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G+F +V+L R+ G+ AMKV+ K+ V+++ +E E ++ +V H I+ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+I+ MD ++GGELF+ + K R VA+ Y ++ A+++ HS+ + +RDL
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 132
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HTTCGTPAYVAPEVISKKGYDGAKAD 178
KPEN+LLD++G++K+TDFG + K + +T CGTP Y+APEV+S K Y+ + D
Sbjct: 133 KPENILLDKNGHIKITDFGFA------KYVPDVTYTLCGTPDYIAPEVVSTKPYNKS-ID 185
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
WS G+++Y +LAG+ PF D N + Y KI + + PP+F+ + + L+++L+ + + R
Sbjct: 186 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 245
Query: 239 IAISK-----IMESSWFK 251
+ + + WFK
Sbjct: 246 LGNLQNGTEDVKNHPWFK 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 5e-84
Identities = 91/257 (35%), Positives = 142/257 (55%), Gaps = 12/257 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LG G+F +V L ++ ++G AMK++ K KV+K+ +E E +++ V +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
S +Y M+ V GGE+F+ + + GR E AR Y Q++ ++ HS + +RDL
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KPENLL+D+ G ++VTDFG + + G T CGTP +APE+I KGY+ A D
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKA-VDW 221
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W+ GV++Y + AG+ PF D + +Y KI G + P FSS+ + L+ LL + R
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
Query: 240 -----AISKIMESSWFK 251
++ I WF
Sbjct: 282 GNLKNGVNDIKNHKWFA 298
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 3e-82
Identities = 83/310 (26%), Positives = 134/310 (43%), Gaps = 42/310 (13%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVEL 59
+L G FA VY A+++ +G+ A+K + ++ I +E+ MK + H +IV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 60 H-------EVMASKSKIYFAMDLVKGGELFNKI----AKGRLREDVARVYFQQLISAVDF 108
E + + + + G+L + ++G L D F Q AV
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 109 CHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-------LKQDGLLH---TTC 156
H + + HRDLK ENLLL G +K+ DFG + H ++ L+ T
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 157 GTPAYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK 214
TP Y PE+I G K DIW+ G ILY+L PF+D + +I G +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGKYS 267
Query: 215 CPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSW----FKKSAPKVVIT---KQEME 265
PP + LI +L NP R++I++++ + PK IT +Q
Sbjct: 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGG 327
Query: 266 FEADKSSKQP 275
+ + S+ P
Sbjct: 328 YGSATLSRGP 337
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-81
Identities = 77/281 (27%), Positives = 141/281 (50%), Gaps = 8/281 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G+F K L ++ + G+ +K + + + E+ +RE++V+ +KH +IV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHR 117
E +Y MD +GG+LF +I +ED +F Q+ A+ H R + HR
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
D+K +N+ L +DG +++ DFG++ + L GTP Y++PE+ K Y+ K+
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYN-NKS 206
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEARRLITKLLDPNPN 236
DIW+ G +LY L F+ ++ ++ KI G F +S + R L+++L NP
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266
Query: 237 SRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPET 277
R +++ I+E + K K + + E K+ + +
Sbjct: 267 DRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS 307
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-80
Identities = 75/259 (28%), Positives = 135/259 (52%), Gaps = 12/259 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G+F KV + + T K AMK + K K ++ + + +E+ +M+ ++H +V L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ +DL+ GG+L + + +E+ +++ +L+ A+D+ ++ + HRD+
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK---GYDGAK 176
KP+N+LLDE G++ +TDF ++A L ++ + T GT Y+APE+ S + GY A
Sbjct: 142 KPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA- 197
Query: 177 ADIWSCGVILYVLLAGFLPF---QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233
D WS GV Y LL G P+ + + P +S E L+ KLL+P
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEP 257
Query: 234 NPNSRI-AISKIMESSWFK 251
NP+ R +S + +
Sbjct: 258 NPDQRFSQLSDVQNFPYMN 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-80
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 25/282 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F+ V L L G A+K + + E+ +RE + ++ H +I+ L
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 62 V----MASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSR 112
+K + + + K G L+N+I L ED + ++ H++
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-------LKQDGLLHTTCGTPAYVAPE 165
G HRDLKP N+LL ++G + D G + T +Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 166 VISKKGYD--GAKADIWSCGVILYVLLAGFLPFQDDNIVSM-YRKIYRGDFKCPPW--FS 220
+ S + + + D+WS G +LY ++ G P+ + P S
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 221 SEARRLITKLLDPNPNSRIAISKIMESSWF-KKSAPKVVITK 261
S +L+ ++ +P+ R I ++ + AP T+
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-80
Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 17/265 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G++ + R GK + K + + + + E+++++ +KH +IV +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 61 E--VMASKSKIYFAMDLVKGGELFNKIAKGR-----LREDVARVYFQQLISAVDFCHSRG 113
+ + + + +Y M+ +GG+L + I KG L E+ QL A+ CH R
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 114 -----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 168
V HRDLKP N+ LD N+K+ DFGL+ H T GTP Y++PE ++
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMN 189
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEARRLI 227
+ Y+ K+DIWS G +LY L A PF + + KI G F+ P +S E +I
Sbjct: 190 RMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 228 TKLLDPNPNSRIAISKIMESSWFKK 252
T++L+ R ++ +I+E+ +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLILE 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-80
Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V+ A++ GK+ +K V + E+ +RE+ + + H +IV +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYN 70
Query: 61 E----------------VMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQ 101
+ ++ M+ G L I K +L + +A F+Q
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 102 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161
+ VD+ HS+ + +RDLKP N+ L + +K+ DFGL LK DG + GT Y
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRSKGTLRY 187
Query: 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS 221
++PE IS + Y + D+++ G+IL LL + + + + G F
Sbjct: 188 MSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII--SDIFDK 242
Query: 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
+ + L+ KLL P R S+I+ + K +P+
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-80
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 11/255 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
LGHG++ +V+ R+ + G+ A+K ++ S K+ +H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ +Y +L G L L E Y + + A+ HS+G+ H D
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
+KP N+ L G K+ DFGL L G G P Y+APE++ + Y AD
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL-QGSYG-TAAD 237
Query: 179 IWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 237
++S G+ + + LP + + + +F SSE R ++ +L+P+P
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKL 295
Query: 238 RIAISKIMESSWFKK 252
R ++ ++
Sbjct: 296 RATAEALLALPVLRQ 310
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-79
Identities = 89/262 (33%), Positives = 142/262 (54%), Gaps = 13/262 (4%)
Query: 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHKHI 56
+LG G + KV+ R + TGK AMKV+ K ++ K E ++++ VKH I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVY 115
V+L + K+Y ++ + GGELF ++ + G ED A Y ++ A+ H +G+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
+RDLKPEN++L+ G++K+TDFGL E + + HT CGT Y+APE++ + G++ A
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235
D WS G ++Y +L G PF +N KI + PP+ + EAR L+ KLL N
Sbjct: 202 -VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNA 260
Query: 236 NSRI-----AISKIMESSWFKK 252
SR+ ++ +F+
Sbjct: 261 ASRLGAGPGDAGEVQAHPFFRH 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 2e-78
Identities = 92/257 (35%), Positives = 137/257 (53%), Gaps = 9/257 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
++G G+F KV LAR+ A+KV+ K ++K + I E +V+ K VKH +V L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + K+YF +D + GGELF + + E AR Y ++ SA+ + HS + +RD
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LKPEN+LLD G++ +TDFGL E+++ + T CGTP Y+APEV+ K+ YD D
Sbjct: 165 LKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-VD 221
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W G +LY +L G PF N MY I + P ++ AR L+ LL + R
Sbjct: 222 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
Query: 239 IA----ISKIMESSWFK 251
+ +I +F
Sbjct: 282 LGAKDDFMEIKSHVFFS 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-78
Identities = 88/257 (34%), Positives = 140/257 (54%), Gaps = 9/257 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L R TG+ AMK++ K+ +I + E V++ +H + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ F M+ GGELF +++ E+ AR Y +++SA+++ HSR V +RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y A D
Sbjct: 132 KLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDW 188
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +P R+
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248
Query: 240 AISK-----IMESSWFK 251
+ME +F
Sbjct: 249 GGGPSDAKEVMEHRFFL 265
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 6e-78
Identities = 92/261 (35%), Positives = 148/261 (56%), Gaps = 13/261 (4%)
Query: 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
+LG G+F KV+L + + + AMKV+ K +KV + K E ++ V H IV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-TLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+LH ++ K+Y +D ++GG+LF +++K E+ + Y +L A+D HS G+ +
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RDLKPEN+LLDE+G++K+TDFGLS E + + ++ CGT Y+APEV++++G+ +
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS- 206
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPN 236
AD WS GV+++ +L G LPFQ + I + P + S EA+ L+ L NP
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPA 266
Query: 237 SRIAISK-----IMESSWFKK 252
+R+ I S+F
Sbjct: 267 NRLGAGPDGVEEIKRHSFFST 287
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 9e-77
Identities = 85/259 (32%), Positives = 137/259 (52%), Gaps = 11/259 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV LAR +TG A+KV+ KD +++ +E E ++ + H + +L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ +++F M+ V GG+L I K R E AR Y ++ISA+ F H +G+ +RD
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD 149
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G+ K+ DFG+ E + T CGTP Y+APE++ + Y A D
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYGPA-VD 206
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +L G PF+ +N ++ I + P W +A ++ + NP R
Sbjct: 207 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
Query: 239 I------AISKIMESSWFK 251
+ I+ +FK
Sbjct: 267 LGSLTQGGEHAILRHPFFK 285
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 1e-76
Identities = 82/254 (32%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
MLG G+F KV+LA +T + A+K + KD V+ +E E V+ + +H + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+K ++F M+ + GG+L I + A Y ++I + F HS+G+ +RD
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD 143
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD+DG++K+ DFG+ E++ D +T CGTP Y+APE++ + Y+ + D
Sbjct: 144 LKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VD 200
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
WS GV+LY +L G PF + ++ I + P W EA+ L+ KL P R
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260
Query: 239 I-AISKIMESSWFK 251
+ I + F+
Sbjct: 261 LGVRGDIRQHPLFR 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-76
Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 56/302 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELH 60
LG G KV N +T + A+K++ + +RE+ + + + HIV +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 77
Query: 61 EV----MASKSKIYFAMDLVKGGELFNKI-AKGRLR--EDVARVYFQQLISAVDFCHSRG 113
+V A + + M+ + GGELF++I +G E A + + A+ + HS
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 114 VYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
+ HRD+KPENLL + LK+TDFG A E +
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AKETT-GE 173
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRG--DFKCPPW--FSSE 222
YD D+WS GVI+Y+LL G+ PF ++ ++ M +I G +F P W S E
Sbjct: 174 KYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 232
Query: 223 ARRLITKLLDPNPNSRIAISKIMESSWFKK--SAPKVVITKQEM--EFEADKSSKQPETL 278
+ LI LL P R+ I++ M W + P+ + + E + + E
Sbjct: 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 292
Query: 279 NA 280
+A
Sbjct: 293 SA 294
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-75
Identities = 82/258 (31%), Positives = 140/258 (54%), Gaps = 10/258 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV L+ T + A+K++ KD VI+ +E E V+ + K + +L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + ++YF M+ V GG+L I + GR +E A Y ++ + F S+G+ +RD
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y + D
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VD 203
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +LAG PF+ ++ +++ I + P S EA + L+ +P R
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
Query: 239 I-----AISKIMESSWFK 251
+ I E ++F+
Sbjct: 264 LGCGPEGERDIKEHAFFR 281
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 8e-75
Identities = 78/268 (29%), Positives = 144/268 (53%), Gaps = 20/268 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
++G G++AKV L R +T + AMKVV K+ V ++ ++ E V + H +V L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H ++S+++F ++ V GG+L + + +L E+ AR Y ++ A+++ H RG+ +RD
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 135
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G++K+TD+G+ E L+ T CGTP Y+APE++ + Y + D
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VD 192
Query: 179 IWSCGVILYVLLAGFLPF---------QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 229
W+ GV+++ ++AG PF + +++ I + P S +A ++
Sbjct: 193 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 252
Query: 230 LLDPNPNSRI------AISKIMESSWFK 251
L+ +P R+ + I +F+
Sbjct: 253 FLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-74
Identities = 46/295 (15%), Positives = 88/295 (29%), Gaps = 48/295 (16%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL- 59
L G + V+L R+++ + A+KV +E++ + + E
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 60 -------------------------HEVMASKSKIYFAM-----DLVKGGELFNKI--AK 87
+ + + M DL + + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 88 GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147
G + QLI S+G+ H P+NL + DG L + D K
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----K 243
Query: 148 QDGLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQDDN--IVSM 204
+ Y E ++ + W G+ +Y + FLPF I
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 205 YRKIYRG-------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
+++ F + LI + L+ + R+ + ME+ F +
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 2e-74
Identities = 88/258 (34%), Positives = 141/258 (54%), Gaps = 10/258 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L + TG+ AMK++ K+ ++ + E V++ +H + L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRD 118
+ ++ F M+ GGELF +++ ED AR Y +++SA+D+ HS + V +RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK ENL+LD+DG++K+TDFGL E +K + T CGTP Y+APEV+ Y A D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 331
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W GV++Y ++ G LPF + + ++ I + + P EA+ L++ LL +P R
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
Query: 239 IAISK-----IMESSWFK 251
+ IM+ +F
Sbjct: 392 LGGGSEDAKEIMQHRFFA 409
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 3e-74
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 49/319 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELH 60
LG+G+ V G+ +A+K + D + EI ++ + H +++ +
Sbjct: 23 LGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYY 75
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--------GRLREDVARVYFQQLISAVDFCHSR 112
+ +Y A++L L + + +E +Q+ S V HS
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 113 GVYHRDLKPENLLLD-------------EDGNLKVTDFGLSAF--SEHLKQDGLLHTTCG 157
+ HRDLKP+N+L+ E+ + ++DFGL S L+ G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 158 TPAYVAPEVISKKGYD------GAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYR 210
T + APE++ + DI+S G + Y +L G PF D S I R
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRESNIIR 252
Query: 211 G-----DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV-ITKQ 262
G + KC +EA LI++++D +P R K++ F + K+ + K
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKV 312
Query: 263 EMEFEADKSSKQPETLNAF 281
E + L F
Sbjct: 313 SDRLEIENRDPPSALLMKF 331
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 3e-74
Identities = 87/263 (33%), Positives = 136/263 (51%), Gaps = 16/263 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V L R+ T K AMK++ K ++IK E +M +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+Y M+ + GG+L N ++ + E AR Y +++ A+D HS G HRD+K
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEVISKKGYD---GA 175
P+N+LLD+ G+LK+ DFG + ++G++ T GTP Y++PEV+ +G D G
Sbjct: 196 PDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRLITKLL 231
+ D WS GV LY +L G PF D++V Y KI ++ P S EA+ LI L
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 312
Query: 232 DPNPNSRIA---ISKIMESSWFK 251
+ R+ + +I +FK
Sbjct: 313 T-DREVRLGRNGVEEIKRHLFFK 334
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 8e-74
Identities = 79/274 (28%), Positives = 136/274 (49%), Gaps = 16/274 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G F++VY A L G +A+K V ++ +EI ++K + H ++++ +
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSRGVY 115
+++ ++L G+L I K + E YF QL SA++ HSR V
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRD+KP N+ + G +K+ D GL F + H+ GTP Y++PE I + GY+
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYN-F 215
Query: 176 KADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPW----FSSEARRLITK 229
K+DIWS G +LY + A PF D N+ S+ +KI + D+ PP +S E R+L+
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNM 273
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 263
++P+P R ++ + + + + +
Sbjct: 274 CINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-73
Identities = 77/268 (28%), Positives = 144/268 (53%), Gaps = 20/268 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
++G G++AKV L R +T + AM+VV K+ V ++ ++ E V + H +V L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H ++S+++F ++ V GG+L + + +L E+ AR Y ++ A+++ H RG+ +RD
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD +G++K+TD+G+ E L+ T CGTP Y+APE++ + Y + D
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VD 235
Query: 179 IWSCGVILYVLLAGFLPF---------QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 229
W+ GV+++ ++AG PF + +++ I + P S +A ++
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 295
Query: 230 LLDPNPNSRI------AISKIMESSWFK 251
L+ +P R+ + I +F+
Sbjct: 296 FLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-73
Identities = 48/295 (16%), Positives = 100/295 (33%), Gaps = 43/295 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK----------- 49
+LG A + +TG+S + V + ++Q+K E+ ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 50 -----------MVKHKHIVELHEVMASKSKIYFAMDLV-----------KGGELFNKIAK 87
+VK ++ V + ++ G L + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 88 GRLREDVARVYF-QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146
+ AR+ Q+I + H G+ H L+P +++LD+ G + +T F +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH-LVRDGA 263
Query: 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAK----ADIWSCGVILYVLLAGFLPFQDDNIV 202
+ P A ++ + D W+ G+ +Y + LP DD +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 203 SMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 257
I+R P R L+ L R+ + ME+ +++ ++
Sbjct: 324 GGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 2e-73
Identities = 62/324 (19%), Positives = 118/324 (36%), Gaps = 31/324 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELH 60
LGHG + R + + +A+K + + RE+ +++ +H +++
Sbjct: 32 LGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYF 84
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ Y A++L L + + QQ S + HS + HRD
Sbjct: 85 CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 119 LKPENLLLDEDGN-----LKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVIS---K 169
LKP N+L+ ++DFGL + GT ++APE++S K
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 170 KGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPWF---SSEARR 225
+ DI+S G + Y +++ G PF + C AR
Sbjct: 204 ENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE 262
Query: 226 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ-----EMEFEADKSSKQPETLNA 280
LI K++ +P R + +++ +F ++ + E E KQ E
Sbjct: 263 LIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLER-GG 321
Query: 281 FHIISLSEGFDLSPLFEEKKRAER 304
++ + +++ + R R
Sbjct: 322 RAVVKMDWRENITVPLQTDLRKFR 345
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-73
Identities = 86/270 (31%), Positives = 149/270 (55%), Gaps = 21/270 (7%)
Query: 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHKH- 55
+LG G + KV+L R + TGK AMKV+ K ++ K E + E V++ ++
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 114
+V LH +++K++ +D + GGELF +++ R E ++Y +++ A++ H G+
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HTTCGTPAYVAPEVI--SKKG 171
+RD+K EN+LLD +G++ +TDFGLS E + + + CGT Y+AP+++ G
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 172 YDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 227
+D A D WS GV++Y LL G PF + ++ + R+I + + P S+ A+ LI
Sbjct: 239 HDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297
Query: 228 TKLLDPNPNSRI-----AISKIMESSWFKK 252
+LL +P R+ +I E +F+K
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-72
Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 22/268 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +V + + K AMK++ K +++K + E V+ K I LH
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ +Y MD GG+L ++K RL E++AR Y +++ A+D H HRD
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEVI-----SKKG 171
+KP+N+L+D +G++++ DFG L +DG + GTP Y++PE++ K
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW---FSSEARRL 226
Y G + D WS GV +Y +L G PF +++V Y KI ++ F+ P S A+ L
Sbjct: 258 Y-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316
Query: 227 ITKLLDPNPNSRI---AISKIMESSWFK 251
I +L+ + R+ I + +F
Sbjct: 317 IRRLICSREH-RLGQNGIEDFKKHPFFS 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-71
Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 22/269 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F++V + + QTG+ AMK++ K ++K G + + E V+ + I +LH
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
++ +Y M+ GG+L ++K R+ ++AR Y +++ A+D H G HRD
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEVISKKGYD--- 173
+KP+N+LLD G++++ DFG L+ DG + GTP Y++PE++ G
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 174 ---GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP---PWFSSEARR 225
G + D W+ GV Y + G PF D+ Y KI Y+ P EAR
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
Query: 226 LITKLLDPNPNSRI---AISKIMESSWFK 251
I +LL P +R+ +F
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 236 bits (602), Expect = 2e-71
Identities = 82/258 (31%), Positives = 140/258 (54%), Gaps = 10/258 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
+LG G+F KV L+ T + A+K++ KD VI+ +E E V+ + K + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
H + ++YF M+ V GG+L I + GR +E A Y ++ + F S+G+ +RD
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y + D
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VD 524
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
W+ GV+LY +LAG PF+ ++ +++ I + P S EA + L+ +P R
Sbjct: 525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
Query: 239 IAISK-----IMESSWFK 251
+ I E ++F+
Sbjct: 585 LGCGPEGERDIKEHAFFR 602
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 4e-71
Identities = 45/304 (14%), Positives = 107/304 (35%), Gaps = 41/304 (13%)
Query: 1 MLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 55
+LG G FA+VY A + + + +KV + + Q+ +K
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER---LKPSMQHM 128
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK------GRLREDVARVYFQQLISAVDFC 109
++ + ++ +L G L N I + + + + +++ ++
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 110 HSRGVYHRDLKPENLLL-----------DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158
H + H D+KP+N +L D L + D G S + + + C T
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248
Query: 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRGDFKCPP 217
+ E++S K ++ + D + +Y +L G ++ +++ ++R
Sbjct: 249 SGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM 307
Query: 218 WFSSEARRLITKLLDPNPNSRI----AISKIMESSWFKKSAPKVVITKQ----EMEFEAD 269
W +L+ + + + ++ F++ + + + E
Sbjct: 308 W-----NEFFHVMLNIPDCHHLPSLDLLRQKLK-KVFQQHYTNKIRALRNRLIVLLLECK 361
Query: 270 KSSK 273
+S K
Sbjct: 362 RSRK 365
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-70
Identities = 70/265 (26%), Positives = 123/265 (46%), Gaps = 17/265 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V+ + TGK A K + K ++ K + E ++ V + IV L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVY 115
+K+ + M ++ GG++ I +E A Y Q++S ++ H R +
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
+RDLKPEN+LLD+DGN++++D GL+ E GTP ++APE++ + YD +
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKCPPWFSSEARRLITKLL 231
D ++ GV LY ++A PF+ + +++ P FS ++ LL
Sbjct: 370 -VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 232 DPNPNSRIAISK-----IMESSWFK 251
+P R+ + F+
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-70
Identities = 70/283 (24%), Positives = 108/283 (38%), Gaps = 40/283 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME----QIKREISVMKMVKHKHI 56
LG G F V+ A+N + A+K I++ E ++ RE+ + ++H I
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKR------IRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 57 VELHEV------------MASKSKIYFAMDLVKGGELFNKIAKGR----LREDVARVYFQ 100
V + K +Y M L + L + + V F
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA----------FSEHLKQDG 150
Q+ AV+F HS+G+ HRDLKP N+ D +KV DFGL +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 210
GT Y++PE I Y K DI+S G+IL+ LL F V +
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLYPF--STQMERVRTLTDVRN 242
Query: 211 GDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
F ++ +L P+P R I+E++ F+
Sbjct: 243 LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-68
Identities = 71/263 (26%), Positives = 125/263 (47%), Gaps = 16/263 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 61 EVMASKSKIYFAMDLVKGGELF---NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+K + + L+ GG+L + + E A Y ++ ++ H + +R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DLKPEN+LLD+ G+++++D GL + H+ + + GT Y+APEV+ + Y +
Sbjct: 311 DLKPENILLDDHGHIRISDLGL---AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-P 366
Query: 178 DIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233
D W+ G +LY ++AG PFQ + R + + FS +AR L ++LL
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCK 426
Query: 234 NPNSRI-----AISKIMESSWFK 251
+P R+ + ++ E FK
Sbjct: 427 DPAERLGCRGGSAREVKEHPLFK 449
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-66
Identities = 81/265 (30%), Positives = 128/265 (48%), Gaps = 18/265 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIV 57
++G G F +VY R TGK AMK + K ++ E ++ +V IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGA 175
RDLKP N+LLDE G+++++D GL+ H + GT Y+APEV+ K YD +
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVS---MYRKIYRGDFKCPPWFSSEARRLITKLLD 232
AD +S G +L+ LL G PF+ + R + P FS E R L+ LL
Sbjct: 372 -ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 430
Query: 233 PNPNSRIAISK-----IMESSWFKK 252
+ N R+ + ES +F+
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-60
Identities = 46/275 (16%), Positives = 96/275 (34%), Gaps = 24/275 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V+ G A+K K V ++ + + +H H+V
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYH 116
A + + GG L + I++ +E + Q+ + + HS + H
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 138
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSE-------------HLKQDGLLHTTCGTPAYVA 163
D+KP N+ + H+ + G ++A
Sbjct: 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLA 198
Query: 164 PEVIS-KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSS 221
EV+ + KADI++ + + ++ + + +I +G + P S
Sbjct: 199 NEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQ 254
Query: 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
E L+ ++ P+P R + +++ S ++ K
Sbjct: 255 EFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 8e-55
Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GT+ VY R+L +A+K + + + EI++ K +KHK+IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 61 EVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ I M+ V GG L +K + E Y +Q++ + + H + H
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 117 RDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--SKKGYD 173
RD+K +N+L++ G LK++DFG S + T GT Y+APE+I +GY
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGY- 202
Query: 174 GAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPP---WFSSEARRLITK 229
G ADIWS G + + G PF + + K+ P S+EA+ I K
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-VHPEIPESMSAEAKAFILK 261
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPK 256
+P+P+ R + ++ + K S+ K
Sbjct: 262 CFEPDPDKRACANDLLVDEFLKVSSKK 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 23/249 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G+F +V+ ++ QTG A+K KV + E+ + IV L+
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLY 116
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ + M+L++GG L I + G L ED A Y Q + +++ H+R + H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 120 KPENLLLDEDGNL-KVTDFGLSAFSEHLKQDGLLHTTC------GTPAYVAPEVISKKGY 172
K +N+LL DG+ + DFG + L+ DGL + GT ++APEV+ K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 229
D AK DIWS ++ +L G P+ + KI + PP + + I +
Sbjct: 234 D-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQE 292
Query: 230 LLDPNPNSR 238
L P R
Sbjct: 293 GLRKEPVHR 301
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 18/231 (7%)
Query: 37 MMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR----LRE 92
M+ +I M K+ V + + K +Y M L + L + + +
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 93 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------- 145
V F Q+ AV+F HS+G+ HRDLKP N+ D +KV DFGL +
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 146 ---LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV 202
+ GT Y++PE I Y K DI+S G+IL+ LL F V
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM--ERV 280
Query: 203 SMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
+ + F + ++ +L P+P R + I+E++ F+
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 2/61 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G F V+ A+N + A+K + + E++ RE+ + ++H IV
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYF 70
Query: 61 E 61
Sbjct: 71 N 71
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-50
Identities = 49/133 (36%), Positives = 83/133 (62%), Gaps = 1/133 (0%)
Query: 273 KQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFN 332
+ P +NAF +I+LS+G +LS LF+ ++ + + RF + R S +I+ E VA ++ F
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 333 VKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPA 392
T + RL+G S + G+LA+ +I+ V PSL +V+V+K G+TLEY++F +L
Sbjct: 62 SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFY-KKLCSK 120
Query: 393 LKDIVWMSTADNP 405
L++I+W +T P
Sbjct: 121 LENIIWRATEGIP 133
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-50
Identities = 60/262 (22%), Positives = 124/262 (47%), Gaps = 18/262 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH- 60
+G G+F VY + +T +A + K+ K ++ K E ++K ++H +IV +
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 61 ---EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--V 114
+ K I +L+ G L + + ++ V R + +Q++ + F H+R +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 115 YHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
HRDLK +N+ + G++K+ D GL+ LK+ GTP ++APE+ ++ YD
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-EEKYD 207
Query: 174 GAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD--FKCPPWFSSEARRLITKL 230
D+++ G+ + + P+ + N +YR++ G E + +I
Sbjct: 208 -ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266
Query: 231 LDPNPNSRIAISKIMESSWFKK 252
+ N + R +I ++ ++F++
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQE 288
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-49
Identities = 81/296 (27%), Positives = 135/296 (45%), Gaps = 64/296 (21%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
+G GT+ V+ A+N +T + +A+K ++ ++ REI ++K +KH
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKR------VR---LDDDDEGVPSSALREICLLKELKH 60
Query: 54 KHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 108
K+IV LH+V+ S K+ DL K + G L ++ + + QL+ + F
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKK----YFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI 167
CHSR V HRDLKP+NLL++ +G LK+ +FGL+ AF ++ T Y P+V+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVV-TLWYRPPDVL 173
Query: 168 --SKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYR-----------GDF 213
+K Y + D+WS G I L P F +++ ++I+R
Sbjct: 174 FGAKL-YSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 214 KCP------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
K P P ++ R L+ LL NP RI+ + ++ +F
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 77/295 (26%), Positives = 119/295 (40%), Gaps = 61/295 (20%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
LG G FA VY AR+ T + +A+K K IK+G + K REI +++ + H
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIK-----K-IKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 54 KHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 108
+I+ L + KS I DL K L + Y + +++
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMETDLEV----IIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTC-GTPAYVAPEV 166
H + HRDLKP NLLLDE+G LK+ DFGL+ +F + +T T Y APE+
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA----YTHQVVTRWYRAPEL 183
Query: 167 I--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----------GDF 213
+ ++ Y D+W+ G IL LL D+ + +I+
Sbjct: 184 LFGARM-YGVG-VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 214 KCP-----------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
P + LI L NP +RI ++ ++ +F
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 1e-48
Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 68/302 (22%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
LG+GT+A VY N TG +A+K +K+ E REIS+MK +KH++IV
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 58 ELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHS 111
L++V+ +++K+ DL K + R L ++ + + QL+ + FCH
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA-----YVAPE 165
+ HRDLKP+NLL+++ G LK+ DFGL+ AF + + Y AP+
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--------FSSEVVTLWYRAPD 178
Query: 166 VI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G---------- 211
V+ S+ Y + DIWSCG IL ++ G F N + I+ G
Sbjct: 179 VLMGSRT-YSTS-IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 212 ----DFK------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249
+ + LL NP+ R++ + + W
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 250 FK 251
F
Sbjct: 297 FA 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 75/307 (24%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
+G GT+ VY A++ G+ +A+K I+ ++ REIS++K + H
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKR------IR---LDAEDEGIPSTAIREISLLKELHH 78
Query: 54 KHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 108
+IV L +V+ S+ + DL K K L++ ++Y QL+ V
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKK----VLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA-----YV 162
CH + HRDLKP+NLL++ DG LK+ DFGL+ AF ++ T Y
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--------YTHEVVTLWYR 186
Query: 163 APEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------- 210
AP+V+ SKK Y + DIWS G I ++ G F KI+
Sbjct: 187 APDVLMGSKK-YSTS-VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
Query: 211 -GDFKCP-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
+ P P F E L++ +L +PN RI+ M +F
Sbjct: 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304
Query: 251 KKSAPKV 257
K P++
Sbjct: 305 KDLDPQI 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 74/300 (24%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
+G GT+ VY A+N G++ A+K I+ +E+ REIS++K +KH
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKK------IR---LEKEDEGIPSTTIREISILKELKH 59
Query: 54 KHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 108
+IV+L++V+ +K ++ DL K + +G L A+ + QL++ + +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKK----LLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA-----YV 162
CH R V HRDLKP+NLL++ +G LK+ DFGL+ AF ++ T Y
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVTLWYR 167
Query: 163 APEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI------------ 208
AP+V+ SKK Y DIWS G I ++ G F + +I
Sbjct: 168 APDVLMGSKK-YSTT-IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 209 --------YRGDFKCP---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
Y +F L++K+L +PN RI + +E ++FK
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-48
Identities = 77/319 (24%), Positives = 131/319 (41%), Gaps = 60/319 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
LG GT+A VY ++ T +A+K I++ E RE+S++K +KH +IV
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKE------IRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 58 ELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 112
LH+++ ++ + DL + + + +++ QL+ + +CH +
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKDLKQ----YLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI--SK 169
V HRDLKP+NLL++E G LK+ DFGL+ A S K + T Y P+++ S
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVV-TLWYRPPDILLGST 176
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------------------- 210
Y D+W G I Y + G F + I+R
Sbjct: 177 D-YSTQ-IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 211 --GDFKCP---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK---KSAPK 256
++ P S+ L+TKLL +RI+ M+ +F + K
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294
Query: 257 VVITKQEMEFEADKSSKQP 275
+ T + + K+
Sbjct: 295 LPDTTSIFALKEIQLQKEA 313
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 68/305 (22%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
LG GT+ +VY A + T +++A+K I+ +E + RE+S++K ++H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKR------IR---LEHEEEGVPGTAIREVSLLKELQH 92
Query: 54 KHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 108
++I+EL V+ +++ DL K +K + V + + QLI+ V+F
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAENDLKK---YMDK--NPDVSMRVIKSFLYQLINGVNF 147
Query: 109 CHSRGVYHRDLKPENLLLD-----EDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV 162
CHSR HRDLKP+NLLL E LK+ DFGL+ AF ++Q H T Y
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEII-TLWYR 204
Query: 163 APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G-------- 211
PE++ + Y + DIWS I +L F D+ + KI+ G
Sbjct: 205 PPEILLGSRHYSTS-VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 212 ------DFK--------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
D+K E L+T +L+ +P RI+ +E +F
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
Query: 252 KSAPK 256
+
Sbjct: 324 HNDFD 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 67/267 (25%), Positives = 134/267 (50%), Gaps = 16/267 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F +V+ + +T K +A+K++ ++ +E I++EI+V+ ++ + +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+K++ M+ + GG + + G L E ++++ +D+ HS HRD+K
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
N+LL E G +K+ DFG++ +K+ +T GTP ++APEVI + YD +KADI
Sbjct: 148 ANVLLSEHGEVKLADFGVAGQLTDTQIKR----NTFVGTPFWMAPEVIKQSAYD-SKADI 202
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW----FSSEARRLITKLLDPNP 235
WS G+ L G P + + + + I + + PP +S + + L+ P
Sbjct: 203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEP 259
Query: 236 NSRIAISKIMESSWFKKSAPKVVITKQ 262
+ R ++++ + ++A K +
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTE 286
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-46
Identities = 39/125 (31%), Positives = 65/125 (52%), Gaps = 6/125 (4%)
Query: 275 PETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 334
+NAF IIS S GF+LS LF + ++ +R E RF + A V+ R EE+ A V
Sbjct: 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVE-RFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 335 TSES-RVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPAL 393
E+ ++++G +KG A+ +I +T L+++EV+K ++ LRP
Sbjct: 62 KKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFF 117
Query: 394 KDIVW 398
++V
Sbjct: 118 VELVH 122
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-46
Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 61/303 (20%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVV--GKDKVIKVGMMEQIKREISVMKMVK---HKHI 56
+G G + VY AR+ +G +A+K V G+ RE+++++ ++ H ++
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 57 VELHEVMASKS-----KIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAV 106
V L +V A+ K+ DL +K L + + +Q + +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRT---YLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 107 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA----- 160
DF H+ + HRDLKPEN+L+ G +K+ DFGL+ +S + TP
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---------TPVVVTLW 184
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------- 210
Y APEV+ + Y D+WS G I + F ++ KI+
Sbjct: 185 YRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 211 -GDFKCP----------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253
D P P +L+ ++L NP+ RI+ + ++ S+ K
Sbjct: 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
Query: 254 APK 256
Sbjct: 304 EGN 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 67/321 (20%), Positives = 125/321 (38%), Gaps = 68/321 (21%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
+G G++ V+ RN TG+ +A+K K ++ IK REI ++K +KH ++V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 58 ELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 112
L EV K +++ ++ + + E + + Q + AV+FCH
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDHTVLH----ELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV------APE 165
HRD+KPEN+L+ + +K+ DFG + + + V +PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YDD-----EVATRWYRSPE 172
Query: 166 VI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-------------- 210
++ Y G D+W+ G + LL+G + + V I +
Sbjct: 173 LLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 211 -----GDFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253
K P S A L+ L +P R+ +++ +F ++
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF-EN 290
Query: 254 APKVVITKQEMEFEADKSSKQ 274
++ +E + A+ Q
Sbjct: 291 IREIEDLAKEHDKPAENLYFQ 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 53/291 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
+G G++ V RN TG+ +A+K K ++ + +K REI ++K ++H+++V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 58 ELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 112
L EV K + Y ++ ++ L V + Y Q+I+ + FCHS
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDHTILD----DLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
+ HRD+KPEN+L+ + G +K+ DFG + + + T Y APE++
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVA-TRWYRAPELLVGDV 200
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G--------------DFKC 215
G D+W+ G ++ + G F D+ + I G F
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 216 ---PPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
P S L K L +P+ R ++++ +F+
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 71/269 (26%), Positives = 126/269 (46%), Gaps = 18/269 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELH 60
+G GT +V+ R +TG +A+K + + ++I ++ V +K +IV+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 61 EVMASKSKIYFAMDLVKGG-ELFNKIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRD 118
+ + ++ AM+L+ E K +G + E + ++ A+ + GV HRD
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-----SKKGYD 173
+KP N+LLDE G +K+ DFG+S L D + G AY+APE I +K YD
Sbjct: 151 VKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 174 GAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 229
+AD+WS G+ L L G P+++ + K+ + + FS + + +
Sbjct: 208 -IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD 266
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPKVV 258
L + R +K++E S+ K+ V
Sbjct: 267 CLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 66/242 (27%), Positives = 131/242 (54%), Gaps = 13/242 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+ V LAR +G+ +A+K++ K + E + E+ +M+ +H ++VE+++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYK 109
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ ++GG L + +++ RL E+ + ++ A+ + H++GV HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
+++LL DG +K++DFG A + K+ + GTP ++APEVIS+ Y + DI
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPEVISRSLYA-TEVDI 224
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPN 236
WS G+++ ++ G P+ D+ V +++ K S R + ++L +P
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 237 SR 238
R
Sbjct: 285 ER 286
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F KVY A+N +TG A KV+ ++ E EI ++ H +IV+L
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 83
Query: 62 VMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
K++ ++ GG + L E +V +Q++ A++F HS+ + HRDL
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVI-----SKKGYD 173
K N+L+ +G++++ DFG+SA + + GTP ++APEV+ YD
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKL 230
KADIWS G+ L + P + N + + KI + D P +S E R +
Sbjct: 201 Y-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIA 259
Query: 231 LDPNPNSRIAISKIMESSWFKKSAPKVVIT 260
LD NP +R + ++++E + +
Sbjct: 260 LDKNPETRPSAAQLLEHPFVSSITSNKALR 289
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 59/274 (21%), Positives = 117/274 (42%), Gaps = 23/274 (8%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELH 60
+G G + V + +G+ MA+K + + +Q+ ++ V M+ +IV+ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 61 EVMASKSKIYFAMDLVKGG-----ELFNKIAKGRLREDVARVYFQQLISAVDFCHS-RGV 114
+ + + M+L+ + + + E++ + A++ +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----SKK 170
HRD+KP N+LLD GN+K+ DFG+S L G Y+APE I S++
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD-----FKCPPWFSSEAR 224
GYD ++D+WS G+ LY L G P+ +++ ++ +GD FS
Sbjct: 205 GYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263
Query: 225 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 258
+ L + + R ++++ + + V
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 70/242 (28%), Positives = 123/242 (50%), Gaps = 13/242 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G VY A ++ TG+ +A++ + + K E I EI VM+ K+ +IV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ + GG L + + + + E ++ + A++F HS V HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 122 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
+N+LL DG++K+TDFG A E K+ T GTP ++APEV+++K Y K DI
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEVVTRKAYGP-KVDI 199
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPN 236
WS G++ ++ G P+ ++N + I + P S+ R + + L+ +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259
Query: 237 SR 238
R
Sbjct: 260 KR 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 77/305 (25%)
Query: 2 LGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVK 52
+G G + KV+ AR+L+ G+ +A+K +V ++ + RE++V++ ++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALK-----RVR----VQTGEEGMPLSTIREVAVLRHLE 69
Query: 53 ---HKHIVELHEV-----MASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYF 99
H ++V L +V ++K+ DL +K+ + + + +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMM 126
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGT 158
QL+ +DF HS V HRDLKP+N+L+ G +K+ DFGL+ +S + T
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---------T 177
Query: 159 PA-----YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--- 210
Y APEV+ + Y D+WS G I + F+ + V KI
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 211 --------GDFKCP----------------PWFSSEARRLITKLLDPNPNSRIAISKIME 246
D P + L+ K L NP RI+ +
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296
Query: 247 SSWFK 251
+F+
Sbjct: 297 HPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 73/307 (23%), Positives = 120/307 (39%), Gaps = 72/307 (23%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REISVMKMVKH 53
+G GTF +V+ AR+ +TG+ +A+K KV+ ME K REI +++++KH
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK-----KVL----MENEKEGFPITALREIKILQLLKH 75
Query: 54 KHIVELHEVMASKS--------KIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQ 100
+++V L E+ +K+ IY DL L + + + + Q
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNV-LVKFTLSEIKRVMQ 131
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTC-GT 158
L++ + + H + HRD+K N+L+ DG LK+ DFGL+ AFS +T T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 159 PAYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------ 210
Y PE++ + Y G D+W G I+ + Q + I +
Sbjct: 192 LWYRPPELLLGERD-Y-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 211 -------------GDFKCPPW-------------FSSEARRLITKLLDPNPNSRIAISKI 244
+ A LI KLL +P RI
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 245 MESSWFK 251
+ +F
Sbjct: 310 LNHDFFW 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 20/248 (8%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G+F V+ A + G +A+K++ ++ + + RE+++MK ++H +IV
Sbjct: 45 IGAGSFGTVHRAEWH---GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC------HSRG- 113
+ + + + G L+ + K RE + ++L A D H+R
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD--ERRRLSMAYDVAKGMNYLHNRNP 158
Query: 114 -VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 172
+ HR+LK NLL+D+ +KV DFGLS + GTP ++APEV+ +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARRLITKL 230
+ K+D++S GVIL+ L P+ + N + + + P + + +I
Sbjct: 217 N-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 275
Query: 231 LDPNPNSR 238
P R
Sbjct: 276 WTNEPWKR 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 38/262 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V A+ K +A+K + + + E+ + V H +IV+L
Sbjct: 16 VGRGAFGVVCKAK--WRAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKL-- 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC------HSR--- 112
A + + M+ +GG L+N + + + HS
Sbjct: 67 YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYT--AAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 113 GVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
+ HRDLKP NLLL G LK+ DFG + + G+ A++APEV
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG-----DFKCPPWFSSEAR 224
Y K D++S G+IL+ ++ PF + + ++ G P
Sbjct: 180 YS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI----E 234
Query: 225 RLITKLLDPNPNSRIAISKIME 246
L+T+ +P+ R ++ +I++
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVK 256
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-42
Identities = 70/284 (24%), Positives = 132/284 (46%), Gaps = 26/284 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G A V A + +A+K + +K M+++ +EI M H +IV +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 62 VMASKSKIYFAM---------DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 112
K +++ M D++K + G L E ++++ +++ H
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISK 169
G HRD+K N+LL EDG++++ DFG+SAF + ++ + T GTP ++APEV+ +
Sbjct: 141 GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200
Query: 170 -KGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYR---------KIYRGDFKCPPW 218
+GYD KADIWS G+ L G P+ + + + D +
Sbjct: 201 VRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK 259
Query: 219 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ 262
+ R++I+ L +P R ++++ +F+K+ K + ++
Sbjct: 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-42
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 11/240 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V+ + +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG-VYHRD 118
S +I M+ + GG L +++ K GR+ E + +I + + + + HRD
Sbjct: 99 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
+KP N+L++ G +K+ DFG+S L D + ++ GT +Y++PE + Y ++D
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVGTRSYMSPERLQGTHYS-VQSD 212
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
IWS G+ L + G P + + R L +SR
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 52/247 (21%), Positives = 108/247 (43%), Gaps = 15/247 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F VY + +A+K++ ++ K E+ V++ +H +I+
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 62 VMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ +G L++ ++ + +Q +D+ H++ + HRDL
Sbjct: 88 YS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD--GAKA 177
K N+ L ED +K+ DFGL+ G+ ++APEVI + + ++
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 178 DIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFK-----CPPWFSSEARRLITKLL 231
D+++ G++LY L+ G LP+ + +N + + RG +RL+ + L
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266
Query: 232 DPNPNSR 238
+ R
Sbjct: 267 KKKRDER 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 68/282 (24%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G++ VY A + +TG+ +A+K V + + ++I +EIS+M+ H+V+ +
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKYYG 91
Query: 62 VMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ M+ G + + ++ L ED Q + +++ H HRD+
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 120 KPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
K N+LL+ +G+ K+ DFG++ K+ +T GTP ++APEVI + GY+ A
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKR----NTVIGTPFWMAPEVIQEIGYNC-VA 206
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPN 234
DIWS G+ + G P+ D + + I F+ P +S + + L +
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKS 266
Query: 235 PNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPE 276
P R +++++ + + + ++ E K +Q
Sbjct: 267 PEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQES 308
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 25/273 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELH 60
LG G + V R++ +G+ MA+K + + +++ ++ + M+ V V +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 61 EVMASKSKIYFAMDLVKGG--ELFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVY 115
+ + ++ M+L+ + + ++ + ED+ ++ A++ HS V
Sbjct: 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----SKKG 171
HRD+KP N+L++ G +K+ DFG+S +L D G Y+APE I ++KG
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPP-----WFSSEARR 225
Y K+DIWS G+ + L P+ +++ P FS+E
Sbjct: 190 YS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPADKFSAEFVD 245
Query: 226 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 258
++ L N R ++M+ +F K
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 53/266 (19%), Positives = 115/266 (43%), Gaps = 28/266 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G F +VY R +A++++ ++ + ++ KRE+ + +H+++V
Sbjct: 40 LIGKGRFGQVYHGRWHGE---VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFM 95
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF--QQLISAVDFCHSRGVYHRD 118
S + L KG L++ + ++ DV + Q+++ + + H++G+ H+D
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 119 LKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
LK +N+ D +G + +TDFGL + +++ L G ++APE+I + D
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 176 --------KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------DFKCPPWFSS 221
+D+++ G I Y L A PF+ ++ ++ G
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEI-- 272
Query: 222 EARRLITKLLDPNPNSRIAISKIMES 247
++ R +K+M+
Sbjct: 273 --SDILLFCWAFEQEERPTFTKLMDM 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 63/265 (23%), Positives = 111/265 (41%), Gaps = 43/265 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG--MMEQIKREISVMKMVKHKHIVEL 59
LG G F + + +TG+ M MK ++I+ +E+ VM+ ++H ++++
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMK-----ELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC------HSR 112
V+ ++ F + +KGG L ++ ++ + Q +S A D HS
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRG-----IIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------------LKQDGLLHTTCGTPA 160
+ HRDL N L+ E+ N+ V DFGL+ +T G P
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM-----YRKIYRGDF-- 213
++APE+I+ + YD K D++S G++L ++ D +M R
Sbjct: 188 WMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 214 KCPPWFSSEARRLITKLLDPNPNSR 238
CPP F + + D +P R
Sbjct: 247 NCPPSF----FPITVRCCDLDPEKR 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 21/252 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM-MEQIKREISVMKMVKHKHIVEL 59
++G G F KVY A + G +A+K D + +E +++E + M+KH +I+ L
Sbjct: 14 IIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY---H 116
V + + M+ +GG L ++ R+ D+ + Q+ +++ H + H
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 117 RDLKPENLLLDEDG--------NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 168
RDLK N+L+ + LK+TDFGL+ + G A++APEVI
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIR 187
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD-FKCPPWFSSEARRL 226
+ +D+WS GV+L+ LL G +PF+ D + Y P +L
Sbjct: 188 ASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 227 ITKLLDPNPNSR 238
+ +P+P+SR
Sbjct: 247 MEDCWNPDPHSR 258
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 66/291 (22%), Positives = 122/291 (41%), Gaps = 22/291 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+GHG+F VY AR+++ + +A+K + + I +E+ ++ ++H + ++
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 62 VMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ + M+ G ++ K L+E + + + HS + HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS---KKGYDGAKA 177
N+LL E G +K+ DFG ++ ++ GTP ++APEVI + YDG K
Sbjct: 182 AGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILAMDEGQYDG-KV 234
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPN 234
D+WS G+ L P + N +S I + + + W S R + L
Sbjct: 235 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQKI 293
Query: 235 PNSRIAISKIMESSWFKKSAPKVVIT-------KQEMEFEADKSSKQPETL 278
P R +++ + + P VI E + + K + L
Sbjct: 294 PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKIL 344
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 64/277 (23%), Positives = 113/277 (40%), Gaps = 51/277 (18%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMVKHKHI 56
+G G F V+ R ++ +A+K + + + + ++ +RE+ +M + H +I
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKG--------RLR--EDVARVYFQQLISAV 106
V+L + M+ V G+L++++ +LR D+A +
Sbjct: 86 VKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL--------GI 135
Query: 107 DFCHSRGVY--HRDLKPENLLLDEDG-----NLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159
++ ++ HRDL+ N+ L KV DFGLS S H + G
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNF 190
Query: 160 AYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY------RKIYRG 211
++APE I + Y KAD +S +ILY +L G PF + + + + R
Sbjct: 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 212 DF--KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
CPP R +I +P R S I++
Sbjct: 250 TIPEDCPPRL----RNVIELCWSGDPKKRPHFSYIVK 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 50/257 (19%), Positives = 97/257 (37%), Gaps = 39/257 (15%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
L +++ R G + +KV+ K + E +++ H +++ +
Sbjct: 18 LNENHSGELWKGRWQ---GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 61 EVMASKSKIYFA--MDLVKGGELFNKIAKGRLRE-----------DVARVYFQQLISAVD 107
S + + G L+N + +G D+AR +
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR--------GMA 125
Query: 108 FCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 165
F H+ + L ++++DED +++ + FS PA+VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-FSFQSP------GRMYAPAWVAPE 178
Query: 166 VISKKGYDGA--KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--KCPPWFSS 221
+ KK D AD+WS V+L+ L+ +PF D + + + K+ PP S
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 222 EARRLITKLLDPNPNSR 238
+L+ ++ +P R
Sbjct: 239 HVSKLMKICMNEDPAKR 255
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 55/282 (19%), Positives = 112/282 (39%), Gaps = 22/282 (7%)
Query: 3 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 62
G V LAR TG+ + ++ + + M+ ++ E+ V K+ H +IV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 63 MASKSKIYFAMDLVKGG---ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++++ + G +L + E Q ++ A+D+ H G HR +
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSV 154
Query: 120 KPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTC----GTPAYVAPEVI--SKKGY 172
K ++L+ DG + ++ + H ++ ++H +++PEV+ + +GY
Sbjct: 155 KASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 214
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 232
D AK+DI+S G+ L G +PF+D M + G P L+
Sbjct: 215 D-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT---VP-------CLLDTSTI 263
Query: 233 PNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQ 274
P ++ S+ + +S S + + +
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 12/245 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + VYLA + +A+K + K +++ +RE+ + H++IV + +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 62 VMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V Y M+ ++G L I G L D A + Q++ + H + HRD+K
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138
Query: 121 PENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
P+N+L+D + LK+ DFG+ + L Q GT Y +PE + D D
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQAKGEATD-ECTD 194
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-----WFSSEARRLITKLLDP 233
I+S G++LY +L G PF + VS+ K + +I + +
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEK 254
Query: 234 NPNSR 238
+ +R
Sbjct: 255 DKANR 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 12/245 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G G VY A + + +A+K++ + +++RE ++ H+V +H
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++Y M L+ G +L + + G L A +Q+ SA+D H+ G HRD+
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDV 160
Query: 120 KPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
KPEN+L+ D + DFG+ + E L Q G T GT Y+APE S+ +A
Sbjct: 161 KPENILVSADDFAYLVDFGIASATTDEKLTQLG---NTVGTLYYMAPERFSESHAT-YRA 216
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDP 233
DI++ +LY L G P+Q D + M I P P +I + +
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAVIARGMAK 275
Query: 234 NPNSR 238
NP R
Sbjct: 276 NPEDR 280
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 32/285 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELH 60
+G+GT+ +VY R+++TG+ A+KV+ + E+IK+EI+++K H++I +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 61 E------VMASKSKIYFAMDLVKGG---ELFNKIAKGRLREDVARVYFQQLISAVDFCHS 111
+++ M+ G +L L+E+ ++++ + H
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKK 170
V HRD+K +N+LL E+ +K+ DFG+SA L + T GTP ++APEVI+
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 171 -----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-----WFS 220
YD K+D+WS G+ + G P D + + I R P +S
Sbjct: 205 ENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---APRLKSKKWS 260
Query: 221 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEME 265
+ + I L N + R A ++M+ + + + + Q +
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKD 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 36/250 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------GMMEQIKREISVMKMVKH 53
+ HG +YLA + V G+ V+K E + V H
Sbjct: 87 CIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 54 KHIVELHEV-----MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 108
IV++ Y M+ V G L + +L A Y +++ A+ +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLLEILPALSY 197
Query: 109 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 168
HS G+ + DLKPEN++L E+ LK+ D G + + G L GTP + APE++
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS---RINSFGYL---YGTPGFQAPEIV- 249
Query: 169 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 228
+ DI++ G L L + + K + RL+
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PVLKTYDSY----GRLLR 302
Query: 229 KLLDPNPNSR 238
+ +DP+P R
Sbjct: 303 RAIDPDPRQR 312
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 69/319 (21%), Positives = 119/319 (37%), Gaps = 78/319 (24%)
Query: 2 LGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G GT+ VY A+ + K A+K + G+ REI++++ +KH +++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELKHPNVISL 83
Query: 60 HEVMASKS--KIYFAM-----DLVK----GGELFNKIAKGRLREDVARVYFQQLISAVDF 108
+V S + K++ DL +L + + Q++ + +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 109 CHSRGVYHRDLKPENLLLDEDGN----LKVTDFGLS-AFSEHLKQDGLLHTTCG--TPAY 161
H+ V HRDLKP N+L+ +G +K+ D G + F+ LK L T Y
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLDPVVVTFWY 201
Query: 162 VAPEVI--SKKGYDGAKADIWSCGVILYVLLAG-------------FLPFQDD------- 199
APE++ ++ Y A DIW+ G I LL P+ D
Sbjct: 202 RAPELLLGARH-YTKA-IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259
Query: 200 -----------------NIVSMYRKIYRGDFKCP----------PWFSSEARRLITKLLD 232
++ + R + S+A L+ KLL
Sbjct: 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319
Query: 233 PNPNSRIAISKIMESSWFK 251
+P RI + M+ +F
Sbjct: 320 MDPIKRITSEQAMQDPYFL 338
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 69/293 (23%), Positives = 129/293 (44%), Gaps = 57/293 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G+G+F V+ A+ +++ + +A+K V +DK RE+ +M++VKH ++V+L
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKA 99
Query: 62 VMASKS------KIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
S + + + + + K K + + ++Y QL+ ++ + H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 111 SRGVYHRDLKPENLLLDED-GNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI- 167
S G+ HRD+KP+NLLLD G LK+ DFG + + + C + Y APE+I
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---AGEPNVSYIC-SRYYRAPELIF 214
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------- 210
Y DIWS G ++ L+ G F ++ + +I +
Sbjct: 215 GATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273
Query: 211 GDFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
+ K P +A LI++LL+ P++R+ + + +F
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-37
Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 72/301 (23%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G+G+F VY A+ +G+ +A+K V +DK K RE+ +M+ + H +IV L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 62 VMASKS------KIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
S + + + + +++ AK L ++Y QL ++ + H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 111 SRGVYHRDLKPENLLLDED-GNLKVTDFGLS-AFSEHLKQDGLLHTTCGTP--AYV---- 162
S G+ HRD+KP+NLLLD D LK+ DFG + G P +Y+
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------------GEPNVSYICSRY 221
Query: 163 --APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--------- 210
APE+I Y + D+WS G +L LL G F D+ V +I +
Sbjct: 222 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 211 --------GDFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 250
+FK P EA L ++LL+ P +R+ + S+F
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
Query: 251 K 251
Sbjct: 341 D 341
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 67/251 (26%), Positives = 116/251 (46%), Gaps = 17/251 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G ++V+LAR+L+ + +A+KV+ D + +RE + H IV ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 61 EV----MASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVY 115
+ + Y M+ V G L + + G + A A++F H G+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 138
Query: 116 HRDLKPENLLLDEDGNLKVTDFGL----SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
HRD+KP N+++ +KV DFG+ + + Q GT Y++PE +
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA---AVIGTAQYLSPEQA-RGD 194
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLI 227
A++D++S G +LY +L G PF D+ VS+ + R D P S++ ++
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVV 254
Query: 228 TKLLDPNPNSR 238
K L NP +R
Sbjct: 255 LKALAKNPENR 265
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 35/246 (14%), Positives = 73/246 (29%), Gaps = 38/246 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
G + + A + + +A+ V V+ ++++ + + + + +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
V+ +++ + ++GG L R Q L +A D H GV P
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRA-MQSLAAAADAAHRAGVALSIDHP 157
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
+ + DG++ + PA + + DI
Sbjct: 158 SRVRVSIDGDVVL----------------------AYPATMPDA--------NPQDDIRG 187
Query: 182 CGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-------PWFSSEARRLITKLLDPN 234
G LY LL P + + S R P + + + + +
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247
Query: 235 PNSRIA 240
R A
Sbjct: 248 GGIRSA 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 50/201 (24%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELH 60
LG G +++V+ A N+ + + +K+ +K ++IKREI +++ ++ +I+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 61 EVM---ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+++ S++ + F ++ + L + R Y +++ A+D+CHS G+ HR
Sbjct: 98 DIVKDPVSRTPALVFEHVN--NTDFKQLYQ-TLTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 118 DLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGYDGA 175
D+KP N+++D E L++ D+GL+ F ++ + + + PE++ + YD +
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYS 211
Query: 176 KADIWSCGVILYVLLAGFLPF 196
D+WS G +L ++ PF
Sbjct: 212 -LDMWSLGCMLASMIFRKEPF 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 54/282 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVMKMVKHKH 55
+G G + V A + +A+K K+ E + REI ++ +H++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIK--------KISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 56 IVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
I+ +++++ + + +Y DL+ +L+ + L D + Q++ + + H
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI-S 168
S V HRDLKP NLLL+ +LK+ DFGL+ G L T Y APE++ +
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 169 KKGYDGAKADIWSCGVILYVLLAG---F-----------------LPFQDD--NIVSMYR 206
KGY + DIWS G IL +L+ F P Q+D I+++
Sbjct: 206 SKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 207 KIY--------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 239
+ Y + + P S+A L+ K+L NP+ RI
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 56/287 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVEL 59
LG G V+ A + K +A+K K++ ++ REI +++ + H +IV++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 60 HEVMASKSK--------------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 105
E++ +Y + + +L N + +G L E+ AR++ QL+
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 106 VDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVA 163
+ + HS V HRDLKP NL ++ ED LK+ DFGL+ H G L T Y +
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 164 PEVI-SKKGYDGAKADIWSCGVILYVLLAG---F-----------------LPFQDD--N 200
P ++ S Y A D+W+ G I +L G F + ++D
Sbjct: 193 PRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251
Query: 201 IVSMYRKIYRGDFKCP--------PWFSSEARRLITKLLDPNPNSRI 239
++S+ R D P P S EA + ++L +P R+
Sbjct: 252 LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 65/285 (22%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G + V A + ++G+ +A+K + + I ++ RE+ ++K ++H++++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQHENVIGL 88
Query: 60 HEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+V S Y M + +L KI + E+ + Q++ + + HS G
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV------APEV 166
V HRDLKP NL ++ED LK+ DFGL+ + YV APEV
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG------------YVVTRWYRAPEV 194
Query: 167 I-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY---------------- 209
I S Y+ DIWS G I+ +L G F+ + + +I
Sbjct: 195 ILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 210 --------------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 239
R DF P S +A L+ K+L+ + + R+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 74/333 (22%), Positives = 125/333 (37%), Gaps = 70/333 (21%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVMKMVKHKH 55
LG G + V A + TG+ +A+K K+ + + REI ++K KH++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 56 IVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
I+ + + S +Y +L+ +L I+ L +D + + Q + AV H
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYV------ 162
V HRDLKP NLL++ + +LKV DFGL G +V
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 163 APEVI-SKKGYDGAKADIWSCGVILYVLLAG--FLPFQD--------------------- 198
APEV+ + Y A D+WSCG IL L P +D
Sbjct: 190 APEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 199 DNIVSMYRKIY---RGDFKCPPWF------SSEARRLITKLLDPNPNSRIAISKIMESSW 249
I S + Y + P + + L+ ++L +P RI + +E +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 250 FKK--------SAPKVVITKQEMEFEADKSSKQ 274
+ + + E + + + +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTK 341
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 65/302 (21%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM---VKHKHIVE 58
G GTF V L + TG S+A+K V +D + RE+ +M+ + H +IV+
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQ 83
Query: 59 LHEVMASKSKI------------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 106
L + + Y L + + + + + +V+ QLI ++
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSI 142
Query: 107 DFCH--SRGVYHRDLKPENLLLD-EDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV 162
H S V HRD+KP N+L++ DG LK+ DFG + S + + C + Y
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS---PSEPNVAYIC-SRYYR 198
Query: 163 APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--------------------- 200
APE+I + Y A DIWS G I ++ G F+ DN
Sbjct: 199 APELIFGNQHYTTA-VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 201 -IVSMYRKIYRGDFKCPPW----------FSSEARRLITKLLDPNPNSRIAISKIMESSW 249
+ + + + K PW + EA L++ LL P R+ + + +
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317
Query: 250 FK 251
F
Sbjct: 318 FD 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 77/381 (20%), Positives = 135/381 (35%), Gaps = 99/381 (25%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F V ++++GK A+K V +D K RE+ +MK++ H +I++L +
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHVNIIKLVD 67
Query: 62 VMASKSK--------------------------------------IYFAMDLVKGGELFN 83
+ + M+ V L
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHK 126
Query: 84 KI-----AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDF 137
+ + + ++ +Y QL AV F HS G+ HRD+KP+NLL++ +D LK+ DF
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 138 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPF 196
G + + + C + Y APE++ Y + D+WS G + L+ G F
Sbjct: 187 GSAKKLI--PSEPSVAYIC-SRFYRAPELMLGATEYTPS-IDLWSIGCVFGELILGKPLF 242
Query: 197 Q-------------------DDNIVSM---YRKIYRGDFKCPPWFS-------SEARRLI 227
+ ++ M Y ++ K W S A L+
Sbjct: 243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302
Query: 228 TKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLS 287
++L P+ RI + M +F + + K ++
Sbjct: 303 EQILRYEPDLRINPYEAMAHPFFD-----------HLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 288 EGFDLSPLFEEKKRAEREELR 308
+ F+ SP E L
Sbjct: 352 QLFNFSP--YELSIIPGNVLN 370
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 63/290 (21%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMVKHKHIV 57
+G G V A + +++A+K K+ + + RE+ +MK V HK+I+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 58 ELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS 111
L V + +Y M+L+ L ++ + L + Q++ + HS
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
G+ HRDLKP N+++ D LK+ DFGL + ++ T Y APEVI G
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI----------------------- 208
Y DIWS G I+ ++ G + F + + + K+
Sbjct: 203 YKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 209 -------------------YRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
+ D + +S+AR L++K+L + + RI
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVMKMVKHKHIV 57
+G G++ V A + + +A+K K+++V ++I REI+++ + H H+V
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 58 ELHEVMASKS-----KIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHS 111
++ +++ K ++Y +++ + L E + L+ V + HS
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA---------- 160
G+ HRDLKP N L+++D ++KV DFGL+ + L +
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 161 --------YV------APEVI-SKKGYDGAKADIWSCGVIL 186
+V APE+I ++ Y A D+WS G I
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIGCIF 274
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 50/278 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G + V A + +TG +A+K + + +I ++ RE+ ++K +KH++++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGL 93
Query: 60 HEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+V +Y L+ G +L N + +L +D + Q++ + + HS
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGY 172
+ HRDLKP NL ++ED LK+ DFGL+ + T Y APE++ + Y
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 173 DGAKADIWSCGVILYVLLAG--FLPFQD--------------------DNIVSMYRKIY- 209
+ DIWS G I+ LL G P D I S + Y
Sbjct: 208 NQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 210 -------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 239
+ +F + A L+ K+L + + RI
Sbjct: 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 53/288 (18%), Positives = 108/288 (37%), Gaps = 49/288 (17%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL- 59
+G G + +V+ G+++A+K+ + E+ M++H++I+
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFI 68
Query: 60 ---HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---- 112
S ++++ + G L++ + L + S + H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 113 ----GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEV 166
+ HRDLK +N+L+ ++G + D GL+ + + GT Y+APEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 167 ISKKGYDGA-----KADIWSCGVILYVLLAGF----------LPFQDDN-----IVSMYR 206
+ + + DIW+ G++L+ + PF D M +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 207 KIYRGDFKCPP----WFSSEARRLITKLL----DPNPNSRIAISKIME 246
+ + P WFS + KL+ NP++R+ +I +
Sbjct: 249 VVCVDQQR-PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 50/278 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G + V A + +TG +A+K + + + ++ RE+ ++K ++H++++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMRHENVIGL 89
Query: 60 HEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+V Y M + G +L + +L ED + Q++ + + H+ G
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGY 172
+ HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEVI + Y
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRY 203
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY----------------------- 209
DIWS G I+ ++ G F+ + + ++I
Sbjct: 204 TQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262
Query: 210 -------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 239
+ DF S A L+ K+L + R+
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 67/330 (20%), Positives = 126/330 (38%), Gaps = 68/330 (20%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMVKHKHIV 57
+G G V A + +++A+K K+ + + RE+ +MK V HK+I+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 58 ELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS 111
L V + +Y M+L+ L ++ + L + Q++ + HS
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 171
G+ HRDLKP N+++ D LK+ DFGL + ++ T Y APEVI G
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 172 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI----------------------- 208
Y DIWS G I+ ++ + F + + + K+
Sbjct: 240 YKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 209 -------------------YRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249
+ D + +S+AR L++K+L +P RI++ ++ +
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358
Query: 250 FKK-----SAPKVVITKQEMEFEADKSSKQ 274
+ + + + + +
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIE 388
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 54/274 (19%), Positives = 102/274 (37%), Gaps = 33/274 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL- 59
+ G F V+ A+ + +A+K+ Q + E+ + +KH++I++
Sbjct: 31 VKARGRFGCVWKAQ--LLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFI 84
Query: 60 ---HEVMASKSKIYFAMDLVKGGELF-----NKIA-KGRLR--EDVAR--VYFQQLISAV 106
+ ++ + G L N ++ E +AR Y + I +
Sbjct: 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 107 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 166
H + HRD+K +N+LL + + DFGL+ E K G H GT Y+APEV
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 167 ISKKGYDGA----KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSE 222
+ + D+++ G++L+ L + D V Y + + P
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA--DGPVDEYMLPFEEEIGQHPSLEDM 262
Query: 223 ARRLITKLLDPNPNSRI-------AISKIMESSW 249
++ K P + + +E W
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK------ 54
++G G+F +V A + + + +A+K+V +K Q EI +++ ++ +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFCHS 111
+++ + E ++ I +L+ L+ I K + + + R + ++ +D H
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 112 RGVYHRDLKPENLLLDEDG--NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 169
+ H DLKPEN+LL + G +KV DFG S + ++T + Y APEVI
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILG 273
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPWFSSEARR 225
Y D+WS G IL LL G+ ++ + G ++R
Sbjct: 274 ARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP--SQKLLDASKR 328
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 53/323 (16%), Positives = 110/323 (34%), Gaps = 49/323 (15%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HKHIVE 58
++G G + VY L + +A+KV + E ++ ++ H +I
Sbjct: 20 LIGRGRYGAVYKGS-LD-ERPVAVKV------FSFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 59 L-----HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS-- 111
+ + M+ G L ++ + + + + H+
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 112 -------RGVYHRDLKPENLLLDEDGNLKVTDFGLS------AFSEHLKQDGLLHTTCGT 158
+ HRDL N+L+ DG ++DFGLS ++D + GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 159 PAYVAPEVI------SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD 212
Y+APEV+ + D+++ G+I + + V Y+ ++ +
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251
Query: 213 FKCPPWF-------SSEARRL-ITKLLDPNPNSRIAISKIMESSWFKK-----SAPKVVI 259
P F S E +R + N + ++ + +E W + +A
Sbjct: 252 VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 260 TKQEMEFEADKSSKQPETLNAFH 282
E+ +++ T + H
Sbjct: 312 RMAELMMIWERNKSVSPTAHHHH 334
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 55/286 (19%), Positives = 100/286 (34%), Gaps = 54/286 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--------QIKREISVMKMVKH 53
+ G++ V + G +A+K V + ++ REI ++ H
Sbjct: 30 ISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 54 KHIVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGR--LREDVARVYFQQLISAV 106
+I+ L ++ + +Y +L+ +L I R + + + ++ +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 107 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 166
H GV HRDL P N+LL ++ ++ + DF L + D Y APE+
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNL---AREDTADANKTHYVTHRWYRAPEL 204
Query: 167 I-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI----------------- 208
+ KG+ D+WS G ++ + F+ + KI
Sbjct: 205 VMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 209 ---------YRGDFKCPPWF------SSEARRLITKLLDPNPNSRI 239
+ W A LI K+L+ NP RI
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-------- 52
LG G F+ V+LA+++ +AMK+V DKV E + EI +++ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKED 81
Query: 53 ---HKHIVELHEVMASKSKIYFAMDLVKGG--------------ELFNKIAKGRLREDVA 95
HI++L + +F G L K +
Sbjct: 82 SMGANHILKLLD--------HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 96 RVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDE------DGNLKVTDFGLSAFSEHLKQ 148
+ +QL+ +D+ H R G+ H D+KPEN+L++ +K+ D G + + +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-- 191
Query: 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 197
+ T Y +PEV+ + ADIWS +++ L+ G F+
Sbjct: 192 ---YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFE 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 38/222 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVI--KVGMMEQIKREISVMKMVKHKHIV 57
+G G++ VYLA + T K++A+K V + + +I K +I REI+++ +K +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-----RILREITILNRLKSDYII 88
Query: 58 ELHEVMASKSK-----IYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHS 111
L++++ +Y +++ +L L E+ + L+ +F H
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPA--------- 160
G+ HRDLKP N LL++D ++KV DFGL + SE P
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 161 ---YV------APEVI-SKKGYDGAKADIWSCGVILYVLLAG 192
+V APE+I ++ Y + DIWS G I LL
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKS-IDIWSTGCIFAELLNM 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 55/289 (19%), Positives = 118/289 (40%), Gaps = 49/289 (16%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL- 59
+G G F +V+ + G+ +A+K+ + + EI M++H++I+
Sbjct: 49 SIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFI 102
Query: 60 ---HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---- 112
++ + ++++ D + G LF+ + + + + S + H
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 113 ----GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEV 166
+ HRDLK +N+L+ ++G + D GL+ + D + GT Y+APEV
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 167 ISKKGYDGA-----KADIWSCGVILYVLLAGF----------LPFQ-----DDNIVSMYR 206
+ +ADI++ G++ + + LP+ D ++ M +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 207 KIYRGDFKCPP----WFSSEARRLITKLL----DPNPNSRIAISKIMES 247
+ + P W S EA R++ K++ N +R+ +I ++
Sbjct: 283 VVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 70/325 (21%), Positives = 120/325 (36%), Gaps = 81/325 (24%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVI--KVGMMEQIKREISVMK-MVKHKHI 56
LG G + V+ + + +TG+ +A+K + + + REI ++ + H++I
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-----RTFREIMILTELSGHENI 71
Query: 57 VELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 114
V L V+ + + +Y D + +L I L + QLI + + HS G+
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA------------Y 161
HRD+KP N+LL+ + ++KV DFGLS +F + + + Y
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 162 V------APEVI-SKKGYDGAKADIWSCGVILYVLLAG---F------------------ 193
V APE++ Y D+WS G IL +L G F
Sbjct: 191 VATRWYRAPEILLGSTKYTKG-IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF 249
Query: 194 --------------------------LPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 227
+ + + K + EA L+
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309
Query: 228 TKLLDPNPNSRIAISKIMESSWFKK 252
KLL NPN RI+ + ++ +
Sbjct: 310 DKLLQFNPNKRISANDALKHPFVSI 334
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 55/292 (18%), Positives = 113/292 (38%), Gaps = 55/292 (18%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL- 59
+G G + +V++ + + G+ +A+KV + + EI +++H++I+
Sbjct: 44 QIGKGRYGEVWMGK-WR-GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFI 97
Query: 60 ---HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---- 112
+ S +++Y D + G L++ + L +S + H+
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 113 ----GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEV 166
+ HRDLK +N+L+ ++G + D GL+ D +T GT Y+ PEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 167 ISKKGYDGA-----KADIWSCGVILYVLLAGF----------LPFQ-----DDNIVSMYR 206
+ + AD++S G+IL+ + LP+ D + M
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 207 KIYR-----------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247
+ +C +L+T+ NP SR+ ++ ++
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTALRVKKT 325
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 56/240 (23%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH------K 54
++G G+F +V A + + +A+K++ K + Q + E+ +++++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKY 116
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFCHS 111
+IV L ++ + +++ L++ + R ++ R + QQ+ +A+ F +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 112 R--GVYHRDLKPENLLLDEDGN--LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 167
+ H DLKPEN+LL +K+ DFG S+ + ++ + Y +PEV+
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRFYRSPEVL 230
Query: 168 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPWFSSEARR 225
YD A D+WS G IL + G F N V KI G P +A +
Sbjct: 231 LGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP--PAHILDQAPK 287
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 33/254 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
+G G F +V+ R +A+K + + +K +E ++K H +IV
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS------CRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC------H 110
L V K IY M+LV+GG+ LR + AR+ + L+ D
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLT-----FLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY----VAPEV 166
S+ HRDL N L+ E LK++DFG+S + DG+ + G APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEA 286
Query: 167 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 224
++ Y +++D+WS G++L+ G P+ + + + +G CP
Sbjct: 287 LNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF 345
Query: 225 RLITKLLDPNPNSR 238
RL+ + P R
Sbjct: 346 RLMEQCWAYEPGQR 359
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 52/262 (19%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVV-GKDKVIKVGMMEQIKREISVMKMVKH-----K 54
+G GTF +V L +++ K A+KVV K K E ++K +++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK-----YTRSAKIEADILKKIQNDDINNN 96
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFCHS 111
+IV+ H + + + G L+ I + + ++Y +++ A+++
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 112 RGVYHRDLKPENLLLDEDG-------------------------NLKVTDFGLSAF-SEH 145
+ H DLKPEN+LLD+ +K+ DFG + F S++
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY 215
Query: 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY 205
+ T Y APEVI G+D + +D+WS G +L L G L F+ +
Sbjct: 216 ------HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 206 RKI--YRGDFKCPPWFSSEARR 225
+ P EA +
Sbjct: 269 AMMESIIQPI--PKNMLYEATK 288
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 75/336 (22%), Positives = 118/336 (35%), Gaps = 98/336 (29%)
Query: 1 MLGHGTFAKVYLARNLQTGKSM-AMKVV-GKDKVIKVGMMEQIKREISVMKMVKHK---- 54
LG GTF KV + GKS A+K++ K E + EI+V+K +K K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEINVLKKIKEKDKEN 80
Query: 55 --HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFC 109
V + + + A +L+ G F + + + R QL A+ F
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 110 HSRGVYHRDLKPENLLLDEDGN-------------------LKVTDFGLSAFSEHLKQDG 150
H + H DLKPEN+L ++V DFG SA +H
Sbjct: 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDHEH--- 195
Query: 151 LLHTTCGTPAYV------APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ-DDNI-- 201
HTT V PEVI + G+ D+WS G IL+ GF FQ +N
Sbjct: 196 --HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREH 247
Query: 202 ------------VSMYRKIYRGDF---KCPPWFSSEARR--------------------- 225
M + + + W + +
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 226 -----LITKLLDPNPNSRIAISKIMESSWFKKSAPK 256
L+ ++L+ +P RI +++ + +F P+
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
LG G F VY + G+ + + V + K ++ + E VM V + H+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------ 110
L + S + L+ G L + +RE + Q L +++C
Sbjct: 80 CRLLGI-CLTSTVQLITQLMPFGCLLD-----YVREHKDNIGSQYL---LNWCVQIAKGM 130
Query: 111 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYVA 163
R + HRDL N+L+ ++K+TDFGL+ L + + G P ++A
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMA 187
Query: 164 PEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
E I + Y ++D+WS GV ++ ++ G P+
Sbjct: 188 LESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDG 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 33/236 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G + +VY K ++ V K +K ME + +E +VMK +KH ++V+L
Sbjct: 228 LGGGQYGEVYEG----VWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC------HS 111
V + Y + + G L LRE + V L+ A
Sbjct: 282 LGVCTREPPFYIITEFMTYGNL-----LDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAPEVISK 169
+ HR+L N L+ E+ +KV DFGL S + D APE ++
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGL---SRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 170 KGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-----FKCPPWF 219
+ K+D+W+ GV+L+ + G P+ ++ +Y + + CP
Sbjct: 394 NKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 448
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 61/271 (22%), Positives = 101/271 (37%), Gaps = 42/271 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVKHKHIV 57
LG G F V + R + V V K ++ E ++ REI ++K ++H +IV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAV---KKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 58 ELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC----- 109
+ V S + + M+ + G L + L++ R+ +L+ C
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSL-----RDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 110 -HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV-----A 163
++ HRDL N+L++ + +K+ DFGL ++ L QD P A
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGL---TKVLPQDKEFFKV-KEPGESPIFWYA 185
Query: 164 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 223
PE +++ + +D+WS GV+LY L F +
Sbjct: 186 PESLTESKFS-VASDVWSFGVVLYEL------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 224 RRLITKL-----LDPNPNSRIAISKIMESSW 249
LI L L I IM W
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECW 269
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 65/264 (24%), Positives = 97/264 (36%), Gaps = 60/264 (22%)
Query: 1 MLGHGTFAKVYLARNLQTGKSM-AMKVV-GKDKVIKVGMMEQIKREISVMKMVKHK---- 54
LG G F KV + + G A+K+V D+ E + EI V++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-----YCEAARSEIQVLEHLNTTDPNS 75
Query: 55 --HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFC 109
V++ E I +L+ G ++ I + D R Q+ +V+F
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 110 HSRGVYHRDLKPENLLLDEDGN-------------------LKVTDFGLSAF-SEHLKQD 149
HS + H DLKPEN+L + +KV DFG + + EH
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---- 190
Query: 150 GLLHTTCGTPAYV------APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS 203
H+T V APEVI G+ D+WS G IL GF F +
Sbjct: 191 ---HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 204 MYRKIYR--GDFKCPPWFSSEARR 225
+ R G P + R+
Sbjct: 242 HLAMMERILGPL--PKHMIQKTRK 263
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 61/271 (22%), Positives = 102/271 (37%), Gaps = 42/271 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVKHKHIV 57
LG G F V + R + V V K ++ E ++ REI ++K ++H +IV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAV---KKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 58 ELHEV--MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC----- 109
+ V A + + M+ + G L + L++ R+ +L+ C
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSL-----RDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 110 -HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV-----A 163
++ HRDL N+L++ + +K+ DFGL ++ L QD + P A
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGL---TKVLPQDKEYYKV-KEPGESPIFWYA 216
Query: 164 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 223
PE +++ + +D+WS GV+LY L F +
Sbjct: 217 PESLTESKFS-VASDVWSFGVVLYEL------FTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 224 RRLITKL-----LDPNPNSRIAISKIMESSW 249
LI L L I IM W
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECW 300
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 69/375 (18%), Positives = 117/375 (31%), Gaps = 146/375 (38%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-------- 52
LG G F+ V+L+ ++Q K +AMKVV + E EI ++K V+
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPN 99
Query: 53 HKHIVEL-----------------HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA 95
+ +V+L EV+ L+K N L
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLG--------HHLLKWIIKSNY---QGLPLPCV 148
Query: 96 RVYFQQLISAVDFCHSR-GVYHRDLKPENLLL---------------------------- 126
+ QQ++ +D+ H++ + H D+KPEN+LL
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 127 ---------------------DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP-AYVAP 164
E +K+ D G + + T Y +
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSL 262
Query: 165 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ---------DDNIVSM----------- 204
EV+ GY+ ADIWS + + L G F+ D++ +++
Sbjct: 263 EVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
Query: 205 ------YRKIY---RGDFK----CPPWFSSEAR---------------RLITKLLDPNPN 236
Y K + +GD K PW E + +L+ P
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 237 SRIAISKIMESSWFK 251
R ++ + W
Sbjct: 382 KRATAAECLRHPWLN 396
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 37/218 (16%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIK------REISVMKMVKHK 54
LG G+F V + +GK++++ V K +K ++ Q + RE++ M + H+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAV----KCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH---- 110
+++ L+ V + +L G L + RLR+ L +
Sbjct: 82 NLIRLYGV-VLTPPMKMVTELAPLGSLLD-----RLRKHQGHFLLGTL---SRYAVQVAE 132
Query: 111 ------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AY 161
S+ HRDL NLLL +K+ DFGL + D P A+
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP--QNDDHYVMQEHRKVPFAW 190
Query: 162 VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
APE + + + +D W GV L+ + G P+
Sbjct: 191 CAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 35/230 (15%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
+LG G F VY + G+ + + V + K ++ + E VM V + H
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASVDNPH 78
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH----- 110
+ L + S + L+ G L + +RE + Q L +++C
Sbjct: 79 VCRLLGI-CLTSTVQLITQLMPFGCLLD-----YVREHKDNIGSQYL---LNWCVQIAKG 129
Query: 111 -----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYV 162
R + HRDL N+L+ ++K+TDFGL+ L + + G P ++
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWM 186
Query: 163 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
A E I + Y ++D+WS GV ++ ++ G P+ + + +G
Sbjct: 187 ALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
+G G F +VY + + V + K +K G E+ + E +M H +I
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAI---KTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH----- 110
+ L V++ + + ++ G L LRE QL+
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGAL-----DKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 111 -SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV---APEV 166
+ HRDL N+L++ + KV+DFGLS E +TT G + APE
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWTAPEA 221
Query: 167 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
IS + + + +D+WS G++++ V+ G P+ +
Sbjct: 222 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
+G G F V+L +A+K I+ G M + E VM + H +V+L
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKT------IREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH------SR 112
+ V ++ I + ++ G L + LR + L+ +D C
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSD-----YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-YVAPEVISK 169
V HRDL N L+ E+ +KV+DFG++ F D ++ GT P + +PEV S
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPVKWASPEVFSF 179
Query: 170 KGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
Y +K+D+WS GV+++ V G +P+++ + + I G
Sbjct: 180 SRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G F V L + + +A+K+ IK G M + + +E M + H +V+
Sbjct: 16 LGSGQFGVVKLGK-WKGQYDVAVKM------IKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH------SR 112
+ V + + IY + + G L N LR + QL+ D C S
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLN-----YLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-YVAPEVISK 169
HRDL N L+D D +KV+DFG++ + D ++ GT P + APEV
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 170 KGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
Y +K+D+W+ G++++ V G +P+
Sbjct: 180 FKYS-SKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-20
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G F V + + +A+K+ IK G M + + E VM + H+ +V+L
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKM------IKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH------SR 112
+ V + I+ + + G L N LRE R QQL+ D C S+
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLN-----YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-YVAPEVISK 169
HRDL N L+++ G +KV+DFGLS + D ++ G+ P + PEV+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 170 KGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
+ +K+DIW+ GV+++ + G +P++
Sbjct: 196 SKFS-SKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 9e-20
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-IKREISVMKMVKHKHIVELH 60
+G G F V L G +A+K IK Q E SVM ++H ++V+L
Sbjct: 29 IGKGEFGDVMLGD--YRGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 61 EV-MASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFCH------S 111
V + K +Y + + G L + LR + + L+ ++D C
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVD-----YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV---APEVIS 168
HRDL N+L+ ED KV+DFGL+ + + G L P V APE +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALR 187
Query: 169 KKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
+K + K+D+WS G++L+ + G +P+ + + ++ +G
Sbjct: 188 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHI 56
+G G F +V R L + K +++ + K +KVG E+ +R E S+M H +I
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAI----KTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------ 110
+ L V+ + + ++ G L + LR+ A+ QL V
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSF-----LRKHDAQFTVIQL---VGMLRGIASGM 160
Query: 111 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV---A 163
G HRDL N+L++ + KV+DFGL E +TT G + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIPIRWTS 218
Query: 164 PEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
PE I+ + + + +D+WS G++L+ V+ G P+ +
Sbjct: 219 PEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVKHKHIV 57
LG G F V L R G + V V K ++ +Q + REI ++K + IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAV---KQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 58 ELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC----- 109
+ V + + M+ + G L + L+ AR+ +L+ + C
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCL-----RDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 110 -HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV-----A 163
SR HRDL N+L++ + ++K+ DFGL+ L + P A
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLA----KLLPLDKDYYVVREPGQSPIFWYA 198
Query: 164 PEVISKKGYDGAKADIWSCGVILY 187
PE +S + ++D+WS GV+LY
Sbjct: 199 PESLSDNIFS-RQSDVWSFGVVLY 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK--REISVMKMVKHKHIVE 58
LG G + +VY K ++ V V K +K ME + +E +VMK +KH ++V+
Sbjct: 21 LGGGQYGEVYEGV----WKKYSLTVAV---KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFCH------ 110
L V + Y + + G L + LRE + V L+ A
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-YVAPEVI 167
+ HRDL N L+ E+ +KV DFGLS G P + APE +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESL 184
Query: 168 SKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
+ + K+D+W+ GV+L+ + G P+ ++ +Y + +
Sbjct: 185 AYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 34/225 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G F +V++ +A+K +K G M +E VMK ++H+ +V+L
Sbjct: 275 LGQGCFGEVWMGT-WNGTTRVAIKT------LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC---------- 109
+ V S+ IY + + G L L+ + + + +L VD
Sbjct: 328 YAV-VSEEPIYIVTEYMSKGSL-----LDFLKGETGK--YLRLPQLVDMAAQIASGMAYV 379
Query: 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAPEVI 167
HRDL+ N+L+ E+ KV DFGL + ++ + APE
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 168 SKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
+ K+D+WS G++L + G +P+ + ++ RG
Sbjct: 437 LYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
+G G +V R L+ + V + K +K G E+ + E S+M H +I
Sbjct: 57 IGSGDSGEVCYGR-LRVPGQRDVPVAI---KALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------ 110
+ L V+ + ++ G L LR + QL+
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDT-----FLRTHDGQFTIMQLV---GMLRGVGAGM 164
Query: 111 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV---A 163
G HRDL N+L+D + KV+DFGLS E +TT G + A
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWTA 222
Query: 164 PEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
PE I+ + + + +D+WS GV+++ VL G P+ +
Sbjct: 223 PEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWN 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 30/223 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G F +V++ T + K +K G M +E VMK ++H+ +V+L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAI-------KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC------HS 111
+ V S+ IY + + G L + L+ + QL+ A
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAPEVISK 169
HRDL+ N+L+ E+ KV DFGL + ++ + APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 170 KGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
+ K+D+WS G++L + G +P+ + ++ RG
Sbjct: 356 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-IKREISVMKMVKHKHIVELH 60
+G G F V L G +A+K IK Q E SVM ++H ++V+L
Sbjct: 201 IGKGEFGDVMLGD--YRGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 61 EV-MASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC------HS 111
V + K +Y + + G L LR + + L+ ++D C
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSL-----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISKK 170
HRDL N+L+ ED KV+DFGL+ + + G L P + APE + +K
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREK 361
Query: 171 GYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
+ K+D+WS G++L+ + G +P+ + + ++ +G
Sbjct: 362 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
+G G F V+ + ++ A+ V + K K + ++ +E M+ H HI
Sbjct: 23 IGEGQFGDVHQGI-YMSPENPALAVAI---KTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH----- 110
V+L V +++ ++ M+L GEL + L+ + LI A
Sbjct: 79 VKLIGV-ITENPVWIIMELCTLGEL-----RSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 111 -SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-YVAPEV 166
S+ HRD+ N+L+ + +K+ DFGLS + E D + P ++APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAPES 188
Query: 167 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
I+ + + + +D+W GV ++ +L+ G PFQ
Sbjct: 189 INFRRFT-SASDVWMFGVCMWEILMHGVKPFQG 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 49/229 (21%), Positives = 90/229 (39%), Gaps = 35/229 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
LG G F V+ + G+S+ + V + KVI+ Q + + + H HI
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCI---KVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------ 110
V L + S + + G L + +R+ + Q L +++
Sbjct: 78 VRLLGL-CPGSSLQLVTQYLPLGSLLD-----HVRQHRGALGPQLL---LNWGVQIAKGM 128
Query: 111 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYVA 163
G+ HR+L N+LL ++V DFG++ L D P ++A
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMA 185
Query: 164 PEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
E I Y ++D+WS GV ++ ++ G P+ + + + +G
Sbjct: 186 LESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G F +V++ +A+K +K G M E ++MK ++H+ +V L
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKS------LKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFCH------S 111
+ V ++ IY + ++ G L + L+ ++ +L+ A
Sbjct: 74 YAV-VTQEPIYIITEYMENGSLVD-----FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH----LKQDGLLHTTCGTPA-YVAPEV 166
R HRDL+ N+L+ + + K+ DFGL+ E ++ P + APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------PIKWTAPEA 181
Query: 167 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
I+ + K+D+WS G++L ++ G +P+ + + + RG
Sbjct: 182 INYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 37/216 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
LG G F +VY K + V V K K K E +MK + H HI
Sbjct: 20 LGEGFFGEVYEGV-YTNHKGEKINVAV---KTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------ 110
V+L ++ + + M+L GEL + L + + L+ +
Sbjct: 76 VKLIGII-EEEPTWIIMELYPYGELGH-----YLERNKNSLKVLTLV---LYSLQICKAM 126
Query: 111 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYVA 163
S HRD+ N+L+ +K+ DFGLS + E D + T P +++
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKASVTRLPIKWMS 182
Query: 164 PEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
PE I+ + + +D+W V ++ +L G PF
Sbjct: 183 PESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFW 217
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 34/215 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
LG G F V K + + + KV+K G + RE +M + + +IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAI----KVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------- 110
L V + M++ GG L L + + + H
Sbjct: 74 RLIGV-CQAEALMLVMEMAGGGPLHK-----FLVGKREEIPVSNV---AELLHQVSMGMK 124
Query: 111 ---SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYVAP 164
+ HRDL N+LL K++DFGLS D P + AP
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPLKWYAP 182
Query: 165 EVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
E I+ + + +++D+WS GV ++ L G P++
Sbjct: 183 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 32/205 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
LG G F KV L R G + +V V K +K +EI +++ + H++I
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAV---KSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 57 VELHEV--MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC---- 109
V+ + + I M+ + G L K L ++ ++ +Q + AV C
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSL-----KEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 110 --HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV----- 162
SR HRDL N+L++ + +K+ DFGL+ + + T
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT----KAIETDKEYYTVKDDRDSPVFWY 196
Query: 163 APEVISKKGYDGAKADIWSCGVILY 187
APE + + + +D+WS GV L+
Sbjct: 197 APECLMQSKFY-IASDVWSFGVTLH 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 35/235 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKHIV 57
LG G F V K + + + KV+K G + RE +M + + +IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAI----KVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------- 110
L V + M++ GG L L + + + H
Sbjct: 400 RLIGV-CQAEALMLVMEMAGGGPLHK-----FLVGKREEIPVSNV---AELLHQVSMGMK 450
Query: 111 ---SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYVAP 164
+ HR+L N+LL K++DFGLS D P + AP
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPLKWYAP 508
Query: 165 EVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPP 217
E I+ + + +++D+WS GV ++ L G P++ + I +G +CPP
Sbjct: 509 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 59
LG G F +V++A + K K +K G M E +VMK ++H +V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAV-------KTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 60 HEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYF-QQLISAVDFCHSRGVYH 116
H V +K IY + + G L F K +G + + F Q+ + F R H
Sbjct: 249 HAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAPEVISKKGYDG 174
RDL+ N+L+ K+ DFGL+ ++ + APE I+ +
Sbjct: 308 RDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 363
Query: 175 AKADIWSCGVILY 187
K+D+WS G++L
Sbjct: 364 IKSDVWSFGILLM 376
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
+G G F V+ + ++ AM V + K K + ++ +E M+ H HI
Sbjct: 398 IGEGQFGDVHQGI-YMSPENPAMAVAI---KTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH------ 110
V+L V +++ ++ M+L GEL + L+ + LI + +
Sbjct: 454 VKLIGV-ITENPVWIIMELCTLGELRS-----FLQVRKFSLDLASLI---LYAYQLSTAL 504
Query: 111 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG-TPA-YVAP 164
S+ HRD+ N+L+ + +K+ DFGLS + ++ + G P ++AP
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAP 561
Query: 165 EVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
E I+ + + + +D+W GV ++ +L+ G PFQ
Sbjct: 562 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 24/200 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKHI 56
LG G F KV L T V V K +K Q + +EI +++ + H+HI
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAV---KALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 57 VELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 114
++ + M+ V G L + + + + ++ QQ+ + + H++
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------LKQDGLLHTTCGTP-AYVAPEVI 167
HRDL N+LLD D +K+ DFGL+ +++DG P + APE +
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWYAPECL 209
Query: 168 SKKGYDGAKADIWSCGVILY 187
+ + +D+WS GV LY
Sbjct: 210 KEYKFY-YASDVWSFGVTLY 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 38/217 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK-----REISVMKMVKHKH 55
LG G F V K + V V K++K + E +VM+ + + +
Sbjct: 25 LGSGNFGTVKKGY--YQMKKVVKTVAV---KILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH----- 110
IV + + M++ + G L + + R V + + ++ H
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR------HVKDKNI---IELVHQVSMG 129
Query: 111 -----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P-AYV 162
HRDL N+LL K++DFGLS + P +
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR--ADENYYKAQTHGKWPVKWY 187
Query: 163 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 198
APE I+ + +K+D+WS GV+++ G P++
Sbjct: 188 APECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 42/235 (17%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
++G G F VY L + V K + E +MK H +
Sbjct: 32 VIGRGHFGCVYHGT-LLDNDGKKIHCAV---KSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 56 IVELHEVMA-SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH--- 110
++ L + S+ + +K G+L + +R + + LI +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 111 ---SRGVYHRDLKPENLLLDEDGNLKVTDFGLS-------AFSEHLKQDGLLHTTCGTPA 160
S+ HRDL N +LDE +KV DFGL+ +S H K L P
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P- 195
Query: 161 YV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
V A E + + + K+D+WS GV+L+ ++ G P+ D N + + +G
Sbjct: 196 -VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 58/238 (24%), Positives = 90/238 (37%), Gaps = 41/238 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK-----REISVMKMVKHKH 55
LG G F V A+ L+ +KV V K++K ++ RE + MK H H
Sbjct: 31 LGKGEFGSVREAQ-LKQEDGSFVKVAV---KMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 56 IVEL------HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDF 108
+ +L + +K G+L + R+ E+ + Q L+ VD
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 109 CH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLLHTTCG 157
SR HRDL N +L ED + V DFGLS L
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL----- 201
Query: 158 TPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
P V A E ++ Y +D+W+ GV ++ ++ G P+ +Y + G
Sbjct: 202 -P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 46/249 (18%), Positives = 81/249 (32%), Gaps = 54/249 (21%)
Query: 2 LGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVKHK 54
LG GTF K++ G+ +V + KV+ + S+M + HK
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLL---KVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH--- 110
H+V + V + + VK G L L+++ + + A
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTY-----LKKNKNCINILWKLEVAKQLAAAMH 127
Query: 111 ---SRGVYHRDLKPENLLLDEDGNL--------KVTDFGLSAFSEHLKQDGLLHTTCGTP 159
+ H ++ +N+LL + + K++D G+S +D
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--PKDI--------- 176
Query: 160 AY------VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD-DN--IVSMYRKIY 209
V PE I D WS G L+ + G P D+ + Y +
Sbjct: 177 -LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 210 RGDFKCPPW 218
+ P
Sbjct: 236 QLP--APKA 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 34/231 (14%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
++G G F VY L + V K + E +MK H +
Sbjct: 96 VIGRGHFGCVYHGT-LLDNDGKKIHCAV---KSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 56 IVELHEVMA-SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH--- 110
++ L + S+ + +K G+L + +R + + LI +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 111 ---SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG------TPAY 161
S+ HRDL N +LDE +KV DFGL+ + D + + T
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM--- 263
Query: 162 VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
A E + + + K+D+WS GV+L+ ++ G P+ D N + + +G
Sbjct: 264 -ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-16
Identities = 52/263 (19%), Positives = 101/263 (38%), Gaps = 43/263 (16%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVG--MMEQIK--REISVMKMVKHKH 55
++G G F VY ++ + K + M + RE +M+ + H +
Sbjct: 28 VIGKGHFGVVYHGE-YIDQAQNRIQCAI---KSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 56 IVELHEV-MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH--- 110
++ L + + + + + + G+L +R + LIS +
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 111 ---SRGVYHRDLKPENLLLDEDGNLKVTDFGLS-------AFSEHLKQDGLLHTTCGTPA 160
+ HRDL N +LDE +KV DFGL+ +S + L P
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P- 191
Query: 161 YV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKC 215
V A E + + K+D+WS GV+L+ +L G P++ + + + +G
Sbjct: 192 -VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ 249
Query: 216 PPWFSSEARRLITKLLDPNPNSR 238
P + +++ + + +P R
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVR 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 46/216 (21%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMV-KHKHI 56
+G G F +V AR + G M + K +K + E+ V+ + H +I
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAI----KRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 57 VELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQLISAV 106
+ L + +Y A++ G L A + + QQL+
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH-- 146
Query: 107 DFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH--LKQDGLLHT 154
F + HRDL N+L+ E+ K+ DFGLS E K G L
Sbjct: 147 -FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL-- 203
Query: 155 TCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
P V A E ++ Y +D+WS GV+L+
Sbjct: 204 ----P--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 43/215 (20%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F KVY R L G +A+K + +++ G Q + E+ ++ M H++++ L
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 61 -------------EVMASKSKIYFAMDLVKGGELFN-----KIAKGRLREDVAR--VYFQ 100
MA+ S + + + +IA G AR Y
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG-----SARGLAYLH 148
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT---CG 157
D C + + HRD+K N+LLDE+ V DFGL+ L H T G
Sbjct: 149 ------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRG 197
Query: 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG 192
T ++APE +S G K D++ GV+L L+ G
Sbjct: 198 TIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 64/262 (24%), Positives = 101/262 (38%), Gaps = 63/262 (24%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHI 56
+G G F VY + ++A+K + I ++K+ EI VM +H+++
Sbjct: 38 KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENL 92
Query: 57 VELH-------------EVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARVYF 99
VEL M + S + L L KIA+G A
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG-----AAN--- 144
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT---C 156
++F H HRD+K N+LLDE K++DFGL+ SE T
Sbjct: 145 -----GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK---FAQTVMTSRIV 196
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGD 212
GT AY+APE + G K+DI+S GV+L ++ G + ++ + +I
Sbjct: 197 GTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE- 253
Query: 213 FKCPPWFSSEARRLITKLLDPN 234
+ I +D
Sbjct: 254 -----------EKTIEDYIDKK 264
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 53/220 (24%), Positives = 83/220 (37%), Gaps = 46/220 (20%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV-KHK 54
LG G F KV A AM V V K++K + E+ V+ + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAV---KMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGEL------------FNKIAKGRLREDVARVYFQQL 102
+IV L + G+L +K + + +D + + L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 103 IS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH---LKQDG 150
+S + F S+ HRDL N+LL K+ DFGL+ ++ +K +
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 151 LLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
L P V APE I Y ++D+WS G+ L+
Sbjct: 208 RL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELH 60
+G G+F ++YL N+QT + +A+K+ Q+ E + ++++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVR 69
Query: 61 EVMASKSKIYFAMDLVKG---GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
MDL+ G +LFN ++ + V + Q+I+ V+F HS+ HR
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFVHSKSFLHR 127
Query: 118 DLKPENLLLDEDGN---LKVTDFGLSAF------SEHLKQDGLLHTTCGTPAYVAPEVIS 168
D+KP+N L+ + + DFGL+ +H+ + T GT Y + V +
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-GTARYAS--VNT 184
Query: 169 KKGYD-GAKADIWSCGVILYVLLAGFLPFQDDNIVSM---YRKIYR 210
G + + D+ S G +L L G LP+Q + Y KI
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 56/237 (23%), Positives = 90/237 (37%), Gaps = 40/237 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIKR-----EISVMKMVKHKH 55
LG G F V L+ ++KV V K +K+ Q + E + MK H +
Sbjct: 42 LGEGEFGSVMEGN-LKQEDGTSLKVAV---KTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 56 IVEL-----HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 109
++ L K + +K G+L + RL + Q L+ VD
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 110 H------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLLHTTCGT 158
+R HRDL N +L +D + V DFGLS + +
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM------ 211
Query: 159 PAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 211
P V A E ++ + Y +K+D+W+ GV ++ + G P+ MY + G
Sbjct: 212 P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELH 60
+G G+F +YL ++ G+ +A+K+ Q+ E + KM++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIR 71
Query: 61 EVMASKSKIYFAMDLVKG---GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
A M+L+ G +LFN ++ + V + Q+IS +++ HS+ HR
Sbjct: 72 WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLL-ADQMISRIEYIHSKNFIHR 129
Query: 118 DLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTT-------CGTPAYVAPEVI 167
D+KP+N L+ + + DFGL+ ++ H GT Y + +
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENKNLTGTARYAS--IN 185
Query: 168 SKKGYD-GAKADIWSCGVILYVLLAGFLPFQ---DDNIVSMYRKIYR 210
+ G + + D+ S G +L G LP+Q Y +I
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELH 60
+G G F ++ L +NL T + +A+K+ Q+ E K + I +++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVY 71
Query: 61 EVMASKSKIYFAMDLVKGG----ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
++L+ G +LF+ + + V + QLIS +++ HS+ + +
Sbjct: 72 YFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMI-AIQLISRMEYVHSKNLIY 128
Query: 117 RDLKPENLLLDEDGNLK-----VTDFGLSAFSEHLKQDGLLH-------TTCGTPAYVAP 164
RD+KPEN L+ GN + DF L+ E++ + H + GT Y++
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALA--KEYIDPETKKHIPYREHKSLTGTARYMS- 185
Query: 165 EVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQ---DDNIVSMYRKIYR 210
+ + G + + D+ + G + L G LP+Q D + Y+KI
Sbjct: 186 -INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 45/229 (19%), Positives = 90/229 (39%), Gaps = 31/229 (13%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELH 60
+G G+F ++ NL + +A+K + Q++ E K + I ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 61 EVMASKSKIYFAMDLVKG---GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
+DL+ G +L + + + VA +Q+++ V H + + +R
Sbjct: 73 YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMA-AKQMLARVQSIHEKSLVYR 130
Query: 118 DLKPENLLL----DEDGN-LKVTDFGLSAFSEHLKQDGLLH-------TTCGTPAYVAPE 165
D+KP+N L+ ++ N + V DFG+ + H GT Y++
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHIPYREKKNLSGTARYMS-- 186
Query: 166 VISKKGYD-GAKADIWSCGVILYVLLAGFLPFQ---DDNIVSMYRKIYR 210
+ + G + + D+ + G + L G LP+Q Y +I
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 42/216 (19%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVKHKHI 56
LG G F KV+LA + M V V K +K + K RE ++ ++H+HI
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAV---KALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 57 VELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQLIS-A 105
V+ + V + + +K G+L + G+ R+ + Q++ A
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 106 VDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLLHT 154
S+ HRDL N L+ + +K+ DFG+S + +L
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-- 197
Query: 155 TCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
P + PE I + + ++D+WS GVIL+
Sbjct: 198 ----P--IRWMPPESIMYRKFT-TESDVWSFGVILW 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMV-KHKHI 56
LG G F KV A GK A+ V K++K K E+ +M + +H++I
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFN--------KIAKGRLREDVARVYFQQLIS-AVD 107
V L + + G+L N + + L+ +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 108 ------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS----AFSEHLKQ-DGLLHTTC 156
F S+ HRD+ N+LL K+ DFGL+ S ++ + + L
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL---- 228
Query: 157 GTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
P V APE I Y ++D+WS G++L+
Sbjct: 229 --P--VKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 51/225 (22%)
Query: 2 LGHGTFAKVYLARNLQ-TGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
LG G F KV A G++ V V K++K E +V+K V H H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAV---KMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 56 IVELHEVMASKSKIYFAMDLVKGGEL------------------FNKIAKGRLREDVARV 97
+++L+ + + ++ K G L ++ + D +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 98 YFQQLIS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH--- 145
LIS A + + HRDL N+L+ E +K++DFGLS + E
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 146 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
+ G + P V A E + Y ++D+WS GV+L+
Sbjct: 208 KRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 44/220 (20%), Positives = 74/220 (33%), Gaps = 49/220 (22%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
LG F KVY V + K +K ++ E + ++H +
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAI---KTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 56 IVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQLISA 105
+V L V+ + G+L + + R + + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV-- 131
Query: 106 VDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDG 150
S V H+DL N+L+ + N+K++D GL L +
Sbjct: 132 -HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 151 LLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
LL P + APE I + +DIWS GV+L+
Sbjct: 191 LL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLW 221
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 2 LGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV-K 52
LG G F +V LA + + KV V K++K E+ E+ +MKM+ K
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAV---KMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQL 102
HK+I+ L +Y ++ G L + + ++ + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 103 IS-AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDG 150
+S A S+ HRDL N+L+ ED +K+ DFGL+ H +G
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 151 LLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
L P V APE + + Y ++D+WS GV+L+
Sbjct: 254 RL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 57/228 (25%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV-KHK 54
LG G F KV A + ++++V V K++K + E+ +M + H+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAV---KMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGEL-----------------FNKIAKGRLREDVARV 97
+IV L IY + G+L + + ED+ +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 98 YFQQLISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH 145
F+ L+ F + + HRDL N+L+ +K+ DFGL+ S+
Sbjct: 170 TFEDLLC---FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 146 L---KQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
+ + L P V APE + + Y K+D+WS G++L+
Sbjct: 227 NYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 2 LGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV-K 52
LG G F +V +A + A+ V V K++K E+ E+ +MKM+ K
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAV---KMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQL 102
HK+I+ L +Y ++ G L + + R ++ F+ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 103 IS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH---LKQDG 150
+S + S+ HRDL N+L+ E+ +K+ DFGL+ + +G
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 151 LLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
L P V APE + + Y ++D+WS GV+++
Sbjct: 220 RL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 52/219 (23%), Positives = 81/219 (36%), Gaps = 45/219 (20%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV-KHK 54
LG G F +V A + V V K++K G E+ ++ + H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAV---KMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 55 HIVELHEV-MASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQLI 103
++V L + ++ K G L F + + LI
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 104 S-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH---LKQDGL 151
+ F SR HRDL N+LL E +K+ DFGL+ + + K D
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 152 LHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
L P + APE I + Y ++D+WS GV+L+
Sbjct: 212 L------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 47/216 (21%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
LG G+F VY +V + K + + + E SVMK H
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAI---KTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE---------DVARVYFQQLIS-A 105
+V L V++ M+L+ G+L K LR +A ++I A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 106 VD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH---LKQDGLLHT 154
+ + ++ HRDL N ++ ED +K+ DFG++ + GLL
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-- 202
Query: 155 TCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
P V +PE + + +D+WS GV+L+
Sbjct: 203 ----P--VRWMSPESLKDGVFT-TYSDVWSFGVVLW 231
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 2 LGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV-K 52
LG G F +V +A + A+ V V K++K E+ E+ +MKM+ K
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAV---KMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 53 HKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQL 102
HK+I+ L +Y ++ G L + + R ++ F+ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 103 IS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSE---HLKQDG 150
+S + S+ HRDL N+L+ E+ +K+ DFGL+ + +G
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 151 LLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
L P V APE + + Y ++D+WS GV+++
Sbjct: 266 RL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 50/209 (23%), Positives = 80/209 (38%), Gaps = 33/209 (15%)
Query: 2 LGHGTFAKVY--LARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHK 54
LGHG F +VY + S ++V V K + EQ + E ++ H+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPS-PLQVAV---KTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 55 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV-YFQQLIS-AVDFCH-- 110
+IV V + M+L+ GG+L + + + R R L+ A D
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 111 ----SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV- 162
HRD+ N LL G K+ DFG++ + + G A +
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS---YYRKGGCAMLP 208
Query: 163 ----APEVISKKGYDGAKADIWSCGVILY 187
PE + + +K D WS GV+L+
Sbjct: 209 VKWMPPEAFMEGIFT-SKTDTWSFGVLLW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVKHKHI 56
LG G F KV+LA + + M V V K +K + RE ++ M++H+HI
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAV---KALKEASESARQDFQREAELLTMLQHQHI 105
Query: 57 VELHEVMASKSKIYFAMDLVKGGEL---------FNKIAKGRLREDVARVYFQQLIS-AV 106
V V + + ++ G+L K+ G + QL++ A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 107 DFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160
HRDL N L+ + +K+ DFG+S D + G
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TD---YYRVGGRT 220
Query: 161 YV-----APEVISKKGYDGAKADIWSCGVILY 187
+ PE I + + ++D+WS GV+L+
Sbjct: 221 MLPIRWMPPESILYRKFT-TESDVWSFGVVLW 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 2e-12
Identities = 27/184 (14%), Positives = 56/184 (30%), Gaps = 47/184 (25%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-----IKREISVMKMV----- 51
+G G F +V+ +A+K++ + V Q I EI + K +
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 52 ----KHKHIVELHEV------------------------------MASKSKIYFAMDLVK 77
+ + + L+ V +++ ++
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTD 136
GG ++ A+ QL +++ + HRDL N+LL + K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205
Query: 137 FGLS 140
Sbjct: 206 TLNG 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 42/229 (18%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F +YLA + A VV K + + G + E+ + V K ++
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSELKFYQRVAKKDCIKKWI 100
Query: 62 VMASKSK------IYFAMDLVKGGE---------------LFNKIAKGRL-REDVARVYF 99
+ KG + + G + V ++
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFKKSTVLQL-G 157
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT--DFGLSAF------SEHLKQD-G 150
+++ +++ H H D+K NLLL +V D+GLS + +++
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 151 LLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQD 198
H GT + + + + KG ++D+ G + L G LP++
Sbjct: 218 KGHN--GTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 48/208 (23%), Positives = 81/208 (38%), Gaps = 31/208 (14%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
LGHG F +VY + + ++V V K + EQ + E ++ H++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAV---KTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY-FQQLIS-AVDFCH--- 110
IV V + ++L+ GG+L + + + R R L+ A D
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 111 ---SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV-- 162
HRD+ N LL G K+ DFG++ + + + G A +
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--RDIYRAG---YYRKGGCAMLPV 250
Query: 163 ---APEVISKKGYDGAKADIWSCGVILY 187
PE + + +K D WS GV+L+
Sbjct: 251 KWMPPEAFMEGIFT-SKTDTWSFGVLLW 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 45/225 (20%), Positives = 77/225 (34%), Gaps = 51/225 (22%)
Query: 2 LGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVKHKH 55
+G G F +V+ AR V V K++K ++ RE ++M + +
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 56 IVELHEVMASKSKIYFAMDLVKGGEL------------FNKIAKGRLREDVARVYFQQLI 103
IV+L V A + + + G+L + +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 104 SAVDFCH-------------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH----- 145
S + R HRDL N L+ E+ +K+ DFGLS
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 146 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 187
+ + P + PE I Y ++D+W+ GV+L+
Sbjct: 232 ADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 69/265 (26%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++GHG F KVY L+ G +A+K + G+ E + EI + +H H+V L
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKRRTPES--SQGIEE-FETEIETLSFCRHPHLVSLI 101
Query: 61 -------------EVMAS---KSKIYFAMDLVKGGELFNKIA---KGRLR--EDVARVYF 99
+ M + K +Y G ++ + RL AR
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLY--------GSDLPTMSMSWEQRLEICIGAAR--- 150
Query: 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTT--- 155
+ + H+R + HRD+K N+LLDE+ K+TDFG+S +E H +
Sbjct: 151 -----GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE----LDQTHLSTVV 201
Query: 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG------FLPFQDDNIVSMYRKIY 209
GT Y+ PE KG K+D++S GV+L+ +L LP + N+ + +
Sbjct: 202 KGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 210 RGDFKCPPWFSSEARRLITKLLDPN 234
+ +++DPN
Sbjct: 261 N-------------NGQLEQIVDPN 272
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 38/244 (15%), Positives = 85/244 (34%), Gaps = 47/244 (19%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-QIKREISV-MKMVKHKHIVEL 59
+Y A T + + +K+ + ++ E + + K + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDS-GPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 60 HEVMASKS----KIYF-----------AMDLVKG---GELFNKIAKGRL-REDVARVYFQ 100
++ ++ + + G + K L V +V
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV-AC 166
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT--DFGLS----------AFSEHLKQ 148
+L+ A++F H H ++ EN+ +D + +VT +G + A+ E +
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 149 DGLLHTTCGTPAYVAPEVISKKGYDGA-KADIWSCGVILYVLLAGFLPFQD---DNIVSM 204
H G +++ + KG + ++D+ S G + L GFLP+ + + M
Sbjct: 227 P---HE--GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279
Query: 205 YRKI 208
+K
Sbjct: 280 KQKQ 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 43/242 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKHKHIVEL 59
+G G F +YLA + +S+ V+KV + + E+ + ++
Sbjct: 43 IGQGGFGCIYLADM-NSSESVGSDA---PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 60 HEVMASKS-----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ-------------- 100
K + + K G+ + + R D+ ++Y
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158
Query: 101 -QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT--DFGLSAF------SEHLKQD-G 150
+++ +++ H H D+K NLLL+ +V D+GL+ + D
Sbjct: 159 LRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 151 LLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYR 206
H GT + + + + G + D+ G + L G LP++D D
Sbjct: 219 RCHD--GTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274
Query: 207 KI 208
KI
Sbjct: 275 KI 276
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 101 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160
Q+ ++F SR HRDL N+LL E +K+ DFGL+ + +D
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKDPDYVRKGDARL 257
Query: 161 YV---APEVISKKGYDGAKADIWSCGVILY 187
+ APE I + Y ++D+WS GV+L+
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 25/164 (15%), Positives = 51/164 (31%), Gaps = 10/164 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMV-KHKHI 56
LG G F +V A K+ + V K++K G + E+ ++ + H ++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 57 VELHEVM-ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
V L + ++ K G L + R + + Y + G
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159
DLK + + + F ++++
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 416 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.72 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.24 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.04 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 97.85 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.27 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.16 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.15 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.75 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.53 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-68 Score=511.41 Aligned_cols=254 Identities=33% Similarity=0.617 Sum_probs=236.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+++|+.|+|||||++++++.+++.+|+|||||+||+
T Consensus 39 ~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~ 118 (311)
T 4aw0_A 39 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118 (311)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 48999999999999999999999999988766555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|++++.+ +.++|..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+............+.||||
T Consensus 119 L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp 198 (311)
T 4aw0_A 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198 (311)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCG
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCc
Confidence 9999976 889999999999999999999999999999999999999999999999999998765544455567889999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+...++.+|.++.+.+|+.+|+++++||.+||+.||.+||
T Consensus 199 ~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~ 277 (311)
T 4aw0_A 199 QYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRL 277 (311)
T ss_dssp GGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGST
T ss_pred ccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCc
Confidence 9999999998887 599999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHH------HhcCccccccCc
Q 014911 240 AISK------IMESSWFKKSAP 255 (416)
Q Consensus 240 s~~e------il~hp~f~~~~~ 255 (416)
|++| |++||||+....
T Consensus 278 t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 278 GCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp TSGGGTCHHHHHTSGGGTTCCC
T ss_pred ChHHHcCCHHHHCCCCcCCCCH
Confidence 9987 589999987543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-67 Score=496.95 Aligned_cols=251 Identities=46% Similarity=0.840 Sum_probs=217.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.+....+......+.+|+.+|+.++|||||++++++.+++.+|+||||| +|+
T Consensus 20 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~ 98 (275)
T 3hyh_A 20 TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 98 (275)
T ss_dssp EEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCC
Confidence 3899999999999999999999999998877666566778999999999999999999999999999999999999 679
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....+.+|||
T Consensus 99 L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~~GT~ 175 (275)
T 3hyh_A 99 LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSP 175 (275)
T ss_dssp HHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------C
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CCccCCeeECc
Confidence 9999875 7899999999999999999999999999999999999999999999999999985443 33456789999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.+|++.++||||+||++|+|++|++||.+.+...++..+..+.+++|.++|+++++||.+||++||.+||
T Consensus 176 ~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 255 (275)
T 3hyh_A 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRI 255 (275)
T ss_dssp TTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred ccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCc
Confidence 99999999998888899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCccccccCc
Q 014911 240 AISKIMESSWFKKSAP 255 (416)
Q Consensus 240 s~~eil~hp~f~~~~~ 255 (416)
|++|+++||||+...+
T Consensus 256 s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 256 SIHEIMQDDWFKVDLP 271 (275)
T ss_dssp CHHHHHHCHHHHTTCC
T ss_pred CHHHHHcCcccccCCC
Confidence 9999999999986543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-65 Score=500.58 Aligned_cols=249 Identities=26% Similarity=0.479 Sum_probs=225.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.+++.+|||||||+||+|
T Consensus 82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 89999999999999999999999999765433 235678999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCC
Q 014911 82 FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161 (416)
Q Consensus 82 ~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 161 (416)
.+++.++++++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ......+.||||.|
T Consensus 159 ~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~Y 236 (346)
T 4fih_A 159 TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYW 236 (346)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGG
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcccccccCcCc
Confidence 9999989999999999999999999999999999999999999999999999999999985433 23345678999999
Q ss_pred CchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 162 ~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+|||++.+.+| +.++|||||||++|+|++|.+||.+.+....+..+..... +.+..+|+++++||.+||+.||++|
T Consensus 237 mAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 315 (346)
T 4fih_A 237 MAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 315 (346)
T ss_dssp CCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred CCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHC
Confidence 99999988887 5999999999999999999999999998888888877643 3344689999999999999999999
Q ss_pred CCHHHHhcCccccccCcc
Q 014911 239 IAISKIMESSWFKKSAPK 256 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~~~ 256 (416)
||++|+|+||||++..++
T Consensus 316 ~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 316 ATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp CCHHHHTTCGGGGGCCCG
T ss_pred cCHHHHhcCHhhcCCCCC
Confidence 999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-65 Score=496.24 Aligned_cols=250 Identities=30% Similarity=0.579 Sum_probs=221.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+.+|++|+|||||++++++.+++.+|||||||+||+
T Consensus 31 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~ 109 (350)
T 4b9d_A 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109 (350)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 3899999999999999999999999998776543 456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|++++.. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... .....+.+|
T Consensus 110 L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~G 187 (350)
T 4b9d_A 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIG 187 (350)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHS
T ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCC
Confidence 9999964 35799999999999999999999999999999999999999999999999999865432 123456789
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
|+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+...++.++..+.+ +.+..+|+++++||.+||+.||.
T Consensus 188 T~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 266 (350)
T 4b9d_A 188 TPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266 (350)
T ss_dssp CCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChh
Confidence 9999999999988875 899999999999999999999999999999999988875 46778999999999999999999
Q ss_pred CcCCHHHHhcCccccccC
Q 014911 237 SRIAISKIMESSWFKKSA 254 (416)
Q Consensus 237 ~R~s~~eil~hp~f~~~~ 254 (416)
+|||++|+|+||||+...
T Consensus 267 ~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 267 DRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp GSCCHHHHHTSHHHHTTG
T ss_pred HCcCHHHHhcCHHhhcCC
Confidence 999999999999998644
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-64 Score=500.79 Aligned_cols=249 Identities=26% Similarity=0.487 Sum_probs=226.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.|+|||||++++++.+++.+|||||||+||+|
T Consensus 159 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 89999999999999999999999999765433 235688999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCC
Q 014911 82 FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161 (416)
Q Consensus 82 ~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 161 (416)
.+++..+++++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ......+.|||+.|
T Consensus 236 ~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~Y 313 (423)
T 4fie_A 236 TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYW 313 (423)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBCCCEECTTT
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccccccccCcCc
Confidence 9999989999999999999999999999999999999999999999999999999999985433 22345678999999
Q ss_pred CchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 162 ~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
||||++.+.+| +.++|||||||++|+|++|.+||.+.+....+..+.... +..+..+|+++++||.+||+.||.+|
T Consensus 314 mAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 392 (423)
T 4fie_A 314 MAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 392 (423)
T ss_dssp CCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTS
T ss_pred CCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 99999988887 599999999999999999999999999888888887763 33455789999999999999999999
Q ss_pred CCHHHHhcCccccccCcc
Q 014911 239 IAISKIMESSWFKKSAPK 256 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~~~ 256 (416)
||+.|+|+||||+...++
T Consensus 393 ~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 393 ATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp CCHHHHTTCGGGGGCCCG
T ss_pred cCHHHHhcCHHhcCCCCC
Confidence 999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-65 Score=488.47 Aligned_cols=249 Identities=36% Similarity=0.658 Sum_probs=220.0
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++. .+++.||||++++...... ....+.+|+.+|++++|||||++++++.+++.+|+|||||+
T Consensus 31 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 109 (304)
T 3ubd_A 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR 109 (304)
T ss_dssp EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCT
T ss_pred EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCC
Confidence 4899999999999984 4688999999987654332 23467899999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
||+|++++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ......+.+
T Consensus 110 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~ 187 (304)
T 3ubd_A 110 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFC 187 (304)
T ss_dssp TCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CCccccccc
Confidence 9999999976 7899999999999999999999999999999999999999999999999999975332 233456789
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
|||.|+|||++.+.+|+ .++|||||||++|+|+||.+||.+.+..+++..+.++.+.+|+.+|+++++||++||+.||.
T Consensus 188 GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 266 (304)
T 3ubd_A 188 GTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPA 266 (304)
T ss_dssp CCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHH
Confidence 99999999999988885 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCC-----HHHHhcCcccccc
Q 014911 237 SRIA-----ISKIMESSWFKKS 253 (416)
Q Consensus 237 ~R~s-----~~eil~hp~f~~~ 253 (416)
+||| ++|+++||||+..
T Consensus 267 ~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 267 NRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp GSTTCSTTTHHHHHTSGGGTTC
T ss_pred HCCCCCcCCHHHHHcCccccCC
Confidence 9998 5899999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-63 Score=472.77 Aligned_cols=244 Identities=24% Similarity=0.479 Sum_probs=214.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLVK 77 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~ 77 (416)
||+|+||+||+|.+..+++.||+|++....... ...+.+.+|+.+|++|+|||||++++++.+ +..+|+|||||+
T Consensus 34 iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~ 112 (290)
T 3fpq_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCC
Confidence 899999999999999999999999998765433 446789999999999999999999999865 356899999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEecc-CCCeEEeeccccccccccccCCccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+... .....
T Consensus 113 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~----~~~~~ 188 (290)
T 3fpq_A 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAK 188 (290)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBE
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC----CCccC
Confidence 9999999976 78999999999999999999999999 999999999999984 7999999999997532 34456
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-cHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDF--KCPPWFSSEARRLITKL 230 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 230 (416)
+.+|||.|+|||++.+ +| +.++|||||||++|+|+||.+||.+. +...++..+..+.. ..+..+++++++||.+|
T Consensus 189 ~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 266 (290)
T 3fpq_A 189 AVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266 (290)
T ss_dssp ESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence 7899999999999865 46 59999999999999999999999764 45566666666543 34566899999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccc
Q 014911 231 LDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~ 252 (416)
|+.||++|||++|+|+||||++
T Consensus 267 L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 267 IRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=478.29 Aligned_cols=243 Identities=28% Similarity=0.387 Sum_probs=215.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+|+.||||+++.+... .+|+.+|+.|+|||||++++++.+++.+|||||||+||+|
T Consensus 66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 89999999999999999999999999865432 3799999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCC---cccccc
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDG---LLHTTC 156 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~---~~~~~~ 156 (416)
.+++.+ +++++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+......... ...+.+
T Consensus 138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~ 217 (336)
T 4g3f_A 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217 (336)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccc
Confidence 999976 8899999999999999999999999999999999999999998 59999999998654322111 223468
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~ 233 (416)
|||.|||||++.+.+|+ .++|||||||++|+|++|.+||.+.+...++.++..... ..|+.+|+++.+||.+||+.
T Consensus 218 GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~ 296 (336)
T 4g3f_A 218 GTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296 (336)
T ss_dssp CCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred cCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccC
Confidence 99999999999988875 899999999999999999999998877777778877664 46788999999999999999
Q ss_pred CCCCcCCHHHH-------------hcCcccccc
Q 014911 234 NPNSRIAISKI-------------MESSWFKKS 253 (416)
Q Consensus 234 dP~~R~s~~ei-------------l~hp~f~~~ 253 (416)
||.+|||+.|+ ++|||+...
T Consensus 297 dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 297 EPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999997 579998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=473.95 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=217.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~~~lV~E 74 (416)
.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.|+|||||++++++.. .+.+|+|||
T Consensus 61 ~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 61 TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 489999999999999999999999999765432 3445778899999999999999999999764 367999999
Q ss_pred ccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc--ccCCc
Q 014911 75 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL--KQDGL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~--~~~~~ 151 (416)
||. |+|++++.. +++++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .....
T Consensus 140 ~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~ 218 (398)
T 4b99_A 140 LME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF 218 (398)
T ss_dssp CCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCC
T ss_pred CCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccc
Confidence 996 589999976 78999999999999999999999999999999999999999999999999999754322 22334
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC----------------
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC---------------- 215 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~---------------- 215 (416)
..+.+||++|+|||++.+..+++.++||||+|||+|+|++|.+||.+.+....+..|.......
T Consensus 219 ~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~ 298 (398)
T 4b99_A 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 298 (398)
T ss_dssp CCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHH
T ss_pred cccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhh
Confidence 5678999999999999887777899999999999999999999999998888877775421111
Q ss_pred ---------------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 216 ---------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 216 ---------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus 299 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 299 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 124689999999999999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=478.36 Aligned_cols=378 Identities=34% Similarity=0.632 Sum_probs=298.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.............+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 23 ~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~ 102 (476)
T 2y94_A 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102 (476)
T ss_dssp EEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 48999999999999999999999999987654444456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..... .....+.+||+
T Consensus 103 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~ 179 (476)
T 2y94_A 103 LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSP 179 (476)
T ss_dssp HHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---TCCBCCCCSCS
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---cccccccCCCc
Confidence 9999976 6899999999999999999999999999999999999999999999999999975432 33456779999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.+||++||+.||.+||
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp 259 (476)
T 2y94_A 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRA 259 (476)
T ss_dssp TTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred CeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCc
Confidence 99999999988877789999999999999999999999999889999999998999999999999999999999999999
Q ss_pred CHHHHhcCccccccCcccccchh--------hhh-hh---------hc--------cCCCCc---------------ccc
Q 014911 240 AISKIMESSWFKKSAPKVVITKQ--------EME-FE---------AD--------KSSKQP---------------ETL 278 (416)
Q Consensus 240 s~~eil~hp~f~~~~~~~~~~~~--------~~~-~~---------~~--------~~~~~~---------------~~~ 278 (416)
|+.++++||||+...+....... +.. .. .+ .....+ ...
T Consensus 260 t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~~~~~~~ 339 (476)
T 2y94_A 260 TIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEA 339 (476)
T ss_dssp CHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-------------------------------CCTTCCS
T ss_pred CHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhchhhhhhh
Confidence 99999999999865332111000 000 00 00 000000 000
Q ss_pred chhh---------------------hhccC--CCC----CCCchh-----HHhhHHHhhhhcccccCChhhhHHHHHHHH
Q 014911 279 NAFH---------------------IISLS--EGF----DLSPLF-----EEKKRAEREELRFATTRPASSVISRFEEVA 326 (416)
Q Consensus 279 ~~~~---------------------~~~~~--~~~----~l~~~~-----~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~ 326 (416)
..|. ....+ ... .+.... ....+..+..+++.++.+|.++|..+..++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p~~im~ev~~al 419 (476)
T 2y94_A 340 KDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAI 419 (476)
T ss_dssp SHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSCHHHHHHHHHHHH
T ss_pred hccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccCCCHHHHHHHHHHHH
Confidence 0000 00000 000 000000 000122345667888899999999999999
Q ss_pred hhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEeeCCeEEEEEEecCCChhhH
Q 014911 327 KAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEY 381 (416)
Q Consensus 327 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~le~ 381 (416)
+.+|+.|+..+ +.|++....+.....+.|.+++|++++..+||||++..|+.++|
T Consensus 420 ~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 420 KQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp HTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred HHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 99999999766 66888763333345677999999999999999999999999886
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=488.86 Aligned_cols=250 Identities=31% Similarity=0.499 Sum_probs=221.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHH---HHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR---EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+ ++.+++.++|||||+++++|.+.+.+|+|||||+
T Consensus 196 ~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~ 275 (689)
T 3v5w_A 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 275 (689)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCC
Confidence 4899999999999999999999999998765543333334444 4666777899999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
||+|++++.+ +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|..... ....+.|
T Consensus 276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~----~~~~t~~ 351 (689)
T 3v5w_A 276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 351 (689)
T ss_dssp SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----CCCCSCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC----CCCCCcc
Confidence 9999999976 8899999999999999999999999999999999999999999999999999975432 3456789
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
|||.|+|||++.+...++.++|+|||||++|+|++|.+||.+. +...+...+....+.+|..+|+++++||.+||+.
T Consensus 352 GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~ 431 (689)
T 3v5w_A 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431 (689)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccC
Confidence 9999999999975444469999999999999999999999763 4456777888889999999999999999999999
Q ss_pred CCCCcCC-----HHHHhcCccccccC
Q 014911 234 NPNSRIA-----ISKIMESSWFKKSA 254 (416)
Q Consensus 234 dP~~R~s-----~~eil~hp~f~~~~ 254 (416)
||.+|++ ++||++||||+...
T Consensus 432 dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 432 DVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp CGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred CHhHCCCCCCCCHHHHhcCccccCCC
Confidence 9999998 79999999998753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=446.63 Aligned_cols=245 Identities=29% Similarity=0.456 Sum_probs=195.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------------E
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------------K 68 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------------~ 68 (416)
.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|++|+|||||++++++.+.+ .
T Consensus 12 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 4899999999999999999999999997654 2344578999999999999999999999986544 4
Q ss_pred EEEEEeccCCCchhhHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 69 IYFAMDLVKGGELFNKIAK-GR---LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 69 ~~lV~E~~~gg~L~~~i~~-~~---l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+|+|||||+||+|.+++.. +. .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~ 169 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecC
Confidence 7999999999999999975 32 4567789999999999999999999999999999999999999999999998654
Q ss_pred ccccC----------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCC
Q 014911 145 HLKQD----------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDF 213 (416)
Q Consensus 145 ~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~ 213 (416)
..... ....+.+|||.|||||++.+.+|+ .++|||||||++|+|++ ||..... ......+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~-- 243 (299)
T 4g31_A 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL-- 243 (299)
T ss_dssp ----------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT--
T ss_pred CCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC--
Confidence 33221 123456899999999999988874 99999999999999996 8865432 2333444433
Q ss_pred CCCC---CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 214 KCPP---WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 214 ~~p~---~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..|+ ..++.+.+||.+||++||.+|||+.|+++||||++.
T Consensus 244 ~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3333 356788999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=455.62 Aligned_cols=245 Identities=28% Similarity=0.457 Sum_probs=202.1
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++. .+++.||||.+.... ...++.+|+.+|+.+ +||||+++++++.+.+.+|+|||||
T Consensus 28 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 28 KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 3899999999999875 468899999986542 235688999999998 6999999999999999999999999
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccc--------
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLK-------- 147 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~-------- 147 (416)
+||+|.+++. .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 103 ~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 180 (361)
T 4f9c_A 103 EHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180 (361)
T ss_dssp CCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-
T ss_pred CcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccc
Confidence 9999999984 59999999999999999999999999999999999999877 799999999997433211
Q ss_pred ------------------cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHH
Q 014911 148 ------------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKI 208 (416)
Q Consensus 148 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i 208 (416)
......+.+|||+|+|||++.+.++++.++||||+|||+|+|++|++||.. .+.......|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I 260 (361)
T 4f9c_A 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQI 260 (361)
T ss_dssp -------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 112245668999999999998877667999999999999999999999954 3333333322
Q ss_pred Hh--------------------------------------CC----------------CCCCCCCCHHHHHHHHHccCCC
Q 014911 209 YR--------------------------------------GD----------------FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 209 ~~--------------------------------------~~----------------~~~p~~~s~~~~~li~~~L~~d 234 (416)
.. .. .+..+.+|++++|||++||++|
T Consensus 261 ~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~d 340 (361)
T 4f9c_A 261 MTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLN 340 (361)
T ss_dssp HHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSC
T ss_pred HHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCC
Confidence 11 00 0112347899999999999999
Q ss_pred CCCcCCHHHHhcCccccc
Q 014911 235 PNSRIAISKIMESSWFKK 252 (416)
Q Consensus 235 P~~R~s~~eil~hp~f~~ 252 (416)
|++|||++|+|+||||++
T Consensus 341 P~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 341 PASRITAEEALLHPFFKD 358 (361)
T ss_dssp TTTSCCHHHHHTSGGGTT
T ss_pred hhHCcCHHHHhcCcccCC
Confidence 999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=444.41 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=214.0
Q ss_pred cccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++|+|||||++++++.+++.+|+|||||
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 899999999999875 36889999999654 2345678999999999999999999999999999999999999
Q ss_pred CCCchhhHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 77 KGGELFNKIAK--------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 77 ~gg~L~~~i~~--------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
+||+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~ 177 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCccccee
Confidence 99999999964 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCC
Q 014911 143 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFS 220 (416)
Q Consensus 143 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s 220 (416)
.............+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..++...+..+. .+.|+.+|
T Consensus 178 ~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 256 (299)
T 4asz_A 178 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 256 (299)
T ss_dssp HTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCC
T ss_pred cCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 5443322233445799999999999988875 99999999999999998 999999999888988888875 56788999
Q ss_pred HHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 221 SEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 221 ~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
+++.+|+.+||+.||++|||+.++ |+|++
T Consensus 257 ~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 257 QEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 999999999999999999999999 45664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-58 Score=445.79 Aligned_cols=242 Identities=22% Similarity=0.351 Sum_probs=206.6
Q ss_pred cccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+.+|++|+|||||++++++.+.+.+|||||||
T Consensus 49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 899999999999865 36889999999643 2345678999999999999999999999999999999999999
Q ss_pred CCCchhhHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 77 KGGELFNKIAK----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 77 ~gg~L~~~i~~----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
+||+|.+++.. +++++.++..|+.|++.||.|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla 205 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccc
Confidence 99999999853 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 218 (416)
+..............+||+.|+|||++.+..| +.++|||||||+||||+| |+.||.+.+..+....+..+. .+.|+.
T Consensus 206 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~ 284 (329)
T 4aoj_A 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284 (329)
T ss_dssp --------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTT
T ss_pred eeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 86544333334456789999999999988877 499999999999999999 999999998888888887764 677889
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+++++.+|+.+||+.||++|||+.||+++
T Consensus 285 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 285 CPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=440.19 Aligned_cols=243 Identities=21% Similarity=0.341 Sum_probs=215.3
Q ss_pred cccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
||+|+||+||+|... .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus 34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 899999999999863 467899999996543 2244578999999999999999999999999999999999999
Q ss_pred CCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 77 KGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 77 ~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
++|+|.+++.. +.+++..+..++.|++.||.|||+++|+||||||+||||+.++++||+|||+
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGl 191 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 191 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCC
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCccc
Confidence 99999999953 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCC
Q 014911 140 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPP 217 (416)
Q Consensus 140 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 217 (416)
|+............+.+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+..++...+..+. .+.|+
T Consensus 192 ar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 270 (308)
T 4gt4_A 192 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD 270 (308)
T ss_dssp BCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 986654444445566789999999999998887 499999999999999998 899999999888888888765 56788
Q ss_pred CCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 218 WFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 218 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.+++.+.+|+.+||+.||.+|||+.||+++
T Consensus 271 ~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 271 DCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=438.67 Aligned_cols=241 Identities=22% Similarity=0.384 Sum_probs=197.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|||||||+||+|
T Consensus 44 iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL 118 (307)
T 3omv_A 44 IGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSL 118 (307)
T ss_dssp CCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBH
T ss_pred EeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCH
Confidence 899999999999863 3599999975443 33456789999999999999999999998754 568999999999999
Q ss_pred hhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 82 FNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 82 ~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
.+++.. +++++..+..++.|++.||+|||++||+||||||+||||+.++++||+|||+|+............+.+||+
T Consensus 119 ~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 198 (307)
T 3omv_A 119 YKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198 (307)
T ss_dssp HHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCT
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCC
Confidence 999964 679999999999999999999999999999999999999999999999999998665444444556779999
Q ss_pred CCCchHHhhhcC--CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHH-HHHhCCC-----CCCCCCCHHHHHHHHHcc
Q 014911 160 AYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR-KIYRGDF-----KCPPWFSSEARRLITKLL 231 (416)
Q Consensus 160 ~y~aPE~~~~~~--~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~-~i~~~~~-----~~p~~~s~~~~~li~~~L 231 (416)
.|||||++.... .++.++|||||||+||||+||+.||.+.+...... .+..+.. ..|+.+++++.+||.+||
T Consensus 199 ~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl 278 (307)
T 3omv_A 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCV 278 (307)
T ss_dssp TSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHT
T ss_pred CccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHc
Confidence 999999997432 23589999999999999999999998865544433 3333321 235668999999999999
Q ss_pred CCCCCCcCCHHHHhcC
Q 014911 232 DPNPNSRIAISKIMES 247 (416)
Q Consensus 232 ~~dP~~R~s~~eil~h 247 (416)
+.||.+|||+.+++++
T Consensus 279 ~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 279 KKVKEERPLFPQILSS 294 (307)
T ss_dssp CSSSTTSCCHHHHHHH
T ss_pred CCCHhHCcCHHHHHHH
Confidence 9999999999987643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=473.68 Aligned_cols=248 Identities=32% Similarity=0.576 Sum_probs=225.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.|+|||||++++++.+.+.+|+|||||.||+
T Consensus 164 ~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 38999999999999999999999999976532 345678999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC--CCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED--GNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|++++.. +++++.+++.|+.||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+.... .....+.|
T Consensus 241 L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~~~~~~~~ 317 (573)
T 3uto_A 241 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTT 317 (573)
T ss_dssp HHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---TSEEEEEC
T ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---CCceeeeE
Confidence 9999964 679999999999999999999999999999999999999854 8899999999986542 34566789
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+....+..|....+.++ +.+|+++++||++||+
T Consensus 318 GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~ 396 (573)
T 3uto_A 318 GTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396 (573)
T ss_dssp SSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSC
T ss_pred ECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 9999999999998887 5999999999999999999999999999999999988876654 4689999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccCc
Q 014911 233 PNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
.||.+|||+.|+|+||||+....
T Consensus 397 ~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 397 ADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp SSGGGSCCHHHHHHSTTTSCCCC
T ss_pred CChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=430.10 Aligned_cols=250 Identities=40% Similarity=0.787 Sum_probs=231.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 22 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 22 TIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 489999999999999999999999999876543 3456788899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||++..... .......+||+
T Consensus 101 L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~ 177 (328)
T 3fe3_A 101 VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAP 177 (328)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS---SCGGGTTSSSG
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC---CCccccccCCc
Confidence 9999965 7899999999999999999999999999999999999999999999999999975432 34456789999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+++.++||||+||++|+|++|..||.+.+.......+..+.+..|..+|+++.+||++||+.||.+||
T Consensus 178 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp GGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSC
T ss_pred ceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCc
Confidence 99999999988888889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCccccccC
Q 014911 240 AISKIMESSWFKKSA 254 (416)
Q Consensus 240 s~~eil~hp~f~~~~ 254 (416)
|++|+++||||+...
T Consensus 258 t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 258 TLEQIMKDRWINAGH 272 (328)
T ss_dssp CHHHHTTCTTTTTTC
T ss_pred CHHHHhcCHhhcCCC
Confidence 999999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=429.66 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=208.7
Q ss_pred CcccCCceEEEEEEEcCC-----CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEe-CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMAS-KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~-~~~~~lV~ 73 (416)
.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|++++| ||||++++++.. ++.+|+||
T Consensus 71 ~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 71 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred EEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 389999999999998654 36899999975532 2345779999999999965 999999999865 46799999
Q ss_pred eccCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEee
Q 014911 74 DLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 136 (416)
Q Consensus 74 E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~D 136 (416)
|||+||+|.+++.. ..+++..+..|+.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~D 228 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 228 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECc
Confidence 99999999999963 2388999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcH-HHHHHHHHhC-CC
Q 014911 137 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI-VSMYRKIYRG-DF 213 (416)
Q Consensus 137 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~-~~~~~~i~~~-~~ 213 (416)
||+|+............+.+||+.|||||++.+..| +.++|||||||+||||+| |..||.+.+. ..+...+..+ .+
T Consensus 229 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~ 307 (353)
T 4ase_A 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 307 (353)
T ss_dssp CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred chhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC
Confidence 999986543322223445689999999999998887 499999999999999998 9999988653 4455555555 46
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.|+.+++++.+||.+||+.||.+|||+.+|++|
T Consensus 308 ~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 308 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7788999999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=427.67 Aligned_cols=251 Identities=33% Similarity=0.648 Sum_probs=225.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++||
T Consensus 30 ~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg 109 (353)
T 3txo_A 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG 109 (353)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCC
Confidence 489999999999999999999999999876555555667888999999988 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ......+.+||
T Consensus 110 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt 187 (353)
T 3txo_A 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGT 187 (353)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--CCccccccCCC
Confidence 99999976 7899999999999999999999999999999999999999999999999999874222 22345567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+...++..+..+...+|.++++++.+||++||+.||.+|
T Consensus 188 ~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R 266 (353)
T 3txo_A 188 PDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266 (353)
T ss_dssp GGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHc
Confidence 99999999988877 48999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCH------HHHhcCccccccC
Q 014911 239 IAI------SKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~------~eil~hp~f~~~~ 254 (416)
|++ +++++||||+...
T Consensus 267 ~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 267 LGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp TTSGGGTCTHHHHTSGGGTTCC
T ss_pred cCCcccCCHHHHhhCCcccCCC
Confidence 998 8999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=421.11 Aligned_cols=251 Identities=35% Similarity=0.658 Sum_probs=229.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~ 91 (337)
T 1o6l_A 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCc
Confidence 48999999999999999999999999987654444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......+.+||+
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~ 169 (337)
T 1o6l_A 92 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 169 (337)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECG
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCCcccccccCh
Confidence 9999976 7899999999999999999999999999999999999999999999999999874221 223456779999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||+.||.+||
T Consensus 170 ~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 170 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp GGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred hhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhc
Confidence 9999999988776 589999999999999999999999999999999999999999999999999999999999999999
Q ss_pred -----CHHHHhcCccccccC
Q 014911 240 -----AISKIMESSWFKKSA 254 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~ 254 (416)
+++++++||||+...
T Consensus 249 g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 249 GGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp TCSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 899999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=414.26 Aligned_cols=248 Identities=35% Similarity=0.746 Sum_probs=228.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 13 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~ 92 (318)
T 1fot_A 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 92 (318)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCC
Confidence 48999999999999999999999999987654444556788899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...+.+||+
T Consensus 93 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~ 167 (318)
T 1fot_A 93 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTP 167 (318)
T ss_dssp HHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCT
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----ccccccCCc
Confidence 9999976 7799999999999999999999999999999999999999999999999999975332 335678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+....+..+......+|+.+++++.+||++||+.||.+||
T Consensus 168 ~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 168 DYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp TTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred cccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999988776 489999999999999999999999999999999999999999999999999999999999999999
Q ss_pred -----CHHHHhcCccccccC
Q 014911 240 -----AISKIMESSWFKKSA 254 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~ 254 (416)
+++++++||||+...
T Consensus 247 ~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp TSSTTTTHHHHTSGGGSSCC
T ss_pred CCcCCCHHHHhcCccccCCC
Confidence 999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=420.93 Aligned_cols=251 Identities=32% Similarity=0.612 Sum_probs=228.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++||
T Consensus 24 ~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg 103 (345)
T 1xjd_A 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 103 (345)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCC
Confidence 489999999999999999999999999876544344567788999999876 9999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......+.+||
T Consensus 104 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt 181 (345)
T 1xjd_A 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGT 181 (345)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--CCCcccCCCCC
Confidence 99999986 7899999999999999999999999999999999999999999999999999874321 22335677899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+...++..+......+|.++++++++||.+||+.||.+|
T Consensus 182 ~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 182 PDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp GGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred cccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHc
Confidence 99999999988776 58999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCHH-HHhcCccccccC
Q 014911 239 IAIS-KIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~~-eil~hp~f~~~~ 254 (416)
|++. ++++||||+...
T Consensus 261 ~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 261 LGVRGDIRQHPLFREIN 277 (345)
T ss_dssp BTTBSCGGGSGGGTTCC
T ss_pred CCChHHHHcCccccCCC
Confidence 9998 999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=425.89 Aligned_cols=251 Identities=41% Similarity=0.815 Sum_probs=224.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+ +|+
T Consensus 16 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~ 94 (336)
T 3h4j_B 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGE 94 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCc
Confidence 4899999999999999999999999997654433344567899999999999999999999999999999999999 779
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+
T Consensus 95 l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~~~~~~~~gt~ 171 (336)
T 3h4j_B 95 LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGSP 171 (336)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---SBTTCCCTTST
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---CcccccccCCc
Confidence 9998865 7899999999999999999999999999999999999999999999999999975432 33456678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+..+....|..+|+++.+||++||+.||.+||
T Consensus 172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rp 251 (336)
T 3h4j_B 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRI 251 (336)
T ss_dssp TTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred CcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999888777789999999999999999999999877666666666667788889999999999999999999999
Q ss_pred CHHHHhcCccccccCc
Q 014911 240 AISKIMESSWFKKSAP 255 (416)
Q Consensus 240 s~~eil~hp~f~~~~~ 255 (416)
|++|+++||||+...+
T Consensus 252 t~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 252 TIQEIRRDPWFNVNLP 267 (336)
T ss_dssp CHHHHTTCHHHHTTCC
T ss_pred CHHHHHhChhhccCCc
Confidence 9999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=423.83 Aligned_cols=251 Identities=30% Similarity=0.604 Sum_probs=223.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++.+...........+.+|..+++++ +||||+++++++.+.+.+|+||||++||
T Consensus 59 ~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 138 (396)
T 4dc2_A 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 138 (396)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCC
Confidence 489999999999999999999999999887665555556788999999887 8999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .......+.+||
T Consensus 139 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--~~~~~~~~~~gt 216 (396)
T 4dc2_A 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGT 216 (396)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--CTTCCBCCCCBC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--cCCCccccccCC
Confidence 99999976 789999999999999999999999999999999999999999999999999997422 223345678999
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---------cHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------NIVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
+.|+|||++.+..| +.++|||||||++|+|++|.+||... ....++..+......+|..+|+++++||++
T Consensus 217 ~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 295 (396)
T 4dc2_A 217 PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 295 (396)
T ss_dssp GGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 99999999988877 59999999999999999999999632 344577888888999999999999999999
Q ss_pred ccCCCCCCcCCH------HHHhcCccccccC
Q 014911 230 LLDPNPNSRIAI------SKIMESSWFKKSA 254 (416)
Q Consensus 230 ~L~~dP~~R~s~------~eil~hp~f~~~~ 254 (416)
||+.||.+||++ +++++||||+...
T Consensus 296 lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 296 FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred HhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 999999999985 8999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=416.69 Aligned_cols=248 Identities=36% Similarity=0.698 Sum_probs=229.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 48 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~ 127 (350)
T 1rdq_E 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127 (350)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCc
Confidence 48999999999999999999999999987655444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.+ +++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...+.+||+
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-----~~~~~~gt~ 202 (350)
T 1rdq_E 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTP 202 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECG
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-----CcccccCCc
Confidence 9999976 7899999999999999999999999999999999999999999999999999975432 234678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+....+..+..+...+|..+++++.+||.+||+.||.+||
T Consensus 203 ~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 203 EALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp GGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred cccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhcc
Confidence 9999999988776 489999999999999999999999999999999999999999999999999999999999999999
Q ss_pred C-----HHHHhcCccccccC
Q 014911 240 A-----ISKIMESSWFKKSA 254 (416)
Q Consensus 240 s-----~~eil~hp~f~~~~ 254 (416)
+ ++++++||||+...
T Consensus 282 ~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTCC
T ss_pred CCccCCHHHHHhCcCcCCCC
Confidence 8 99999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=413.60 Aligned_cols=251 Identities=31% Similarity=0.609 Sum_probs=225.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++||
T Consensus 16 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg 95 (345)
T 3a8x_A 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 95 (345)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCC
Confidence 489999999999999999999999999887766666678899999999987 8999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......+.+||
T Consensus 96 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~~~~~~~~~gt 173 (345)
T 3a8x_A 96 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGT 173 (345)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--TTCCBCCCCSC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--CCCcccccCCC
Confidence 99999976 7899999999999999999999999999999999999999999999999999874221 22345667899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---------DNIVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
+.|+|||++.+..| +.++|+|||||++|+|++|..||.. .+...++..+......+|..+++++++||.+
T Consensus 174 ~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 252 (345)
T 3a8x_A 174 PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 252 (345)
T ss_dssp GGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999988777 5899999999999999999999975 3445667788888889999999999999999
Q ss_pred ccCCCCCCcCCH------HHHhcCccccccC
Q 014911 230 LLDPNPNSRIAI------SKIMESSWFKKSA 254 (416)
Q Consensus 230 ~L~~dP~~R~s~------~eil~hp~f~~~~ 254 (416)
||+.||.+||++ +++++||||+...
T Consensus 253 lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 253 FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred HhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 999999999995 8999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=415.43 Aligned_cols=249 Identities=33% Similarity=0.578 Sum_probs=224.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++
T Consensus 19 ~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 98 (361)
T 2yab_A 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98 (361)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCC
Confidence 48999999999999999999999999987654321 135788999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----CeEEeeccccccccccccCCcc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~----~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... ....
T Consensus 99 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~---~~~~ 175 (361)
T 2yab_A 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEF 175 (361)
T ss_dssp SCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT---TCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC---CCcc
Confidence 9999999976 6799999999999999999999999999999999999998877 799999999975433 2334
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLIT 228 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 228 (416)
...+||+.|+|||++.+.++ +.++|||||||++|+|++|.+||.+.+....+..+..+.+.++ +.+|+.+++||.
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 254 (361)
T 2yab_A 176 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254 (361)
T ss_dssp CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHH
Confidence 56789999999999987776 5899999999999999999999999999999999988877665 468999999999
Q ss_pred HccCCCCCCcCCHHHHhcCcccccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+||.+|||+.|+++||||+..
T Consensus 255 ~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 255 KLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHCCCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=417.33 Aligned_cols=251 Identities=33% Similarity=0.599 Sum_probs=228.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 27 ~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg 106 (353)
T 2i0e_A 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 106 (353)
T ss_dssp EEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 489999999999999999999999999876544445567888999999988 8999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......+.+||
T Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt 184 (353)
T 2i0e_A 107 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGT 184 (353)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--CCcccccccCC
Confidence 99999986 7899999999999999999999999999999999999999999999999999874221 22345667899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+.++ +.++|+|||||++|+|++|.+||.+.+...++..+......+|..+|+++.+||.+||+.||.+|
T Consensus 185 ~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 263 (353)
T 2i0e_A 185 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263 (353)
T ss_dssp GGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSC
T ss_pred ccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 99999999988777 58999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-----HHHHhcCccccccC
Q 014911 239 IA-----ISKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s-----~~eil~hp~f~~~~ 254 (416)
|+ ++++++||||+...
T Consensus 264 ~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 264 LGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp TTCSTTHHHHHHTSGGGTTCC
T ss_pred CCCCCCCHHHHhcCccccCCC
Confidence 95 69999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=419.96 Aligned_cols=252 Identities=28% Similarity=0.541 Sum_probs=225.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||+.||+
T Consensus 22 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~ 101 (384)
T 4fr4_A 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGD 101 (384)
T ss_dssp EEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCc
Confidence 48999999999999999999999999987665555566789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ......+.+||+
T Consensus 102 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~---~~~~~~~~~gt~ 178 (384)
T 4fr4_A 102 LRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTK 178 (384)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---TTCCBCCCCSCG
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc---CCCceeccCCCc
Confidence 9999986 679999999999999999999999999999999999999999999999999997543 234456788999
Q ss_pred CCCchHHhhhc--CCCCchhhHHHHHHHHHHHhcCCCCCCC---CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCC
Q 014911 160 AYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 160 ~y~aPE~~~~~--~~~~~~~DvwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 234 (416)
.|+|||++... ..++.++|||||||++|+|++|..||.. .........+.......|..+++.+.+||.+||+.|
T Consensus 179 ~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~d 258 (384)
T 4fr4_A 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPN 258 (384)
T ss_dssp GGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred cccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCC
Confidence 99999999642 2235899999999999999999999974 345567777778888999999999999999999999
Q ss_pred CCCcCC-HHHHhcCccccccCc
Q 014911 235 PNSRIA-ISKIMESSWFKKSAP 255 (416)
Q Consensus 235 P~~R~s-~~eil~hp~f~~~~~ 255 (416)
|.+||+ ++++++||||+....
T Consensus 259 P~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 259 PDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp GGGSCCSHHHHHTSGGGTTCCH
T ss_pred HhHhcccHHHHHcChhhhcCCH
Confidence 999998 899999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=401.34 Aligned_cols=250 Identities=28% Similarity=0.495 Sum_probs=221.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+.+|+||||+.||+
T Consensus 27 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp EEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 389999999999999999999999999765432 34678899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.
T Consensus 104 L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 181 (297)
T 3fxz_A 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181 (297)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCGG
T ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--ccccCCccCCcC
Confidence 999999888999999999999999999999999999999999999999999999999998754332 223455689999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCCCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKLLDPNPNS 237 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~ 237 (416)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+... ....|..+++.+.+||.+||+.||.+
T Consensus 182 y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 260 (297)
T 3fxz_A 182 WMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260 (297)
T ss_dssp GCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTT
T ss_pred ccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhH
Confidence 999999988777 58999999999999999999999988776655555433 34456778999999999999999999
Q ss_pred cCCHHHHhcCccccccCcc
Q 014911 238 RIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 238 R~s~~eil~hp~f~~~~~~ 256 (416)
|||+.++++||||+...+.
T Consensus 261 Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 261 RGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp SCCHHHHTTCGGGGGCCCG
T ss_pred CcCHHHHhhChhhcccCcc
Confidence 9999999999999865443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=422.64 Aligned_cols=254 Identities=33% Similarity=0.535 Sum_probs=223.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 76 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~ 155 (410)
T 3v8s_A 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155 (410)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 48999999999999999999999999976543333334568899999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....+.+||+.
T Consensus 156 L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~ 234 (410)
T 3v8s_A 156 LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPD 234 (410)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGG
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999997543211 112346789999
Q ss_pred CCchHHhhhcCC---CCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHHHHHHHHHccCC
Q 014911 161 YVAPEVISKKGY---DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP--PWFSSEARRLITKLLDP 233 (416)
Q Consensus 161 y~aPE~~~~~~~---~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~ 233 (416)
|+|||++...+. ++.++|||||||++|+|++|.+||.+.+....+.++.... +.+| ..+|+++++||++||+.
T Consensus 235 Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~ 314 (410)
T 3v8s_A 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 314 (410)
T ss_dssp GCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSC
T ss_pred ccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccC
Confidence 999999986552 3589999999999999999999999999988888887642 3444 46999999999999999
Q ss_pred CCCC--cCCHHHHhcCccccccCc
Q 014911 234 NPNS--RIAISKIMESSWFKKSAP 255 (416)
Q Consensus 234 dP~~--R~s~~eil~hp~f~~~~~ 255 (416)
+|.+ |++++||++||||+....
T Consensus 315 ~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 315 REVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp GGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred hhhhCCCCCHHHHhcCccccCCCH
Confidence 9998 999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=414.29 Aligned_cols=251 Identities=36% Similarity=0.614 Sum_probs=218.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.+|+||||+.||
T Consensus 45 ~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg 124 (373)
T 2r5t_A 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124 (373)
T ss_dssp EEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCC
Confidence 48999999999999999999999999988766555555677778877 57789999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......+.+||
T Consensus 125 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt 202 (373)
T 2r5t_A 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNSTTSTFCGT 202 (373)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--CCCCCCSBSCC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--CCCccccccCC
Confidence 99999976 7899999999999999999999999999999999999999999999999999874322 23345677999
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..| +.++|+|||||++|+|++|..||.+.+...++..+......+|+.+++.+++||.+||+.||.+|
T Consensus 203 ~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 203 PEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp CCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGS
T ss_pred ccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhC
Confidence 99999999988777 48999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCH----HHHhcCccccccC
Q 014911 239 IAI----SKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~----~eil~hp~f~~~~ 254 (416)
|++ .++++||||+...
T Consensus 282 ~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 282 LGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp TTTTTTHHHHHTSGGGTTCC
T ss_pred CCCCCCHHHHhCCccccCCC
Confidence 996 6999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=419.71 Aligned_cols=248 Identities=37% Similarity=0.692 Sum_probs=221.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||+.||+
T Consensus 18 ~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 96 (444)
T 3soa_A 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96 (444)
T ss_dssp EEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCB
T ss_pred EeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCC
Confidence 4899999999999999999999999998765432 345678999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec---cCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|++.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ........+
T Consensus 97 L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~--~~~~~~~~~ 174 (444)
T 3soa_A 97 LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFA 174 (444)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT--TCCBCCCSC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC--CCceeeccc
Confidence 9999875 7799999999999999999999999999999999999998 457899999999975443 223345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+....+..+..+....|. .+++++.+||.+||+
T Consensus 175 gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 253 (444)
T 3soa_A 175 GTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLT 253 (444)
T ss_dssp SCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred CCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcC
Confidence 9999999999988776 58999999999999999999999999999999999888766553 579999999999999
Q ss_pred CCCCCcCCHHHHhcCccccc
Q 014911 233 PNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~ 252 (416)
.||.+|||+.|+|+||||+.
T Consensus 254 ~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 254 INPSKRITAAEALKHPWISH 273 (444)
T ss_dssp SSTTTSCCHHHHHHSCTTHH
T ss_pred CChhHCCCHHHHhcCccccC
Confidence 99999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=405.19 Aligned_cols=252 Identities=35% Similarity=0.627 Sum_probs=216.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+
T Consensus 14 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 489999999999999999999999999755432 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............+||+
T Consensus 92 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 171 (323)
T 3tki_A 92 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171 (323)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCG
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCc
Confidence 9999976 579999999999999999999999999999999999999999999999999998655444444556778999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP--PWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~ 236 (416)
.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||.+||+.||.
T Consensus 172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 251 (323)
T 3tki_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 251 (323)
T ss_dssp GGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChh
Confidence 9999999988877678999999999999999999999875543 33334443333333 45899999999999999999
Q ss_pred CcCCHHHHhcCccccccC
Q 014911 237 SRIAISKIMESSWFKKSA 254 (416)
Q Consensus 237 ~R~s~~eil~hp~f~~~~ 254 (416)
+|||+.|+++||||+...
T Consensus 252 ~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 252 ARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp TSCCHHHHTTCTTTTCCC
T ss_pred hCcCHHHHhhChhhcccc
Confidence 999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=408.26 Aligned_cols=247 Identities=36% Similarity=0.691 Sum_probs=221.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+.||+
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~ 114 (362)
T 2bdw_A 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114 (362)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 389999999999999999999999999876543 2445788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .......+
T Consensus 115 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~ 191 (362)
T 2bdw_A 115 LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFA 191 (362)
T ss_dssp HHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---CCSCCCSC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---CcccccCC
Confidence 9999975 6799999999999999999999999999999999999998654 599999999975442 23345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+....+..+..+.+..|. .+++++.+||.+||+
T Consensus 192 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 270 (362)
T 2bdw_A 192 GTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 270 (362)
T ss_dssp SCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSC
T ss_pred CCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcC
Confidence 9999999999988776 48999999999999999999999999988889898888776553 479999999999999
Q ss_pred CCCCCcCCHHHHhcCccccc
Q 014911 233 PNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~ 252 (416)
.||.+|||+.++++||||..
T Consensus 271 ~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 271 VNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SSGGGSCCHHHHTTSHHHHT
T ss_pred CChhhCcCHHHHhcCcccCC
Confidence 99999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=404.60 Aligned_cols=240 Identities=19% Similarity=0.309 Sum_probs=188.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----KIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~ 76 (416)
.||+|+||+||+|++ +|+.||||+++... ........|+..+.+++|||||++++++..++ .+|||||||
T Consensus 10 ~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 10 SIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 389999999999997 68999999996542 11223345666777899999999999987653 689999999
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~--------gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
+||+|.+++...+++++.+.+++.|++.||+|||++ ||+||||||+|||++.++++||+|||+|+.......
T Consensus 84 ~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 163 (303)
T 3hmm_A 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence 999999999988899999999999999999999987 999999999999999999999999999986543221
Q ss_pred --CCcccccccCCCCCchHHhhhcCC-----CCchhhHHHHHHHHHHHhcCCCCCCCC---------------cHHHHHH
Q 014911 149 --DGLLHTTCGTPAYVAPEVISKKGY-----DGAKADIWSCGVILYVLLAGFLPFQDD---------------NIVSMYR 206 (416)
Q Consensus 149 --~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwSlGvil~~lltG~~Pf~~~---------------~~~~~~~ 206 (416)
.....+.+||+.|+|||++.+... ++.++|||||||+||||+||.+||... ....+..
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 243 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHH
Confidence 112345689999999999975421 246899999999999999997766321 2233444
Q ss_pred HHHhCC--CCCCCCC-----CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 207 KIYRGD--FKCPPWF-----SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 207 ~i~~~~--~~~p~~~-----s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+.... ..+|... ++.+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 444332 2333322 246889999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=402.82 Aligned_cols=245 Identities=27% Similarity=0.484 Sum_probs=221.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 12 ~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 3899999999999999999999999986442 334678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc--CCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..... .......+
T Consensus 88 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~ 164 (321)
T 1tki_A 88 IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLF 164 (321)
T ss_dssp HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEE
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---CCcccccc
Confidence 9999976 46999999999999999999999999999999999999987 78999999999975432 23445678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....+ +.+|+++.+||.+||.
T Consensus 165 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T 1tki_A 165 TAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp SCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred CChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcC
Confidence 9999999999987655 5899999999999999999999999998888999988877665 3689999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
.||.+|||+.|+++||||+..
T Consensus 244 ~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 244 KERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SSGGGSCCHHHHHHSHHHHSC
T ss_pred CChhHCcCHHHHhcChhhccC
Confidence 999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=399.59 Aligned_cols=250 Identities=34% Similarity=0.592 Sum_probs=222.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+..+|+.||+|++........ ...+.+.+|+.+|+.++||||+++++++.+.+..|+||||++
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 97 (326)
T 2y0a_A 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97 (326)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCC
Confidence 38999999999999999999999999987654321 135789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----CeEEeeccccccccccccCCcc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~----~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... ....
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~---~~~~ 174 (326)
T 2y0a_A 98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEF 174 (326)
T ss_dssp SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT---TSCC
T ss_pred CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC---CCcc
Confidence 9999999976 6799999999999999999999999999999999999999887 799999999975432 2234
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLIT 228 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 228 (416)
...+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+.......+.......+ +.+++.+.+||.
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (326)
T 2y0a_A 175 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253 (326)
T ss_dssp CCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHH
Confidence 56689999999999987776 5899999999999999999999999888888888877766554 468999999999
Q ss_pred HccCCCCCCcCCHHHHhcCccccccC
Q 014911 229 KLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||+.||.+|||+.++++||||+...
T Consensus 254 ~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 254 RLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHccCChhhCCCHHHHhcCCCccCCc
Confidence 99999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=406.72 Aligned_cols=248 Identities=40% Similarity=0.719 Sum_probs=208.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++....... +.+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+
T Consensus 27 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 102 (361)
T 3uc3_A 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102 (361)
T ss_dssp EESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence 3899999999999999999999999997654332 568899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC--eEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--LKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++..... .......+|
T Consensus 103 L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~g 179 (361)
T 3uc3_A 103 LYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVG 179 (361)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcC
Confidence 9999975 78999999999999999999999999999999999999987776 99999999874222 223355679
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCCCCCCC--CCCHHHHHHHHHcc
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPP--WFSSEARRLITKLL 231 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L 231 (416)
|+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+ .......+.......|. .+++.+.+||.+||
T Consensus 180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 259 (361)
T 3uc3_A 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259 (361)
T ss_dssp -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHS
T ss_pred CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHc
Confidence 9999999999988887666999999999999999999998743 34555666666666655 57999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccCc
Q 014911 232 DPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+.||.+|||+.++++||||....+
T Consensus 260 ~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 260 VADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp CSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred cCChhHCcCHHHHHhCcchhcCCc
Confidence 999999999999999999976543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=397.28 Aligned_cols=249 Identities=38% Similarity=0.690 Sum_probs=214.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-----------------------hhhHHHHHHHHHHHHhCCCCCcc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----------------------VGMMEQIKREISVMKMVKHKHIV 57 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~Ei~il~~l~hpnIv 57 (416)
.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+|+.++||||+
T Consensus 20 ~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 99 (298)
T 2zv2_A 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVV 99 (298)
T ss_dssp EEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 3899999999999999999999999997654321 11235688999999999999999
Q ss_pred eEEEEEEe--CCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 58 ELHEVMAS--KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 58 ~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
++++++.+ ...+|+||||+++++|.+++..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 179 (298)
T 2zv2_A 100 KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179 (298)
T ss_dssp CEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEe
Confidence 99999986 6789999999999999998877889999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCC--CCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~ 213 (416)
|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 180 Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 257 (298)
T 2zv2_A 180 DFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257 (298)
T ss_dssp CCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccC
Confidence 9999975432 1223455689999999999876542 36789999999999999999999999888888778777665
Q ss_pred CCC--CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 214 KCP--PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 214 ~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
..| +.+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 258 EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 554 46899999999999999999999999999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=421.52 Aligned_cols=251 Identities=34% Similarity=0.654 Sum_probs=217.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++...+.+|+||||++||+
T Consensus 155 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~ 234 (446)
T 4ejn_A 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 234 (446)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCB
T ss_pred EEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCc
Confidence 48999999999999999999999999987654444455678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|..... ......+.+||
T Consensus 235 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt 312 (446)
T 4ejn_A 235 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGT 312 (446)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--CCcccccccCC
Confidence 9999976 779999999999999999999998 9999999999999999999999999999874322 22334567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||.+|
T Consensus 313 ~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 313 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp GGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred ccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHh
Confidence 99999999988777 59999999999999999999999999999999999999999999999999999999999999999
Q ss_pred C-----CHHHHhcCccccccC
Q 014911 239 I-----AISKIMESSWFKKSA 254 (416)
Q Consensus 239 ~-----s~~eil~hp~f~~~~ 254 (416)
| |++++++||||+...
T Consensus 392 ~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp TTCSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCCCHHHHHhCccccCCC
Confidence 9 999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=401.07 Aligned_cols=250 Identities=36% Similarity=0.665 Sum_probs=214.7
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccc-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
+||+|+||+||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++...+.+|+||||+
T Consensus 24 ~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3a62_A 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL 103 (327)
T ss_dssp EEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred EEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCC
Confidence 4899999999999985 689999999997654322 233466889999999999999999999999999999999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........
T Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~ 181 (327)
T 3a62_A 104 SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTF 181 (327)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTT
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc--CCcccccc
Confidence 99999999976 7799999999999999999999999999999999999999999999999999874322 12234566
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|+.+++++++||.+||+.||
T Consensus 182 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp 260 (327)
T 3a62_A 182 CGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNA 260 (327)
T ss_dssp SSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCG
T ss_pred CCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCH
Confidence 89999999999987776 58999999999999999999999999988899999999999999999999999999999999
Q ss_pred CCcC-----CHHHHhcCcccccc
Q 014911 236 NSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 236 ~~R~-----s~~eil~hp~f~~~ 253 (416)
.+|| ++.++++||||+..
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGGSSC
T ss_pred hhccCCCCCCHHHHHcCCcccCC
Confidence 9999 88999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=390.86 Aligned_cols=250 Identities=30% Similarity=0.529 Sum_probs=211.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||||+.| +
T Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 38999999999999999999999999986653 334557888999999999999999999999999999999999987 5
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 87 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t 164 (292)
T 3o0g_A 87 LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVT 164 (292)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSCCCSCCSC
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccccccCCccc
Confidence 5555543 7899999999999999999999999999999999999999999999999999975432 22334556789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCC-CCCCcHHHHHHHHHhCC-------------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYRGD------------------------- 212 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~P-f~~~~~~~~~~~i~~~~------------------------- 212 (416)
+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+....
T Consensus 165 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T 3o0g_A 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244 (292)
T ss_dssp GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCT
T ss_pred cCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccC
Confidence 9999999998777567999999999999999987776 56666666655554310
Q ss_pred ----CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 ----FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...++.+++.+++||.+||+.||.+|||++|+++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred CcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 012234789999999999999999999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=390.26 Aligned_cols=249 Identities=34% Similarity=0.664 Sum_probs=223.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+||||+++|+
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (279)
T 3fdn_A 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 95 (279)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCc
Confidence 38999999999999999999999999976654444456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... .......||+
T Consensus 96 l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~ 171 (279)
T 3fdn_A 96 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTL 171 (279)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----ccccccCCCC
Confidence 9999976 7899999999999999999999999999999999999999999999999998864332 2234567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.......|..+++.+.+||.+||+.||.+||
T Consensus 172 ~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 172 DYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp TTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSC
T ss_pred CccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCC
Confidence 9999999987665 589999999999999999999999999988999999888999999999999999999999999999
Q ss_pred CHHHHhcCccccccC
Q 014911 240 AISKIMESSWFKKSA 254 (416)
Q Consensus 240 s~~eil~hp~f~~~~ 254 (416)
|+.++++||||+...
T Consensus 251 s~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 251 MLREVLEHPWITANS 265 (279)
T ss_dssp CHHHHHHCHHHHHHC
T ss_pred CHHHHhhCccccCCc
Confidence 999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=403.52 Aligned_cols=248 Identities=34% Similarity=0.648 Sum_probs=216.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+..+|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++|
T Consensus 31 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 110 (351)
T 3c0i_A 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG 110 (351)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSS
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 4899999999999999999999999997543221 12357889999999999999999999999999999999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeeccccccccccccCC
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~~~~~~~~~ 150 (416)
|+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...... ..
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--~~ 188 (351)
T 3c0i_A 111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GL 188 (351)
T ss_dssp CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT--SC
T ss_pred CCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC--Ce
Confidence 999888753 24899999999999999999999999999999999999987665 999999999754431 22
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHH
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRL 226 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 226 (416)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ...+..+..+....+ +.+++++++|
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 266 (351)
T 3c0i_A 189 VAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDL 266 (351)
T ss_dssp BCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred eecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 2445689999999999988776 589999999999999999999998864 456677777766554 4689999999
Q ss_pred HHHccCCCCCCcCCHHHHhcCccccc
Q 014911 227 ITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 227 i~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
|.+||+.||.+|||+.++++||||+.
T Consensus 267 i~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 267 VRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhcChhhcC
Confidence 99999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=418.71 Aligned_cols=255 Identities=30% Similarity=0.527 Sum_probs=221.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+++.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|+||||++||+
T Consensus 81 ~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~ 160 (437)
T 4aw2_A 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160 (437)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCc
Confidence 48999999999999999999999999976544333334458899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....... .......+||
T Consensus 161 L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT 239 (437)
T 4aw2_A 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 239 (437)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSC
T ss_pred HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCC
Confidence 9999976 689999999999999999999999999999999999999999999999999997543211 1123446899
Q ss_pred CCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCC---CCCHHHHHHHHH
Q 014911 159 PAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPP---WFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~---~~s~~~~~li~~ 229 (416)
+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+.++... .+.+|. .+|+++++||++
T Consensus 240 ~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~ 319 (437)
T 4aw2_A 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR 319 (437)
T ss_dssp GGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHT
T ss_pred cCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHH
Confidence 99999999972 233468999999999999999999999999988888888653 345554 489999999999
Q ss_pred ccCCCCCC--cCCHHHHhcCccccccCcc
Q 014911 230 LLDPNPNS--RIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 230 ~L~~dP~~--R~s~~eil~hp~f~~~~~~ 256 (416)
||..+|++ |++++|+++||||+.....
T Consensus 320 lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 320 LICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp TSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred HhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 99998888 9999999999999875543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=387.33 Aligned_cols=253 Identities=44% Similarity=0.827 Sum_probs=220.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (276)
T 2h6d_A 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97 (276)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCc
Confidence 38999999999999999999999999976544334456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... .......+||+
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~ 174 (276)
T 2h6d_A 98 LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSP 174 (276)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---CcceecccCCc
Confidence 9999975 7899999999999999999999999999999999999999999999999999875432 22334567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....|..++..+.++|.+||+.||.+||
T Consensus 175 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 254 (276)
T 2h6d_A 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRA 254 (276)
T ss_dssp --CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCC
Confidence 99999999887776689999999999999999999999998888888888888888999999999999999999999999
Q ss_pred CHHHHhcCccccccCcc
Q 014911 240 AISKIMESSWFKKSAPK 256 (416)
Q Consensus 240 s~~eil~hp~f~~~~~~ 256 (416)
|+.++++||||+...+.
T Consensus 255 s~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 255 TIKDIREHEWFKQDLPS 271 (276)
T ss_dssp CHHHHHHSHHHHTTCCG
T ss_pred CHHHHHhChhhccCchh
Confidence 99999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=407.53 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=203.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--EEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKS--KIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++...+ .+|+||||+.
T Consensus 16 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp C-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 58999999999999999999999999865432 3345577889999999997 999999999997654 7999999997
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccc-----------
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL----------- 146 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~----------- 146 (416)
++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 -~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 173 (388)
T 3oz6_A 95 -TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173 (388)
T ss_dssp -EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCC
T ss_pred -cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccc
Confidence 58999998888999999999999999999999999999999999999999999999999999754321
Q ss_pred --------ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-C----
Q 014911 147 --------KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-F---- 213 (416)
Q Consensus 147 --------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~---- 213 (416)
.........+||++|+|||++.+...++.++||||+||++|+|++|.+||.+.+....+..+.... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~ 253 (388)
T 3oz6_A 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNE 253 (388)
T ss_dssp C---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 112234556899999999999875555799999999999999999999999988776666654210 0
Q ss_pred ------------------------------------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 214 ------------------------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 214 ------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
..+..+++++.+||.+||+.||.+|||++|+++||||+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 254 DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333 (388)
T ss_dssp HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTT
T ss_pred HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHH
Confidence 01125789999999999999999999999999999997
Q ss_pred cc
Q 014911 252 KS 253 (416)
Q Consensus 252 ~~ 253 (416)
..
T Consensus 334 ~~ 335 (388)
T 3oz6_A 334 IF 335 (388)
T ss_dssp TT
T ss_pred Hh
Confidence 54
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=393.12 Aligned_cols=249 Identities=30% Similarity=0.475 Sum_probs=206.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||||+.| +
T Consensus 28 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 28 KVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 3899999999999984 689999999975543 234457788999999999999999999999999999999999986 7
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 105 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t 182 (311)
T 3niz_A 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVT 182 (311)
T ss_dssp HHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--CCC---CCCCC
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--CcccccCCccc
Confidence 8888765 4599999999999999999999999999999999999999999999999999975432 12234456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CC-----------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF----------------------- 213 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~----------------------- 213 (416)
+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+... ..
T Consensus 183 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (311)
T 3niz_A 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262 (311)
T ss_dssp CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCC
T ss_pred CCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccccccc
Confidence 99999999987555579999999999999999999999876655444444321 00
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...+.+++++.+||.+||++||.+|||++|+++||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 01234688999999999999999999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=433.91 Aligned_cols=251 Identities=33% Similarity=0.601 Sum_probs=230.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 348 ~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg 427 (674)
T 3pfq_A 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427 (674)
T ss_dssp ESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSC
T ss_pred EEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCC
Confidence 489999999999999999999999999876544445567788999999987 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +++++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ......+.+||
T Consensus 428 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~GT 505 (674)
T 3pfq_A 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGT 505 (674)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--TTCCBCCCCSC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--CCcccccccCC
Confidence 99999986 8899999999999999999999999999999999999999999999999999974322 22345677999
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+...++..|......+|..+++++.+||++||+.||.+|
T Consensus 506 ~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 584 (674)
T 3pfq_A 506 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584 (674)
T ss_dssp SSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTC
T ss_pred CcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHC
Confidence 99999999988777 59999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCH-----HHHhcCccccccC
Q 014911 239 IAI-----SKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~-----~eil~hp~f~~~~ 254 (416)
|++ ++|++||||+...
T Consensus 585 ~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 585 LGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp TTCSTTHHHHHHSSGGGSSCC
T ss_pred CCCCCCcHHHHhcCccccCCC
Confidence 998 9999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=387.62 Aligned_cols=249 Identities=37% Similarity=0.693 Sum_probs=226.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+||||+++|+
T Consensus 21 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 100 (284)
T 2vgo_A 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 100 (284)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCc
Confidence 38999999999999999999999999976544443445788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ......+||+
T Consensus 101 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~ 176 (284)
T 2vgo_A 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTL 176 (284)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS----SCBCCCCSCG
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc----cccccccCCC
Confidence 9999976 7899999999999999999999999999999999999999999999999999864332 2234567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|+.+++.+.+||.+||+.||.+||
T Consensus 177 ~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 255 (284)
T 2vgo_A 177 DYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRL 255 (284)
T ss_dssp GGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCC
Confidence 9999999987766 589999999999999999999999988888888888888889999999999999999999999999
Q ss_pred CHHHHhcCccccccC
Q 014911 240 AISKIMESSWFKKSA 254 (416)
Q Consensus 240 s~~eil~hp~f~~~~ 254 (416)
|+.++++||||+...
T Consensus 256 s~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 256 PLKGVMEHPWVKANS 270 (284)
T ss_dssp CHHHHHTCHHHHHHC
T ss_pred CHHHHhhCHHHHhhc
Confidence 999999999998644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=412.46 Aligned_cols=253 Identities=30% Similarity=0.520 Sum_probs=218.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|+||||++||+
T Consensus 68 ~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~ 147 (412)
T 2vd5_A 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147 (412)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCc
Confidence 48999999999999999999999999976544333445568899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++....... .......+||
T Consensus 148 L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt 226 (412)
T 2vd5_A 148 LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGT 226 (412)
T ss_dssp HHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECSSCCSC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-ccccceeccc
Confidence 9999976 479999999999999999999999999999999999999999999999999997543211 1122356899
Q ss_pred CCCCchHHhhh------cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCC---CCCCHHHHHHH
Q 014911 159 PAYVAPEVISK------KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCP---PWFSSEARRLI 227 (416)
Q Consensus 159 ~~y~aPE~~~~------~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p---~~~s~~~~~li 227 (416)
+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+....+.++... ....| ..+|+++++||
T Consensus 227 ~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli 306 (412)
T 2vd5_A 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFI 306 (412)
T ss_dssp GGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHH
T ss_pred cCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHH
Confidence 99999999974 223368999999999999999999999999988888888653 23344 57999999999
Q ss_pred HHccCCCCCCc---CCHHHHhcCccccccCc
Q 014911 228 TKLLDPNPNSR---IAISKIMESSWFKKSAP 255 (416)
Q Consensus 228 ~~~L~~dP~~R---~s~~eil~hp~f~~~~~ 255 (416)
++||. +|.+| ++++++++||||+....
T Consensus 307 ~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 307 QRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp HTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred HHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99999 99998 59999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=391.59 Aligned_cols=247 Identities=26% Similarity=0.493 Sum_probs=219.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 53 lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 8999999999999999999999999975542 3356788999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCC
Q 014911 82 FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161 (416)
Q Consensus 82 ~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 161 (416)
.+++...++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||+.|
T Consensus 130 ~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y 207 (321)
T 2c30_A 130 TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYW 207 (321)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGG
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccccccCCccc
Confidence 99998888999999999999999999999999999999999999999999999999998754332 2223456899999
Q ss_pred CchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 162 ~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... ..+..+++.+.+||.+||+.||.+|
T Consensus 208 ~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 286 (321)
T 2c30_A 208 MAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286 (321)
T ss_dssp CCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred cCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhC
Confidence 99999987766 5899999999999999999999999888777777766543 2334578999999999999999999
Q ss_pred CCHHHHhcCccccccC
Q 014911 239 IAISKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~ 254 (416)
||+.++++||||....
T Consensus 287 ps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 287 ATAQELLDHPFLLQTG 302 (321)
T ss_dssp CCHHHHHTSGGGGGCC
T ss_pred cCHHHHhcChhhccCC
Confidence 9999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=394.47 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=207.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+++.+|+||||+.| +
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 88 (317)
T 2pmi_A 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-D 88 (317)
T ss_dssp -------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-B
T ss_pred EECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-C
Confidence 48999999999999999999999999976542 23346788999999999999999999999999999999999985 9
Q ss_pred hhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 81 LFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 81 L~~~i~~-------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 166 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFS 166 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC--CCCCC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC--cccCC
Confidence 9998864 24899999999999999999999999999999999999999999999999999754321 22344
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CC------------------
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF------------------ 213 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~------------------ 213 (416)
..+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T 2pmi_A 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246 (317)
T ss_dssp CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTC
T ss_pred CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccc
Confidence 5679999999999987555569999999999999999999999998877666665431 00
Q ss_pred --------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 214 --------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 214 --------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
..+..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 012247889999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=395.40 Aligned_cols=245 Identities=37% Similarity=0.698 Sum_probs=197.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|.+..+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||++||
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 489999999999999999999999999643 2356789999999997 999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeeccccccccccccCCccccc
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... ......+.
T Consensus 92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~ 169 (325)
T 3kn6_A 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTP 169 (325)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC--CCCccccc
Confidence 99999976 6799999999999999999999999999999999999998766 799999999975432 22334567
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-------HHHHHHHHHhCCCCCCC----CCCHHHH
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-------IVSMYRKIYRGDFKCPP----WFSSEAR 224 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~----~~s~~~~ 224 (416)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ .......+..+.+..+. .++++++
T Consensus 170 ~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK 248 (325)
T ss_dssp --------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHH
T ss_pred CCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHH
Confidence 89999999999988777 489999999999999999999998643 35677777777766653 5899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+||++||.+|||+.++++||||+...
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=384.06 Aligned_cols=252 Identities=33% Similarity=0.580 Sum_probs=229.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||||+.|++
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 101 (294)
T 2rku_A 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101 (294)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCC
Confidence 48999999999999999999999999987765555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ........||+
T Consensus 102 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~ 179 (294)
T 2rku_A 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTP 179 (294)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--ccccccccCCC
Confidence 9999876 77999999999999999999999999999999999999999999999999998754321 22234567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++||||+|+++|+|++|..||...+....+..+.......|..+++.+.++|.+||+.||.+||
T Consensus 180 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 258 (294)
T 2rku_A 180 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 258 (294)
T ss_dssp SSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCc
Confidence 9999999987666 589999999999999999999999998888888888888889999999999999999999999999
Q ss_pred CHHHHhcCccccccCc
Q 014911 240 AISKIMESSWFKKSAP 255 (416)
Q Consensus 240 s~~eil~hp~f~~~~~ 255 (416)
|+.++++||||.....
T Consensus 259 s~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 259 TINELLNDEFFTSGYI 274 (294)
T ss_dssp CGGGGGGSHHHHTSCC
T ss_pred CHHHHhhChheecCCc
Confidence 9999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=423.03 Aligned_cols=250 Identities=29% Similarity=0.484 Sum_probs=224.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 191 ~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~ 270 (576)
T 2acx_A 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270 (576)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 48999999999999999999999999987655444556778899999999999999999999999999999999999999
Q ss_pred hhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. + .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .......+|
T Consensus 271 L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~---~~~~~~~~G 347 (576)
T 2acx_A 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVG 347 (576)
T ss_dssp HHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT---TCCEECCCS
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc---CccccccCC
Confidence 9999975 2 499999999999999999999999999999999999999999999999999975432 233456789
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
|+.|+|||++.+..| +.++|||||||++|+|++|.+||.+. ....+...+......+|..+|+++++||.+||+.
T Consensus 348 T~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~ 426 (576)
T 2acx_A 348 TVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCK 426 (576)
T ss_dssp CGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccC
Confidence 999999999988776 48999999999999999999999875 3456777777778888999999999999999999
Q ss_pred CCCCcC-----CHHHHhcCccccccC
Q 014911 234 NPNSRI-----AISKIMESSWFKKSA 254 (416)
Q Consensus 234 dP~~R~-----s~~eil~hp~f~~~~ 254 (416)
||.+|| +++|+++||||+...
T Consensus 427 dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 427 DPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp SGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred CHHHcCCCCCCCHHHHHhChhhccCC
Confidence 999999 789999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=419.13 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=224.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 192 ~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~ 271 (543)
T 3c4z_A 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD 271 (543)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCC
Confidence 48999999999999999999999999987655444556788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .....+.
T Consensus 272 L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~~ 349 (543)
T 3c4z_A 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGY 349 (543)
T ss_dssp HHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CCCBCCC
T ss_pred HHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC--Ccccccc
Confidence 9999864 35999999999999999999999999999999999999999999999999999754321 1223456
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 231 (416)
+||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+. +...+...+......+|+.+|+.+.+||.+||
T Consensus 350 ~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 428 (543)
T 3c4z_A 350 AGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428 (543)
T ss_dssp CSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred cCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhc
Confidence 89999999999988777 48999999999999999999999875 45677888888888899999999999999999
Q ss_pred CCCCCCcCC-----HHHHhcCccccccC
Q 014911 232 DPNPNSRIA-----ISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s-----~~eil~hp~f~~~~ 254 (416)
+.||.+||+ ++++++||||+...
T Consensus 429 ~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 429 QKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp CSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred cCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 999999996 58999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=416.85 Aligned_cols=249 Identities=36% Similarity=0.643 Sum_probs=223.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+
T Consensus 33 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 112 (484)
T 3nyv_A 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112 (484)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC
Confidence 48999999999999999999999999987765544567889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 113 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~ 189 (484)
T 3nyv_A 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKI 189 (484)
T ss_dssp HHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC---CCSHHHHT
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc---ccccccCC
Confidence 9999875 789999999999999999999999999999999999999 5678899999999975432 33455678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+..+ ..+|+++++||++||+
T Consensus 190 gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 267 (484)
T 3nyv_A 190 GTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLT 267 (484)
T ss_dssp TGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTC
T ss_pred CCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCC
Confidence 9999999999976 45 5899999999999999999999999999999999988865443 3489999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+|||+.++++||||+...
T Consensus 268 ~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 268 YVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SSGGGSCCHHHHHTSHHHHHHT
T ss_pred CChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=392.01 Aligned_cols=253 Identities=32% Similarity=0.577 Sum_probs=230.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||||+.|++
T Consensus 48 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 127 (335)
T 2owb_A 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127 (335)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCC
Confidence 48999999999999999999999999987765555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||+
T Consensus 128 L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~ 205 (335)
T 2owb_A 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTP 205 (335)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCC
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cccccccCCCc
Confidence 9999876 77999999999999999999999999999999999999999999999999999754322 22334567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|..+++.+.+||.+||+.||.+||
T Consensus 206 ~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 284 (335)
T 2owb_A 206 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 284 (335)
T ss_dssp SSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCc
Confidence 9999999987766 589999999999999999999999998888888888888899999999999999999999999999
Q ss_pred CHHHHhcCccccccCcc
Q 014911 240 AISKIMESSWFKKSAPK 256 (416)
Q Consensus 240 s~~eil~hp~f~~~~~~ 256 (416)
|+.++++||||.....+
T Consensus 285 s~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 285 TINELLNDEFFTSGYIP 301 (335)
T ss_dssp CGGGGGGSHHHHTSCCC
T ss_pred CHHHHhcCccccCCCcc
Confidence 99999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=402.89 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=210.1
Q ss_pred CcccC--CceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+| +||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+|+||||+.|
T Consensus 32 ~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 48999 9999999999999999999999876543 35567889999999999999999999999999999999999999
Q ss_pred CchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc-----cCC
Q 014911 79 GELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK-----QDG 150 (416)
Q Consensus 79 g~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-----~~~ 150 (416)
|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....... ...
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 190 (389)
T 3gni_B 111 GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190 (389)
T ss_dssp CBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCC
T ss_pred CCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccc
Confidence 999999965 569999999999999999999999999999999999999999999999999886432211 112
Q ss_pred cccccccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------
Q 014911 151 LLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------- 212 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------- 212 (416)
.....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+..+.
T Consensus 191 ~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (389)
T 3gni_B 191 FPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269 (389)
T ss_dssp CCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------
T ss_pred ccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccc
Confidence 2334579999999999987 344 589999999999999999999998755433333222111
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 ------------------------------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+.+..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp ------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 123455789999999999999999999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=386.75 Aligned_cols=247 Identities=30% Similarity=0.506 Sum_probs=207.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+||||+.+ +
T Consensus 9 ~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 9 KIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 389999999999998 78999999999765432 23346788999999999999999999999999999999999986 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t 163 (288)
T 1ob3_A 86 LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVT 163 (288)
T ss_dssp HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CC
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cccccccccc
Confidence 9988865 67999999999999999999999999999999999999999999999999998754321 2223456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CC-----------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF----------------------- 213 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~----------------------- 213 (416)
+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+... ..
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T 1ob3_A 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243 (288)
T ss_dssp CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCC
T ss_pred ccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccC
Confidence 99999999977655579999999999999999999999988776665555331 00
Q ss_pred ----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 214 ----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 214 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
..++.+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012347899999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=388.34 Aligned_cols=250 Identities=32% Similarity=0.616 Sum_probs=209.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+++.||||++..... .....+.+|+.+++++ +||||+++++++.+.+.+|+||||++||
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence 48999999999999999999999999976532 3456788999999985 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeecccccccccccc-----CC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQ-----DG 150 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~~~~~~~-----~~ 150 (416)
+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++........ ..
T Consensus 97 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 176 (316)
T 2ac3_A 97 SILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176 (316)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------------
T ss_pred cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccc
Confidence 99999976 77999999999999999999999999999999999999998876 99999999875432211 11
Q ss_pred cccccccCCCCCchHHhhh-----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---------------HHHHHHHHHh
Q 014911 151 LLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDN---------------IVSMYRKIYR 210 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---------------~~~~~~~i~~ 210 (416)
.....+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||.+.+ .......+..
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 255 (316)
T 2ac3_A 177 ELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255 (316)
T ss_dssp -----CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH
T ss_pred ccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc
Confidence 2345579999999999975 334 589999999999999999999997753 2446677777
Q ss_pred CCCCCC----CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 211 GDFKCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 211 ~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+....| ..+++.+++||.+||+.||.+|||+.++++||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 777666 35899999999999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=401.47 Aligned_cols=246 Identities=33% Similarity=0.546 Sum_probs=214.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+
T Consensus 96 ~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp ECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred EEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 38999999999999999999999999976532 345688999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe--ccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~ 249 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNF 249 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT---TCBCCCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC---cccccccc
Confidence 9998864 469999999999999999999999999999999999999 5667899999999985443 23344567
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+.......+.......+ +.+++++++||.+||+
T Consensus 250 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI 328 (373)
T ss_dssp SSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred CCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence 9999999999976655 5899999999999999999999999988888888887766554 4689999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+|||+.++++||||+..
T Consensus 329 ~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 329 KEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SSGGGSCCHHHHHHSHHHHCH
T ss_pred CChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=398.64 Aligned_cols=242 Identities=33% Similarity=0.642 Sum_probs=212.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|.+..+|+.||||++.+... ...+|+.++.++ +||||+++++++.+.+.+|+||||+.||
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 48999999999999999999999999976542 234688888887 7999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-C---CeEEeeccccccccccccCCcccc
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-G---NLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~---~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++..... ......+
T Consensus 102 ~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~ 179 (342)
T 2qr7_A 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMT 179 (342)
T ss_dssp BHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC--TTCCBCC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC--CCCceec
Confidence 99999976 679999999999999999999999999999999999998543 3 499999999975433 2234567
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC---CcHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDFKCP----PWFSSEARRLI 227 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 227 (416)
.+||+.|+|||++.+.+|. .++|||||||++|+|++|..||.+ .+...+...+..+.+..+ +.+|+++++||
T Consensus 180 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 258 (342)
T 2qr7_A 180 PCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLV 258 (342)
T ss_dssp SSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHH
T ss_pred cCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHH
Confidence 7899999999999877664 899999999999999999999985 456678888888877654 46899999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccccc
Q 014911 228 TKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
++||+.||.+|||+.++++||||..
T Consensus 259 ~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 259 SKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHCCCChhHCcCHHHHhcCCeecC
Confidence 9999999999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=379.89 Aligned_cols=249 Identities=36% Similarity=0.685 Sum_probs=222.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||||+.|++
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 91 (284)
T 3kk8_A 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91 (284)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred hhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence 389999999999999999999999999766543 3445788899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++..... ........
T Consensus 92 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~ 168 (284)
T 3kk8_A 92 LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFA 168 (284)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS---SCBCCCSC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc---CccccCCC
Confidence 9988875 77999999999999999999999999999999999999987765 99999999975432 23334567
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+....| ..+++++.+||.+||+
T Consensus 169 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (284)
T 3kk8_A 169 GTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 247 (284)
T ss_dssp SCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred CCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcc
Confidence 9999999999988776 5899999999999999999999999998888888888766554 3579999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+|||+.|+++||||+...
T Consensus 248 ~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 248 VNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp SSTTTSCCHHHHTTSHHHHSCC
T ss_pred cChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=379.53 Aligned_cols=245 Identities=38% Similarity=0.653 Sum_probs=221.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 48999999999999999999999999976543 235678999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..... ........
T Consensus 93 L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~ 169 (277)
T 3f3z_A 93 LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKV 169 (277)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT---TSCBCCCC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC---ccchhccC
Confidence 9999875 779999999999999999999999999999999999999 7888999999999875432 33445668
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+. .+.++|||||||++|+|++|..||...+.......+..+....|. .+++.+.+||.+||+
T Consensus 170 ~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (277)
T 3f3z_A 170 GTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT 247 (277)
T ss_dssp SCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred CCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHcc
Confidence 99999999998654 468999999999999999999999999988888888888777765 689999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+|||+.++++||||++.
T Consensus 248 ~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 248 KSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SSTTTSCCHHHHTTSHHHHHH
T ss_pred CChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=399.66 Aligned_cols=247 Identities=28% Similarity=0.554 Sum_probs=219.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+|+||||+.||+
T Consensus 58 ~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 38999999999999999999999999976532 234578899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc--CCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... .......+
T Consensus 135 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~---~~~~~~~~ 211 (387)
T 1kob_A 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTT 211 (387)
T ss_dssp HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TSCEEEEC
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC---Ccceeeec
Confidence 9999975 46999999999999999999999999999999999999974 46799999999975432 23345668
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+++++.+||.+||+
T Consensus 212 gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 290 (387)
T 1kob_A 212 ATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 290 (387)
T ss_dssp SSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred cCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcC
Confidence 9999999999987766 5899999999999999999999999988888888877765443 4579999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.||.+|||+.++++||||+...
T Consensus 291 ~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 291 KEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SSGGGSCCHHHHHTSTTTSSCC
T ss_pred CChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=412.46 Aligned_cols=250 Identities=36% Similarity=0.651 Sum_probs=219.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch----------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----------GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 70 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 70 (416)
.||+|+||+||+|++..+++.||||++.+...... ...+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 43 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 122 (504)
T 3q5i_A 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122 (504)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 48999999999999999999999999976553321 34578899999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeecccccccccc
Q 014911 71 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHL 146 (416)
Q Consensus 71 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~~~ 146 (416)
+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 201 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK- 201 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCC-
Confidence 99999999999999875 7899999999999999999999999999999999999999876 699999999986443
Q ss_pred ccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHH
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSE 222 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 222 (416)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+..+ +.+|++
T Consensus 202 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (504)
T 3q5i_A 202 --DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE 277 (504)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred --CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHH
Confidence 234456789999999999864 44 5899999999999999999999999999999999998877665 568999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+++||++||++||.+|||++++++||||+....
T Consensus 278 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 999999999999999999999999999986543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=387.17 Aligned_cols=250 Identities=33% Similarity=0.578 Sum_probs=222.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 19 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (321)
T 2a2a_A 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98 (321)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCC
Confidence 38999999999999999999999999977553321 135789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----CeEEeeccccccccccccCCcc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~----~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..... ....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~ 175 (321)
T 2a2a_A 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEF 175 (321)
T ss_dssp SCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT---TCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc---cccc
Confidence 9999999976 6799999999999999999999999999999999999999888 799999999975432 2234
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLIT 228 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 228 (416)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ +.+++.+.+||.
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 254 (321)
T 2a2a_A 176 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHH
T ss_pred cccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHH
Confidence 55679999999999987766 5899999999999999999999999988888888887766655 468999999999
Q ss_pred HccCCCCCCcCCHHHHhcCccccccC
Q 014911 229 KLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||+.||.+|||+.++++||||+...
T Consensus 255 ~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 255 KLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHcCCChhhCcCHHHHhcCccccCCC
Confidence 99999999999999999999997543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=385.24 Aligned_cols=251 Identities=32% Similarity=0.658 Sum_probs=198.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||||+++++
T Consensus 18 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (278)
T 3cok_A 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGE 97 (278)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCc
Confidence 38999999999999999999999999976554444456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .......+||
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~ 175 (278)
T 3cok_A 98 MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLCGT 175 (278)
T ss_dssp HHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--CCcceeccCC
Confidence 9999976 57999999999999999999999999999999999999999999999999998754322 1223456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+.......|..++.++.+||.+||+.||.+|
T Consensus 176 ~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 254 (278)
T 3cok_A 176 PNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADR 254 (278)
T ss_dssp -----------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhC
Confidence 99999999987665 58999999999999999999999887766666666666677888899999999999999999999
Q ss_pred CCHHHHhcCccccccC
Q 014911 239 IAISKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~ 254 (416)
||+.++++||||....
T Consensus 255 ps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 255 LSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CCHHHHTTSTTTC---
T ss_pred CCHHHHhcCccccCCC
Confidence 9999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=384.84 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=209.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..|+||||+.+++
T Consensus 10 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 38999999999999999999999999866543 23445678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||+
T Consensus 89 l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~ 166 (311)
T 4agu_A 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATR 166 (311)
T ss_dssp HHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------G
T ss_pred HHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccccCCCcCCc
Confidence 9998875 67999999999999999999999999999999999999999999999999999754422 22345568999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---------------------CCCCC--
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---------------------DFKCP-- 216 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------------~~~~p-- 216 (416)
.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+... ..+.+
T Consensus 167 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 4agu_A 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPED 246 (311)
T ss_dssp GGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSS
T ss_pred cccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccc
Confidence 9999999987555579999999999999999999999988766554443221 01111
Q ss_pred --------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 217 --------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 217 --------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.+++.+.+||.+||++||.+|||++|+++||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 247 MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 35788999999999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=411.65 Aligned_cols=247 Identities=36% Similarity=0.644 Sum_probs=214.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..++..||||++.+..... .....+.+|+.+++.++||||+++++++.+...+|+|||||.||+
T Consensus 44 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 122 (494)
T 3lij_A 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122 (494)
T ss_dssp EEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCc
Confidence 3899999999999999999999999998665332 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC---CCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... .......+
T Consensus 123 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~ 199 (494)
T 3lij_A 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERL 199 (494)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT---TBCBCCCC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC---CccccccC
Confidence 9998865 789999999999999999999999999999999999999764 4599999999976543 23345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+....+ +.+|+.+++||++||+
T Consensus 200 gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 277 (494)
T 3lij_A 200 GTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQ 277 (494)
T ss_dssp SCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred CCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCC
Confidence 9999999999864 44 5899999999999999999999999999999999988876554 3489999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+|||+.++++||||+..
T Consensus 278 ~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 278 FDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp SSTTTSCCHHHHHTCHHHHHH
T ss_pred CChhhCccHHHHhcCcccccC
Confidence 999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=377.98 Aligned_cols=252 Identities=35% Similarity=0.621 Sum_probs=218.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++
T Consensus 14 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 489999999999999999999999999765432 345788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...............+||+
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 171 (276)
T 2yex_A 92 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171 (276)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCG
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCcccc
Confidence 9999976 579999999999999999999999999999999999999999999999999997654433333455678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCC--CCCCCHHHHHHHHHccCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKC--PPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~ 236 (416)
.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+..+....... ++.+++.+.+||.+||+.||.
T Consensus 172 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 251 (276)
T 2yex_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 251 (276)
T ss_dssp GGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCch
Confidence 9999999987777668999999999999999999999876542 2333444333322 345899999999999999999
Q ss_pred CcCCHHHHhcCccccccC
Q 014911 237 SRIAISKIMESSWFKKSA 254 (416)
Q Consensus 237 ~R~s~~eil~hp~f~~~~ 254 (416)
+|||+.++++||||+...
T Consensus 252 ~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 252 ARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp TSCCHHHHTTCTTTTCCC
T ss_pred hCCCHHHHhcCccccChh
Confidence 999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=411.53 Aligned_cols=249 Identities=35% Similarity=0.648 Sum_probs=218.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.+|+.++||||+++++++.+.+.+|+||||+.||+
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 107 (486)
T 3mwu_A 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (486)
T ss_dssp EEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCc
Confidence 4899999999999999999999999997654322 335788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec---cCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... .......+
T Consensus 108 L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~ 184 (486)
T 3mwu_A 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRI 184 (486)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC---C----CCT
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC---CCccCCCc
Confidence 9999865 7899999999999999999999999999999999999995 456799999999975433 23345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+..+ ..+|+++++||.+||+
T Consensus 185 gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 262 (486)
T 3mwu_A 185 GTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262 (486)
T ss_dssp TGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTC
T ss_pred CCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcC
Confidence 9999999999875 34 5899999999999999999999999999888888888765443 3479999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccCc
Q 014911 233 PNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+||.+|||+.++++||||+....
T Consensus 263 ~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 263 FHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp SSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=391.43 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=203.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+|+||||+.| +
T Consensus 41 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 118 (329)
T 3gbz_A 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118 (329)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred EEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-C
Confidence 489999999999999999999999999765432 23456778999999999999999999999999999999999985 9
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-----cCCCeEEeeccccccccccccCCcccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-----EDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-----~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ......
T Consensus 119 L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~ 196 (329)
T 3gbz_A 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTH 196 (329)
T ss_dssp HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----------
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCC
Confidence 9999976 6799999999999999999999999999999999999995 4445999999999754322 223455
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CC---------CC-------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FK---------CP------- 216 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~---------~p------- 216 (416)
.+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.... .. .+
T Consensus 197 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
T 3gbz_A 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFP 276 (329)
T ss_dssp ---CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred CcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhh
Confidence 6789999999999876655799999999999999999999999988776666654321 00 00
Q ss_pred ------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 217 ------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 217 ------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 277 KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 11678999999999999999999999999999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=394.14 Aligned_cols=245 Identities=31% Similarity=0.562 Sum_probs=215.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++..+|+.||||++........ .....+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 31 ~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 110 (335)
T 3dls_A 31 PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110 (335)
T ss_dssp ECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 48999999999999999999999999987653321 1334567899999999999999999999999999999999
Q ss_pred cCCC-chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 76 VKGG-ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 76 ~~gg-~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 111 ~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~ 187 (335)
T 3dls_A 111 HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFY 187 (335)
T ss_dssp CTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT---TCCBC
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC---CCcee
Confidence 8766 99999986 5799999999999999999999999999999999999999999999999999975432 33445
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++.+||.+||++
T Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~~li~~~L~~ 261 (335)
T 3dls_A 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKELMSLVSGLLQP 261 (335)
T ss_dssp EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHHHHHHHHTCS
T ss_pred ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHHHHHHHHHccC
Confidence 678999999999999888877899999999999999999999986432 23344566777999999999999999
Q ss_pred CCCCcCCHHHHhcCccccccC
Q 014911 234 NPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 234 dP~~R~s~~eil~hp~f~~~~ 254 (416)
||.+|||+.++++||||+...
T Consensus 262 dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 262 VPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp SGGGSCCHHHHHHCTTTTCCC
T ss_pred ChhhCcCHHHHhcCccccCCc
Confidence 999999999999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=377.45 Aligned_cols=245 Identities=33% Similarity=0.607 Sum_probs=210.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred eeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 389999999999999999999999999766432 345788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccCCcc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..... ....
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~---~~~~ 183 (285)
T 3is5_A 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHS 183 (285)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------
T ss_pred HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC---cccC
Confidence 9998843 569999999999999999999999999999999999999 4567899999999975443 2234
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC---CCCCHHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP---PWFSSEARRLITK 229 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~ 229 (416)
...+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+++.+.+||.+
T Consensus 184 ~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (285)
T 3is5_A 184 TNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261 (285)
T ss_dssp ---CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHH
T ss_pred cCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHH
Confidence 55679999999999864 34 5899999999999999999999999888877777766554433 3378999999999
Q ss_pred ccCCCCCCcCCHHHHhcCccccc
Q 014911 230 LLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
||++||.+|||+.|+++||||+.
T Consensus 262 ~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 262 MLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=382.78 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=207.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc--hhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCC-----EEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVK---HKHIVELHEVMASKS-----KIY 70 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~-----~~~ 70 (416)
.||+|+||+||+|++..+|+.||||++....... ......+.+|+.+++.++ ||||+++++++.... .+|
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~ 95 (308)
T 3g33_A 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95 (308)
T ss_dssp EECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEE
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEE
Confidence 3899999999999999999999999997543211 122346678888877764 999999999998765 689
Q ss_pred EEEeccCCCchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc
Q 014911 71 FAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 71 lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 147 (416)
+||||+.| +|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-- 172 (308)
T 3g33_A 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-- 172 (308)
T ss_dssp EEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT--
T ss_pred EEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC--
Confidence 99999975 999999762 399999999999999999999999999999999999999999999999999975432
Q ss_pred cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CC-----------
Q 014911 148 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FK----------- 214 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~----------- 214 (416)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+.... .+
T Consensus 173 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (308)
T 3g33_A 173 -QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 250 (308)
T ss_dssp -CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSC
T ss_pred -CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 334456789999999999988776 589999999999999999999999988877776664321 00
Q ss_pred --------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 215 --------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 215 --------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..+.+++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1134789999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=392.33 Aligned_cols=245 Identities=38% Similarity=0.673 Sum_probs=199.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 60 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 3899999999999999999999999997543 23567899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..... .......+
T Consensus 135 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~ 211 (349)
T 2w4o_A 135 LFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVC 211 (349)
T ss_dssp HHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc---cccccccc
Confidence 9999976 67999999999999999999999999999999999999975 88999999999875432 23345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCC----CCCCHHHHHHHHHcc
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP----PWFSSEARRLITKLL 231 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~~li~~~L 231 (416)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+.......+ +.++.++.+||.+||
T Consensus 212 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (349)
T 2w4o_A 212 GTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLI 290 (349)
T ss_dssp -CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTS
T ss_pred CCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHc
Confidence 9999999999987766 58999999999999999999999775543 46667766654433 457999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccC
Q 014911 232 DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.||.+|||+.++++||||....
T Consensus 291 ~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 291 VLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp CSSGGGSCCHHHHHHSTTTTSTT
T ss_pred cCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=391.80 Aligned_cols=254 Identities=32% Similarity=0.540 Sum_probs=214.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||++|
T Consensus 33 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g 112 (345)
T 3hko_A 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112 (345)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCC
Confidence 489999999999999999999999999765432 234567899999999999999999999999999999999999999
Q ss_pred CchhhHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceec
Q 014911 79 GELFNKIAK-----------------------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHR 117 (416)
Q Consensus 79 g~L~~~i~~-----------------------------------------~~l~e~~~~~~~~qll~aL~ylH~~gi~Hr 117 (416)
|+|.+++.. ..+++..++.++.|++.||.|||++||+||
T Consensus 113 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~ 192 (345)
T 3hko_A 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192 (345)
T ss_dssp CBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred CcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999851 124678899999999999999999999999
Q ss_pred cCCCCcEEeccCC--CeEEeeccccccccccccCC--cccccccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcC
Q 014911 118 DLKPENLLLDEDG--NLKVTDFGLSAFSEHLKQDG--LLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAG 192 (416)
Q Consensus 118 Dlkp~NIll~~~~--~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG 192 (416)
||||+||+++.++ .+||+|||++.......... ......||+.|+|||++... ...+.++|||||||++|+|++|
T Consensus 193 Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 272 (345)
T 3hko_A 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272 (345)
T ss_dssp CCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999998777 89999999998654322221 23566799999999999752 3346899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 193 FLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 193 ~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..||.+.+.......+.......+. .+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 273 AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred CCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999998888888888776654432 3799999999999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=390.23 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=212.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--------CCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--------KSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------~~~~~lV 72 (416)
.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp ECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 3899999999999999999999999997654332 334567899999999999999999999977 4579999
Q ss_pred EeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc--c
Q 014911 73 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK--Q 148 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~ 148 (416)
|||+.| +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 103 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 181 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181 (351)
T ss_dssp EECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSS
T ss_pred EeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccc
Confidence 999986 77777765 679999999999999999999999999999999999999999999999999997654222 1
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC----------
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---------- 218 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---------- 218 (416)
.......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.......++.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 261 (351)
T 3mi9_A 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 261 (351)
T ss_dssp CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGG
T ss_pred ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchh
Confidence 2234556789999999999876555799999999999999999999999988777666665422211111
Q ss_pred ----------------------CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 219 ----------------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 219 ----------------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
.++.+.+||.+||+.||.+|||++|+++||||+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 262 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp GTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 2677999999999999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=402.20 Aligned_cols=242 Identities=34% Similarity=0.612 Sum_probs=201.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEe----CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMAS----KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 75 (416)
+||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++.. ...+|+||||
T Consensus 69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 389999999999999999999999998632 3567888887 45689999999999876 6679999999
Q ss_pred cCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CCCeEEeeccccccccccccC
Q 014911 76 VKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 76 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 149 (416)
+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~---~ 217 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---H 217 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC---C
Confidence 999999999975 25999999999999999999999999999999999999998 78899999999975432 2
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH----HHHHHHHhCCCCCC----CCCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCP----PWFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~----~~~~~i~~~~~~~p----~~~s~ 221 (416)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.. .....+..+.+..| ..+++
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp ---------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence 33467789999999999987776 48999999999999999999999775432 24455666665554 35899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
++.+||++||+.||.+|||+.++++||||....
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=405.96 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=192.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-----KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~lV~E~ 75 (416)
+||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...+|+||||
T Consensus 60 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 138 (458)
T 3rp9_A 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138 (458)
T ss_dssp C-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred EeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence 5899999999999999999999999996543 233456788999999999999999999999843 3579999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-----
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD----- 149 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----- 149 (416)
+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.........
T Consensus 139 ~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 217 (458)
T 3rp9_A 139 A-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217 (458)
T ss_dssp C-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC
T ss_pred c-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccc
Confidence 8 4699999876 67999999999999999999999999999999999999999999999999999865422110
Q ss_pred --------------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-----------CCCCCCC
Q 014911 150 --------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-----------GFLPFQD 198 (416)
Q Consensus 150 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-----------G~~Pf~~ 198 (416)
......+||++|+|||++.....++.++||||||||+|+|++ |.++|.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g 297 (458)
T 3rp9_A 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297 (458)
T ss_dssp ---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-
T ss_pred cCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCC
Confidence 134556899999999988655545699999999999999998 7777866
Q ss_pred CcH--------------------HHHHHHHHh--C--------------------CC---------CCCCCCCHHHHHHH
Q 014911 199 DNI--------------------VSMYRKIYR--G--------------------DF---------KCPPWFSSEARRLI 227 (416)
Q Consensus 199 ~~~--------------------~~~~~~i~~--~--------------------~~---------~~p~~~s~~~~~li 227 (416)
.+. ......+.. + .+ ...+..++++.+||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 377 (458)
T 3rp9_A 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLL 377 (458)
T ss_dssp -------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHH
T ss_pred CccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHH
Confidence 431 111111110 0 00 11234689999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccccccC
Q 014911 228 TKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+||+.||.+|||++|+|+||||+...
T Consensus 378 ~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 378 KRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhccCccccCCHHHHhcCHhhhhcC
Confidence 999999999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=396.53 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=207.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... ..+|+|||
T Consensus 32 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 38999999999999999999999999965432 334567889999999999999999999999765 35699999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 111 ~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~ 184 (367)
T 1cm8_A 111 FM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTG 184 (367)
T ss_dssp CC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCS
T ss_pred cC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCc
Confidence 99 88999999888899999999999999999999999999999999999999999999999999975432 2345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
.+||++|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 185 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 264 (367)
T 1cm8_A 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264 (367)
T ss_dssp SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred CcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh
Confidence 68999999999998744456999999999999999999999999877666655533110
Q ss_pred ----------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 ----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..++..++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12345789999999999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=408.44 Aligned_cols=246 Identities=28% Similarity=0.472 Sum_probs=204.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... ..+|+|||
T Consensus 69 ~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E 147 (464)
T 3ttj_A 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147 (464)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence 38999999999999999999999999976532 334567888999999999999999999999654 57899999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ......
T Consensus 148 ~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~ 222 (464)
T 3ttj_A 148 LMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 222 (464)
T ss_dssp CCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC--
T ss_pred CCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCC
Confidence 9976 56666654 499999999999999999999999999999999999999999999999999975432 334566
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
.+||+.|+|||++.+.+|. .++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 223 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~ 301 (464)
T 3ttj_A 223 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301 (464)
T ss_dssp --CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTS
T ss_pred CcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcc
Confidence 7899999999999988775 899999999999999999999999887776666543110
Q ss_pred ------CCCCCC---------------CHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 214 ------KCPPWF---------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 214 ------~~p~~~---------------s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+|..+ ++++++||.+||++||.+|||++|+|+||||+..
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000001 4679999999999999999999999999999854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=389.36 Aligned_cols=249 Identities=33% Similarity=0.616 Sum_probs=218.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-----chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||.||+|++..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++...+..|+|||
T Consensus 101 ~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 180 (365)
T 2y7j_A 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180 (365)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEEC
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEE
Confidence 389999999999999999999999999765421 112356788999999999 79999999999999999999999
Q ss_pred ccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 75 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 75 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
|+.|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..... .....
T Consensus 181 ~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~---~~~~~ 257 (365)
T 2y7j_A 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLR 257 (365)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT---TCCBC
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC---Ccccc
Confidence 9999999999976 6799999999999999999999999999999999999999999999999999875432 23345
Q ss_pred ccccCCCCCchHHhhhc-----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHH
Q 014911 154 TTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEAR 224 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 224 (416)
..+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+....+ ..+++.+.
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 337 (365)
T 2y7j_A 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337 (365)
T ss_dssp CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHH
T ss_pred cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHH
Confidence 67899999999998643 2235899999999999999999999999888888888877766543 45789999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
+||.+||+.||.+|||+.++++||||+.
T Consensus 338 ~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 338 DLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999973
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=388.38 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=216.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..|+||||+. |+
T Consensus 61 ~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~ 139 (348)
T 1u5q_A 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 139 (348)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred EEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CC
Confidence 38999999999999999999999999987654444556789999999999999999999999999999999999997 57
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....+||
T Consensus 140 l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt 213 (348)
T 1u5q_A 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 213 (348)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSC
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCC
Confidence 8888753 6799999999999999999999999999999999999999999999999999875432 2356799
Q ss_pred CCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCC
Q 014911 159 PAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 159 ~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~d 234 (416)
+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+..+..+ .+..+++.+.+||.+||+.|
T Consensus 214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 293 (348)
T 1u5q_A 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293 (348)
T ss_dssp GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 99999999863 233358999999999999999999999988777666666655432 24568999999999999999
Q ss_pred CCCcCCHHHHhcCccccccCcc
Q 014911 235 PNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 235 P~~R~s~~eil~hp~f~~~~~~ 256 (416)
|.+|||++++++||||....++
T Consensus 294 P~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 294 PQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp GGGSCCHHHHTTCHHHHSCCCT
T ss_pred hhhCcCHHHHhhChhhhccCCc
Confidence 9999999999999999865543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=382.08 Aligned_cols=254 Identities=32% Similarity=0.611 Sum_probs=220.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-hhhHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKHKHIVELHEVMA--SKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++. +....|+||||+.
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (305)
T 2wtk_C 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV 91 (305)
T ss_dssp EEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCS
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhcc
Confidence 4899999999999999999999999997654321 234578999999999999999999999984 4568999999998
Q ss_pred CCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 78 GGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 78 gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
++ |.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..............
T Consensus 92 ~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 170 (305)
T 2wtk_C 92 CG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170 (305)
T ss_dssp EE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECC
T ss_pred CC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccccccccc
Confidence 86 6666653 5799999999999999999999999999999999999999999999999999986544333444456
Q ss_pred cccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 155 TCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
..||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+..+....|..+++.+.+||.+||+.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~ 250 (305)
T 2wtk_C 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEY 250 (305)
T ss_dssp CCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCS
T ss_pred CCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccC
Confidence 67999999999997543 33579999999999999999999999999888889999988899999999999999999999
Q ss_pred CCCCcCCHHHHhcCccccccCc
Q 014911 234 NPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 234 dP~~R~s~~eil~hp~f~~~~~ 255 (416)
||.+|||+.++++||||+...+
T Consensus 251 dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 251 EPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp STTTSCCHHHHHHSHHHHSCCC
T ss_pred ChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999987544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=398.67 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=202.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
+||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... ..+|+||||
T Consensus 33 ~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 111 (432)
T 3n9x_A 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111 (432)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence 4899999999999999999999999997543 2334567889999999999999999999999766 679999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-----
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD----- 149 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----- 149 (416)
+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.........
T Consensus 112 ~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 190 (432)
T 3n9x_A 112 AD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190 (432)
T ss_dssp CS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----------
T ss_pred CC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccc
Confidence 86 599999987 56999999999999999999999999999999999999999999999999999865432211
Q ss_pred ---------------CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC-----------CCCCCCCc---
Q 014911 150 ---------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-----------FLPFQDDN--- 200 (416)
Q Consensus 150 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG-----------~~Pf~~~~--- 200 (416)
......+||++|+|||++.....++.++||||+||++|+|++| .++|.+.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~ 270 (432)
T 3n9x_A 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270 (432)
T ss_dssp --------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC
T ss_pred ccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccc
Confidence 2346778999999999986555557999999999999999984 44454432
Q ss_pred --------------HHHHHHHH------------------------HhCCCCCC-------CCCCHHHHHHHHHccCCCC
Q 014911 201 --------------IVSMYRKI------------------------YRGDFKCP-------PWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 201 --------------~~~~~~~i------------------------~~~~~~~p-------~~~s~~~~~li~~~L~~dP 235 (416)
.......+ .......+ +.+++++.+||.+||+.||
T Consensus 271 ~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 350 (432)
T 3n9x_A 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNP 350 (432)
T ss_dssp ----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSST
T ss_pred cCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCc
Confidence 01111111 11111111 4579999999999999999
Q ss_pred CCcCCHHHHhcCccccccC
Q 014911 236 NSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~~~ 254 (416)
.+|||++|+|+||||+...
T Consensus 351 ~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 351 NKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp TTSCCHHHHHTCGGGTTTC
T ss_pred ccCCCHHHHhcChhhhhcc
Confidence 9999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=388.48 Aligned_cols=249 Identities=27% Similarity=0.470 Sum_probs=204.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+||||+.| +
T Consensus 9 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (324)
T 3mtl_A 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 85 (324)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred EEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-C
Confidence 389999999999999999999999999654321 1112345799999999999999999999999999999999975 8
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ........+||
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t 163 (324)
T 3mtl_A 86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVT 163 (324)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------C
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--CccccccccCc
Confidence 9888875 4599999999999999999999999999999999999999999999999999875432 12234456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--C-----------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--F----------------------- 213 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~----------------------- 213 (416)
+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.... .
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (324)
T 3mtl_A 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYR 243 (324)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCC
T ss_pred ccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccccccc
Confidence 999999999875555799999999999999999999999988777666654311 0
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 244 AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred chhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 01134688999999999999999999999999999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=372.50 Aligned_cols=249 Identities=34% Similarity=0.618 Sum_probs=217.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 91 (283)
T 3bhy_A 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 91 (283)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecC
Confidence 38999999999999999999999999977654321 135789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----CeEEeeccccccccccccCCcc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~----~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..... ....
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~---~~~~ 168 (283)
T 3bhy_A 92 GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEF 168 (283)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC---CCcc
Confidence 9999999975 7799999999999999999999999999999999999999877 799999999875432 2223
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLIT 228 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 228 (416)
....||+.|+|||++....+ +.++||||||+++|+|++|..||.+.+.......+.......+ +.+++.+.+||.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (283)
T 3bhy_A 169 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247 (283)
T ss_dssp ---CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHH
T ss_pred cccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHH
Confidence 45679999999999987766 5899999999999999999999999888888888777665554 568999999999
Q ss_pred HccCCCCCCcCCHHHHhcCcccccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||+.||.+|||+.++++||||+..
T Consensus 248 ~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 248 RLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=379.45 Aligned_cols=246 Identities=40% Similarity=0.751 Sum_probs=217.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+||||++|++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 48999999999999999999999999976532 223568899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.... .......+
T Consensus 93 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~ 168 (304)
T 2jam_A 93 LFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTAC 168 (304)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC----CBTTHHHH
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC----CCcccccc
Confidence 9999875 789999999999999999999999999999999999999 778899999999987432 22345567
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..+....+ +.+++.+.+||.+||+
T Consensus 169 ~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (304)
T 2jam_A 169 GTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLE 247 (304)
T ss_dssp SCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHC
T ss_pred CCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcC
Confidence 9999999999987766 5899999999999999999999999888888888887765443 4689999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.||.+|||+.++++||||+...
T Consensus 248 ~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 248 KDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp SSTTTSCCHHHHHTSHHHHSSC
T ss_pred CChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999997643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=382.34 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=216.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+|+.||+|++....... .....+.+|+.+++.+. ||||+++++++...+..|+||||+.||
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 3899999999999999999999999997654332 34568889999999994 699999999999999999999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CCCeEEeeccccccccccccCCccc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..... .....
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~---~~~~~ 191 (327)
T 3lm5_A 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELR 191 (327)
T ss_dssp EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC---ccccc
Confidence 99999854 67999999999999999999999999999999999999987 78999999999975432 22334
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITK 229 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~ 229 (416)
..+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+....+..+.......+ ..+++.+.+||.+
T Consensus 192 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 270 (327)
T 3lm5_A 192 EIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270 (327)
T ss_dssp --CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred cccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHH
Confidence 5689999999999987776 4899999999999999999999999988888777776654433 4589999999999
Q ss_pred ccCCCCCCcCCHHHHhcCccccccCcc
Q 014911 230 LLDPNPNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f~~~~~~ 256 (416)
||+.||.+|||++++++||||+.....
T Consensus 271 ~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 271 LLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp HSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred HcCCChhhCcCHHHHhCCHhhcccccc
Confidence 999999999999999999999875433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=385.69 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=209.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+..|+||||+.|++
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 48999999999999999999999999976543 23445678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||+
T Consensus 111 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~ 188 (331)
T 4aaa_A 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATR 188 (331)
T ss_dssp HHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCC
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--ccccCCCcCCc
Confidence 9888764 67999999999999999999999999999999999999999999999999999754332 22345567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-------------------CCCC-----
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------DFKC----- 215 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~----- 215 (416)
.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ....
T Consensus 189 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
T 4aaa_A 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKE 268 (331)
T ss_dssp TTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSS
T ss_pred cccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccc
Confidence 9999999987655579999999999999999999999988766554444321 0111
Q ss_pred -------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 216 -------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 216 -------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+.+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 269 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 269 REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 13478999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=388.63 Aligned_cols=240 Identities=25% Similarity=0.440 Sum_probs=207.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----HKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+. ||||+++++++...+..|+||||
T Consensus 42 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 117 (360)
T 3llt_A 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117 (360)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred EEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence 3899999999999999999999999996432 34467788999999996 99999999999999999999999
Q ss_pred cCCCchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc------------------------
Q 014911 76 VKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE------------------------ 128 (416)
Q Consensus 76 ~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~------------------------ 128 (416)
+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 118 ~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (360)
T 3llt_A 118 L-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196 (360)
T ss_dssp C-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEE
T ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccccccc
Confidence 9 88999999763 4999999999999999999999999999999999999975
Q ss_pred -CCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHH
Q 014911 129 -DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK 207 (416)
Q Consensus 129 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~ 207 (416)
++.+||+|||++..... .....+||+.|+|||++.+.++ +.++|||||||++|+|++|..||...+.......
T Consensus 197 ~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 197 KSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp SCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 78899999999975332 2345679999999999988777 4899999999999999999999998877666665
Q ss_pred HHhCCCCCCC----------------------------------------------CCCHHHHHHHHHccCCCCCCcCCH
Q 014911 208 IYRGDFKCPP----------------------------------------------WFSSEARRLITKLLDPNPNSRIAI 241 (416)
Q Consensus 208 i~~~~~~~p~----------------------------------------------~~s~~~~~li~~~L~~dP~~R~s~ 241 (416)
+.....+.|. ..++.+.+||.+||++||.+|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 5443222221 123678899999999999999999
Q ss_pred HHHhcCcccc
Q 014911 242 SKIMESSWFK 251 (416)
Q Consensus 242 ~eil~hp~f~ 251 (416)
.|+|+||||+
T Consensus 351 ~elL~hp~f~ 360 (360)
T 3llt_A 351 AELLKHKFLE 360 (360)
T ss_dssp HHHTTSGGGC
T ss_pred HHHhcCcccC
Confidence 9999999995
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=371.87 Aligned_cols=244 Identities=20% Similarity=0.313 Sum_probs=207.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|.+..+++.||||++....... .....+.+|+.++..+ +||||+++++++.+.+..|+||||++|+
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 96 (289)
T 1x8b_A 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96 (289)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred hhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCC
Confidence 3899999999999999999999999997654333 3456788999999999 9999999999999999999999999999
Q ss_pred chhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-------------------CeEEe
Q 014911 80 ELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-------------------NLKVT 135 (416)
Q Consensus 80 ~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-------------------~~kl~ 135 (416)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+
T Consensus 97 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 176 (289)
T 1x8b_A 97 SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176 (289)
T ss_dssp BHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEEC
T ss_pred cHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEc
Confidence 99999964 5699999999999999999999999999999999999998544 79999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FK 214 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~ 214 (416)
|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+..... ...+..+. ..
T Consensus 177 Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~ 247 (289)
T 1x8b_A 177 DLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPR 247 (289)
T ss_dssp CCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCCCC
T ss_pred ccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCCCC
Confidence 9999875432 22346999999999998765556899999999999999999988766543 33444443 35
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 215 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.|+.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 248 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 248 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 6778999999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=389.53 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=213.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
.||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++... ...|+||||
T Consensus 34 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 34 YIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 4899999999999999999999999996433 234457888999999999999999999999665 479999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCcccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~ 154 (416)
+.| +|.+++..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ......
T Consensus 112 ~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 190 (364)
T 3qyz_A 112 MET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190 (364)
T ss_dssp CSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred cCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccc
Confidence 975 999999888899999999999999999999999999999999999999999999999999986543322 223455
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--C--------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D-------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~-------------------- 212 (416)
.+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+... .
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (364)
T 3qyz_A 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270 (364)
T ss_dssp CCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred cccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh
Confidence 689999999999876665579999999999999999999999887665555444321 0
Q ss_pred C---------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 F---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~---------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
. ..++.+++++.+||.+||++||.+|||+.|+++||||+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred cCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 0 01245789999999999999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=373.29 Aligned_cols=245 Identities=23% Similarity=0.468 Sum_probs=211.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 33 ~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 389999999999999999999999999765543 3456788999999999999999999999865 46799999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEec-cCCCeEEeeccccccccccccCCcc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
+||+|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+||+++ .++.+||+|||++.... ....
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~----~~~~ 187 (290)
T 1t4h_A 112 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFA 187 (290)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC----TTSB
T ss_pred CCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc----cccc
Confidence 99999999987 78999999999999999999999999 99999999999998 78899999999987433 2334
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-cHHHHHHHHHhCCC--CCCCCCCHHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDF--KCPPWFSSEARRLITK 229 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 229 (416)
....||+.|+|||++.+ .+ +.++|||||||++|+|++|..||... +....+..+..+.. ..+...++++.+||.+
T Consensus 188 ~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 265 (290)
T 1t4h_A 188 KAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265 (290)
T ss_dssp EESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred ccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHH
Confidence 55679999999998864 34 58999999999999999999999874 44455555544432 3345678999999999
Q ss_pred ccCCCCCCcCCHHHHhcCccccc
Q 014911 230 LLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
||+.||.+|||+.++++||||++
T Consensus 266 ~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 266 CIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=387.78 Aligned_cols=251 Identities=28% Similarity=0.423 Sum_probs=210.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|++..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+.+..|+||||+.+
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 96 (346)
T 1ua2_A 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96 (346)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC
Confidence 4899999999999999999999999997543221 11234678999999999999999999999999999999999986
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..... ........+
T Consensus 97 -~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~ 173 (346)
T 1ua2_A 97 -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQV 173 (346)
T ss_dssp -EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCCSC
T ss_pred -CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC--CcccCCccc
Confidence 88888875 4699999999999999999999999999999999999999999999999999975432 223345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CC---CC----------------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF---KC---------------- 215 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~---~~---------------- 215 (416)
||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+... .. ..
T Consensus 174 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T 1ua2_A 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253 (346)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred ccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccC
Confidence 9999999999976655568999999999999999999999998877776666542 10 00
Q ss_pred -------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 216 -------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 216 -------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 254 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 134578999999999999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=372.71 Aligned_cols=251 Identities=31% Similarity=0.553 Sum_probs=219.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc------chhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI------KVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++++. ||||+++++++...+..|+||
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 103 (298)
T 1phk_A 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103 (298)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEE
Confidence 389999999999999999999999999765421 1133467889999999995 999999999999999999999
Q ss_pred eccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 74 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 74 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ....
T Consensus 104 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~ 180 (298)
T 1phk_A 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 180 (298)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT---TCCB
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCC---Cccc
Confidence 99999999999976 6899999999999999999999999999999999999999999999999999875432 2334
Q ss_pred cccccCCCCCchHHhhh-----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHH
Q 014911 153 HTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEA 223 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 223 (416)
...+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+..+....+ +.+++.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (298)
T 1phk_A 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260 (298)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHH
Confidence 55679999999999862 22335899999999999999999999999888888888877765543 3478999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+||.+||+.||.+|||+.++++||||++..
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 9999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=383.10 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=205.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+ .+++.||||++...... ....+.+.+|+.+|+.++| |||+++++++.+.+.+|+||| +.+
T Consensus 16 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 16 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 489999999999997 57899999999766432 3456788999999999986 999999999999999999999 557
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++...............+|
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 171 (343)
T 3dbq_A 93 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 171 (343)
T ss_dssp EEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcC
Confidence 899999976 6799999999999999999999999999999999999996 67899999999986554333333456789
Q ss_pred CCCCCchHHhhh----------cCCCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHh--CCCCCCCCCCHHHH
Q 014911 158 TPAYVAPEVISK----------KGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYR--GDFKCPPWFSSEAR 224 (416)
Q Consensus 158 t~~y~aPE~~~~----------~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~ 224 (416)
|+.|+|||++.+ ....+.++|||||||++|+|++|..||.... .......+.. .....|...++++.
T Consensus 172 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (343)
T 3dbq_A 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251 (343)
T ss_dssp CCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 999999999965 1334689999999999999999999998743 2333444433 24566778899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+||+.||.+|||+.++++||||+...
T Consensus 252 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 252 DVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 999999999999999999999999998543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=390.96 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=208.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+|+||| +.+
T Consensus 63 ~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 63 QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 48999999999999854 89999999977654 3345678999999999996 5999999999999999999999 567
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...............+|
T Consensus 140 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 218 (390)
T 2zmd_A 140 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218 (390)
T ss_dssp EEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCc
Confidence 899999976 6799999999999999999999999999999999999995 68999999999986544333333456789
Q ss_pred CCCCCchHHhhhc----------CCCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHhC--CCCCCCCCCHHHH
Q 014911 158 TPAYVAPEVISKK----------GYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEAR 224 (416)
Q Consensus 158 t~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~ 224 (416)
|+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ....|.+.++++.
T Consensus 219 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (390)
T 2zmd_A 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298 (390)
T ss_dssp CGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHH
Confidence 9999999999752 234689999999999999999999998753 33444555443 3466788899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+||+.||.+|||+.++++||||+...
T Consensus 299 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 999999999999999999999999998543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=373.64 Aligned_cols=250 Identities=25% Similarity=0.453 Sum_probs=222.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++......|+||||++|++
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 389999999999999999999999999765432 346789999999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ........||+.
T Consensus 107 L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~ 184 (303)
T 3a7i_A 107 ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPF 184 (303)
T ss_dssp HHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCCBCCCCSCGG
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--ccccCccCCCcC
Confidence 999999889999999999999999999999999999999999999999999999999999754332 122345679999
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.... ...+..++..+.+||.+||+.||.+||
T Consensus 185 y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 185 WMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp GCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSC
T ss_pred ccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCc
Confidence 999999987766 489999999999999999999999888777666665554 345677899999999999999999999
Q ss_pred CHHHHhcCccccccCc
Q 014911 240 AISKIMESSWFKKSAP 255 (416)
Q Consensus 240 s~~eil~hp~f~~~~~ 255 (416)
|+.++++||||.....
T Consensus 264 s~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 264 TAKELLKHKFILRNAK 279 (303)
T ss_dssp CHHHHTTCHHHHHHCC
T ss_pred CHHHHhhChhhhcCCC
Confidence 9999999999976543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=390.54 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=194.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... ..+|+|+|
T Consensus 36 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp ECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 38999999999999999999999999965432 334567888999999999999999999998654 56899999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+ |++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 115 ~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~ 188 (367)
T 2fst_X 115 LM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTG 188 (367)
T ss_dssp CC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------------
T ss_pred cc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCC
Confidence 99 78999999888899999999999999999999999999999999999999999999999999975332 2345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 212 (416)
.+||++|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+....
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 268 (367)
T 2fst_X 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268 (367)
T ss_dssp --CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHT
T ss_pred cCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhc
Confidence 6899999999999875555699999999999999999999999988766665553310
Q ss_pred -CCC--------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 -FKC--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 -~~~--------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
... .+..++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 011 124688999999999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=379.16 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=198.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+|+.||||++.......... ....+|+..+.. .+||||+++++++.+.+.+|+||||+ ++
T Consensus 64 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~ 141 (311)
T 3p1a_A 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141 (311)
T ss_dssp EEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CC
T ss_pred eeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CC
Confidence 3899999999999999999999999986654333233 344455555544 49999999999999999999999999 66
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .......+|
T Consensus 142 ~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~g 218 (311)
T 3p1a_A 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AGAGEVQEG 218 (311)
T ss_dssp BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCC
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CCCCcccCC
Confidence 89888865 5699999999999999999999999999999999999999999999999999875432 233445679
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--KCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP 235 (416)
|+.|+|||++.+ .+ +.++||||+||++|+|++|..|+..... ...+..+.. ..+..+++++.+||.+||++||
T Consensus 219 t~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 293 (311)
T 3p1a_A 219 DPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293 (311)
T ss_dssp CGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred CccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCCh
Confidence 999999999875 44 5899999999999999999766655432 233333322 2345689999999999999999
Q ss_pred CCcCCHHHHhcCccccc
Q 014911 236 NSRIAISKIMESSWFKK 252 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~ 252 (416)
.+|||+.++++||||+.
T Consensus 294 ~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 294 KLRATAEALLALPVLRQ 310 (311)
T ss_dssp TTSCCHHHHHTSGGGSC
T ss_pred hhCcCHHHHHhCccccC
Confidence 99999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=385.23 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=211.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----KIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.... ..|+||||+
T Consensus 19 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~ 98 (311)
T 3ork_A 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98 (311)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecC
Confidence 4899999999999999999999999998766555566678999999999999999999999986543 459999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Ccccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 154 (416)
+|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .....
T Consensus 99 ~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 178 (311)
T 3ork_A 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178 (311)
T ss_dssp CEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccc
Confidence 99999999975 78999999999999999999999999999999999999999999999999999754432211 22334
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC----PPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~~ 230 (416)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....... ++.+++++.+||.+|
T Consensus 179 ~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (311)
T 3ork_A 179 VIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 257 (311)
T ss_dssp ---CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred cCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHH
Confidence 579999999999988766 589999999999999999999999988877766666554433 245899999999999
Q ss_pred cCCCCCCcCCHHHHhcCcccccc
Q 014911 231 LDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
|+.||.+||+..+++.|+|++..
T Consensus 258 l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 258 LAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=381.99 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=202.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-------------
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------------- 67 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------------- 67 (416)
.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 13 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 4899999999999999999999999997654 2345678999999999999999999999985543
Q ss_pred --------------------------------------------EEEEEEeccCCCchhhHHhcC----CCCHHHHHHHH
Q 014911 68 --------------------------------------------KIYFAMDLVKGGELFNKIAKG----RLREDVARVYF 99 (416)
Q Consensus 68 --------------------------------------------~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~ 99 (416)
..|+||||++||+|.+++... ..++..+..++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~ 170 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHH
Confidence 489999999999999999762 35667789999
Q ss_pred HHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC----------CcccccccCCCCCchHHhhh
Q 014911 100 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD----------GLLHTTCGTPAYVAPEVISK 169 (416)
Q Consensus 100 ~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~ 169 (416)
.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ......+||+.|+|||++.+
T Consensus 171 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 250 (332)
T 3qd2_B 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250 (332)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC
T ss_pred HHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC
Confidence 99999999999999999999999999999999999999999865432211 12344579999999999988
Q ss_pred cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCc
Q 014911 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEARRLITKLLDPNPNSRIAISKIMESS 248 (416)
Q Consensus 170 ~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 248 (416)
..+ +.++||||+||++|+|++|..|+... ......+.....+. +...++.+.+||.+||++||.+|||+.++++||
T Consensus 251 ~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 251 NNY-SHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp CCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred CCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 776 58999999999999999998775332 22333333332221 234578899999999999999999999999999
Q ss_pred cccc
Q 014911 249 WFKK 252 (416)
Q Consensus 249 ~f~~ 252 (416)
||++
T Consensus 328 ~f~~ 331 (332)
T 3qd2_B 328 IFEN 331 (332)
T ss_dssp TCCC
T ss_pred hhhc
Confidence 9975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.85 Aligned_cols=242 Identities=27% Similarity=0.427 Sum_probs=204.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe---------------
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--------------- 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------------- 65 (416)
.||+|+||+||+|++..+|+.||||++..+... ..+|+.+|+.++||||+++++++..
T Consensus 14 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 489999999999999999999999998655322 2379999999999999999999844
Q ss_pred -----------------------CCEEEEEEeccCCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceec
Q 014911 66 -----------------------KSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHR 117 (416)
Q Consensus 66 -----------------------~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~Hr 117 (416)
...+|+||||++| +|.+.+.. +.+++..++.++.||+.||.|||++||+||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~ 165 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165 (383)
T ss_dssp -----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence 3458999999985 77666642 679999999999999999999999999999
Q ss_pred cCCCCcEEec-cCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCC
Q 014911 118 DLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF 196 (416)
Q Consensus 118 Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf 196 (416)
||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++|+|++|.+||
T Consensus 166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999998 688999999999975432 233456678999999999987665579999999999999999999999
Q ss_pred CCCcHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 197 QDDNIVSMYRKIYRG-----------------DFK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 197 ~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.+.+..+....+... ... +|..+++++.+||.+||++||.+|||+.|+++|
T Consensus 243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 998777666655431 011 345678999999999999999999999999999
Q ss_pred cccccc
Q 014911 248 SWFKKS 253 (416)
Q Consensus 248 p~f~~~ 253 (416)
|||+..
T Consensus 323 p~f~~~ 328 (383)
T 3eb0_A 323 PFFDHL 328 (383)
T ss_dssp GGGHHH
T ss_pred HHHHHH
Confidence 999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=386.00 Aligned_cols=252 Identities=33% Similarity=0.591 Sum_probs=216.2
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++. .+|+.||||++...... .....+.+.+|+.+|+.+ +||||+++++++...+.+|+||||
T Consensus 61 ~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 140 (355)
T 1vzo_A 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140 (355)
T ss_dssp EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECC
T ss_pred EeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeec
Confidence 3899999999999985 58999999999764432 112335677899999999 699999999999999999999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+.||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 141 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 219 (355)
T 1vzo_A 141 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYD 219 (355)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCG
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccC
Confidence 999999999976 789999999999999999999999999999999999999999999999999997543221 222345
Q ss_pred cccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 155 TCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
.+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+.....+.|+.+++.+.+||.+
T Consensus 220 ~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 299 (355)
T 1vzo_A 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299 (355)
T ss_dssp GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHH
Confidence 6899999999999753 23468999999999999999999999743 345566677777788899999999999999
Q ss_pred ccCCCCCCcC-----CHHHHhcCcccccc
Q 014911 230 LLDPNPNSRI-----AISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~R~-----s~~eil~hp~f~~~ 253 (416)
||+.||.+|| |+.++++||||+..
T Consensus 300 ~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 300 LLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999 99999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=395.15 Aligned_cols=249 Identities=34% Similarity=0.644 Sum_probs=201.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|.+..+++.||||++.+..... ......+.+|+.+|++++||||+++++++. ....|+||||
T Consensus 142 ~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~ 220 (419)
T 3i6u_A 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLEL 220 (419)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEc
Confidence 3899999999999999999999999998754321 112235789999999999999999999975 4568999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeeccccccccccccCCc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHLKQDGL 151 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~ 151 (416)
++||+|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... ...
T Consensus 221 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~ 297 (419)
T 3i6u_A 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSL 297 (419)
T ss_dssp CTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------
T ss_pred CCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC---Ccc
Confidence 999999999875 7799999999999999999999999999999999999997655 499999999986432 334
Q ss_pred ccccccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCCCCC----CCCCHHHH
Q 014911 152 LHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFKCP----PWFSSEAR 224 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~~~s~~~~ 224 (416)
..+.+||+.|+|||++.. ....+.++|||||||++|+|++|.+||..... ......+..+....+ +.+++.+.
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 377 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377 (419)
T ss_dssp -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHH
Confidence 456789999999999853 22335799999999999999999999976533 234455555555443 45899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+||+.||.+|||+.++++||||+..
T Consensus 378 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 378 DLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=372.41 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=211.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+|+||||++|++
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~ 97 (294)
T 4eqm_A 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97 (294)
T ss_dssp EEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCC
Confidence 38999999999999999999999999977665555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .......+||+
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~ 176 (294)
T 4eqm_A 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTV 176 (294)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCc
Confidence 9999976 779999999999999999999999999999999999999999999999999997544321 12234467999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHccCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-----CPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~d 234 (416)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.............+ .++.+++.+.++|.+||+.|
T Consensus 177 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 255 (294)
T 4eqm_A 177 QYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKD 255 (294)
T ss_dssp SSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred cccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCC
Confidence 9999999988776 58999999999999999999999998876665555544332 34668999999999999999
Q ss_pred CCCcCCHHHHhcCcccc
Q 014911 235 PNSRIAISKIMESSWFK 251 (416)
Q Consensus 235 P~~R~s~~eil~hp~f~ 251 (416)
|.+||+..+.+.+.|..
T Consensus 256 p~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 256 KANRYKTIQEMKDDLSS 272 (294)
T ss_dssp GGGSCSSHHHHHHHHHT
T ss_pred HhHccccHHHHHHHHHH
Confidence 99999666666666643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=392.06 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=189.9
Q ss_pred CcccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 76 (416)
+||+|+||+||+|++. .+++.||||++..... ...+.+|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 4899999999999976 5789999999965432 2467899999999999999999999954 77999999999
Q ss_pred CCCchhhHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe----ccCCCeEEeecccccc
Q 014911 77 KGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAF 142 (416)
Q Consensus 77 ~gg~L~~~i~~----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll----~~~~~~kl~DFGla~~ 142 (416)
.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|..
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 75 88887752 149999999999999999999999999999999999999 6778999999999986
Q ss_pred ccccc-cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH---------HHHHHHHh--
Q 014911 143 SEHLK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------SMYRKIYR-- 210 (416)
Q Consensus 143 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~---------~~~~~i~~-- 210 (416)
..... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.. .....+..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~ 261 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence 54321 1123456789999999999987665679999999999999999999999765431 22222221
Q ss_pred CCCCC------------------------------------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 211 GDFKC------------------------------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 211 ~~~~~------------------------------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.... ....++.+.+||.+||++||.+|||++|+|+||||....
T Consensus 262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 11100 011267899999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=384.25 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=211.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 40 ~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 3899999999999999999999999997653 33456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++...... .....+||
T Consensus 118 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt 193 (360)
T 3eqc_A 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGT 193 (360)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCC
Confidence 9999976 7899999999999999999999996 9999999999999999999999999998754321 23456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHH--------------------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR-------------------------------- 206 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~-------------------------------- 206 (416)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+......
T Consensus 194 ~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
T 3eqc_A 194 RSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272 (360)
T ss_dssp CTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------------
T ss_pred CCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCC
Confidence 99999999988766 589999999999999999999998766543322
Q ss_pred ----------HHHhCCC-CCC-CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 207 ----------KIYRGDF-KCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 207 ----------~i~~~~~-~~p-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+..... ..+ ..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 2222221 122 24789999999999999999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=387.22 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=200.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~lV~E 74 (416)
.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+ .+|+|||
T Consensus 32 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e 110 (371)
T 2xrw_A 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110 (371)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred eeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence 38999999999999999999999999976532 3345677889999999999999999999997665 8999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+.| +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 111 ~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~ 185 (371)
T 2xrw_A 111 LMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 185 (371)
T ss_dssp CCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------------
T ss_pred cCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc---ccccCC
Confidence 9975 7888875 4599999999999999999999999999999999999999999999999999975432 223455
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC-------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC------------------- 215 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~------------------- 215 (416)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 186 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (371)
T 2xrw_A 186 YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264 (371)
T ss_dssp ----CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSS
T ss_pred ceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhC
Confidence 689999999999988776 489999999999999999999999988777666665421110
Q ss_pred -----------------CC------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 216 -----------------PP------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 216 -----------------p~------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
|. ..++++++||++||+.||.+|||++|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 265 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00 015678999999999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=369.30 Aligned_cols=250 Identities=30% Similarity=0.534 Sum_probs=218.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....|+||||++|
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 489999999999999999999999999766543 3456789999999999999999999998754 6789999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~g-----i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~-- 169 (279)
T 2w5a_A 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169 (279)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-----
T ss_pred CCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc--
Confidence 999999964 24999999999999999999999999 999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLI 227 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 227 (416)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.. ..|..+++++.++|
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 248 (279)
T 2w5a_A 170 TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248 (279)
T ss_dssp CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHH
Confidence 112334579999999999987766 4899999999999999999999999888888888877765 56778999999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccccccC
Q 014911 228 TKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+||+.||.+|||+.++++|+|+....
T Consensus 249 ~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 249 TRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999999999999999997643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=373.27 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=205.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE--------------eC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--------------SK 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--------------~~ 66 (416)
.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp ECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 389999999999999999999999998654 2345678899999999999999999999873 45
Q ss_pred CEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-cCCCeEEeeccccccccc
Q 014911 67 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~ 145 (416)
...|+||||+. |+|.+++..+++++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~ 173 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--
T ss_pred CceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCC
Confidence 78999999998 5999999988999999999999999999999999999999999999997 566899999999986542
Q ss_pred cc-cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-----------
Q 014911 146 LK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------- 213 (416)
Q Consensus 146 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 213 (416)
.. .........+|+.|+|||++......+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (320)
T 2i6l_A 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253 (320)
T ss_dssp ------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHH
T ss_pred CcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhh
Confidence 21 122334557899999999987655556999999999999999999999998877666555543211
Q ss_pred -------------------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 214 -------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 214 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..++.+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 254 SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 01245899999999999999999999999999999998644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=392.71 Aligned_cols=245 Identities=25% Similarity=0.432 Sum_probs=206.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC------CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV------KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
+||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++...+.+|+|||
T Consensus 104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 4899999999999999999999999996542 3346777899988877 57899999999999999999999
Q ss_pred ccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC--eEEeeccccccccccccC
Q 014911 75 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--LKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~--~kl~DFGla~~~~~~~~~ 149 (416)
|+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|....
T Consensus 180 ~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~----- 253 (429)
T 3kvw_A 180 LLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----- 253 (429)
T ss_dssp CCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-----
T ss_pred ccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC-----
Confidence 996 589999875 34999999999999999999999999999999999999999987 9999999986432
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC----------------
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---------------- 213 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---------------- 213 (416)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~ 332 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence 23446789999999999998877 5999999999999999999999999877666555432100
Q ss_pred ----C---------------------------------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccc
Q 014911 214 ----K---------------------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 214 ----~---------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f 250 (416)
. ++...++.+.+||.+||++||.+|||+.|+|+||||
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence 0 011237889999999999999999999999999999
Q ss_pred cccCcc
Q 014911 251 KKSAPK 256 (416)
Q Consensus 251 ~~~~~~ 256 (416)
+...+.
T Consensus 413 ~~~~~~ 418 (429)
T 3kvw_A 413 RRRLPK 418 (429)
T ss_dssp C-----
T ss_pred ccCCCC
Confidence 875443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=370.63 Aligned_cols=250 Identities=30% Similarity=0.465 Sum_probs=211.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 3899999999999999999999999986543 2345788899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .......||
T Consensus 103 l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~ 180 (302)
T 2j7t_A 103 VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGT 180 (302)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CC
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCC
Confidence 9998864 679999999999999999999999999999999999999999999999999876432211 122345799
Q ss_pred CCCCchHHhh----hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHcc
Q 014911 159 PAYVAPEVIS----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLL 231 (416)
Q Consensus 159 ~~y~aPE~~~----~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L 231 (416)
+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+..... ..|..++..+.+||.+||
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (302)
T 2j7t_A 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIAL 260 (302)
T ss_dssp GGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHS
T ss_pred hhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHc
Confidence 9999999985 223345899999999999999999999999888777777766543 235568999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccCc
Q 014911 232 DPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
+.||.+|||+.++++||||+....
T Consensus 261 ~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 261 DKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp CSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ccChhhCCCHHHHhcChHHhhhcc
Confidence 999999999999999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=373.77 Aligned_cols=243 Identities=24% Similarity=0.451 Sum_probs=204.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMAS--KSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++..+++.||||++.... ...+.+|+.+++.++ ||||+++++++.+ ....++||||+.
T Consensus 43 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 4899999999999999999999999986432 367889999999997 9999999999988 678999999999
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+++|.+++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... .......+
T Consensus 117 ~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~ 191 (330)
T 3nsz_A 117 NTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRV 191 (330)
T ss_dssp CCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT---TCCCCSCC
T ss_pred chhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC---CCcccccc
Confidence 999999885 489999999999999999999999999999999999999777 799999999975433 23345668
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-cHHHHH-------------HHHHhCCCCC-------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMY-------------RKIYRGDFKC------- 215 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~~~~~~-------------~~i~~~~~~~------- 215 (416)
||+.|+|||++.+....+.++|||||||++|+|++|..||... +..... ..+.......
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (330)
T 3nsz_A 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 271 (330)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHH
T ss_pred ccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhh
Confidence 9999999999987555579999999999999999999999543 221111 1122222211
Q ss_pred -----------------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 216 -----------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 216 -----------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+..+++++.+||.+||++||.+|||++|+++||||+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 272 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 122789999999999999999999999999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=379.72 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=209.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++... ...|+||||
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred EEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 4899999999999999999999999996432 334456788999999999999999999987654 679999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC------
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD------ 149 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~------ 149 (416)
+. ++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 96 ~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 174 (353)
T 2b9h_A 96 MQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174 (353)
T ss_dssp CS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred cC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccc
Confidence 97 59999998888999999999999999999999999999999999999999999999999999765432111
Q ss_pred --CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--C-------------
Q 014911 150 --GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D------------- 212 (416)
Q Consensus 150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~------------- 212 (416)
......+||+.|+|||++......+.++|||||||++|+|++|.+||.+.+.......+... .
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (353)
T 2b9h_A 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP 254 (353)
T ss_dssp -----CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCH
T ss_pred cccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccc
Confidence 11234578999999999876555579999999999999999999999988765544433210 0
Q ss_pred ---------CC--------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 ---------FK--------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ---------~~--------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. .++.+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 1246789999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=397.29 Aligned_cols=240 Identities=18% Similarity=0.268 Sum_probs=198.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHH---HHHhCCCCCcceEE-------EEEEeCCE--
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS---VMKMVKHKHIVELH-------EVMASKSK-- 68 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~~~~~~~-- 68 (416)
.||+|+||+||+|++..+|+.||||++...........+.+.+|+. +++.++||||++++ +++.+.+.
T Consensus 80 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 159 (377)
T 3byv_A 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159 (377)
T ss_dssp EEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCS
T ss_pred eeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcc
Confidence 3899999999999999999999999998765555566788999995 45555899999998 77766542
Q ss_pred ---------------EEEEEeccCCCchhhHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 014911 69 ---------------IYFAMDLVKGGELFNKIAK-GRLRE-------DVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 125 (416)
Q Consensus 69 ---------------~~lV~E~~~gg~L~~~i~~-~~l~e-------~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIl 125 (416)
.|+||||+ +|+|.+++.. +.+++ ..+..++.||+.||+|||++||+||||||+|||
T Consensus 160 ~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 238 (377)
T 3byv_A 160 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238 (377)
T ss_dssp EEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred ccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 89999999 6799999975 44555 788889999999999999999999999999999
Q ss_pred eccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhhc-----------CCCCchhhHHHHHHHHHHHhcCCC
Q 014911 126 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-----------GYDGAKADIWSCGVILYVLLAGFL 194 (416)
Q Consensus 126 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DvwSlGvil~~lltG~~ 194 (416)
++.++.+||+|||+|.... ......+| +.|+|||++.+. .+ +.++|||||||++|+|++|..
T Consensus 239 l~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 239 LDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp ECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHHHHHSSC
T ss_pred EcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHHHHHCCC
Confidence 9999999999999987422 23456678 999999999877 55 599999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 195 PFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
||.+.+.......+. ..++.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 312 Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 312 PITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 998765443322222 334678999999999999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=367.51 Aligned_cols=249 Identities=29% Similarity=0.501 Sum_probs=208.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 4899999999999999999999999997653 2345778999999999999999999999999999999999999999
Q ss_pred hhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-CCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++...... .......
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 183 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTETF 183 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCC
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CCccccc
Confidence 99999752 4679999999999999999999999999999999999987 899999999998754322 1223456
Q ss_pred ccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCcHH--HHHH-HHHhCCCCCCCCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIV--SMYR-KIYRGDFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~~~li~~~L 231 (416)
.||+.|+|||++.... ..+.++|||||||++|+|++|..||...+.. .... .........|..+++++.+||.+||
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 263 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHc
Confidence 7999999999997643 2358999999999999999999999754322 2222 2223345677889999999999999
Q ss_pred CCCCCCcCCHHHHhcCccccccC
Q 014911 232 DPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 232 ~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.||.+|||+.++++||||+...
T Consensus 264 ~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 264 EPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=368.30 Aligned_cols=247 Identities=35% Similarity=0.648 Sum_probs=217.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+++.||||++....... .....+.+|+.+++.++||||+++++++...+..|+||||+.|++
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 107 (287)
T 2wei_A 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (287)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCC
Confidence 4899999999999999999999999997654332 345788999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..... ........
T Consensus 108 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~ 184 (287)
T 2wei_A 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRI 184 (287)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC---CSSCSCHH
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC---CCcccccc
Confidence 9998865 7899999999999999999999999999999999999997644 699999999875432 22334557
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+ ..+++++.+||.+||+
T Consensus 185 ~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 262 (287)
T 2wei_A 185 GTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262 (287)
T ss_dssp HHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred CcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcc
Confidence 89999999998754 4 5899999999999999999999999988888888877765443 4589999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+|||+.++++||||+..
T Consensus 263 ~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 263 FHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp SSGGGSCCHHHHHHSHHHHHH
T ss_pred cChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=375.43 Aligned_cols=249 Identities=34% Similarity=0.651 Sum_probs=205.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-----chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|++..+++.||||++...... .......+.+|+.+++.++||||+++++++...+ .|+||||
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~ 95 (322)
T 2ycf_A 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLEL 95 (322)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEEC
T ss_pred EEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEec
Confidence 489999999999999999999999999765431 1122346889999999999999999999997766 8999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeeccccccccccccCCc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGL 151 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~~~~~~~~~~ 151 (416)
+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..... ...
T Consensus 96 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~ 172 (322)
T 2ycf_A 96 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSL 172 (322)
T ss_dssp CTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC---CHH
T ss_pred CCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc---ccc
Confidence 999999999875 67999999999999999999999999999999999999987765 99999999875432 222
Q ss_pred ccccccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCC----CCCCHHHH
Q 014911 152 LHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP----PWFSSEAR 224 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~ 224 (416)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+..+....+ ..+++.+.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHH
Confidence 345679999999999853 233358999999999999999999999765432 34444555554432 45899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+||+.||.+|||+.++++||||+..
T Consensus 253 ~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 99999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=369.61 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=194.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++...... ......+.++...++.++||||+++++++.+++..|+||||+.| +
T Consensus 14 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 91 (290)
T 3fme_A 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-S 91 (290)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-E
T ss_pred hcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-c
Confidence 389999999999999999999999999765322 23334455566668889999999999999999999999999975 8
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|.+++.. +.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..... ......
T Consensus 92 l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~ 168 (290)
T 3fme_A 92 LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDI 168 (290)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------------
T ss_pred hHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc---cccccc
Confidence 8777642 5799999999999999999999998 999999999999999999999999999975433 223344
Q ss_pred cccCCCCCchHHhh---hcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHH-HhCCCCCC-CCCCHHHHHHHH
Q 014911 155 TCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKI-YRGDFKCP-PWFSSEARRLIT 228 (416)
Q Consensus 155 ~~gt~~y~aPE~~~---~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i-~~~~~~~p-~~~s~~~~~li~ 228 (416)
..||+.|+|||++. .....+.++||||+||++|+|++|..||.. .......... .......+ ..+++++.+||.
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (290)
T 3fme_A 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 248 (290)
T ss_dssp -CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHH
T ss_pred cCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHH
Confidence 57999999999972 333346899999999999999999999986 3333333333 33333333 468999999999
Q ss_pred HccCCCCCCcCCHHHHhcCcccccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||+.||.+|||+.++++||||+..
T Consensus 249 ~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 249 QCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=369.46 Aligned_cols=247 Identities=26% Similarity=0.468 Sum_probs=212.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++...+.+|+||||+.|++
T Consensus 36 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp ECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 3899999999999999999999999997643 23578899999999999999999999999999999999999999
Q ss_pred hhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ........||
T Consensus 111 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~ 188 (314)
T 3com_A 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGT 188 (314)
T ss_dssp HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--BSCBCCCCSC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--ccccCccCCC
Confidence 999996 367999999999999999999999999999999999999999999999999999754332 1223456799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP 235 (416)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.... +..|..+++.+.+||.+||+.||
T Consensus 189 ~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 267 (314)
T 3com_A 189 PFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSP 267 (314)
T ss_dssp GGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCT
T ss_pred CCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCCh
Confidence 99999999987766 489999999999999999999999877665555554443 23456689999999999999999
Q ss_pred CCcCCHHHHhcCccccccCc
Q 014911 236 NSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 236 ~~R~s~~eil~hp~f~~~~~ 255 (416)
.+|||+.++++||||+....
T Consensus 268 ~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 268 EQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp TTSCCHHHHTTSHHHHTCCC
T ss_pred hhCcCHHHHHhCHHHhcCCc
Confidence 99999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=373.77 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++ +|+.||||++...... ....+.+.+|+.++++++||||+++++++...+..|+||||+.||+
T Consensus 44 ~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 44 KIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred EeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 389999999999987 6889999999765433 3456788999999999999999999999999999999999999999
Q ss_pred hhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 81 LFNKIAKG----RLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 81 L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|.+++... .+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++...... ......
T Consensus 121 L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~ 198 (309)
T 3p86_A 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKS 198 (309)
T ss_dssp HHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------------
T ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--cccccc
Confidence 99999763 2999999999999999999999999 999999999999999999999999999753321 122345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--RGDFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~ 232 (416)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. ......|..+++.+.+||.+||+
T Consensus 199 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 277 (309)
T 3p86_A 199 AAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277 (309)
T ss_dssp ---CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcc
Confidence 679999999999988776 589999999999999999999999988877766664 33467788899999999999999
Q ss_pred CCCCCcCCHHHHhc--Cccccc
Q 014911 233 PNPNSRIAISKIME--SSWFKK 252 (416)
Q Consensus 233 ~dP~~R~s~~eil~--hp~f~~ 252 (416)
.||.+|||+.++++ +++++.
T Consensus 278 ~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 278 NEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SSGGGSCCHHHHHHHHHHHHC-
T ss_pred CChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999987 455544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=384.29 Aligned_cols=248 Identities=25% Similarity=0.526 Sum_probs=217.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh--------------hHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG--------------MMEQIKREISVMKMVKHKHIVELHEVMASK 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 66 (416)
.||+|+||+||+|.+ +|+.||||++......... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 38 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 38 TLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 489999999999998 9999999999765433211 127899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchhhH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEee
Q 014911 67 SKIYFAMDLVKGGELFNK------IAK---GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTD 136 (416)
Q Consensus 67 ~~~~lV~E~~~gg~L~~~------i~~---~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~D 136 (416)
+..|+||||++||+|.++ +.. +.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~d 195 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECC
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEec
Confidence 999999999999999998 653 579999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccCCcccccccCCCCCchHHhhhc-CCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCCC
Q 014911 137 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFK 214 (416)
Q Consensus 137 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~~ 214 (416)
||++..... .......||+.|+|||++.+. .+.+.++||||+||++|+|++|..||...+. ......+..+...
T Consensus 196 fg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~ 271 (348)
T 2pml_X 196 FGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271 (348)
T ss_dssp CTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCC
T ss_pred ccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcC
Confidence 999975432 234556799999999999876 4443489999999999999999999998766 6777888777776
Q ss_pred CC-------------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 215 CP-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 215 ~p-------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.| +.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 66 66899999999999999999999999999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=388.64 Aligned_cols=242 Identities=31% Similarity=0.456 Sum_probs=200.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK------SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~~~~lV~E 74 (416)
+||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++... ..+++|||
T Consensus 61 ~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 48999999999999999999999999865432 234799999999999999999988531 24779999
Q ss_pred ccCCCchhhHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeecccccccccccc
Q 014911 75 LVKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 75 ~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~ 148 (416)
|+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~--- 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT---
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc---
Confidence 9986 6665553 2679999999999999999999999999999999999999965 5689999999975432
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------- 211 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------------- 211 (416)
.......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.+.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 223345689999999999977644569999999999999999999999988766555554321
Q ss_pred CCC------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 212 DFK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 212 ~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+. +++.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 234568999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=375.28 Aligned_cols=252 Identities=27% Similarity=0.484 Sum_probs=189.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp ECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred eeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 489999999999999899999999998655322 335678899999999999999999999999999999999999999
Q ss_pred hhhHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc---c
Q 014911 81 LFNKIAK---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK---Q 148 (416)
Q Consensus 81 L~~~i~~---------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~---~ 148 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 179 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccc
Confidence 9999862 459999999999999999999999999999999999999999999999999987543321 1
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC----------CCCCC
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------KCPPW 218 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------~~p~~ 218 (416)
........||+.|+|||++......+.++|||||||++|+|++|..||...+............. ..+..
T Consensus 180 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (303)
T 2vwi_A 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK 259 (303)
T ss_dssp --------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCC
T ss_pred hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhh
Confidence 12234567999999999997633346899999999999999999999988765544444433322 12345
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 260 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred hhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 789999999999999999999999999999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=388.45 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=200.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~lV~E 74 (416)
+||+|+||+||+|++..+++ ||+|.+...... ..+|+.+|+.++||||+++++++...+ .+|+|||
T Consensus 47 ~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 47 VIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 48999999999999987766 888877654322 237999999999999999999985433 4899999
Q ss_pred ccCCCchhhHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-cCCCeEEeeccccccccccccC
Q 014911 75 LVKGGELFNKIA----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i~----~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~ 149 (416)
|+.++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|..... .
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~---~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA---G 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT---T
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC---C
Confidence 998754333321 36799999999999999999999999999999999999999 789999999999975432 2
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------C
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----------------D 212 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (416)
......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+.......+.+. .
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 23445678999999999987665579999999999999999999999998776665555431 0
Q ss_pred CC------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 FK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.. +++.+++++.+||.+||++||.+|||+.++++||||+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 01 2345789999999999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=375.84 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=196.1
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE------EE
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI------YF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~------~l 71 (416)
.||+|+||+||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++...... |+
T Consensus 30 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 108 (323)
T 3qup_A 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108 (323)
T ss_dssp EEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEE
T ss_pred eecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEE
Confidence 48999999999999877765 89999997654333 4467899999999999999999999999877665 99
Q ss_pred EEeccCCCchhhHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 72 AMDLVKGGELFNKIAKG-------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~~-------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
||||+.||+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~ 188 (323)
T 3qup_A 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188 (323)
T ss_dssp EEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccc
Confidence 99999999999998641 59999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|+.+++.
T Consensus 189 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (323)
T 3qup_A 189 SGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEE 267 (323)
T ss_dssp ------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHH
Confidence 4332233334457888999999988776 599999999999999999 999999988777777776654 5677889999
Q ss_pred HHHHHHHccCCCCCCcCC-------HHHHhcCccccccCccc
Q 014911 223 ARRLITKLLDPNPNSRIA-------ISKIMESSWFKKSAPKV 257 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s-------~~eil~hp~f~~~~~~~ 257 (416)
+.+||.+||+.||.+||| +++++.|||+......+
T Consensus 268 l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 268 VYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 999999999999999999 78899999998765443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=383.34 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=215.2
Q ss_pred CcccCCceEEEEEE-----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++......|+||||
T Consensus 78 ~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp ECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 38999999999999 45678899999996432 234456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeecccccccc
Q 014911 76 VKGGELFNKIAK--------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~ 144 (416)
+.||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++....
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~ 235 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccc
Confidence 999999999975 2489999999999999999999999999999999999999665 49999999997654
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++.
T Consensus 236 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 314 (367)
T 3l9p_A 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 314 (367)
T ss_dssp HHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 4333334455678999999999988776 489999999999999998 999999999888888887764 4567789999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
+.+||.+||+.||.+|||+.+++++.|+-.
T Consensus 315 l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 315 VYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 999999999999999999999999988743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=380.97 Aligned_cols=244 Identities=22% Similarity=0.407 Sum_probs=212.0
Q ss_pred CcccCCceEEEEEEEc-------CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNL-------QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|+.+ +||||+++++++...+.+|+|
T Consensus 88 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 3899999999999975 355689999997553 334567899999999999 899999999999999999999
Q ss_pred EeccCCCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 245 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEc
Confidence 9999999999999752 37899999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 213 (416)
|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 246 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 324 (370)
T 2psq_A 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 324 (370)
T ss_dssp CCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred cccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9999985543332233344567889999999988776 599999999999999999 999999988777777776654 4
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 325 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 325 DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677899999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=370.71 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=207.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe------CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS------KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~------~~~~~lV~ 73 (416)
.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++.+ +||||+++++++.. .+..|+||
T Consensus 31 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 48999999999999999999999999975432 236788999999998 79999999999977 56899999
Q ss_pred eccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC
Q 014911 74 DLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 74 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 184 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VG 184 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC--cc
Confidence 99999999999975 56999999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccccCCCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHH
Q 014911 151 LLHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEAR 224 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~ 224 (416)
......||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+ .+..+++.+.
T Consensus 185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 264 (326)
T 2x7f_A 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 264 (326)
T ss_dssp ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHH
T ss_pred ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHH
Confidence 2345679999999999862 223358999999999999999999999988777666666554332 2456899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+||..||.+|||+.++++||||+...
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.11 Aligned_cols=245 Identities=26% Similarity=0.445 Sum_probs=206.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE------EEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI------YFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~------~lV~E 74 (416)
.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.. |+|||
T Consensus 49 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 127 (371)
T 4exu_A 49 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127 (371)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence 38999999999999999999999999976542 334567888999999999999999999999877654 99999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+. ++|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 128 ~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~ 200 (371)
T 4exu_A 128 FMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTG 200 (371)
T ss_dssp CCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------C
T ss_pred ccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCC
Confidence 997 588877744 499999999999999999999999999999999999999999999999999975432 2345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------------- 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 212 (416)
.+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (371)
T 4exu_A 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS 280 (371)
T ss_dssp TTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHH
T ss_pred cccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhc
Confidence 6789999999999874445689999999999999999999999887766655553310
Q ss_pred -C--------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 -F--------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 -~--------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
. ..++.+++.+.+||.+||++||.+|||+.|+++||||+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 281 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred cCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 1124578999999999999999999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=373.92 Aligned_cols=244 Identities=25% Similarity=0.439 Sum_probs=202.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--KIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~lV~E~~~g 78 (416)
+||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+ ..|+||||++|
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 489999999999999999999999999755432 33567789999999999999999999998765 88999999999
Q ss_pred CchhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe----ccCCCeEEeeccccccccccccCC
Q 014911 79 GELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 79 g~L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll----~~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..... ..
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~---~~ 170 (319)
T 4euu_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DE 170 (319)
T ss_dssp CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT---TC
T ss_pred CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC---CC
Confidence 9999999752 39999999999999999999999999999999999999 7778899999999975433 23
Q ss_pred cccccccCCCCCchHHhhh-------cCCCCchhhHHHHHHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCC------
Q 014911 151 LLHTTCGTPAYVAPEVISK-------KGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDF------ 213 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~------ 213 (416)
.....+||+.|+|||++.. ....+.++|||||||++|+|++|..||... ........+..+..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~ 250 (319)
T 4euu_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250 (319)
T ss_dssp CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEE
T ss_pred ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchh
Confidence 3455679999999999863 233468999999999999999999999642 22344444444322
Q ss_pred -------------CCC------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcc
Q 014911 214 -------------KCP------PWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249 (416)
Q Consensus 214 -------------~~p------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 249 (416)
..| ..+++.+.+||.+||+.||.+|||++|+++||=
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111 123567889999999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=387.76 Aligned_cols=246 Identities=17% Similarity=0.188 Sum_probs=189.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC--CCCCcceEE-------EEEEeC-----
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV--KHKHIVELH-------EVMASK----- 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~~~----- 66 (416)
.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.| +||||++++ +++...
T Consensus 69 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~ 148 (371)
T 3q60_A 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148 (371)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSS
T ss_pred eccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCe
Confidence 389999999999999999999999999887654555667888886555555 699988865 555433
Q ss_pred ------------CEEEEEEeccCCCchhhHHhc--CCCCHHHH------HHHHHHHHHHHHHHHHcCceeccCCCCcEEe
Q 014911 67 ------------SKIYFAMDLVKGGELFNKIAK--GRLREDVA------RVYFQQLISAVDFCHSRGVYHRDLKPENLLL 126 (416)
Q Consensus 67 ------------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~------~~~~~qll~aL~ylH~~gi~HrDlkp~NIll 126 (416)
..+|+||||+. |+|.+++.. ..+++... ..++.||+.||+|||++||+||||||+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll 227 (371)
T 3q60_A 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI 227 (371)
T ss_dssp SBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred eeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE
Confidence 34899999998 799999975 34544444 5667999999999999999999999999999
Q ss_pred ccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH-
Q 014911 127 DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS- 203 (416)
Q Consensus 127 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~- 203 (416)
+.+|.+||+|||+|..... ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.....
T Consensus 228 ~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 301 (371)
T 3q60_A 228 MPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301 (371)
T ss_dssp CTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred CCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence 9999999999999975432 1224567799999999976 455 599999999999999999999998764321
Q ss_pred -HHHH-----HHhCCC--CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 204 -MYRK-----IYRGDF--KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 204 -~~~~-----i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+.. ...... +.++.+++.+.+||.+||++||.+|||+.++++||||+..
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 0000 001122 2235789999999999999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.31 Aligned_cols=245 Identities=26% Similarity=0.441 Sum_probs=206.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE------EEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK------IYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~------~~lV~E 74 (416)
.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+. +|+|||
T Consensus 31 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 109 (353)
T 3coi_A 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109 (353)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence 38999999999999999999999999976432 33456788999999999999999999999977654 599999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 110 ~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~ 182 (353)
T 3coi_A 110 FMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTG 182 (353)
T ss_dssp CCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------
T ss_pred ccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-----Cccc
Confidence 997 588887754 599999999999999999999999999999999999999999999999999875432 2345
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------------- 211 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------------------- 211 (416)
.+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 183 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (353)
T 3coi_A 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS 262 (353)
T ss_dssp -CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHT
T ss_pred cccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHh
Confidence 678999999999987445568999999999999999999999988766555544321
Q ss_pred --------CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 212 --------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 212 --------~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
....++.+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 263 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 012234679999999999999999999999999999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=365.50 Aligned_cols=246 Identities=28% Similarity=0.516 Sum_probs=201.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-------------CC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-------------KS 67 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------------~~ 67 (416)
.||+|+||+||+|++..+|+.||||++... ....+.+.+|+.+++.++||||+++++++.+ .+
T Consensus 13 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred eeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 489999999999999999999999999643 2445788999999999999999999998855 46
Q ss_pred EEEEEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 68 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 68 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
..|+||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 168 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC
T ss_pred ceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhccc
Confidence 78999999999999999975 3588999999999999999999999999999999999999999999999999875432
Q ss_pred cc------------cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhCC
Q 014911 146 LK------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD 212 (416)
Q Consensus 146 ~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~ 212 (416)
.. .........||+.|+|||++.+.+..+.++||||+||++|+|++ ||.. .+.......+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~ 245 (303)
T 1zy4_A 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS 245 (303)
T ss_dssp -------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTT
T ss_pred ccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccc
Confidence 11 01223456799999999999876555699999999999999998 6654 33445556666555
Q ss_pred CCCCC----CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 FKCPP----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 ~~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
...|+ ..++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 55444 456779999999999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=375.83 Aligned_cols=246 Identities=28% Similarity=0.367 Sum_probs=195.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-------EEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-------KIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-------~~~lV~ 73 (416)
.||+|+||+||+|++..+|+.||||++....... ....+++..++.++||||+++++++.... .+|+||
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp ---------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 4899999999999999999999999986554322 34567888889999999999999986533 389999
Q ss_pred eccCCCchhhHH----hc-CCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEecc-CCCeEEeeccccccccc
Q 014911 74 DLVKGGELFNKI----AK-GRLREDVARVYFQQLISAVDFCH--SRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 74 E~~~gg~L~~~i----~~-~~l~e~~~~~~~~qll~aL~ylH--~~gi~HrDlkp~NIll~~-~~~~kl~DFGla~~~~~ 145 (416)
||+.|+ |.+.+ .. ..+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|||++.....
T Consensus 106 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~ 184 (360)
T 3e3p_A 106 EYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184 (360)
T ss_dssp ECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT
T ss_pred eccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC
Confidence 999875 43333 22 57999999999999999999999 999999999999999997 89999999999975443
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------- 212 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------- 212 (416)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 185 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 185 ---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp ---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred ---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence 2233456789999999999776655799999999999999999999999988776666654310
Q ss_pred -------------------CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 -------------------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 -------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...+...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 011222568899999999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=377.92 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=201.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc--------chhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--------KVGMMEQIKREISVMKMVKHKHIVELHEVMAS-----KS 67 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~ 67 (416)
.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 29 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 29 FISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 4899999999999985 4999999999654322 12234789999999999999999999999843 34
Q ss_pred EEEEEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 68 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 68 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
.+|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC------
T ss_pred eEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccccc
Confidence 7999999998 588888865 4699999999999999999999999999999999999999999999999999974332
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--------------
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------- 211 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 211 (416)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 187 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 263 (362)
T 3pg1_A 187 ---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263 (362)
T ss_dssp ------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSC
T ss_pred ---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccc
Confidence 233445679999999999987555579999999999999999999999998776665555321
Q ss_pred ----------CCC--------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCc
Q 014911 212 ----------DFK--------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 212 ----------~~~--------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 255 (416)
... .++.+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 001 12356889999999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=372.20 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=213.2
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 54 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 3899999999999987 456899999997553 234567899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC
Q 014911 76 VKGGELFNKIAK-------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 76 ~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 211 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCC
Confidence 999999999965 4689999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 014911 131 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 209 (416)
Q Consensus 131 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 209 (416)
.+||+|||++................+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 290 (343)
T 1luf_A 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290 (343)
T ss_dssp CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHh
Confidence 999999999976543332233445678999999999988776 599999999999999999 999999988888888877
Q ss_pred hCCC-CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 210 RGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 210 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.+.. ..|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 291 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 291 DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 7654 5678899999999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=373.18 Aligned_cols=244 Identities=32% Similarity=0.567 Sum_probs=213.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVK--HKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++..+|+.||||++........ .....+.+|+.+++.++ ||||+++++++...+..++|||+
T Consensus 50 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 129 (320)
T 3a99_A 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129 (320)
T ss_dssp ECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEc
Confidence 48999999999999999999999999977643321 11245668999999996 59999999999999999999999
Q ss_pred cCC-CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-cCCCeEEeeccccccccccccCCcc
Q 014911 76 VKG-GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 76 ~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
+.+ ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 130 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~----~~~ 205 (320)
T 3a99_A 130 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVY 205 (320)
T ss_dssp CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS----SCB
T ss_pred CCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc----ccc
Confidence 986 899999976 7899999999999999999999999999999999999999 778999999999875432 233
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccC
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 232 (416)
....||+.|+|||++....+.+.++|||||||++|+|++|..||...+ .+.......+..+++++.+||.+||+
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~ 279 (320)
T 3a99_A 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLA 279 (320)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTC
T ss_pred cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHHHHHHcc
Confidence 456799999999999888776788999999999999999999997643 23456667788899999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.||.+|||+.++++||||+...
T Consensus 280 ~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 280 LRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp SSGGGSCCHHHHHTSGGGSSCC
T ss_pred CChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=358.75 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=210.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|+||||++|++
T Consensus 17 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 17 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 3899999999999986 5778999999765432 3578899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......+|
T Consensus 92 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~ 170 (269)
T 4hcu_A 92 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFP 170 (269)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCC
T ss_pred HHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccc
Confidence 9999965 5699999999999999999999999999999999999999999999999999975433211 122344567
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....+ +.++||||+||++|+|++ |..||...+.......+..+ ....|..+++.+.++|.+||+.||.
T Consensus 171 ~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 249 (269)
T 4hcu_A 171 VKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 249 (269)
T ss_dssp GGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcc
Confidence 88999999987776 489999999999999999 99999999888888888776 3455677899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.++++|
T Consensus 250 ~Rps~~~ll~~ 260 (269)
T 4hcu_A 250 DRPAFSRLLRQ 260 (269)
T ss_dssp GSCCHHHHHHH
T ss_pred cCcCHHHHHHH
Confidence 99999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=370.14 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=209.5
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 56 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred EEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 48999999999999986655 59999997543 23445788999999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-cccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHT 154 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 154 (416)
||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ....
T Consensus 134 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 213 (325)
T 3kul_A 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213 (325)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC-
T ss_pred CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccC
Confidence 9999999964 579999999999999999999999999999999999999999999999999998654322211 1223
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 232 (416)
..+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||.+||+
T Consensus 214 ~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 292 (325)
T 3kul_A 214 GKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWH 292 (325)
T ss_dssp --CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHcc
Confidence 346778999999987766 489999999999999999 99999998888888877765 456677899999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.||.+|||+.++++
T Consensus 293 ~dp~~Rps~~eil~ 306 (325)
T 3kul_A 293 KDRAQRPRFSQIVS 306 (325)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=369.82 Aligned_cols=242 Identities=29% Similarity=0.443 Sum_probs=204.0
Q ss_pred CcccCCceEEEEEEE-cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC------CcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARN-LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK------HIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||+||+|.+ ..+|+.||||++.... ...+.+.+|+.+++.++|+ +|+++++++...+..|+||
T Consensus 21 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 96 (339)
T 1z57_A 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96 (339)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred EEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence 489999999999998 5688999999996432 3457788999999988765 4999999999999999999
Q ss_pred eccCCCchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-------------------CCC
Q 014911 74 DLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------------------DGN 131 (416)
Q Consensus 74 E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-------------------~~~ 131 (416)
||+ +++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++. ++.
T Consensus 97 e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (339)
T 1z57_A 97 ELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175 (339)
T ss_dssp ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCC
T ss_pred cCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCC
Confidence 999 88999999762 5899999999999999999999999999999999999987 668
Q ss_pred eEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC
Q 014911 132 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG 211 (416)
Q Consensus 132 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~ 211 (416)
+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+...
T Consensus 176 ~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 176 IKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp EEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred ceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999875332 2345679999999999988776 58999999999999999999999987766544443221
Q ss_pred CCCCC--------------------------------------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 212 DFKCP--------------------------------------------PWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 212 ~~~~p--------------------------------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..+.| ...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 11111 1124678899999999999999999999999
Q ss_pred cccccc
Q 014911 248 SWFKKS 253 (416)
Q Consensus 248 p~f~~~ 253 (416)
|||+..
T Consensus 330 p~f~~~ 335 (339)
T 1z57_A 330 PFFDLL 335 (339)
T ss_dssp GGGGGG
T ss_pred HHHHHH
Confidence 999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=380.09 Aligned_cols=240 Identities=25% Similarity=0.452 Sum_probs=197.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC--------CCCcceEEEEEE----eCCE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--------HKHIVELHEVMA----SKSK 68 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~~----~~~~ 68 (416)
.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||+++++++. ....
T Consensus 44 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 3899999999999999999999999996432 34567889999999985 788999999987 5668
Q ss_pred EEEEEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCC--------------
Q 014911 69 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDG-------------- 130 (416)
Q Consensus 69 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~-------------- 130 (416)
+|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~ 198 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---
T ss_pred EEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHh
Confidence 99999999 5567666643 4699999999999999999999998 999999999999999776
Q ss_pred -----------------------------------CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCc
Q 014911 131 -----------------------------------NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175 (416)
Q Consensus 131 -----------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (416)
.+||+|||++..... .....+||+.|+|||++.+..+ +.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~ 272 (397)
T 1wak_A 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGY-NT 272 (397)
T ss_dssp ------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSCC-CT
T ss_pred hcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcCCCC-Cc
Confidence 799999999975432 2345679999999999988776 48
Q ss_pred hhhHHHHHHHHHHHhcCCCCCCCCc------HHHHHHHHHh--CC-----------------------------------
Q 014911 176 KADIWSCGVILYVLLAGFLPFQDDN------IVSMYRKIYR--GD----------------------------------- 212 (416)
Q Consensus 176 ~~DvwSlGvil~~lltG~~Pf~~~~------~~~~~~~i~~--~~----------------------------------- 212 (416)
++|||||||++|+|++|..||...+ .......+.. +.
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999997643 1222222211 00
Q ss_pred -----CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccc
Q 014911 213 -----FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 213 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 251 (416)
...+...++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 111222346788999999999999999999999999996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.93 Aligned_cols=244 Identities=24% Similarity=0.391 Sum_probs=206.0
Q ss_pred CcccCCceEEEEEE-----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC-EEEEEE
Q 014911 1 MLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS-KIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~-~~~lV~ 73 (416)
.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++...+ .+|+||
T Consensus 29 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 38999999999999 55677899999997543 223456789999999999 7999999999988754 499999
Q ss_pred eccCCCchhhHHhcCC----------------------------------------------------------------
Q 014911 74 DLVKGGELFNKIAKGR---------------------------------------------------------------- 89 (416)
Q Consensus 74 E~~~gg~L~~~i~~~~---------------------------------------------------------------- 89 (416)
||++||+|.+++....
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999997521
Q ss_pred ---CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCCCchHH
Q 014911 90 ---LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 166 (416)
Q Consensus 90 ---l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 166 (416)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................||+.|+|||+
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 89999999999999999999999999999999999999999999999999975543322223445678999999999
Q ss_pred hhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHH
Q 014911 167 ISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISK 243 (416)
Q Consensus 167 ~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~e 243 (416)
+.+..+ +.++|||||||++|+|++ |..||.+.+.. .....+..+ ....|..+++++.++|.+||+.||.+|||+.+
T Consensus 267 ~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 267 IFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp HHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 988776 499999999999999998 99999886543 333334333 45677889999999999999999999999999
Q ss_pred HhcC
Q 014911 244 IMES 247 (416)
Q Consensus 244 il~h 247 (416)
+++|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.37 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=208.0
Q ss_pred CcccCCceEEEEEEEc-CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEE-----eCCEEEE
Q 014911 1 MLGHGTFAKVYLARNL-QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMA-----SKSKIYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-----~~~~~~l 71 (416)
.||+|+||+||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++. .....|+
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred eecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence 3899999999999995 678999999997654321 2223566788877766 8999999999987 5678999
Q ss_pred EEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 72 AMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
||||+. |+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 97 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~-- 173 (326)
T 1blx_A 97 VFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173 (326)
T ss_dssp EEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--
T ss_pred EEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC--
Confidence 999998 499999875 34999999999999999999999999999999999999999999999999999754432
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------- 212 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------- 212 (416)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (326)
T 1blx_A 174 -MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251 (326)
T ss_dssp -GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred -CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch
Confidence 23345679999999999987766 589999999999999999999999988776666654310
Q ss_pred -----------CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 -----------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 -----------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...++.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 252 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 012345789999999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=378.52 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=209.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|+||||++||+
T Consensus 121 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 3899999999999999999999999986542 22345678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++
T Consensus 199 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~ 278 (377)
T 3cbl_A 199 FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278 (377)
T ss_dssp HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEE
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCC
Confidence 9999975 46999999999999999999999999999999999999999999999999998743221111111223357
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.
T Consensus 279 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 357 (377)
T 3cbl_A 279 VKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPG 357 (377)
T ss_dssp GGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCch
Confidence 78999999987766 589999999999999998 99999998877777666655 3567788999999999999999999
Q ss_pred CcCCHHHHhc
Q 014911 237 SRIAISKIME 246 (416)
Q Consensus 237 ~R~s~~eil~ 246 (416)
+|||+.++++
T Consensus 358 ~Rps~~~i~~ 367 (377)
T 3cbl_A 358 QRPSFSTIYQ 367 (377)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=365.83 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=211.0
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 3899999999999983 456899999997543 334567889999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-C------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC
Q 014911 76 VKGGELFNKIAK-G------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 76 ~~gg~L~~~i~~-~------------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
+.||+|.+++.. + .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~ 187 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCC
Confidence 999999999975 2 289999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 014911 131 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 209 (416)
Q Consensus 131 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 209 (416)
.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 188 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 266 (314)
T 2ivs_A 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266 (314)
T ss_dssp EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhh
Confidence 999999999975443222222334457889999999987766 589999999999999999 999999988777777766
Q ss_pred hCC-CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 210 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 210 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.+. ...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 653 45677899999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=373.89 Aligned_cols=244 Identities=23% Similarity=0.417 Sum_probs=213.7
Q ss_pred CcccCCceEEEEEEEcCC-------CcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQT-------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||+||+|++..+ +..||||++.... .......+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus 76 ~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 389999999999997643 3579999997653 334567889999999999 999999999999999999999
Q ss_pred EeccCCCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 233 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 233 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEc
Confidence 9999999999999753 39999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DF 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~ 213 (416)
|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 234 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 312 (382)
T 3tt0_A 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 312 (382)
T ss_dssp SCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999986544333333445567889999999987766 599999999999999999 99999999888888877766 35
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 313 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 313 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677899999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=367.47 Aligned_cols=244 Identities=31% Similarity=0.601 Sum_probs=207.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhC----CCCCcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMV----KHKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++++ +||||+++++++...+..|+||
T Consensus 38 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~ 117 (312)
T 2iwi_A 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117 (312)
T ss_dssp EEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEE
T ss_pred EEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEE
Confidence 38999999999999999999999999976543221 1223456799999998 8999999999999999999999
Q ss_pred ec-cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec-cCCCeEEeeccccccccccccCC
Q 014911 74 DL-VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 74 E~-~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
|+ +.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++..... .
T Consensus 118 e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~----~ 193 (312)
T 2iwi_A 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----E 193 (312)
T ss_dssp ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCS----S
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhccc----C
Confidence 99 789999999976 6799999999999999999999999999999999999999 788999999999875442 2
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 230 (416)
......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+.......+..+++.+.+||.+|
T Consensus 194 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~ 267 (312)
T 2iwi_A 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVSPDCCALIRRC 267 (312)
T ss_dssp CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCCHHHHHHHHHH
Confidence 34456799999999999887776678999999999999999999997643 244566778888999999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccccC
Q 014911 231 LDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
|+.||.+|||+.++++||||+...
T Consensus 268 l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 268 LAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp TCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ccCChhhCcCHHHHhcChhhcCch
Confidence 999999999999999999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.19 Aligned_cols=240 Identities=28% Similarity=0.501 Sum_probs=198.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|.+ +|+.||||++....... ....+.+.+|+.+++.++||||+++++++...+..|+||||++|+
T Consensus 14 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 14 IIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 489999999999998 58999999987654322 234578899999999999999999999999999999999999999
Q ss_pred chhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEecc--------CCCeEEeecccccccccccc
Q 014911 80 ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG---VYHRDLKPENLLLDE--------DGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 80 ~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~g---i~HrDlkp~NIll~~--------~~~~kl~DFGla~~~~~~~~ 148 (416)
+|.+++..+++++..++.++.|++.||.|||++| |+||||||+||+++. ++.+||+|||++......
T Consensus 92 ~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 169 (271)
T 3dtc_A 92 PLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-- 169 (271)
T ss_dssp EHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------
T ss_pred CHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc--
Confidence 9999998888999999999999999999999999 999999999999986 678999999999754322
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHH
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRL 226 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l 226 (416)
......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.... .+.|..+++.+.++
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (271)
T 3dtc_A 170 --TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246 (271)
T ss_dssp --------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHH
T ss_pred --cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHH
Confidence 2235579999999999988766 589999999999999999999999988776666665554 45677899999999
Q ss_pred HHHccCCCCCCcCCHHHHhcC
Q 014911 227 ITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 227 i~~~L~~dP~~R~s~~eil~h 247 (416)
|.+||+.||.+|||+.+++++
T Consensus 247 i~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 247 MEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCcccCcCHHHHHHH
Confidence 999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=364.55 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=202.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||+.||+
T Consensus 17 ~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 489999999999999999999999988543 33556789999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC--------
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-------- 150 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-------- 150 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 94 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 173 (310)
T 3s95_A 94 LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173 (310)
T ss_dssp HHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccc
Confidence 9999976 679999999999999999999999999999999999999999999999999997643322111
Q ss_pred ----cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH-----HHHHHHhCCCCCCCCCCH
Q 014911 151 ----LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS-----MYRKIYRGDFKCPPWFSS 221 (416)
Q Consensus 151 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~-----~~~~i~~~~~~~p~~~s~ 221 (416)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||....... ...... ....|+.+++
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 250 (310)
T 3s95_A 174 PDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYCPPNCPP 250 (310)
T ss_dssp ------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHTCCTTCCT
T ss_pred cccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cccCCCCCCH
Confidence 1125679999999999988776 489999999999999999999987532110 001111 1234677899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+.++|.+||+.||.+|||+.++++
T Consensus 251 ~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 251 SFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp THHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=372.28 Aligned_cols=241 Identities=34% Similarity=0.596 Sum_probs=176.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~ 76 (416)
+||+|+||+||+|++..+|+.||||++.... ....+....++.++||||+++++++.. ...+|+||||+
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 4899999999999999999999999986432 122223334667899999999999876 55689999999
Q ss_pred CCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC---CCeEEeeccccccccccccCC
Q 014911 77 KGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 77 ~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~ 150 (416)
.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..... .
T Consensus 109 ~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~----~ 184 (336)
T 3fhr_A 109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----N 184 (336)
T ss_dssp TTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc----c
Confidence 99999999976 269999999999999999999999999999999999999864 4599999999874432 2
Q ss_pred cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHH----HHHHHhCCCCCC----CCCCHH
Q 014911 151 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM----YRKIYRGDFKCP----PWFSSE 222 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p----~~~s~~ 222 (416)
.....+||+.|+|||++....+ +.++|||||||++|+|++|..||...+.... ...+.......| ..++++
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263 (336)
T ss_dssp -------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred ccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence 3456688999999999976665 4899999999999999999999977654432 222322333222 458999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+.+||.+||+.||.+|||+.++++||||+..
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 264 AKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=353.73 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=208.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++
T Consensus 15 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 15 ELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 3899999999999874 6778999999765432 3578899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......+|
T Consensus 90 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~ 168 (268)
T 3sxs_A 90 LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFP 168 (268)
T ss_dssp HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCC
T ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcC
Confidence 9999975 4599999999999999999999999999999999999999999999999999975433211 112234467
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|..+++.+.++|.+||+.||.
T Consensus 169 ~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 247 (268)
T 3sxs_A 169 VKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPE 247 (268)
T ss_dssp GGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGG
T ss_pred cccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChh
Confidence 78999999987766 489999999999999999 999999988887777777664 345667899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.+++++
T Consensus 248 ~Rps~~~ll~~ 258 (268)
T 3sxs_A 248 KRPTFQQLLSS 258 (268)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=355.62 Aligned_cols=240 Identities=21% Similarity=0.367 Sum_probs=207.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+||||+.|++
T Consensus 31 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 31 ELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp ECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred hcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 3899999999999875 6778999999765432 3578899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......+|
T Consensus 106 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~ 184 (283)
T 3gen_A 106 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFP 184 (283)
T ss_dssp HHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSC
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccC
Confidence 9999975 6799999999999999999999999999999999999999999999999999975433211 122334567
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....+ +.++||||+||++|+|++ |..||...+.......+..+. ...|..+++.+.+||.+||+.||.
T Consensus 185 ~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 263 (283)
T 3gen_A 185 VRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263 (283)
T ss_dssp GGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred cccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChh
Confidence 88999999987776 589999999999999998 999999988888888877664 455677899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.++++|
T Consensus 264 ~Rps~~~ll~~ 274 (283)
T 3gen_A 264 ERPTFKILLSN 274 (283)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=374.51 Aligned_cols=242 Identities=26% Similarity=0.422 Sum_probs=203.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CC-----CcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HK-----HIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+ +|+++++++...+..|+|||
T Consensus 61 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 4899999999999999999999999996432 34567888999998885 55 49999999999999999999
Q ss_pred ccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEec--cCCCeEEeeccccccccccc
Q 014911 75 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCH--SRGVYHRDLKPENLLLD--EDGNLKVTDFGLSAFSEHLK 147 (416)
Q Consensus 75 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH--~~gi~HrDlkp~NIll~--~~~~~kl~DFGla~~~~~~~ 147 (416)
|+.| +|.+++.. +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||++.....
T Consensus 137 ~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-- 213 (382)
T 2vx3_A 137 MLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-- 213 (382)
T ss_dssp CCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--
T ss_pred cCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--
Confidence 9965 99999975 45999999999999999999999 57999999999999995 477899999999975432
Q ss_pred cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC------------
Q 014911 148 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC------------ 215 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 215 (416)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 214 ---~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (382)
T 2vx3_A 214 ---RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKAR 289 (382)
T ss_dssp ---CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHH
T ss_pred ---ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHH
Confidence 2345689999999999988776 489999999999999999999999988776666654321000
Q ss_pred ------------------------CCCC----------------------------CHHHHHHHHHccCCCCCCcCCHHH
Q 014911 216 ------------------------PPWF----------------------------SSEARRLITKLLDPNPNSRIAISK 243 (416)
Q Consensus 216 ------------------------p~~~----------------------------s~~~~~li~~~L~~dP~~R~s~~e 243 (416)
++.. ++++++||.+||++||.+|||+.|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e 369 (382)
T 2vx3_A 290 KFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369 (382)
T ss_dssp HHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHH
Confidence 0000 137899999999999999999999
Q ss_pred HhcCcccccc
Q 014911 244 IMESSWFKKS 253 (416)
Q Consensus 244 il~hp~f~~~ 253 (416)
+|+||||+..
T Consensus 370 ~L~hp~f~~~ 379 (382)
T 2vx3_A 370 ALQHSFFKKT 379 (382)
T ss_dssp HTTSGGGCC-
T ss_pred HhcCcccccC
Confidence 9999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=367.07 Aligned_cols=243 Identities=21% Similarity=0.361 Sum_probs=200.7
Q ss_pred CcccCCceEEEEEEEcCCCcEE----EEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.... .++|+||+
T Consensus 22 ~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~ 98 (327)
T 3poz_A 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred EEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence 4899999999999998888765 666664332 2234578899999999999999999999998765 78899999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 178 (327)
T 3poz_A 99 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178 (327)
T ss_dssp TTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccC
Confidence 99999999975 5699999999999999999999999999999999999999999999999999986554333333344
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.|+.++.++.+++.+||+
T Consensus 179 ~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (327)
T 3poz_A 179 GKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 257 (327)
T ss_dssp -CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTC
T ss_pred CCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 557889999999988776 599999999999999999 999999887776666665553 56778899999999999999
Q ss_pred CCCCCcCCHHHHhcC
Q 014911 233 PNPNSRIAISKIMES 247 (416)
Q Consensus 233 ~dP~~R~s~~eil~h 247 (416)
.||.+|||+.+++++
T Consensus 258 ~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 258 IDADSRPKFRELIIE 272 (327)
T ss_dssp SCGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=369.17 Aligned_cols=243 Identities=20% Similarity=0.350 Sum_probs=205.9
Q ss_pred CcccCCceEEEEEEEcCCCcE----EEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++. .+..|+||||+
T Consensus 20 ~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 489999999999999888886 66676643321 122345678999999999999999999986 45689999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 97 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 176 (325)
T 3kex_A 97 PLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176 (325)
T ss_dssp TTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC---
T ss_pred CCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccC
Confidence 99999999975 5799999999999999999999999999999999999999999999999999987654433334455
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 232 (416)
..||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..++.++.++|.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (325)
T 3kex_A 177 AKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWM 255 (325)
T ss_dssp --CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTC
T ss_pred CCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcC
Confidence 678889999999987776 599999999999999999 99999988777777777665 356677889999999999999
Q ss_pred CCCCCcCCHHHHhcC
Q 014911 233 PNPNSRIAISKIMES 247 (416)
Q Consensus 233 ~dP~~R~s~~eil~h 247 (416)
.||.+|||+.++++|
T Consensus 256 ~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 256 IDENIRPTFKELANE 270 (325)
T ss_dssp SCTTTSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=368.93 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=206.5
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+++++ +||||+++++++...+..|+|||
T Consensus 52 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 4899999999999973 467789999997543 223446889999999999 89999999999999999999999
Q ss_pred ccCCCchhhHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC
Q 014911 75 LVKGGELFNKIAKG------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 75 ~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
|++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~ 209 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCC
Confidence 99999999999752 278999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 014911 131 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 209 (416)
Q Consensus 131 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 209 (416)
.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 210 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 288 (344)
T 1rjb_A 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288 (344)
T ss_dssp EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHH
Confidence 999999999986544332223345567899999999988776 599999999999999998 999998866544443433
Q ss_pred hC--CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcc
Q 014911 210 RG--DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249 (416)
Q Consensus 210 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 249 (416)
.. ....|..+++.+.+||.+||+.||.+|||+.++++|..
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 33 34567789999999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=359.85 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=203.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.+++.++ ||||+++++++...+..|+||| +.+
T Consensus 35 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 35 QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 3899999999999984 5899999999765432 345678999999999997 5999999999999999999999 567
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...............+|
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~g 190 (313)
T 3cek_A 112 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190 (313)
T ss_dssp EEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------C
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCC
Confidence 899999976 6799999999999999999999999999999999999996 48999999999986544333333345679
Q ss_pred CCCCCchHHhhhc----------CCCCchhhHHHHHHHHHHHhcCCCCCCCCc-HHHHHHHHHhC--CCCCCCCCCHHHH
Q 014911 158 TPAYVAPEVISKK----------GYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEAR 224 (416)
Q Consensus 158 t~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~ 224 (416)
|+.|+|||++... ...+.++|||||||++|+|++|..||.... .......+... ....|...++.+.
T Consensus 191 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (313)
T 3cek_A 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270 (313)
T ss_dssp CGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHH
Confidence 9999999998652 234589999999999999999999998753 23333444333 3456777899999
Q ss_pred HHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 225 RLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 225 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+||+.||.+|||+.++++||||+...
T Consensus 271 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=367.35 Aligned_cols=242 Identities=27% Similarity=0.423 Sum_probs=202.2
Q ss_pred CcccCCceEEEEEEEcCCC-cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC------cceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH------IVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||+||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+++++...+..|+||
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T 2eu9_A 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101 (355)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence 3899999999999998777 699999996432 34567889999999997665 999999999999999999
Q ss_pred eccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe-------------------ccCCC
Q 014911 74 DLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL-------------------DEDGN 131 (416)
Q Consensus 74 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll-------------------~~~~~ 131 (416)
||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 102 e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 180 (355)
T 2eu9_A 102 ELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180 (355)
T ss_dssp ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCC
T ss_pred ecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCc
Confidence 999 5677777754 369999999999999999999999999999999999999 56789
Q ss_pred eEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC
Q 014911 132 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG 211 (416)
Q Consensus 132 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~ 211 (416)
+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+...
T Consensus 181 ~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (355)
T 2eu9_A 181 IRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254 (355)
T ss_dssp EEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEeecCccccccc-----cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999975332 2345679999999999988776 48999999999999999999999987765544443322
Q ss_pred CCCCCC--------------------------------------------CCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 212 DFKCPP--------------------------------------------WFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 212 ~~~~p~--------------------------------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..+.|. ..+..+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111111 123578899999999999999999999999
Q ss_pred cccccc
Q 014911 248 SWFKKS 253 (416)
Q Consensus 248 p~f~~~ 253 (416)
|||+..
T Consensus 335 p~f~~~ 340 (355)
T 2eu9_A 335 PFFAGL 340 (355)
T ss_dssp GGGGGC
T ss_pred hhhcCC
Confidence 999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.46 Aligned_cols=237 Identities=23% Similarity=0.314 Sum_probs=203.8
Q ss_pred CcccCCceEEEEEEEcCCC-------cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTG-------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 15 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 3899999999999998877 479999996543 244578999999999999999999999999999999999
Q ss_pred eccCCCchhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC--------eEEeeccccccc
Q 014911 74 DLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--------LKVTDFGLSAFS 143 (416)
Q Consensus 74 E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~--------~kl~DFGla~~~ 143 (416)
||+.||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~ 171 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171 (289)
T ss_dssp ECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT
T ss_pred ECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccc
Confidence 999999999999763 3999999999999999999999999999999999999999887 999999998643
Q ss_pred cccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHH
Q 014911 144 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPWFSSE 222 (416)
Q Consensus 144 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 222 (416)
.. .....||+.|+|||++.+....+.++|||||||++|+|++ |.+||...+.... ..........|...+++
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 244 (289)
T 4fvq_A 172 LP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQLPAPKAAE 244 (289)
T ss_dssp SC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCSSCT
T ss_pred cC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCCCCCCCCHH
Confidence 22 2345689999999999874445699999999999999999 5566665554433 34445566777778999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+||.+||+.||.+|||+.++++|
T Consensus 245 l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 245 LANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp THHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=357.90 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=191.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+|+.||||++...... ......+.++..+++.++||||+++++++...+.+|+||||+ ++.
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred eeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 389999999999999999999999999765432 223344555666788899999999999999999999999999 555
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+...... +.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..... ........|
T Consensus 110 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~ 186 (318)
T 2dyl_A 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAG 186 (318)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC---CccccccCC
Confidence 5555543 6799999999999999999999995 999999999999999999999999999875432 223345679
Q ss_pred CCCCCchHHhhh----cCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhCCCC-CC--CCCCHHHHHHHHH
Q 014911 158 TPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFK-CP--PWFSSEARRLITK 229 (416)
Q Consensus 158 t~~y~aPE~~~~----~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~~s~~~~~li~~ 229 (416)
|+.|+|||++.. ....+.++||||+||++|+|++|..||.. .+.......+.....+ .| ..+++++.+||.+
T Consensus 187 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 266 (318)
T 2dyl_A 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD 266 (318)
T ss_dssp CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHH
T ss_pred CccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHH
Confidence 999999999952 22335899999999999999999999987 3444555555555432 23 3589999999999
Q ss_pred ccCCCCCCcCCHHHHhcCcccccc
Q 014911 230 LLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
||+.||.+|||+.++++||||+..
T Consensus 267 ~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 267 CLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HccCChhHCcCHHHHhhCHHHHhc
Confidence 999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=361.86 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=212.3
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|.+. .+++.||||++..... ......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 3899999999999876 4678999999975432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 76 VKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+.||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~ 189 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccc
Confidence 999999999864 357999999999999999999999999999999999999999999999999997554
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.
T Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (322)
T 1p4o_A 190 ETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM 268 (322)
T ss_dssp GGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 3322222344567899999999987776 589999999999999999 899999988888887777654 4567789999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.+||.+||+.||.+|||+.++++|
T Consensus 269 l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 269 LFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=355.10 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=210.3
Q ss_pred CcccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++ ..+..|+||||+.|
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 3899999999999864 578899999997653 334567899999999999999999999999 45669999999999
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHTT 155 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~ 155 (416)
++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 173 (287)
T 1u59_A 94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173 (287)
T ss_dssp EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccc
Confidence 999999964 5699999999999999999999999999999999999999999999999999975432211 1112334
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|+.+++.+.++|.+||+.
T Consensus 174 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~ 252 (287)
T 1u59_A 174 KWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIY 252 (287)
T ss_dssp CCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred cccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCC
Confidence 56889999999987766 489999999999999998 999999988777777776654 567788999999999999999
Q ss_pred CCCCcCCHHHHhcCcc
Q 014911 234 NPNSRIAISKIMESSW 249 (416)
Q Consensus 234 dP~~R~s~~eil~hp~ 249 (416)
||.+|||+.+++++.+
T Consensus 253 ~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 253 KWEDRPDFLTVEQRMR 268 (287)
T ss_dssp SGGGSCCHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHH
Confidence 9999999999998744
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=363.27 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=208.4
Q ss_pred CcccCCceEEEEEE-----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++......|+||||
T Consensus 37 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp ECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 38999999999999 56788899999996432 234456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC---CeEEeecccccccc
Q 014911 76 VKGGELFNKIAKG--------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~---~~kl~DFGla~~~~ 144 (416)
++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~ 194 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccc
Confidence 9999999999752 389999999999999999999999999999999999999544 59999999987544
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++.
T Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (327)
T 2yfx_A 195 RASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 273 (327)
T ss_dssp C------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 3332233345568999999999987776 589999999999999998 999999988877777776654 4566789999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
+.++|.+||+.||.+|||+.++++|.|+-.
T Consensus 274 l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 274 VYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999988743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=361.45 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=207.4
Q ss_pred CcccCCceEEEEEEE-----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|.+ ..+++.||||++..... ....+.+.+|+.+++.+ +||||+++++++...+..|+|||
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 389999999999985 45788999999975532 23457899999999999 99999999999999999999999
Q ss_pred ccCCCchhhHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 75 LVKGGELFNKIAKG-------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 75 ~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 187 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEEC
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEc
Confidence 99999999999753 38999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHH-HhC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKI-YRG-D 212 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i-~~~-~ 212 (416)
|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.......... ..+ .
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 266 (313)
T 1t46_A 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (313)
T ss_dssp CCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred cccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC
Confidence 9999976544332223344567889999999987766 599999999999999999 99999886544333333 332 2
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 213 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 213 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 34567789999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=354.98 Aligned_cols=240 Identities=24% Similarity=0.398 Sum_probs=211.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||+.|++
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp ESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred ecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 3899999999999999999999999996543 345788899999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ........+
T Consensus 96 L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~ 174 (288)
T 3kfa_A 96 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKF 174 (288)
T ss_dssp HHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEE
T ss_pred HHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCcc
Confidence 9999975 459999999999999999999999999999999999999999999999999997544221 122334457
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....|..+++.+.+||.+||+.||
T Consensus 175 ~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 253 (288)
T 3kfa_A 175 PIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 253 (288)
T ss_dssp CGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCCh
Confidence 889999999988776 599999999999999999 99999988777776666655 456677899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 254 ~~Rps~~~~~~ 264 (288)
T 3kfa_A 254 SDRPSFAEIHQ 264 (288)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.85 Aligned_cols=238 Identities=22% Similarity=0.295 Sum_probs=202.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.+ +||||+++++++...+..|+||||+ |+
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp ECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 489999999999999999999999998755322 3578999999999 9999999999999999999999999 99
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC-----eEEeeccccccccccccCC--
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-----LKVTDFGLSAFSEHLKQDG-- 150 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~-----~kl~DFGla~~~~~~~~~~-- 150 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++..........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 169 (330)
T 2izr_A 90 SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169 (330)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBC
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccc
Confidence 99999974 67999999999999999999999999999999999999998887 9999999998643322111
Q ss_pred ---cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC---CcHHHHHHHHHhCCCCCC-----CCC
Q 014911 151 ---LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDFKCP-----PWF 219 (416)
Q Consensus 151 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~~p-----~~~ 219 (416)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+....+..+.......| ..+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (330)
T 2izr_A 170 PYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENF 248 (330)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTC
T ss_pred cccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccC
Confidence 1346789999999999988776 5999999999999999999999987 344455555544332222 224
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+ ++.++|..||+.||.+||++.++++
T Consensus 249 p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 249 P-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp H-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred h-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 4 9999999999999999999998875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=362.81 Aligned_cols=244 Identities=22% Similarity=0.409 Sum_probs=210.0
Q ss_pred CcccCCceEEEEEEEc-------CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNL-------QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||+||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus 42 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred EEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 3899999999999986 467789999997553 234567889999999999 899999999999999999999
Q ss_pred EeccCCCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 199 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEc
Confidence 9999999999999752 38999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 213 (416)
|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 200 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 278 (334)
T 2pvf_A 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278 (334)
T ss_dssp CCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC
T ss_pred cccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC
Confidence 9999975443222122234457889999999987766 589999999999999999 999999988888877777664 4
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 279 DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5677899999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=371.07 Aligned_cols=243 Identities=26% Similarity=0.487 Sum_probs=199.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-----------CCCcceEEEEEEeCC--
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----------HKHIVELHEVMASKS-- 67 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~~~~~~-- 67 (416)
.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 101 (373)
T 1q8y_A 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101 (373)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred eeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence 3899999999999999999999999996543 23467889999999886 899999999987654
Q ss_pred --EEEEEEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEecc------CCCeEEe
Q 014911 68 --KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDE------DGNLKVT 135 (416)
Q Consensus 68 --~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~------~~~~kl~ 135 (416)
.+++||||+ |++|.+++.. +.+++..+..++.||+.||.|||++ ||+||||||+|||++. .+.+||+
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~ 180 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred CceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEc
Confidence 899999999 8899999975 4599999999999999999999998 9999999999999954 3479999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH------HHHHHHHH
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI------VSMYRKIY 209 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~------~~~~~~i~ 209 (416)
|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+. ......+.
T Consensus 181 Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 181 DLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp CCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred ccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 9999975432 2344579999999999988776 5999999999999999999999986541 11111111
Q ss_pred ------------------------------------------hCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 210 ------------------------------------------RGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 210 ------------------------------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.....+|+.+++++.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 11223334456789999999999999999999999999
Q ss_pred ccccccC
Q 014911 248 SWFKKSA 254 (416)
Q Consensus 248 p~f~~~~ 254 (416)
|||+...
T Consensus 335 p~f~~~~ 341 (373)
T 1q8y_A 335 PWLKDTL 341 (373)
T ss_dssp GGGTTCT
T ss_pred hhhhccc
Confidence 9998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.39 Aligned_cols=242 Identities=21% Similarity=0.362 Sum_probs=200.7
Q ss_pred CcccCCceEEEEEEEcCCCcEE----EEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.... .++|+||+
T Consensus 22 ~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 4899999999999999888866 555553322 2234578899999999999999999999998765 78999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~ 178 (327)
T 3lzb_A 99 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178 (327)
T ss_dssp SSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccC
Confidence 99999999975 5799999999999999999999999999999999999999999999999999986544333333344
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.|+.++.++.+||.+||+
T Consensus 179 ~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 257 (327)
T 3lzb_A 179 GKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWM 257 (327)
T ss_dssp -CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTC
T ss_pred CCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 567889999999988776 499999999999999999 999999987777766666553 56778899999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.||.+|||+.++++
T Consensus 258 ~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 258 IDADSRPKFRELII 271 (327)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=354.53 Aligned_cols=242 Identities=25% Similarity=0.387 Sum_probs=197.6
Q ss_pred CcccCCceEEEEEEEcCC---CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .+..|+||||+.
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 98 (281)
T 1mp8_A 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 98 (281)
T ss_dssp EEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence 389999999999998654 4579999986542 3345678899999999999999999999984 567899999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 177 (281)
T 1mp8_A 99 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKG 177 (281)
T ss_dssp TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc-ccccccC
Confidence 9999999975 369999999999999999999999999999999999999999999999999997654321 1122334
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.|+.+++.+.++|.+||+.
T Consensus 178 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (281)
T 1mp8_A 178 KLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 256 (281)
T ss_dssp -CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 56789999999987776 489999999999999996 999999887777777776654 567788999999999999999
Q ss_pred CCCCcCCHHHHhcC
Q 014911 234 NPNSRIAISKIMES 247 (416)
Q Consensus 234 dP~~R~s~~eil~h 247 (416)
||.+|||+.+++++
T Consensus 257 ~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 257 DPSRRPRFTELKAQ 270 (281)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=357.77 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=202.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++...+..|+||||++|++
T Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 2h34_A 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120 (309)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEE
T ss_pred EEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCC
Confidence 48999999999999999999999999976655444556889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ........||+
T Consensus 121 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~ 199 (309)
T 2h34_A 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTL 199 (309)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCG
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCc
Confidence 9999976 779999999999999999999999999999999999999999999999999987544321 12234567999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..... ..++.+++.+.++|.+||+.||.
T Consensus 200 ~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 278 (309)
T 2h34_A 200 YYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPE 278 (309)
T ss_dssp GGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGG
T ss_pred CccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHH
Confidence 9999999977665 5899999999999999999999998877655544443322 34567899999999999999999
Q ss_pred CcC-CHHHHhc
Q 014911 237 SRI-AISKIME 246 (416)
Q Consensus 237 ~R~-s~~eil~ 246 (416)
+|| |++++++
T Consensus 279 ~Rp~s~~~l~~ 289 (309)
T 2h34_A 279 DRYVTCGDLSA 289 (309)
T ss_dssp GSCSSHHHHHH
T ss_pred HHHHhHHHHHH
Confidence 999 7888764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=361.04 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCCcEE--EEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSM--AMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||.||+|++..+|..+ |+|.+.... .......+.+|+.+++++ +||||+++++++.+.+..|+||||++
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 4899999999999999888865 999886432 223456788999999999 89999999999999999999999999
Q ss_pred CCchhhHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 78 GGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 78 gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~ 189 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence 99999999753 5999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 218 (416)
..... ........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..
T Consensus 190 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 1fvr_A 190 RGQEV---YVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265 (327)
T ss_dssp ESSCE---ECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTT
T ss_pred ccccc---cccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCC
Confidence 74322 112234457889999999987766 589999999999999998 99999999888888777665 3456778
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+++.+.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 266 CDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=350.03 Aligned_cols=236 Identities=19% Similarity=0.308 Sum_probs=205.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E~~~g 78 (416)
.||+|+||+||+|++ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+. ...|+||||++|
T Consensus 17 ~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 17 KLNENHSGELWKGRW--QGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEETTEEEEEEEE--TTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HhcCCCcceEEEEEE--CCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 389999999999998 4889999999765433 24457799999999999999999999999887 789999999999
Q ss_pred CchhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCCeEEeeccccccccccccCCccc
Q 014911 79 GELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 79 g~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
|+|.+++... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++... ...
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-------~~~ 166 (271)
T 3kmu_A 94 GSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSP 166 (271)
T ss_dssp CBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-------SCT
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee-------ccc
Confidence 9999999863 4899999999999999999999999 999999999999999999999999986532 223
Q ss_pred ccccCCCCCchHHhhhcCCCC--chhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Q 014911 154 TTCGTPAYVAPEVISKKGYDG--AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITK 229 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~--~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 229 (416)
...||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.++|.+
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 457899999999998755432 3799999999999999999999998877776666544 346678899999999999
Q ss_pred ccCCCCCCcCCHHHHhc
Q 014911 230 LLDPNPNSRIAISKIME 246 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~ 246 (416)
||+.||.+|||+.++++
T Consensus 247 ~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 247 CMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=348.78 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=209.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++
T Consensus 15 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 15 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred EecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 3899999999999985 6789999999765432 3678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........++
T Consensus 90 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~ 168 (267)
T 3t9t_A 90 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFP 168 (267)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCC
T ss_pred HHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-cccccccccc
Confidence 9999975 569999999999999999999999999999999999999999999999999987543221 1112334578
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|..+++.+.++|.+||+.||.
T Consensus 169 ~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 247 (267)
T 3t9t_A 169 VKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 247 (267)
T ss_dssp GGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChh
Confidence 88999999987776 589999999999999999 999999988888888877663 455677899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||+.+++++
T Consensus 248 ~Rps~~~ll~~ 258 (267)
T 3t9t_A 248 DRPAFSRLLRQ 258 (267)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=362.50 Aligned_cols=240 Identities=19% Similarity=0.249 Sum_probs=195.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----KIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~ 76 (416)
+||+|+||+||+|++ .++.||||++.... .......+|+.+++.++||||+++++++.... .+|+||||+
T Consensus 31 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 31 VKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEECSTTCEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred eecccCceEEEEEEE--CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 489999999999987 48999999996543 23345667999999999999999999997743 589999999
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR----------GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~----------gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
++|+|.+++..+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~ 184 (322)
T 3soc_A 105 EKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184 (322)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTT
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccc
Confidence 999999999988899999999999999999999999 9999999999999999999999999999765544
Q ss_pred ccCCcccccccCCCCCchHHhhhcCC----CCchhhHHHHHHHHHHHhcCCCCCCCCc----------------HHHHHH
Q 014911 147 KQDGLLHTTCGTPAYVAPEVISKKGY----DGAKADIWSCGVILYVLLAGFLPFQDDN----------------IVSMYR 206 (416)
Q Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DvwSlGvil~~lltG~~Pf~~~~----------------~~~~~~ 206 (416)
.........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.. ......
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (322)
T 3soc_A 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQE 264 (322)
T ss_dssp SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHH
T ss_pred cCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhh
Confidence 33334455689999999999976322 2357899999999999999999997532 222333
Q ss_pred HHHhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 207 KIYRGDF--KCPPW-----FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 207 ~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+..... ..+.. .++.+.+||.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 265 VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3322221 11111 2345999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=355.26 Aligned_cols=242 Identities=23% Similarity=0.389 Sum_probs=199.1
Q ss_pred CcccCCceEEEEEE----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 74 (416)
.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred eeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 38999999999998 5678999999998644 23455788999999999999999999999854 456899999
Q ss_pred ccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cc
Q 014911 75 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~ 151 (416)
|++||+|.+++.. .++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173 (295)
T ss_dssp CCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----------
T ss_pred eCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeee
Confidence 9999999999976 45999999999999999999999999999999999999999999999999999865432211 12
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH----------------HHHHHHHh-CCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV----------------SMYRKIYR-GDFK 214 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~----------------~~~~~i~~-~~~~ 214 (416)
.....+++.|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+.. ...+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 3ugc_A 174 KEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252 (295)
T ss_dssp --CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC
T ss_pred ccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC
Confidence 233457778999999988876 59999999999999999999998754321 12222222 2456
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 215 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 253 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67889999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.93 Aligned_cols=243 Identities=20% Similarity=0.318 Sum_probs=205.7
Q ss_pred CcccCCceEEEEEEE--cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++ ..+..|+||||+.|
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 389999999999954 56788999999976542 234467899999999999999999999999 56778999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Ccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTC 156 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 156 (416)
++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .......
T Consensus 102 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 181 (291)
T 1xbb_A 102 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181 (291)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCC
Confidence 999999986 56999999999999999999999999999999999999999999999999998754332111 1112234
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 234 (416)
+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.+.++|.+||+.|
T Consensus 182 ~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 260 (291)
T 1xbb_A 182 WPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 260 (291)
T ss_dssp CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 6788999999987766 489999999999999999 999999988887777776654 5667889999999999999999
Q ss_pred CCCcCCHHHHhc
Q 014911 235 PNSRIAISKIME 246 (416)
Q Consensus 235 P~~R~s~~eil~ 246 (416)
|.+|||+.++++
T Consensus 261 p~~Rps~~~l~~ 272 (291)
T 1xbb_A 261 VENRPGFAAVEL 272 (291)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=368.25 Aligned_cols=243 Identities=20% Similarity=0.330 Sum_probs=198.7
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|++++||||+++++++...+..|+||||++
T Consensus 52 ~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp EEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 4899999999999886 567789999996543 23455789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-cccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHT 154 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 154 (416)
||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ....
T Consensus 130 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 209 (373)
T 2qol_A 130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209 (373)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccC
Confidence 9999999976 469999999999999999999999999999999999999999999999999998654322111 1122
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 232 (416)
..+++.|+|||++....+ +.++|||||||++|+|++ |..||...+.......+..+ ..+.|..++..+.+||.+||+
T Consensus 210 ~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~ 288 (373)
T 2qol_A 210 GKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288 (373)
T ss_dssp ----CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTC
T ss_pred CCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhC
Confidence 245778999999988776 489999999999999998 99999998888777777655 345566789999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
.||.+|||+.++++
T Consensus 289 ~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 289 KDRNNRPKFEQIVS 302 (373)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhhCcCHHHHHH
Confidence 99999999999885
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=362.43 Aligned_cols=243 Identities=22% Similarity=0.356 Sum_probs=206.8
Q ss_pred CcccCCceEEEEEEEcCCCc-----EEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGK-----SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++...+..|+|||
T Consensus 53 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 48999999999999987665 79999997553 224457889999999999 89999999999999999999999
Q ss_pred ccCCCchhhHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccc
Q 014911 75 LVKGGELFNKIAK---------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 139 (416)
Q Consensus 75 ~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGl 139 (416)
|+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 210 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGG
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccc
Confidence 9999999999863 2479999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCC
Q 014911 140 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG--DFKCP 216 (416)
Q Consensus 140 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p 216 (416)
+................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+... ....|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
T 2i1m_A 211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289 (333)
T ss_dssp GCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred ccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC
Confidence 986543322222344567889999999988776 599999999999999998 99999886544444333332 34557
Q ss_pred CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 217 PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 217 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
..+++.+.+||.+||+.||.+|||+.++++
T Consensus 290 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 290 AFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 778999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=351.37 Aligned_cols=239 Identities=18% Similarity=0.266 Sum_probs=203.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +|||++++++++......|+||||+ |+
T Consensus 17 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 38999999999999999999999999865432 23577899999999 7999999999999999999999999 99
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC-----eEEeeccccccccccccC---
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-----LKVTDFGLSAFSEHLKQD--- 149 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~-----~kl~DFGla~~~~~~~~~--- 149 (416)
+|.+++.. .++++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (298)
T 1csn_A 91 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170 (298)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBC
T ss_pred CHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccc
Confidence 99999975 46999999999999999999999999999999999999988776 999999999865433221
Q ss_pred --CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---cHHHHHHHHHhCCC-----CCCCCC
Q 014911 150 --GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDF-----KCPPWF 219 (416)
Q Consensus 150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~-----~~p~~~ 219 (416)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+..+..... ..++.+
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1csn_A 171 PYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 249 (298)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTS
T ss_pred cccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhC
Confidence 12345679999999999987776 59999999999999999999999873 33444444433221 223568
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++++.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 250 PEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 999999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=357.53 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=198.8
Q ss_pred CcccCCceEEEEEEEcC---CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~lV 72 (416)
.||+|+||+||+|.+.. ++..||+|++...... ....+.+.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 41 ~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v 119 (313)
T 3brb_A 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119 (313)
T ss_dssp EEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEE
T ss_pred ceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEE
Confidence 38999999999998765 5668999999765432 344578899999999999999999999987755 35999
Q ss_pred EeccCCCchhhHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 73 MDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
|||+.+|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199 (313)
T ss_dssp EECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred EecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999999999999831 4699999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHH
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEA 223 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 223 (416)
...........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+
T Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 278 (313)
T 3brb_A 200 GDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDEL 278 (313)
T ss_dssp -----------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHH
T ss_pred ccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 322223344567889999999987766 589999999999999999 99999988877777777665 356677899999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcC
Q 014911 224 RRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.++|.+||+.||.+|||+.+++++
T Consensus 279 ~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 279 YEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=349.41 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=201.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM----MEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~ 103 (287)
T 4f0f_A 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFV 103 (287)
T ss_dssp ECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECC
T ss_pred ccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEec
Confidence 3899999999999999999999999997654332221 267899999999999999999999997666 7999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCC-----eEEeeccccccccccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGN-----LKVTDFGLSAFSEHLK 147 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~-----~kl~DFGla~~~~~~~ 147 (416)
+||+|.+.+.. ..+++..+..++.|++.||.|||++| |+||||||+||+++.++. +||+|||++....
T Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~--- 180 (287)
T 4f0f_A 104 PCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--- 180 (287)
T ss_dssp TTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS---
T ss_pred CCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc---
Confidence 99999998864 57999999999999999999999999 999999999999998886 9999999987332
Q ss_pred cCCcccccccCCCCCchHHhhh-cCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH--HHHHHHHhC--CCCCCCCCCHH
Q 014911 148 QDGLLHTTCGTPAYVAPEVISK-KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV--SMYRKIYRG--DFKCPPWFSSE 222 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~--~~~~~i~~~--~~~~p~~~s~~ 222 (416)
.......||+.|+|||++.. ....+.++||||+||++|+|++|..||...+.. .....+... ....|..+++.
T Consensus 181 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T 4f0f_A 181 --HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258 (287)
T ss_dssp --SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred --ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHH
Confidence 23445679999999999843 222358999999999999999999999875432 223333333 34567789999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.+||.+||+.||.+|||+.++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=362.87 Aligned_cols=243 Identities=24% Similarity=0.367 Sum_probs=201.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+||||++||+
T Consensus 46 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 46 LIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp CSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred eeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 489999999999996 578999999886543 2346788999999999999999999999999999999999999999
Q ss_pred hhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAKG-----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~~-----~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...............
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 201 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCC
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccccc
Confidence 99999652 4899999999999999999999999999999999999999999999999999754433333334556
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHH-------HHHHHhCCC----------CCCCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM-------YRKIYRGDF----------KCPPW 218 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~-------~~~i~~~~~----------~~p~~ 218 (416)
.||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ......+.. ..++.
T Consensus 202 ~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T 2qkw_B 202 KGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280 (321)
T ss_dssp EEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHH
T ss_pred CCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHH
Confidence 79999999999987776 5899999999999999999999976432111 111111111 11222
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcCc
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMESS 248 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp 248 (416)
.+..+.+++.+||+.||.+|||+.+++++.
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 456789999999999999999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=359.83 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=184.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++...+..|+||||+.|
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred eeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 38999999999999999999999999976532 223345556665 77788999999999999999999999999986
Q ss_pred chhhHHh------cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 80 ELFNKIA------KGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 80 ~L~~~i~------~~~l~e~~~~~~~~qll~aL~ylH~~-gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
+|.+++. .+.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..... ....
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc---cccc
Confidence 7777765 36799999999999999999999999 999999999999999999999999999875432 2223
Q ss_pred cccccCCCCCchHHhh----hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCC-CC----CCCCCHH
Q 014911 153 HTTCGTPAYVAPEVIS----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDF-KC----PPWFSSE 222 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~-~~----p~~~s~~ 222 (416)
....||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+.. .. +..+++.
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261 (327)
T ss_dssp -----------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHH
T ss_pred ccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHH
Confidence 3457999999999983 3444 58999999999999999999999875432 22222222221 12 2358999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 223 ARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+.+||.+||+.||.+|||+.++++||||....
T Consensus 262 l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999999999999999999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=358.21 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=206.1
Q ss_pred CcccCCceEEEEEEE-----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC-EEEEEE
Q 014911 1 MLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS-KIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~-~~~lV~ 73 (416)
.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+++.+ +||||+++++++...+ .+|+||
T Consensus 34 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred EEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 389999999999985 3577899999997553 223456789999999999 7999999999987654 599999
Q ss_pred eccCCCchhhHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEee
Q 014911 74 DLVKGGELFNKIAKGR-----------------LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 136 (416)
Q Consensus 74 E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~D 136 (416)
||++||+|.+++.... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 191 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 191 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECC
Confidence 9999999999997632 88999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcH-HHHHHHHHhC-CC
Q 014911 137 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI-VSMYRKIYRG-DF 213 (416)
Q Consensus 137 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~-~~~~~~i~~~-~~ 213 (416)
||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+. ......+..+ ..
T Consensus 192 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 270 (316)
T 2xir_A 192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270 (316)
T ss_dssp CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred CccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC
Confidence 999975543222222344568899999999988776 499999999999999998 9999987653 3334444443 35
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677899999999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=349.76 Aligned_cols=243 Identities=31% Similarity=0.558 Sum_probs=197.7
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..|+||||+.+++
T Consensus 39 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (310)
T 2wqm_A 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118 (310)
T ss_dssp EEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCB
T ss_pred eecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCC
Confidence 38999999999999999999999999986555555567789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 81 LFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .......
T Consensus 119 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 196 (310)
T 2wqm_A 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSL 196 (310)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------
T ss_pred HHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC--Ccccccc
Confidence 9999863 56999999999999999999999999999999999999999999999999998754432 1223455
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC--cHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHcc
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKC--PPWFSSEARRLITKLL 231 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L 231 (416)
.||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +.......+.....+. +..+++++.+||.+||
T Consensus 197 ~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 275 (310)
T 2wqm_A 197 VGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 275 (310)
T ss_dssp --CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHT
T ss_pred CCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHc
Confidence 79999999999987766 58999999999999999999999764 3344555555544322 2568999999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
+.||.+|||+.++++
T Consensus 276 ~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 276 NPDPEKRPDVTYVYD 290 (310)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhhCCCHHHHHH
Confidence 999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=357.08 Aligned_cols=244 Identities=20% Similarity=0.315 Sum_probs=203.3
Q ss_pred CcccCCceEEEEEEEcCCC----cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTG----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 51 ~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4899999999999986553 469999997543 2344567889999999999999999999999999999999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-ccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLH 153 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~ 153 (416)
.||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......... ...
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 208 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccC
Confidence 99999999975 579999999999999999999999999999999999999999999999999997654322111 112
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L 231 (416)
...+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.++|.+||
T Consensus 209 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 287 (333)
T 1mqb_A 209 GGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 287 (333)
T ss_dssp --CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHT
T ss_pred CCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHc
Confidence 2346788999999987766 589999999999999999 99999988888777777765 35667789999999999999
Q ss_pred CCCCCCcCCHHHHhcC
Q 014911 232 DPNPNSRIAISKIMES 247 (416)
Q Consensus 232 ~~dP~~R~s~~eil~h 247 (416)
+.||.+|||+.+++++
T Consensus 288 ~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 288 QQERARRPKFADIVSI 303 (333)
T ss_dssp CSSTTTSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.77 Aligned_cols=243 Identities=26% Similarity=0.437 Sum_probs=201.4
Q ss_pred CcccCCceEEEEEE----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEe
Q 014911 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~E 74 (416)
.||+|+||+||+|+ +..+++.||||++.... .....+.+.+|+.+++.++||||+++++++... ..+|+|||
T Consensus 28 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred ccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 38999999999999 56789999999997554 223457889999999999999999999999876 67999999
Q ss_pred ccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cc
Q 014911 75 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~ 151 (416)
|++||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ..
T Consensus 106 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 185 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 185 (302)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEEC
T ss_pred eCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceec
Confidence 9999999999954 57999999999999999999999999999999999999999999999999999765432211 12
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC---------------cHHHHHHHHHhC-CCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------------NIVSMYRKIYRG-DFKC 215 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~---------------~~~~~~~~i~~~-~~~~ 215 (416)
.....||+.|+|||++.+..+. .++||||+||++|+|++|..|+... ........+..+ ..+.
T Consensus 186 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T 4e5w_A 186 KDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC 264 (302)
T ss_dssp CCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCC
T ss_pred cCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCC
Confidence 3345688889999999887764 8999999999999999999986432 112223333332 4567
Q ss_pred CCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 216 PPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 216 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
|+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 265 PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 7889999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=348.37 Aligned_cols=237 Identities=29% Similarity=0.489 Sum_probs=204.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe---------------
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--------------- 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------------- 65 (416)
.||+|+||.||+|++..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 4899999999999999999999999997543 346689999999999999999998854
Q ss_pred -CCEEEEEEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 66 -KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 66 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
...+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 4568999999999999999964 579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCH
Q 014911 142 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS 221 (416)
Q Consensus 142 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 221 (416)
.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ......+..+ ..+..+++
T Consensus 171 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~ 242 (284)
T 2a19_B 171 SLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--IISDIFDK 242 (284)
T ss_dssp ESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCH
T ss_pred eccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccccCCH
Confidence 5433 223345679999999999987766 58999999999999999999988542 2333344333 35677899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
.+.+||.+||+.||.+|||+.++++|+|.-.
T Consensus 243 ~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999988643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=349.93 Aligned_cols=243 Identities=20% Similarity=0.338 Sum_probs=206.3
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-EEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI-YFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~lV~E~~ 76 (416)
+||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. |+||||+
T Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred eeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 48999999999999766555 79999986532 334567889999999999999999999999776655 9999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc--cCCcc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK--QDGLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~ 152 (416)
.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 185 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccC
Confidence 99999999975 568999999999999999999999999999999999999999999999999997543322 12233
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHc
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 230 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 230 (416)
....+|+.|+|||.+.+..+ +.++||||+||++|+|++ |.+||...+.......+..+. ...|..+++.+.+||.+|
T Consensus 186 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 264 (298)
T 3pls_A 186 RHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQC 264 (298)
T ss_dssp SCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHH
Confidence 44568899999999987766 489999999999999999 666677776666666665554 456778999999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|+.||.+|||+.++++
T Consensus 265 l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 265 WEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=369.97 Aligned_cols=233 Identities=24% Similarity=0.453 Sum_probs=202.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-KIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~~~gg 79 (416)
.||+|+||+||+|.+ +|+.||||++.... ..+.+.+|+.+|++++||||+++++++.... .+|+||||+++|
T Consensus 200 ~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 200 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred eecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 389999999999998 47899999997543 3367889999999999999999999987655 799999999999
Q ss_pred chhhHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~-~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. + .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-----~~~~~~ 347 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGK 347 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------C
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-----cccCCC
Confidence 99999975 3 379999999999999999999999999999999999999999999999999874322 122346
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d 234 (416)
+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.|
T Consensus 348 ~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d 426 (450)
T 1k9a_A 348 LPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLD 426 (450)
T ss_dssp CCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 7889999999987776 489999999999999998 99999988777777777665 45678889999999999999999
Q ss_pred CCCcCCHHHHhc
Q 014911 235 PNSRIAISKIME 246 (416)
Q Consensus 235 P~~R~s~~eil~ 246 (416)
|.+|||+.++++
T Consensus 427 p~~Rpt~~~l~~ 438 (450)
T 1k9a_A 427 AATRPTFLQLRE 438 (450)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.62 Aligned_cols=240 Identities=23% Similarity=0.447 Sum_probs=188.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++. ..||+|++..... .....+.+.+|+.+++.++||||++++++. .....++||||+.|++
T Consensus 31 ~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 31 RIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred EecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 3899999999999863 3599999976543 334567899999999999999999999965 5566899999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++................||
T Consensus 106 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 185 (289)
T 3og7_A 106 LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185 (289)
T ss_dssp HHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CC
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCC
Confidence 9999964 57999999999999999999999999999999999999999999999999999765543334445566899
Q ss_pred CCCCchHHhh---hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCCC-----CCCCCCHHHHHHHHH
Q 014911 159 PAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFK-----CPPWFSSEARRLITK 229 (416)
Q Consensus 159 ~~y~aPE~~~---~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~~-----~p~~~s~~~~~li~~ 229 (416)
+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+. ......+..+... .+..+++.+.+||.+
T Consensus 186 ~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (289)
T 3og7_A 186 ILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 264 (289)
T ss_dssp CTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHH
T ss_pred ccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHH
Confidence 9999999986 3333 5799999999999999999999987544 3444444444332 234678999999999
Q ss_pred ccCCCCCCcCCHHHHhc
Q 014911 230 LLDPNPNSRIAISKIME 246 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~ 246 (416)
||+.||.+|||+.++++
T Consensus 265 ~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 265 CLKKKRDERPSFPRILA 281 (289)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=378.35 Aligned_cols=240 Identities=23% Similarity=0.401 Sum_probs=209.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+..++..||||++..... ..+.+.+|+.+|++++||||+++++++.....+|+||||+.+|+
T Consensus 227 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp ESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 38999999999999999999999999975432 35678999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ........+
T Consensus 303 L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~ 381 (495)
T 1opk_A 303 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKF 381 (495)
T ss_dssp HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCC
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcC
Confidence 9999975 458999999999999999999999999999999999999999999999999998643211 111223346
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+||.+||+.||
T Consensus 382 ~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 460 (495)
T 1opk_A 382 PIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 460 (495)
T ss_dssp CGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcCh
Confidence 778999999987766 589999999999999999 99999998877777666654 356678899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 461 ~~RPs~~el~~ 471 (495)
T 1opk_A 461 SDRPSFAEIHQ 471 (495)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=347.45 Aligned_cols=242 Identities=25% Similarity=0.366 Sum_probs=202.9
Q ss_pred CcccCCceEEEEEEEcC---CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.++ ..|+||||+.
T Consensus 19 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~ 95 (281)
T 3cc6_A 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYP 95 (281)
T ss_dssp EEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCT
T ss_pred EEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCC
Confidence 48999999999998754 34469999997653 224467899999999999999999999998654 5689999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .......
T Consensus 96 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 174 (281)
T 3cc6_A 96 YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVT 174 (281)
T ss_dssp TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CC
T ss_pred CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc-ccccccC
Confidence 9999999975 469999999999999999999999999999999999999999999999999987544321 1122344
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+|+.|+|||++....+ +.++|||||||++|+|++ |..||...+.......+..+ ..+.|..+++.+.++|.+||+.
T Consensus 175 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 253 (281)
T 3cc6_A 175 RLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDY 253 (281)
T ss_dssp CCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 57889999999987776 589999999999999998 99999877666666666554 3566778999999999999999
Q ss_pred CCCCcCCHHHHhcC
Q 014911 234 NPNSRIAISKIMES 247 (416)
Q Consensus 234 dP~~R~s~~eil~h 247 (416)
||.+|||+.+++++
T Consensus 254 ~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 254 DPSDRPRFTELVCS 267 (281)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=370.65 Aligned_cols=238 Identities=24% Similarity=0.409 Sum_probs=206.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ...+|+||||+.+|+
T Consensus 195 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 195 KLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 3899999999999984 577899999975432 3578899999999999999999999986 667899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......+
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~ 347 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKF 347 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSS
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcc
Confidence 9999975 3699999999999999999999999999999999999999999999999999986432211 11223346
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||
T Consensus 348 ~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp 426 (454)
T 1qcf_A 348 PIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 426 (454)
T ss_dssp CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 778999999987776 599999999999999999 99999998888887777765 356678899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 427 ~~RPt~~~i~~ 437 (454)
T 1qcf_A 427 EERPTFEYIQS 437 (454)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=349.72 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCC---cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM-ASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..++ ..+|+|.+.... .....+.+.+|+.++++++||||+++++++ ..++..|+||||+
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred eeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 4899999999999975433 368999886533 334567889999999999999999999985 5567889999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc--CCcc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~ 152 (416)
.||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 189 (298)
T 3f66_A 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189 (298)
T ss_dssp TTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC---
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccc
Confidence 99999999975 5689999999999999999999999999999999999999999999999999975433221 1223
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKL 230 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 230 (416)
....+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+.. ..|..+++.+.++|.+|
T Consensus 190 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 268 (298)
T 3f66_A 190 TGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 268 (298)
T ss_dssp --CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHH
Confidence 34567889999999988776 489999999999999999 7888888776666666665543 45677899999999999
Q ss_pred cCCCCCCcCCHHHHhc
Q 014911 231 LDPNPNSRIAISKIME 246 (416)
Q Consensus 231 L~~dP~~R~s~~eil~ 246 (416)
|+.||.+|||+.++++
T Consensus 269 l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 269 WHPKAEMRPSFSELVS 284 (298)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=383.31 Aligned_cols=242 Identities=20% Similarity=0.324 Sum_probs=206.4
Q ss_pred cccCCceEEEEEEE--cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ...|+||||+.||
T Consensus 377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g 454 (635)
T 4fl3_A 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 454 (635)
T ss_dssp EEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred eccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence 89999999999955 46778999999976533 33456789999999999999999999999965 4588999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccccccc
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~g 157 (416)
+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......+
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~ 534 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCC
Confidence 99999976 67999999999999999999999999999999999999999999999999999865432211 12233456
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+||.+||+.||
T Consensus 535 t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP 613 (635)
T 4fl3_A 535 PVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 613 (635)
T ss_dssp CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred ceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence 788999999988777 499999999999999998 999999998888888877664 56788899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 614 ~~RPs~~~l~~ 624 (635)
T 4fl3_A 614 ENRPGFAAVEL 624 (635)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=348.38 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=198.5
Q ss_pred CcccCCceEEEEEEEcC-CCc--EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQ-TGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+.. +++ .||||++...........+.+.+|+.+++.++||||+++++++.... .++||||+.
T Consensus 25 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~ 103 (291)
T 1u46_A 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAP 103 (291)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCT
T ss_pred eecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEeccc
Confidence 38999999999998643 333 69999997665444456788999999999999999999999998765 899999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Ccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHT 154 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 154 (416)
+++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... .....
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 183 (291)
T 1u46_A 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183 (291)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred CCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhcc
Confidence 9999999975 56999999999999999999999999999999999999999999999999998765432211 11234
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHcc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L 231 (416)
..+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+.... .+.+..+++.+.++|.+||
T Consensus 184 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 262 (291)
T 1u46_A 184 RKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262 (291)
T ss_dssp --CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHc
Confidence 467888999999987766 489999999999999999 999999988888887776653 4456679999999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
+.||.+|||+.++++
T Consensus 263 ~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 263 AHKPEDRPTFVALRD 277 (291)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=368.12 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=189.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+|+.+ +||||+++++++.+.+.+|+|||||. |
T Consensus 22 ~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 22 ILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 48999999998764 4689999999986432 35678999999876 89999999999999999999999996 5
Q ss_pred chhhHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-------------CCeEEeecc
Q 014911 80 ELFNKIAKGRL--------REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-------------GNLKVTDFG 138 (416)
Q Consensus 80 ~L~~~i~~~~l--------~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-------------~~~kl~DFG 138 (416)
+|.+++..... ++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99999976332 233456799999999999999999999999999999754 379999999
Q ss_pred ccccccccccC--CcccccccCCCCCchHHhhh------cCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 014911 139 LSAFSEHLKQD--GLLHTTCGTPAYVAPEVISK------KGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 209 (416)
Q Consensus 139 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 209 (416)
++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+..... ..+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~ 251 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNII 251 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHh
Confidence 99865432211 12345689999999999965 1334689999999999999999 999998765432 2344
Q ss_pred hCCCCCCC-------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 210 RGDFKCPP-------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 210 ~~~~~~p~-------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.+....+. .+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 44333322 245789999999999999999999999999999754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.19 Aligned_cols=238 Identities=22% Similarity=0.372 Sum_probs=204.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.. +..|+||||+.|++
T Consensus 20 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 20 RLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (279)
T ss_dssp EEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred eecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCC
Confidence 3899999999999974 667899999965432 24678899999999999999999999864 45899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......+
T Consensus 94 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~ 172 (279)
T 1qpc_A 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKF 172 (279)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCC
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCC
Confidence 9999975 2699999999999999999999999999999999999999999999999999975443211 11233456
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.+.++|.+||+.||
T Consensus 173 ~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 251 (279)
T 1qpc_A 173 PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251 (279)
T ss_dssp CTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccCh
Confidence 889999999987666 589999999999999999 999999988877777776653 45667899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.++++
T Consensus 252 ~~Rps~~~l~~ 262 (279)
T 1qpc_A 252 EDRPTFDYLRS 262 (279)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCCCHHHHHH
Confidence 99999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=356.35 Aligned_cols=244 Identities=16% Similarity=0.169 Sum_probs=192.7
Q ss_pred CcccCCceEEEEEEEcC---CCcEEEEEEeecCcccchh--------hHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 014911 1 MLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVG--------MMEQIKREISVMKMVKHKHIVELHEVMAS---- 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 65 (416)
.||+|+||+||+|.+.. ++..||||++......... ....+.+|+.+++.++||||+++++++..
T Consensus 44 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~ 123 (345)
T 2v62_A 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123 (345)
T ss_dssp EC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSS
T ss_pred eEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCC
Confidence 48999999999999987 8889999999765321100 11346678899999999999999999988
Q ss_pred CCEEEEEEeccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC--CeEEeecccccc
Q 014911 66 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--NLKVTDFGLSAF 142 (416)
Q Consensus 66 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~--~~kl~DFGla~~ 142 (416)
....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 124 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 124 RSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202 (345)
T ss_dssp CEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEE
T ss_pred CcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCcee
Confidence 78999999999 9999999976 5799999999999999999999999999999999999999887 999999999976
Q ss_pred ccccccC-----CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC--CcHHHHHHHHHhCCCCC
Q 014911 143 SEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRGDFKC 215 (416)
Q Consensus 143 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~--~~~~~~~~~i~~~~~~~ 215 (416)
....... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+...............
T Consensus 203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 281 (345)
T 2v62_A 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL 281 (345)
T ss_dssp SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT
T ss_pred cccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccc
Confidence 5432211 12245679999999999987766 5999999999999999999999965 22222222111111112
Q ss_pred C---------CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 216 P---------PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 216 p---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
| ..+++++.++|.+||+.||.+|||+.++++
T Consensus 282 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 282 PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2 268899999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=352.63 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=200.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcc-cchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
||+|+||+||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+
T Consensus 39 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 116 (307)
T 2nru_A 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116 (307)
T ss_dssp EEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCc
Confidence 89999999999986 788999999975432 233456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++................
T Consensus 117 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 196 (307)
T 2nru_A 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV 196 (307)
T ss_dssp HHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCC
T ss_pred HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccC
Confidence 9999863 459999999999999999999999999999999999999999999999999987654332222334457
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH----HHHHHHHhCCC-----------CCCCCCCH
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDF-----------KCPPWFSS 221 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~----~~~~~i~~~~~-----------~~p~~~s~ 221 (416)
||+.|+|||++.+. + +.++|||||||++|+|++|..||...... .....+..... ..+...+.
T Consensus 197 g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (307)
T 2nru_A 197 GTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE 274 (307)
T ss_dssp SCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHH
T ss_pred CCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHH
Confidence 99999999998654 3 58999999999999999999999875432 22222222111 12223457
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.+.+++.+||+.||.+|||+.+++++
T Consensus 275 ~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 275 AMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.26 Aligned_cols=239 Identities=21% Similarity=0.296 Sum_probs=197.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE-VMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++|++++..+. +....+..|+||||+ ++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 489999999999999999999999998765432 35789999999999877655544 457788999999999 89
Q ss_pred chhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccC-----
Q 014911 80 ELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQD----- 149 (416)
Q Consensus 80 ~L~~~i~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~----- 149 (416)
+|.+++. .+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (296)
T 3uzp_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169 (296)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccc
Confidence 9999997 3679999999999999999999999999999999999999 48889999999999765433221
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCCCCC-----CCCCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKC-----PPWFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~-----p~~~s~ 221 (416)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ....+..+....... ++.+++
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T 3uzp_A 170 RENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 248 (296)
T ss_dssp CCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred ccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCH
Confidence 12345679999999999988776 589999999999999999999998632 222333333322222 367899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++.+||.+||+.||.+|||+.++++
T Consensus 249 ~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 249 EFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 9999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=366.62 Aligned_cols=242 Identities=24% Similarity=0.436 Sum_probs=199.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--KIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~lV~E~~~g 78 (416)
+||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+ ..|+||||++|
T Consensus 16 ~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 489999999999999999999999999754432 33567789999999999999999999998765 78999999999
Q ss_pred CchhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe----ccCCCeEEeeccccccccccccCC
Q 014911 79 GELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDG 150 (416)
Q Consensus 79 g~L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll----~~~~~~kl~DFGla~~~~~~~~~~ 150 (416)
|+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 94 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~ 170 (396)
T 4eut_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---E 170 (396)
T ss_dssp EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---G
T ss_pred CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC---C
Confidence 9999999752 39999999999999999999999999999999999999 77778999999999754432 2
Q ss_pred cccccccCCCCCchHHhhhc-------CCCCchhhHHHHHHHHHHHhcCCCCCCC----CcHHHHHHHHHhCCCC-----
Q 014911 151 LLHTTCGTPAYVAPEVISKK-------GYDGAKADIWSCGVILYVLLAGFLPFQD----DNIVSMYRKIYRGDFK----- 214 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~~lltG~~Pf~~----~~~~~~~~~i~~~~~~----- 214 (416)
.....+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.. .........+..+...
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~ 250 (396)
T 4eut_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250 (396)
T ss_dssp GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEE
T ss_pred ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchh
Confidence 33456799999999998752 2225789999999999999999999964 2233445555544321
Q ss_pred --------------CC------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 215 --------------CP------PWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 215 --------------~p------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.| ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred heeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 11 1134678899999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=353.06 Aligned_cols=243 Identities=25% Similarity=0.408 Sum_probs=204.4
Q ss_pred CcccCCceEEEEEE----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--SKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E 74 (416)
.||+|+||+||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++. +....|+|||
T Consensus 30 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 48999999999999 56789999999996542 344577899999999999999999999886 5678999999
Q ss_pred ccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cc
Q 014911 75 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~ 151 (416)
|++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ..
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 186 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186 (327)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEEC
T ss_pred ecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCcccee
Confidence 9999999999975 56999999999999999999999999999999999999999999999999999865432211 12
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH---------------HHHHHHHhC-CCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------------SMYRKIYRG-DFKC 215 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~---------------~~~~~i~~~-~~~~ 215 (416)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+..+ ..+.
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lxl_A 187 REPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265 (327)
T ss_dssp SSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC
T ss_pred eccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC
Confidence 234468888999999987766 58999999999999999999999654332 222333332 3466
Q ss_pred CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 216 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 216 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
|+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 266 PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=368.30 Aligned_cols=238 Identities=24% Similarity=0.390 Sum_probs=202.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|++++||||+++++++.. ...|+||||+++|+
T Consensus 191 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 191 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 38999999999999864 46799999976542 24678999999999999999999999866 67899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ........+
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~ 343 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKF 343 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------C
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcc
Confidence 9999964 469999999999999999999999999999999999999999999999999997544211 112233456
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|+.+++.+.+||.+||+.||
T Consensus 344 ~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP 422 (452)
T 1fmk_A 344 PIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422 (452)
T ss_dssp CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999987776 599999999999999999 99999998888887777665 356788899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||++++++
T Consensus 423 ~~Rpt~~~l~~ 433 (452)
T 1fmk_A 423 EERPTFEYLQA 433 (452)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=345.94 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=196.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE-VMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+. ++...+..|+||||+ ++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 489999999999999999999999987655432 35778999999998877666555 457788999999999 89
Q ss_pred chhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccC-----
Q 014911 80 ELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQD----- 149 (416)
Q Consensus 80 ~L~~~i~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~----- 149 (416)
+|.+++. .+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 169 (296)
T 4hgt_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169 (296)
T ss_dssp BHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCC
Confidence 9999997 3679999999999999999999999999999999999999 78899999999999865433221
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH---HHHHHHHHhCCCCC-----CCCCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---VSMYRKIYRGDFKC-----PPWFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~~~~~~~-----p~~~s~ 221 (416)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+. ...+..+....... +..+++
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T 4hgt_A 170 RENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 248 (296)
T ss_dssp CCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred CcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCH
Confidence 12345679999999999988776 5999999999999999999999976422 12222332222222 266899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++.+||.+||+.||.+|||+.++++
T Consensus 249 ~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 249 EFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 9999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=378.69 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=204.4
Q ss_pred cccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.+|+||||+.||
T Consensus 344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 799999999999875 456689999997653 22356789999999999999999999999976 5599999999999
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Ccccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 156 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......... .......
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 500 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCC
Confidence 99999964 56999999999999999999999999999999999999999999999999999764322111 1112234
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 234 (416)
+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|+.+++++.+||.+||+.|
T Consensus 501 ~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d 579 (613)
T 2ozo_A 501 WPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 579 (613)
T ss_dssp -CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 5689999999987776 489999999999999998 999999988888888887664 5678889999999999999999
Q ss_pred CCCcCCHHHHhc
Q 014911 235 PNSRIAISKIME 246 (416)
Q Consensus 235 P~~R~s~~eil~ 246 (416)
|.+|||+.++++
T Consensus 580 P~~RPs~~~l~~ 591 (613)
T 2ozo_A 580 WEDRPDFLTVEQ 591 (613)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=368.84 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=190.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||. ....+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+....|+||||+. |
T Consensus 31 ~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 31 VLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred eeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 489999999764 33468999999999654322 345899999999 79999999999999999999999996 5
Q ss_pred chhhHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CC--CeEEeecccccccccccc-CCc
Q 014911 80 ELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DG--NLKVTDFGLSAFSEHLKQ-DGL 151 (416)
Q Consensus 80 ~L~~~i~~~--~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~--~~kl~DFGla~~~~~~~~-~~~ 151 (416)
+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++ .+||+|||+|........ ...
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~ 182 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceee
Confidence 999999763 4666678899999999999999999999999999999953 23 578999999975543211 123
Q ss_pred ccccccCCCCCchHHhhhc--CCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCC---CCCCCHHHHH
Q 014911 152 LHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKC---PPWFSSEARR 225 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~ 225 (416)
....+||+.|+|||++... ...+.++|||||||++|+|++ |..||...........+....... +...+..+.+
T Consensus 183 ~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (432)
T 3p23_A 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE 262 (432)
T ss_dssp ---CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHH
T ss_pred ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHH
Confidence 3456799999999999742 223579999999999999999 999997765443332222222211 1224566899
Q ss_pred HHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 226 LITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
||.+||+.||.+|||+.++++||||...
T Consensus 263 li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 263 LIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 9999999999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=352.43 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=197.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA----SKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lV~E~~ 76 (416)
.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. .....|+||||+
T Consensus 36 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 4899999999999999999999999986542 345678899999999999999999999986 345899999999
Q ss_pred CCCchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-
Q 014911 77 KGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG- 150 (416)
Q Consensus 77 ~gg~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 150 (416)
.+|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~ 192 (317)
T 2buj_A 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192 (317)
T ss_dssp TTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHH
T ss_pred CCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccc
Confidence 99999999864 569999999999999999999999999999999999999999999999999887543211110
Q ss_pred ------cccccccCCCCCchHHhhhcCC--CCchhhHHHHHHHHHHHhcCCCCCCCCcHH--HHHHHHHh-CCCCCCCCC
Q 014911 151 ------LLHTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNIV--SMYRKIYR-GDFKCPPWF 219 (416)
Q Consensus 151 ------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGvil~~lltG~~Pf~~~~~~--~~~~~i~~-~~~~~p~~~ 219 (416)
......||+.|+|||++..... .+.++|||||||++|+|++|..||...... .....+.. ...+.++.+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (317)
T 2buj_A 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272 (317)
T ss_dssp HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTS
T ss_pred ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccC
Confidence 1123467999999999865432 358999999999999999999999642110 11112221 223445678
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
++.+.+||.+||+.||.+|||+.+++++
T Consensus 273 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 9999999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=351.20 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEE----cCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARN----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 74 (416)
.||+|+||+||+|.. ..+|+.||||++.... .......+.+|+.+++.++||||+++++++.+ ...+|+|||
T Consensus 38 ~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred eecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 389999999988754 4588999999997653 23456789999999999999999999999987 478999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLH 153 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 153 (416)
|+++|+|.+++....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ....
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 195 (318)
T 3lxp_A 116 YVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195 (318)
T ss_dssp CCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC--
T ss_pred cccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999765432111 1233
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH---------------HHHHHHHhC-CCCCCC
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------------SMYRKIYRG-DFKCPP 217 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~---------------~~~~~i~~~-~~~~p~ 217 (416)
...+|+.|+|||++.+..+. .++|||||||++|+|++|..||...... .....+..+ ..+.|.
T Consensus 196 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T 3lxp_A 196 DGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD 274 (318)
T ss_dssp -CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCT
T ss_pred CCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCc
Confidence 45678889999999877664 8999999999999999999999764321 122222222 346677
Q ss_pred CCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 218 WFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 218 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.+++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 275 KCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999999999999999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.48 Aligned_cols=233 Identities=23% Similarity=0.440 Sum_probs=196.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-SKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++... +..|+||||++|+
T Consensus 28 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 28 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 389999999999987 58899999986543 346788999999999999999999987544 5789999999999
Q ss_pred chhhHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~ 175 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGK 175 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCC
Confidence 999999752 3899999999999999999999999999999999999999999999999998743321 23446
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d 234 (416)
+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+++.+.++|.+||+.|
T Consensus 176 ~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 254 (278)
T 1byg_A 176 LPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 254 (278)
T ss_dssp CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCC
Confidence 7899999999987766 589999999999999998 99999988777777776655 35667789999999999999999
Q ss_pred CCCcCCHHHHhc
Q 014911 235 PNSRIAISKIME 246 (416)
Q Consensus 235 P~~R~s~~eil~ 246 (416)
|.+|||+.++++
T Consensus 255 p~~Rps~~~l~~ 266 (278)
T 1byg_A 255 AAMRPSFLQLRE 266 (278)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.48 Aligned_cols=221 Identities=32% Similarity=0.583 Sum_probs=184.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEe----CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMAS----KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 75 (416)
+||+|+||+||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ...+|+||||
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred ccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 489999999999999999999999998542 3567889888 66799999999999987 7789999999
Q ss_pred cCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CCCeEEeeccccccccccccC
Q 014911 76 VKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 76 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 149 (416)
++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 172 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---- 172 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence 999999999976 25999999999999999999999999999999999999998 78899999999863221
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHH----HHhCCCCCC----CCCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK----IYRGDFKCP----PWFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~----i~~~~~~~p----~~~s~ 221 (416)
..+ +.++||||+||++|+|++|..||.+.+....... +..+....| ..+++
T Consensus 173 --------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 173 --------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp --------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred --------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence 123 4789999999999999999999987654332211 112223333 46899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
++.+||.+||+.||.+|||+.++++||||+...
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 999999999999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=361.54 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=196.4
Q ss_pred CcccCCceEEEEEEEcCCC---cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA-SKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~~ 76 (416)
.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+..|+||||+
T Consensus 96 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred EeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 3899999999999876433 468999886432 3345678999999999999999999999864 456889999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC--Ccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~ 152 (416)
.||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus 174 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 253 (373)
T 3c1x_A 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253 (373)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------
T ss_pred CCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccccccc
Confidence 99999999975 45899999999999999999999999999999999999999999999999999754322111 112
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHc
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 230 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 230 (416)
....+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+. ...|..+++.+.++|.+|
T Consensus 254 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~c 332 (373)
T 3c1x_A 254 TGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 332 (373)
T ss_dssp ----CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 33457889999999988776 499999999999999999 789998876655555665554 455778999999999999
Q ss_pred cCCCCCCcCCHHHHhcC
Q 014911 231 LDPNPNSRIAISKIMES 247 (416)
Q Consensus 231 L~~dP~~R~s~~eil~h 247 (416)
|+.||.+|||+.+++++
T Consensus 333 l~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 333 WHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=357.84 Aligned_cols=244 Identities=16% Similarity=0.184 Sum_probs=192.2
Q ss_pred CcccCCceEEEEEEEcCC-----CcEEEEEEeecCcccchh--------hHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 014911 1 MLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVG--------MMEQIKREISVMKMVKHKHIVELHEVMASK- 66 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 66 (416)
.||+|+||+||+|.+..+ ++.||||++......... ......+|+..++.++||||+++++++...
T Consensus 42 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 121 (364)
T 3op5_A 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK 121 (364)
T ss_dssp ECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEE
T ss_pred EEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeecc
Confidence 489999999999998764 588999998765321100 012344566677888999999999998764
Q ss_pred ---CEEEEEEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec--cCCCeEEeeccc
Q 014911 67 ---SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD--EDGNLKVTDFGL 139 (416)
Q Consensus 67 ---~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~--~~~~~kl~DFGl 139 (416)
...|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 122 ~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~ 200 (364)
T 3op5_A 122 NGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200 (364)
T ss_dssp TTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTT
T ss_pred CCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCc
Confidence 5689999999 9999999975 6799999999999999999999999999999999999999 889999999999
Q ss_pred cccccccccCC-----cccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHH-HH---h
Q 014911 140 SAFSEHLKQDG-----LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK-IY---R 210 (416)
Q Consensus 140 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~-i~---~ 210 (416)
+.......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+.. .. .
T Consensus 201 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 279 (364)
T 3op5_A 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR 279 (364)
T ss_dssp CEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH
T ss_pred ceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhh
Confidence 97654332211 1234569999999999988776 5999999999999999999999985321111111 10 0
Q ss_pred CCC-------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 211 GDF-------KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 211 ~~~-------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
... -.+..+++++.+++..||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 280 ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 000 012567899999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=343.00 Aligned_cols=238 Identities=21% Similarity=0.354 Sum_probs=190.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEe----CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMAS----KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~----~~~~~lV~E 74 (416)
.||+|+||+||+|++ +|+.||||++... ......+|..++.. ++||||+++++++.. ...+|+|||
T Consensus 15 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 15 CVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp EEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred eeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 489999999999998 7899999998543 23455667777766 799999999998644 356899999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH--------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH--------~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
|+++|+|.+++..+.+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 166 (301)
T 3q4u_A 87 YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166 (301)
T ss_dssp CCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred hccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccc
Confidence 999999999998888999999999999999999999 999999999999999999999999999999754432
Q ss_pred ccC--CcccccccCCCCCchHHhhhcCCC-----CchhhHHHHHHHHHHHhcC----------CCCCCCCc----HHHHH
Q 014911 147 KQD--GLLHTTCGTPAYVAPEVISKKGYD-----GAKADIWSCGVILYVLLAG----------FLPFQDDN----IVSMY 205 (416)
Q Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwSlGvil~~lltG----------~~Pf~~~~----~~~~~ 205 (416)
... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||.... .....
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~ 246 (301)
T 3q4u_A 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246 (301)
T ss_dssp TTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred cccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhh
Confidence 111 112345799999999999765332 2689999999999999999 88985521 12222
Q ss_pred HHHHhCC---CCCCCC-----CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 206 RKIYRGD---FKCPPW-----FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 206 ~~i~~~~---~~~p~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
....... ...|.. .++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2322221 222221 3467999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.27 Aligned_cols=242 Identities=30% Similarity=0.450 Sum_probs=180.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEE--------eCCEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMA--------SKSKIYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--------~~~~~~l 71 (416)
+||+|+||+||+|++..+|+.||||++.... ......+.+|+.+++.+. ||||+++++++. ....+|+
T Consensus 35 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 4899999999999999999999999985543 244567889999999996 999999999984 4456899
Q ss_pred EEeccCCCchhhHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 72 AMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 112 v~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190 (337)
T ss_dssp EEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred EEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence 999996 589888753 56999999999999999999999999 99999999999999999999999999976543
Q ss_pred cccC----------CcccccccCCCCCchHHhh---hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC
Q 014911 146 LKQD----------GLLHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD 212 (416)
Q Consensus 146 ~~~~----------~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~ 212 (416)
.... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||............ ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~ 267 (337)
T 3ll6_A 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--YS 267 (337)
T ss_dssp CC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------------CC
T ss_pred cCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--cc
Confidence 2211 1112456999999999983 3334 58999999999999999999999876544332221 12
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcc
Q 014911 213 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249 (416)
Q Consensus 213 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 249 (416)
.+.+...++.+.+||.+||+.||.+|||+.++++|-+
T Consensus 268 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 3345567889999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=343.59 Aligned_cols=232 Identities=26% Similarity=0.447 Sum_probs=191.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++ .++.||||++... ...+.+.+|+.+++.++||||+++++++.+ ..|+||||++||+
T Consensus 15 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 15 VVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp EEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred EeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 489999999999997 5789999998543 345678899999999999999999998764 4799999999999
Q ss_pred hhhHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEeccCCC-eEEeeccccccccccccCCcc
Q 014911 81 LFNKIAKG----RLREDVARVYFQQLISAVDFCHS---RGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 81 L~~~i~~~----~l~e~~~~~~~~qll~aL~ylH~---~gi~HrDlkp~NIll~~~~~-~kl~DFGla~~~~~~~~~~~~ 152 (416)
|.+++... .+++..+..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++..... ..
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~~ 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HM 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----cc
Confidence 99999753 37899999999999999999999 89999999999999999887 79999999874332 12
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc--HHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIYRG-DFKCPPWFSSEARRLITK 229 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 229 (416)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+..+ ..+.+..+++.+.++|.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239 (307)
T ss_dssp ----CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHH
T ss_pred ccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHH
Confidence 34569999999999987766 589999999999999999999998643 22333333333 345667799999999999
Q ss_pred ccCCCCCCcCCHHHHhcC
Q 014911 230 LLDPNPNSRIAISKIMES 247 (416)
Q Consensus 230 ~L~~dP~~R~s~~eil~h 247 (416)
||+.||.+|||+.+++++
T Consensus 240 ~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 240 CWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.79 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=196.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+ .+|+.||||++....... ....+.+|+.+++.++||||+++++++.+.+..|+||||+.||+
T Consensus 37 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 113 (326)
T 3uim_A 37 ILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113 (326)
T ss_dssp EEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred eEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCC
Confidence 389999999999985 578999999997654322 12368899999999999999999999999999999999999999
Q ss_pred hhhHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 81 LFNKIAKG-----RLREDVARVYFQQLISAVDFCHSR---GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 81 L~~~i~~~-----~l~e~~~~~~~~qll~aL~ylH~~---gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...... .....
T Consensus 114 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 192 (326)
T 3uim_A 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVT 192 (326)
T ss_dssp HHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS-SSCEE
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc-ccccc
Confidence 99999752 399999999999999999999999 9999999999999999999999999999765422 22234
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCCC---------------
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDF--------------- 213 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~--------------- 213 (416)
....||+.|+|||++.+..+ +.++||||+||++|+|++|..||+... .......+.....
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 3uim_A 193 TAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271 (326)
T ss_dssp CCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT
T ss_pred ccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc
Confidence 45569999999999987766 589999999999999999999996211 0001111111110
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcc
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 249 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 249 (416)
..++..++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111122467999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.42 Aligned_cols=236 Identities=16% Similarity=0.260 Sum_probs=193.3
Q ss_pred CcccCCceEEEEE-----EEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLA-----RNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||+||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||+++++++...+..|+|
T Consensus 72 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 3899999999999 467889999999986432 356778888888887 99999999999999999999
Q ss_pred EeccCCCchhhHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-----------CCCeEEe
Q 014911 73 MDLVKGGELFNKIA------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-----------DGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-----------~~~~kl~ 135 (416)
|||++||+|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEe
Confidence 99999999999996 256999999999999999999999999999999999999998 8999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 215 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~ 215 (416)
|||+|...............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .....-.
T Consensus 226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~ 300 (365)
T 3e7e_A 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----KPEGLFR 300 (365)
T ss_dssp CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEE----EECSCCT
T ss_pred eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCce----eechhcc
Confidence 9999976544334445566789999999999988876 5999999999999999999999965432100 0001111
Q ss_pred CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 216 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 216 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
..+.++.+.+++..||+.+|.+|++..+.+.+
T Consensus 301 ~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 301 RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 22457789999999999999999765555443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=352.13 Aligned_cols=236 Identities=14% Similarity=0.193 Sum_probs=194.7
Q ss_pred CcccCCceEEEEEEEcCC--------CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcce--------------
Q 014911 1 MLGHGTFAKVYLARNLQT--------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE-------------- 58 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-------------- 58 (416)
.||+|+||+||+|++..+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 49 ~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 389999999999999874 889999998654 35779999999999999987
Q ss_pred -EEEEEEe-CCEEEEEEeccCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC--C
Q 014911 59 -LHEVMAS-KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--N 131 (416)
Q Consensus 59 -l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~--~ 131 (416)
+++++.. ....|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 6777766 78999999999 9999999975 5799999999999999999999999999999999999999998 8
Q ss_pred eEEeeccccccccccccC-----CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc--HHHH
Q 014911 132 LKVTDFGLSAFSEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSM 204 (416)
Q Consensus 132 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~--~~~~ 204 (416)
+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ....
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 278 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence 999999999765433211 12244579999999999987766 589999999999999999999998753 2222
Q ss_pred HHH---HHhCCCCCC------CCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 205 YRK---IYRGDFKCP------PWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 205 ~~~---i~~~~~~~p------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
... +.......+ ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 279 MKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 222 222222222 246899999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=368.92 Aligned_cols=238 Identities=24% Similarity=0.391 Sum_probs=205.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.. ..+|+||||+.+|+
T Consensus 274 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 274 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred ecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 38999999999999864 46799999976542 23678999999999999999999999866 67899999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~ 426 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKF 426 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTS
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcC
Confidence 9999974 4599999999999999999999999999999999999999999999999999975432110 11123346
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+||.+||+.||
T Consensus 427 ~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP 505 (535)
T 2h8h_A 427 PIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505 (535)
T ss_dssp CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 788999999987776 589999999999999999 99999998888888777665 356678899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
.+|||+.+|++
T Consensus 506 ~~RPt~~~l~~ 516 (535)
T 2h8h_A 506 EERPTFEYLQA 516 (535)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=345.79 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=189.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC--CCCCcceEEEEEEeC----CEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV--KHKHIVELHEVMASK----SKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~----~~~~lV~E 74 (416)
.||+|+||+||+|++ +|+.||||++.... .....+|..++..+ +||||+++++++... ..+|+|||
T Consensus 44 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 115 (337)
T 3mdy_A 44 QIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115 (337)
T ss_dssp EEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred EeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence 489999999999998 48999999985432 23445566666554 899999999999887 78999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~--------gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
|++||+|.+++....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 116 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 195 (337)
T 3mdy_A 116 YHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195 (337)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccc
Confidence 99999999999888899999999999999999999999 9999999999999999999999999999754332
Q ss_pred ccCC--cccccccCCCCCchHHhhhcCCCCc-----hhhHHHHHHHHHHHhcC----------CCCCCCC-----cHHHH
Q 014911 147 KQDG--LLHTTCGTPAYVAPEVISKKGYDGA-----KADIWSCGVILYVLLAG----------FLPFQDD-----NIVSM 204 (416)
Q Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DvwSlGvil~~lltG----------~~Pf~~~-----~~~~~ 204 (416)
.... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||... .....
T Consensus 196 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 275 (337)
T 3mdy_A 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275 (337)
T ss_dssp -------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred cccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhh
Confidence 2111 1235679999999999987655432 49999999999999999 7777542 12222
Q ss_pred HHHHHhC--CCCCCC-----CCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 205 YRKIYRG--DFKCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 205 ~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
...+... ....|. .+++.+.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222 122332 245679999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=365.52 Aligned_cols=241 Identities=19% Similarity=0.246 Sum_probs=189.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC-CCc---------c------------e
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHI---------V------------E 58 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v------------~ 58 (416)
+||+|+||+||+|.+..+|+.||||++...........+.+++|+.+++.++| +|+ + .
T Consensus 85 ~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (413)
T 3dzo_A 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164 (413)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---
T ss_pred ccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCc
Confidence 48999999999999999999999999975544443446789999999999987 221 1 1
Q ss_pred EEEEEEe-----CCEEEEEEeccCCCchhhHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 014911 59 LHEVMAS-----KSKIYFAMDLVKGGELFNKIA--------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 125 (416)
Q Consensus 59 l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~--------~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIl 125 (416)
+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NIL 243 (413)
T 3dzo_A 165 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243 (413)
T ss_dssp ------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEE
Confidence 1111111 22367777766 569998884 234778889999999999999999999999999999999
Q ss_pred eccCCCeEEeeccccccccccccCCcccccccCCCCCchHHhh----------hcCCCCchhhHHHHHHHHHHHhcCCCC
Q 014911 126 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS----------KKGYDGAKADIWSCGVILYVLLAGFLP 195 (416)
Q Consensus 126 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DvwSlGvil~~lltG~~P 195 (416)
++.++.+||+|||++...... ..+.+| +.|+|||++. ...+ +.++|||||||++|+|++|+.|
T Consensus 244 l~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 244 LDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp ECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCC
T ss_pred EecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999998754332 456678 9999999994 2223 4799999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 196 FQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 196 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
|...+.......+. .....+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 317 f~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 317 NTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp CCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 98876544333332 2234678999999999999999999999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=357.34 Aligned_cols=235 Identities=17% Similarity=0.274 Sum_probs=192.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-----chhhHHHHHHHHHHHHhCC---------CCCcceEEEEEE--
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVK---------HKHIVELHEVMA-- 64 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv~l~~~~~-- 64 (416)
.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+|+.++ ||||+++.+++.
T Consensus 27 ~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~ 104 (336)
T 2vuw_A 27 KIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104 (336)
T ss_dssp EEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred eecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence 389999999999998 7899999999876432 2234578889999999885 888888888753
Q ss_pred ----------------------------eCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCce
Q 014911 65 ----------------------------SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH-SRGVY 115 (416)
Q Consensus 65 ----------------------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH-~~gi~ 115 (416)
..+.+|+||||+.+|++.+.+.++.+++..++.++.||+.||.||| ++||+
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~iv 184 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFE 184 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCB
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 2688999999999998888887788999999999999999999999 99999
Q ss_pred eccCCCCcEEeccCC--------------------CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCc
Q 014911 116 HRDLKPENLLLDEDG--------------------NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175 (416)
Q Consensus 116 HrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (416)
||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||++.+.. +.
T Consensus 185 HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~--~~ 255 (336)
T 2vuw_A 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG--DY 255 (336)
T ss_dssp CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS--SH
T ss_pred ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC--cc
Confidence 999999999999987 899999999985442 2458999999999998665 58
Q ss_pred hhhHHHHHHH-HHHHhcCCCCCCCCcH-HHHHHHHHhC-CCCC------CCCCCHHHHHHHHHccCCCCCCcCCHHHHh-
Q 014911 176 KADIWSCGVI-LYVLLAGFLPFQDDNI-VSMYRKIYRG-DFKC------PPWFSSEARRLITKLLDPNPNSRIAISKIM- 245 (416)
Q Consensus 176 ~~DvwSlGvi-l~~lltG~~Pf~~~~~-~~~~~~i~~~-~~~~------p~~~s~~~~~li~~~L~~dP~~R~s~~eil- 245 (416)
++||||+|++ .+++++|..||.+... ......+... .... ++.+|+++++||++||+.| |+.|+|
T Consensus 256 ~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~ 330 (336)
T 2vuw_A 256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLC 330 (336)
T ss_dssp HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHH
T ss_pred ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHh
Confidence 9999998777 7789999999965321 1223333321 1111 1236889999999999977 999999
Q ss_pred cCcccc
Q 014911 246 ESSWFK 251 (416)
Q Consensus 246 ~hp~f~ 251 (416)
+||||+
T Consensus 331 ~Hp~f~ 336 (336)
T 2vuw_A 331 QHSLFK 336 (336)
T ss_dssp HCGGGC
T ss_pred cCCCcC
Confidence 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=345.97 Aligned_cols=241 Identities=23% Similarity=0.392 Sum_probs=200.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|.+.. .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.|++
T Consensus 40 ~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 40 LIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp BCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred EeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 48999999999999853 49999997654322 233567789999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc---cCCccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK---QDGLLHTT 155 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~---~~~~~~~~ 155 (416)
|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... ........
T Consensus 116 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 194 (319)
T 2y4i_B 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194 (319)
T ss_dssp HHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccC
Confidence 9999986 3599999999999999999999999999999999999998 6899999999987543221 12233445
Q ss_pred ccCCCCCchHHhhhc--------CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC--CCCCCHHHHH
Q 014911 156 CGTPAYVAPEVISKK--------GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFSSEARR 225 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~--------~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 225 (416)
.||+.|+|||++... ...+.++|||||||++|+|++|..||...+.......+..+..+. +..++..+.+
T Consensus 195 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 274 (319)
T 2y4i_B 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD 274 (319)
T ss_dssp SGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHH
T ss_pred CCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHH
Confidence 699999999999742 233689999999999999999999999988887777776654432 2357899999
Q ss_pred HHHHccCCCCCCcCCHHHHhc
Q 014911 226 LITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 226 li~~~L~~dP~~R~s~~eil~ 246 (416)
+|.+||+.||.+|||+.++++
T Consensus 275 li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 275 ILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.48 Aligned_cols=242 Identities=23% Similarity=0.388 Sum_probs=200.3
Q ss_pred CcccCCceEEEEEE----EcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEEEEe
Q 014911 1 MLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~lV~E 74 (416)
.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+ .+|+|||
T Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 38999999999998 4678999999999654 2345678999999999999999999999986544 7899999
Q ss_pred ccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cc
Q 014911 75 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GL 151 (416)
Q Consensus 75 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~ 151 (416)
|++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ..
T Consensus 125 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~ 204 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 204 (326)
T ss_dssp CCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEEC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccccccc
Confidence 9999999999976 45999999999999999999999999999999999999999999999999999765432211 11
Q ss_pred ccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH----------------HHHHHHHh-CCCC
Q 014911 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV----------------SMYRKIYR-GDFK 214 (416)
Q Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~----------------~~~~~i~~-~~~~ 214 (416)
.....+++.|+|||++.+..+ +.++|||||||++|+|++|..||...... .+...+.. ...+
T Consensus 205 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (326)
T 2w1i_A 205 KEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283 (326)
T ss_dssp SSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC
T ss_pred ccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC
Confidence 223457778999999987766 48999999999999999999998653211 11122222 2356
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 215 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 284 ~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 284 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67789999999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.08 Aligned_cols=245 Identities=19% Similarity=0.317 Sum_probs=185.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHH--HHhCCCCCcceEEEEEEe-----CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV--MKMVKHKHIVELHEVMAS-----KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~-----~~~~~lV~ 73 (416)
.||+|+||+||+|++ +++.||||++.... ...+..|..+ +..++||||+++++.+.. ...+|+||
T Consensus 20 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 20 LIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred ecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 489999999999987 78999999996442 2233344444 455899999999986532 34689999
Q ss_pred eccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 74 DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---------GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 74 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~---------gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
||++||+|.+++.....++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 92 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171 (336)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecc
Confidence 999999999999888889999999999999999999999 99999999999999999999999999997543
Q ss_pred ccc------cCCcccccccCCCCCchHHhhhc------CCCCchhhHHHHHHHHHHHhcCCCCCCCC-c-----------
Q 014911 145 HLK------QDGLLHTTCGTPAYVAPEVISKK------GYDGAKADIWSCGVILYVLLAGFLPFQDD-N----------- 200 (416)
Q Consensus 145 ~~~------~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~----------- 200 (416)
... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 251 (336)
T 3g2f_A 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251 (336)
T ss_dssp SSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHH
T ss_pred cccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcc
Confidence 221 11223355799999999999752 12246899999999999999997665321 1
Q ss_pred ------HHHHHHHHHhC--CCCCCCC------CCHHHHHHHHHccCCCCCCcCCHHHHhc------Ccccccc
Q 014911 201 ------IVSMYRKIYRG--DFKCPPW------FSSEARRLITKLLDPNPNSRIAISKIME------SSWFKKS 253 (416)
Q Consensus 201 ------~~~~~~~i~~~--~~~~p~~------~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~f~~~ 253 (416)
.......+... ...+|.. +++.+.+||.+||+.||.+|||+.++++ ++|-++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 252 VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 11111111111 2233333 2347999999999999999999999954 5666543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.14 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=199.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|+| ++|..+..++...+..|+||||+ |+
T Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 589999999999999999999999998755432 347789999999986 66777777778899999999999 89
Q ss_pred chhhHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEe---ccCCCeEEeeccccccccccccC-----
Q 014911 80 ELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQD----- 149 (416)
Q Consensus 80 ~L~~~i~--~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~~~----- 149 (416)
+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 88 sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (483)
T 3sv0_A 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (483)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred CHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccc
Confidence 9999997 4679999999999999999999999999999999999999 68899999999999865433221
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCCC-----CCCCCCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDF-----KCPPWFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~-----~~p~~~s~ 221 (416)
......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.. ....+..+..... .++..+++
T Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (483)
T 3sv0_A 168 RENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPT 246 (483)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCH
T ss_pred ccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcH
Confidence 12236689999999999988776 599999999999999999999998743 3334444333221 22356899
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 222 EARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
++.+||..||+.||.+||++.+|++
T Consensus 247 ~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 247 EFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999987765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=369.19 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=204.8
Q ss_pred CcccCCceEEEEEEEcCC---CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|.+..+ +..||||.+.... .....+.+.+|+.+|+.++||||+++++++. .+..|+||||++
T Consensus 397 ~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~ 473 (656)
T 2j0j_A 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 473 (656)
T ss_dssp EEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence 389999999999998654 4579999886432 3345578999999999999999999999984 456899999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 474 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~ 552 (656)
T 2j0j_A 474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKG 552 (656)
T ss_dssp TCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc-ceeccCC
Confidence 9999999975 368999999999999999999999999999999999999999999999999997543321 1122334
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.+|+.|+|||++....+ +.++||||+||++|+|++ |..||.+.+.......+..+. .+.|+.+++.+.+||.+||+.
T Consensus 553 ~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~ 631 (656)
T 2j0j_A 553 KLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 631 (656)
T ss_dssp -CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCC
Confidence 56789999999987776 589999999999999997 999999988888887777654 567888999999999999999
Q ss_pred CCCCcCCHHHHhc
Q 014911 234 NPNSRIAISKIME 246 (416)
Q Consensus 234 dP~~R~s~~eil~ 246 (416)
||.+|||+.++++
T Consensus 632 dP~~RPs~~el~~ 644 (656)
T 2j0j_A 632 DPSRRPRFTELKA 644 (656)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=339.18 Aligned_cols=239 Identities=20% Similarity=0.352 Sum_probs=196.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMASKS----KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~----~~~lV~E 74 (416)
.||+|+||+||+|.+ +|+.||||++... ....+.+|+.+++. ++||||+++++++.... .+|+|||
T Consensus 49 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e 120 (342)
T 1b6c_B 49 SIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120 (342)
T ss_dssp EEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred eecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence 389999999999998 6899999998543 23567789999887 78999999999998876 8999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeccCCCCcEEeccCCCeEEeecccccccccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH--------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 146 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH--------~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 146 (416)
|+++|+|.+++.+..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 121 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 121 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200 (342)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred ecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccc
Confidence 999999999999888999999999999999999999 899999999999999999999999999999754432
Q ss_pred ccC--CcccccccCCCCCchHHhhhcCCC-----CchhhHHHHHHHHHHHhcC----------CCCCCCC-----cHHHH
Q 014911 147 KQD--GLLHTTCGTPAYVAPEVISKKGYD-----GAKADIWSCGVILYVLLAG----------FLPFQDD-----NIVSM 204 (416)
Q Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwSlGvil~~lltG----------~~Pf~~~-----~~~~~ 204 (416)
... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||... .....
T Consensus 201 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 280 (342)
T 1b6c_B 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280 (342)
T ss_dssp TTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHH
Confidence 211 023455799999999999765322 2589999999999999999 8898664 23344
Q ss_pred HHHHHhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 205 YRKIYRGDF--KCPPW-----FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 205 ~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
...+..... ..|.. .++.+.+||.+||+.||.+|||+.++++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 444433322 22321 23578999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=377.08 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=202.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~~~lV~E 74 (416)
.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.. .+..|+|||
T Consensus 21 ~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence 4899999999999999999999999986542 33456788999999999999999999998755 677899999
Q ss_pred ccCCCchhhHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC---eEEeeccccccccccc
Q 014911 75 LVKGGELFNKIAK-G---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLK 147 (416)
Q Consensus 75 ~~~gg~L~~~i~~-~---~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---~kl~DFGla~~~~~~~ 147 (416)
|++||+|.+++.. + .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 99 y~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~-- 176 (676)
T 3qa8_A 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-- 176 (676)
T ss_dssp CCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS--
T ss_pred eCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccc--
Confidence 9999999999975 2 5999999999999999999999999999999999999998775 89999999985433
Q ss_pred cCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHH---------H-----HhCCC
Q 014911 148 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK---------I-----YRGDF 213 (416)
Q Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~---------i-----~~~~~ 213 (416)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........+.. + ..+..
T Consensus 177 -~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~ 254 (676)
T 3qa8_A 177 -GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254 (676)
T ss_dssp -CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSC
T ss_pred -ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccc
Confidence 233455689999999999987766 5899999999999999999999976532211100 0 01111
Q ss_pred ------CCC----CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 214 ------KCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 214 ------~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
+.| +.+++.+.+||.+||++||.+|||+.++++||||+.
T Consensus 255 ~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 111 125678999999999999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=327.06 Aligned_cols=214 Identities=15% Similarity=0.189 Sum_probs=182.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++...+..|+||||+.|++
T Consensus 38 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~ 117 (286)
T 3uqc_A 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117 (286)
T ss_dssp EEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEE
T ss_pred EEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCC
Confidence 38999999999999999999999999987765555566889999999999999999999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
|.+++..+ ....++..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 118 L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------------------- 174 (286)
T 3uqc_A 118 LQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------------------- 174 (286)
T ss_dssp HHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------------------
T ss_pred HHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------------------
Confidence 99999776 4666788999999999999999999999999999999999999998554
Q ss_pred CCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHH---HHHhCCC----CCCCCCCHHHHHHHHHccCC
Q 014911 161 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR---KIYRGDF----KCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 161 y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~---~i~~~~~----~~p~~~s~~~~~li~~~L~~ 233 (416)
|++| .+.++|||||||++|+|++|..||.+.+...... ....+.. ..++.+++.+.+||.+||+.
T Consensus 175 ~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 246 (286)
T 3uqc_A 175 TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG 246 (286)
T ss_dssp CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCT
T ss_pred ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHccc
Confidence 3332 3589999999999999999999998765322110 0111111 12356899999999999999
Q ss_pred CCCCcCCHHHHhc
Q 014911 234 NPNSRIAISKIME 246 (416)
Q Consensus 234 dP~~R~s~~eil~ 246 (416)
||.+| |+.++++
T Consensus 247 dP~~R-s~~el~~ 258 (286)
T 3uqc_A 247 DGGIR-SASTLLN 258 (286)
T ss_dssp TSSCC-CHHHHHH
T ss_pred CCccC-CHHHHHH
Confidence 99999 9999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=367.42 Aligned_cols=231 Identities=24% Similarity=0.377 Sum_probs=192.6
Q ss_pred CcccCCceEEEEEEEcC-CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-----EEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK-----IYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-----~~lV~E 74 (416)
.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+. .|+|||
T Consensus 87 ~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 38999999999999976 79999999986542 23445678899999999999999999999987654 799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..... ...
T Consensus 165 ~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~------~~~ 236 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGY 236 (681)
T ss_dssp CCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC------CSC
T ss_pred eCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc------CCc
Confidence 9999999988765 79999999999999999999999999999999999999875 999999999875432 145
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--PWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~ 232 (416)
.+||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+.... ...... ...++.+.+||.+||+
T Consensus 237 ~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~ 306 (681)
T 2pzi_A 237 LYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRLLRRAID 306 (681)
T ss_dssp CCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHHHHHHHTC
T ss_pred cCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHHHHhhhcc
Confidence 67999999999987653 68999999999999999999998763211 000000 1146789999999999
Q ss_pred CCCCCcCCHHHHhcCcccc
Q 014911 233 PNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~ 251 (416)
+||.+||+..+.+.|+|+.
T Consensus 307 ~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 307 PDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp SSGGGSCSSHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHH
Confidence 9999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=317.31 Aligned_cols=230 Identities=12% Similarity=0.104 Sum_probs=160.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCccc-------chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-------KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 73 (416)
++.|++|.+..++....|+.+|+|++.+.... .....+.+.+|+.+|+++ .||||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 35688888888888889999999999765432 123346799999999999 6999999999999999999999
Q ss_pred eccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 74 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 74 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||++|++|.++|.+ +++++. .|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~~ 396 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSWP 396 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCS
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCccc
Confidence 99999999999987 677764 5899999999999999999999999999999999999999999975433 22345
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccC
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 232 (416)
.+.+||+.|+|||++.+.. ..++|+||+|++++.+.++..|+. ..+.. .|.. ...+..+...++.
T Consensus 397 ~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l~~ 461 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALFEK 461 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHHHT
T ss_pred cCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHHhC
Confidence 6779999999999997653 367999999999998877654431 11111 1111 1124566777778
Q ss_pred CCCCCcCCHHHHhcCcccc
Q 014911 233 PNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~ 251 (416)
.+|..|+.......++|..
T Consensus 462 ~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 462 KAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp GGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCChhhhccchhHH
Confidence 8888888777766666653
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=246.30 Aligned_cols=131 Identities=37% Similarity=0.700 Sum_probs=116.3
Q ss_pred CccccchhhhhccCCCCCCCchhHHhhHHHhhhhcccccCChhhhHHHHHHHHhhcccEEEeecCeEEEEeeecCCccee
Q 014911 274 QPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKL 353 (416)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (416)
.|..+|||++|++|+|+|||+||+......++++||+++.||+.++++|+++|+.+||+|+++++++++++..+|+||.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 46679999999999999999999764422356899999999999999999999999999999888899999999999999
Q ss_pred EEEEEEEEeeCCeEEEEEEecCCChhhHHHHhhhhhhhhcccceeccccccc
Q 014911 354 AINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNP 405 (416)
Q Consensus 354 ~~~~~v~~~~~~~~~ve~~~~~Gd~le~~~~~~~~l~~~l~div~~~~~~~~ 405 (416)
++.+||||++|+++||||+|++||++||+++|. +||++|+||||+|+++..
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~-~Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHH-HHHHHSTTTBCC------
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHH-HHHHHhhcceecCCCCCc
Confidence 999999999999999999999999999999776 899999999999998664
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-33 Score=229.58 Aligned_cols=122 Identities=30% Similarity=0.474 Sum_probs=107.6
Q ss_pred CccccchhhhhccCCCCCCCchhHHhhHHHhhhhcccccCChhhhHHHHHHHHhhcccEEEeecCeEEEEeeecCCccee
Q 014911 274 QPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKL 353 (416)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (416)
.|..+|||++|++|+|+|||+||++... .++++||+|+.||+.++++||++|+.+||+|++++++ ++..+|+||+|
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~-~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l 77 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNF 77 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCS-SCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccc-cccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccE
Confidence 4567999999999999999999976322 3568999999999999999999999999999988875 66688999999
Q ss_pred EEEEEEEEeeCCeEEEEEEecCCChhhHHHHhhhhhhhhcccceec
Q 014911 354 AINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWM 399 (416)
Q Consensus 354 ~~~~~v~~~~~~~~~ve~~~~~Gd~le~~~~~~~~l~~~l~div~~ 399 (416)
++.+||||++|+++||||+|++||++||++||+++||++|+||||+
T Consensus 78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999999988999999999995
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=267.94 Aligned_cols=185 Identities=18% Similarity=0.176 Sum_probs=145.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|+||+||+|. ..++.+|+|.......... ...+.+.+|+.+|++++||||+++..+....+..|+||||
T Consensus 343 ~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 343 LIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -----CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred EEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 48999999999994 4678999998765433221 1245689999999999999999554444567777999999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-----
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG----- 150 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~----- 150 (416)
++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 421 ~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~ 491 (540)
T 3en9_A 421 INGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV 491 (540)
T ss_dssp CCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence 999999999876 6789999999999999999999999999999998 99999999998654322111
Q ss_pred cccccccCCCCCchHHhhh--cCCCCchhhHHHHHHHHHHHhcCCCCCC
Q 014911 151 LLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQ 197 (416)
Q Consensus 151 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~~lltG~~Pf~ 197 (416)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+-..++.+|.
T Consensus 492 ~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 492 FKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 2246789999999999976 5553 67899999888888777766663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=217.64 Aligned_cols=142 Identities=15% Similarity=0.220 Sum_probs=113.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---------------hhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---------------GMMEQIKREISVMKMVKHKHIVELHEVMAS 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 65 (416)
.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+|+.++|+++..+ +..
T Consensus 97 ~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~---~~~ 172 (282)
T 1zar_A 97 LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV---YAW 172 (282)
T ss_dssp EEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE---EEE
T ss_pred EeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeE---Eec
Confidence 389999999999999 8899999999965432110 134678899999999985555554 433
Q ss_pred CCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccc
Q 014911 66 KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 145 (416)
Q Consensus 66 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 145 (416)
+..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|.
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~---- 240 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV---- 240 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE----
T ss_pred -cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe----
Confidence 45699999999999988 422 23557999999999999999999999999999999 9999999999986
Q ss_pred cccCCcccccccCCCCCchHHhhh
Q 014911 146 LKQDGLLHTTCGTPAYVAPEVISK 169 (416)
Q Consensus 146 ~~~~~~~~~~~gt~~y~aPE~~~~ 169 (416)
.+..+.|||.+.+
T Consensus 241 -----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 241 -----------EVGEEGWREILER 253 (282)
T ss_dssp -----------ETTSTTHHHHHHH
T ss_pred -----------ECCCCCHHHHHHH
Confidence 3556899998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-22 Score=187.15 Aligned_cols=134 Identities=18% Similarity=0.214 Sum_probs=104.3
Q ss_pred CcccCCceEEEEEEEcCCCcE--EEEEEeecCcccc---------------------hhhHHHHHHHHHHHHhCCCCCc-
Q 014911 1 MLGHGTFAKVYLARNLQTGKS--MAMKVVGKDKVIK---------------------VGMMEQIKREISVMKMVKHKHI- 56 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~hpnI- 56 (416)
.||+|+||.||+|.+..+|+. ||||++......- ......+.+|+.+|+.+.|++|
T Consensus 54 ~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 133 (258)
T 1zth_A 54 VISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVS 133 (258)
T ss_dssp EEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 389999999999998788999 9999975432110 0112468899999999988754
Q ss_pred -ceEEEEEEeCCEEEEEEeccCC-C----chhhHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEeccC
Q 014911 57 -VELHEVMASKSKIYFAMDLVKG-G----ELFNKIAKGRLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDED 129 (416)
Q Consensus 57 -v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH-~~gi~HrDlkp~NIll~~~ 129 (416)
+.+++. +..|+||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 134 ~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~- 206 (258)
T 1zth_A 134 VPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID- 206 (258)
T ss_dssp CCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-
T ss_pred CCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-
Confidence 445543 246899999942 3 56655432 345678899999999999999 999999999999999988
Q ss_pred CCeEEeecccccc
Q 014911 130 GNLKVTDFGLSAF 142 (416)
Q Consensus 130 ~~~kl~DFGla~~ 142 (416)
.++|+|||+|..
T Consensus 207 -~~~liDFG~a~~ 218 (258)
T 1zth_A 207 -KVYFIDMGQAVT 218 (258)
T ss_dssp -SEEECCCTTCEE
T ss_pred -cEEEEECccccc
Confidence 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=9.2e-19 Score=172.12 Aligned_cols=133 Identities=16% Similarity=0.221 Sum_probs=97.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc-----------ch----hh----HHHHHHHHHHHHhCCCCCcceEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----------KV----GM----MEQIKREISVMKMVKHKHIVELHE 61 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----------~~----~~----~~~~~~Ei~il~~l~hpnIv~l~~ 61 (416)
.||.|+||.||+|.+ .+|+.||||+++..... .. .. .-...+|...|.++.++++....-
T Consensus 102 ~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p 180 (397)
T 4gyi_A 102 RIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEP 180 (397)
T ss_dssp EEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCE
T ss_pred EeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCee
Confidence 389999999999997 57999999998643211 00 00 012346788888886655433222
Q ss_pred EEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC----------
Q 014911 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---------- 131 (416)
Q Consensus 62 ~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~---------- 131 (416)
+.... .++||||+.|++|..+.. .+.+..++.||+.+|.|||++||+||||||.|||++++|.
T Consensus 181 ~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 181 IAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp EEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred eeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence 22222 379999999988866532 2345678999999999999999999999999999998873
Q ss_pred eEEeeccccc
Q 014911 132 LKVTDFGLSA 141 (416)
Q Consensus 132 ~kl~DFGla~ 141 (416)
+.|+||+-+.
T Consensus 254 ~~iID~~Q~V 263 (397)
T 4gyi_A 254 PIIIXFPQMV 263 (397)
T ss_dssp EEECCCTTCE
T ss_pred eEEEEeCCcc
Confidence 8899999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=7.9e-13 Score=123.28 Aligned_cols=131 Identities=15% Similarity=0.133 Sum_probs=105.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+|.|+++.||++.. .++.+++|+....... ....+.+|+.+++.+. +.++.+++++....+..|+||||++|.+
T Consensus 22 ~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 22 TEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp CSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred ccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 56788899999975 4688999998653211 1235889999999984 6788999999999999999999999999
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHS------------------------------------------------- 111 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~------------------------------------------------- 111 (416)
|.+... +......++.++..+|..||+
T Consensus 97 l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (263)
T 3tm0_A 97 CSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp HHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHH
T ss_pred hhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHH
Confidence 877632 222345788899999999998
Q ss_pred ----------cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 ----------RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 ----------~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
..++|+|++|.||++++++.+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.6e-12 Score=118.01 Aligned_cols=125 Identities=14% Similarity=0.152 Sum_probs=95.9
Q ss_pred ccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccCCCc
Q 014911 3 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH--IVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 3 G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..|+||||++|.+
T Consensus 29 ~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 29 IGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 3566799999964 567889999975431 235778999999885434 6678998888888999999999988
Q ss_pred hhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------------------
Q 014911 81 LFNKIAKGRLREDVARVYFQQLISAVDFCHSRG----------------------------------------------- 113 (416)
Q Consensus 81 L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~g----------------------------------------------- 113 (416)
|. .. ..+ ...++.++...|..||+..
T Consensus 102 l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 102 LL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 84 21 122 2356677888888888653
Q ss_pred -----------ceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 114 -----------VYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 114 -----------i~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=9.6e-12 Score=121.51 Aligned_cols=136 Identities=18% Similarity=0.358 Sum_probs=104.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEee--cCcccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVG--KDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASK---SKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~lV~E 74 (416)
|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.|. +..+++++.++.+. +..|+|||
T Consensus 46 l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 46 FKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp CCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred cCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 68899999999986 34678888775 32211 12356889999999997 45688999888766 45899999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS------------------------------------------- 111 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~------------------------------------------- 111 (416)
|++|..+.+... ..+++.....++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 122 FVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp CCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred ecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 999988755322 347888889999999999999997
Q ss_pred ---------------cCceeccCCCCcEEeccCCC--eEEeecccccc
Q 014911 112 ---------------RGVYHRDLKPENLLLDEDGN--LKVTDFGLSAF 142 (416)
Q Consensus 112 ---------------~gi~HrDlkp~NIll~~~~~--~kl~DFGla~~ 142 (416)
.+++|+|++|.||+++.++. +.|+||+.++.
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998764 68999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.9e-12 Score=119.30 Aligned_cols=180 Identities=18% Similarity=0.222 Sum_probs=122.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCC--cceEEEEEEeCC---EEEEEEec
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKH--IVELHEVMASKS---KIYFAMDL 75 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lV~E~ 75 (416)
++.|.+..||++. ..+++|+.... .....+.+|..+|+.+ .+.. +.+++......+ ..|+||++
T Consensus 28 ~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 28 SGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp EEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred cCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 5789999999863 45888986422 3456789999999887 3332 455555443333 45899999
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS-------------------------------------------- 111 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~-------------------------------------------- 111 (416)
++|.+|.+... ..++.++...++.|+...|..||+
T Consensus 98 i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 98 IKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred cCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 99988875433 347888888999999999999996
Q ss_pred --------------cCceeccCCCCcEEecc--CCCeEEeeccccccccccccCCcccccccCCCC---CchHHhh----
Q 014911 112 --------------RGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY---VAPEVIS---- 168 (416)
Q Consensus 112 --------------~gi~HrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~---- 168 (416)
..++|+|++|.||+++. .+.+.|+||+.+....... .......+ ..|+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHHHHH
Confidence 13799999999999998 4567899999886432110 00111111 2333211
Q ss_pred hcCCC---------CchhhHHHHHHHHHHHhcCCCCCCC
Q 014911 169 KKGYD---------GAKADIWSCGVILYVLLAGFLPFQD 198 (416)
Q Consensus 169 ~~~~~---------~~~~DvwSlGvil~~lltG~~Pf~~ 198 (416)
..+.. ....+.|++|.++|.+.+|..+|-.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 11111 1236999999999999999888743
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.7e-09 Score=86.19 Aligned_cols=86 Identities=13% Similarity=0.205 Sum_probs=74.1
Q ss_pred cccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEee-CCeEEEEEEecCCChhhHHHHh
Q 014911 308 RFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFC 385 (416)
Q Consensus 308 r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~le~~~~~ 385 (416)
.-+|..+|.+++..|+++++.+|+.++.++ +.+++.......++.+.|++||+++. +++++|+|+|..||++.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 346788999999999999999999999877 57888764444567899999999996 8999999999999999999999
Q ss_pred hhhhhhhcc
Q 014911 386 SNELRPALK 394 (416)
Q Consensus 386 ~~~l~~~l~ 394 (416)
. +|-+.|+
T Consensus 112 ~-~il~~L~ 119 (120)
T 3ose_A 112 S-KIANELK 119 (120)
T ss_dssp H-HHHHHCC
T ss_pred H-HHHHHhc
Confidence 7 5777664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=9.8e-08 Score=91.03 Aligned_cols=130 Identities=19% Similarity=0.233 Sum_probs=94.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEeccC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK---HIVELHEVMA-SKSKIYFAMDLVK 77 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E~~~ 77 (416)
++.|....||+. |..+++|+-.. ......+.+|..+|+.|.+. .|.+.+.+.. ..+..|+|||+++
T Consensus 27 l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 27 LGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred cCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 567888899988 56688888421 23456889999999999642 3667777664 4556789999999
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR--------------------------------------------- 112 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~--------------------------------------------- 112 (416)
|.++.+... ..++......++.|+...|..||+.
T Consensus 97 G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 97 GQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp SEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred CeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 988866322 2356666666666676666666642
Q ss_pred ---------------CceeccCCCCcEEecc---CCCe-EEeecccccc
Q 014911 113 ---------------GVYHRDLKPENLLLDE---DGNL-KVTDFGLSAF 142 (416)
Q Consensus 113 ---------------gi~HrDlkp~NIll~~---~~~~-kl~DFGla~~ 142 (416)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4554 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.1e-07 Score=88.54 Aligned_cols=129 Identities=15% Similarity=0.227 Sum_probs=96.4
Q ss_pred CCce-EEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCchh
Q 014911 5 GTFA-KVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELF 82 (416)
Q Consensus 5 G~fg-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~ 82 (416)
|..+ .||+......+..+.+|+-.. .....+.+|..+|+.|. +--|.+++.+..+.+..|+|||+++|.++.
T Consensus 35 G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 35 GQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp SSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred CCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4443 699988777778899998642 34567889999999884 334778888889999999999999998877
Q ss_pred hHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------
Q 014911 83 NKIAKGRLREDVARVYFQQLISAVDFCHS--------------------------------------------------- 111 (416)
Q Consensus 83 ~~i~~~~l~e~~~~~~~~qll~aL~ylH~--------------------------------------------------- 111 (416)
+..... ......+..++...|.-||+
T Consensus 109 ~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 109 QVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred ccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 665432 12233455666666666663
Q ss_pred -------cCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 112 -------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 112 -------~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
..++|+|++|.||+++.++.+-|+||+.+..
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877678999998863
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=4.7e-07 Score=89.30 Aligned_cols=77 Identities=9% Similarity=0.084 Sum_probs=49.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcc-cch---hhHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKV---GMMEQIKREISVMKMVKH--K-HIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~lV~E 74 (416)
||.|.++.||++....+++.++||....... ... ...+.+..|..+|+.+.. | .+.+++.+ +....++|||
T Consensus 38 lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE 115 (397)
T 2olc_A 38 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 115 (397)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred CCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEE
Confidence 7899999999997655678999998643211 000 123456789999988742 3 45566654 3445689999
Q ss_pred ccCCCc
Q 014911 75 LVKGGE 80 (416)
Q Consensus 75 ~~~gg~ 80 (416)
+++|..
T Consensus 116 ~l~g~~ 121 (397)
T 2olc_A 116 DLSHLK 121 (397)
T ss_dssp CCTTSE
T ss_pred eCCCcc
Confidence 998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=3.9e-07 Score=88.38 Aligned_cols=80 Identities=14% Similarity=0.180 Sum_probs=53.3
Q ss_pred ccCCceEEEEEEEc--C----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeC---CEEE
Q 014911 3 GHGTFAKVYLARNL--Q----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H--KHIVELHEVMASK---SKIY 70 (416)
Q Consensus 3 G~G~fg~Vy~a~~~--~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~---~~~~ 70 (416)
+.|....+|+.... . ++..+++|+..............+.+|+.+|+.|. + ..+.+++.+..+. +..|
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 67889999988752 0 26678899865432000000135678899988874 2 3577888877655 3578
Q ss_pred EEEeccCCCchh
Q 014911 71 FAMDLVKGGELF 82 (416)
Q Consensus 71 lV~E~~~gg~L~ 82 (416)
+|||+++|..+.
T Consensus 110 ~v~e~l~G~~l~ 121 (357)
T 3ats_A 110 FLMDYVEGVVPP 121 (357)
T ss_dssp EEEECCCCBCCC
T ss_pred EEEEecCCCChh
Confidence 999999986654
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.33 E-value=9.7e-07 Score=71.88 Aligned_cols=85 Identities=13% Similarity=0.186 Sum_probs=70.3
Q ss_pred ccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEee-CCeEEEEEEecCCChhhHHHHhh
Q 014911 309 FATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFCS 386 (416)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~le~~~~~~ 386 (416)
-+|..+|..++..+..+++++++.++.++ +.+++....+..+..+.|++||+.+. .+++.|+|+|.+||...|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 35678999999999999999999999755 55777653333456899999999994 78999999999999999999998
Q ss_pred hhhhhhcc
Q 014911 387 NELRPALK 394 (416)
Q Consensus 387 ~~l~~~l~ 394 (416)
+|-..|+
T Consensus 113 -~IL~eLk 119 (126)
T 1v5s_A 113 -KIANELK 119 (126)
T ss_dssp -HHHHHTT
T ss_pred -HHHHHHh
Confidence 4666665
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.4e-06 Score=79.99 Aligned_cols=131 Identities=14% Similarity=0.147 Sum_probs=76.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----HKHIVELH-E--VMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~lV~ 73 (416)
|+.|..+.||++.. . +..+++|+..... ..+..|..+++.|. .|.++... + +....+..|++|
T Consensus 40 l~gG~~n~~~~v~~-~-~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 40 IQGNQMALVWKVHT-D-SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp CC----CEEEEEEE-T-TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred ccccccCcEEEEEe-C-CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 45577899999976 2 3458999986421 33445556555542 34444310 0 123467889999
Q ss_pred eccCCCchh--------------hHHhc--CCC--C-----------HH--------H----------------------
Q 014911 74 DLVKGGELF--------------NKIAK--GRL--R-----------ED--------V---------------------- 94 (416)
Q Consensus 74 E~~~gg~L~--------------~~i~~--~~l--~-----------e~--------~---------------------- 94 (416)
+|++|.++. ..+.. ..+ + .. .
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 11111 111 1 00 0
Q ss_pred -HHHHHHHHHHHHHHHH-------------HcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 95 -ARVYFQQLISAVDFCH-------------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 95 -~~~~~~qll~aL~ylH-------------~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
+..+..++..++.+|+ ..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 2579999999999999888899999999765
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=9.5e-06 Score=63.78 Aligned_cols=84 Identities=12% Similarity=0.285 Sum_probs=69.5
Q ss_pred ccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEeeCCeEEEEEEecCCC--------hh
Q 014911 309 FATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGD--------TL 379 (416)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd--------~l 379 (416)
..+...|.+++..+..+.+.+|+.|+..+ +.+++....+.....+.|.+++|.+.+..+|+||++..|| ++
T Consensus 12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~ 91 (106)
T 4eai_A 12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTI 91 (106)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHH
T ss_pred ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcE
Confidence 45667789999999999999999999776 6788886433334578999999999999999999999994 89
Q ss_pred hHHHHhhhhhhhhc
Q 014911 380 EYNQFCSNELRPAL 393 (416)
Q Consensus 380 e~~~~~~~~l~~~l 393 (416)
+|-++|.+ +-..|
T Consensus 92 ~F~d~ca~-li~~l 104 (106)
T 4eai_A 92 EFFEMCAN-LIKIL 104 (106)
T ss_dssp HHHHHHHH-HHHHC
T ss_pred eHHHHHHH-HHHHH
Confidence 99999984 54444
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.04 E-value=4.2e-05 Score=63.75 Aligned_cols=72 Identities=7% Similarity=0.192 Sum_probs=58.2
Q ss_pred ccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEeeCCeEEEEEEecCCChhh
Q 014911 309 FATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLE 380 (416)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~le 380 (416)
..++..|.+++..+..+.+.+|+.||+.+ +.|++....+.....+.|.+++|++.+..+||||++..||+-|
T Consensus 9 IrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 9 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 44667889999999999999999999877 6788887433223368999999999999999999999998755
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=5.4e-05 Score=63.91 Aligned_cols=76 Identities=8% Similarity=0.178 Sum_probs=60.4
Q ss_pred hhhcccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEeeCCeEEEEEEecCCChhh
Q 014911 305 EELRFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLE 380 (416)
Q Consensus 305 ~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~le 380 (416)
...-..++..|.+++..+..+.+.+|+.||+.+ +.|++....+-....+.|.+++|++.+..+||||++..||+-|
T Consensus 19 WhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 19 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 334456778899999999999999999999877 6688887432222368999999999999999999999998755
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.93 E-value=0.00011 Score=65.76 Aligned_cols=120 Identities=19% Similarity=0.136 Sum_probs=80.1
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH-~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+.+.. ++++|+++|.++.|.+.+|.-+- .+.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 78888864 78999999999999999987762 12222444567999999999988764 2110 1
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
....+.|||... ...+.+.=|||||+++|..+--..| ...+..+|+.+.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 233567888753 2235788999999999988842111 123456899999999999866
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.9e-05 Score=76.20 Aligned_cols=32 Identities=22% Similarity=0.445 Sum_probs=28.1
Q ss_pred HHcCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 110 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 110 H~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
+...++|+|++|.||+++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998876 99999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00011 Score=69.95 Aligned_cols=72 Identities=8% Similarity=0.216 Sum_probs=58.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
|+.|.+..+|+... ++..+++|+.... ....+.+|...|+.|. ...+++++.+....+..|+|||+++|
T Consensus 44 l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 44 LYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp ECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 67899999999975 5678889987532 2467889999998883 36788899888888899999999998
Q ss_pred Cch
Q 014911 79 GEL 81 (416)
Q Consensus 79 g~L 81 (416)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.00015 Score=58.49 Aligned_cols=74 Identities=14% Similarity=0.212 Sum_probs=56.4
Q ss_pred ccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEeeCCeEEEEEEecCCChhhHH
Q 014911 309 FATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYN 382 (416)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~le~~ 382 (416)
..++..|.+++..+..+.+.+++.|+..+ +.+++..........+.+.+++|++.+..+|+||++..||..|+.
T Consensus 12 IrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~ 86 (130)
T 4eag_A 12 IRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG 86 (130)
T ss_dssp BCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred eecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence 34567788999999999999999999876 678887644444446889999999999999999999999976544
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=6.2e-05 Score=62.12 Aligned_cols=86 Identities=10% Similarity=0.183 Sum_probs=67.6
Q ss_pred hcccccCChhhhHHHHHHHHhhcccEEEee---------c-CeEEEEeeecCC-----cceeEEEEEEEEeeCCeEEEEE
Q 014911 307 LRFATTRPASSVISRFEEVAKAVKFNVKTS---------E-SRVRLQGQESGR-----KGKLAINADIFAVTPSLLVVEV 371 (416)
Q Consensus 307 ~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~-----~~~l~~~~~v~~~~~~~~~ve~ 371 (416)
.-..|+..|.++|..+..+.+.+|+.|+.. + +.|++....+.. ...+.|.+++|++.++.+||||
T Consensus 15 lGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDF 94 (137)
T 2qrd_A 15 FGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDV 94 (137)
T ss_dssp ESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEE
T ss_pred cccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEE
Confidence 345577789999999999999999999976 5 558777633221 2368899999999999999999
Q ss_pred EecCCC---------------h----hhHHHHhhhhhhhhc
Q 014911 372 KKDNGD---------------T----LEYNQFCSNELRPAL 393 (416)
Q Consensus 372 ~~~~Gd---------------~----le~~~~~~~~l~~~l 393 (416)
+..+|+ . +.|-.+|.. |-..|
T Consensus 95 k~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~-Li~eL 134 (137)
T 2qrd_A 95 KSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAM-LVCKL 134 (137)
T ss_dssp EEEEEEESCC-------------CCCTTHHHHHHH-HHHHH
T ss_pred EecCCccccccCccccccCCccccccccHHHHHHH-HHHHH
Confidence 999999 5 888888874 54444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.69 E-value=9.7e-05 Score=70.68 Aligned_cols=32 Identities=28% Similarity=0.392 Sum_probs=27.4
Q ss_pred HcCceeccCCCCcEEeccC----CCeEEeecccccc
Q 014911 111 SRGVYHRDLKPENLLLDED----GNLKVTDFGLSAF 142 (416)
Q Consensus 111 ~~gi~HrDlkp~NIll~~~----~~~kl~DFGla~~ 142 (416)
...++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6799999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=5.8e-05 Score=71.27 Aligned_cols=128 Identities=14% Similarity=0.147 Sum_probs=71.1
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc-CCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLV-KGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~-~gg 79 (416)
|+.|....+|++ ..+++|+....... .-...+|+.+++.+...++ .+++... .+.-++++||+ +|.
T Consensus 26 l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 26 RLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred cCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 567888999998 45888987543111 1123468888877642222 4565543 33347899999 664
Q ss_pred chhhH---------------H---hc-C-CC----C-HHHHHHHHHH--------------HHHHHHHHH--------Hc
Q 014911 80 ELFNK---------------I---AK-G-RL----R-EDVARVYFQQ--------------LISAVDFCH--------SR 112 (416)
Q Consensus 80 ~L~~~---------------i---~~-~-~l----~-e~~~~~~~~q--------------ll~aL~ylH--------~~ 112 (416)
++... + .. . .+ . ...+..+..+ +...+..+. ..
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 44210 0 01 0 01 0 1111111111 111111111 12
Q ss_pred CceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 113 gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
.++|+|+.|.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5677899999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00014 Score=68.98 Aligned_cols=133 Identities=14% Similarity=0.166 Sum_probs=74.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----HKHIVELH-E--VMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~lV~ 73 (416)
|+.|....+|++... +| .+++|+..... ..+.+..|+.+++.|. -|.++... + +....+..+++|
T Consensus 30 i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 30 IAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp ECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred cCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 456788899999752 33 68899886521 1134567777777663 23333210 0 112346789999
Q ss_pred eccCCCchhh--------------HHhc--CCC--------CHHHHHHH---------------HHHHHHHHHHHHH---
Q 014911 74 DLVKGGELFN--------------KIAK--GRL--------REDVARVY---------------FQQLISAVDFCHS--- 111 (416)
Q Consensus 74 E~~~gg~L~~--------------~i~~--~~l--------~e~~~~~~---------------~~qll~aL~ylH~--- 111 (416)
++++|..+.. .+.. ..+ ....-... -..+...+.++++
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9999854311 1111 011 10000000 0113344555542
Q ss_pred ----cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 ----RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 ----~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999877656899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00033 Score=69.76 Aligned_cols=71 Identities=11% Similarity=0.173 Sum_probs=47.4
Q ss_pred cccCCceEEEEEEEcC-------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 73 (416)
|+.|....||++.... ++..+.+|+..... ..+.+.+|..+++.|...+ ..++++.+.+ .+|+
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 5678889999998643 35789999884321 1134557999998885333 3677776542 2899
Q ss_pred eccCCCch
Q 014911 74 DLVKGGEL 81 (416)
Q Consensus 74 E~~~gg~L 81 (416)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00036 Score=68.29 Aligned_cols=132 Identities=15% Similarity=0.166 Sum_probs=80.8
Q ss_pred cccCCceEEEEEEEcC-------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 73 (416)
|..|-...+|++.... +++.+.+|+..... .....+.+|..+++.|. +.-..++++.+.+ .+||
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 4457778899987632 35789999863311 12456678999998874 3334667766543 2999
Q ss_pred eccCCCchhh--------------HHh---cC-----C-CC--HHHHHHHHHHHHH-------------------HHHHH
Q 014911 74 DLVKGGELFN--------------KIA---KG-----R-LR--EDVARVYFQQLIS-------------------AVDFC 109 (416)
Q Consensus 74 E~~~gg~L~~--------------~i~---~~-----~-l~--e~~~~~~~~qll~-------------------aL~yl 109 (416)
||++|.+|.. .+. .. + .. ...+.++..++-. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999855421 111 11 1 11 3455666655432 23333
Q ss_pred H----H----cCceeccCCCCcEEeccC----CCeEEeeccccc
Q 014911 110 H----S----RGVYHRDLKPENLLLDED----GNLKVTDFGLSA 141 (416)
Q Consensus 110 H----~----~gi~HrDlkp~NIll~~~----~~~kl~DFGla~ 141 (416)
. . ..++|+|+.+.||+++.+ +.+.++||..++
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 2 359999999999999876 689999999886
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00065 Score=64.53 Aligned_cols=130 Identities=14% Similarity=0.120 Sum_probs=75.8
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC--CCcceEEEE-----EEeCCEEEEEEeccC
Q 014911 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEV-----MASKSKIYFAMDLVK 77 (416)
Q Consensus 5 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~-----~~~~~~~~lV~E~~~ 77 (416)
|....||++.. .+|+.+++|+...... ....+..|..+++.|.. -.+++++.. ....+..+++|++++
T Consensus 36 g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 36 SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 77788998764 4566799999864321 23466778888877632 123333332 223567789999998
Q ss_pred CCchh-----------hH---Hhc----CC------CCHHHH----------------------HHHHHHHHHHHHHH--
Q 014911 78 GGELF-----------NK---IAK----GR------LREDVA----------------------RVYFQQLISAVDFC-- 109 (416)
Q Consensus 78 gg~L~-----------~~---i~~----~~------l~e~~~----------------------~~~~~qll~aL~yl-- 109 (416)
|..+. .. +.. .. .+.... ...+.+++..+.-+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 85431 01 110 00 111110 11112222222222
Q ss_pred --HHcCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 110 --HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 110 --H~~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
....++|+|++|.||+++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234589999999999998 4 89999999765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00042 Score=67.31 Aligned_cols=72 Identities=13% Similarity=0.127 Sum_probs=43.1
Q ss_pred cccCCceEEEEEEEcC--------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 014911 2 LGHGTFAKVYLARNLQ--------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFA 72 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV 72 (416)
|+.|....+|++.... .+..+++|+...... .......|..+++.|...+ +.++++.. .+ ++|
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 5667788999998643 136788898754321 1112467888888874333 45676654 22 689
Q ss_pred EeccCCCch
Q 014911 73 MDLVKGGEL 81 (416)
Q Consensus 73 ~E~~~gg~L 81 (416)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0015 Score=62.84 Aligned_cols=31 Identities=16% Similarity=0.381 Sum_probs=27.8
Q ss_pred cCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 112 ~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999998764
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0017 Score=55.39 Aligned_cols=82 Identities=11% Similarity=0.149 Sum_probs=63.5
Q ss_pred ccccCChhhhHHHHHHHHhhcccEEEeec----CeEEEEeeecCC----------cceeEEEEEEEEeeCCeEEEEEEec
Q 014911 309 FATTRPASSVISRFEEVAKAVKFNVKTSE----SRVRLQGQESGR----------KGKLAINADIFAVTPSLLVVEVKKD 374 (416)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----------~~~l~~~~~v~~~~~~~~~ve~~~~ 374 (416)
..++..|.+++..+..+.+.+|+.|++.+ +.|++.. +.+. ...+.|.+++|++.++.+||||+ .
T Consensus 55 IrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw-~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~ 132 (179)
T 3t4n_A 55 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRW-KYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-F 132 (179)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEE-CC-----------CCCEEEEEEEEEEEETTEEEEEEE-E
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEE-eCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-e
Confidence 45667889999999999999999999753 5588875 2221 13588999999999999999999 6
Q ss_pred CC----------------------ChhhHHHHhhhhhhhhc
Q 014911 375 NG----------------------DTLEYNQFCSNELRPAL 393 (416)
Q Consensus 375 ~G----------------------d~le~~~~~~~~l~~~l 393 (416)
.| .+..|-.+|.+ |--+|
T Consensus 133 ~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~-LI~eL 172 (179)
T 3t4n_A 133 DGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTK-LIMEL 172 (179)
T ss_dssp EEEECC----------------CCCCHHHHHHHHH-HHHHH
T ss_pred ccccccccccccccccccccccccCCccHHHHHHH-HHHHH
Confidence 67 66788888874 54444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0055 Score=61.38 Aligned_cols=72 Identities=11% Similarity=0.213 Sum_probs=46.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCCc
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
|+.|-...+|++.....+..+++|+...... ... .-.+|..+++.|...++ .++++++. +. +||||++|.+
T Consensus 116 lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 116 INGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp ECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred cCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 5667789999998754457889998743211 111 12589999998864444 57777763 32 4999998844
Q ss_pred h
Q 014911 81 L 81 (416)
Q Consensus 81 L 81 (416)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0067 Score=56.47 Aligned_cols=71 Identities=14% Similarity=0.158 Sum_probs=49.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEEEEeccCC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H--KHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+|.|..+.||+... .+|+.|.+|+-...... ....+.+|+..|+.|. . --+.+.+.+ +. -++||||+.+
T Consensus 23 ~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~ 94 (288)
T 3f7w_A 23 RGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDE 94 (288)
T ss_dssp EEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCC
T ss_pred cCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeecc
Confidence 68899999999985 67899999986543321 2235778999999884 2 235555554 22 3789999987
Q ss_pred Cc
Q 014911 79 GE 80 (416)
Q Consensus 79 g~ 80 (416)
+.
T Consensus 95 ~~ 96 (288)
T 3f7w_A 95 RP 96 (288)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.012 Score=58.39 Aligned_cols=72 Identities=13% Similarity=0.218 Sum_probs=45.6
Q ss_pred cccCCceEEEEEEEcCC-------CcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQT-------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 73 (416)
|..|-...+|++..... +..+++++..... ...-...+|..+++.|. +.-..++++.+. + ++||
T Consensus 78 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ 149 (424)
T 3mes_A 78 IFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE 149 (424)
T ss_dssp ECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred cCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence 44577788999986421 5789999864422 11112357888888874 333456665432 2 7899
Q ss_pred eccCCCch
Q 014911 74 DLVKGGEL 81 (416)
Q Consensus 74 E~~~gg~L 81 (416)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.16 E-value=0.033 Score=54.61 Aligned_cols=29 Identities=34% Similarity=0.591 Sum_probs=25.0
Q ss_pred ceeccCCCCcEEe------ccCCCeEEeecccccc
Q 014911 114 VYHRDLKPENLLL------DEDGNLKVTDFGLSAF 142 (416)
Q Consensus 114 i~HrDlkp~NIll------~~~~~~kl~DFGla~~ 142 (416)
++|+|+.+.||++ ++++.+.++||.+|+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4456799999999873
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.15 E-value=1.4 Score=39.18 Aligned_cols=82 Identities=15% Similarity=0.078 Sum_probs=63.9
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHH-HHHHcCceeccCCCCcEEeccCC
Q 014911 52 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVD-FCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 52 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~-ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
.||++ -..+-.+.+.+.+.++.-+++.=+..+ ..++..+.++++.+|+.... ++ ..-+|=-|+|+||++|.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 68888 666668889988888887665555555 34788888988888887655 33 4557788999999999999
Q ss_pred CeEEeeccc
Q 014911 131 NLKVTDFGL 139 (416)
Q Consensus 131 ~~kl~DFGl 139 (416)
.+++.=.|+
T Consensus 122 ~p~i~hRGi 130 (219)
T 4ano_A 122 EPFFLHVGV 130 (219)
T ss_dssp CEEESCCEE
T ss_pred cEEEEEcCC
Confidence 999988775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.75 E-value=2.4 Score=37.49 Aligned_cols=85 Identities=16% Similarity=0.265 Sum_probs=63.5
Q ss_pred CCCCCcceEEEEEEeCCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC
Q 014911 51 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 51 l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
..||+.+.. .+-.+.+.+.+.++.-+.+.=+..+ ..++....++++.+|+....++ ..=+|=-|+|+||+++.++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 368999977 6777778877777765543333334 3478888999999998877443 4457888999999999999
Q ss_pred CeEEeecccc
Q 014911 131 NLKVTDFGLS 140 (416)
Q Consensus 131 ~~kl~DFGla 140 (416)
.+++.=.|+-
T Consensus 117 ~p~i~~RGik 126 (215)
T 4ann_A 117 LPIAKTRGLQ 126 (215)
T ss_dssp CEEESCCEET
T ss_pred CEEEEEccCc
Confidence 9999877753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.53 E-value=0.082 Score=52.87 Aligned_cols=57 Identities=9% Similarity=0.146 Sum_probs=14.3
Q ss_pred ceEEEEEEEcCCCcEEEE------EEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014911 7 FAKVYLARNLQTGKSMAM------KVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 64 (416)
Q Consensus 7 fg~Vy~a~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 64 (416)
||.||+|.......+||+ |....... ..+....+.+|..+++.++|||+++.+.+..
T Consensus 152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 999999998765668888 65533222 2233456778999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 416 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-87 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-83 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-83 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-80 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-78 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-74 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-73 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-73 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-72 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-71 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-71 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-71 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-71 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-67 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-66 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-64 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-64 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-60 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-60 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-60 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-59 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-58 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-57 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-56 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-54 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 5e-07 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (677), Expect = 1e-87
Identities = 86/254 (33%), Positives = 142/254 (55%), Gaps = 6/254 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F VYLAR Q+ +A+KV+ K ++ K G+ Q++RE+ + ++H +I+ L+
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+++Y ++ G ++ ++ K + E Y +L +A+ +CHS+ V HRD+K
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK 133
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLL G LK+ DFG S + T CGT Y+ PE+I + +D K D+W
Sbjct: 134 PENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHD-EKVDLW 188
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
S GV+ Y L G PF+ + Y++I R +F P + + AR LI++LL NP+ R
Sbjct: 189 SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPM 248
Query: 241 ISKIMESSWFKKSA 254
+ +++E W ++
Sbjct: 249 LREVLEHPWITANS 262
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (649), Expect = 5e-83
Identities = 85/253 (33%), Positives = 141/253 (55%), Gaps = 2/253 (0%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G+F+ V LAR L T + A+K++ K +IK + + RE VM + H V+L+
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
K+YF + K GEL I K G E R Y +++SA+++ H +G+ HRDL
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 134
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KPEN+LL+ED ++++TDFG + + ++ GT YV+PE++++K +D+
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDL 193
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W+ G I+Y L+AG PF+ N +++KI + ++ P F +AR L+ KLL + R+
Sbjct: 194 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRL 253
Query: 240 AISKIMESSWFKK 252
++ K
Sbjct: 254 GCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 6e-83
Identities = 92/259 (35%), Positives = 146/259 (56%), Gaps = 6/259 (2%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + +V LA N T +++A+K+V + + E IK+EI + KM+ H+++V+ +
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 70
Query: 62 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ Y ++ GGELF++I + E A+ +F QL++ V + H G+ HRD+K
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 130
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLLLDE NLK++DFGL+ + ++ LL+ CGT YVAPE++ ++ + D+W
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 181 SCGVILYVLLAGFLPF-QDDNIVSMYRKIYRGDFKCPPW--FSSEARRLITKLLDPNPNS 237
SCG++L +LAG LP+ Q + Y PW S L+ K+L NP++
Sbjct: 191 SCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 250
Query: 238 RIAISKIMESSWFKKSAPK 256
RI I I + W+ K K
Sbjct: 251 RITIPDIKKDRWYNKPLKK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 3e-80
Identities = 71/257 (27%), Positives = 131/257 (50%), Gaps = 9/257 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G VY A ++ TG+ +A++ + + K E I EI VM+ K+ +IV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 121
+++ M+ + GG L + + + + E ++ + A++F HS V HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 122 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 181
+N+LL DG++K+TDFG A + T GTP ++APEV+++K Y K DIWS
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWS 201
Query: 182 CGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKLLDPNPNSR 238
G++ ++ G P+ ++N + I + + P S+ R + + LD + R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 239 IAISKIMESSWFKKSAP 255
+ ++++ + K + P
Sbjct: 262 GSAKELLQHQFLKIAKP 278
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 7e-78
Identities = 72/264 (27%), Positives = 128/264 (48%), Gaps = 14/264 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F KVY A+N +T A KV+ +E EI ++ H +IV+L +
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLD 76
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ ++ ++ GG + + + L E +V +Q + A+++ H + HRDL
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 136
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----SKKGYDGA 175
K N+L DG++K+ DFG+SA + + + GTP ++APEV+ SK
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLD 232
KAD+WS G+ L + P + N + + KI + + P +SS + + K L+
Sbjct: 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLE 254
Query: 233 PNPNSRIAISKIMESSWFKKSAPK 256
N ++R S++++ + + K
Sbjct: 255 KNVDARWTTSQLLQHPFVTVDSNK 278
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (616), Expect = 9e-78
Identities = 61/283 (21%), Positives = 120/283 (42%), Gaps = 13/283 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+GHG+F VY AR+++ + +A+K + + I +E+ ++ ++H + ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 62 VMASKSKIYFAMDLVKGGELF-NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+ + M+ G ++ K L+E + + + HS + HRD+K
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--SKKGYDGAKAD 178
N+LL E G +K+ DFG ++ ++ GTP ++APEVI +G K D
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW--FSSEARRLITKLLDPNPN 236
+WS G+ L P + N +S I + + +S R + L P
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256
Query: 237 SRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLN 279
R +++ + + P VI ++ + ++ + L
Sbjct: 257 DRPTSEVLLKHRFVLRERPPTVI--MDLIQRTKDAVRELDNLQ 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 238 bits (609), Expect = 3e-76
Identities = 81/259 (31%), Positives = 122/259 (47%), Gaps = 15/259 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+ TG + A K V E +++EI M +++H +V LH+
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHD 90
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+++ + + GGELF K+A ++ ED A Y +Q+ + H H DL
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 150
Query: 120 KPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
KPEN++ LK+ DFGL+A HL + T GT + APEV K G
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYT 206
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK----CPPWFSSEARRLITKLLDP 233
D+WS GV+ Y+LL+G PF +N R + D+ S + + I KLL
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266
Query: 234 NPNSRIAISKIMESSWFKK 252
+PN+R+ I + +E W
Sbjct: 267 DPNTRMTIHQALEHPWLTP 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 238 bits (608), Expect = 4e-76
Identities = 70/259 (27%), Positives = 123/259 (47%), Gaps = 15/259 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+ TG+ K + + +K EIS+M + H ++ LH+
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHD 93
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
K ++ ++ + GGELF++IA ++ E Y +Q + H + H D+
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 153
Query: 120 KPENLLLD--EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
KPEN++ + + ++K+ DFGL + L D ++ T T + APE++ ++
Sbjct: 154 KPENIMCETKKASSVKIIDFGL---ATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYT 209
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDP 233
D+W+ GV+ YVLL+G PF ++ + + + R D++ S EA+ I LL
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269
Query: 234 NPNSRIAISKIMESSWFKK 252
P R+ + +E W K
Sbjct: 270 EPRKRLTVHDALEHPWLKG 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 2e-74
Identities = 75/261 (28%), Positives = 129/261 (49%), Gaps = 17/261 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G++ + R GK + K + + + + + E+++++ +KH +IV ++
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 62 VMASKS--KIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRG- 113
+ ++ +Y M+ +GG+L + I K L E+ QL A+ CH R
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 114 ----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 169
V HRDLKP N+ LD N+K+ DFGL+ H GTP Y++PE +++
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNR 188
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLIT 228
Y+ K+DIWS G +LY L A PF + + KI G F + P +S E +IT
Sbjct: 189 MSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIIT 247
Query: 229 KLLDPNPNSRIAISKIMESSW 249
++L+ R ++ +I+E+
Sbjct: 248 RMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 229 bits (585), Expect = 1e-73
Identities = 85/269 (31%), Positives = 133/269 (49%), Gaps = 20/269 (7%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV------GMMEQIKREISVMKMVK-H 53
+LG G + V + T K A+K++ + E +E+ +++ V H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 112
+I++L + + + + DL+K GELF+ + K L E R + L+ + H
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 172
+ HRDLKPEN+LLD+D N+K+TDFG S L L CGTP+Y+APE+I
Sbjct: 130 NIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMN 186
Query: 173 D-----GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPW--FSSEA 223
D G + D+WS GVI+Y LLAG PF + M R I G+ F P W +S
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246
Query: 224 RRLITKLLDPNPNSRIAISKIMESSWFKK 252
+ L+++ L P R + + +F++
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 3e-73
Identities = 81/255 (31%), Positives = 134/255 (52%), Gaps = 6/255 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 59
MLG G+F KV+LA +T + A+K + KD V+ +E E V+ + +H + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+K ++F M+ + GG+L I + + A Y ++I + F HS+G+ +RD
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD 128
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
LK +N+LLD+DG++K+ DFG+ + D +T CGTP Y+APE++ + Y+ D
Sbjct: 129 LKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN-HSVD 185
Query: 179 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238
WS GV+LY +L G PF + ++ I + P W EA+ L+ KL P R
Sbjct: 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 239 I-AISKIMESSWFKK 252
+ I + F++
Sbjct: 246 LGVRGDIRQHPLFRE 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 227 bits (579), Expect = 3e-72
Identities = 101/295 (34%), Positives = 155/295 (52%), Gaps = 17/295 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G F++V LA + +T K +A+K + K + G ++ EI+V+ +KH +IV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALD 73
Query: 61 EVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
++ S +Y M LV GGELF++I KG E A Q++ AV + H G+ HRDL
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 120 KPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
KPENLL DED + ++DFGLS +L T CGTP YVAPEV+++K Y
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS-KA 189
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232
D WS GVI Y+LL G+ PF D+N ++ +I + +++ S A+ I L++
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249
Query: 233 PNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKS---SKQPETLNAFHII 284
+P R + ++ W Q + + K+ SK + NA ++
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVV 304
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 226 bits (576), Expect = 9e-72
Identities = 87/257 (33%), Positives = 151/257 (58%), Gaps = 12/257 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V+L R+ G+ AMKV+ K+ V+++ +E E ++ +V H I+ +
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 62 VMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
+I+ MD ++GGELF+ R VA+ Y ++ A+++ HS+ + +RDLK
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 131
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PEN+LLD++G++K+TDFG + + + +T CGTP Y+APEV+S K Y+ D W
Sbjct: 132 PENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN-KSIDWW 185
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
S G+++Y +LAG+ PF D N + Y KI + + PP+F+ + + L+++L+ + + R+
Sbjct: 186 SFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLG 245
Query: 241 -----ISKIMESSWFKK 252
+ WFK+
Sbjct: 246 NLQNGTEDVKNHPWFKE 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-71
Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 53/303 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G V+ + +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDL 119
S +I M+ + GG L + K GR+ E + +I + + + + HRD+
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 180 WSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPW------------------ 218
WS G+ L + G P + + M+ GD P
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP 246
Query: 219 -----------------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255
FS E + + K L NP R + ++M ++ K+S
Sbjct: 247 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306
Query: 256 KVV 258
+ V
Sbjct: 307 EEV 309
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 2e-71
Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 16/264 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V+ + K+ K V +K+EIS++ + +H++I+ LHE
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHE 68
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
S ++ + + G ++F +I L E Y Q+ A+ F HS + H D+
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 120 KPENLLLDEDGN--LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
+PEN++ + +K+ +FG + LK P Y APEV
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQHDVVS-TAT 184
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDP 233
D+WS G ++YVLL+G PF + + I ++ S EA + +LL
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 234 NPNSRIAISKIMESSWFKKSAPKV 257
SR+ S+ ++ W K+ +V
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERV 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 8e-71
Identities = 61/261 (23%), Positives = 123/261 (47%), Gaps = 18/261 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F VY + +T +A + K+ K ++ K E ++K ++H +IV ++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 62 VMASKSK----IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--V 114
S K I +L+ G L + + ++ V R + +Q++ + F H+R +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 115 YHRDLKPENLLL-DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
HRDLK +N+ + G++K+ D GL+ K+ GTP ++APE+ +K YD
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEK-YD 190
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRG--DFKCPPWFSSEARRLITKL 230
D+++ G+ + + P+ + N +YR++ G E + +I
Sbjct: 191 -ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249
Query: 231 LDPNPNSRIAISKIMESSWFK 251
+ N + R +I ++ ++F+
Sbjct: 250 IRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 9e-71
Identities = 86/257 (33%), Positives = 138/257 (53%), Gaps = 9/257 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG GTF KV L R TG+ AMK++ K+ +I + E V++ +H + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ F M+ GGELF +++ E+ AR Y +++SA+++ HSR V +RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
K ENL+LD+DG++K+TDFGL + T CGTP Y+APEV+ Y D
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDW 188
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239
W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +P R+
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248
Query: 240 A-----ISKIMESSWFK 251
++ME +F
Sbjct: 249 GGGPSDAKEVMEHRFFL 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-69
Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 18/259 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME---QIKREISVMKMVKHKH-- 55
+LG G F VY + +A+K V KD++ G + ++ E+ ++K V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRG 113
++ L + ++ + + +G L+E++AR +F Q++ AV CH+ G
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 114 VYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 172
V HRD+K EN+L+D + G LK+ DFG A + D + GT Y PE I Y
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 173 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 232
G A +WS G++LY ++ G +PF+ D +I RG SSE + LI L
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLA 240
Query: 233 PNPNSRIAISKIMESSWFK 251
P+ R +I W +
Sbjct: 241 LRPSDRPTFEEIQNHPWMQ 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 1e-68
Identities = 85/280 (30%), Positives = 143/280 (51%), Gaps = 18/280 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI---KVGMMEQIKREISVMKMVKHKHIVE 58
LG G FA V R TG A K + K + + E I+RE+S++K ++H +++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
LHEV +K+ + ++LV GGELF+ + K L E+ A + +Q+++ V + HS + H
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 118 DLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 173
DLKPEN++L + +K+ DFGL+ + GTP +VAPE+++ +
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194
Query: 174 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK----CPPWFSSEARRLITK 229
+AD+WS GVI Y+LL+G PF D + +++ S+ A+ I +
Sbjct: 195 -LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 230 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEM--EFE 267
LL +P R+ I ++ W K + ++ +FE
Sbjct: 254 LLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-68
Identities = 57/266 (21%), Positives = 113/266 (42%), Gaps = 16/266 (6%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G+F VY + +A+K++ + + K E+ V++ +H +I+
Sbjct: 16 IGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRHVNILLFMG 71
Query: 62 VMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+ ++ +G L++ + + + +Q +D+ H++ + HRDL
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--SKKGYDGAKA 177
K N+ L ED +K+ DFGL+ G+ ++APEVI K ++
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------KCPPWFSSEARRLITKLL 231
D+++ G++LY L+ G LP+ + N + + K +RL+ + L
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 232 DPNPNSRIAISKIMES-SWFKKSAPK 256
+ R +I+ S +S PK
Sbjct: 251 KKKRDERPLFPQILASIELLARSLPK 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 215 bits (549), Expect = 4e-67
Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 16/263 (6%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIV 57
++G G F +VY R TGK AMK + K ++ E ++ +V IV
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 58 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 116
+ + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 130
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RDLKP N+LLDE G+++++D GL+ H + GT Y+APEV+ K +
Sbjct: 131 RDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 177 ADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233
AD +S G +L+ LL G PF+ + R + P FS E R L+ LL
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246
Query: 234 NPNSRIAISK-----IMESSWFK 251
+ N R+ + ES +F+
Sbjct: 247 DVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 210 bits (535), Expect = 3e-66
Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 11/261 (4%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+LG G ++V+LAR+L+ + +A+KV+ D + +RE + H IV ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 61 EVMASKSK----IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVY 115
+ +++ Y M+ V G L + + G + A A++F H G+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 133
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 174
HRD+KP N+++ +KV DFG++ ++ GT Y++PE D
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD- 192
Query: 175 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKL 230
A++D++S G +LY +L G PF D+ VS+ + R D P S++ ++ K
Sbjct: 193 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 252
Query: 231 LDPNPNSRIAISKIMESSWFK 251
L NP +R + M + +
Sbjct: 253 LAKNPENRYQTAAEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 9e-66
Identities = 90/257 (35%), Positives = 140/257 (54%), Gaps = 12/257 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G+F +V L ++ ++G AMK++ K KV+K+ +E E +++ V +V+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
S +Y M+ V GGE+F+ + + GR E AR Y Q++ ++ HS + +RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
PENLL+D+ G ++VTDFG + G T CGTP +APE+I KGY+ D W
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN-KAVDWW 222
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 240
+ GV++Y + AG+ PF D + +Y KI G + P FSS+ + L+ LL + R
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
Query: 241 -----ISKIMESSWFKK 252
++ I WF
Sbjct: 283 NLKNGVNDIKNHKWFAT 299
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-64
Identities = 84/274 (30%), Positives = 132/274 (48%), Gaps = 31/274 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
+LG G KV N +T + A+K++ + +RE+ + + + HIV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRI 70
Query: 60 HEV----MASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR 112
+V A + + M+ + GGELF++I E A + + A+ + HS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 113 GVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 169
+ HRD+KPENLL + LK+TDFG F++ L T C TP YVAPEV+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------DFKCPPW--FSS 221
+ YD D+WS GVI+Y+LL G+ PF ++ +++ + +F P W S
Sbjct: 188 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255
E + LI LL P R+ I++ M W +S
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 8e-64
Identities = 69/282 (24%), Positives = 109/282 (38%), Gaps = 33/282 (11%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVE 58
LG G FA VY AR+ T + +A+K + K G+ REI +++ + H +I+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 117
L + KS I D ++ L + Y + +++ H + HR
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DLKP NLLLDE+G LK+ DFGL+ + T Y APE++ G
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 178 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------------------------ 213
D+W+ G IL LL D+ + +I+
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 214 ----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
+ LI L NP +RI ++ ++ +F
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-63
Identities = 67/314 (21%), Positives = 126/314 (40%), Gaps = 42/314 (13%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
+G G + V A + +A+K + + ++ REI ++ +H++I+ ++
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 61 EVMASKS----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
+++ + + K + + + G +L+ + L D + Q++ + + HS V H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 132
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVISKKGYDGA 175
RDLKP NLLL+ +LK+ DFGL+ ++ T T Y APE++
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--------------------YRGDFKC 215
DIWS G IL +L+ F + + I
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252
Query: 216 P-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK----SAPKVVIT 260
P P S+A L+ K+L NP+ RI + + + + ++ S +
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 312
Query: 261 KQEMEFEADKSSKQ 274
+ + E D K+
Sbjct: 313 PFKFDMELDDLPKE 326
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-61
Identities = 55/251 (21%), Positives = 107/251 (42%), Gaps = 19/251 (7%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V L G +A+K + D + E SVM ++H ++V+L
Sbjct: 15 IGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 62 VMA-SKSKIYFAMDLVKGGELFNKI---AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 117
V+ K +Y + + G L + + + L D + + A+++ HR
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DL N+L+ ED KV+DFGL+ + + T + APE + +K + K+
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFS-TKS 181
Query: 178 DIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235
D+WS G++L+ + + G +P+ + + ++ +G P ++ +
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDA 241
Query: 236 NSRIAISKIME 246
R + ++ E
Sbjct: 242 AMRPSFLQLRE 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-60
Identities = 54/262 (20%), Positives = 102/262 (38%), Gaps = 10/262 (3%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V K + + + + + E++ RE +M + + +IV L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 62 VMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
V + M++ GG L + + + Q+ + + + HRDL
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 120 KPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
N+LL K++DFGLS A + APE I+ + + +++D
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSD 194
Query: 179 IWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236
+WS GV ++ L+ G P++ + I +G +CPP E L++
Sbjct: 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWE 254
Query: 237 SRIAISKI---MESSWFKKSAP 255
R + M + ++ ++
Sbjct: 255 DRPDFLTVEQRMRACYYSLASK 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 50/263 (19%), Positives = 109/263 (41%), Gaps = 11/263 (4%)
Query: 2 LGHGTFAKVYLA--RNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
LG G F V + + K++A+K++ K++ + +++ E +VM+ + + +IV +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+ M++ + G L + + +++ Q+ + + HRD
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 119 LKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
L N+LL K++DFGLS A + APE I+ + +K+
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKS 191
Query: 178 DIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235
D+WS GV+++ + G P++ + + +G+ CP E L+ +
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 236 NSRIAISKIME--SSWFKKSAPK 256
+R + + +++ +
Sbjct: 252 ENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-60
Identities = 52/253 (20%), Positives = 94/253 (37%), Gaps = 9/253 (3%)
Query: 2 LGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 58
LG G+F V S+A+K + D + + M+ RE++ M + H++++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYH 116
L+ V+ + + +L G L +++ K G Y Q+ + + S+ H
Sbjct: 76 LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RDL NLLL +K+ DFGL ++ P K
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194
Query: 177 ADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLLDP 233
+D W GV L+ + G P+ N + KI + P + ++ +
Sbjct: 195 SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH 254
Query: 234 NPNSRIAISKIME 246
P R + +
Sbjct: 255 KPEDRPTFVALRD 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-60
Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 34/282 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY ARN TG+ +A+K + D + G+ REIS++K + H +IV+L +
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 62 VMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
V+ +++K+Y + + + + A + + + Y QL+ + FCHS V HRDL
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
KP+NLL++ +G +K+ DFGL+ T Y APE++ Y DI
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 180 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------------------------- 213
WS G I ++ F D+ + +I+R
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 214 ---KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
K P + R L++++L +PN RI+ + +F+
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 7e-60
Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 44/294 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GTF +V+ AR+ +TG+ +A+K V + K G REI +++++KH+++V L E
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 62 VMAS--------KSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 112
+ + K IY D + + + Q L++ + + H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 113 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLLHTTCGTPAYVAPEVISKK 170
+ HRD+K N+L+ DG LK+ DFGL+ K T Y PE++ +
Sbjct: 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP------------- 217
G D+W G I+ + Q + I + P
Sbjct: 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 218 -------------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
A LI KLL +P RI + +F
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 3e-59
Identities = 81/322 (25%), Positives = 129/322 (40%), Gaps = 56/322 (17%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 60
++G+G+F VY A+ +G+ +A+K V +DK RE+ +M+ + H +IV L
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLR 79
Query: 61 EVMASKSK------IYFAMDLVKGGEL----FNKIAKGRLREDVARVYFQQLISAVDFCH 110
S + + +D V AK L ++Y QL ++ + H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 111 SRGVYHRDLKPENLLLDEDGNL-KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 169
S G+ HRD+KP+NLLLD D + K+ DFG + L + + + Y APE+I
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSYICSRYYRAPELIFG 196
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------ 211
+ D+WS G +L LL G F D+ V +I +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 212 ----DFKCPPW-------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK------SA 254
K PW EA L ++LL+ P +R+ + S+F +
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 255 PKVVITKQEMEFEADKSSKQPE 276
P T F + S P
Sbjct: 317 PNGRDTPALFNFTTQELSSNPP 338
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 192 bits (488), Expect = 5e-59
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 34/281 (12%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ VY A+N G++ A+K + +K G+ REIS++K +KH +IV+L++
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 62 VMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+ +K ++ + + + +G L A+ + QL++ + +CH R V HRDLK
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
P+NLL++ +G LK+ DFGL+ T Y AP+V+ DIW
Sbjct: 128 PQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 181 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------------- 213
S G I ++ G F + +I+R
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 214 --KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252
L++K+L +PN RI + +E ++FK+
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-58
Identities = 55/278 (19%), Positives = 105/278 (37%), Gaps = 34/278 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVM-KMVKHKH 55
+LG G F KV A K+ V K++K E + E+ +M ++ H++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK------------------------GRLR 91
IV L IY + G+L N + L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 92 EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 151
+ + Q+ ++F + HRDL N+L+ +K+ DFGL+ +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 222
Query: 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYR 210
++APE + + Y K+D+WS G++L+ + + G P+ + + + K+ +
Sbjct: 223 RGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281
Query: 211 GDFK--CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
FK P + + E ++ + R + +
Sbjct: 282 NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-58
Identities = 68/313 (21%), Positives = 129/313 (41%), Gaps = 47/313 (15%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G + V A + +TG +A+K + + + ++ RE+ ++K ++H++++ L +
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 62 VMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
V Y M + G +L + +L ED + Q++ + + H+ G+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 143
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEVI
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF---------------- 219
DIWS G I+ ++ G F+ + + ++I + P F
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 220 ---------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKK---SAPKVVITK 261
S A L+ K+L + R+ + + +F+ + + + K
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK 318
Query: 262 QEMEFEADKSSKQ 274
+ F+ +
Sbjct: 319 YDDSFDDVDRTLD 331
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-58
Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 15/266 (5%)
Query: 2 LGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHK-HI 56
LG G + KV+L R + TGK AMKV+ K ++ K E + E V++ ++ +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVY 115
V LH +++K++ +D + GGELF +++ R E ++Y +++ A++ H G+
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 151
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
+RD+K EN+LLD +G++ +TDFGLS + + V
Sbjct: 152 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211
Query: 176 KADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITKLL 231
D WS GV++Y LL G PF D + R+I + + P S+ A+ LI +LL
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271
Query: 232 DPNPNSRIA-----ISKIMESSWFKK 252
+P R+ +I E +F+K
Sbjct: 272 MKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-58
Identities = 66/312 (21%), Positives = 127/312 (40%), Gaps = 45/312 (14%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G + V A + +TG +A+K + + + ++ RE+ ++K +KH++++ L +
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 62 VMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 116
V + + + + G +L N + +L +D + Q++ + + HS + H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 176
RDLKP NL ++ED LK+ DFGL+ ++ T Y APE++ +
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQT 199
Query: 177 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF----------------- 219
DIWS G I+ LL G F + + + I R
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259
Query: 220 --------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA---PKVVITKQ 262
+ A L+ K+L + + RI ++ + ++F + + V
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319
Query: 263 EMEFEADKSSKQ 274
+ FE+
Sbjct: 320 DQSFESRDLLID 331
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-58
Identities = 52/251 (20%), Positives = 110/251 (43%), Gaps = 15/251 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F V + + +A+K++ + + + ++ E VM + H+ +V+L+
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYG 66
Query: 62 VMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 119
V + I+ + + G L N + + R + + + A+++ S+ HRDL
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKGYDGAKA 177
N L+++ G +KV+DFGL S ++ D + + PEV+ + +K+
Sbjct: 127 AARNCLVNDQGVVKVSDFGL---SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKS 182
Query: 178 DIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235
DIW+ GV+++ + + G +P++ I +G P S + ++
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 242
Query: 236 NSRIAISKIME 246
+ R ++
Sbjct: 243 DERPTFKILLS 253
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-58
Identities = 60/262 (22%), Positives = 108/262 (41%), Gaps = 15/262 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V++ T + +A+K + + E +E VMK ++H+ +V+L+
Sbjct: 25 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 79
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFCHSRGVYHRD 118
V+ S+ IY + + G L + + + Q+ S + + HRD
Sbjct: 80 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 138
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
L+ N+L+ E+ KV DFGL+ E + + APE + K+D
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFT-IKSD 196
Query: 179 IWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236
+WS G++L L G +P+ + ++ RG CPP L+ + P
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 256
Query: 237 SRIAISKIME--SSWFKKSAPK 256
R + +F + P+
Sbjct: 257 ERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 1e-57
Identities = 60/268 (22%), Positives = 123/268 (45%), Gaps = 13/268 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G + +VY + ++A+K + +D + +E+ +E +VMK +KH ++V+L
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 62 VMASKSKIYFAMDLVKGGELFNKIA---KGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
V + Y + + G L + + + + V Q+ SA+++ + HRD
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
L N L+ E+ +KV DFGLS + APE ++ + K+D
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS-IKSD 198
Query: 179 IWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236
+W+ GV+L+ + G P+ ++ +Y + + + P + L+ NP+
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 258
Query: 237 SRIAISKIMES--SWFKKSAPKVVITKQ 262
R + ++I ++ + F++S+ + K+
Sbjct: 259 DRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (477), Expect = 2e-57
Identities = 54/258 (20%), Positives = 104/258 (40%), Gaps = 15/258 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMVKHKHI 56
++G G F +V GK + K +K G E+ E S+M H ++
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAI---KTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 57 VELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 114
+ L V+ + + + ++ G L F + G+ + + + + +
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 149
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT---CGTPAYVAPEVISKKG 171
HRDL N+L++ + KV+DFGLS F E D + + APE I +
Sbjct: 150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209
Query: 172 YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITK 229
+ +D+WS G++++ +++ G P+ D + I + P S +L+
Sbjct: 210 FTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD 268
Query: 230 LLDPNPNSRIAISKIMES 247
+ N R +I+ +
Sbjct: 269 CWQKDRNHRPKFGQIVNT 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-57
Identities = 55/287 (19%), Positives = 109/287 (37%), Gaps = 6/287 (2%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVE 58
+LG G F VY + G+ + + V K + ++I E VM V + H+
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR-EDVARVYFQQLISAVDFCHSRGVYHR 117
L + + + + G L + Q+ +++ R + HR
Sbjct: 76 LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 135
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
DL N+L+ ++K+TDFGL+ +++ ++A E I + Y ++
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQS 194
Query: 178 DIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235
D+WS GV ++ L+ G P+ + + +G+ PP + + ++ K +
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA 254
Query: 236 NSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFH 282
+SR +++ P+ + Q E S A
Sbjct: 255 DSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALM 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-57
Identities = 56/249 (22%), Positives = 108/249 (43%), Gaps = 11/249 (4%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F V+L +A+K + + + + E E VM + H +V+L+
Sbjct: 13 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 67
Query: 62 VMASKSKIYFAMDLVKGGELFNKIAKGRLR--EDVARVYFQQLISAVDFCHSRGVYHRDL 119
V ++ I + ++ G L + + R + + + + V HRDL
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 120 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 179
N L+ E+ +KV+DFG++ F Q T + +PEV S Y +K+D+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDV 185
Query: 180 WSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNS 237
WS GV+++ + + G +P+++ + + I G P S+ +++ P
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPED 245
Query: 238 RIAISKIME 246
R A S+++
Sbjct: 246 RPAFSRLLR 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 6e-57
Identities = 76/285 (26%), Positives = 124/285 (43%), Gaps = 34/285 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G GT+ V+ A+N +T + +A+K V D G+ REI ++K +KHK+IV LH+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 62 VMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 120
V+ S K+ + + G L ++ + + QL+ + FCHSR V HRDLK
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 121 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 180
P+NLL++ +G LK+ +FGL+ T Y P+V+ D+W
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 181 SCGVILYVLLAGFLP-FQDDNIVSMYRKIYRGDF-------------------------- 213
S G I L P F +++ ++I+R
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 214 ---KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 255
P ++ R L+ LL NP RI+ + ++ +F P
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-56
Identities = 55/267 (20%), Positives = 103/267 (38%), Gaps = 24/267 (8%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVEL 59
++G G F +V AR + G M + + E+ V+ K+ H +I+ L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQL 102
+ +Y A++ G L + + K L + +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 103 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 162
+D+ + HRDL N+L+ E+ K+ DFGLS E + ++
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWM 193
Query: 163 APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFS 220
A E + +D+WS GV+L+ +++ G P+ +Y K+ +G + P
Sbjct: 194 AIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 252
Query: 221 SEARRLITKLLDPNPNSRIAISKIMES 247
E L+ + P R + ++I+ S
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 5e-56
Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 43/288 (14%)
Query: 2 LGHGTFAKVYLARNLQT-GKSMAMKVVGKDKVIKVGMMEQIKREISVMKM---VKHKHIV 57
+G G + KV+ AR+L+ G+ +A+K V + + + GM RE++V++ +H ++V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 58 ELHEVMAS-----KSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCH 110
L +V ++K+ + V +K+ + + + + QL+ +DF H
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 111 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 170
S V HRDLKP+N+L+ G +K+ DFGL+ + T Y APEV+ +
Sbjct: 134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQS 190
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------- 211
Y D+WS G I + F+ + V KI
Sbjct: 191 SYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 212 --------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
K + L+ K L NP RI+ + +F+
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-55
Identities = 54/250 (21%), Positives = 106/250 (42%), Gaps = 13/250 (5%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
LG G F +V++ +A+K + + + + E ++MK ++H+ +V L+
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYA 75
Query: 62 VMASKSKIYFAMDLVKGGELFNKI---AKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
V+ ++ IY + ++ G L + + + +L + Q+ + F R HRD
Sbjct: 76 VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 119 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 178
L+ N+L+ + + K+ DFGL+ E + + APE I G K+D
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 179 IWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236
+WS G++L ++ G +P+ + + + RG P E +L+ P
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252
Query: 237 SRIAISKIME 246
R +
Sbjct: 253 DRPTFDYLRS 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-54
Identities = 59/251 (23%), Positives = 111/251 (44%), Gaps = 8/251 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKS-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 59
+G G F V+ + +A+ + + E+ +E M+ H HIV+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 60 HEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHR 117
V+ +++ ++ M+L GEL + + L +Y QL +A+ + S+ HR
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 118 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
D+ N+L+ + +K+ DFGLS + E ++APE I+ + + +
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTS-AS 190
Query: 178 DIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235
D+W GV ++ +L+ G PFQ + +I G+ PP L+TK +P
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 250
Query: 236 NSRIAISKIME 246
+ R +++
Sbjct: 251 SRRPRFTELKA 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 5e-54
Identities = 54/277 (19%), Positives = 100/277 (36%), Gaps = 35/277 (12%)
Query: 2 LGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
+G G F +V+ AR + +A+K++ ++ M +RE ++M + +I
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNI 78
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-------------------------LR 91
V+L V A + + + G+L + L
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 92 EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 151
+Q+ + + + R HRDL N L+ E+ +K+ DFGLS
Sbjct: 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 198
Query: 152 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL-PFQDDNIVSMYRKIYR 210
++ PE I Y ++D+W+ GV+L+ + + L P+ + +
Sbjct: 199 DGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 211 GDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
G+ CP E L+ P R + I
Sbjct: 258 GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 178 bits (453), Expect = 2e-53
Identities = 62/292 (21%), Positives = 120/292 (41%), Gaps = 53/292 (18%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELH 60
LG G +++V+ A N+ + + +K+ +K ++IKREI +++ ++ +I+ L
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 61 EVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
+++ + V + L + R Y +++ A+D+CHS G+ HRD
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRD 154
Query: 119 LKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 177
+KP N+++D E L++ D+GL+ F + + + PE++
Sbjct: 155 VKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211
Query: 178 DIWSCGVILYVLLAGFLPFQDDN--------------IVSMYRKIYRGDFKCPPWF---- 219
D+WS G +L ++ PF + +Y I + + + P F
Sbjct: 212 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271
Query: 220 --------------------SSEARRLITKLLDPNPNSRIAISKIMESSWFK 251
S EA + KLL + SR+ + ME +F
Sbjct: 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-51
Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 13/256 (5%)
Query: 1 MLGHGTFAKVYLARNLQTGKS---MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 57
++G G F VY L A+K + +++ +G + Q E +MK H +++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 58 ELHEV-MASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 114
L + + S+ + +K G+L F + + Q+ + F S+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 115 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKGY 172
HRDL N +LDE +KV DFGL+ + D + + T ++A E + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-QTQK 210
Query: 173 DGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 230
K+D+WS GV+L+ L+ G P+ D N + + +G P + ++ K
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 231 LDPNPNSRIAISKIME 246
P R + S+++
Sbjct: 271 WHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-51
Identities = 56/273 (20%), Positives = 103/273 (37%), Gaps = 31/273 (11%)
Query: 2 LGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKH 55
LG G F KV A ++A+K++ + E + E+ V+ + H +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMN 88
Query: 56 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-------------------GRLREDVAR 96
IV L + G+L N + + L +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
+ Q+ + F S+ HRDL N+LL K+ DFGL+ ++ +
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFK- 214
++APE I ++D+WS G+ L+ L + G P+ + S + K+ + F+
Sbjct: 209 LPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267
Query: 215 -CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
P +E ++ D +P R +I++
Sbjct: 268 LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (433), Expect = 8e-51
Identities = 44/265 (16%), Positives = 91/265 (34%), Gaps = 26/265 (9%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELH 60
+G G+F ++ NL + +A+K + Q++ E K++ I ++
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 61 EVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDL 119
+DL+ GR + +Q+++ V H + + +RD+
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 127
Query: 120 KPENLLLDE-----DGNLKVTDFGLSAF-----SEHLKQDGLLHTTCGTPAYVAPEVISK 169
KP+N L+ + V DFG+ F ++ GT Y++
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 170 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---MYRKIYRGDFKCPPW-----FSS 221
+ + D+ + G + L G LP+Q + Y +I P F
Sbjct: 188 REQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 222 EARRLITKLLDPNPNSRIAISKIME 246
E + + + ++ +
Sbjct: 247 EFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-51
Identities = 48/253 (18%), Positives = 98/253 (38%), Gaps = 8/253 (3%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVE 58
++G G F +VY + + V K E +M H +I+
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 59 LHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYH 116
L V++ + + ++ G L + + G + + + + + + H
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133
Query: 117 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT-TCGTPAYVAPEVISKKGYDGA 175
RDL N+L++ + KV+DFGLS E + + + APE IS + +
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS- 192
Query: 176 KADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDP 233
+D+WS G++++ ++ G P+ + + + + I G P S +L+ +
Sbjct: 193 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 252
Query: 234 NPNSRIAISKIME 246
R + I+
Sbjct: 253 ERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 9e-51
Identities = 59/272 (21%), Positives = 113/272 (41%), Gaps = 30/272 (11%)
Query: 2 LGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KH 53
LG G F +V LA + K +A+K++ D K + + E+ +MKM+ KH
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 78
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-----------------AKGRLREDVAR 96
K+I+ L +Y ++ G L + + +L
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 97 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156
Q+ +++ S+ HRDL N+L+ ED +K+ DFGL+ H+
Sbjct: 139 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FK 214
++APE + + Y ++D+WS GV+L+ + G P+ + +++ + G
Sbjct: 199 LPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 257
Query: 215 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 246
P ++E ++ P+ R +++E
Sbjct: 258 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 1e-50
Identities = 48/273 (17%), Positives = 97/273 (35%), Gaps = 27/273 (9%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVEL 59
+G G+F +YL ++ G+ +A+K+ Q+ E + KM++ I +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTI 68
Query: 60 HEVMASKSKIYFAMDLVKGGELF-NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 118
A M+L+ + + Q+IS +++ HS+ HRD
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 119 LKPENLL---LDEDGNLKVTDFGLSAFSEHLKQDGLLH-----TTCGTPAYVAPEVISKK 170
+KP+N L + + + DFGL+ + + GT Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 171 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--------CPPWFSSE 222
+ D+ S G +L G LP+Q + +K R K + SE
Sbjct: 189 EQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 223 ARRLITKLLDPNPNSRI---AISKIMESSWFKK 252
+ + + + ++ + + ++
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-49
Identities = 70/329 (21%), Positives = 127/329 (38%), Gaps = 58/329 (17%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G V A + +++A+K + + + ++ RE+ +MK V HK+I+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 83
Query: 62 VMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 115
V + +Y M+L+ ++ + L + Q++ + HS G+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCGIKHLHSAGII 141
Query: 116 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 175
HRDLKP N+++ D LK+ DFGL+ + ++ T Y APEVI GY
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKE- 197
Query: 176 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF---------------- 219
DIWS G I+ ++ + F + + + K+ P F
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 220 --------------------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKK- 252
+S+AR L++K+L +P RI++ ++ +
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317
Query: 253 --SAPKVVITKQEMEFEADKSSKQPETLN 279
A Q + + D+ E
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREHTIEEWK 346
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-48
Identities = 52/264 (19%), Positives = 97/264 (36%), Gaps = 21/264 (7%)
Query: 2 LGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
LG G+F VY + +A+K V + + + E SVMK H+
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHV 85
Query: 57 VELHEVMASKSKIYFAMDLVKGGELFNKI-----------AKGRLREDVARVYFQQLISA 105
V L V++ M+L+ G+L + + ++
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 106 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 165
+ + ++ HRDL N ++ ED +K+ DFG++ +++PE
Sbjct: 146 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205
Query: 166 VISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRGD-FKCPPWFSSEA 223
+ + +D+WS GV+L+ + P+Q + + R + G P
Sbjct: 206 SLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML 264
Query: 224 RRLITKLLDPNPNSRIAISKIMES 247
L+ NP R + +I+ S
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-47
Identities = 55/271 (20%), Positives = 104/271 (38%), Gaps = 28/271 (10%)
Query: 2 LGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 56
LG G F +V A T +++A+K++ K+ + ++ + H ++
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 57 VELHEVMASK-SKIYFAMDLVKGGELFNKI-----------------AKGRLREDVARVY 98
V L + ++ K G L + K L + Y
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 99 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158
Q+ ++F SR HRDL N+LL E +K+ DFGL+
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199
Query: 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRGD--FKC 215
++APE I + Y ++D+WS GV+L+ + + P+ I + + + +
Sbjct: 200 LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 258
Query: 216 PPWFSSEARRLITKLLDPNPNSRIAISKIME 246
P + + E + + P+ R S+++E
Sbjct: 259 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 49/286 (17%), Positives = 108/286 (37%), Gaps = 47/286 (16%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 61
+G G F +V+ + G+ +A+K+ + + EI M++H++I+
Sbjct: 11 IGKGRFGEVWRGK--WRGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIA 64
Query: 62 VM----ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS------ 111
+ ++++ D + G LF+ + + + + S + H
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 112 --RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVI 167
+ HRDLK +N+L+ ++G + D GL+ + D + GT Y+APEV+
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 168 S-----KKGYDGAKADIWSCGVILYVLLAGFLPF---------------QDDNIVSMYRK 207
K +ADI++ G++ + + D ++ M +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 208 IYRG--DFKCPPWFSS-----EARRLITKLLDPNPNSRIAISKIME 246
+ P + S +++ + N +R+ +I +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 1e-40
Identities = 65/366 (17%), Positives = 117/366 (31%), Gaps = 91/366 (24%)
Query: 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-------- 53
LG G F+ V+LA+++ +AMK+V DKV E + EI +++ V
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTKEDS 76
Query: 54 ---KHIVELHEVMASKSKIYFAMDLVKGG------ELFNKIAKGRLREDVARVYFQQLIS 104
HI++L + K + +V L K + + +QL+
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 105 AVDFC-HSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 162
+D+ G+ H D+KPEN+L++ + ++ D + T Y
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 163 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY----------------- 205
+PEV+ + ADIWS +++ L+ G F+ D S
Sbjct: 197 SPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 206 -------------------------------RKIYRGDFKCPPWFSSEARRLITKLLDPN 234
+ +K + E ++ +L +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 235 PNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLSP 294
P R ++ W K + E + G D+
Sbjct: 316 PRKRADAGGLVNHPWLKDTLG-------------------MEEIRVPDRELYGSGSDIPG 356
Query: 295 LFEEKK 300
FEE +
Sbjct: 357 WFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 3e-21
Identities = 32/199 (16%), Positives = 64/199 (32%), Gaps = 25/199 (12%)
Query: 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKD-------KVIKVGMMEQIKREISVMKMVKH 53
++G G + V+ + + +K K + +
Sbjct: 7 LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 54 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 113
+ + +L + K + ++ EL + R+R + ++ V + RG
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLM--ELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 114 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS---KK 170
+ H DL N+L+ E+G + + DF S +L I +
Sbjct: 124 IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--------RNIITYFSR 174
Query: 171 GYDGAKADIWSCGVILYVL 189
Y + DI S I +L
Sbjct: 175 TY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 45.5 bits (108), Expect = 5e-07
Identities = 10/82 (12%), Positives = 29/82 (35%), Gaps = 2/82 (2%)
Query: 311 TTRPASSVISRFEEVAKAVKFNVKTSES-RVRLQGQESGRKGKLAINADIFAV-TPSLLV 368
++ S ++ +V A + + E + + + + ++ + SL
Sbjct: 17 SSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNG 76
Query: 369 VEVKKDNGDTLEYNQFCSNELR 390
V K+ +G ++ + S
Sbjct: 77 VRFKRISGTSIAFKNIASKIAN 98
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 416 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.3 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 97.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.12 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.41 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-64 Score=474.54 Aligned_cols=247 Identities=34% Similarity=0.671 Sum_probs=229.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||+|++.+....+......+.+|+.+|+.++||||+++++++.+++.+|+|||||+||+
T Consensus 13 ~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~ 92 (263)
T d2j4za1 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92 (263)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 38999999999999999999999999987665555566789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... .......+||+
T Consensus 93 L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~~~~~~~Gt~ 168 (263)
T d2j4za1 93 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTL 168 (263)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CCCCEETTEEG
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CCcccccCCCC
Confidence 9999976 789999999999999999999999999999999999999999999999999997543 23345678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.+| +.++|||||||++|+|++|..||.+.+....+..+.+..+.+|+.+|+++++||.+||++||.+||
T Consensus 169 ~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~ 247 (263)
T d2j4za1 169 DYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 247 (263)
T ss_dssp GGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCc
Confidence 9999999998877 489999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCccccc
Q 014911 240 AISKIMESSWFKK 252 (416)
Q Consensus 240 s~~eil~hp~f~~ 252 (416)
|++|+|+||||+.
T Consensus 248 t~~eil~hp~~~~ 260 (263)
T d2j4za1 248 MLREVLEHPWITA 260 (263)
T ss_dssp CHHHHHTCHHHHH
T ss_pred CHHHHHcCcCcCC
Confidence 9999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-64 Score=472.88 Aligned_cols=253 Identities=35% Similarity=0.623 Sum_probs=218.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++...... +..+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 489999999999999999999999999766432 334678899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.............+.+||+
T Consensus 90 L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~ 169 (271)
T d1nvra_ 90 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169 (271)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCc
Confidence 9999976 679999999999999999999999999999999999999999999999999998766544445566789999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCCC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP--PWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~ 236 (416)
.|+|||++.+.++++.++|||||||++|+|++|.+||...+.. ..+..+.......+ +.+|+++++||.+||+.||+
T Consensus 170 ~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 249 (271)
T d1nvra_ 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 249 (271)
T ss_dssp GGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChh
Confidence 9999999998888778899999999999999999999775443 33333433333222 45899999999999999999
Q ss_pred CcCCHHHHhcCccccccCc
Q 014911 237 SRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 237 ~R~s~~eil~hp~f~~~~~ 255 (416)
+|||++|+++||||++..+
T Consensus 250 ~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 250 ARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp TSCCHHHHTTCTTTTCCCC
T ss_pred HCcCHHHHhcCHhhCcCCC
Confidence 9999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-63 Score=475.94 Aligned_cols=253 Identities=34% Similarity=0.632 Sum_probs=228.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+
T Consensus 15 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~ 94 (288)
T d1uu3a_ 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94 (288)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCC
Confidence 48999999999999999999999999987665555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|.............+.+||+
T Consensus 95 L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 95 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174 (288)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCG
T ss_pred HHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCc
Confidence 9999876 889999999999999999999999999999999999999999999999999998765544444556778999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+..| +.++||||+||++|+|++|..||.+.+...++.++.++.+.+|..+|+++++||++||++||++||
T Consensus 175 ~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 253 (288)
T d1uu3a_ 175 QYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRL 253 (288)
T ss_dssp GGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGST
T ss_pred cccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCc
Confidence 9999999988877 589999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHH------HhcCccccccC
Q 014911 240 AISK------IMESSWFKKSA 254 (416)
Q Consensus 240 s~~e------il~hp~f~~~~ 254 (416)
|++| +++||||+...
T Consensus 254 t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 254 GCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp TSGGGTCHHHHHTSGGGTTCC
T ss_pred CHHHHcCCHHHHcCCccCCCC
Confidence 9987 58899998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=468.77 Aligned_cols=247 Identities=28% Similarity=0.504 Sum_probs=221.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|++++||||+++++++.+.+.+|+|||||+||+|
T Consensus 28 iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 89999999999999999999999999765432 346789999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCCC
Q 014911 82 FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 161 (416)
Q Consensus 82 ~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 161 (416)
.+++.++.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ........+||+.|
T Consensus 105 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y 182 (293)
T d1yhwa1 105 TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYW 182 (293)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCBCCCCSCGGG
T ss_pred HHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccccccccCCCc
Confidence 9999888899999999999999999999999999999999999999999999999999985433 22344567899999
Q ss_pred CchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 162 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 162 ~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+|||++.+.+| +.++||||+||++|+|++|..||.+.+.......+... .+..|+.+|+++++||.+||++||.+|
T Consensus 183 ~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 261 (293)
T d1yhwa1 183 MAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261 (293)
T ss_dssp CCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTS
T ss_pred cChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHC
Confidence 99999988777 48999999999999999999999988876666555543 345567799999999999999999999
Q ss_pred CCHHHHhcCccccccC
Q 014911 239 IAISKIMESSWFKKSA 254 (416)
Q Consensus 239 ~s~~eil~hp~f~~~~ 254 (416)
||+.|+|+||||+...
T Consensus 262 ~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 262 GSAKELLQHQFLKIAK 277 (293)
T ss_dssp CCHHHHTTCGGGGGCC
T ss_pred cCHHHHhcCHhhCCCC
Confidence 9999999999998644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-62 Score=474.22 Aligned_cols=250 Identities=35% Similarity=0.662 Sum_probs=232.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+.+.+|+|||||+||+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~ 91 (337)
T d1o6la_ 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91 (337)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCc
Confidence 48999999999999999999999999987765555667889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|++++.+ +.++++.++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ......+.+|||
T Consensus 92 L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~~~~~~~GT~ 169 (337)
T d1o6la_ 92 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 169 (337)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECG
T ss_pred hhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CCcccccceeCH
Confidence 9999986 7899999999999999999999999999999999999999999999999999985432 233456789999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+...++..+..+.+.+|..+|+++++||++||++||.+|+
T Consensus 170 ~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 170 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp GGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred HHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhc
Confidence 9999999998888 589999999999999999999999999999999999999999999999999999999999999999
Q ss_pred C-----HHHHhcCcccccc
Q 014911 240 A-----ISKIMESSWFKKS 253 (416)
Q Consensus 240 s-----~~eil~hp~f~~~ 253 (416)
+ ++|+++||||+..
T Consensus 249 ~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TCSTTTHHHHHTSGGGTTC
T ss_pred ccccccHHHHHcCcccccC
Confidence 5 8999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-61 Score=462.95 Aligned_cols=247 Identities=37% Similarity=0.708 Sum_probs=206.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
+||+|+||+||+|++..+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++.+++.+|+|||||+||+
T Consensus 16 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp ESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 4899999999999999999999999998765432 33568899999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec---cCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|..... .....+.+
T Consensus 94 L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~ 170 (307)
T d1a06a_ 94 LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTAC 170 (307)
T ss_dssp HHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------------
T ss_pred HHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---CCeeeeee
Confidence 9999976 7899999999999999999999999999999999999995 578899999999985432 33456778
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+.......+.++....+ +.+|+++++||.+||+
T Consensus 171 GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 249 (307)
T d1a06a_ 171 GTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249 (307)
T ss_dssp --CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred eCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHcc
Confidence 9999999999988877 4899999999999999999999999998888899988765443 5689999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+|||++|+++||||+..
T Consensus 250 ~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 250 KDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SSGGGSCCHHHHHHSTTTTSS
T ss_pred CCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=460.53 Aligned_cols=248 Identities=28% Similarity=0.467 Sum_probs=219.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++.+|+|||||+||+
T Consensus 19 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 38999999999999999999999999976532 345678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... .....+.+||
T Consensus 96 L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt 173 (288)
T d2jfla1 96 VDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGT 173 (288)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccc
Confidence 9999754 56999999999999999999999999999999999999999999999999999754322 1223467899
Q ss_pred CCCCchHHhh-----hcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHc
Q 014911 159 PAYVAPEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKL 230 (416)
Q Consensus 159 ~~y~aPE~~~-----~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~ 230 (416)
+.|+|||++. ..+| +.++|||||||++|+|++|.+||.+.+..+.+..+..+.. ..|+.+|+++++||.+|
T Consensus 174 ~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~ 252 (288)
T d2jfla1 174 PYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252 (288)
T ss_dssp CTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHH
T ss_pred cccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 9999999985 2334 5899999999999999999999999888888888887753 34567899999999999
Q ss_pred cCCCCCCcCCHHHHhcCccccccC
Q 014911 231 LDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
|++||.+|||++|+++||||+...
T Consensus 253 L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 253 LEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp SCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred ccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999998543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-61 Score=461.92 Aligned_cols=248 Identities=35% Similarity=0.748 Sum_probs=230.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+++.+|+|||||.||+
T Consensus 11 ~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 90 (316)
T d1fota_ 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90 (316)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcc
Confidence 48999999999999999999999999987665555567889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ...+.+||+
T Consensus 91 l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~ 165 (316)
T d1fota_ 91 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTP 165 (316)
T ss_dssp HHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCT
T ss_pred ccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----ccccccCcc
Confidence 9999976 6799999999999999999999999999999999999999999999999999975432 345678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+....+.++..+....|+.+|++++++|.+||++||.+|+
T Consensus 166 ~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 166 DYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp TTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred cccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhcc
Confidence 99999999888775 89999999999999999999999999999999999999999999999999999999999999996
Q ss_pred -----CHHHHhcCccccccC
Q 014911 240 -----AISKIMESSWFKKSA 254 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~ 254 (416)
|++++++||||++..
T Consensus 245 ~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 245 GNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TSSTTTTHHHHTSGGGSSCC
T ss_pred ccchhhHHHHHcCcccccCC
Confidence 999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-61 Score=453.00 Aligned_cols=246 Identities=30% Similarity=0.543 Sum_probs=209.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~g 78 (416)
.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|++++||||+++++++.+ .+.+|+|||||+|
T Consensus 11 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 489999999999999999999999999876543 3456789999999999999999999999865 4568999999999
Q ss_pred CchhhHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEeccCCCeEEeecccccccccccc
Q 014911 79 GELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 148 (416)
Q Consensus 79 g~L~~~i~~-----~~l~e~~~~~~~~qll~aL~ylH~~g-----i~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 148 (416)
|+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|......
T Consensus 90 g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-- 167 (269)
T d2java1 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 167 (269)
T ss_dssp EEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----
T ss_pred CcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC--
Confidence 999999853 56999999999999999999999987 999999999999999999999999999865432
Q ss_pred CCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Q 014911 149 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLI 227 (416)
Q Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 227 (416)
.....+.+||+.|+|||++.+.+| +.++|||||||++|+|++|..||.+.+..++...+..+.. ..|..+|+++.+||
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li 246 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 246 (269)
T ss_dssp --------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred CCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 233456789999999999988777 4999999999999999999999999999999999888765 46778999999999
Q ss_pred HHccCCCCCCcCCHHHHhcCccc
Q 014911 228 TKLLDPNPNSRIAISKIMESSWF 250 (416)
Q Consensus 228 ~~~L~~dP~~R~s~~eil~hp~f 250 (416)
++||++||.+|||++|+++|||.
T Consensus 247 ~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 247 TRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-60 Score=458.79 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=221.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|++|+|||||++++++.+++.+|+|||||.||+|
T Consensus 23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 102 (309)
T d1u5ra_ 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCch
Confidence 89999999999999999999999999877665556677899999999999999999999999999999999999999999
Q ss_pred hhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCCC
Q 014911 82 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 160 (416)
Q Consensus 82 ~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 160 (416)
..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ....+||+.
T Consensus 103 ~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~ 176 (309)
T d1u5ra_ 103 DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPY 176 (309)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGG
T ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCcc
Confidence 877654 7899999999999999999999999999999999999999999999999999975332 345689999
Q ss_pred CCchHHhhhc--CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHccCCCCC
Q 014911 161 YVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 161 y~aPE~~~~~--~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~ 236 (416)
|+|||++.+. +.++.++|||||||++|+|++|..||.+.+.......+..+..+. +..+|+++++||.+||++||.
T Consensus 177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 256 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256 (309)
T ss_dssp GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChh
Confidence 9999999642 233589999999999999999999999988887777777765433 445899999999999999999
Q ss_pred CcCCHHHHhcCccccccCc
Q 014911 237 SRIAISKIMESSWFKKSAP 255 (416)
Q Consensus 237 ~R~s~~eil~hp~f~~~~~ 255 (416)
+|||++|+|+||||....+
T Consensus 257 ~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 257 DRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp GSCCHHHHTTCHHHHSCCC
T ss_pred HCcCHHHHHhCHHhcCCCC
Confidence 9999999999999976543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-60 Score=450.95 Aligned_cols=249 Identities=34% Similarity=0.595 Sum_probs=224.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+
T Consensus 17 ~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (293)
T d1jksa_ 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96 (293)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 48999999999999999999999999987654322 235789999999999999999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC----CeEEeeccccccccccccCCcc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~----~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|..... ....
T Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~---~~~~ 173 (293)
T d1jksa_ 97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEF 173 (293)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT---SCBC
T ss_pred CccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC---Cccc
Confidence 9999999976 7899999999999999999999999999999999999998877 499999999975432 3345
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLIT 228 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 228 (416)
.+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+.......+ +.+|+++++||+
T Consensus 174 ~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 252 (293)
T d1jksa_ 174 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252 (293)
T ss_dssp SCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHH
Confidence 56789999999999987766 5999999999999999999999999999999999988876654 568999999999
Q ss_pred HccCCCCCCcCCHHHHhcCcccccc
Q 014911 229 KLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 229 ~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||++||.+|||++|+++||||+..
T Consensus 253 ~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 253 RLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999854
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-60 Score=463.04 Aligned_cols=248 Identities=36% Similarity=0.700 Sum_probs=230.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+.+|+.++||||+++++++.+...+|+||||+.||+
T Consensus 48 ~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~ 127 (350)
T d1rdqe_ 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127 (350)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccc
Confidence 48999999999999999999999999987665555667789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ...+.+||+
T Consensus 128 l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~ 202 (350)
T d1rdqe_ 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTP 202 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECG
T ss_pred hhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----ccccccCcc
Confidence 9999976 7899999999999999999999999999999999999999999999999999985432 345678999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCcC
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 239 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 239 (416)
.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+....+..+..+.+..|+.+|+++.+||++||++||.+|+
T Consensus 203 ~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 203 EALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp GGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred ccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhcc
Confidence 99999999988774 89999999999999999999999999999999999999999999999999999999999999995
Q ss_pred -----CHHHHhcCccccccC
Q 014911 240 -----AISKIMESSWFKKSA 254 (416)
Q Consensus 240 -----s~~eil~hp~f~~~~ 254 (416)
|++++++||||+...
T Consensus 282 ~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTCC
T ss_pred ccccccHHHHHcCccccCCC
Confidence 999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-60 Score=445.68 Aligned_cols=243 Identities=24% Similarity=0.480 Sum_probs=212.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLVK 77 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~ 77 (416)
||+|+||+||+|++..+++.||+|++....... ...+.+.+|+++|++++|||||++++++.+ ...+|+||||++
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~ 95 (270)
T d1t4ha_ 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95 (270)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence 899999999999999999999999997765433 446789999999999999999999999865 457899999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEec-cCCCeEEeeccccccccccccCCccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLH 153 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~g--i~HrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~ 153 (416)
||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+|+... .....
T Consensus 96 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~----~~~~~ 171 (270)
T d1t4ha_ 96 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAK 171 (270)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBE
T ss_pred CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc----CCccC
Confidence 9999999976 78999999999999999999999999 99999999999996 57899999999997533 23445
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCC-cHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDF--KCPPWFSSEARRLITKL 230 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 230 (416)
+.+|||.|+|||++.+ +| +.++||||+||++|+|++|..||.+. +...++..+..+.. ..+..+++++++||.+|
T Consensus 172 ~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 249 (270)
T d1t4ha_ 172 AVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249 (270)
T ss_dssp ESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHH
Confidence 6789999999999865 45 59999999999999999999999765 45556666665543 23456899999999999
Q ss_pred cCCCCCCcCCHHHHhcCcccc
Q 014911 231 LDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~ 251 (416)
|++||++|||++|+++||||+
T Consensus 250 l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 250 IRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-59 Score=459.63 Aligned_cols=247 Identities=28% Similarity=0.556 Sum_probs=223.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|++|+||||+++++++.+++.+|+|||||+||+
T Consensus 36 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 48999999999999999999999999976542 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEec--cCCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD--EDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~--~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|++++.. .++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|..... .....+.+
T Consensus 113 L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~~~~~~~~ 189 (352)
T d1koba_ 113 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTT 189 (352)
T ss_dssp HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TSCEEEEC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC---CCceeecc
Confidence 9998865 4699999999999999999999999999999999999998 578999999999986442 34566788
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+....+..+..+....| +.+|+++++||.+||+
T Consensus 190 gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 268 (352)
T d1koba_ 190 ATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268 (352)
T ss_dssp SSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred CcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 9999999999988877 5999999999999999999999999999999999988876554 4689999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||.+|||++|+|+||||+...
T Consensus 269 ~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 269 KEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp SSGGGSCCHHHHHTSTTTSSCC
T ss_pred CChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-59 Score=459.27 Aligned_cols=247 Identities=32% Similarity=0.578 Sum_probs=223.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++.+|+|||||+||+
T Consensus 33 ~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 38999999999999999999999999976532 345778999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc--CCCeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.... .....+.+
T Consensus 110 L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~---~~~~~~~~ 186 (350)
T d1koaa2 110 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTT 186 (350)
T ss_dssp HHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---TSCEEEEC
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc---ccccceec
Confidence 9999953 67999999999999999999999999999999999999964 57899999999985432 34456788
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+.+| +.++|||||||++|+|++|..||.+.+..+.+..+.......+ +.+|+++++||.+||+
T Consensus 187 gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 265 (350)
T d1koaa2 187 GTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265 (350)
T ss_dssp SCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCC
T ss_pred CcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 9999999999998877 4899999999999999999999999999999999988876554 3589999999999999
Q ss_pred CCCCCcCCHHHHhcCccccccC
Q 014911 233 PNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~~ 254 (416)
+||++|||++|+|+||||+...
T Consensus 266 ~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 266 ADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SSGGGSCCHHHHHHSTTTSCTT
T ss_pred CChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-60 Score=457.37 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=209.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.+|+.++|||||++++++.+++.+|+||||++||+
T Consensus 13 ~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 3899999999999999999999999997653 23456789999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.+ +++++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+|..... ....+.+||
T Consensus 91 L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~~~~~~~GT 166 (322)
T d1s9ja_ 91 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166 (322)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HTC---CCS
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----CccccccCC
Confidence 9999975 789999999999999999999997 5999999999999999999999999999986543 223567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHH---------------------------------
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY--------------------------------- 205 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~--------------------------------- 205 (416)
+.|+|||++.+.+| +.++||||+||++|+|++|+.||.+.+.....
T Consensus 167 ~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T d1s9ja_ 167 RSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245 (322)
T ss_dssp SCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------
T ss_pred ccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccc
Confidence 99999999998877 48999999999999999999999765422110
Q ss_pred ---------HHHHhCC-CCCC-CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 206 ---------RKIYRGD-FKCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 206 ---------~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..+.... ...| ..+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 1111111 1111 1268899999999999999999999999999999854
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-60 Score=455.30 Aligned_cols=250 Identities=32% Similarity=0.609 Sum_probs=227.1
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
+||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.++. .++||||+++++++.+++.+|+||||++||
T Consensus 9 ~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g 88 (320)
T d1xjda_ 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88 (320)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCC
Confidence 4899999999999999999999999998765444455566777777765 689999999999999999999999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ........+||
T Consensus 89 ~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt 166 (320)
T d1xjda_ 89 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGT 166 (320)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSC
T ss_pred cHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccccccccCCC
Confidence 99999976 7899999999999999999999999999999999999999999999999999975432 23344567899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCCCCc
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 238 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 238 (416)
+.|+|||++.+.+|+ .++||||+||++|+|++|+.||.+.+...++.++..+.+.+|+.+|+++++||++||++||.+|
T Consensus 167 ~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 245 (320)
T d1xjda_ 167 PDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245 (320)
T ss_dssp GGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCC
Confidence 999999999988875 8999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCHH-HHhcCcccccc
Q 014911 239 IAIS-KIMESSWFKKS 253 (416)
Q Consensus 239 ~s~~-eil~hp~f~~~ 253 (416)
||+. ++++||||+..
T Consensus 246 ~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 246 LGVRGDIRQHPLFREI 261 (320)
T ss_dssp BTTBSCGGGSGGGTTC
T ss_pred cCHHHHHHhCchhccC
Confidence 9995 89999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-58 Score=439.16 Aligned_cols=249 Identities=32% Similarity=0.563 Sum_probs=222.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc------hhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK------VGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 73 (416)
.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+|++++ ||||+++++++.+++.+|+||
T Consensus 10 ~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivm 89 (277)
T d1phka_ 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEE
Confidence 4899999999999999999999999998765432 123456889999999997 999999999999999999999
Q ss_pred eccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcc
Q 014911 74 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 74 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 90 E~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~---~~~~ 166 (277)
T d1phka_ 90 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 166 (277)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT---TCCB
T ss_pred EcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC---CCce
Confidence 99999999999965 8899999999999999999999999999999999999999999999999999986443 3344
Q ss_pred cccccCCCCCchHHhhhc-----CCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHH
Q 014911 153 HTTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEA 223 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 223 (416)
...+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.+.......+..+....+. .+|+++
T Consensus 167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 246 (277)
T d1phka_ 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246 (277)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence 567899999999999642 23368999999999999999999999999998888888887665433 689999
Q ss_pred HHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 224 RRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 224 ~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
++||.+||++||.+|||++|+++||||+.
T Consensus 247 ~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 247 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-59 Score=458.06 Aligned_cols=249 Identities=31% Similarity=0.496 Sum_probs=216.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHH---HHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK---REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+||+|++..+|+.||||++.+...........+. +|+.+++.++||||+++++++.+.+.+|+|||||+
T Consensus 11 ~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~ 90 (364)
T d1omwa3 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90 (364)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecC
Confidence 489999999999999999999999999765543333333344 44677778899999999999999999999999999
Q ss_pred CCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
||+|.+++.+ +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... ......+
T Consensus 91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~----~~~~~~~ 166 (364)
T d1omwa3 91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 166 (364)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS----SCCCSCC
T ss_pred CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC----Ccccccc
Confidence 9999999976 7899999999999999999999999999999999999999999999999999985432 2345678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 233 (416)
||+.|+|||++.....++.++|||||||++|+|++|..||.+.+ ...+...+.......|+.+|+++++||.+||++
T Consensus 167 GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 246 (364)
T d1omwa3 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246 (364)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCS
T ss_pred cccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHccc
Confidence 99999999999765545699999999999999999999998754 334445555566778889999999999999999
Q ss_pred CCCCcCC-----HHHHhcCcccccc
Q 014911 234 NPNSRIA-----ISKIMESSWFKKS 253 (416)
Q Consensus 234 dP~~R~s-----~~eil~hp~f~~~ 253 (416)
||.+||| ++++++||||+..
T Consensus 247 dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 247 DVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp STTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999 7999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=448.10 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=213.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
+||+|+||+||+|++..+|+.||||+++...... ......+.+|+.+|+.++|||||++++++.+++.+|+||||+.|
T Consensus 5 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~ 84 (299)
T d1ua2a_ 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84 (299)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred EeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcc
Confidence 4899999999999999999999999997654322 12235688999999999999999999999999999999999999
Q ss_pred CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 79 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 79 g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
+++...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ......+.+|
T Consensus 85 ~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~~~g 162 (299)
T d1ua2a_ 85 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVV 162 (299)
T ss_dssp EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCCSCC
T ss_pred hHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccceec
Confidence 888777764 6799999999999999999999999999999999999999999999999999975433 2233456789
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--------------------CC--
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------KC-- 215 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------~~-- 215 (416)
|+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+...++.+... ..
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ua2a_ 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242 (299)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCC
Confidence 99999999998766667999999999999999999999999888777776653200 00
Q ss_pred ------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 216 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 216 ------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+.+++++.+||++||++||++|||++|+|+||||++..
T Consensus 243 ~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 124688999999999999999999999999999998643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=446.99 Aligned_cols=245 Identities=27% Similarity=0.483 Sum_probs=221.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..... ....+.+|+.+|+.++||||+++++++.+++.+|+|||||+||+
T Consensus 12 ~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 38999999999999999999999999976532 23568899999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC--CeEEeeccccccccccccCCcccccc
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--NLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
|++++.. .++++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.... ......+.+
T Consensus 88 L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---~~~~~~~~~ 164 (321)
T d1tkia_ 88 IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLF 164 (321)
T ss_dssp HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---TTCEEEEEE
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---cCCcccccc
Confidence 9999975 3799999999999999999999999999999999999998554 79999999997543 234456778
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLD 232 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~ 232 (416)
||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+.++.+.+|. .+|+++++||.+||+
T Consensus 165 ~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T d1tkia_ 165 TAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp SCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred cccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHcc
Confidence 9999999999987776 58999999999999999999999999999999999998877663 689999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||.+|||++|+++||||+..
T Consensus 244 ~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 244 KERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SSGGGSCCHHHHHHSHHHHSC
T ss_pred CChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=438.26 Aligned_cols=243 Identities=33% Similarity=0.586 Sum_probs=215.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchh---hHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG---MMEQIKREISVMKMVK--HKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
+||+|+||+||+|++..+|+.||||++.+....... ....+.+|+.+|++++ ||||+++++++.+++..|+||||
T Consensus 11 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~ 90 (273)
T d1xwsa_ 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90 (273)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence 489999999999999999999999999876543221 1234668999999997 89999999999999999999999
Q ss_pred cCC-CchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccC-CCeEEeeccccccccccccCCcc
Q 014911 76 VKG-GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLL 152 (416)
Q Consensus 76 ~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~ 152 (416)
+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|.... ....
T Consensus 91 ~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~----~~~~ 166 (273)
T d1xwsa_ 91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVY 166 (273)
T ss_dssp CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC----SSCB
T ss_pred ccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc----cccc
Confidence 986 578888865 789999999999999999999999999999999999999855 789999999997543 2344
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccC
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 232 (416)
.+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+ .+.++...+|+.+|+++++||++||+
T Consensus 167 ~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~li~~~L~ 240 (273)
T d1xwsa_ 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLA 240 (273)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTC
T ss_pred cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHHHHHHHHcc
Confidence 567899999999999988887788999999999999999999998643 45677888999999999999999999
Q ss_pred CCCCCcCCHHHHhcCcccccc
Q 014911 233 PNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp~f~~~ 253 (416)
+||++|||++|+++||||++.
T Consensus 241 ~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 241 LRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SSGGGSCCHHHHHTSGGGSSC
T ss_pred CCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=434.34 Aligned_cols=253 Identities=30% Similarity=0.481 Sum_probs=212.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|++++||||+++++++.+++.+|+||||+.|+.
T Consensus 9 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~ 87 (298)
T d1gz8a_ 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87 (298)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCch
Confidence 489999999999999999999999999765432 2345788999999999999999999999999999999999997754
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
+...... +.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+|..... ........+||
T Consensus 88 ~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt 165 (298)
T d1gz8a_ 88 KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVT 165 (298)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSBCTTCCBCC
T ss_pred hhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccccceeeccc
Confidence 4433332 5699999999999999999999999999999999999999999999999999975432 22345566899
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC------------------CC-----
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------------------KC----- 215 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------------------~~----- 215 (416)
+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+.......+..... ..
T Consensus 166 ~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T d1gz8a_ 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWAR 245 (298)
T ss_dssp CTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCC
T ss_pred ceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccc
Confidence 9999999998888888999999999999999999999998887666555533100 01
Q ss_pred ------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccCcc
Q 014911 216 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 256 (416)
Q Consensus 216 ------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 256 (416)
.+.+|+++++||++||++||.+|||++|+++||||++...+
T Consensus 246 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 12467899999999999999999999999999999875443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-58 Score=443.89 Aligned_cols=242 Identities=34% Similarity=0.606 Sum_probs=206.3
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEe----CCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMAS----KSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~----~~~~~lV~E~ 75 (416)
+||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++.+ ++||||+++++++.+ ...+|+||||
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 489999999999999999999999998643 457789998654 589999999999876 4679999999
Q ss_pred cCCCchhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CCCeEEeeccccccccccccC
Q 014911 76 VKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 76 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 149 (416)
|+||+|++++.. .++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... .
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~---~ 167 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---H 167 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC---C
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC---C
Confidence 999999999975 36999999999999999999999999999999999999986 45699999999975443 3
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHH----HHHHHhCCCCCCC----CCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM----YRKIYRGDFKCPP----WFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~----~~s~ 221 (416)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|+||.+||.+.+.... ...+..+.+.+|. .+|+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 246 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCH
T ss_pred CccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCH
Confidence 345677899999999999888774 899999999999999999999987654333 3333444445553 4799
Q ss_pred HHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 222 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
++++||++||+.||++|||+.|+++||||....
T Consensus 247 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 999999999999999999999999999997543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-56 Score=423.01 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=211.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+.+..|++|||+.++.
T Consensus 9 ~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 9 KIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred EEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 3899999999999985 889999999977653 23445789999999999999999999999999999999999999887
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
+...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ........|++
T Consensus 87 ~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~~ 164 (286)
T d1ob3a_ 87 KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTL 164 (286)
T ss_dssp HHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCC
T ss_pred HHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccccceecccc
Confidence 7777764 78999999999999999999999999999999999999999999999999999764432 22344557999
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--------------------------
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------------------------- 213 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------------- 213 (416)
.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++.....
T Consensus 165 ~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T d1ob3a_ 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244 (286)
T ss_dssp TTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred hhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCc
Confidence 999999998877778999999999999999999999998877766665532100
Q ss_pred ---CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccc
Q 014911 214 ---KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 252 (416)
Q Consensus 214 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 252 (416)
..++.+|+++.+||++||++||++|||++|+++||||++
T Consensus 245 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred chhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112446899999999999999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=423.12 Aligned_cols=246 Identities=20% Similarity=0.343 Sum_probs=209.6
Q ss_pred cccCCceEEEEEEEc--CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+||
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g 92 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELG 92 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCC
Confidence 899999999999864 4567899999965543 334567899999999999999999999998654 578999999999
Q ss_pred chhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccccccc
Q 014911 80 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTCG 157 (416)
Q Consensus 80 ~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~g 157 (416)
+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ .......|
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 172 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCC
Confidence 99999976 67999999999999999999999999999999999999999999999999999764432211 12234568
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|+.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+..++...+.++. .+.|+.+|+++.+||.+||+.||
T Consensus 173 t~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp 251 (277)
T d1xbba_ 173 PVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251 (277)
T ss_dssp CGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred CceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCH
Confidence 999999999988776 489999999999999998 999999988888888887764 57788899999999999999999
Q ss_pred CCcCCHHHH---hcCccc
Q 014911 236 NSRIAISKI---MESSWF 250 (416)
Q Consensus 236 ~~R~s~~ei---l~hp~f 250 (416)
.+|||++++ |+|+|+
T Consensus 252 ~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 252 ENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTSCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHhhCHHh
Confidence 999999998 466665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-56 Score=420.28 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=212.9
Q ss_pred cccCCceEEEEEEEcC--CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 2 LGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+++|++++|||||++++++.++ .+|+|||||+||
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g 93 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGG 93 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCC
Confidence 8999999999998764 45589999997543 334567899999999999999999999998654 589999999999
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCcccccc
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~ 156 (416)
+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......+
T Consensus 94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~ 173 (285)
T d1u59a_ 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173 (285)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSC
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccc
Confidence 99999854 5799999999999999999999999999999999999999999999999999986543221 12233457
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 234 (416)
||+.|+|||++....+ +.++||||+||++|||+| |..||.+.+..++...+..+. .+.|+.+|+++.+||.+||+.|
T Consensus 174 gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~ 252 (285)
T d1u59a_ 174 WPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252 (285)
T ss_dssp CCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred cCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 8999999999988776 499999999999999998 999999988888888887764 5778899999999999999999
Q ss_pred CCCcCCHHHH---hcCcccc
Q 014911 235 PNSRIAISKI---MESSWFK 251 (416)
Q Consensus 235 P~~R~s~~ei---l~hp~f~ 251 (416)
|++|||+.+| |+|+|+.
T Consensus 253 p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 253 WEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHHH
Confidence 9999999888 5677764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9e-56 Score=418.98 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=209.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----KIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+|+.||||++.+....+......+.+|+.+|+.++||||+++++++...+ .+|+||||+
T Consensus 14 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~ 93 (277)
T d1o6ya_ 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93 (277)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECC
Confidence 4899999999999999999999999998876666666788999999999999999999999987643 489999999
Q ss_pred CCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc-cCCcccc
Q 014911 77 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK-QDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-~~~~~~~ 154 (416)
+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+....... ......+
T Consensus 94 ~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 173 (277)
T d1o6ya_ 94 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173 (277)
T ss_dssp CEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----------
T ss_pred CCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccccccccc
Confidence 99999999876 789999999999999999999999999999999999999999999999999886543322 2233456
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHc
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC----PPWFSSEARRLITKL 230 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~~ 230 (416)
.+||+.|+|||++.+..|+ .++||||+||++|+|+||.+||.+.+..+...++....... ++.+|+++.+||.+|
T Consensus 174 ~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 252 (277)
T d1o6ya_ 174 VIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 252 (277)
T ss_dssp -----TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHH
T ss_pred ccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHH
Confidence 7899999999999887774 89999999999999999999999998888887777665433 356899999999999
Q ss_pred cCCCCCCcCCHHHHhcCcccc
Q 014911 231 LDPNPNSRIAISKIMESSWFK 251 (416)
Q Consensus 231 L~~dP~~R~s~~eil~hp~f~ 251 (416)
|++||.+||+..+.+.|+|.+
T Consensus 253 L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 253 LAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp TCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCCHhHCHhHHHHHHHHHHH
Confidence 999999999544445567654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=422.80 Aligned_cols=248 Identities=28% Similarity=0.422 Sum_probs=207.3
Q ss_pred CcccCCceEEEEEEEcCC-CcEEEEEEeecCcccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----CCEEEE
Q 014911 1 MLGHGTFAKVYLARNLQT-GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMAS-----KSKIYF 71 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~~~~~l 71 (416)
.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.| +||||+++++++.. ...+|+
T Consensus 14 ~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 389999999999999765 6789999997654322 2233566788887766 79999999999853 357899
Q ss_pred EEeccCCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC
Q 014911 72 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 72 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 149 (416)
+|||+.|+.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 93 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~ 169 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---Q 169 (305)
T ss_dssp EEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---G
T ss_pred EEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc---c
Confidence 9999999877555433 6799999999999999999999999999999999999999999999999999875433 2
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-----------------
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----------------- 212 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------------- 212 (416)
....+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+.......+....
T Consensus 170 ~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 248 (305)
T d1blxa_ 170 MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248 (305)
T ss_dssp GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG
T ss_pred ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhh
Confidence 345677899999999999988874 89999999999999999999999988877766664310
Q ss_pred ----------CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 ----------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 ----------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
...+..+|+.+++||++||++||.+|||++|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 01234578999999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=428.47 Aligned_cols=244 Identities=21% Similarity=0.342 Sum_probs=207.9
Q ss_pred CcccCCceEEEEEEEcCCCc-----EEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGK-----SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
+||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.+.+|+|||
T Consensus 44 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 48999999999999876554 699999865432 23346788999999998 89999999999999999999999
Q ss_pred ccCCCchhhHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC
Q 014911 75 LVKGGELFNKIAKG------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 130 (416)
Q Consensus 75 ~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~ 130 (416)
||+||+|.+++... .+++..++.|+.|++.||+|||++||+||||||+|||++.++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~ 201 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCC
Confidence 99999999999642 388999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 014911 131 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 209 (416)
Q Consensus 131 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 209 (416)
.+||+|||+|+............+.+||+.|+|||++.+..| +.++||||+||++|||+| |.+||.+.+......++.
T Consensus 202 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~ 280 (325)
T d1rjba_ 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280 (325)
T ss_dssp EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999986554433333456678999999999988877 499999999999999998 899998866555555554
Q ss_pred hC--CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 210 RG--DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 210 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
.. .++.|..+|+++++||.+||+.||++|||++||++|
T Consensus 281 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44 346678899999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=417.57 Aligned_cols=242 Identities=23% Similarity=0.409 Sum_probs=198.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|+.. ..||||+++..... ....+.+.+|+.+|++++||||++++++.. .+.+|+|||||+||+
T Consensus 15 ~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp EEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 3899999999999753 35999999765443 345678999999999999999999999864 456899999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. +++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.............+.+||
T Consensus 90 L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 169 (276)
T d1uwha_ 90 LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169 (276)
T ss_dssp HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCC
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccC
Confidence 9999964 67999999999999999999999999999999999999999999999999999876554444455677899
Q ss_pred CCCCchHHhhhcC--CCCchhhHHHHHHHHHHHhcCCCCCCCCcHHH-HHHHHHhCCC-----CCCCCCCHHHHHHHHHc
Q 014911 159 PAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNIVS-MYRKIYRGDF-----KCPPWFSSEARRLITKL 230 (416)
Q Consensus 159 ~~y~aPE~~~~~~--~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~-~~~~i~~~~~-----~~p~~~s~~~~~li~~~ 230 (416)
+.|+|||++.... .++.++||||+||++|||+||..||.+.+... ....+..+.. ..+..+++++.+||.+|
T Consensus 170 ~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~c 249 (276)
T d1uwha_ 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAEC 249 (276)
T ss_dssp GGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHH
T ss_pred cccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHH
Confidence 9999999996432 23689999999999999999999998865543 3444444322 24567899999999999
Q ss_pred cCCCCCCcCCHHHHhcC
Q 014911 231 LDPNPNSRIAISKIMES 247 (416)
Q Consensus 231 L~~dP~~R~s~~eil~h 247 (416)
|+.||.+|||+.+++++
T Consensus 250 l~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 250 LKKKRDERPLFPQILAS 266 (276)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=428.82 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=207.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------KIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------~~~lV~E 74 (416)
.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+ .+|+|||
T Consensus 25 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 38999999999999999999999999976543 3355678999999999999999999999997654 5799999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
|+ |++|...+..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|.... .....
T Consensus 104 ~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~-----~~~~~ 177 (346)
T d1cm8a_ 104 FM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTG 177 (346)
T ss_dssp CC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-----SSCCS
T ss_pred cc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-----Ccccc
Confidence 99 6688888888899999999999999999999999999999999999999999999999999997543 23456
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---------------------
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--------------------- 213 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 213 (416)
.+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 178 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (346)
T d1cm8a_ 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257 (346)
T ss_dssp SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhcc
Confidence 78999999999998877778999999999999999999999998876655444322110
Q ss_pred ----------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 214 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 214 ----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
..++.+++++.+||++||++||.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1234578999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-55 Score=418.04 Aligned_cols=240 Identities=23% Similarity=0.381 Sum_probs=209.5
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||++..+.. ..+++.+|+.+|++++|||||++++++.+++.+|+|||||++|+
T Consensus 24 ~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp ETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 38999999999999999999999999975542 34678999999999999999999999999999999999999999
Q ss_pred hhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccccc
Q 014911 81 LFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 157 (416)
Q Consensus 81 L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 157 (416)
|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...... ........|
T Consensus 100 l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g 178 (287)
T d1opja_ 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKF 178 (287)
T ss_dssp HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEE
T ss_pred hHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccc
Confidence 9999864 468999999999999999999999999999999999999999999999999998644321 112233468
Q ss_pred CCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCC-CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 014911 158 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 235 (416)
Q Consensus 158 t~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~-~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 235 (416)
|+.|+|||++.+..| +.++||||+||++|+|++|. +||.+.+...++..+..+ ..+.|+.+|+++.+||.+||+.||
T Consensus 179 ~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP 257 (287)
T d1opja_ 179 PIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 257 (287)
T ss_dssp CGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCH
Confidence 999999999988877 49999999999999999954 556666766666666554 356788899999999999999999
Q ss_pred CCcCCHHHHhc
Q 014911 236 NSRIAISKIME 246 (416)
Q Consensus 236 ~~R~s~~eil~ 246 (416)
++|||++++++
T Consensus 258 ~~Rps~~ei~~ 268 (287)
T d1opja_ 258 SDRPSFAEIHQ 268 (287)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=421.95 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=207.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--------CCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--------KSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------~~~~~lV 72 (416)
.||+|+||+||+|++..+|+.||||++...... .....++.+|+.+|++++||||+++++++.. .+.+|+|
T Consensus 17 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 489999999999999999999999999776543 2445678899999999999999999999855 3468999
Q ss_pred EeccCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccc--cC
Q 014911 73 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK--QD 149 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~ 149 (416)
|||+.++.+...... ..+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 96 ~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~ 175 (318)
T d3blha1 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175 (318)
T ss_dssp EECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----C
T ss_pred EeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccccc
Confidence 999988766655443 679999999999999999999999999999999999999999999999999997554322 22
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC------------
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP------------ 217 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~------------ 217 (416)
....+.+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+.......+.......++
T Consensus 176 ~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T d3blha1 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 255 (318)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC---
T ss_pred ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhh
Confidence 33455689999999999987755579999999999999999999999988877666555442111110
Q ss_pred --------------------CCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 218 --------------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 218 --------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
..++++++||.+||++||++|||++|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 256 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp ----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred hhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 0267889999999999999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-55 Score=418.34 Aligned_cols=244 Identities=21% Similarity=0.337 Sum_probs=201.2
Q ss_pred CcccCCceEEEEEEEcCCCc---EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+||+|++..+|+ .||||.+.... .....+.+.+|+.+|++++|||||++++++..++.+|+|||||+
T Consensus 33 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 48999999999999987665 58899886543 23445689999999999999999999999999999999999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCc---c
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL---L 152 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~---~ 152 (416)
||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.......... .
T Consensus 111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 190 (299)
T d1jpaa_ 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190 (299)
T ss_dssp TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeec
Confidence 9999998875 5799999999999999999999999999999999999999999999999999986554322211 1
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHc
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 230 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 230 (416)
....||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+...+...+..+. .+.|..+++.+.+||.+|
T Consensus 191 ~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 269 (299)
T d1jpaa_ 191 LGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDC 269 (299)
T ss_dssp -----CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHH
Confidence 22457899999999988777 489999999999999998 899999998888888887664 567778999999999999
Q ss_pred cCCCCCCcCCHHHHhcC
Q 014911 231 LDPNPNSRIAISKIMES 247 (416)
Q Consensus 231 L~~dP~~R~s~~eil~h 247 (416)
|+.||.+|||+.|++++
T Consensus 270 l~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 270 WQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCSSTTTSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=410.79 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++. +++.||||++...... .+.+.+|+.++++++||||+++++++..++.+|+||||+++|+
T Consensus 12 ~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 12 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 3899999999999985 6788999999765432 3578999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..++++.+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+...... ........||
T Consensus 87 L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt 165 (263)
T d1sm2a_ 87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFP 165 (263)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------------C
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-ceeecceecC
Confidence 9999865 568999999999999999999999999999999999999999999999999997654322 1223446789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+...+...+..+. ...|..+++++.+||.+||+.||+
T Consensus 166 ~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~ 244 (263)
T d1sm2a_ 166 VKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244 (263)
T ss_dssp TTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHh
Confidence 999999999888774 89999999999999999 688888888888888887764 456778899999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||++++++|
T Consensus 245 ~Rps~~~il~~ 255 (263)
T d1sm2a_ 245 DRPAFSRLLRQ 255 (263)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=405.77 Aligned_cols=240 Identities=21% Similarity=0.372 Sum_probs=214.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++ .+++.||||++.+.... .+.+.+|+.++++++||||+++++++.+++.+|+||||+++|+
T Consensus 11 ~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 11 ELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 489999999999998 47889999999876543 3578999999999999999999999999999999999999999
Q ss_pred hhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 81 LFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 81 L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|...... .........||
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~t 164 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFP 164 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCCCSCCC
T ss_pred HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-CceeecccCCC
Confidence 9999754 67999999999999999999999999999999999999999999999999999755432 22233446789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....|+ .++||||+||++|||+| |+.||.+.+..++...+..+. ...|..+++.+.+||++||+.||+
T Consensus 165 ~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~ 243 (258)
T d1k2pa_ 165 VRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 243 (258)
T ss_dssp GGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred CCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHh
Confidence 999999999988875 89999999999999998 899999999888888888764 466778999999999999999999
Q ss_pred CcCCHHHHhcC
Q 014911 237 SRIAISKIMES 247 (416)
Q Consensus 237 ~R~s~~eil~h 247 (416)
+|||++++++|
T Consensus 244 ~RPt~~eil~~ 254 (258)
T d1k2pa_ 244 ERPTFKILLSN 254 (258)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-55 Score=412.29 Aligned_cols=243 Identities=22% Similarity=0.381 Sum_probs=210.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+|++++|||||++++++.+ +.+|+||||+++|+|
T Consensus 21 iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 21 LGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL 94 (272)
T ss_dssp EEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred EecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcH
Confidence 899999999999974 678899999975542 23678999999999999999999998754 567999999999999
Q ss_pred hhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 82 FNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 82 ~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
.+++.. .++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...... ........||
T Consensus 95 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt 173 (272)
T d1qpca_ 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFP 173 (272)
T ss_dssp HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCC
T ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-cccccccCCc
Confidence 998754 369999999999999999999999999999999999999999999999999998654321 1223456789
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....| +.++||||+||++|||+| |.+||...+.......+..+. ...|+.+++++.+||.+||+.||+
T Consensus 174 ~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~ 252 (272)
T d1qpca_ 174 IKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252 (272)
T ss_dssp TTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHh
Confidence 99999999987776 599999999999999999 567777778778888887653 566788999999999999999999
Q ss_pred CcCCHHHHhc--Cccccc
Q 014911 237 SRIAISKIME--SSWFKK 252 (416)
Q Consensus 237 ~R~s~~eil~--hp~f~~ 252 (416)
+|||++++++ |+||..
T Consensus 253 ~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 253 DRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHhhhhhhc
Confidence 9999999998 788853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=422.25 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=208.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----KIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~ 76 (416)
.||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|++|+||||+++++++.... ..+++++|+
T Consensus 15 ~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp ECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 3899999999999999999999999997543 3345678899999999999999999999986643 234445566
Q ss_pred CCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccccccc-CCccccc
Q 014911 77 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHTT 155 (416)
Q Consensus 77 ~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~ 155 (416)
.||+|++++..+++++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|........ .......
T Consensus 93 ~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 172 (345)
T d1pmea_ 93 MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172 (345)
T ss_dssp CCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCC
T ss_pred cCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccc
Confidence 799999999888899999999999999999999999999999999999999999999999999976544322 2334567
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC------------------------
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------------ 211 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------------ 211 (416)
+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+...........
T Consensus 173 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T d1pmea_ 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252 (345)
T ss_dssp CSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred cccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccC
Confidence 89999999999977666679999999999999999999999887665444333210
Q ss_pred C-C------CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 212 D-F------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 212 ~-~------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
. . ...+.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 0 01235788999999999999999999999999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=423.08 Aligned_cols=243 Identities=31% Similarity=0.437 Sum_probs=204.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~~~lV~E 74 (416)
+||+|+||+||+|++..+|+.||||++..+... ..+|+.+|++++||||+++++++.. ...+|+|||
T Consensus 27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred EEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 489999999999999999999999999765422 2379999999999999999999854 346899999
Q ss_pred ccCCCchhhHH---h-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccC
Q 014911 75 LVKGGELFNKI---A-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQD 149 (416)
Q Consensus 75 ~~~gg~L~~~i---~-~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 149 (416)
||+++.+.... . ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~---~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---G 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT---T
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC---C
Confidence 99876433332 2 25699999999999999999999999999999999999999876 899999999875432 3
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------C
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----------------D 212 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (416)
....+.+||+.|+|||++.+...++.++||||+||++|+|++|.+||...+....+..+.+. .
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 34456789999999999887666679999999999999999999999988776665555321 0
Q ss_pred CC------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 FK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 ~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.. ..+.+++++.+||++||++||.+|||+.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 11 123478999999999999999999999999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=408.01 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=215.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGE 80 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 80 (416)
.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....++|++++.|++
T Consensus 9 ~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred EEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 48999999999999999999999999977653 34567889999999999999999999999999999999999999999
Q ss_pred hhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccCC
Q 014911 81 LFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 159 (416)
Q Consensus 81 L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 159 (416)
|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ........+++
T Consensus 88 l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~~ 165 (292)
T d1unla_ 88 KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTL 165 (292)
T ss_dssp HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSCCCSCCSCG
T ss_pred cccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Cccceeecccc
Confidence 9888876 68999999999999999999999999999999999999999999999999999754432 22334456788
Q ss_pred CCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCC-CCCcHHHHHHHHHhCC--------------------------
Q 014911 160 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF-QDDNIVSMYRKIYRGD-------------------------- 212 (416)
Q Consensus 160 ~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf-~~~~~~~~~~~i~~~~-------------------------- 212 (416)
.|+|||++....+.+.++||||+||++|+|++|..|| .+.+......++....
T Consensus 166 ~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T d1unla_ 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245 (292)
T ss_dssp GGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTT
T ss_pred chhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccccccc
Confidence 9999999988877779999999999999999999885 5555555555543210
Q ss_pred ---CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 213 ---FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 213 ---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
...++.+++.+.+||++||++||.+|||++|+|+||||++-.
T Consensus 246 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 112234688999999999999999999999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=415.28 Aligned_cols=251 Identities=33% Similarity=0.599 Sum_probs=216.4
Q ss_pred CcccCCceEEEEEEEc---CCCcEEEEEEeecCccc-chhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKH-KHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|++. .+|+.||||++.+.... +....+.+.+|+.+|++++| |||+++++++.+...+|++|||
T Consensus 31 ~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~ 110 (322)
T d1vzoa_ 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110 (322)
T ss_dssp EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeec
Confidence 3899999999999874 47899999999765532 22334678899999999976 8999999999999999999999
Q ss_pred cCCCchhhHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 76 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 76 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ......+
T Consensus 111 ~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~-~~~~~~~ 189 (322)
T d1vzoa_ 111 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD 189 (322)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG-GGGGGCG
T ss_pred ccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc-ccccccc
Confidence 999999999976 78999999999999999999999999999999999999999999999999999754432 2233456
Q ss_pred cccCCCCCchHHhhhcC-CCCchhhHHHHHHHHHHHhcCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014911 155 TCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITK 229 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 229 (416)
.+|++.|+|||.+.... +.+.++|||||||+||+|++|..||.+.+ ...+.........+.|+.+|+++.+||++
T Consensus 190 ~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 269 (322)
T d1vzoa_ 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 269 (322)
T ss_dssp GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHH
Confidence 78999999999997654 34689999999999999999999997753 33445555667778888999999999999
Q ss_pred ccCCCCCCcC-----CHHHHhcCccccc
Q 014911 230 LLDPNPNSRI-----AISKIMESSWFKK 252 (416)
Q Consensus 230 ~L~~dP~~R~-----s~~eil~hp~f~~ 252 (416)
||++||.+|| |++|+++||||+.
T Consensus 270 ~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 270 LLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999 4899999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=419.90 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=209.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~ 75 (416)
.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++... ...+++|+|
T Consensus 25 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp ECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 38999999999999999999999999976543 234456788999999999999999999998643 344666777
Q ss_pred cCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 76 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 76 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+.||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++..... ...+.
T Consensus 104 ~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~ 178 (348)
T d2gfsa1 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGY 178 (348)
T ss_dssp CCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSS
T ss_pred ecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-----ccccc
Confidence 8899999999888899999999999999999999999999999999999999999999999999875432 34556
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC---------------------
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--------------------- 214 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--------------------- 214 (416)
+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+......
T Consensus 179 ~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (348)
T d2gfsa1 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258 (348)
T ss_dssp CHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTS
T ss_pred cccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhc
Confidence 79999999999988877789999999999999999999999988776666655432111
Q ss_pred --C--------CCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 215 --C--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 215 --~--------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
. ...+|+++++||++||+.||.+|||+.|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 1 12468999999999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=411.08 Aligned_cols=244 Identities=21% Similarity=0.354 Sum_probs=205.1
Q ss_pred CcccCCceEEEEEEEcCCCc----EEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
+||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ ..++++||+
T Consensus 16 ~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred EEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 48999999999999988887 57777775432 223467899999999999999999999999865 467888999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
.+|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.............
T Consensus 93 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 172 (317)
T d1xkka_ 93 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172 (317)
T ss_dssp TTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC------
T ss_pred cCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccc
Confidence 99999998865 5799999999999999999999999999999999999999999999999999987654333333445
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccC
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 232 (416)
..||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+...+...+..+. ++.|+.+++++.+||.+||+
T Consensus 173 ~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~ 251 (317)
T d1xkka_ 173 GKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251 (317)
T ss_dssp --CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTC
T ss_pred cccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCC
Confidence 578999999999988877 599999999999999998 899999988777777777765 57788899999999999999
Q ss_pred CCCCCcCCHHHHhcCc
Q 014911 233 PNPNSRIAISKIMESS 248 (416)
Q Consensus 233 ~dP~~R~s~~eil~hp 248 (416)
.||.+|||+.++++|.
T Consensus 252 ~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 252 IDADSRPKFRELIIEF 267 (317)
T ss_dssp SSGGGSCCHHHHHHHH
T ss_pred CChhhCcCHHHHHHHH
Confidence 9999999999999884
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=401.31 Aligned_cols=243 Identities=20% Similarity=0.311 Sum_probs=201.6
Q ss_pred CcccCCceEEEEEEEcCCC----cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTG----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
+||+|+||+||+|.+..++ ..||||++..... ......+.+|+.+|++++|||||++++++.+.+..|+||||+
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 4899999999999987655 4799999965432 234567899999999999999999999999999999999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC-Cccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLH 153 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 153 (416)
.+|++.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||+|+........ ....
T Consensus 92 ~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 171 (283)
T d1mqba_ 92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171 (283)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred ccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEec
Confidence 99999998865 67999999999999999999999999999999999999999999999999999865433221 1233
Q ss_pred ccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014911 154 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLL 231 (416)
Q Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 231 (416)
...||+.|+|||++.+..++ .++|||||||++|||++ |.+||...+...++..+..+. .+.|..+++.+.+||.+||
T Consensus 172 ~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 250 (283)
T d1mqba_ 172 GGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250 (283)
T ss_dssp --CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHT
T ss_pred cCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHC
Confidence 45689999999999887764 89999999999999999 566677777777777777653 5667789999999999999
Q ss_pred CCCCCCcCCHHHHhc
Q 014911 232 DPNPNSRIAISKIME 246 (416)
Q Consensus 232 ~~dP~~R~s~~eil~ 246 (416)
+.||++|||+.++++
T Consensus 251 ~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 251 QQERARRPKFADIVS 265 (283)
T ss_dssp CSSTTTSCCHHHHHH
T ss_pred cCCHhHCcCHHHHHH
Confidence 999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=402.52 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=206.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 81 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 81 (416)
||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.+|+||||+++|+|
T Consensus 25 iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 25 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred EeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCch
Confidence 89999999999998655 57999999755432 3678999999999999999999999854 568999999999999
Q ss_pred hhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccccC
Q 014911 82 FNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 158 (416)
Q Consensus 82 ~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 158 (416)
..++.. +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ........||
T Consensus 99 ~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt 177 (285)
T d1fmka3 99 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFP 177 (285)
T ss_dssp HHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CC
T ss_pred hhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-ceeecccccc
Confidence 988853 569999999999999999999999999999999999999999999999999997654321 2233446799
Q ss_pred CCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCCC
Q 014911 159 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPN 236 (416)
Q Consensus 159 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~ 236 (416)
+.|+|||++....+ +.++||||+||++|+|++ |.+||...+..+....+..+ ..+.|+.+++++++||.+||+.||+
T Consensus 178 ~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 256 (285)
T d1fmka3 178 IKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 256 (285)
T ss_dssp GGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHh
Confidence 99999999988777 499999999999999999 56667777777778777765 4578889999999999999999999
Q ss_pred CcCCHHHHhc--CccccccC
Q 014911 237 SRIAISKIME--SSWFKKSA 254 (416)
Q Consensus 237 ~R~s~~eil~--hp~f~~~~ 254 (416)
+|||++++++ ++||....
T Consensus 257 ~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 257 ERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp GSCCHHHHHHHHHTTTSCSC
T ss_pred HCcCHHHHHHHHhhhhcCCC
Confidence 9999999987 88987643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-53 Score=408.23 Aligned_cols=243 Identities=24% Similarity=0.451 Sum_probs=202.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASK--SKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++... ..+|+|||||.
T Consensus 42 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 3899999999999999999999999986432 357889999999995 99999999999754 56999999999
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCC-CeEEeeccccccccccccCCcccccc
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+++|.... +++++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..... .......+
T Consensus 116 ~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~---~~~~~~~~ 190 (328)
T d3bqca1 116 NTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRV 190 (328)
T ss_dssp SCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT---TCCCCSCC
T ss_pred CCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC---CCcccccc
Confidence 99997764 4699999999999999999999999999999999999998766 599999999985443 23446678
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcH-HHHHHHHH-------------hCCCC--------
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIY-------------RGDFK-------- 214 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~-------------~~~~~-------- 214 (416)
||+.|+|||++.+...++.++||||+||++|+|++|..||...+. ......+. .....
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 270 (328)
T d3bqca1 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270 (328)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT
T ss_pred cCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchh
Confidence 999999999998776667999999999999999999999976432 11111111 00000
Q ss_pred ----------------CCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCccccccC
Q 014911 215 ----------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 254 (416)
Q Consensus 215 ----------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 254 (416)
.+..+|+++++||++||++||.+|||++|+|+||||+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 1123688999999999999999999999999999998643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=401.43 Aligned_cols=242 Identities=25% Similarity=0.387 Sum_probs=200.2
Q ss_pred CcccCCceEEEEEEEcCCC---cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
+||+|+||+||+|++..++ ..||||.+.... .....+.+.+|+.+|++++||||+++++++. .+.+|+||||++
T Consensus 14 ~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 4899999999999987543 468888875432 3345678999999999999999999999985 567899999999
Q ss_pred CCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCccccc
Q 014911 78 GGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 155 (416)
Q Consensus 78 gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 155 (416)
+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+...... .......
T Consensus 91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~ 169 (273)
T d1mp8a_ 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKG 169 (273)
T ss_dssp TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc-ceeccce
Confidence 9999998754 579999999999999999999999999999999999999999999999999998654322 2233455
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 233 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 233 (416)
.||+.|+|||++....|+ .++|||||||++|||++ |.+||.+.+..+++..+..+. .+.|+.+|+++.+||.+||+.
T Consensus 170 ~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~ 248 (273)
T d1mp8a_ 170 KLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 248 (273)
T ss_dssp -CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 789999999999887774 89999999999999998 999999988888888887765 578889999999999999999
Q ss_pred CCCCcCCHHHHhcC
Q 014911 234 NPNSRIAISKIMES 247 (416)
Q Consensus 234 dP~~R~s~~eil~h 247 (416)
||.+|||+.||++|
T Consensus 249 dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 249 DPSRRPRFTELKAQ 262 (273)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=412.00 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=197.0
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------KSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~~~lV~E 74 (416)
.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. .+.+|+|||
T Consensus 24 ~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp ECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 48999999999999999999999999987654 33456788999999999999999999999953 478999999
Q ss_pred ccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccc
Q 014911 75 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 154 (416)
Q Consensus 75 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 154 (416)
||.|+ +.+.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++..... ......
T Consensus 103 y~~~~-l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~ 177 (355)
T d2b1pa1 103 LMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 177 (355)
T ss_dssp CCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred ccchH-HHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc---cccccc
Confidence 99775 444443 5699999999999999999999999999999999999999999999999999875443 334456
Q ss_pred cccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHHHhC----------------------C
Q 014911 155 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------------D 212 (416)
Q Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------------------~ 212 (416)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++... .
T Consensus 178 ~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (355)
T d2b1pa1 178 YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256 (355)
T ss_dssp ---CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTS
T ss_pred ccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcC
Confidence 689999999999988766 58999999999999999999999888766555444321 1
Q ss_pred CCCC--------------------CCCCHHHHHHHHHccCCCCCCcCCHHHHhcCcccccc
Q 014911 213 FKCP--------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 253 (416)
Q Consensus 213 ~~~p--------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 253 (416)
.... ...|+++++||++||++||++|||++|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 0135788999999999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-52 Score=399.54 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=212.3
Q ss_pred cccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014911 2 LGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 76 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 76 (416)
||+|+||+||+|++. .+++.||||++.... .....+.+.+|+.+|+.++||||+++++++...+..+++|||+
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~ 98 (301)
T d1lufa_ 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98 (301)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEec
Confidence 899999999999975 356799999997543 2344578999999999999999999999999999999999999
Q ss_pred CCCchhhHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCC
Q 014911 77 KGGELFNKIAKG-------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 131 (416)
Q Consensus 77 ~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~ 131 (416)
.+|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+++
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~ 178 (301)
T d1lufa_ 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178 (301)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCc
Confidence 999999998531 3789999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC-CCCCCCCcHHHHHHHHHh
Q 014911 132 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYR 210 (416)
Q Consensus 132 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~ 210 (416)
+||+|||+|.............+.+||+.|+|||.+.+..|+ .++|||||||++|||++| .+||.+.+..+....+..
T Consensus 179 ~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~ 257 (301)
T d1lufa_ 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257 (301)
T ss_dssp EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 999999999866554444455667899999999999988875 999999999999999998 578999998888888887
Q ss_pred CCC-CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 211 GDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 211 ~~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.. +.|..+++++.+||.+||+.||++|||+.||++
T Consensus 258 ~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 258 GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 764 467789999999999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=396.37 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=199.0
Q ss_pred cccCCceEEEEEEEcC-CC--cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014911 2 LGHGTFAKVYLARNLQ-TG--KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 78 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 78 (416)
||+|+||+||+|++.. ++ ..||||++.+.........+.+.+|+.+|++++||||+++++++.+ ...|+||||+++
T Consensus 16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~ 94 (273)
T d1u46a_ 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPL 94 (273)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecC
Confidence 8999999999998653 33 3789999987766555667889999999999999999999999965 467899999999
Q ss_pred CchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCC-ccccc
Q 014911 79 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHTT 155 (416)
Q Consensus 79 g~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 155 (416)
|++.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......... .....
T Consensus 95 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~ 174 (273)
T d1u46a_ 95 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174 (273)
T ss_dssp CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC----
T ss_pred cchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCcc
Confidence 999988764 679999999999999999999999999999999999999999999999999998654432222 22344
Q ss_pred ccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccC
Q 014911 156 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLLD 232 (416)
Q Consensus 156 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~ 232 (416)
.|++.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+..+....+.+.. ++.|+.+|+++.+||.+||+
T Consensus 175 ~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 253 (273)
T d1u46a_ 175 KVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253 (273)
T ss_dssp -CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcC
Confidence 67889999999988766 589999999999999998 899999999998888887764 35567899999999999999
Q ss_pred CCCCCcCCHHHHhc
Q 014911 233 PNPNSRIAISKIME 246 (416)
Q Consensus 233 ~dP~~R~s~~eil~ 246 (416)
+||++|||+.+|++
T Consensus 254 ~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 254 HKPEDRPTFVALRD 267 (273)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=396.03 Aligned_cols=243 Identities=23% Similarity=0.423 Sum_probs=210.3
Q ss_pred CcccCCceEEEEEEEcCCC-------cEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQTG-------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 72 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 72 (416)
.||+|+||.||+|++..++ ..||||++..+.. ......+.+|...+.++ +|||||++++++.+++.+|+|
T Consensus 20 ~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp ECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 3899999999999986654 3799999976542 23456788899998888 899999999999999999999
Q ss_pred EeccCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 73 MDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 73 ~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
|||+.+|+|.+++.. .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~ 177 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEec
Confidence 999999999999963 248999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CC
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DF 213 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~ 213 (416)
|||++...............+||+.|+|||.+.+..| +.++|||||||++|+|++ |.+||.+.+...++..+..+ .+
T Consensus 178 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~ 256 (299)
T d1fgka_ 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 256 (299)
T ss_dssp STTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987766555555566789999999999988877 499999999999999998 79999999988888887765 45
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.|.++++++.+||.+||+.||++|||+.|+++
T Consensus 257 ~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 257 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 778899999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=398.35 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=206.9
Q ss_pred CcccCCceEEEEEEEcCCCcE--EEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 014911 1 MLGHGTFAKVYLARNLQTGKS--MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVK 77 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 77 (416)
.||+|+||+||+|++..+|.. ||||.+.... .....+.+.+|+.+|+++ +||||+++++++.+++.+|+||||++
T Consensus 17 ~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 489999999999999888875 6677764332 223456789999999998 79999999999999999999999999
Q ss_pred CCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccc
Q 014911 78 GGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 140 (416)
Q Consensus 78 gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla 140 (416)
||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a 174 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence 9999999853 46899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC-CCCCCCCcHHHHHHHHHhC-CCCCCCC
Q 014911 141 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRG-DFKCPPW 218 (416)
Q Consensus 141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 218 (416)
...... ......+||+.|+|||.+....| +.++|||||||++|+|++| .+||.+.+...++..+..+ .++.|..
T Consensus 175 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~ 250 (309)
T d1fvra_ 175 RGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250 (309)
T ss_dssp ESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTT
T ss_pred cccccc---ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence 754432 22345678999999999988877 4899999999999999996 5789999999988888775 4567788
Q ss_pred CCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 219 FSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 219 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+++++.+||.+||+.||++|||+.++++|
T Consensus 251 ~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=397.51 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=196.4
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe-CCEEEEEE
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS-KSKIYFAM 73 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~~~~~lV~ 73 (416)
.||+|+||+||+|.+.. +++.||||++..... ......+.+|..++.++ +||||+.+++++.. ...+|+||
T Consensus 20 ~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred EEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 38999999999999754 456899999865432 23446677788877776 68999999998765 45789999
Q ss_pred eccCCCchhhHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEee
Q 014911 74 DLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 136 (416)
Q Consensus 74 E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~D 136 (416)
|||+||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~D 177 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 177 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEcc
Confidence 99999999999853 2488999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC-CCCCCCCcHH-HHHHHHHhC-CC
Q 014911 137 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIV-SMYRKIYRG-DF 213 (416)
Q Consensus 137 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG-~~Pf~~~~~~-~~~~~i~~~-~~ 213 (416)
||+|+............+.+||+.|+|||++.+..+ +.++||||+||++|+|+|| .+||.+.+.. .....+..+ .+
T Consensus 178 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~ 256 (299)
T d1ywna1 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256 (299)
T ss_dssp ------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred CcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999986554444444556789999999999988776 5999999999999999986 6788776543 344444444 45
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcC
Q 014911 214 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 247 (416)
Q Consensus 214 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 247 (416)
+.|+.+++++.+||.+||+.||.+|||++|+++|
T Consensus 257 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 257 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6778899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=390.06 Aligned_cols=234 Identities=24% Similarity=0.443 Sum_probs=199.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~gg 79 (416)
.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|+.+|++++||||+++++++.+ .+.+|+||||+++|
T Consensus 14 ~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 14 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 389999999999998 57899999996543 34678999999999999999999998854 46689999999999
Q ss_pred chhhHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccCCcccccc
Q 014911 80 ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 156 (416)
Q Consensus 80 ~L~~~i~~---~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 156 (416)
+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||++..... ...+..
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~ 161 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGK 161 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-----CCcccc
Confidence 99999964 3499999999999999999999999999999999999999999999999999975432 234557
Q ss_pred cCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCC
Q 014911 157 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPN 234 (416)
Q Consensus 157 gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d 234 (416)
+|+.|+|||++.+..+ +.++||||+||++|||+| |.+||...+...+...+..+ ..+.|+.+++.+.+||.+||+.|
T Consensus 162 ~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~d 240 (262)
T d1byga_ 162 LPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 240 (262)
T ss_dssp CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccC
Confidence 8999999999988777 599999999999999998 89999998888888888765 46778889999999999999999
Q ss_pred CCCcCCHHHHhcC
Q 014911 235 PNSRIAISKIMES 247 (416)
Q Consensus 235 P~~R~s~~eil~h 247 (416)
|.+|||+.+++++
T Consensus 241 P~~Rps~~~l~~~ 253 (262)
T d1byga_ 241 AAMRPSFLQLREQ 253 (262)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=393.95 Aligned_cols=243 Identities=21% Similarity=0.286 Sum_probs=213.5
Q ss_pred CcccCCceEEEEEEEcC-----CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014911 1 MLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 75 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 75 (416)
.||+|+||+||+|.+.. ++..||||+++... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 27 ~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 38999999999998753 45789999997543 234456789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeecccccccc
Q 014911 76 VKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 144 (416)
Q Consensus 76 ~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~ 144 (416)
+.+|+|.+++.. ..++...+..++.|++.||.|||+++|+||||||+|||++.++++||+|||+|....
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~ 184 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceecc
Confidence 999999998853 236889999999999999999999999999999999999999999999999998665
Q ss_pred ccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcC-CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHH
Q 014911 145 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 222 (416)
Q Consensus 145 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 222 (416)
............||+.|+|||.+.+..+. .++||||+||++|||+|| .+||.+.+....+..+.++. .+.|+.+++.
T Consensus 185 ~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 263 (308)
T d1p4oa_ 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM 263 (308)
T ss_dssp GGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHH
Confidence 54443344555789999999999888774 899999999999999997 68999999888888887765 4567889999
Q ss_pred HHHHHHHccCCCCCCcCCHHHHhc
Q 014911 223 ARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 223 ~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
+.+||.+||+.||++|||++++++
T Consensus 264 l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 264 LFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=391.28 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=207.7
Q ss_pred CcccCCceEEEEEEEc-----CCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 74 (416)
.||+|+||+||+|++. .+++.||||++..... ......+.+|+.+++.+ +|||||++++++.++...|+|||
T Consensus 30 ~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 4899999999999863 5677999999976542 24456788999999999 69999999999999999999999
Q ss_pred ccCCCchhhHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEe
Q 014911 75 LVKGGELFNKIAKG-------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 135 (416)
Q Consensus 75 ~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~ 135 (416)
||+||+|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+|++
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~ 187 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEEC
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCccccc
Confidence 99999999998642 48999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhc-CCCCCCCCcHHHHHHHHH-hC-C
Q 014911 136 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY-RG-D 212 (416)
Q Consensus 136 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~-~~-~ 212 (416)
|||++...............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+....+..+. .+ .
T Consensus 188 DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~ 266 (311)
T d1t46a_ 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (311)
T ss_dssp CCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred ccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999987654443334455689999999999987766 599999999999999998 777777766544444443 33 3
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 213 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 213 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
...|..+++++.+||.+||++||++|||+++|++
T Consensus 267 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4556778999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=387.52 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=202.4
Q ss_pred CcccCCceEEEEEEEcCCC---cEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEecc
Q 014911 1 MLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAMDLV 76 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 76 (416)
+||+|+||+||+|++..++ ..||||++++.. .....+.+.+|+++|++++||||+++++++.. +...|+|||||
T Consensus 34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred EEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4899999999999986643 369999986432 34556889999999999999999999999765 56899999999
Q ss_pred CCCchhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccccccccC--Ccc
Q 014911 77 KGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLL 152 (416)
Q Consensus 77 ~gg~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~ 152 (416)
++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 99999999875 45788899999999999999999999999999999999999999999999999865432221 122
Q ss_pred cccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCC-CcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHc
Q 014911 153 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRG-DFKCPPWFSSEARRLITKL 230 (416)
Q Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 230 (416)
....||+.|+|||++....+ +.++|||||||++|||+||..||.. .+.......+..+ ....|+.+++++.+||.+|
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHH
Confidence 33568999999999988776 5999999999999999996666644 4444555666655 3566788999999999999
Q ss_pred cCCCCCCcCCHHHHhcC
Q 014911 231 LDPNPNSRIAISKIMES 247 (416)
Q Consensus 231 L~~dP~~R~s~~eil~h 247 (416)
|+.||++|||+.|+++|
T Consensus 271 l~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=369.84 Aligned_cols=245 Identities=20% Similarity=0.265 Sum_probs=194.8
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|+| |+.+.+++.+.+..++||||+.|
T Consensus 14 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~- 87 (299)
T d1ckia_ 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP- 87 (299)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-
T ss_pred EEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-
Confidence 389999999999999999999999998765322 35778999999997665 55667777889999999999954
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc---CCCeEEeeccccccccccccC-----
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEHLKQD----- 149 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~---~~~~kl~DFGla~~~~~~~~~----- 149 (416)
+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+........
T Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 167 (299)
T d1ckia_ 88 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167 (299)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCC
T ss_pred chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceec
Confidence 66665543 67999999999999999999999999999999999999864 456999999999865543221
Q ss_pred CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHHHHHHHH---HhCC-----CCCCCCCCH
Q 014911 150 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---YRGD-----FKCPPWFSS 221 (416)
Q Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~~~~~~i---~~~~-----~~~p~~~s~ 221 (416)
....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||...........+ .... ...++.+|+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 246 (299)
T d1ckia_ 168 RENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246 (299)
T ss_dssp CBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCH
T ss_pred cccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCH
Confidence 22345689999999999998877 49999999999999999999999875543322221 1111 123457899
Q ss_pred HHHHHHHHccCCCCCCcCCHHH---HhcCccccc
Q 014911 222 EARRLITKLLDPNPNSRIAISK---IMESSWFKK 252 (416)
Q Consensus 222 ~~~~li~~~L~~dP~~R~s~~e---il~hp~f~~ 252 (416)
++.+||.+||+.||.+||++++ +|+|+|.+.
T Consensus 247 ~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 247 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 9999999999999999999874 567777543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=370.31 Aligned_cols=239 Identities=19% Similarity=0.309 Sum_probs=186.9
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEeccC
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----KIYFAMDLVK 77 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~~ 77 (416)
||+|+||+||+|++ +|+.||||+++.+. ........|+..+..++||||+++++++...+ .+|+||||++
T Consensus 11 iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 89999999999986 78999999986442 11122334555666789999999999987643 6899999999
Q ss_pred CCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCceeccCCCCcEEeccCCCeEEeecccccccccccc-
Q 014911 78 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHS--------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ- 148 (416)
Q Consensus 78 gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~--------~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~- 148 (416)
+|+|.+++.+..++++....++.|++.||.|||+ +||+||||||+||||+.++.+||+|||++........
T Consensus 85 ~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~ 164 (303)
T d1vjya_ 85 HGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164 (303)
T ss_dssp TCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcc
Confidence 9999999998889999999999999999999996 6999999999999999999999999999986543221
Q ss_pred -CCcccccccCCCCCchHHhhhcCC-----CCchhhHHHHHHHHHHHhcCCCCCCC---------------CcHHHHHHH
Q 014911 149 -DGLLHTTCGTPAYVAPEVISKKGY-----DGAKADIWSCGVILYVLLAGFLPFQD---------------DNIVSMYRK 207 (416)
Q Consensus 149 -~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwSlGvil~~lltG~~Pf~~---------------~~~~~~~~~ 207 (416)
.......+||+.|+|||++..... .+.++|||||||+||||+||.+||.. .........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T d1vjya_ 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244 (303)
T ss_dssp ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHH
Confidence 123345689999999999875432 24689999999999999999888732 122333333
Q ss_pred HHhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 208 IYRGDF--KCPPW-----FSSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 208 i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
...... .+|.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 333222 22222 1245889999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-47 Score=361.73 Aligned_cols=239 Identities=18% Similarity=0.262 Sum_probs=198.9
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg 79 (416)
.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|+| |||+.+++++......|+||||+ |+
T Consensus 12 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 389999999999999999999999998654322 356789999999975 89999999999999999999999 67
Q ss_pred chhhHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEecc-----CCCeEEeeccccccccccccC---
Q 014911 80 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-----DGNLKVTDFGLSAFSEHLKQD--- 149 (416)
Q Consensus 80 ~L~~~i~~--~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~-----~~~~kl~DFGla~~~~~~~~~--- 149 (416)
+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+........
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (293)
T d1csna_ 86 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165 (293)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBC
T ss_pred CHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccce
Confidence 99998865 57999999999999999999999999999999999999974 568999999999865432211
Q ss_pred --CcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCc---HHHHHHHHHhCC-----CCCCCCC
Q 014911 150 --GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGD-----FKCPPWF 219 (416)
Q Consensus 150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~-----~~~p~~~ 219 (416)
....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.. ....+..+.... ...++.+
T Consensus 166 ~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (293)
T d1csna_ 166 PYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244 (293)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTS
T ss_pred eecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCC
Confidence 23445689999999999988777 599999999999999999999997542 333333332211 1234568
Q ss_pred CHHHHHHHHHccCCCCCCcCCHHHHhc
Q 014911 220 SSEARRLITKLLDPNPNSRIAISKIME 246 (416)
Q Consensus 220 s~~~~~li~~~L~~dP~~R~s~~eil~ 246 (416)
|+++.+++..|+..+|++||+++.+.+
T Consensus 245 p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 245 PEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 899999999999999999999877643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-46 Score=364.63 Aligned_cols=244 Identities=25% Similarity=0.449 Sum_probs=190.6
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-----------CCCcceEEEEEE--eCC
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----------HKHIVELHEVMA--SKS 67 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~~~--~~~ 67 (416)
.||+|+||+||+|++..+|+.||||+++++. ...+.+.+|+.+++.++ ||||+++++++. ...
T Consensus 20 ~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 4899999999999999999999999997653 23467788999988875 578999998875 456
Q ss_pred EEEEEEeccCCCchhhHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEeccCCC------eEEee
Q 014911 68 KIYFAMDLVKGGELFNKIA----KGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGN------LKVTD 136 (416)
Q Consensus 68 ~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~~~~qll~aL~ylH~-~gi~HrDlkp~NIll~~~~~------~kl~D 136 (416)
..+++|+++..+....... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++. ++++|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~d 175 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 175 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECC
T ss_pred ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEee
Confidence 7788888776654433322 2579999999999999999999998 89999999999999987764 99999
Q ss_pred ccccccccccccCCcccccccCCCCCchHHhhhcCCCCchhhHHHHHHHHHHHhcCCCCCCCCcHH------HHHHHHHh
Q 014911 137 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV------SMYRKIYR 210 (416)
Q Consensus 137 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~~lltG~~Pf~~~~~~------~~~~~i~~ 210 (416)
||.|..... .....+||+.|+|||++...+|+ .++||||+||++++|++|+.||...+.. ........
T Consensus 176 fg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 176 LGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp CTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred ccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 999874332 23556899999999999988875 8999999999999999999999754321 01100000
Q ss_pred --C----------------------------------------CCCCCCCCCHHHHHHHHHccCCCCCCcCCHHHHhcCc
Q 014911 211 --G----------------------------------------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESS 248 (416)
Q Consensus 211 --~----------------------------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 248 (416)
+ ....++..++++.+||.+||++||.+|||++|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 0011122357899999999999999999999999999
Q ss_pred cccccC
Q 014911 249 WFKKSA 254 (416)
Q Consensus 249 ~f~~~~ 254 (416)
||++..
T Consensus 330 ~f~~~~ 335 (362)
T d1q8ya_ 330 WLKDTL 335 (362)
T ss_dssp GGTTCT
T ss_pred ccCCCC
Confidence 998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.6e-26 Score=201.06 Aligned_cols=131 Identities=18% Similarity=0.259 Sum_probs=104.2
Q ss_pred CcccCCceEEEEEEEcCCCcEEEEEEeecCccc---------------chhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014911 1 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI---------------KVGMMEQIKREISVMKMVKHKHIVELHEVMAS 65 (416)
Q Consensus 1 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 65 (416)
.||+|+||+||+|++ .+|+.||||+++..... .........+|...+..+.|++++..+++..
T Consensus 7 ~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~- 84 (191)
T d1zara2 7 LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG- 84 (191)
T ss_dssp EEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET-
T ss_pred EeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC-
Confidence 389999999999998 57899999987542211 0011234567899999999999999887642
Q ss_pred CCEEEEEEeccCCCchhhHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEeccCCCeEEeeccccccc
Q 014911 66 KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 143 (416)
Q Consensus 66 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~aL~ylH~~gi~HrDlkp~NIll~~~~~~kl~DFGla~~~ 143 (416)
.+++|||+.+..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+|...
T Consensus 85 ---~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~ 152 (191)
T d1zara2 85 ---NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152 (191)
T ss_dssp ---TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEET
T ss_pred ---CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccC
Confidence 279999998865533 4556678899999999999999999999999999999865 4899999998743
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.30 E-value=6.6e-12 Score=97.33 Aligned_cols=86 Identities=14% Similarity=0.193 Sum_probs=76.7
Q ss_pred cccccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEee-CCeEEEEEEecCCChhhHHHHh
Q 014911 308 RFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFC 385 (416)
Q Consensus 308 r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~-~~~~~ve~~~~~Gd~le~~~~~ 385 (416)
..+|..+|++|+..|+++++.+|+.++.++ +.++..+..++.++.+.|++||+++. +++++|+|+|..||+++|+++|
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~ 93 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 93 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHH
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHH
Confidence 346788999999999999999999998775 67999998888899999999999995 8999999999999999999999
Q ss_pred hhhhhhhcc
Q 014911 386 SNELRPALK 394 (416)
Q Consensus 386 ~~~l~~~l~ 394 (416)
. +|-..|+
T Consensus 94 ~-~il~~l~ 101 (102)
T d1ul7a_ 94 S-KIANELK 101 (102)
T ss_dssp H-HHHHHCC
T ss_pred H-HHHHhcc
Confidence 7 5665553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=1.6e-07 Score=84.59 Aligned_cols=129 Identities=15% Similarity=0.124 Sum_probs=88.3
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCchhh
Q 014911 5 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELFN 83 (416)
Q Consensus 5 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~ 83 (416)
|+.+.||+.. .+++.+.+|+....... ....+.+|...++.+. +--+.+++.+...++..|+||++++|.++.+
T Consensus 25 ~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 25 MSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence 3447899886 36667788887544322 2345678888888774 4346788888888999999999999987765
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------------
Q 014911 84 KIAKGRLREDVARVYFQQLISAVDFCHS---------------------------------------------------- 111 (416)
Q Consensus 84 ~i~~~~l~e~~~~~~~~qll~aL~ylH~---------------------------------------------------- 111 (416)
...... ....++.++...+..||+
T Consensus 100 ~~~~~~----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 100 EYEDEQ----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp HTTTCS----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred cccccc----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 443221 122233344444444442
Q ss_pred -------cCceeccCCCCcEEeccCCCeEEeecccccc
Q 014911 112 -------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 142 (416)
Q Consensus 112 -------~gi~HrDlkp~NIll~~~~~~kl~DFGla~~ 142 (416)
..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999998766667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.18 E-value=3.5e-06 Score=75.17 Aligned_cols=121 Identities=14% Similarity=0.134 Sum_probs=80.2
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEEEeccCCCchhhH
Q 014911 7 FAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASKSKIYFAMDLVKGGELFNK 84 (416)
Q Consensus 7 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 84 (416)
-+.||+... .++..+.+|...... ...+.+|...|+.|. .-.+.+++.+..+++..|+||++++|.++.+.
T Consensus 24 ~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 24 DAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp SCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred CCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 367998875 567778889764432 234677888888763 33467888888888899999999998655331
Q ss_pred HhcCCCCHHHHHHHHHHHHHH---------------------------------------------------HHHHHH--
Q 014911 85 IAKGRLREDVARVYFQQLISA---------------------------------------------------VDFCHS-- 111 (416)
Q Consensus 85 i~~~~l~e~~~~~~~~qll~a---------------------------------------------------L~ylH~-- 111 (416)
. .+... .+.++... +..+..
T Consensus 97 ~----~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 97 H----LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp C----CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred c----ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 1 11111 01112222 222222
Q ss_pred -----cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 -----RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 -----~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 237999999999999887667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=4.3e-06 Score=80.10 Aligned_cols=78 Identities=13% Similarity=0.162 Sum_probs=49.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeecC-cccc---hhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEEEEe
Q 014911 2 LGHGTFAKVYLARNLQTGKSMAMKVVGKD-KVIK---VGMMEQIKREISVMKMVK-H--KHIVELHEVMASKSKIYFAMD 74 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~lV~E 74 (416)
||.|....||++.+..+++.++||.-... +... .-..++...|..+|+.+. + ..+++++.+ ++...++|||
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE 111 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 111 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEe
Confidence 68899999999998778889999965321 1111 012345667888888763 2 346666654 4455678999
Q ss_pred ccCCCch
Q 014911 75 LVKGGEL 81 (416)
Q Consensus 75 ~~~gg~L 81 (416)
++.+..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred ccCCccc
Confidence 9987544
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.85 E-value=4.2e-05 Score=61.24 Aligned_cols=71 Identities=7% Similarity=0.190 Sum_probs=58.9
Q ss_pred cccCChhhhHHHHHHHHhhcccEEEeec-CeEEEEeeecCCcceeEEEEEEEEeeCCeEEEEEEecCCChhh
Q 014911 310 ATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLE 380 (416)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~v~~~~~~~~~ve~~~~~Gd~le 380 (416)
.++..|.+|+..+..+.+.+|+.|++.+ +.|++..........+.|.+++|++.+..+||||+...|+-.|
T Consensus 6 rS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 6 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 4667889999999999999999999877 6799988444444578899999999999999999999998655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.12 E-value=0.001 Score=62.88 Aligned_cols=71 Identities=10% Similarity=0.125 Sum_probs=47.8
Q ss_pred cccCCceEEEEEEEcC-------CCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014911 2 LGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 73 (416)
Q Consensus 2 LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 73 (416)
|+.|-.-.+|++.... .++.|.+++..... . .-...+|..+++.+. +.-..++++++.+ .+|+
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 5667888999998643 34567777765221 2 235668999999885 4334577877643 6889
Q ss_pred eccCCCch
Q 014911 74 DLVKGGEL 81 (416)
Q Consensus 74 E~~~gg~L 81 (416)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.06 E-value=0.0011 Score=51.77 Aligned_cols=63 Identities=11% Similarity=0.204 Sum_probs=50.5
Q ss_pred cccCChhhhHHHHHHHHhhcccEEEeec----------CeEEEEeee-----cCCcceeEEEEEEEEeeCCeEEEEEE
Q 014911 310 ATTRPASSVISRFEEVAKAVKFNVKTSE----------SRVRLQGQE-----SGRKGKLAINADIFAVTPSLLVVEVK 372 (416)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~~l~~~~~v~~~~~~~~~ve~~ 372 (416)
.|+..|-+++..+..+.+++|+.|++-+ +.|++.... .+....+.|.+++|++.++.+||||+
T Consensus 8 RSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK 85 (127)
T d2qrda1 8 RCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVK 85 (127)
T ss_dssp EEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEE
T ss_pred ccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEc
Confidence 4678899999999999999999998654 457777422 12233578899999999999999998
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.00085 Score=61.76 Aligned_cols=67 Identities=12% Similarity=0.202 Sum_probs=44.7
Q ss_pred eEEEEEEEcCCCcEEEEEEeecCcccchhhHHHHHHHHHHHHhCCCCCc--ceEE-----EEEEeCCEEEEEEeccCCC
Q 014911 8 AKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI--VELH-----EVMASKSKIYFAMDLVKGG 79 (416)
Q Consensus 8 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lV~E~~~gg 79 (416)
-.||++.. .+|+.|++|+.+...- ..+++..|...+..|...+| +... ..+......+.+++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999975 6788999999865432 23667788888877742211 1111 1234577889999999873
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=96.74 E-value=0.0022 Score=52.61 Aligned_cols=70 Identities=10% Similarity=0.073 Sum_probs=50.2
Q ss_pred hhhcccccCChhhhHHHHHHHHhhcccEEEeec----CeEEEEeeecC---------CcceeEEEEEEEEeeCCeEEEEE
Q 014911 305 EELRFATTRPASSVISRFEEVAKAVKFNVKTSE----SRVRLQGQESG---------RKGKLAINADIFAVTPSLLVVEV 371 (416)
Q Consensus 305 ~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~l~~~~~v~~~~~~~~~ve~ 371 (416)
...-..|+..|-+++..+..+.+++|+.|++.+ +.|++....+. ....+.|.+++|++.++.+||||
T Consensus 46 WhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDF 125 (171)
T d2qlva1 46 WHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDF 125 (171)
T ss_dssp CEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEE
T ss_pred eeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEE
Confidence 334456788999999999999999999998654 55777752111 11247889999999999999999
Q ss_pred Eec
Q 014911 372 KKD 374 (416)
Q Consensus 372 ~~~ 374 (416)
+-+
T Consensus 126 K~~ 128 (171)
T d2qlva1 126 KFD 128 (171)
T ss_dssp EEE
T ss_pred ecC
Confidence 853
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.41 E-value=0.0028 Score=57.59 Aligned_cols=30 Identities=30% Similarity=0.412 Sum_probs=27.1
Q ss_pred cCceeccCCCCcEEeccCCCeEEeeccccc
Q 014911 112 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 141 (416)
Q Consensus 112 ~gi~HrDlkp~NIll~~~~~~kl~DFGla~ 141 (416)
.|++|+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999875
|